MetLife (MET) 10-K 27 Feb 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
In Billions, except Share data, unless otherwise specified	Dec. 31, 2013	Feb. 19, 2014	Jun. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'METLIFE INC	'	'
Entity Central Index Key	'0001099219	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Amendment Flag	'false	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Entity Public Float	'	'	$50.20
Entity Common Stock, Shares Outstanding	'	1,123,537,362	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Investments:	'	'
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	$350,187	$374,266
Equity securities available-for-sale, at estimated fair value (cost: $3,012 and $2,838, respectively)	3,402	2,891
Fair value option and trading securities, at estimated fair value (includes $662 and $659, respectively, of actively traded securities; and $92 and $112, respectively, relating to variable interest entities)	17,423	16,348
Mortgage loans:	'	'
Held-for-investment, principally at amortized cost (net of valuation allowances of $322 and $347, respectively; includes $1,621 and $2,715, respectively, at estimated fair value, relating to variable interest entities; includes $338 and $0, respectively, under the fair value option)	57,703	56,592
Held-for-sale, principally at estimated fair value (includes $0 and $49, respectively, under the fair value option)	3	414
Mortgage loans, net	57,706	57,006
Policy loans (includes $2 and $0, respectively, relating to variable interest entities)	11,764	11,884
Real estate and real estate joint ventures (includes $1,141 and $10, respectively, relating to variable interest entities; includes $186 and $1, respectively, of real estate held-for-sale)	10,712	9,918
Other limited partnership interests (includes $53 and $274, respectively, relating to variable interest entities)	7,401	6,688
Short-term investments, principally at estimated fair value (includes $8 and $0, respectively, relating to variable interest entities)	13,955	16,906
Other invested assets, principally at estimated fair value (includes $78 and $81, respectively, relating to variable interest entities)	16,229	21,145
Total investments	488,779	517,052
Cash and cash equivalents, principally at estimated fair value (includes $70 and $99, respectively, relating to variable interest entities)	7,585	15,738
Accrued investment income (includes $26 and $13, respectively, relating to variable interest entities)	4,255	4,374
Premiums, reinsurance and other receivables (includes $22 and $5, respectively, relating to variable interest entities)	21,859	21,634
Deferred policy acquisition costs and value of business acquired (includes $255 and $0, respectively, relating to variable interest entities)	26,706	24,761
Goodwill	10,542	9,953
Other assets (includes $152 and $5, respectively, relating to variable interest entities)	8,369	7,876
Separate account assets (includes $1,033 and $0, respectively, relating to variable interest entities)	317,201	235,393
Total assets	885,296	836,781
Liabilities	'	'
Future policy benefits (includes $516 and $0, respectively, relating to variable interest entities)	187,942	192,351
Policyholder account balances (includes $56 and $0, respectively, relating to variable interest entities)	212,885	225,821
Other policy-related balances (includes $123 and $0, respectively, relating to variable interest entities)	15,214	15,463
Policyholder dividends payable	675	728
Policyholder dividend obligation	1,771	3,828
Payables for collateral under securities loaned and other transactions	30,411	33,687
Bank deposits	0	6,416
Short-term debt	175	100
Long-term debt (includes $1,868 and $2,527, respectively, at estimated fair value, relating to variable interest entities)	18,653	19,062
Collateral financing arrangements	4,196	4,196
Junior subordinated debt securities	3,193	3,192
Current income tax payable	186	401
Deferred income tax liability	6,643	8,693
Other liabilities (includes $88 and $40, respectively, relating to variable interest entities)	23,168	22,492
Separate account liabilities (includes $1,033 and $0, respectively, relating to variable interest entities)	317,201	235,393
Total liabilities	822,313	771,823
Contingencies, Commitments and Guarantees (Note 21)	'	'
Redeemable noncontrolling interests	887	121
MetLife, Inc.'s stockholders' equity:	'	'
Preferred stock, par value $0.01 per share; 200,000,000 shares authorized: 84,000,000 shares issued and outstanding; $2,100 aggregate liquidation preference	1	1
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,125,224,024 and 1,094,880,623 shares issued at December 31, 2013 and 2012, respectively; 1,122,030,137 and 1,091,686,736 shares outstanding at December 31, 2013 and 2012, respectively	11	11
Additional paid-in capital	29,277	28,011
Retained earnings	27,332	25,205
Treasury stock, at cost; 3,193,887 shares at December 31, 2013 and 2012	-172	-172
Accumulated other comprehensive income (loss)	5,104	11,397
Total MetLife, Inc.'s stockholders' equity	61,553	64,453
Noncontrolling interests	543	384
Total equity	62,096	64,837
Total liabilities and equity	$885,296	$836,781

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, except Share data, unless otherwise specified
Investments:	'	'
Amortized cost of fixed maturity securities available-for-sale	$333,599	$340,870
Fixed maturity securities relating to variable interest entities	350,187	374,266
Cost of equity securities available-for-sale	3,012	2,838
Actively traded securities	662	659
Fair value option and trading securities relating to variable interest entities	17,423	16,348
Mortgage loans:	'	'
Mortgage loans valuation allowances	322	347
Mortgage loans, at estimated fair value	57,703	56,592
Mortgage loans held-for-sale under fair value option	3	414
Policy loans	11,764	11,884
Real estate and real estate joint ventures relating to variable interest entities	10,712	9,918
Real estate held-for-sale	186	1
Other limited partnership interests relating to variable interest entities	7,401	6,688
Short-term Investments	13,955	16,906
Other invested assets relating to variable interest entities	16,229	21,145
Cash and cash equivalents relating to variable interest entities	7,585	15,738
Accrued investment income relating to variable interest entities	4,255	4,374
Premiums, reinsurance and other receivables relating to variable interest entities	21,859	21,634
Deferred policy acquisition costs and value of business acquired relating to variable interest entities	26,706	24,761
Other assets relating to variable interest entities	8,369	7,876
Separate account assets	317,201	235,393
Liabilities	'	'
Future policy benefits relating to variable interest entities	187,942	192,351
Policyholder account balances	212,885	225,821
Other policy-related balances relating to variable interest entities	15,214	15,463
Long-term debt at estimated fair value, relating to variable interest entities	18,653	19,062
Other liabilities relating to variable interest entities	23,168	22,492
Separate account liabilities	317,201	235,393
MetLife, Inc.'s stockholders' equity:	'	'
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued	84,000,000	84,000,000
Preferred stock, shares outstanding	84,000,000	84,000,000
Preferred stock, aggregate liquidation preference	$2,100	$2,100
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	1,125,224,024	1,094,880,623
Common stock, shares outstanding	1,122,030,137	1,091,686,736
Treasury stock, shares	3,193,887	3,193,887
Mortgage Loans Held-for-sale [Member]	'	'
Mortgage loans:	'	'
Mortgage loans held-for-sale under fair value option	0	49
Residential Mortgage Loans - FVO [Member]	'	'
Mortgage loans:	'	'
Mortgage loans, at estimated fair value	338	0
Variable interest entities [Member]	'	'
Investments:	'	'
Fixed maturity securities relating to variable interest entities	4,005	3,378
Fair value option and trading securities relating to variable interest entities	92	112
Mortgage loans:	'	'
Mortgage loans, at estimated fair value	1,621	2,715
Policy loans	2	0
Real estate and real estate joint ventures relating to variable interest entities	1,141	10
Other limited partnership interests relating to variable interest entities	53	274
Short-term Investments	8	0
Other invested assets relating to variable interest entities	78	81
Cash and cash equivalents relating to variable interest entities	70	99
Accrued investment income relating to variable interest entities	26	13
Premiums, reinsurance and other receivables relating to variable interest entities	22	5
Deferred policy acquisition costs and value of business acquired relating to variable interest entities	255	0
Other assets relating to variable interest entities	152	5
Separate account assets	1,033	0
Liabilities	'	'
Future policy benefits relating to variable interest entities	516	0
Policyholder account balances	56	0
Other policy-related balances relating to variable interest entities	123	0
Long-term debt at estimated fair value, relating to variable interest entities	1,868	2,527
Other liabilities relating to variable interest entities	88	40
Separate account liabilities	$1,033	$0

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenues	'	'	'
Premiums	$37,674	$37,975	$36,361
Universal life and investment-type product policy fees	9,451	8,556	7,806
Net investment income	22,232	21,984	19,585
Other revenues	1,920	1,906	2,532
Net investment gains (losses):	'	'	'
Other-than-temporary impairments on fixed maturity securities	-106	-346	-924
Other-than-temporary impairments on fixed maturity securities transferred to other comprehensive income (loss)	-60	29	-31
Other net investment gains (losses)	327	-35	88
Total net investment gains (losses)	161	-352	-867
Net derivative gains (losses)	-3,239	-1,919	4,824
Total revenues	68,199	68,150	70,241
Expenses	'	'	'
Policyholder benefits and claims	38,107	37,987	35,471
Interest credited to policyholder account balances	8,179	7,729	5,603
Policyholder dividends	1,259	1,369	1,446
Goodwill impairment	0	1,868	0
Other expenses	16,602	17,755	18,537
Total expenses	64,147	66,708	61,057
Income (loss) from continuing operations before provision for income tax	4,052	1,442	9,184
Provision for income tax expense (benefit)	661	128	2,793
Income (loss) from continuing operations, net of income tax	3,391	1,314	6,391
Income (loss) from discontinued operations, net of income tax	2	48	24
Net income (loss)	3,393	1,362	6,415
Less: Net income (loss) attributable to noncontrolling interests	25	38	-8
Net income (loss) attributable to MetLife, Inc.	3,368	1,324	6,423
Less: Preferred stock dividends	122	122	122
Preferred stock redemption premium	0	0	146
Net income (loss) available to MetLife, Inc.'s common shareholders	$3,246	$1,202	$6,155
Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.'s common shareholders per common share:	'	'	'
Basic	$2.94	$1.08	$5.79
Diluted	$2.91	$1.08	$5.74
Net income (loss) available to MetLife, Inc.'s common shareholders per common share:	'	'	'
Basic	$2.94	$1.12	$5.81
Diluted	$2.91	$1.12	$5.76
Cash dividends declared per common share	$1.01	$0.74	$0.74

Consolidated_Statements_Of_Com

Consolidated Statements Of Comprehensive Income (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Statement of Comprehensive Income [Abstract]	'		'		'
Net income (loss) attributable to MetLife, Inc.	$3,368		$1,324		$6,423
Net income (loss) attributable to noncontrolling interests	25	[1]	29	[1]	5	[1]
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest	3,393	[1]	1,353	[1]	6,428	[1]
Other comprehensive income (loss):	'		'		'
Unrealized investment gains (losses), net of related offsets	-8,086		9,394		6,867
Unrealized gains (losses) on derivatives	-899		-239		1,573
Foreign currency translation adjustments	-975		-139		9
Defined benefit plans adjustment	1,292		-842		-760
Other comprehensive income (loss), before income tax	-8,668		8,174		7,689
Income tax (expense) benefit related to items of other comprehensive income (loss)	2,329		-2,851		-2,789
Other comprehensive income (loss), net of income tax	-6,339		5,323		4,900
Comprehensive income (loss)	-2,946		6,676		11,328
Less: Comprehensive income (loss) attributable to noncontrolling interest, net of income tax	-21		38		-33
Comprehensive income (loss) attributable to MetLife, Inc.	($2,925)		$6,638		$11,361
[1]	Net income (loss) attributable to noncontrolling interests and net income (loss) exclude gains (losses) of redeemable noncontrolling interests of less than $1 million, $9 millionB and ($13)B millionB for the years ended DecemberB 31, 2013, 2012 and 2011, respectively.

Recovered_Sheet1

Consolidated Statements of Comprehensive Income (Parenthetical) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
			Maximum [Member]
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	$9	($13)	$1

Consolidated_Statements_of_Equ

Consolidated Statements of Equity (USD $)

Total

Convertible Preferred Stock

Noncontrolling Interests

Total MetLife, Inc.'s Stockholders' Equity

Preferred Stock

Common Stock

Additional Paid-in Capital

Treasury Stock at Cost

Retained Earnings

Accumulated Other Comprehensive Income (Loss) Net Unrealized Investment Gains (Losses)

Accumulated Other Comprehensive Income (Loss) Other-Than-Temporary Impairments

Accumulated Other Comprehensive Income (Loss) Foreign Currency Translation Adjustments

Accumulated Other Comprehensive Income (Loss) Defined Benefit Plans Adjustment

In Millions

Beginning Balance at Dec. 31, 2010

$47,218

$0

$365

$46,853

$1

$10

$26,423

($172)

$19,446

$3,488

($366)

($528)

($1,449)

Redemption of convertible preferred stock

-2,805

'

'

-2,805

'

'

-2,805

'

'

'

'

'

'

Preferred stock redemption premium

-146

-146

'

-146

'

'

'

'

-146

'

'

'

'

Common stock issuance

2,950

'

'

2,950

'

1

2,949

'

'

'

'

'

'

Stock-based compensation

215

'

'

215

'

'

215

'

'

'

'

'

'

Dividends on preferred stock

-122

'

'

-122

'

'

'

'

-122

'

'

'

'

Dividends on common stock

-787

'

'

-787

'

'

'

'

-787

'

'

'

'

Change in equity of noncontrolling interests

38

'

38

0

'

'

'

'

'

'

'

'

'

Net income (loss)

6,428

[1]

'

5

[2]

6,423

'

'

'

'

6,423

'

'

'

'

Other comprehensive income (loss), net of income tax

4,900

'

-38

4,938

'

'

'

'

'

5,627

-75

-120

-494

Ending Balance at Dec. 31, 2011

57,889

0

370

57,519

1

11

26,782

-172

24,814

9,115

-441

-648

-1,943

Redemption of convertible preferred stock

0

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock redemption premium

0

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issuance

1,000

'

'

1,000

'

'

1,000

'

'

'

'

'

'

Stock-based compensation

229

'

'

229

'

'

229

'

'

'

'

'

'

Dividends on preferred stock

-122

'

'

-122

'

'

'

'

-122

'

'

'

'

Dividends on common stock

-811

'

'

-811

'

'

'

'

-811

'

'

'

'

Change in equity of noncontrolling interests

-24

'

-24

0

'

'

'

'

'

'

'

'

'

Net income (loss)

1,353

[1]

'

29

[2]

1,324

'

'

'

'

1,324

'

'

'

'

Other comprehensive income (loss), net of income tax

5,323

'

9

5,314

'

'

'

'

'

5,527

218

115

-546

Ending Balance at Dec. 31, 2012

64,837

'

384

64,453

1

11

28,011

-172

25,205

14,642

-223

-533

-2,489

Redemption of convertible preferred stock

0

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock redemption premium

0

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issuance

1,000

'

'

1,000

'

'

1,000

'

'

'

'

'

'

Stock-based compensation

305

'

'

305

'

'

305

'

'

'

'

'

'

Dividends on preferred stock

-122

'

'

-122

'

'

'

'

-122

'

'

'

'

Dividends on common stock

-1,119

'

'

-1,119

'

'

'

'

-1,119

'

'

'

'

Change in equity of noncontrolling interests

141

'

180

-39

'

'

-39

'

'

'

'

'

'

Net income (loss)

3,393

[1]

'

25

[2]

3,368

'

'

'

'

3,368

'

'

'

'

Other comprehensive income (loss), net of income tax

-6,339

'

-46

-6,293

'

'

'

'

'

-6,089

84

-1,126

838

Ending Balance at Dec. 31, 2013

$62,096

'

$543

$61,553

$1

$11

$29,277

($172)

$27,332

$8,553

($139)

($1,659)

($1,651)

[1]

Net income (loss) attributable to noncontrolling interests and net income (loss) exclude gains (losses) of redeemable noncontrolling interests of less than $1 million, $9 millionB and ($13)B millionB for the years ended DecemberB 31, 2013, 2012 and 2011, respectively.

[2]

At December 31, 2013, 2012 and 2011, Net income (loss) attributable to noncontrolling interests excludes gains (losses) of redeemable noncontrolling interests of less than of $1 million, $9 million and ($13)B million, respectively.

Consolidated_Statements_of_Equ1

Consolidated Statements of Equity (Parenthetical) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
			Maximum [Member]
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	$9	($13)	$1

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities	'	'	'
Net income (loss)	$3,393	$1,362	$6,415
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'	'
Depreciation and amortization expenses	714	596	679
Amortization of premiums and accretion of discounts associated with investments, net	-167	-426	-477
(Gains) losses on investments and derivatives and from sales of businesses, net	4,011	3,197	-3,181
(Income) loss from equity method investments, net of dividends or distributions	99	108	315
Interest credited to policyholder account balances	8,179	7,729	5,603
Interest credited to bank deposits	2	78	95
Universal life and investment-type product policy fees	-9,451	-8,556	-7,806
Goodwill impairment	0	1,868	0
Change in fair value option and trading securities	-1,433	1,900	648
Change in residential mortgage loans held-for-sale, net	373	3,370	-4,530
Change in mortgage servicing rights	0	153	-60
Change in accrued investment income	293	219	525
Change in premiums, reinsurance and other receivables	-582	-109	58
Change in deferred policy acquisition costs and value of business acquired, net	-920	-1,139	-591
Change in income tax	871	-883	1,742
Change in other assets	1,767	2,951	2,360
Change in insurance-related liabilities and policy-related balances	6,897	5,918	7,081
Change in other liabilities	1,008	-1,699	1,136
Other, net	1,077	523	261
Net cash provided by (used in) operating activities	16,131	17,160	10,273
Cash flows from investing activities	'	'	'
Sales, maturities and repayments of fixed maturity securities	117,523	103,823	104,302
Sales, maturities and repayments of equity securities	725	1,140	2,006
Sales, maturities and repayments of mortgage loans	12,881	14,673	13,486
Sales, maturities and repayments of real estate and real estate joint ventures	356	1,018	1,296
Sales, maturities and repayments of other limited partnership interests	807	974	1,121
Purchases of fixed maturity securities	-117,826	-115,793	-116,939
Purchases of equity securities	-943	-627	-1,481
Purchases of mortgage loans	-14,677	-11,442	-14,694
Purchases of real estate and real estate joint ventures	-1,880	-1,942	-1,534
Purchases of other limited partnership interests	-1,356	-1,323	-1,147
Cash received in connection with freestanding derivatives	1,567	1,933	2,815
Cash paid in connection with freestanding derivatives	-6,710	-3,258	-3,478
Net change in securitized reverse residential mortgage loans	0	-1,198	0
Sales of businesses, net of cash and cash equivalents disposed of $14, $29 and $54, respectively	393	576	126
Sale of bank deposits	-6,395	0	0
Sale of interest in joint venture	0	0	265
Disposal of subsidiary	0	0	4
Purchases of businesses, net of cash and cash equivalents acquired of $20, $33 and $70, respectively	-1,840	-16	-163
Net change in policy loans	-112	-111	-66
Net change in short-term investments	2,955	593	-7,949
Net change in other invested assets	-547	-791	-19
Other, net	-86	-158	-169
Net cash provided by (used in) investing activities	-15,165	-11,929	-22,218
Cash flows from financing activities	'	'	'
Policyholder account balances: Deposits	79,193	91,284	91,946
Policyholder account balances: Withdrawals	-84,874	-86,994	-87,625
Net change in payables for collateral under securities loaned and other transactions	-3,276	-29	6,444
Net change in bank deposits	8	-4,169	96
Net change in short-term debt	75	-586	380
Long-term debt issued	1,372	750	1,346
Long-term debt repaid	-1,746	-1,702	-2,042
Collateral financing arrangements repaid	0	-349	-502
Cash received (paid) in connection with collateral financing arrangements	0	-44	37
Net change in liability for securitized reverse residential mortgage loans	0	1,198	0
Cash received in connection with redeemable noncontrolling interests	774	0	0
Common stock issued, net of issuance costs	1,000	1,000	2,950
Redemption of convertible preferred stock	0	0	-2,805
Preferred stock redemption premium	0	0	-146
Dividends on preferred stock	-122	-122	-122
Dividends on common stock	-1,119	-811	-787
Other, net	-192	609	212
Net cash provided by (used in) financing activities	-8,907	35	9,382
Effect of change in foreign currency exchange rates on cash and cash equivalents balances	-212	11	-22
Change in cash and cash equivalents	-8,153	5,277	-2,585
Cash and cash equivalents, beginning of year	15,738	10,461	13,046
Cash and cash equivalents, end of year	7,585	15,738	10,461
Cash and cash equivalents, subsidiaries held-for-sale, beginning of year	0	0	89
Cash and cash equivalents, subsidiaries held-for-sale, end of year	0	0	0
Cash and cash equivalents, from continuing operations, beginning of year	15,738	10,461	12,957
Cash and cash equivalents, from continuing operations, end of year	7,585	15,738	10,461
Supplemental disclosures of cash flow information:	'	'	'
Net cash paid for Interest	1,270	1,335	1,565
Net cash paid for income tax	677	554	676
Business acquisitions:	'	'	'
Assets acquired	2,988	595	327
Liabilities assumed	-972	-579	-94
Noncontrolling interests assumed	-176	0	0
Cash paid, excluding transaction costs of $17, $0 and $0, respectively	1,840	16	233
Real estate and real estate joint ventures acquired in satisfaction of debt	59	553	292
Collateral financing arrangements repaid	0	102	148
Redemption of advances agreements in long-term debt	0	3,806	0
Issuance of funding agreements in policyholder account balances	$0	$3,806	$0

Consolidated_Statements_of_Cas1

Consolidated Statements of Cash Flows (Parenthetical) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from investing activities	'	'	'
Cash disposed from sale of businesses	$14	$29	$54
Cash received from purchase of businesses	20	33	70
Business acquisitions:	'	'	'
Cash paid excluding transaction costs	$17	$0	$0

Business_Basis_of_Presentation

Business, Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Business, Basis of Presentation and Summary of Significant Accounting Policies	'
	1. Business, Basis of Presentation and Summary of Significant Accounting Policies
	Business
	“MetLife” or the “Company” refers to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates. MetLife is a leading global provider of insurance, annuities and employee benefit programs throughout the United States, Japan, Latin America, Asia, Europe and the Middle East. MetLife offers life insurance, annuities, property & casualty insurance, and other financial services to individuals, as well as group insurance and retirement & savings products and services to corporations and other institutions.
	MetLife is organized into six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; and Latin America (collectively, the “Americas”); Asia; and Europe, the Middle East and Africa (“EMEA”).
	Basis of Presentation
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from estimates.
	Consolidation
	The accompanying consolidated financial statements include the accounts of MetLife, Inc. and its subsidiaries, as well as partnerships and joint ventures in which the Company has control, and variable interest entities (“VIEs”) for which the Company is the primary beneficiary. Intercompany accounts and transactions have been eliminated.
	Certain international subsidiaries have a fiscal year-end of November 30. Accordingly, the Company’s consolidated financial statements reflect the assets and liabilities of such subsidiaries as of November 30, 2013 and 2012 and the operating results of such subsidiaries for the years ended November 30, 2013, 2012 and 2011.
	Discontinued Operations
	The results of operations of a component of the Company that has either been disposed of or is classified as held-for-sale are reported in discontinued operations if certain criteria are met. In order to qualify for a discontinued operation, the operations and cash flows of the component have been or will be eliminated from the ongoing operations of the Company, and the Company will not have any significant continuing involvement in the operations of the component after the disposal transaction.
	Separate Accounts
	Separate accounts are established in conformity with insurance laws and are generally not chargeable with liabilities that arise from any other business of the Company. Separate account assets are subject to general account claims only to the extent the value of such assets exceeds the separate account liabilities. The Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if:
	•	such separate accounts are legally recognized;
	•	assets supporting the contract liabilities are legally insulated from the Company’s general account liabilities;
	•	investments are directed by the contractholder; and
	•	all investment performance, net of contract fees and assessments, is passed through to the contractholder.
	The Company reports separate account assets at their fair value which is based on the estimated fair values of the underlying assets comprising the individual separate account portfolios. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line in the statements of operations. Separate accounts credited with a contractual investment return are combined on a line-by-line basis with the Company’s general account assets, liabilities, revenues and expenses and the accounting for these investments is consistent with the methodologies described herein for similar financial instruments held within the general account. Unit-linked separate account investments that are directed by contractholders but do not meet one or more of the other above criteria are included in fair value option (“FVO”) and trading securities.
	The Company’s revenues reflect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Such fees are included in universal life and investment-type product policy fees in the statements of operations.
	Reclassifications
	Certain amounts in the prior years’ consolidated financial statements and related footnotes thereto have been reclassified to conform with the current year presentation as discussed throughout the Notes to the Consolidated Financial Statements.
	Summary of Significant Accounting Policies
	The following are the Company’s significant accounting policies with references to notes providing additional information on such policies and critical accounting estimates relating to such policies.
	Accounting Policy	Note
	Insurance	4
	Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles	5
	Reinsurance	6
	Investments	8
	Derivatives	9
	Fair Value	10
	Goodwill	11
	Employee Benefit Plans	18
	Income Tax	19
	Litigation Contingencies	21
	Insurance
	Future Policy Benefit Liabilities and Policyholder Account Balances
	The Company establishes liabilities for amounts payable under insurance policies. Generally, amounts are payable over an extended period of time and related liabilities are calculated as the present value of future expected benefits to be paid reduced by the present value of future expected premiums. Such liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy benefits are mortality, morbidity, policy lapse, renewal, retirement, disability incidence, disability terminations, investment returns, inflation, expenses and other contingent events as appropriate to the respective product type and geographical area. These assumptions are established at the time the policy is issued and are intended to estimate the experience for the period the policy benefits are payable. Utilizing these assumptions, liabilities are established on a block of business basis. For long duration insurance contracts, assumptions such as mortality, morbidity and interest rates are “locked in” upon the issuance of new business. However, significant adverse changes in experience on such contracts may require the establishment of premium deficiency reserves. Such reserves are determined based on the then current assumptions and do not include a provision for adverse deviation.
	Premium deficiency reserves may also be established for short duration contracts to provide for expected future losses. These reserves are based on actuarial estimates of the amount of loss inherent in that period, including losses incurred for which claims have not been reported. The provisions for unreported claims are calculated using studies that measure the historical length of time between the incurred date of a claim and its eventual reporting to the Company. Anticipated investment income is considered in the calculation of premium deficiency losses for short duration contracts.
	Liabilities for universal and variable life secondary guarantees and paid-up guarantees are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the accumulation period based on total expected assessments. The assumptions used in estimating the secondary and paid-up guarantee liabilities are consistent with those used for amortizing deferred policy acquisition costs (“DAC”), and are thus subject to the same variability and risk as further discussed herein. The assumptions of investment performance and volatility for variable products are consistent with historical experience of appropriate underlying equity indices, such as the Standard & Poor’s Ratings Services (“S&P”) 500 Index. The benefits used in calculating the liabilities are based on the average benefits payable over a range of scenarios.
	The Company regularly reviews its estimates of liabilities for future policy benefits and compares them with its actual experience. Differences result in changes to the liability balances with related charges or credits to benefit expenses in the period in which the changes occur.
	Policyholder account balances (“PABs”) relate to contract or contract features where the Company has no significant insurance risk.
	The Company issues directly and assumes through reinsurance certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (i.e., the benefit base) less withdrawals. These guarantees are accounted for as insurance liabilities or as embedded derivatives depending on how and when the benefit is paid. Specifically, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring (i) the occurrence of specific insurable event, or (ii) the policyholder to annuitize. Alternatively, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either (i) the occurrence of a specific insurable event, or (ii) annuitization. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models.
	Guarantees accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits (“GMDBs”), the portion of guaranteed minimum income benefits (“GMIBs”) that require annuitization, and the life-contingent portion of guaranteed minimum withdrawal benefits (“GMWBs”).
	Guarantees accounted for as embedded derivatives in PABs include the non life-contingent portion of GMWBs, guaranteed minimum accumulation benefits (“GMABs”) and the portion of GMIBs that do not require annuitization. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent “excess” fees and are reported in universal life and investment-type product policy fees.
	Other Policy-Related Balances
	Other policy-related balances include policy and contract claims, unearned revenue liabilities, premiums received in advance, policyholder dividends due and unpaid, policyholder dividends left on deposit and negative value of business acquired.
	The liability for policy and contract claims generally relates to incurred but not reported death, disability, long-term care (“LTC”) and dental claims, as well as claims which have been reported but not yet settled. The liability for these claims is based on the Company’s estimated ultimate cost of settling all claims. The Company derives estimates for the development of incurred but not reported claims principally from analyses of historical patterns of claims by business line. The methods used to determine these estimates are continually reviewed. Adjustments resulting from this continuous review process and differences between estimates and payments for claims are recognized in policyholder benefits and claims expense in the period in which the estimates are changed or payments are made.
	The unearned revenue liability relates to universal life-type and investment-type products and represents policy charges for services to be provided in future periods. The charges are deferred as unearned revenue and amortized using the product’s estimated gross profits and margins, similar to DAC as discussed further herein. Such amortization is recorded in universal life and investment-type product policy fees.
	The Company accounts for the prepayment of premiums on its individual life, group life and health contracts as premium received in advance and applies the cash received to premiums when due.
	See “— Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles” for a discussion of negative value of business acquired.
	Recognition of Insurance Revenues and Deposits
	Premiums related to traditional life, annuity policies with life contingencies, long-duration accident and health, and credit insurance policies are recognized as revenues when due from policyholders. Policyholder benefits and expenses are provided to recognize profits over the estimated lives of the insurance policies. When premiums are due over a significantly shorter period than the period over which benefits are provided, any excess profit is deferred and recognized into earnings in a constant relationship to insurance in-force or, for annuities, the amount of expected future policy benefit payments.
	Premiums related to short-duration non-medical health and disability, accident and health, and certain credit insurance contracts are recognized on a pro rata basis over the applicable contract term.
	Deposits related to universal life-type and investment-type products are credited to PABs. Revenues from such contracts consist of fees for mortality, policy administration and surrender charges and are recorded in universal life and investment-type product policy fees in the period in which services are provided. Amounts that are charged to earnings include interest credited and benefit claims incurred in excess of related PABs.
	Premiums related to property and casualty contracts are recognized as revenue on a pro rata basis over the applicable contract term. Unearned premiums, representing the portion of premium written related to the unexpired coverage, are also included in future policy benefits.
	Premiums, policy fees, policyholder benefits and expenses are presented net of reinsurance.
	Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles
	The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. Such costs include:
	•	incremental direct costs of contract acquisition, such as commissions;
	•	the portion of an employee’s total compensation and benefits related to time spent selling, underwriting or processing the issuance of new and renewal insurance business only with respect to actual policies acquired or renewed;
	•	other essential direct costs that would not have been incurred had a policy not been acquired or renewed; and
	•	in limited circumstances, the costs of direct-response advertising, the primary purpose of which is to elicit sales to customers who could be shown to have responded specifically to the advertising and that results in probable future benefits.
	All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred.
Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity, and investment-type contracts in-force at the acquisition date. The estimated fair value of the acquired liabilities is based on projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns, nonperformance risk adjustment and other factors. Actual experience on the purchased business may vary from these projections.
DAC and VOBA are amortized as follows:
Products:			In proportion to the following over estimated lives of the contracts:
•	Nonparticipating and non-dividend-paying traditional contracts:			Historic actual and expected future gross premiums.
	•	Term insurance
	•	Nonparticipating whole life insurance
	•	Traditional group life insurance
	•	Non-medical health insurance
	•	Accident and health insurance
•	Participating, dividend-paying traditional contracts			Actual and expected future gross margins.
•	Fixed and variable universal life contracts			Actual and expected future gross profits.
•	Fixed and variable deferred annuity contracts
•	Credit insurance contracts			Historic and future earned premium.
•	Property and casualty insurance contracts
•	Other short-duration contracts
See Note 5 for additional information on DAC and VOBA amortization.
The recovery of DAC and VOBA is dependent upon the future profitability of the related business. DAC and VOBA are aggregated in the financial statements for reporting purposes.
The Company generally has two different types of sales inducements which are included in other assets: (i) the policyholder receives a bonus whereby the policyholder’s initial account balance is increased by an amount equal to a specified percentage of the customer’s deposit; and (ii) the policyholder receives a higher interest rate using a dollar cost averaging method than would have been received based on the normal general account interest rate credited. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. The amortization of sales inducements is included in policyholder benefits and claims. Each year, or more frequently if circumstances indicate a potential recoverability issue exists, the Company reviews deferred sales inducements to determine the recoverability of the asset.
Value of distribution agreements acquired (“VODA”) is reported in other assets and represents the present value of expected future profits associated with the expected future business derived from the distribution agreements acquired as part of a business combination. Value of customer relationships acquired (“VOCRA”) is also reported in other assets and represents the present value of the expected future profits associated with the expected future business acquired through existing customers of the acquired company or business. The VODA and VOCRA associated with past business combinations are amortized over useful lives ranging from 10 to 40 years and such amortization is included in other expenses. Each year, or more frequently if circumstances indicate a possible impairment exists, the Company reviews VODA and VOCRA to determine whether the asset is impaired.
For certain acquired blocks of business, the estimated fair value of the in-force contract obligations exceeded the book value of assumed in-force insurance policy liabilities, resulting in negative VOBA, which is presented separately from VOBA as an additional insurance liability. The fair value of the in-force contract obligations is based on projections by each block of business. Negative VOBA is amortized over the policy period in proportion to the approximate consumption of losses included in the liability usually expressed in terms of insurance in-force or account value. Such amortization is recorded as a contra-expense in other expenses.
Reinsurance
For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The Company reviews all contractual features, including those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims.
For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid (received), and the liabilities ceded (assumed) related to the underlying contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is recorded as an adjustment to DAC and recognized as a component of other expenses on a basis consistent with the way the acquisition costs on the underlying reinsured contracts would be recognized. Subsequent amounts paid (received) on the reinsurance of in-force blocks, as well as amounts paid (received) related to new business, are recorded as ceded (assumed) premiums; and ceded (assumed) premiums, reinsurance and other receivables (future policy benefits) are established.
For prospective reinsurance of short-duration contracts that meet the criteria for reinsurance accounting, amounts paid (received) are recorded as ceded (assumed) premiums and ceded (assumed) unearned premiums. Unearned premiums are reflected as a component of premiums, reinsurance and other receivables (future policy benefits). Such amounts are amortized through earned premiums over the remaining contract period in proportion to the amount of insurance protection provided. For retroactive reinsurance of short-duration contracts that meet the criteria of reinsurance accounting, amounts paid (received) in excess of the related insurance liabilities ceded (assumed) are recognized immediately as a loss and are reported in the appropriate line item within the statement of operations. Any gain on such retroactive agreement is deferred and is amortized as part of DAC, primarily using the recovery method.
Amounts currently recoverable under reinsurance agreements are included in premiums, reinsurance and other receivables and amounts currently payable are included in other liabilities. Assets and liabilities relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance.
Premiums, fees and policyholder benefits and claims include amounts assumed under reinsurance agreements and are net of reinsurance ceded. Amounts received from reinsurers for policy administration are reported in other revenues. With respect to GMIBs, a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. These embedded derivatives are included in premiums, reinsurance and other receivables with changes in estimated fair value reported in policyholder benefits and claims.
If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. Periodically, the Company evaluates the adequacy of the expected payments or recoveries and adjusts the deposit asset or liability through other revenues or other expenses, as appropriate.
Investments
Net Investment Income and Net Investment Gains (Losses)
Income on investments is reported within net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported within net investment gains (losses), unless otherwise stated herein.
Fixed Maturity and Equity Securities
The majority of the Company’s fixed maturity and equity securities are classified as available-for-sale (“AFS”) and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of other comprehensive income (loss) (“OCI”), net of policyholder-related amounts and deferred income taxes. All security transactions are recorded on a trade date basis. Investment gains and losses on sales are determined on a specific identification basis.
Interest income on fixed maturity securities is recognized when earned using an effective yield method giving effect to amortization of premiums and accretion of discounts. Prepayment fees are recognized when earned. Dividends on equity securities are recognized when declared.
The Company periodically evaluates fixed maturity and equity securities for impairment. The assessment of whether impairments have occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in estimated fair value, as well as an analysis of the gross unrealized losses by severity and/or age as described in Note 8 “— Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities.”
For fixed maturity securities in an unrealized loss position, an other-than-temporary impairment (“OTTI”) is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exist, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings (“credit loss”). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors (“noncredit loss”) is recorded in OCI.
With respect to equity securities, the Company considers in its OTTI analysis its intent and ability to hold a particular equity security for a period of time sufficient to allow for the recovery of its estimated fair value to an amount equal to or greater than cost. If a sale decision is made for an equity security and recovery to an amount at least equal to cost prior to the sale is not expected, the security will be deemed to be other-than-temporarily impaired in the period that the sale decision was made and an OTTI loss will be recorded in earnings. The OTTI loss recognized is the entire difference between the security’s cost and its estimated fair value.
FVO and Trading Securities
FVO and trading securities are stated at estimated fair value and include investments for which the FVO has been elected (“FVO Securities”) and investments that are actively purchased and sold (“Actively Traded Securities”). FVO Securities include:
•	fixed maturity and equity securities held-for-investment by the general account to support asset and liability management strategies for certain insurance products and investments in certain separate accounts (“FVO general account securities”);
•	contractholder-directed investments supporting unit-linked variable annuity type liabilities which do not qualify for presentation and reporting as separate account summary total assets and liabilities. These investments are primarily mutual funds and, to a lesser extent, fixed maturity and equity securities, short-term investments and cash and cash equivalents. The investment returns on these investments inure to contractholders and are offset by a corresponding change in PABs through interest credited to policyholder account balances (“FVO contractholder-directed unit-linked investments”); and
•	securities held by consolidated securitization entities (“CSEs”) (“FVO securities held by CSEs”).
Actively Traded Securities principally include fixed maturity securities and short sale agreement liabilities, which are included in other liabilities.
Changes in estimated fair value of these securities are included in net investment income, except for certain securities included in FVO Securities where changes are included in net investment gains (losses).
Mortgage Loans
The Company disaggregates its mortgage loan investments into three portfolio segments: commercial, agricultural, and residential. The accounting policies that are applicable to all portfolio segments are presented below and the accounting policies related to each of the portfolio segments are included in Note 8.
Mortgage Loans Held-For-Investment
Mortgage loans held-for-investment are stated at unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses, and are net of valuation allowances. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts.
Also included in mortgage loans held-for-investment are commercial mortgage loans held by CSEs and residential mortgage loans for which the FVO was elected. These mortgage loans are stated at estimated fair value. Changes in estimated fair value are recognized in net investment gains (losses) for commercial mortgage loans held by CSEs — FVO, and net investment income for residential mortgage loans.
Mortgage Loans Held-For-Sale
Mortgage loans held-for-sale that were previously designated as held-for-investment, but now are designated as held-for-sale and mortgage loans originated with the intent to sell for which FVO was not elected, are stated at the lower of amortized cost or estimated fair value.
Policy Loans
Policy loans are stated at unpaid principal balances. Interest income on such loans is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy’s anniversary date. Valuation allowances are not established for policy loans, as they are fully collateralized by the cash surrender value of the underlying insurance policies. Any unpaid principal or interest on the loan is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy.
Real Estate
Real estate held-for-investment is stated at cost less accumulated depreciation. Depreciation is provided on a straight-line basis over the estimated useful life of the asset (typically 20 to 55 years). Rental income associated with such real estate is recognized on a straight-line basis over the term of the respective leases. The Company periodically reviews its real estate held-for-investment for impairment and tests for recoverability whenever events or changes in circumstances indicate the carrying value may not be recoverable and exceeds its estimated fair value. Properties whose carrying values are greater than their undiscounted cash flows are written down to their estimated fair value, which is generally computed using the present value of expected future cash flows discounted at a rate commensurate with the underlying risks.
Real estate for which the Company commits to a plan to sell within one year and actively markets in its current condition for a reasonable price in comparison to its estimated fair value is classified as held-for-sale. Real estate held-for-sale is stated at the lower of depreciated cost or estimated fair value less expected disposition costs and is not depreciated.
Real Estate Joint Ventures and Other Limited Partnership Interests
The Company uses the equity method of accounting for investments in equity securities when it has significant influence or at least 20% interest and for investments in real estate joint ventures and other limited partnership interests (“investees”) when it has more than a minor ownership interest or more than a minor influence over the investee’s operations, but does not have a controlling financial interest. The Company generally recognizes its share of the investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period.
The Company uses the cost method of accounting for investments in which it has virtually no influence over the investee’s operations. The Company recognizes distributions on cost method investments as earned or received. Because of the nature and structure of these cost method investments, they do not meet the characteristics of an equity security in accordance with applicable accounting standards.
The Company routinely evaluates its equity method and cost method investments for impairment. For equity method investees, the Company considers financial and other information provided by the investee, other known information and inherent risks in the underlying investments, as well as future capital commitments, in determining whether an impairment has occurred. The Company considers its cost method investments for impairment when the carrying value of such investments exceeds the net asset value (“NAV”). The Company takes into consideration the severity and duration of this excess when determining whether the cost method investment is impaired.
Short-term Investments
Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value.
Other Invested Assets
Other invested assets consist principally of the following:
•	Freestanding derivatives with positive estimated fair values are described in “— Derivatives” below.
•	Tax credit and renewable energy partnerships derive a significant source of investment return in the form of income tax credits or other tax incentives. Where tax credits are guaranteed by a creditworthy third party, the investment is accounted for under the effective yield method. Otherwise, the investment is accounted for under the equity method.
•	Leveraged leases are recorded net of non-recourse debt. Income on leveraged leases is recognized by applying the leveraged lease’s estimated rate of return to the net investment in the lease. The Company regularly reviews residual values for impairment.
•	Funds withheld represent a receivable for amounts contractually withheld by ceding companies in accordance with reinsurance agreements. The Company recognizes interest on funds withheld at rates defined by the terms of the agreement which may be contractually specified or directly related to the underlying investments.
•	Investments in joint ventures that engage in insurance underwriting activities are accounted for under the equity method.
Securities Lending Program
Securities lending transactions, whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. The Company obtains collateral at the inception of the loan, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned, and maintains it at a level greater than or equal to 100% for the duration of the loan. The Company is liable to return to the counterparties the cash collateral received. Security collateral on deposit from counterparties in connection with the securities lending transactions may not be sold or repledged, unless the counterparty is in default, and is not reflected in the financial statements. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, within net investment income.
Derivatives
Freestanding Derivatives
Freestanding derivatives are carried in the Company’s balance sheets either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.
Accruals on derivatives are generally recorded in accrued investment income or within other liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in other invested assets or other liabilities.
If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses) except as follows:
Statement of Operations Presentation:	Derivative:
Policyholder benefits and claims	•	Economic hedges of variable annuity guarantees included in future policy benefits
Net investment income	•	Economic hedges of equity method investments in joint ventures
	•	All derivatives held in relation to trading portfolios
	•	Derivatives held within contractholder-directed unit-linked investments
Other revenues	•	Derivatives held in connection with the Company’s previous mortgage banking activities
Hedge Accounting
To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. Hedge designation and financial statement presentation of changes in estimated fair value of the hedging derivatives are as follows:
•	Fair value hedge (a hedge of the estimated fair value of a recognized asset or liability) - in net derivative gains (losses), consistent with the change in fair value of the hedged item attributable to the designated risk being hedged.
•	Cash flow hedge (a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability) - effectiveness in OCI (deferred gains or losses on the derivative are reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item); ineffectiveness in net derivative gains (losses).
•	Net investment in a foreign operation hedge - effectiveness in OCI, consistent with the translation adjustment for the hedged net investment in the foreign operation; ineffectiveness in net derivative gains (losses).
The changes in estimated fair values of the hedging derivatives are exclusive of any accruals that are separately reported in the statement of operations within interest income or interest expense to match the location of the hedged item. Accruals on derivatives in net investment hedges are recognized in OCI.
In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. Assessments of hedge effectiveness and measurements of ineffectiveness are also subject to interpretation and estimation and different interpretations or estimates may have a material effect on the amount reported in net income.
The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.
When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried in the balance sheets at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statements of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.
When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date or within two months of that date, the derivative continues to be carried in the balance sheets at its estimated fair value, with changes in estimated fair value recognized currently in net derivative gains (losses). Deferred gains and losses of a derivative recorded in OCI pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in net derivative gains (losses).
In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value in the balance sheets, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).
Embedded Derivatives
The Company sells variable annuities and issues certain insurance products and investment contracts and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if:
•	the combined instrument is not accounted for in its entirety at fair value with changes in fair value recorded in earnings;
•	the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and
•	a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument.
Such embedded derivatives are carried in the balance sheets at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses) except for those in policyholder benefits and claims related to ceded reinsurance of GMIB. If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income. Additionally, the Company may elect to carry an entire contract on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income if that contract contains an embedded derivative that requires bifurcation. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent “excess” fees and are reported in universal life and investment-type product policy fees.
Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition.
Subsequent to initial recognition, fair values are based on unadjusted quoted prices for identical assets or liabilities in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical assets or liabilities, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of assets and liabilities.
Goodwill
Goodwill represents the future economic benefits arising from net assets acquired in a business combination that are not individually identified and recognized. Goodwill is calculated as the excess of cost over the estimated fair value of such net assets acquired, is not amortized, and is tested for impairment based on a fair value approach at least annually or more frequently if events or circumstances indicate that there may be justification for conducting an interim test. The Company performs its annual goodwill impairment testing during the third quarter of each year based upon data as of the close of the second quarter. Goodwill associated with a business acquisition is not tested for impairment during the year the business is acquired unless there is a significant identified impairment event.
The impairment test is performed at the reporting unit level, which is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level. For purposes of goodwill impairment testing, if the carrying value of a reporting unit exceeds its estimated fair value, there may be an indication of impairment. In such instances, the implied fair value of the goodwill is determined in the same manner as the amount of goodwill that would be determined in a business combination. The excess of the carrying value of goodwill over the implied fair value of goodwill would be recognized as an impairment and recorded as a charge against net income.
On an ongoing basis, the Company evaluates potential triggering events that may affect the estimated fair value of the Company’s reporting units to assess whether any goodwill impairment exists. Deteriorating or adverse market conditions for certain reporting units may have a significant impact on the estimated fair value of these reporting units and could result in future impairments of goodwill.
Employee Benefit Plans
Certain subsidiaries of MetLife, Inc. (the “Subsidiaries”) sponsor and/or administer various plans that provide defined benefit pension and other postretirement benefits covering eligible employees and sales representatives. Measurement dates used for all of the Subsidiaries’ defined benefit pension and other postretirement benefit plans correspond with the fiscal year ends of sponsoring Subsidiaries, which are December 31 for U.S. Subsidiaries and November 30 for most non-U.S. Subsidiaries.
The Company recognizes the funded status of the projected benefit obligation (“PBO”) for pension benefits and the accumulated postretirement benefit obligation (“APBO”) for other postretirement benefits for each of its plans. The Company recognizes an expense for differences between actual experience and estimates over the average future service period of participants. The actuarial gains (losses), prior service costs (credit) and the remaining net transition asset or obligation not yet included in net periodic benefit costs are charged to accumulated OCI (“AOCI”), net of income tax.
The Subsidiaries also sponsor defined contribution plans for substantially all U.S. employees under which a portion of employee contributions is matched. Applicable matching contributions are made each payroll period. Accordingly, the Company recognizes compensation cost for current matching contributions. As all contributions are transferred currently as earned to the defined contribution plans, no liability for matching contributions is recognized in the balance sheets.
Income Tax
MetLife, Inc. and its includable life insurance and non-life insurance subsidiaries file a consolidated U.S. federal income tax return in accordance with the provisions of the Internal Revenue Code of 1986, as amended (the “Code”). Non-includable subsidiaries file either separate individual corporate tax returns or separate consolidated tax returns.
The Company’s accounting for income taxes represents management’s best estimate of various events and transactions.
Deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse.
The realization of deferred tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Factors in management’s determination include the performance of the business and its ability to generate capital gains. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination, consideration is given to, among other things, the following:
•	future taxable income exclusive of reversing temporary differences and carryforwards;
•	future reversals of existing taxable temporary differences;
•	taxable income in prior carryback years; and
•	tax planning strategies.
The Company may be required to change its provision for income taxes in certain circumstances. Examples of such circumstances include when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, future events, such as changes in tax laws, tax regulations, or interpretations of such laws or regulations, could have an impact on the provision for income tax and the effective tax rate. Any such changes could significantly affect the amounts reported in the financial statements in the year these changes occur.
The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included within other liabilities and are charged to earnings in the period that such determination is made.
The Company classifies interest recognized as interest expense and penalties recognized as a component of income tax.
Litigation Contingencies
The Company is a party to a number of legal actions and is involved in a number of regulatory investigations. Given the inherent unpredictability of these matters, it is difficult to estimate the impact on the Company’s financial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Except as otherwise disclosed in Note 21, legal costs are recognized as incurred. On a quarterly and annual basis, the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reflected in the Company’s financial statements.
Other Accounting Policies
Redeemable Noncontrolling Interests
Redeemable noncontrolling interests associated with certain joint ventures and partially-owned consolidated subsidiaries are reported in the temporary section of the balance sheet.
Stock-Based Compensation
The Company grants certain employees and directors stock-based compensation awards under various plans that are subject to specific vesting conditions. With the exception of performance shares granted in 2013 which are remeasured quarterly, the cost of all stock-based transactions is measured at fair value at grant date and recognized over the period during which a grantee is required to provide services in exchange for the award. Although the terms of the Company’s stock-based plans do not accelerate vesting upon retirement, or the attainment of retirement eligibility, the requisite service period subsequent to attaining such eligibility is considered nonsubstantive. Accordingly, the Company recognizes compensation expense related to stock-based awards over the shorter of the requisite service period or the period to attainment of retirement eligibility. An estimation of future forfeitures of stock-based awards is incorporated into the determination of compensation expense when recognizing expense over the requisite service period.
Cash and Cash Equivalents
The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at amortized cost, which approximates estimated fair value.
Property, Equipment, Leasehold Improvements and Computer Software
Property, equipment and leasehold improvements, which are included in other assets, are stated at cost, less accumulated depreciation and amortization. Depreciation is determined using the straight-line method over the estimated useful lives of the assets, as appropriate. The estimated life is generally 40 years for company occupied real estate property, from one to 25 years for leasehold improvements, and from three to seven years for all other property and equipment. The cost basis of the property, equipment and leasehold improvements was $2.0 billion and $2.5 billion at December 31, 2013 and 2012, respectively. Accumulated depreciation and amortization of property, equipment and leasehold improvements was $1.0 billion and $1.3 billion at December 31, 2013 and 2012, respectively. Related depreciation and amortization expense was $183 million, $208 million and $199 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Computer software, which is included in other assets, is stated at cost, less accumulated amortization. Purchased software costs, as well as certain internal and external costs incurred to develop internal-use computer software during the application development stage, are capitalized. Such costs are amortized generally over a four-year period using the straight-line method. The cost basis of computer software was $1.7 billion and $1.5 billion at December 31, 2013 and 2012, respectively. Accumulated amortization of capitalized software was $1.1 billion and $932 million at December 31, 2013 and 2012, respectively. Related amortization expense was $216 million, $221 million and $217 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Other Revenues
Other revenues include, in addition to items described elsewhere herein, advisory fees, broker-dealer commissions and fees, administrative service fees, and changes in account value relating to corporate-owned life insurance (“COLI”). Such fees and commissions are recognized in the period in which services are performed. Under certain COLI contracts, if the Company reports certain unlikely adverse results in its financial statements, withdrawals would not be immediately available and would be subject to market value adjustment, which could result in a reduction of the account value.
Policyholder Dividends
Policyholder dividends are approved annually by the insurance subsidiaries’ boards of directors. The aggregate amount of policyholder dividends is related to actual interest, mortality, morbidity and expense experience for the year, as well as management’s judgment as to the appropriate level of statutory surplus to be retained by the insurance subsidiaries.
Foreign Currency
Assets, liabilities and operations of foreign affiliates and subsidiaries are recorded based on the functional currency of each entity. The determination of the functional currency is made based on the appropriate economic and management indicators. With the exception of certain foreign operations, primarily Japan, where multiple functional currencies exist, the local currencies of foreign operations are the functional currencies. Assets and liabilities of foreign affiliates and subsidiaries are translated from the functional currency to U.S. dollars at the exchange rates in effect at each year-end and income and expense accounts are translated at the average exchange rates during the year. The resulting translation adjustments are charged or credited directly to OCI, net of applicable taxes. Gains and losses from foreign currency transactions, including the effect of re-measurement of monetary assets and liabilities to the appropriate functional currency, are reported as part of net investment gains (losses) in the period in which they occur.
Earnings Per Common Share
Basic earnings per common share are computed based on the weighted average number of common shares, or their equivalent, outstanding during the period. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares. Diluted earnings per common share include the dilutive effect of the assumed: (i) exercise or issuance of stock-based awards using the treasury stock method; (ii) settlement of stock purchase contracts underlying common equity units using the treasury stock method; and (iii) settlement of accelerated common stock repurchase contracts. Under the treasury stock method, exercise or issuance of stock-based awards and settlement of the stock purchase contracts underlying common equity units is assumed to occur with the proceeds used to purchase common stock at the average market price for the period.
Adoption of New Accounting Pronouncements
Effective July 17, 2013, the Company adopted new guidance regarding derivatives that permits the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) to be used as a U.S. benchmark interest rate for hedge accounting purposes, in addition to the United States Treasury and London Interbank Offered Rate (“LIBOR”). Also, this new guidance removes the restriction on using different benchmark rates for similar hedges. The new guidance did not have a material impact on the financial statements upon adoption, but may impact the selection of benchmark interest rates for hedging relationships in the future.
Effective January 1, 2013, the Company adopted new guidance regarding comprehensive income that requires an entity to provide information about the amounts reclassified out of AOCI by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of AOCI by the respective line items of net income but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under GAAP that provide additional detail about those amounts. The adoption was prospectively applied and resulted in additional disclosures in Note 16.
Effective January 1, 2013, the Company adopted new guidance regarding balance sheet offsetting disclosures which requires an entity to disclose information about offsetting and related arrangements for derivatives, including bifurcated embedded derivatives, repurchase and reverse repurchase agreements, and securities borrowing and lending transactions, to enable users of its financial statements to understand the effects of those arrangements on its financial position. Entities are required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. The adoption was retrospectively applied and resulted in additional disclosures related to derivatives in Note 9.
On January 1, 2012, the Company adopted new guidance regarding accounting for DAC, which was retrospectively applied. The guidance specifies that only costs related directly to successful acquisition of new or renewal contracts can be capitalized as DAC; all other acquisition-related costs must be expensed as incurred. Under the new guidance, advertising costs may only be included in DAC if the capitalization criteria in the direct-response advertising guidance in Subtopic 340-20, Other Assets and Deferred Costs—Capitalized Advertising Costs, are met. As a result, certain direct marketing, sales manager compensation and administrative costs previously capitalized by the Company will no longer be deferred.
On January 1, 2012, the Company adopted new guidance regarding comprehensive income, which was retrospectively applied, that provides companies with the option to present the total of comprehensive income, components of net income, and the components of OCI either in a single continuous statement of comprehensive income or in two separate but consecutive statements in annual financial statements. The standard eliminates the option to present components of OCI as part of the statement of changes in stockholders’ equity. The Company adopted the two-statement approach for annual financial statements.
Effective January 1, 2012, the Company adopted new guidance on goodwill impairment testing that simplifies how an entity tests goodwill for impairment. This new guidance allows an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value as a basis for determining whether it needs to perform the quantitative two-step goodwill impairment test. Only if an entity determines, based on qualitative assessment, that it is more likely than not that a reporting unit’s fair value is less than its carrying value will it be required to calculate the fair value of the reporting unit. The qualitative assessment is optional and the Company is permitted to bypass it for any reporting unit in any period and begin its impairment analysis with the quantitative calculation. The Company is permitted to perform the qualitative assessment in any subsequent period.
Effective January 1, 2012, the Company adopted new guidance regarding fair value measurements that establishes common requirements for measuring fair value and for disclosing information about fair value measurements in accordance with GAAP and International Financial Reporting Standards. Some of the amendments clarify the Financial Accounting Standards Board’s (“FASB”) intent on the application of existing fair value measurement requirements. Other amendments change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. The adoption did not have a material impact on the Company’s financial statements other than the expanded disclosures in Note 10.
Future Adoption of New Accounting Pronouncements
In March 2013, the FASB issued new guidance regarding foreign currency (Accounting Standards Update (“ASU”) 2013-05, Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity), effective prospectively for fiscal years and interim reporting periods within those years beginning after December 15, 2013. The amendments require an entity that ceases to have a controlling financial interest in a subsidiary or group of assets within a foreign entity to apply the guidance in Subtopic 830-30, Foreign Currency Matters — Translation of Financial Statements, to release any related cumulative translation adjustment into net income. Accordingly, the cumulative translation adjustment should be released into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided. For an equity method investment that is a foreign entity, the partial sale guidance in section 830-30-40, Derecognition, still applies. As such, a pro rata portion of the cumulative translation adjustment should be released into net income upon a partial sale of such an equity method investment. The Company does not expect the adoption of this new guidance to have a material impact on its financial statements.
In February 2013, the FASB issued new guidance regarding liabilities (ASU 2013-04, Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date), effective retrospectively for fiscal years beginning after December 15, 2013 and interim periods within those years. The amendments require an entity to measure obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of the guidance is fixed at the reporting date, as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. In addition, the amendments require an entity to disclose the nature and amount of the obligation, as well as other information about the obligation. The Company does not expect the adoption of this new guidance to have a material impact on its financial statements.
In July 2011, the FASB issued new guidance on other expenses (ASU 2011-06, Other Expenses (Topic 720): Fees Paid to the Federal Government by Health Insurers), effective for calendar years beginning after December 31, 2013. The objective of this standard is to address how health insurers should recognize and classify in their income statements fees mandated by the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act. The amendments in this standard specify that the liability for the fee should be estimated and recorded in full once the entity provides qualifying health insurance in the applicable calendar year in which the fee is payable with a corresponding deferred cost that is amortized to expense using the straight-line method of allocation unless another method better allocates the fee over the calendar year that it is payable. In accordance with the adoption of the new accounting pronouncement on January 1, 2014, the Company recorded $57 million in other liabilities, and a corresponding deferred cost, in other assets.

Segment_Information

Segment Information	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Segment Information	'
	2. Segment Information
	MetLife is organized into six segments, reflecting three broad geographic regions: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; and Latin America (collectively, the “Americas”); Asia; and EMEA. In addition, the Company reports certain of its results of operations in Corporate & Other, which includes MetLife Home Loans LLC (“MLHL”), the surviving, non-bank entity of the merger of MetLife Bank, National Association (“MetLife Bank”) with and into MLHL (see Note 3) and other business activities.
	Americas
	The Americas consists of the following segments:
	Retail
	The Retail segment offers a broad range of protection products and services and a variety of annuities to individuals and employees of corporations and other institutions, and is organized into two businesses: Life & Other and Annuities. Life & Other insurance products and services include variable life, universal life, term life and whole life products. Additionally, through broker-dealer affiliates, the Company offers a full range of mutual funds and other securities products. Life & Other products and services also include individual disability income products and personal lines property & casualty insurance, including private passenger automobile, homeowners and personal excess liability insurance. Annuities includes a variety of variable and fixed annuities which provide for both asset accumulation and asset distribution needs.
	Group, Voluntary & Worksite Benefits
	The Group, Voluntary & Worksite Benefits segment offers a broad range of protection products and services to individuals and corporations, as well as other institutions and their respective employees, and is organized into two businesses: Group and Voluntary & Worksite. Group insurance products and services include variable life, universal life and term life products. Group insurance products and services also include dental, group short- and long-term disability and accidental death & dismemberment coverages. The Voluntary & Worksite business includes personal lines property & casualty insurance, including private passenger automobile, homeowners and personal excess liability insurance offered to employees on a voluntary basis. The Voluntary & Worksite business also includes LTC, prepaid legal plans and critical illness products.
	Corporate Benefit Funding
	The Corporate Benefit Funding segment offers a broad range of annuity and investment products, including guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets. This segment also includes structured settlements and certain products to fund postretirement benefits and company-, bank- or trust-owned life insurance used to finance non-qualified benefit programs for executives.
	Latin America
	The Latin America segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include life insurance, accident and health insurance, group medical, dental, credit insurance, endowment and retirement & savings products written in Latin America. Starting in the first quarter of 2013, the Latin America segment includes U.S. sponsored direct business, comprised of group and individual products sold through sponsoring organizations and affinity groups. Products included are life, dental, group short- and long-term disability, accidental death & dismemberment coverages, property & casualty and other accident and health coverages, as well as non-insurance products such as identity protection.
	Asia
	The Asia segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include whole life, term life, variable life, universal life, accident and health insurance, fixed and variable annuities, credit insurance and endowment products.
	EMEA
	The EMEA segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include life insurance, accident and health insurance, credit insurance, annuities, endowment and retirement & savings products.
	Corporate & Other
	Corporate & Other contains the excess capital not allocated to the segments, external integration costs, internal resource costs for associates committed to acquisitions, enterprise-wide strategic initiative restructuring charges, and various start-up and certain run-off businesses. Start-up businesses include expatriate benefits insurance, as well as direct and digital marketing products. Corporate & Other also includes assumed reinsurance of certain variable annuity products from the Company’s former operating joint venture in Japan. Under this in-force reinsurance agreement, the Company reinsures living and death benefit guarantees issued in connection with variable annuity products. Corporate & Other also includes our investment management business through which we offer fee-based investment management services to institutional clients. Additionally, Corporate & Other includes interest expense related to the majority of the Company’s outstanding debt and expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes the elimination of intersegment amounts, which generally relate to intersegment loans, which bear interest rates commensurate with related borrowings.
	Financial Measures and Segment Accounting Policies
	Operating earnings is the measure of segment profit or loss the Company uses to evaluate segment performance and allocate resources. Consistent with GAAP guidance for segment reporting, operating earnings is the Company’s measure of segment performance and is reported below. Operating earnings should not be viewed as a substitute for income (loss) from continuing operations, net of income tax. The Company believes the presentation of operating earnings as the Company measures it for management purposes enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business.
	Operating earnings is defined as operating revenues less operating expenses, both net of income tax.
	Operating revenues and operating expenses exclude results of discontinued operations and other businesses that have been or will be sold or exited by MetLife. Operating revenues also excludes net investment gains (losses) and net derivative gains (losses). Operating expenses also excludes goodwill impairments.
	The following additional adjustments are made to GAAP revenues, in the line items indicated, in calculating operating revenues:
	•	Universal life and investment-type product policy fees excludes the amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity GMIB fees (“GMIB Fees”);
	•	Net investment income: (i) includes amounts for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment, (ii) includes income from discontinued real estate operations, (iii) excludes post-tax operating earnings adjustments relating to insurance joint ventures accounted for under the equity method, (iv) excludes certain amounts related to contractholder-directed unit-linked investments, and (v) excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and
	•	Other revenues are adjusted for settlements of foreign currency earnings hedges.
	The following additional adjustments are made to GAAP expenses, in the line items indicated, in calculating operating expenses:
	•	Policyholder benefits and claims and policyholder dividends excludes: (i) changes in the policyholder dividend obligation related to net investment gains (losses) and net derivative gains (losses), (ii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments and amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass through adjustments, (iii) benefits and hedging costs related to GMIBs (“GMIB Costs”), and (iv) market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”);
	•	Interest credited to policyholder account balances includes adjustments for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of PABs but do not qualify for hedge accounting treatment and excludes amounts related to net investment income earned on contractholder-directed unit-linked investments;
	•	Amortization of DAC and VOBA excludes amounts related to: (i) net investment gains (losses) and net derivative gains (losses), (ii) GMIB Fees and GMIB Costs, and (iii) Market Value Adjustments;
	•	Amortization of negative VOBA excludes amounts related to Market Value Adjustments;
	•	Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and
	•	Other expenses excludes costs related to: (i) noncontrolling interests, (ii) implementation of new insurance regulatory requirements, and (iii) acquisition and integration costs.
	Operating earnings also excludes the recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance.
	Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for the years ended December 31, 2013, 2012 and 2011 and at December 31, 2013 and 2012. The segment accounting policies are the same as those used to prepare the Company’s consolidated financial statements, except for operating earnings adjustments as defined above. In addition, segment accounting policies include the method of capital allocation described below.
	Economic capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The economic capital model accounts for the unique and specific nature of the risks inherent in the Company’s business.
	The Company’s economic capital model aligns segment allocated equity with emerging standards and consistent risk principles. The model applies statistics-based risk evaluation principles to the material risks to which the Company is exposed. These consistent risk principles include calibrating required economic capital shock factors to a specific confidence level and time horizon and applying an industry standard method for the inclusion of diversification benefits among risk types.
	For the Company’s domestic segments, net investment income is credited or charged based on the level of allocated equity; however, changes in allocated equity do not impact the Company’s consolidated net investment income, operating earnings or income (loss) from continuing operations, net of income tax.
	Net investment income is based upon the actual results of each segment’s specifically identifiable investment portfolios adjusted for allocated equity. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee compensation costs incurred by each segment; and (iii) cost estimates included in the Company’s product pricing.
			Operating Earnings
			Americas
	Year Ended December 31, 2013		Retail				Group,				Corporate			Latin			Total			Asia			EMEA			Corporate			Total			Adjustments			Total
							Voluntary				Benefit			America												& Other									Consolidated
							& Worksite				Funding
							Benefits
			(In millions)
	Revenues
	Premiums		$	6,528			$	15,250			$	2,859		$	2,824		$	27,461		$	7,801		$	2,297		$	116		$	37,675		$	(1	)	$	37,674
	Universal life and investment-type product policy fees		4,912				688				247			991			6,838			1,722			386			139			9,085			366			9,451
	Net investment income		7,898				1,856				5,790			1,246			16,790			2,915			498			381			20,584			1,648			22,232
	Other revenues		1,018				418				278			23			1,737			92			97			28			1,954			(34		)	1,920
	Net investment gains (losses)		—				—				—			—			—			—			—			—			—			161			161
	Net derivative gains (losses)		—				—				—			—			—			—			—			—			—			(3,239		)	(3,239		)
	Total revenues		20,356				18,212				9,174			5,084			52,826			12,530			3,278			664			69,298			(1,099		)	68,199
	Expenses
	Policyholder benefits and claims and policyholder dividends		9,028				14,227				5,402			2,454			31,111			5,755			1,039			63			37,968			1,398			39,366
	Interest credited to policyholder account balances		2,331				155				1,233			417			4,136			1,690			147			42			6,015			2,164			8,179
	Goodwill impairment		—				—				—			—			—			—			—			—			—			—			—
	Capitalization of DAC		(1,309		)		(141		)		(27		)	(424		)	(1,901		)	(2,143		)	(714		)	(28		)	(4,786		)	—			(4,786		)
	Amortization of DAC and VOBA		1,384				140				23			310			1,857			1,542			683			1			4,083			(533		)	3,550
	Amortization of negative VOBA		—				—				—			(2		)	(2		)	(427		)	(95		)	—			(524		)	(55		)	(579		)
	Interest expense on debt		—				1				9			—			10			—			1			1,148			1,159			123			1,282
	Other expenses		5,084				2,380				523			1,612			9,599			4,312			1,810			894			16,615			520			17,135
Total expenses		16,518				16,762				7,163			4,367			44,810			10,729			2,871			2,120			60,530			3,617			64,147
Provision for income tax expense (benefit)		1,314				488				704			143			2,649			557			78			(925		)	2,359			(1,698		)	661
Operating earnings		$	2,524			$	962			$	1,307		$	574		$	5,367		$	1,244		$	329		$	(531	)	6,409
Adjustments to:
Total revenues																												(1,099		)
Total expenses																												(3,617		)
Provision for income tax (expense) benefit																												1,698
Income (loss) from continuing operations, net of income tax																												$	3,391					$	3,391
At December 31, 2013		Retail				Group,				Corporate			Latin			Asia (1)			EMEA			Corporate			Total
						Voluntary				Benefit			America									& Other
						& Worksite				Funding
						Benefits
		(In millions)
Total assets		$	349,516			$	43,404			$	220,612		$	69,874		$	119,717		$	33,382		$	48,791		$	885,296
Separate account assets		$	172,382			$	644			$	77,023		$	49,660		$	8,996		$	8,496		$	—		$	317,201
Separate account liabilities		$	172,382			$	644			$	77,023		$	49,660		$	8,996		$	8,496		$	—		$	317,201
______________
-1	Total assets includes $98.4 billion of assets from the Japan operations which represents 11% of total consolidated assets.
		Operating Earnings
		Americas
Year Ended December 31, 2012		Retail				Group,				Corporate			Latin			Total			Asia			EMEA			Corporate			Total			Adjustments			Total
						Voluntary				Benefit			America												& Other									Consolidated
						& Worksite				Funding
						Benefits
		(In millions)
Revenues
Premiums		$	6,532			$	14,794			$	3,237		$	2,578		$	27,141		$	8,344		$	2,370		$	56		$	37,911		$	64		$	37,975
Universal life and investment-type product policy fees		4,561				662				225			785			6,233			1,491			333			155			8,212			344			8,556
Net investment income		7,670				1,768				5,703			1,198			16,339			2,895			535			703			20,472			1,512			21,984
Other revenues		879				422				259			16			1,576			26			121			33			1,756			150			1,906
Net investment gains (losses)		—				—				—			—			—			—			—			—			—			(352		)	(352		)
Net derivative gains (losses)		—				—				—			—			—			—			—			—			—			(1,919		)	(1,919		)
Total revenues		19,642				17,646				9,424			4,577			51,289			12,756			3,359			947			68,351			(201		)	68,150
Expenses
Policyholder benefits and claims and policyholder dividends		9,010				13,691				5,704			2,231			30,636			5,819			1,196			119			37,770			1,586			39,356
Interest credited to policyholder account balances		2,375				167				1,358			393			4,293			1,784			126			39			6,242			1,487			7,729
Goodwill impairment		—				—				—			—			—			—			—			—			—			1,868			1,868
Capitalization of DAC		(1,753		)		(138		)		(29		)	(353		)	(2,273		)	(2,288		)	(723		)	—			(5,284		)	(5		)	(5,289		)
Amortization of DAC and VOBA		1,607				133				22			224			1,986			1,563			626			2			4,177			22			4,199
Amortization of negative VOBA		—				—				—			(5		)	(5		)	(456		)	(94		)	—			(555		)	(67		)	(622		)
Interest expense on debt		—				1				8			(1		)	8			5			1			1,176			1,190			166			1,356
Other expenses		5,369				2,351				478			1,375			9,573			4,738			1,810			559			16,680			1,431			18,111
Total expenses		16,608				16,205				7,541			3,864			44,218			11,165			2,942			1,895			60,220			6,488			66,708
Provision for income tax expense (benefit)		1,032				481				659			130			2,302			554			146			(679		)	2,323			(2,195		)	128
Operating earnings		$	2,002			$	960			$	1,224		$	583		$	4,769		$	1,037		$	271		$	(269	)	5,808
Adjustments to:
Total revenues																												(201		)
Total expenses																												(6,488		)
Provision for income tax (expense) benefit																												2,195
Income (loss) from continuing operations, net of income tax																												$	1,314					$	1,314
At December 31, 2012		Retail				Group,				Corporate			Latin			Asia (1)			EMEA			Corporate			Total
						Voluntary				Benefit			America									& Other
						& Worksite				Funding
						Benefits
		(In millions)
Total assets		$	332,387			$	44,138			$	217,352		$	23,272		$	131,138		$	23,474		$	65,020		$	836,781
Separate account assets		$	150,513			$	532			$	71,875		$	4,200		$	8,273		$	—		$	—		$	235,393
Separate account liabilities		$	150,513			$	532			$	71,875		$	4,200		$	8,273		$	—		$	—		$	235,393
______________
-1	Total assets includes $111.0 billion of assets from the Japan operations which represents 13% of total consolidated assets.
		Operating Earnings
		Americas
Year Ended December 31, 2011		Retail				Group,				Corporate			Latin			Total			Asia			EMEA			Corporate			Total			Adjustments			Total
						Voluntary				Benefit			America												& Other									Consolidated
						& Worksite Benefits				Funding
		(In millions)
Revenues
Premiums		$	6,711			$	13,949			$	2,848		$	2,514		$	26,022		$	7,716		$	2,477		$	54		$	36,269		$	92		$	36,361
Universal life and investment-type product policy fees		4,096				630				232			757			5,715			1,343			315			155			7,528			278			7,806
Net investment income		7,414				1,768				5,506			1,025			15,713			2,475			562			888			19,638			(53		)	19,585
Other revenues		779				390				249			15			1,433			36			123			60			1,652			880			2,532
Net investment gains (losses)		—				—				—			—			—			—			—			—			—			(867		)	(867		)
Net derivative gains (losses)		—				—				—			—			—			—			—			—			—			4,824			4,824
Total revenues		19,000				16,737				8,835			4,311			48,883			11,570			3,477			1,157			65,087			5,154			70,241
Expenses
Policyholder benefits and claims and policyholder dividends		9,220				13,015				5,287			2,064			29,586			5,239			1,290			126			36,241			676			36,917
Interest credited to policyholder account balances		2,412				178				1,323			371			4,284			1,607			166			—			6,057			(454		)	5,603
Goodwill impairment		—				—				—			—			—			—			—			—			—			—			—
Capitalization of DAC		(2,339		)		(176		)		(25		)	(295		)	(2,835		)	(2,045		)	(669		)	—			(5,549		)	(9		)	(5,558		)
Amortization of DAC and VOBA		1,845				186				17			207			2,255			1,486			613			1			4,355			543			4,898
Amortization of negative VOBA		—				—				—			(6		)	(6		)	(560		)	(53		)	—			(619		)	(78		)	(697		)
Interest expense on debt		1				—				9			1			11			—			—			1,293			1,304			325			1,629
Other expenses		5,854				2,198				513			1,305			9,870			4,522			1,723			505			16,620			1,645			18,265
Total expenses		16,993				15,401				7,124			3,647			43,165			10,249			3,070			1,925			58,409			2,648			61,057
Provision for income tax expense (benefit)		672				445				599			150			1,866			441			156			(584		)	1,879			914			2,793
Operating earnings		$	1,335			$	891			$	1,112		$	514		$	3,852		$	880		$	251		$	(184	)	4,799
Adjustments to:
Total revenues																												5,154
Total expenses																												(2,648		)
Provision for income tax (expense) benefit																												(914		)
Income (loss) from continuing operations, net of income tax																												$	6,391					$	6,391
The following table presents total premiums, universal life and investment-type product policy fees and other revenues by major product groups of the Company’s segments, as well as Corporate & Other:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Life insurance (1)	$	32,176			$	31,723			$	30,486
Accident and health insurance	13,214				13,255				12,269
Property and casualty insurance	3,270				3,117				3,043
Non-insurance	385				342				901
Total	$	49,045			$	48,437			$	46,699
______________
-1	Includes annuities and corporate benefit funding products.
Revenues derived from any customer did not exceed 10% of consolidated premiums, universal life and investment-type product policy fees and other revenues for the years ended December 31, 2013, 2012 and 2011.
The following table presents total premiums, universal life and investment-type product policy fees and other revenues associated with the Company’s U.S. and foreign operations:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
U.S.	$	32,529			$	31,500			$	30,108
Foreign:
Japan	7,373				7,833				7,184
Other	9,143				9,104				9,407
Total	$	49,045			$	48,437			$	46,699

Acquisitions_and_Dispositions

Acquisitions and Dispositions	12 Months Ended
	Dec. 31, 2013
Business Combinations [Abstract]	'
Acquisitions and Dispositions	'
	3. Acquisitions and Dispositions
	2013 Acquisition
	ProVida
	Description of Transaction
	On October 1, 2013, MetLife completed its previously announced acquisition of Administradora de Fondos de Pensiones Provida S.A. (“ProVida”), the largest private pension fund administrator in Chile based on assets under management and number of pension fund contributors. The acquisition of ProVida supports the Company's growth strategy in emerging markets and further strengthens the Company's overall position in Chile. Pursuant to an agreement with Banco Bilbao Vizcaya Argentaria, S.A. and BBVA Inversiones Chile S.A. (together, "BBVA"), a subsidiary of MetLife, Inc. acquired 64.32% of the outstanding shares of ProVida from BBVA and conducted a public cash tender offer, through which MetLife acquired an additional 27.06% of the outstanding shares of ProVida. As a result, as of October 1, 2013, MetLife owned 91.38% of the total outstanding shares of ProVida, for a total acquisition price of $1.9 billion.
	MetLife’s accounting for pension products sold in foreign jurisdictions, where the sale and administration of those products are restricted by government regulations to pension companies, is under an insurance company accounting model. ProVida’s assets under management meet the qualifications for separate account presentation. As such, the portion of the assets representing pension participants’ funds are reported at estimated fair value as separate account assets, with an equivalent amount reported as separate account liabilities. The fair value of separate account assets and liabilities as of the acquisition date was $45.2 billion. ProVida’s mandatory ownership interest in the funds (the “Encaje investment” ) representing a 1% interest in each of the funds offered, is accounted for as FVO Securities and reported in fair value option and trading securities on the balance sheet. Direct and incremental costs resulting in successful sales are capitalized and amortized over the estimated gross profits of the new business sold. Additionally, a portion of the revenue collected through fees on ProVida’s mandatory savings product are deferred and recognized when future services are provided to participants who have stopped contributing to the savings product due to retirement, disability or unemployment (“non-contributors”).
	Allocation of Purchase Price
	Of the $1.9 billion purchase price, $631 million and $159 million was allocated to the fair value of tangible assets acquired and liabilities assumed, respectively, of which $451 million in assets represented the Encaje investment. Additionally, $941 million was allocated to VOBA, which represented the value of the future profit margin from existing in-force pension participants (“acquired affiliates”) who are contributors as of the acquisition date and is subject to amortization as a percentage of estimated gross profits from the acquired contributing affiliates over an estimated weighted average period of 15 years. The amounts allocated to the ProVida trade name and goodwill were $179 million and $1.1 billion, respectively, both of which are not subject to amortization. The value of the trade name represents the savings or relief from royalty costs due to owning the ProVida name. Goodwill represents the expected future profits resulting from new sales after the acquisition date. The purchase price was also allocated to a future service liability (“FSL”) of $589 million attributable to acquired affiliates who are currently not contributing or will become non-contributors in the future. This liability represents the discounted future cost of servicing these affiliate accounts. The FSL will be released to earnings over the non-contributor phase period based on the actual expenses incurred during the respective period for servicing non-contributors from the acquired business. The allocated purchase price also included deferred tax assets and deferred tax liabilities of $118 million and $224 million, respectively, which are attributable to the intangible assets and liabilities, excluding goodwill, established at the purchase date. No portion of goodwill is expected to be deductible for tax purposes. The fair value of noncontrolling interests was $176 million, and is valued based upon the offered public cash tender price for each outstanding share of ProVida not acquired by MetLife.
	Revenues and Earnings of ProVida
	Revenues and net income of $100 million and $42 million, respectively, resulting from the acquisition of ProVida since the acquisition date, are included in the consolidated statement of operations within the Latin America segment for the year ended December 31, 2013.
	Costs Related to Acquisition
	The Company incurred $18 million of transaction costs for the year ended December 31, 2013. Such costs have been expensed as incurred and are included in other expenses. These expenses have been recorded within Corporate & Other.
	Integration-related expenses incurred for the year ended December 31, 2013 and included in other expenses were $12 million. Integration costs represent incremental costs directly relating to integrating ProVida, including expenses for severance, consulting and the integration of information systems. These expenses have been recorded within Corporate & Other.
	2013 Dispositions
	MetLife Bank
	On January 11, 2013, MetLife Bank and MetLife, Inc. completed the sale of MetLife Bank’s $6.4 billion of deposits to GE Capital Retail Bank for $6.4 billion in net consideration paid. On February 14, 2013, MetLife, Inc. announced that it had received the required approvals from both the Federal Deposit Insurance Corporation and the Board of Governors of the Federal Reserve System (the “Federal Reserve Board”) to de-register as a bank holding company. Subsequently, MetLife Bank terminated its deposit insurance and MetLife, Inc. de-registered as a bank holding company. In August 2013, MetLife Bank merged with and into MLHL, its former subsidiary, with MLHL as the surviving, non-bank entity.
	MetLife Bank has sold or has otherwise committed to exit substantially all of its operations. In conjunction with exiting MetLife Bank’s businesses (the “MetLife Bank Divestiture”), for the years ended December 31, 2013, 2012 and 2011, the Company recorded net losses of $115 million, $163 million and $212 million, respectively, net of income tax, related to the gain on disposal of the depository business, the loss on disposal of mortgage servicing rights (“MSRs”), gains (losses) on securities and mortgage loans sold and other costs related to MetLife Bank’s businesses. The Company expects to incur additional charges of $20 million to $45 million, exclusive of incremental legal settlements, related to the MetLife Bank Divestiture. See Note 21.
	Total assets and liabilities recorded in the consolidated balance sheets related to MetLife Bank’s businesses were $446 million and $282 million at December 31, 2013, respectively and $7.8 billion and $6.8 billion at December 31, 2012, respectively. Each of the businesses that were exited as part of the MetLife Bank Divestiture could not be separated from the rest of the operations since the Company did not separately manage the businesses as a reportable segment, operating segment, or reporting unit. As a result, the businesses have not been reported as discontinued operations in the consolidated financial statements.
	MetLife Bank has historically taken advantage of collateralized borrowing opportunities with the Federal Home Loan Bank (“FHLB”) of New York (“FHLB of NY”). In January 2012, MetLife Bank discontinued taking advances from the FHLB of NY. In April 2012, MetLife Bank transferred cash to Metropolitan Life Insurance Company (“MLIC”) related to $3.8 billion of outstanding advances which had been included in long-term debt, and MLIC assumed the associated obligations under terms similar to those of the transferred advances by issuing funding agreements which are included in PABs. See Note 12.
	Caribbean Business
	In 2011, the Company entered into an agreement to sell its insurance operations in the Caribbean region, Panama and Costa Rica (the “Caribbean Business”). As a result of this agreement, the Company recorded a loss of $21 million, net of income tax, for the year ended December 31, 2011. During 2012, regulatory approvals were obtained for a majority of the jurisdictions and closings were finalized with the buyer, resulting in a gain of $5 million, net of income tax. Sales in the remaining jurisdictions closed in 2013, resulting in a loss of $2 million, net of income tax. These amounts are reflected in net investment gains (losses) within the consolidated statements of operations. The results of the Caribbean Business are included in continuing operations.
	2012 Disposition
	American Life U.K. Assumption Reinsurance
	During July 2012, the Company completed the disposal, through a ceded assumption reinsurance agreement, of certain closed blocks of business in the United Kingdom (“U.K.”), to a third party. Simultaneously, the Company recaptured from the third party the indemnity reinsurance agreement related to this business, previously reinsured as of July 1, 2011. These transactions resulted in a decrease in both insurance and reinsurance assets and liabilities of $4.1 billion. The Company recognized a gain of $25 million, net of income tax, on the transactions for the year ended December 31, 2012, which was recorded in net investment gains (losses) in the consolidated statement of operations.
	2011 Dispositions
	MSI MetLife
	On April 1, 2011, the Company sold its 50% interest in Mitsui Sumitomo MetLife Insurance Co., Ltd. (“MSI MetLife”), a Japan domiciled life insurance company, to its joint venture partner, MS&AD Insurance Group Holdings, Inc. (“MS&AD”), for $269 million (¥22.5 billion) in cash consideration, less $4 million (¥310 million) to reimburse MS&AD for specific expenses incurred related to the transaction. The accumulated other comprehensive losses in the foreign currency translation adjustment component of equity resulting from the hedges of the Company’s investment in the joint venture of $46 million, net of income tax, were released upon sale but did not impact net income for the year ended December 31, 2011 as such losses were considered in the overall impairment evaluation of the investment prior to the sale. During the year ended December 31, 2011, the Company recorded a loss of $57 million, net of income tax, in net investment gains (losses) within the consolidated statements of operations related to the sale. The Company’s operating earnings relating to its investment in MSI MetLife were included in the Asia segment.
	MetLife Taiwan
	On November 1, 2011, the Company sold its wholly-owned subsidiary, MetLife Taiwan Insurance Company Limited (“MetLife Taiwan”) for $180 million in cash consideration. The net assets sold were $282 million, resulting in a loss on disposal of $64 million, net of income tax, recorded in discontinued operations, for the year ended December 31, 2011. Income (loss) from the operations of MetLife Taiwan of $20 million, net of income tax, for the year ended December 31, 2011, was also recorded in discontinued operations. See “— Discontinued Operations” below.
	2010 Acquisition of ALICO
	Description of Transaction
	On November 1, 2010, MetLife, Inc. acquired all of the issued and outstanding capital stock of American Life Insurance Company (“American Life”) from AM Holdings LLC (formerly known as ALICO Holdings LLC) (“AM Holdings”), a subsidiary of American International Group, Inc. (“AIG”), and Delaware American Life Insurance Company (“DelAm”) from AIG (American Life, together with DelAm, collectively, “ALICO”) (the “ALICO Acquisition”) for a total purchase price of $16.4 billion. The ALICO Acquisition significantly broadened the Company’s diversification by product, distribution and geography, meaningfully accelerated MetLife’s global growth strategy, and provides the opportunity to build an international franchise leveraging the key strengths of ALICO.
	Branch Restructuring
	On March 4, 2010, American Life entered into a closing agreement (the “Closing Agreement”) with the Commissioner of the Internal Revenue Service (“IRS”) with respect to a U.S. withholding tax issue arising as a result of payments made by its foreign branches. The Closing Agreement provides that American Life’s foreign branches will not be required to withhold U.S. income tax on the income portion of payments made pursuant to American Life’s life insurance and annuity contracts (“Covered Payments”) for any tax periods beginning on January 1, 2005 and ending on December 31, 2013 (the “Deferral Period”). The Closing Agreement required that American Life submit a plan to the IRS within 90 days after the close of the ALICO Acquisition, indicating the steps American Life would take (on a country by country basis) to ensure that no substantial amount of U.S. withholding tax will arise from Covered Payments made by American Life’s foreign branches to foreign customers after the Deferral Period. Such plan, which was submitted to the IRS on January 29, 2011, involves the transfer of businesses from certain of the foreign branches of American Life to one or more existing or newly-formed subsidiaries of MetLife, Inc. or American Life. See Note 19 for additional information regarding the valuation allowance related to branch restructuring.
	A liability of $277 million was recognized in purchase accounting at November 1, 2010 for the anticipated and estimated costs associated with restructuring American Life’s foreign branches into subsidiaries in connection with the Closing Agreement. This liability has been reduced based on payments through December 31, 2013. In addition, based on revised estimates of anticipated costs, this liability was reduced by $29 million for the year ended December 31, 2013, which was recorded as a reduction in other expenses in the consolidated statement of operations, resulting in a liability of $11 million at December 31, 2013.
	See Notes 11 and 17 for additional information on goodwill and other expenses, respectively, related to the ALICO Acquisition.
	Discontinued Operations
	The following table summarizes the amounts that have been reflected as discontinued operations in the consolidated statements of operations. Income (loss) from discontinued operations includes real estate classified as held-for-sale or sold.
		Years Ended December 31,
		2013		2012		2011
		(In millions)
	Total revenues	$	3	$	74	$	484
	Total expenses	—		—		363
	Income (loss) before provision for income tax	3		74		121
	Provision for income tax expense (benefit)	1		26		33
	Income (loss) from operations of discontinued operations, net of income tax	2		48		88
	Gain (loss) on disposal of operations, net of income tax	—		—		(64		)
	Income (loss) from discontinued operations, net of income tax	$	2	$	48	$	24

Insurance

Insurance	12 Months Ended
	Dec. 31, 2013
Insurance [Abstract]	'
Insurance	'
	4. Insurance
	Insurance Liabilities
	Insurance liabilities are comprised of future policy benefits, PABs and other policy-related balances. Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at:
		December 31,
		2013				2012
		(In millions)
	Retail	$	134,915			$	138,082
	Group, Voluntary & Worksite Benefits	29,521				29,996
	Corporate Benefit Funding	112,591				117,065
	Latin America	16,162				16,055
	Asia	93,066				103,064
	EMEA	21,657				20,200
	Corporate & Other	8,129				9,173
	Total	$	416,041			$	433,635
	Future policy benefits are measured as follows:
	Product Type:	Measurement Assumptions:
	Participating life	Aggregate of (i) net level premium reserves for death and endowment policy benefits (calculated based upon the non-forfeiture interest rate, ranging from 3% to 7% for domestic business and 1% to 13% for international business, and mortality rates guaranteed in calculating the cash surrender values described in such contracts); and (ii) the liability for terminal dividends for domestic business.
	Nonparticipating life	Aggregate of the present value of expected future benefit payments and related expenses less the present value of expected future net premiums. Assumptions as to mortality and persistency are based upon the Company’s experience when the basis of the liability is established. Interest rate assumptions for the aggregate future policy benefit liabilities range from 2% to 10% for domestic business and 1% to 13% for international business.
	Individual and group	Present value of expected future payments. Interest rate assumptions used in establishing such liabilities range from 1% to 11% for domestic business and 1% to 12% for international business.
	traditional fixed annuities
	after annuitization
	Non-medical health	The net level premium method and assumptions as to future morbidity, withdrawals and interest, which provide a margin for adverse deviation. Interest rate assumptions used in establishing such liabilities range from 4% to 7% (primarily related to domestic business).
	insurance
	Disabled lives	Present value of benefits method and experience assumptions as to claim terminations, expenses and interest. Interest rate assumptions used in establishing such liabilities range from 2% to 8% for domestic business and 1% to 9% for international business.
	Property and casualty	The amount estimated for claims that have been reported but not settled and claims incurred but not reported are based upon the Company’s historical experience and other actuarial assumptions that consider the effects of current developments, anticipated trends and risk management programs, reduced for anticipated salvage and subrogation.
	insurance
	Participating business represented 5% and 6% of the Company’s life insurance in-force at December 31, 2013 and 2012, respectively. Participating policies represented 19%, 20% and 21% of gross life insurance premiums for the years ended December 31, 2013, 2012 and 2011, respectively.
	PABs are equal to: (i) policy account values, which consist of an accumulation of gross premium payments and investment performance; (ii) credited interest, ranging from 1% to 13% for domestic business and 1% to 12% for international business, less expenses, mortality charges and withdrawals; and (iii) fair value adjustments relating to business combinations.
	Guarantees
	The Company issues variable annuity products with guaranteed minimum benefits. The non-life contingent portion of GMWBs and the portion of certain GMIBs that does not require annuitization are accounted for as embedded derivatives in PABs and are further discussed in Note 9. Guarantees accounted for as insurance liabilities include:
	Guarantee:				Measurement Assumptions:
	GMDBs	Ÿ	A return of purchase payment upon death even if the account value is reduced to zero.		Ÿ	Present value of expected death benefits in excess of the projected account balance recognizing the excess ratably over the accumulation period based on the present value of total expected assessments.
		Ÿ	An enhanced death benefit may be available for an additional fee.		Ÿ	Assumptions are consistent with those used for amortizing DAC, and are thus subject to the same variability and risk.
					Ÿ	Investment performance and volatility assumptions are consistent with the historical experience of the appropriate underlying equity index, such as the S&P 500 Index.
					Ÿ	Benefit assumptions are based on the average benefits payable over a range of scenarios.
	GMIBs	Ÿ	After a specified period of time determined at the time of issuance of the variable annuity contract, a minimum accumulation of purchase payments, even if the account value is reduced to zero, that can be annuitized to receive a monthly income stream that is not less than a specified amount.		Ÿ	Present value of expected income benefits in excess of the projected account balance at any future date of annuitization and recognizing the excess ratably over the accumulation period based on present value of total expected assessments.
		Ÿ	Certain contracts also provide for a guaranteed lump sum return of purchase premium in lieu of the annuitization benefit.		Ÿ	Assumptions are consistent with those used for estimating GMDB liabilities.
					Ÿ	Calculation incorporates an assumption for the percentage of the potential annuitizations that may be elected by the contractholder.
	GMWBs	Ÿ	A return of purchase payment via partial withdrawals, even if the account value is reduced to zero, provided that cumulative withdrawals in a contract year do not exceed a certain limit.		Ÿ	Expected value of the life contingent payments and expected assessments using assumptions consistent with those used for estimating the GMDB liabilities.
		Ÿ	Certain contracts include guaranteed withdrawals that are life contingent.
	The Company also issues annuity contracts that apply a lower rate on funds deposited if the contractholder elects to surrender the contract for cash and a higher rate if the contractholder elects to annuitize (“two tier annuities”). These guarantees include benefits that are payable in the event of death, maturity or at annuitization. Additionally, the Company issues universal and variable life contracts where the Company contractually guarantees to the contractholder a secondary guarantee or a guaranteed paid-up benefit.
	Information regarding the liabilities for guarantees (excluding base policy liabilities and embedded derivatives) relating to annuity and universal and variable life contracts was as follows:
		Annuity Contracts							Universal and Variable
									Life Contracts
		GMDBs				GMIBs			Secondary				Paid-Up			Total
									Guarantees				Guarantees
		(In millions)
	Direct and Assumed
	Balance at January 1, 2011	$	272			$	623		$	3,991			$	198		$	5,084
	Incurred guaranteed benefits (1)	273				269			496				23			1,061
	Paid guaranteed benefits	(113		)		(10		)	(24		)		—			(147		)
	Balance at December 31, 2011	432				882			4,463				221			5,998
	Incurred guaranteed benefits (1)	252				771			348				25			1,396
	Paid guaranteed benefits	(117		)		(18		)	(26		)		—			(161		)
	Balance at December 31, 2012	567				1,635			4,785				246			7,233
	Incurred guaranteed benefits (1)	200				229			(64		)		20			385
	Paid guaranteed benefits	(82		)		(13		)	(23		)		—			(118		)
	Balance at December 31, 2013	$	685			$	1,851		$	4,698			$	266		$	7,500
	Ceded
	Balance at January 1, 2011	$	39			$	(1	)	$	594			$	139		$	771
	Incurred guaranteed benefits	35				9			20				16			80
	Paid guaranteed benefits	(20		)		—			—				—			(20		)
	Balance at December 31, 2011	54				8			614				155			831
Incurred guaranteed benefits	22				1			139				18			180
Paid guaranteed benefits	(20		)		—			—				—			(20		)
Balance at December 31, 2012	56				9			753				173			991
Incurred guaranteed benefits	(5		)		—			175				14			184
Paid guaranteed benefits	(10		)		(2		)	—				—			(12		)
Balance at December 31, 2013	$	41			$	7		$	928			$	187		$	1,163
Net
Balance at January 1, 2011	$	233			$	624		$	3,397			$	59		$	4,313
Incurred guaranteed benefits	238				260			476				7			981
Paid guaranteed benefits	(93		)		(10		)	(24		)		—			(127		)
Balance at December 31, 2011	378				874			3,849				66			5,167
Incurred guaranteed benefits	230				770			209				7			1,216
Paid guaranteed benefits	(97		)		(18		)	(26		)		—			(141		)
Balance at December 31, 2012	511				1,626			4,032				73			6,242
Incurred guaranteed benefits	205				229			(239		)		6			201
Paid guaranteed benefits	(72		)		(11		)	(23		)		—			(106		)
Balance at December 31, 2013	$	644			$	1,844		$	3,770			$	79		$	6,337
______________
-1	Secondary guarantees include the effects of foreign currency translation of ($597) million, ($39) million and $231 million at December 31, 2013, 2012 and 2011, respectively.
Account balances of contracts with insurance guarantees were invested in separate account asset classes as follows at:
	December 31,
	2013				2012
	(In millions)
Fund Groupings:
Equity	$	79,036			$	66,469
Balanced	75,928				67,230
Bond	10,632				11,188
Money Market	1,157				1,291
Total	$	166,753			$	146,178
Based on the type of guarantee, the Company defines net amount at risk as listed below. These amounts include direct and assumed business, but exclude offsets from hedging or reinsurance, if any.
Variable Annuity Guarantees
In the Event of Death
Defined as the death benefit less the total contract account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.
At Annuitization
Defined as the amount (if any) that would be required to be added to the total contract account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contractholders have achieved.
Two Tier Annuities
Defined as the excess of the upper tier, adjusted for a profit margin, less the lower tier, as of the balance sheet date. These contracts apply a lower rate on funds if the contractholder elects to surrender the contract for cash and a higher rate if the contractholder elects to annuitize.
Universal and Variable Life Contracts
Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date.
Information regarding the types of guarantees relating to annuity contracts and universal and variable life contracts was as follows at:
	December 31,
	2013							2012
	In the				At			In the				At
	Event of Death				Annuitization			Event of Death				Annuitization
	(In millions)
Annuity Contracts (1)
Variable Annuity Guarantees
Total contract account value (2)	$	201,395			$	100,527		$	184,095			$	89,137
Separate account value	$	164,500			$	96,459		$	143,893			$	84,354
Net amount at risk	$	4,203			$	1,219		$	9,501			$	4,593
Average attained age of contractholders	63 years				63 years			62 years				62 years
Two Tier Annuities
General account value	N/A				$	880		N/A				$	848
Net amount at risk	N/A				$	234		N/A				$	232
Average attained age of contractholders	N/A				50 years			N/A				51 years
	December 31,
	2013							2012
	Secondary				Paid-Up			Secondary				Paid-Up
	Guarantees				Guarantees			Guarantees				Guarantees
	(In millions)
Universal and Variable Life Contracts (1)
Account value (general and separate account)	$	16,048			$	3,700		$	14,256			$	3,828
Net amount at risk	$	185,920			$	21,737		$	189,197			$	23,276
Average attained age of policyholders	55 years				60 years			54 years				60 years
______________
-1	The Company’s annuity and life contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.
-2	Includes amounts, which are not reported in the consolidated balance sheets, from assumed reinsurance of certain variable annuity products from the Company’s former operating joint venture in Japan.
Obligations Under Funding Agreements
The Company issues fixed and floating rate funding agreements, which are denominated in either U.S. dollars or foreign currencies, to certain special purpose entities (“SPEs”) that have issued either debt securities or commercial paper for which payment of interest and principal is secured by such funding agreements. During the years ended December 31, 2013, 2012 and 2011, the Company issued $37.7 billion, $35.1 billion and $39.9 billion, respectively, and repaid $36.8 billion, $31.1 billion and $41.6 billion, respectively, of such funding agreements. At December 31, 2013 and 2012, liabilities for funding agreements outstanding, which are included in PABs, were $31.2 billion and $30.0 billion, respectively.
Certain of the Company’s subsidiaries are members of regional banks in the FHLB system (“FHLBanks”). Holdings of common stock of FHLBanks, included in equity securities, were as follows at:
	December 31,
	2013				2012
	(In millions)
FHLB of NY	$	700			$	736
FHLB of Des Moines	$	76			$	83
FHLB of Boston	$	64			$	67
FHLB of Pittsburgh	$	30			$	14
Such subsidiaries have also entered into funding agreements with FHLBanks and the Federal Agricultural Mortgage Corporation, a federally chartered instrumentality of the U.S. (“Farmer Mac”). The liability for such funding agreements is included in PABs. Information related to such funding agreements was as follows at:
	Liability							Collateral
	December 31,
	2013				2012			2013					2012
	(In millions)
FHLB of NY (1)	$	12,770			$	13,512		$	14,287		-2		$	14,611	-2
Farmer Mac (3)	$	2,750			$	2,750		$	3,159				$	3,159
FHLB of Des Moines (1)	$	1,405			$	1,405		$	1,596		-2		$	1,902	-2
FHLB of Boston (1)	$	450			$	450		$	808		-2		$	537	-2
FHLB of Pittsburgh (1)	$	375			$	—		$	976		-2		$	810	-2
______________
-1	Represents funding agreements issued to the applicable FHLBank in exchange for cash and for which such FHLBank has been granted a lien on certain assets, some of which are in the custody of such FHLBank, including residential mortgage-backed securities (“RMBS”), to collateralize obligations under advances evidenced by funding agreements. The Company is permitted to withdraw any portion of the collateral in the custody of such FHLBank as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by the Company, such FHLBank’s recovery on the collateral is limited to the amount of the Company’s liability to such FHLBank.
-2	Advances are collateralized by mortgage-backed securities. The amount of collateral presented is at estimated fair value.
-3	Represents funding agreements issued to certain SPEs that have issued debt securities for which payment of interest and principal is secured by such funding agreements, and such debt securities are also guaranteed as to payment of interest and principal by Farmer Mac. The obligations under these funding agreements are secured by a pledge of certain eligible agricultural real estate mortgage loans and may, under certain circumstances, be secured by other qualified collateral. The amount of collateral presented is at carrying value.
Liabilities for Unpaid Claims and Claim Expenses
Information regarding the liabilities for unpaid claims and claim expenses relating to property and casualty, group accident and non-medical health policies and contracts, which are reported in future policy benefits and other policy-related balances, was as follows:
	Years Ended December 31,
	2013				2012			2011
	(In millions)
Balance at January 1,	$	10,436			$	10,117		$	10,708
Less: Reinsurance recoverables	1,581				1,436			2,198
Net balance at January 1,	8,855				8,681			8,510
Incurred related to:
Current year	8,660				8,399			9,028
Prior years (1)	(86		)		(69		)	(199		)
Total incurred	8,574				8,330			8,829
Paid related to:
Current year	(6,083		)		(5,689		)	(6,238		)
Prior years	(2,377		)		(2,467		)	(2,420		)
Total paid	(8,460		)		(8,156		)	(8,658		)
Net balance at December 31,	8,969				8,855			8,681
Add: Reinsurance recoverables	1,661				1,581			1,436
Balance at December 31,	$	10,630			$	10,436		$	10,117
______________
-1	During 2013, 2012 and 2011, as a result of changes in estimates of insured events in the respective prior year, claims and claim adjustment expenses associated with prior years decreased due to a reduction in prior year automobile bodily injury and homeowners’ severity and improved loss ratio for non-medical health claim liabilities.
Separate Accounts
Separate account assets and liabilities include two categories of account types: pass-through separate accounts totaling $265.4 billion and $185.9 billion at December 31, 2013 and 2012, respectively, for which the policyholder assumes all investment risk, and separate accounts for which the Company contractually guarantees either a minimum return or account value to the policyholder which totaled $51.8 billion and $49.5 billion at December 31, 2013 and 2012, respectively. The latter category consisted primarily of funding agreements and participating close-out contracts. The average interest rate credited on these contracts was 2.23% and 2.80% at December 31, 2013 and 2012, respectively.
For the years ended December 31, 2013, 2012 and 2011, there were no investment gains (losses) on transfers of assets from the general account to the separate accounts.

Deferred_Policy_Acquisition_Co

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles	12 Months Ended
	Dec. 31, 2013
Deferred Policy Acquisition Costs and Value of Business Acquired [Abstract]	'
Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles	'
	5. Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles
	See Note 1 for a description of capitalized acquisition costs.
	Nonparticipating and Non-Dividend-Paying Traditional Contracts
	The Company amortizes DAC and VOBA related to these contracts (term insurance, nonparticipating whole life insurance, traditional group life insurance, non-medical health insurance, and accident and health insurance) over the appropriate premium paying period in proportion to the historic actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, morbidity, persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policyholder benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. Absent a premium deficiency, variability in amortization after policy issuance or acquisition is caused only by variability in premium volumes.
	Participating, Dividend-Paying Traditional Contracts
	The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross margins. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The future gross margins are dependent principally on investment returns, policyholder dividend scales, mortality, persistency, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inflation. For participating contracts within the closed block (dividend-paying traditional contracts) future gross margins are also dependent upon changes in the policyholder dividend obligation. See Note 7. Of these factors, the Company anticipates that investment returns, expenses, persistency and other factor changes, as well as policyholder dividend scales are reasonably likely to impact significantly the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross margins with the actual gross margins for that period. When the actual gross margins change from previously estimated gross margins, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross margins exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross margins are below the previously estimated gross margins. Each reporting period, the Company also updates the actual amount of business in-force, which impacts expected future gross margins. When expected future gross margins are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross margins are above the previously estimated expected future gross margins. Each period, the Company also reviews the estimated gross margins for each block of business to determine the recoverability of DAC and VOBA balances.
	Fixed and Variable Universal Life Contracts and Fixed and Variable Deferred Annuity Contracts
	The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties, the effect of any hedges used and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses and persistency are reasonably likely to impact significantly the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. Each period, the Company also reviews the estimated gross profits for each block of business to determine the recoverability of DAC and VOBA balances.
	Credit Insurance, Property and Casualty Insurance and Other Short-Duration Contracts
	The Company amortizes DAC for these contracts, which is primarily composed of commissions and certain underwriting expenses, in proportion to historic and future earned premium over the applicable contract term.
	Factors Impacting Amortization
	Separate account rates of return on variable universal life contracts and variable deferred annuity contracts affect in-force account balances on such contracts each reporting period, which can result in significant fluctuations in amortization of DAC and VOBA. Returns that are higher than the Company’s long-term expectation produce higher account balances, which increases the Company’s future fee expectations and decreases future benefit payment expectations on minimum death and living benefit guarantees, resulting in higher expected future gross profits. The opposite result occurs when returns are lower than the Company’s long-term expectation. The Company’s practice to determine the impact of gross profits resulting from returns on separate accounts assumes that long-term appreciation in equity markets is not changed by short-term market fluctuations, but is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes.
	The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These assumptions primarily relate to investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC and VOBA amortization will decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease.
	Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If such modification, referred to as an internal replacement, substantially changes the contract, the associated DAC or VOBA is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed.
	Amortization of DAC and VOBA is attributed to net investment gains (losses) and net derivative gains (losses), and to other expenses for the amount of gross margins or profits originating from transactions other than investment gains and losses. Unrealized investment gains and losses represent the amount of DAC and VOBA that would have been amortized if such gains and losses had been recognized.
	Information regarding DAC and VOBA was as follows:
		Years Ended December 31,
		2013			2012			2011
		(In millions)
	DAC
	Balance at January 1,	$	17,150		$	15,240		$	13,377
	Capitalizations	4,786			5,289			5,558
	Amortization related to:
	Net investment gains (losses) and net derivative gains (losses)	192			(40		)	(478		)
	Other expenses	(2,812		)	(2,875		)	(2,614		)
	Total amortization	(2,620		)	(2,915		)	(3,092		)
	Unrealized investment gains (losses)	924			(516		)	(427		)
	Effect of foreign currency translation and other	(466		)	52			(176		)
	Balance at December 31,	19,774			17,150			15,240
	VOBA
	Balance at January 1,	7,611			9,379			11,088
	Acquisitions (1)	947			55			11
	Amortization related to:
	Net investment gains (losses) and net derivative gains (losses)	3			(1		)	(49		)
	Other expenses	(933		)	(1,283		)	(1,757		)
	Total amortization	(930		)	(1,284		)	(1,806		)
	Unrealized investment gains (losses)	358			(197		)	(361		)
	Effect of foreign currency translation and other	(1,054		)	(342		)	447
	Balance at December 31,	6,932			7,611			9,379
	Total DAC and VOBA
	Balance at December 31,	$	26,706		$	24,761		$	24,619
	______________
	(1) See Note 3 for a description of acquisitions.
	Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at:
		December 31,
		2013			2012
		(In millions)
	Retail	$	12,882		$	11,500
	Group, Voluntary & Worksite Benefits	382			382
	Corporate Benefit Funding	99			96
	Latin America	2,201			1,231
	Asia	9,077			9,554
	EMEA	2,039			1,998
	Corporate & Other	26			—
	Total	$	26,706		$	24,761
	Information regarding other policy-related intangibles was as follows:
		Years Ended December 31,
		2013			2012			2011
		(In millions)
	Deferred Sales Inducements
	Balance at January 1,	$	930		$	926		$	918
	Capitalization	58			81			140
	Amortization	(36		)	(77		)	(132		)
Effect of foreign currency translation	(2		)	—			—
Balance at December 31,	$	950		$	930		$	926
VODA and VOCRA
Balance at January 1,	$	1,108		$	1,264		$	1,094
Acquisitions	—			—			213
Amortization (1)	(84		)	(150		)	(60		)
Effect of foreign currency translation	(49		)	(6		)	17
Balance at December 31,	$	975		$	1,108		$	1,264
Accumulated amortization	$	418		$	334		$	184
Negative VOBA
Balance at January 1,	$	2,916		$	3,657		$	4,287
Acquisitions	—			10			7
Amortization	(579		)	(622		)	(697		)
Effect of foreign currency translation	(175		)	(129		)	60
Balance at December 31,	$	2,162		$	2,916		$	3,657
Accumulated amortization	$	1,962		$	1,383		$	761
____________
-1	In connection with the Company’s annual impairment testing of VOCRA, it was determined that the VOCRA included in the Group, Voluntary & Worksite Benefits segment, associated with a previously acquired dental business, was impaired as the undiscounted future cash flows associated with the asset were lower than its current carrying value. This shortfall in undiscounted future cash flows is primarily the result of actual persistency experience being less favorable than what was assumed when the asset was acquired. As a result of this impairment, the Company wrote the asset down to its estimated fair value, which was determined using the discounted cash flow valuation approach. The Company recorded a non-cash charge of $77 million ($50 million, net of income tax) for the impairment of the VOCRA balance to other expenses in the consolidated statement of operations for the year ended December 31, 2012.
The estimated future amortization expense (credit) to be reported in other expenses for the next five years is as follows:
	VOBA			VODA and VOCRA			Negative VOBA
	(In millions)
2014	$	846		$	80		$	(438	)
2015	$	700		$	79		$	(353	)
2016	$	596		$	75		$	(271	)
2017	$	516		$	71		$	(154	)
2018	$	448		$	66		$	(68	)

Reinsurance

Reinsurance	12 Months Ended
	Dec. 31, 2013
Reinsurance Disclosures [Abstract]	'
Reinsurance	'
	6. Reinsurance
	The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by third parties. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.
	Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 8.
	Americas — Excluding Latin America
	For its Retail Life & Other insurance products, the Company has historically reinsured the mortality risk primarily on an excess of retention basis or on a quota share basis. The Company currently reinsures 90% of the mortality risk in excess of $2 million for most products and reinsures up to 90% of the mortality risk for certain other products. In addition to reinsuring mortality risk as described above, the Company reinsures other risks, as well as specific coverages. Placement of reinsurance is done primarily on an automatic basis and also on a facultative basis for risks with specified characteristics. On a case by case basis, the Company may retain up to $20 million per life and reinsure 100% of amounts in excess of the amount the Company retains. The Company evaluates its reinsurance programs routinely and may increase or decrease its retention at any time.
	The Company’s Retail Annuities business reinsures a portion of the living and death benefit guarantees issued in connection with its variable annuities. Under these reinsurance agreements, the Company pays a reinsurance premium generally based on fees associated with the guarantees collected from policyholders, and receives reimbursement for benefits paid or accrued in excess of account values, subject to certain limitations. The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer.
	For certain policies within the Group, Voluntary & Worksite Benefits segment, the Company generally retains most of the risk and only cedes particular risks on certain client arrangements. The majority of the Company’s reinsurance activity within this segment relates to client agreements for employer sponsored captive programs, risk-sharing agreements and multinational pooling.
	The Company, through its property & casualty business within the Retail and Group, Voluntary & Worksite Benefits segments, purchases reinsurance to manage its exposure to large losses (primarily catastrophe losses) and to protect statutory surplus. The Company cedes to reinsurers losses and premiums based upon the exposure of the policies subject to reinsurance. To manage exposure to large property & casualty losses, the Company purchases property catastrophe, casualty and property per risk excess of loss reinsurance protection.
	The Company’s Corporate Benefit Funding segment has periodically engaged in reinsurance activities, on an opportunistic basis. The impact of these activities on the financial results of this segment has not been significant and there were no additional transactions during the periods presented.
	Latin America, Asia and EMEA
	For life insurance products, the Company currently reinsures, depending on the product, risks in excess of $5 million to external reinsurers on a yearly renewable term basis. The Company may also reinsure certain risks with external reinsurers depending upon the nature of the risk and local regulatory requirements. For selected large corporate clients, the Company reinsures group employee benefits or credit insurance business with various client-affiliated reinsurance companies, covering policies issued to the employees or customers of the clients. Additionally, the Company cedes and assumes risk with other insurance companies when either company requires a business partner with the appropriate local licensing to issue certain types of policies in certain countries. In these cases, the assuming company typically underwrites the risks, develops the products and assumes most or all of the risk. The Company also has reinsurance agreements in force that reinsure a portion of the living and death benefit guarantees issued in connection with variable annuity products. Under these agreements, the Company pays reinsurance fees associated with the guarantees collected from policyholders, and receives reimbursement for benefits paid or accrued in excess of account values, subject to certain limitations.
	Corporate & Other
	The Company also reinsures, through 100% quota share reinsurance agreements, certain run-off LTC and workers’ compensation business written by MetLife Insurance Company of Connecticut (“MICC”).
	Corporate & Other also has a reinsurance agreement, whereby it assumes the living and death benefit guarantees issued in connection with certain variable annuity products. Under this agreement, the Company receives reinsurance fees associated with the guarantees collected from policyholders, and provides reimbursement for benefits paid or accrued in excess of account values, subject to certain limitations.
	Catastrophe Coverage
	The Company has exposure to catastrophes which could contribute to significant fluctuations in the Company’s results of operations. In the Americas, excluding Latin America, the Company uses excess of retention and quota share reinsurance agreements to provide greater diversification of risk and minimize exposure to larger risks. Currently, for Latin America, Asia and EMEA, the Company purchases catastrophe coverage to insure risks within certain countries deemed by management to be exposed to the greatest catastrophic risks.
	Reinsurance Recoverables
	The Company reinsures its business through a diversified group of well-capitalized, highly rated reinsurers. The Company analyzes recent trends in arbitration and litigation outcomes in disputes, if any, with its reinsurers. The Company monitors ratings and evaluates the financial strength of its reinsurers by analyzing their financial statements. In addition, the reinsurance recoverable balance due from each reinsurer is evaluated as part of the overall monitoring process. Recoverability of reinsurance recoverable balances is evaluated based on these analyses. The Company generally secures large reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. These reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance, which at December 31, 2013 and 2012, were not significant.
	The Company has secured certain reinsurance recoverable balances with various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit. The Company had $5.6 billion and $5.7 billion of unsecured reinsurance recoverable balances at December 31, 2013 and 2012, respectively.
	At December 31, 2013, the Company had $14.4 billion of net ceded reinsurance recoverables. Of this total, $10.6 billion, or 74%, were with the Company’s five largest ceded reinsurers, including $2.6 billion of net ceded reinsurance recoverables which were unsecured. At December 31, 2012, the Company had $14.1 billion of net ceded reinsurance recoverables. Of this total, $10.4 billion, or 74%, were with the Company’s five largest ceded reinsurers, including $2.8 billion of net ceded reinsurance recoverables which were unsecured.
	The Company has reinsured with an unaffiliated third-party reinsurer, 59.25% of the closed block through a modified coinsurance agreement. The Company accounts for this agreement under the deposit method of accounting. The Company, having the right of offset, has offset the modified coinsurance deposit with the deposit recoverable.
	The amounts in the consolidated statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows:
		Years Ended December 31,
		2013			2012			2011
		(In millions)
	Premiums
	Direct premiums	$	38,476		$	38,719		$	37,185
	Reinsurance assumed	1,472			1,488			1,484
	Reinsurance ceded	(2,274		)	(2,232		)	(2,308		)
	Net premiums	$	37,674		$	37,975		$	36,361
	Universal life and investment-type product policy fees
	Direct universal life and investment-type product policy fees	$	10,197		$	9,216		$	8,455
	Reinsurance assumed	139			155			154
	Reinsurance ceded	(885		)	(815		)	(803		)
	Net universal life and investment-type product policy fees	$	9,451		$	8,556		$	7,806
	Policyholder benefits and claims
	Direct policyholder benefits and claims	$	40,211		$	39,262		$	37,588
	Reinsurance assumed	1,047			1,167			1,101
	Reinsurance ceded	(3,151		)	(2,442		)	(3,218		)
	Net policyholder benefits and claims	$	38,107		$	37,987		$	35,471
	Other expenses
	Direct other expenses	$	16,712		$	17,848		$	18,672
	Reinsurance assumed	147			228			168
	Reinsurance ceded	(257		)	(321		)	(303		)
	Net other expenses	$	16,602		$	17,755		$	18,537
	The amounts in the consolidated balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at:
		December 31,
		2013											2012
		Direct			Assumed			Ceded			Total		Direct		Assumed		Ceded			Total
											Balance									Balance
											Sheet									Sheet
		(In millions)
	Assets
	Premiums, reinsurance and other receivables	$	6,248		$	593		$	15,018		$	21,859	$	6,286	$	548	$	14,800		$	21,634
	Deferred policy acquisition costs and value of business acquired	26,954			104			(352		)	26,706		24,789		92		(120		)	24,761
	Total assets	$	33,202		$	697		$	14,666		$	48,565	$	31,075	$	640	$	14,680		$	46,395
	Liabilities
	Future policy benefits	$	185,908		$	2,034		$	—		$	187,942	$	190,321	$	2,031	$	(1	)	$	192,351
	Policyholder account balances	211,610			1,277			(2		)	212,885		223,229		2,594		(2		)	225,821
	Other policy-related balances	14,838			353			23			15,214		15,142		313		8			15,463
	Other liabilities	19,591			533			3,044			23,168		18,925		543		3,024			22,492
	Total liabilities	$	431,947		$	4,197		$	3,065		$	439,209	$	447,617	$	5,481	$	3,029		$	456,127
	Reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on reinsurance were $2.3 billion at both December 31, 2013 and 2012. The deposit liabilities on reinsurance were $37 million and $45 million at December 31, 2013 and 2012, respectively.

Closed_Block

Closed Block	12 Months Ended
	Dec. 31, 2013
Closed Block Disclosure [Abstract]	'
Closed Block	'
	7. Closed Block
	On April 7, 2000 (the “Demutualization Date”), MLIC converted from a mutual life insurance company to a stock life insurance company and became a wholly-owned subsidiary of MetLife, Inc. The conversion was pursuant to an order by the New York Superintendent of Insurance approving MLIC’s plan of reorganization, as amended (the “Plan”). On the Demutualization Date, MLIC established a closed block for the benefit of holders of certain individual life insurance policies of MLIC. Assets have been allocated to the closed block in an amount that has been determined to produce cash flows which, together with anticipated revenues from the policies included in the closed block, are reasonably expected to be sufficient to support obligations and liabilities relating to these policies, including, but not limited to, provisions for the payment of claims and certain expenses and taxes, and to provide for the continuation of policyholder dividend scales in effect for 1999, if the experience underlying such dividend scales continues, and for appropriate adjustments in such scales if the experience changes. At least annually, the Company compares actual and projected experience against the experience assumed in the then-current dividend scales. Dividend scales are adjusted periodically to give effect to changes in experience.
	The closed block assets, the cash flows generated by the closed block assets and the anticipated revenues from the policies in the closed block will benefit only the holders of the policies in the closed block. To the extent that, over time, cash flows from the assets allocated to the closed block and claims and other experience related to the closed block are, in the aggregate, more or less favorable than what was assumed when the closed block was established, total dividends paid to closed block policyholders in the future may be greater than or less than the total dividends that would have been paid to these policyholders if the policyholder dividend scales in effect for 1999 had been continued. Any cash flows in excess of amounts assumed will be available for distribution over time to closed block policyholders and will not be available to stockholders. If the closed block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from assets outside of the closed block. The closed block will continue in effect as long as any policy in the closed block remains in-force. The expected life of the closed block is over 100 years.
	The Company uses the same accounting principles to account for the participating policies included in the closed block as it used prior to the Demutualization Date. However, the Company establishes a policyholder dividend obligation for earnings that will be paid to policyholders as additional dividends as described below. The excess of closed block liabilities over closed block assets at the Demutualization Date (adjusted to eliminate the impact of related amounts in AOCI) represents the estimated maximum future earnings from the closed block expected to result from operations attributed to the closed block after income taxes. Earnings of the closed block are recognized in income over the period the policies and contracts in the closed block remain in-force. Management believes that over time the actual cumulative earnings of the closed block will approximately equal the expected cumulative earnings due to the effect of dividend changes. If, over the period the closed block remains in existence, the actual cumulative earnings of the closed block are greater than the expected cumulative earnings of the closed block, the Company will pay the excess of the actual cumulative earnings of the closed block over the expected cumulative earnings to closed block policyholders as additional policyholder dividends unless offset by future unfavorable experience of the closed block and, accordingly, will recognize only the expected cumulative earnings in income with the excess recorded as a policyholder dividend obligation. If over such period, the actual cumulative earnings of the closed block are less than the expected cumulative earnings of the closed block, the Company will recognize only the actual earnings in income. However, the Company may change policyholder dividend scales in the future, which would be intended to increase future actual earnings until the actual cumulative earnings equal the expected cumulative earnings.
	Experience within the closed block, in particular mortality and investment yields, as well as realized and unrealized gains and losses, directly impact the policyholder dividend obligation. Amortization of the closed block DAC, which resides outside of the closed block, is based upon cumulative actual and expected earnings within the closed block. Accordingly, the Company’s net income continues to be sensitive to the actual performance of the closed block.
	Closed block assets, liabilities, revenues and expenses are combined on a line-by-line basis with the assets, liabilities, revenues and expenses outside the closed block based on the nature of the particular item.
	Information regarding the closed block liabilities and assets designated to the closed block was as follows at:
		December 31,
		2013				2012
		(In millions)
	Closed Block Liabilities
	Future policy benefits	$	42,076			$	42,586
	Other policy-related balances	298				298
	Policyholder dividends payable	456				466
	Policyholder dividend obligation	1,771				3,828
	Current income tax payable	18				—
	Other liabilities	582				602
	Total closed block liabilities	45,201				47,780
	Assets Designated to the Closed Block
	Investments:
	Fixed maturity securities available-for-sale, at estimated fair value	28,374				30,546
	Equity securities available-for-sale, at estimated fair value	86				41
	Mortgage loans	6,155				6,192
	Policy loans	4,669				4,670
	Real estate and real estate joint ventures	492				459
	Other invested assets	814				953
	Total investments	40,590				42,861
	Cash and cash equivalents	238				381
	Accrued investment income	477				481
	Premiums, reinsurance and other receivables	98				107
	Current income tax recoverable	—				2
	Deferred income tax assets	293				319
	Total assets designated to the closed block	41,696				44,151
	Excess of closed block liabilities over assets designated to the closed block	3,505				3,629
	Amounts included in AOCI:
	Unrealized investment gains (losses), net of income tax	1,502				2,891
	Unrealized gains (losses) on derivatives, net of income tax	(3		)		9
	Allocated to policyholder dividend obligation, net of income tax	(1,151		)		(2,488		)
	Total amounts included in AOCI	348				412
	Maximum future earnings to be recognized from closed block assets and liabilities	$	3,853			$	4,041
	Information regarding the closed block policyholder dividend obligation was as follows:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Balance at January 1,	$	3,828			$	2,919			$	876
	Change in unrealized investment and derivative gains (losses)	(2,057		)		909				2,043
	Balance at December 31,	$	1,771			$	3,828			$	2,919
	Information regarding the closed block revenues and expenses was as follows:
			Years Ended December 31,
			2013				2012				2011
			(In millions)
	Revenues
	Premiums		$	1,987			$	2,139			$	2,306
	Net investment income		2,130				2,188				2,231
	Net investment gains (losses)		25				61				32
	Net derivative gains (losses)		(6		)		(12		)		8
	Total revenues		4,136				4,376				4,577
	Expenses
	Policyholder benefits and claims		2,702				2,783				2,991
	Policyholder dividends		979				1,072				1,137
	Other expenses		165				179				193
	Total expenses		3,846				4,034				4,321
	Revenues, net of expenses before provision for income tax expense (benefit)		290				342				256
Provision for income tax expense (benefit)		101				120				89
Revenues, net of expenses and provision for income tax expense (benefit) from continuing operations		189				222				167
Revenues, net of expenses and provision for income tax expense (benefit) from discontinued operations		—				10				1
Revenues, net of expenses and provision for income tax expense (benefit)		$	189			$	232			$	168
MLIC charges the closed block with federal income taxes, state and local premium taxes and other additive state or local taxes, as well as investment management expenses relating to the closed block as provided in the Plan. MLIC also charges the closed block for expenses of maintaining the policies included in the closed block.

Investments

Investments	12 Months Ended
	Dec. 31, 2013
Investments, Debt and Equity Securities [Abstract]	'
Investments	'
	8. Investments
	See Note 10 for information about the fair value hierarchy for investments and the related valuation methodologies.
	Investment Risks and Uncertainties
	Investments are exposed to the following primary sources of risk: credit, interest rate, liquidity, market valuation, currency and real estate risk. The financial statement risks, stemming from such investment risks, are those associated with the determination of estimated fair values, the diminished ability to sell certain investments in times of strained market conditions, the recognition of impairments, the recognition of income on certain investments and the potential consolidation of VIEs. The use of different methodologies, assumptions and inputs relating to these financial statement risks may have a material effect on the amounts presented within the consolidated financial statements.
	The determination of valuation allowances and impairments is highly subjective and is based upon periodic evaluations and assessments of known and inherent risks associated with the respective asset class. Such evaluations and assessments are revised as conditions change and new information becomes available.
	The recognition of income on certain investments (e.g. structured securities, including mortgage-backed securities, asset-backed securities (“ABS”), certain structured investment transactions and FVO and trading securities) is dependent upon certain factors such as prepayments and defaults, and changes in such factors could result in changes in amounts to be earned.
	Fixed Maturity and Equity Securities AFS
	Fixed Maturity and Equity Securities AFS by Sector
	The following table presents the fixed maturity and equity securities AFS by sector. Redeemable preferred stock is reported within U.S. corporate and foreign corporate fixed maturity securities and non-redeemable preferred stock is reported within equity securities. Included within fixed maturity securities are structured securities including RMBS, commercial mortgage-backed securities (“CMBS”) and ABS.
		December 31, 2013																				December 31, 2012
		Cost or				Gross Unrealized												Estimated				Cost or				Gross Unrealized									Estimated
		Amortized																Fair				Amortized													Fair
		Cost				Gains				Temporary				OTTI				Value				Cost				Gains			Temporary			OTTI			Value
										Losses				Losses															Losses			Losses
																		(In millions)
	Fixed maturity securities
	U.S. corporate	$	100,203			$	7,495			$	1,229			$	—			$	106,469			$	102,669			$	11,887		$	430		$	—		$	114,126
	Foreign corporate (1)	59,778				3,939				565				—				63,152				61,806				5,654			277			(1		)	67,184
	Foreign government	50,717				4,107				387				—				54,437				51,967				5,440			71			—			57,336
	U.S. Treasury and agency	43,928				2,251				1,056				—				45,123				41,874				6,104			11			—			47,967
	RMBS	34,167				1,584				490				206				35,055				35,666				2,477			315			349			37,479
	CMBS	16,115				605				170				—				16,550				18,177				1,009			57			—			19,129
	ABS	15,458				296				171				12				15,571				15,762				404			156			13			15,997
	State and political subdivision	13,233				903				306				—				13,830				12,949				2,169			70			—			15,048
	Total fixed maturity securities	$	333,599			$	21,180			$	4,374			$	218			$	350,187			$	340,870			$	35,144		$	1,387		$	361		$	374,266
	Equity securities
	Common stock	$	1,927			$	431			$	5			$	—			$	2,353			$	2,034			$	147		$	19		$	—		$	2,162
	Non-redeemable preferred stock	1,085				76				112				—				1,049				804				65			140			—			729
	Total equity securities	$	3,012			$	507			$	117			$	—			$	3,402			$	2,838			$	212		$	159		$	—		$	2,891
	______________
	-1	The noncredit loss component of OTTI losses for foreign corporate securities was in an unrealized gain position of $1 million at December 31, 2012, due to increases in estimated fair value subsequent to initial recognition of noncredit losses on such securities. See also “— Net Unrealized Investment Gains (Losses).”
	The Company held non-income producing fixed maturity securities with an estimated fair value of $74 million and $85 million with unrealized gains (losses) of $23 million and $11 million at December 31, 2013 and 2012, respectively.
	Methodology for Amortization of Premium and Accretion of Discount on Structured Securities
	Amortization of premium and accretion of discount on structured securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for single class and multi-class mortgage-backed and ABS are estimated using inputs obtained from third-party specialists and based on management’s knowledge of the current market. For credit-sensitive mortgage-backed and ABS and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other mortgage-backed and ABS, the effective yield is recalculated on a retrospective basis.
	Maturities of Fixed Maturity Securities
	The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at:
		December 31,
		2013								2012
		Amortized				Estimated				Amortized				Estimated
		Cost				Fair				Cost				Fair
						Value								Value
		(In millions)
	Due in one year or less	$	15,828			$	16,030			$	24,177			$	24,394
	Due after one year through five years	70,467				74,229				66,973				70,759
	Due after five years through ten years	78,159				83,223				82,376				91,975
	Due after ten years	103,405				109,529				97,739				114,533
	Subtotal	267,859				283,011				271,265				301,661
	Structured securities (RMBS, CMBS and ABS)	65,740				67,176				69,605				72,605
	Total fixed maturity securities	$	333,599			$	350,187			$	340,870			$	374,266
	Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. RMBS, CMBS and ABS are shown separately, as they are not due at a single maturity.
	Continuous Gross Unrealized Losses for Fixed Maturity and Equity Securities AFS by Sector
	The following table presents the estimated fair value and gross unrealized losses of fixed maturity and equity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position.
		31-Dec-13																December 31, 2012
		Less than 12 Months								Equal to or Greater than 12 Months								Less than 12 Months								Equal to or Greater than 12 Months
		Estimated				Gross				Estimated				Gross				Estimated				Gross				Estimated			Gross
		Fair				Unrealized				Fair				Unrealized				Fair				Unrealized				Fair			Unrealized
		Value				Losses				Value				Losses				Value				Losses				Value			Losses
		(In millions, except number of securities)
	Fixed maturity securities
	U.S. corporate	$	13,889			$	808			$	3,807			$	421			$	3,799			$	88			$	3,695		$	342
	Foreign corporate	9,019				402				2,320				163				2,783				96				2,873			180
	Foreign government	5,052				336				1,846				51				1,431				22				543			49
	U.S. Treasury and agency	15,225				1,037				357				19				1,951				11				—			—
RMBS	10,754				363				2,302				333				735				31				4,098			633
CMBS	3,696				142				631				28				842				11				577			46
ABS	3,772				59				978				124				1,920				30				1,410			139
State and political subdivision	3,109				225				351				81				260				4				251			66
Total fixed maturity securities	$	64,516			$	3,372			$	12,592			$	1,220			$	13,721			$	293			$	13,447		$	1,455
Equity securities
Common stock	$	81			$	4			$	16			$	1			$	201			$	18			$	14		$	1
Non-redeemable preferred stock	364				65				191				47				—				—				295			140
Total equity securities	$	445			$	69			$	207			$	48			$	201			$	18			$	309		$	141
Total number of securities in an	4,480								1,571								1,941								1,335
unrealized loss position
Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities
Evaluation and Measurement Methodologies
Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below cost or amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) with respect to fixed maturity securities, whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to structured securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; and (viii) other subjective factors, including concentrations and information obtained from regulators and rating agencies.
The methodology and significant inputs used to determine the amount of credit loss on fixed maturity securities are as follows:
•	The Company calculates the recovery value by performing a discounted cash flow analysis based on the present value of future cash flows. The discount rate is generally the effective interest rate of the security prior to impairment.
•	When determining collectability and the period over which value is expected to recover, the Company applies considerations utilized in its overall impairment evaluation process which incorporates information regarding the specific security, fundamentals of the industry and geographic area in which the security issuer operates, and overall macroeconomic conditions. Projected future cash flows are estimated using assumptions derived from management’s best estimates of likely scenario-based outcomes after giving consideration to a variety of variables that include, but are not limited to: payment terms of the security; the likelihood that the issuer can service the interest and principal payments; the quality and amount of any credit enhancements; the security’s position within the capital structure of the issuer; possible corporate restructurings or asset sales by the issuer; and changes to the rating of the security or the issuer by rating agencies.
•	Additional considerations are made when assessing the unique features that apply to certain structured securities including, but not limited to: the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying loans or assets backing a particular security, and the payment priority within the tranche structure of the security.
•	When determining the amount of the credit loss for U.S. and foreign corporate securities, foreign government securities and state and political subdivision securities, the estimated fair value is considered the recovery value when available information does not indicate that another value is more appropriate. When information is identified that indicates a recovery value other than estimated fair value, management considers in the determination of recovery value the same considerations utilized in its overall impairment evaluation process as described above, as well as any private and public sector programs to restructure such securities.
With respect to securities that have attributes of debt and equity (perpetual hybrid securities), consideration is given in the OTTI analysis as to whether there has been any deterioration in the credit of the issuer and the likelihood of recovery in value of the securities that are in a severe and extended unrealized loss position. Consideration is also given as to whether any perpetual hybrid securities, with an unrealized loss, regardless of credit rating, have deferred any dividend payments. When an OTTI loss has occurred, the OTTI loss is the entire difference between the perpetual hybrid security’s cost and its estimated fair value with a corresponding charge to earnings.
The cost or amortized cost of fixed maturity and equity securities is adjusted for OTTI in the period in which the determination is made. The Company does not change the revised cost basis for subsequent recoveries in value.
In periods subsequent to the recognition of OTTI on a fixed maturity security, the Company accounts for the impaired security as if it had been purchased on the measurement date of the impairment. Accordingly, the discount (or reduced premium) based on the new cost basis is accreted over the remaining term of the fixed maturity security in a prospective manner based on the amount and timing of estimated future cash flows.
Current Period Evaluation
Based on the Company’s current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company’s current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company has concluded that these securities are not other-than-temporarily impaired at December 31, 2013. Future OTTI will depend primarily on economic fundamentals, issuer performance (including changes in the present value of future cash flows expected to be collected), and changes in credit ratings, collateral valuation, interest rates and credit spreads. If economic fundamentals deteriorate or if there are adverse changes in the above factors, OTTI may be incurred in upcoming periods.
Gross unrealized losses on fixed maturity securities increased $2.9 billion during the year ended December 31, 2013 from $1.7 billion to $4.6 billion. The increase in gross unrealized losses for the year ended December 31, 2013, was primarily attributable to an increase in interest rates, partially offset by narrowing credit spreads.
At December 31, 2013, $296 million of the total $4.6 billion of gross unrealized losses were from 95 fixed maturity securities with an unrealized loss position of 20% or more of amortized cost for six months or greater.
Investment Grade Fixed Maturity Securities
Of the $296 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $165 million, or 56%, are related to gross unrealized losses on 64 investment grade fixed maturity securities. Unrealized losses on investment grade fixed maturity securities are principally related to widening credit spreads and, with respect to fixed-rate fixed maturity securities, rising interest rates since purchase.
Below Investment Grade Fixed Maturity Securities
Of the $296 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $131 million, or 44%, are related to gross unrealized losses on 31 below investment grade fixed maturity securities. Unrealized losses on below investment grade fixed maturity securities are principally related to non-agency RMBS (primarily alternative residential mortgage loans) and ABS (primarily foreign ABS) and are the result of significantly wider credit spreads resulting from higher risk premiums since purchase, largely due to economic and market uncertainties including concerns over unemployment levels and valuations of residential real estate supporting non-agency RMBS. Management evaluates non-agency RMBS and ABS based on actual and projected cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security.
Equity Securities
Gross unrealized losses on equity securities decreased $42 million during the year ended December 31, 2013 from $159 million to $117 million. Of the $117 million, $39 million were from 11 equity securities with gross unrealized losses of 20% or more of cost for 12 months or greater, all of which were financial services industry investment grade non-redeemable preferred stock, of which 65% were rated A or better.
Mortgage Loans
Mortgage Loans by Portfolio Segment
Mortgage loans are summarized as follows at:
	December 31,
	2013							2012
	Carrying				% of			Carrying				% of
	Value				Total			Value				Total
	(In millions)							(In millions)
Mortgage loans held-for-investment:
Commercial	$	40,926			70.9	%		$	40,472			71	%
Agricultural	12,391				21.5			12,843				22.5
Residential	2,772				4.8			958				1.7
Subtotal (1)	56,089				97.2			54,273				95.2
Valuation allowances	(322		)		(0.6	)		(347		)		(0.6	)
Subtotal mortgage loans held-for-investment, net	55,767				96.6			53,926				94.6
Residential — FVO	338				0.6			—				—
Commercial mortgage loans held by CSEs — FVO	1,598				2.8			2,666				4.7
Total mortgage loans held-for-investment, net	57,703				100			56,592				99.3
Mortgage loans held-for-sale	3				—			414				0.7
Total mortgage loans, net	$	57,706			100	%		$	57,006			100	%
______________
-1	Purchases of mortgage loans were $2.2 billion and $205 million for the years ended December 31, 2013 and 2012, respectively.
See “— Variable Interest Entities” for discussion of CSEs.
Mortgage Loans and Valuation Allowance by Portfolio Segment
The carrying value prior to valuation allowance (“recorded investment”) in mortgage loans held-for-investment, by portfolio segment, by method of evaluation of credit loss, and the related valuation allowances, by type of credit loss, were as follows at:
	December 31,
	2013																2012
	Commercial				Agricultural				Residential				Total				Commercial				Agricultural				Residential			Total
	(In millions)
Mortgage loans:
Evaluated individually for credit losses	$	506			$	100			$	16			$	622			$	539			$	181			$	13		$	733
Evaluated collectively for credit losses	40,420				12,291				2,756				55,467				39,933				12,662				945			53,540
Total mortgage loans	40,926				12,391				2,772				56,089				40,472				12,843				958			54,273
Valuation allowances:
Specific credit losses	58				7				1				66				94				21				2			117
Non-specifically identified credit losses	200				37				19				256				199				31				—			230
Total valuation allowances	258				44				20				322				293				52				2			347
Mortgage loans, net of valuation allowance	$	40,668			$	12,347			$	2,752			$	55,767			$	40,179			$	12,791			$	956		$	53,926
Valuation Allowance Rollforward by Portfolio Segment
The changes in the valuation allowance, by portfolio segment, were as follows:
	Commercial				Agricultural				Residential				Total
	(In millions)
Balance at January 1, 2011	$	562			$	88			$	14			$	664
Provision (release)	(152		)		(3		)		10				(145		)
Charge-offs, net of recoveries	(12		)		(4		)		(3		)		(19		)
Transfers to held-for-sale (1)	—				—				(19		)		(19		)
Balance at December 31, 2011	398				81				2				481
Provision (release)	(92		)		—				6				(86		)
Charge-offs, net of recoveries	(13		)		(24		)		—				(37		)
Transfers to held-for-sale (1)	—				(5		)		(6		)		(11		)
Balance at December 31, 2012	293				52				2				347
Provision (release)	(35		)		4				18				(13		)
Charge-offs, net of recoveries	—				(12		)		—				(12		)
Transfers to held-for-sale	—				—				—				—
Balance at December 31, 2013	$	258			$	44			$	20			$	322
______________
-1	The valuation allowance on and the related carrying value of certain residential mortgage loans held-for-investment were transferred to mortgage loans held-for-sale in connection with the MetLife Bank Divestiture. See Note 3.
Valuation Allowance Methodology
Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for all three portfolio segments as the excess carrying value of a loan over either (i) the present value of expected future cash flows discounted at the loan’s original effective interest rate, (ii) the estimated fair value of the loan’s underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan’s observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for all loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company’s experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.
Commercial and Agricultural Mortgage Loan Portfolio Segments
The Company typically uses several years of historical experience in establishing non-specific valuation allowances which captures multiple economic cycles. For evaluations of commercial mortgage loans, in addition to historical experience, management considers factors that include the impact of a rapid change to the economy, which may not be reflected in the loan portfolio, and recent loss and recovery trend experience as compared to historical loss and recovery experience. For evaluations of agricultural mortgage loans, in addition to historical experience, management considers factors that include increased stress in certain sectors, which may be evidenced by higher delinquency rates, or a change in the number of higher risk loans. On a quarterly basis, management incorporates the impact of these current market events and conditions on historical experience in determining the non-specific valuation allowance established for commercial and agricultural mortgage loans.
All commercial mortgage loans are reviewed on an ongoing basis which may include an analysis of the property financial statements and rent roll, lease rollover analysis, property inspections, market analysis, estimated valuations of the underlying collateral, loan-to-value ratios, debt service coverage ratios, and tenant creditworthiness. All agricultural mortgage loans are monitored on an ongoing basis. The monitoring process focuses on higher risk loans, which include those that are classified as restructured, delinquent or in foreclosure, as well as loans with higher loan-to-value ratios and lower debt service coverage ratios. The monitoring process for agricultural mortgage loans is generally similar to the commercial mortgage loan monitoring process, with a focus on higher risk loans, including reviews on a geographic and property-type basis. Higher risk loans are reviewed individually on an ongoing basis for potential credit loss and specific valuation allowances are established using the methodology described above. Quarterly, the remaining loans are reviewed on a pool basis by aggregating groups of loans that have similar risk characteristics for potential credit loss, and non-specific valuation allowances are established as described above using inputs that are unique to each segment of the loan portfolio.
For commercial mortgage loans, the primary credit quality indicator is the debt service coverage ratio, which compares a property’s net operating income to amounts needed to service the principal and interest due under the loan. Generally, the lower the debt service coverage ratio, the higher the risk of experiencing a credit loss. The Company also reviews the loan-to-value ratio of its commercial mortgage loan portfolio. Loan-to-value ratios compare the unpaid principal balance of the loan to the estimated fair value of the underlying collateral. Generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss. The debt service coverage ratio and loan-to-value ratio, as well as the values utilized in calculating these ratios, are updated annually, on a rolling basis, with a portion of the loan portfolio updated each quarter.
For agricultural mortgage loans, the Company’s primary credit quality indicator is the loan-to-value ratio. The values utilized in calculating this ratio are developed in connection with the ongoing review of the agricultural mortgage loan portfolio and are routinely updated.
Residential Mortgage Loan Portfolio Segment
The Company’s residential mortgage loan portfolio is comprised primarily of closed end, amortizing residential mortgage loans. For evaluations of residential mortgage loans, the key inputs of expected frequency and expected loss reflect current market conditions, with expected frequency adjusted, when appropriate, for differences from market conditions and the Company’s historical experience. In contrast to the commercial and agricultural mortgage loan portfolios, residential mortgage loans are smaller-balance homogeneous loans that are collectively evaluated for impairment. Non-specific valuation allowances are established using the evaluation framework described above for pools of loans with similar risk characteristics from inputs that are unique to the residential segment of the loan portfolio. Loan specific valuation allowances are only established on residential mortgage loans when they have been restructured and are established using the methodology described above for all loan portfolio segments.
For residential mortgage loans, the Company’s primary credit quality indicator is whether the loan is performing or nonperforming. The Company generally defines nonperforming residential mortgage loans as those that are 60 or more days past due and/or in non-accrual status which is assessed monthly. Generally, nonperforming residential mortgage loans have a higher risk of experiencing a credit loss.
Credit Quality of Commercial Mortgage Loans
The credit quality of commercial mortgage loans held-for-investment, were as follows at:
	Recorded Investment																			Estimated				% of
	Debt Service Coverage Ratios												Total				% of			Fair				Total
	> 1.20x				1.00x - 1.20x				< 1.00x								Total			Value
	(In millions)																			(In millions)
December 31, 2013:
Loan-to-value ratios:
Less than 65%	$	30,552			$	614			$	841			$	32,007			78.2	%		$	33,519			78.9	%
65% to 75%	6,360				438				149				6,947				17			7,039				16.6
76% to 80%	525				192				189				906				2.2			892				2.1
Greater than 80%	661				242				163				1,066				2.6			1,006				2.4
Total	$	38,098			$	1,486			$	1,342			$	40,926			100	%		$	42,456			100	%
December 31, 2012:
Loan-to-value ratios:
Less than 65%	$	29,839			$	730			$	722			$	31,291			77.3	%		$	33,730			78.3	%
65% to 75%	5,057				672				153				5,882				14.6			6,129				14.2
76% to 80%	938				131				316				1,385				3.4			1,436				3.3
Greater than 80%	1,085				552				277				1,914				4.7			1,787				4.2
Total	$	36,919			$	2,085			$	1,468			$	40,472			100	%		$	43,082			100	%
Credit Quality of Agricultural Mortgage Loans
The credit quality of agricultural mortgage loans held-for-investment, were as follows at:
	December 31,
	2013							2012
	Recorded				% of			Recorded				% of
	Investment				Total			Investment				Total
	(In millions)							(In millions)
Loan-to-value ratios:
Less than 65%	$	11,461			92.5	%		$	11,908			92.7	%
65% to 75%	729				5.9			590				4.6
76% to 80%	84				0.7			92				0.7
Greater than 80%	117				0.9			253				2
Total	$	12,391			100	%		$	12,843			100	%
The estimated fair value of agricultural mortgage loans held-for-investment was $12.7 billion and $13.3 billion at December 31, 2013 and 2012, respectively.
Credit Quality of Residential Mortgage Loans
The credit quality of residential mortgage loans held-for-investment, were as follows at:
	December 31,
	2013							2012
	Recorded				% of			Recorded				% of
	Investment				Total			Investment				Total
	(In millions)							(In millions)
Performance indicators:
Performing	$	2,693			97.1	%		$	929			97	%
Nonperforming	79				2.9			29				3
Total	$	2,772			100	%		$	958			100	%
The estimated fair value of residential mortgage loans held-for-investment was $2.8 billion and $1.0 billion at December 31, 2013 and 2012, respectively.
Past Due and Interest Accrual Status of Mortgage Loans
The Company has a high quality, well performing mortgage loan portfolio, with 99% of all mortgage loans classified as performing at both December 31, 2013 and 2012. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days. The past due and accrual status of mortgage loans at recorded investment, prior to valuation allowances, by portfolio segment, were as follows at:
	Past Due								Greater than 90 Days Past Due								Nonaccrual Status
									and Still Accruing Interest
	31-Dec-13				31-Dec-12				31-Dec-13				31-Dec-12				31-Dec-13				31-Dec-12
	(In millions)
Commercial	$	12			$	2			$	12			$	—			$	191			$	84
Agricultural	44				116				—				53				47				67
Residential	79				29				—				—				65				18
Total	$	135			$	147			$	12			$	53			$	303			$	169
Impaired Mortgage Loans
Impaired mortgage loans held-for-investment, including those modified in a troubled debt restructuring, by portfolio segment, were as follows at and for the years ended:
	Loans with a Valuation Allowance																Loans without a Valuation Allowance								All Impaired Loans
	Unpaid				Recorded				Valuation				Carrying				Unpaid				Recorded				Unpaid			Carrying			Average			Interest
	Principal				Investment				Allowances				Value				Principal				Investment				Principal			Value			Recorded			Income
	Balance																Balance								Balance						Investment
	(In millions)
December 31, 2013:
Commercial	$	214			$	210			$	58			$	152			$	299			$	296			$	513		$	448		$	526		$	15
Agricultural	68				66				7				59				35				34				103			93			153			9
Residential	12				12				1				11				5				4				17			15			14			—
Total	$	294			$	288			$	66			$	222			$	339			$	334			$	633		$	556		$	693		$	24
December 31, 2012:
Commercial	$	445			$	436			$	94			$	342			$	103			$	103			$	548		$	445		$	464		$	14
Agricultural	110				107				21				86				79				74				189			160			204			8
Residential	13				13				2				11				—				—				13			11			13			—
Total	$	568			$	556			$	117			$	439			$	182			$	177			$	750		$	616		$	681		$	22
Unpaid principal balance is generally prior to any charge-offs. Interest income recognized is primarily cash basis income. The average recorded investment for commercial, agricultural and residential mortgage loans was $313 million, $252 million and $23 million, respectively, for the year ended December 31, 2011; and interest income recognized for commercial, agricultural and residential mortgage loans was $6 million, $5 million and $0, respectively, for the year ended December 31, 2011.
Mortgage Loans Modified in a Troubled Debt Restructuring
For a small portion of the mortgage loan portfolio, classified as troubled debt restructurings, concessions are granted related to borrowers experiencing financial difficulties. Generally, the types of concessions include: reduction of the contractual interest rate, extension of the maturity date at an interest rate lower than current market interest rates, and/or a reduction of accrued interest. The amount, timing and extent of the concession granted is considered in determining any impairment or changes in the specific valuation allowance recorded with the restructuring. Through the continuous monitoring process, a specific valuation allowance may have been recorded prior to the quarter when the mortgage loan is modified in a troubled debt restructuring. Accordingly, the carrying value (after specific valuation allowance) before and after modification through a troubled debt restructuring may not change significantly, or may increase if the expected recovery is higher than the pre-modification recovery assessment. The number of mortgage loans and carrying value after specific valuation allowance of mortgage loans modified during the period in a troubled debt restructuring were as follows:
	Years Ended December 31,
	2013											2012
	Number of			Carrying Value after Specific								Number of			Carrying Value after Specific
	Mortgage Loans			Valuation Allowance								Mortgage Loans			Valuation Allowance
				Pre-Modification				Post-Modification							Pre-Modification				Post-Modification
				(In millions)											(In millions)
Commercial	1			$	49			$	49			1			$	222			$	199
Agricultural	3			28				28				5			17				16
Residential	27			5				5				—			—				—
Total	31			$	82			$	82			6			$	239			$	215
The Company had one residential mortgage loan modified in a troubled debt restructuring with a subsequent payment default with a carrying value of less than $1 million at December 31, 2013. There were no mortgage loans modified in a troubled debt restructuring with a subsequent payment default at December 31, 2012. Payment default is determined in the same manner as delinquency status as described above.
Other Invested Assets
Other invested assets is comprised primarily of freestanding derivatives with positive estimated fair values (see Note 9), tax credit and renewable energy partnerships, and leveraged leases.
Leveraged Leases
Investment in leveraged leases consisted of the following at:
	December 31,
	2013				2012
	(In millions)
Rental receivables, net	$	1,491			$	1,564
Estimated residual values	1,325				1,474
Subtotal	2,816				3,038
Unearned income	(870		)		(1,040		)
Investment in leveraged leases, net of non-recourse debt	$	1,946			$	1,998
Rental receivables are generally due in periodic installments. The payment periods range from one to 15 years but in certain circumstances can be over 30 years. For rental receivables, the primary credit quality indicator is whether the rental receivable is performing or nonperforming, which is assessed monthly. The Company generally defines nonperforming rental receivables as those that are 90 days or more past due. At December 31, 2013 and 2012, all rental receivables were performing.
The deferred income tax liability related to leveraged leases was $1.6 billion at both December 31, 2013 and 2012.
The components of income from investment in leveraged leases, excluding net investment gains (losses), were as follows:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Income from investment in leveraged leases	$	82			$	57			$	125
Less: Income tax expense on leveraged leases	29				20				44
Investment income after income tax from investment in leveraged leases	$	53			$	37			$	81
Cash Equivalents
The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $3.8 billion and $6.1 billion at December 31, 2013 and 2012, respectively.
Net Unrealized Investment Gains (Losses)
The components of net unrealized investment gains (losses), included in AOCI, were as follows:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Fixed maturity securities	$	16,672			$	33,641			$	21,096
Fixed maturity securities with noncredit OTTI losses in AOCI	(218		)		(361		)		(724		)
Total fixed maturity securities	16,454				33,280				20,372
Equity securities	390				97				(167		)
Derivatives	375				1,274				1,514
Other	(73		)		(30		)		72
Subtotal	17,146				34,621				21,791
Amounts allocated from:
Insurance liability loss recognition	(898		)		(6,049		)		(3,996		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	6				19				47
DAC and VOBA	(1,190		)		(2,485		)		(1,800		)
Policyholder dividend obligation	(1,771		)		(3,828		)		(2,919		)
Subtotal	(3,853		)		(12,343		)		(8,668		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	73				119				236
Deferred income tax benefit (expense)	(4,956		)		(7,973		)		(4,694		)
Net unrealized investment gains (losses)	8,410				14,424				8,665
Net unrealized investment gains (losses) attributable to noncontrolling interests	4				(5		)		9
Net unrealized investment gains (losses) attributable to MetLife, Inc.	$	8,414			$	14,419			$	8,674
The changes in fixed maturity securities with noncredit OTTI losses included in AOCI were as follows:
	Years Ended December 31,
	2013				2012
	(In millions)
Balance at January 1,	$	(361	)		$	(724	)
Noncredit OTTI losses and subsequent changes recognized (1)	60				(29		)
Securities sold with previous noncredit OTTI loss	149				177
Subsequent changes in estimated fair value	(66		)		215
Balance at December 31,	$	(218	)		$	(361	)
______________
-1	Noncredit OTTI losses and subsequent changes recognized, net of DAC, were $52 million and ($21) million for the years ended December 31, 2013 and 2012, respectively.
The changes in net unrealized investment gains (losses) were as follows:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Balance at January 1,	$	14,419			$	8,674			$	3,122
Fixed maturity securities on which noncredit OTTI losses have been recognized	143				363				(123		)
Unrealized investment gains (losses) during the year	(17,618		)		12,467				14,823
Unrealized investment gains (losses) of subsidiary at the date of disposal	—				—				(105		)
Unrealized investment gains (losses) relating to:
Insurance liability gain (loss) recognition	5,151				(2,053		)		(3,406		)
Insurance liability gain (loss) recognition of subsidiary at the date of disposal	—				—				82
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(13		)		(28		)		9
DAC and VOBA	1,295				(685		)		(808		)
DAC and VOBA of subsidiary at date of disposal	—				—				11
Policyholder dividend obligation	2,057				(909		)		(2,043		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	(46		)		(117		)		39
Deferred income tax benefit (expense)	3,017				(3,279		)		(2,936		)
Deferred income tax benefit (expense) of subsidiary at date of disposal	—				—				4
Net unrealized investment gains (losses)	8,405				14,433				8,669
Net unrealized investment gains (losses) attributable to noncontrolling interests	9				(14		)		5
Balance at December 31,	$	8,414			$	14,419			$	8,674
Change in net unrealized investment gains (losses)	$	(6,014	)		$	5,759			$	5,547
Change in net unrealized investment gains (losses) attributable to noncontrolling interests	9				(14		)		5
Change in net unrealized investment gains (losses) attributable to MetLife, Inc.	$	(6,005	)		$	5,745			$	5,552
Concentrations of Credit Risk
Investments in any counterparty that were greater than 10% of the Company’s equity, other than the U.S. government and its agencies, were in fixed income securities of the Japanese government and its agencies with an estimated fair value of $21.7 billion and $22.4 billion at December 31, 2013 and 2012, respectively. The Company’s investment in fixed maturity and equity securities to counterparties that primarily conduct business in Japan, including Japan government and agency fixed maturity securities, was $26.9 billion and $28.7 billion at December 31, 2013 and 2012, respectively.
Securities Lending
Elements of the securities lending program are presented below at:
	December 31,
	2013				2012
	(In millions)
Securities on loan: (1)
Amortized cost	$	27,094			$	23,380
Estimated fair value	$	27,595			$	27,077
Cash collateral on deposit from counterparties (2)	$	28,319			$	27,727
Security collateral on deposit from counterparties (3)	$	—			$	104
Reinvestment portfolio — estimated fair value	$	28,481			$	28,112
______________
-1	Included within fixed maturity securities, short-term investments, equity securities and cash and cash equivalents.
-2	Included within payables for collateral under securities loaned and other transactions.
-3	Security collateral on deposit from counterparties may not be sold or repledged, unless the counterparty is in default, and is not reflected in the consolidated financial statements.
Invested Assets on Deposit, Held in Trust and Pledged as Collateral
Invested assets on deposit, held in trust and pledged as collateral are presented below at estimated fair value for cash and cash equivalents, short-term investments, fixed maturity and equity securities, and FVO and trading securities, and at carrying value for mortgage loans at:
	December 31,
	2013				2012
	(In millions)
Invested assets on deposit (regulatory deposits)	$	2,153			$	2,362
Invested assets held in trust (collateral financing arrangements and reinsurance agreements)	11,004				12,434
Invested assets pledged as collateral (1)	23,770				23,251
Total invested assets on deposit, held in trust and pledged as collateral	$	36,927			$	38,047
______________
-1	The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Notes 4 and 12), collateral financing arrangements (see Note 13) and derivative transactions (see Note 9).
In the second quarter of 2013, MetLife, Inc. announced its plans to merge three U.S. based life insurance companies and an offshore reinsurance subsidiary to create one larger U.S. based and U.S. regulated life insurance company (the “Mergers”). The companies to be merged are MICC, MetLife Investors USA Insurance Company (“MLI-USA”) and MetLife Investors Insurance Company (“MLIIC”), each a U.S. insurance company that issues variable annuity products in addition to other products, and Exeter Reassurance Company, Ltd. (“Exeter”), a reinsurance company that mainly reinsures guarantees associated with variable annuity products. MICC, which is expected to be renamed and domiciled in Delaware, will be the surviving entity. In October 2013, Exeter, formerly a Cayman Islands company, was re-domesticated to Delaware. Effective January 1, 2014, following receipt of New York State Department of Financial Services (the “Department of Financial Services”) approval, MICC withdrew its license to issue insurance policies and annuity contracts in New York. Also effective January 1, 2014, MICC reinsured with an affiliate all existing New York insurance policies and annuity contracts that include a separate account feature; on December 31, 2013, MICC deposited investments with an estimated fair market value of $6.3 billion into a custodial account, which became restricted on January 1, 2014, to secure MICC’s remaining New York policyholder liabilities not covered by the reinsurance. The Mergers are expected to occur in the fourth quarter of 2014, subject to regulatory approvals. See Note 12 for information regarding the impact of the re-domestication of Exeter on availability under our credit facilities.
See “— Securities Lending” for securities on loan and Note 7 for investments designated to the closed block.
Purchased Credit Impaired Investments
Investments acquired with evidence of credit quality deterioration since origination and for which it is probable at the acquisition date that the Company will be unable to collect all contractually required payments are classified as purchased credit impaired (“PCI”) investments. For each investment, the excess of the cash flows expected to be collected as of the acquisition date over its acquisition date fair value is referred to as the accretable yield and is recognized as net investment income on an effective yield basis. If subsequently, based on current information and events, it is probable that there is a significant increase in cash flows previously expected to be collected or if actual cash flows are significantly greater than cash flows previously expected to be collected, the accretable yield is adjusted prospectively. The excess of the contractually required payments (including interest) as of the acquisition date over the cash flows expected to be collected as of the acquisition date is referred to as the nonaccretable difference, and this amount is not expected to be realized as net investment income. Decreases in cash flows expected to be collected can result in OTTI or the recognition of mortgage loan valuation allowances.
The Company’s PCI investments, by invested asset class, were as follows at:
	December 31,
	2013				2012				2013				2012
	Fixed Maturity Securities								Mortgage Loans
	(In millions)
Outstanding principal and interest balance (1)	$	5,319			$	4,905			$	291			$	440
Carrying value (2)	$	4,109			$	3,900			$	138			$	199
______________
-1	Represents the contractually required payments, which is the sum of contractual principal, whether or not currently due, and accrued interest.
-2	Estimated fair value plus accrued interest for fixed maturity securities and amortized cost, plus accrued interest, less any valuation allowances, for mortgage loans.
The following table presents information about PCI investments acquired during the periods indicated:
	Years Ended December 31,
	2013				2012				2013				2012
	Fixed Maturity Securities								Mortgage Loans
	(In millions)
Contractually required payments (including interest)	$	1,872			$	2,083			$	—			$	—
Cash flows expected to be collected (1)	$	1,446			$	1,524			$	—			$	—
Fair value of investments acquired	$	978			$	991			$	—			$	—
______________
-1	Represents undiscounted principal and interest cash flow expectations, at the date of acquisition.
The following table presents activity for the accretable yield on PCI investments:
	Years Ended December 31,
	2013				2012				2013				2012
	Fixed Maturity Securities								Mortgage Loans
	(In millions)
Accretable yield, January 1,	$	2,665			$	2,311			$	184			$	254
Investments purchased	468				533				—				—
Accretion recognized in earnings	(260		)		(203		)		(87		)		(71		)
Disposals	(152		)		(102		)		—				—
Reclassification (to) from nonaccretable difference	25				126				(23		)		1
Accretable yield, December 31,	$	2,746			$	2,665			$	74			$	184
Collectively Significant Equity Method Investments
The Company holds investments in real estate joint ventures, real estate funds and other limited partnership interests consisting of leveraged buy-out funds, hedge funds, private equity funds, joint ventures and other funds. The portion of these investments accounted for under the equity method had a carrying value of $12.1 billion at December 31, 2013. The Company’s maximum exposure to loss related to these equity method investments is limited to the carrying value of these investments plus unfunded commitments of $4.0 billion at December 31, 2013. Except for certain real estate joint ventures, the Company’s investments in real estate funds and other limited partnership interests are generally of a passive nature in that the Company does not participate in the management of the entities.
As described in Note 1, the Company generally records its share of earnings in its equity method investments using a three-month lag methodology and within net investment income. Aggregate net investment income from these equity method investments exceeded 10% of the Company’s consolidated pre-tax income (loss) from continuing operations for two of the three most recent annual periods: 2013 and 2012. The Company is providing the following aggregated summarized financial data for such equity method investments, for the most recent annual periods, in order to provide comparative information. This aggregated summarized financial data does not represent the Company’s proportionate share of the assets, liabilities, or earnings of such entities.
The aggregated summarized financial data presented below reflects the latest available financial information and is as of, and for, the years ended December 31, 2013, 2012 and 2011. Aggregate total assets of these entities totaled $303.4 billion and $285.2 billion at December 31, 2013 and 2012, respectively. Aggregate total liabilities of these entities totaled $29.7 billion and $28.8 billion at December 31, 2013 and 2012, respectively. Aggregate net income (loss) of these entities totaled $26.3 billion, $17.9 billion and $9.7 billion for the years ended December 31, 2013, 2012 and 2011, respectively. Aggregate net income (loss) from the underlying entities in which the Company invests is primarily comprised of investment income, including recurring investment income and realized and unrealized investment gains (losses).
Variable Interest Entities
The Company has invested in certain structured transactions (including CSEs), formed trusts to invest proceeds from certain collateral financing arrangements and has insurance operations that are VIEs. In certain instances, the Company holds both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, is deemed to be the primary beneficiary or consolidator of the entity.
The determination of the VIE’s primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party’s relationship with or involvement in the entity, an estimate of the entity’s expected losses and expected residual returns and the allocation of such estimates to each party involved in the entity. The Company generally uses a qualitative approach to determine whether it is the primary beneficiary. However, for VIEs that are investment companies or apply measurement principles consistent with those utilized by investment companies, the primary beneficiary is based on a risks and rewards model and is defined as the entity that will absorb a majority of a VIE’s expected losses, receive a majority of a VIE’s expected residual returns if no single entity absorbs a majority of expected losses, or both. The Company reassesses its involvement with VIEs on a quarterly basis. The use of different methodologies, assumptions and inputs in the determination of the primary beneficiary could have a material effect on the amounts presented within the consolidated financial statements.
Consolidated VIEs
The following table presents the total assets and total liabilities relating to VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at December 31, 2013 and 2012. Creditors or beneficial interest holders of VIEs where the Company is the primary beneficiary have no recourse to the general credit of the Company, as the Company’s obligation to the VIEs is limited to the amount of its committed investment.
	December 31,
	2013								2012
	Total				Total				Total				Total
	Assets				Liabilities				Assets				Liabilities
	(In millions)
MRSC (collateral financing arrangement (primarily securities)) (1)	$	3,440			$	—			$	3,439			$	—
Operating joint venture (2)	2,095				1,777				—				—
CSEs (assets (primarily loans) and liabilities (primarily debt)) (3)	1,630				1,457				2,730				2,545
Investments:
Real estate joint ventures (4)	1,181				443				11				14
Other invested assets	82				7				85				—
FVO and trading securities	69				—				71				—
Other limited partnership interests	61				—				356				8
Total	$	8,558			$	3,684			$	6,692			$	2,567
______________
-1	See Note 13 for a description of the MetLife Reinsurance Company of South Carolina (“MRSC”) collateral financing arrangement.
-2	Assets of the operating joint venture are primarily fixed maturity securities and separate account assets. Liabilities of the operating joint venture are primarily future policy benefits, other policyholder funds and separate account liabilities. The assets and liabilities of the operating joint venture were consolidated in earlier periods; however, as a result of the quarterly reassessment in the first quarter of 2013, it was determined to be a consolidated VIE.
-3	The Company consolidates entities that are structured as CMBS and as collateralized debt obligations. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company’s exposure was limited to that of its remaining investment in these entities of $154 million and $168 million at estimated fair value at December 31, 2013 and 2012, respectively. The long-term debt bears interest primarily at fixed rates ranging from 2.25% to 5.57%, payable primarily on a monthly basis. Interest expense related to these obligations, included in other expenses, was $122 million, $163 million and $324 million for the years ended December 31, 2013, 2012 and 2011 respectively.
-4	The Company consolidated an open ended core real estate fund formed in the fourth quarter of 2013, which represented the majority of the balances at December 31, 2013. Assets of the real estate fund are a real estate investment trust which holds primarily traditional core income-producing real estate which has associated liabilities that are primarily non-recourse debt secured by certain real estate assets of the fund. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company’s exposure was limited to that of its investment in the real estate fund of $178 million at carrying value at December 31, 2013. The long-term debt bears interest primarily at fixed rates ranging from 1.39% to 4.45%, payable primarily on a monthly basis. Interest expense related to these obligations, included in other expenses, was less than $1 million for the year ended December 31, 2013.
Unconsolidated VIEs
The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at:
	December 31,
	2013								2012
	Carrying				Maximum				Carrying				Maximum
	Amount				Exposure				Amount				Exposure
					to Loss (1)								to Loss (1)
	(In millions)
Fixed maturity securities AFS:
Structured securities (RMBS, CMBS and ABS) (2)	$	67,176			$	67,176			$	72,605			$	72,605
U.S. and foreign corporate	3,966				3,966				5,287				5,287
Other limited partnership interests	5,041				6,994				4,436				5,908
Other invested assets	1,509				1,897				1,117				1,431
FVO and trading securities	619				619				563				563
Mortgage loans	106				106				351				351
Real estate joint ventures	70				71				150				157
Equity securities AFS:
Non-redeemable preferred stock	35				35				32				32
Total	$	78,522			$	80,864			$	84,541			$	86,334
______________
-1	The maximum exposure to loss relating to fixed maturity securities AFS, FVO and trading securities and equity securities AFS is equal to their carrying amounts or the carrying amounts of retained interests. The maximum exposure to loss relating to other limited partnership interests, mortgage loans and real estate joint ventures is equal to the carrying amounts plus any unfunded commitments of the Company. For certain of its investments in other invested assets, the Company’s return is in the form of income tax credits which are guaranteed by creditworthy third parties. For such investments, the maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments, reduced by income tax credits guaranteed by third parties of $257 million and $318 million at December 31, 2013 and 2012, respectively. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee.
-2	For these variable interests, the Company’s involvement is limited to that of a passive investor.
As described in Note 21, the Company makes commitments to fund partnership investments in the normal course of business. Excluding these commitments, the Company did not provide financial or other support to investees designated as VIEs during the years ended December 31, 2013, 2012 and 2011.
Net Investment Income
The components of net investment income were as follows:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Investment income:
Fixed maturity securities	$	15,071			$	15,218			$	15,037
Equity securities	127				133				141
FVO and trading securities — Actively Traded Securities and FVO general account securities (1)	65				88				31
Mortgage loans	3,020				3,191				3,164
Policy loans	620				626				641
Real estate and real estate joint ventures	909				834				688
Other limited partnership interests	955				845				681
Cash, cash equivalents and short-term investments	181				163				167
International joint ventures	10				19				(12		)
Other	165				131				178
Subtotal	21,123				21,248				20,716
Less: Investment expenses	1,198				1,090				1,019
Subtotal, net	19,925				20,158				19,697
FVO and trading securities — FVO contractholder-directed unit-linked investments (1)	2,172				1,473				(453		)
Securitized reverse residential mortgage loans	—				177				—
FVO CSEs - interest income:
Commercial mortgage loans	132				172				332
Securities	3				4				9
Subtotal	2,307				1,826				(112		)
Net investment income	$	22,232			$	21,984			$	19,585
______________
-1	Changes in estimated fair value subsequent to purchase for securities still held as of the end of the respective years included in net investment income were as follows:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Actively Traded Securities and FVO general account securities	$	18			$	51			$	(3	)
FVO contractholder-directed unit-linked investments	$	1,579			$	1,170			$	(647	)
See “— Variable Interest Entities” for discussion of CSEs.
Net Investment Gains (Losses)
Components of Net Investment Gains (Losses)
The components of net investment gains (losses) were as follows:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Total gains (losses) on fixed maturity securities:
Total OTTI losses recognized — by sector and industry:
U.S. and foreign corporate securities — by industry:
Utility	$	(48	)		$	(61	)		$	(10	)
Consumer	(11		)		(19		)		(50		)
Finance	(10		)		(32		)		(56		)
Transportation	(3		)		(17		)		—
Communications	(2		)		(19		)		(41		)
Technology	—				(6		)		(1		)
Industrial	—				(5		)		(11		)
Total U.S. and foreign corporate securities	(74		)		(159		)		(169		)
RMBS	(80		)		(97		)		(214		)
CMBS	(12		)		(51		)		(32		)
ABS	—				(9		)		(54		)
State and political subdivision	—				(1		)		—
Foreign government	—				—				(486		)
OTTI losses on fixed maturity securities recognized in earnings	(166		)		(317		)		(955		)
Fixed maturity securities — net gains (losses) on sales and disposals	561				253				25
Total gains (losses) on fixed maturity securities (1)	395				(64		)		(930		)
Total gains (losses) on equity securities:
Total OTTI losses recognized — by sector:
Non-redeemable preferred stock	(20		)		—				(38		)
Common stock	(6		)		(34		)		(22		)
OTTI losses on equity securities recognized in earnings	(26		)		(34		)		(60		)
Equity securities — net gains (losses) on sales and disposals	31				38				37
Total gains (losses) on equity securities	5				4				(23		)
FVO and trading securities — FVO general account securities	15				17				(2		)
Mortgage loans (1)	22				57				175
Real estate and real estate joint ventures	(19		)		(36		)		134
Other limited partnership interests	(48		)		(36		)		4
Other investment portfolio gains (losses)	22				(151		)		(7		)
Subtotal — investment portfolio gains (losses) (1)	392				(209		)		(649		)
FVO CSEs:
Commercial mortgage loans	(52		)		7				(84		)
Securities	2				—				—
Long-term debt — related to commercial mortgage loans	85				25				97
Long-term debt — related to securities	(2		)		(7		)		(8		)
Non-investment portfolio gains (losses) (2)	(264		)		(168		)		(223		)
Subtotal FVO CSEs and non-investment portfolio gains (losses)	(231		)		(143		)		(218		)
Total net investment gains (losses)	$	161			$	(352	)		$	(867	)
______________
-1	Investment portfolio gains (losses) for the years ended December 31, 2012 and 2011 includes a net gain (loss) of $37 million and ($153) million, respectively, as a result of the MetLife Bank Divestiture, which is comprised of gains (losses) on investments sold of $78 million and $1 million, respectively, and impairments on mortgage loans of ($41) million and ($154) million, respectively. See Note 3.
-2	Non-investment portfolio gains (losses) for the years ended December 31, 2013 and 2012 includes a gain of $30 million and $33 million, respectively, related to certain dispositions as more fully described in Note 3. Non-investment portfolio gains (losses) for the year ended December 31, 2011 includes a loss of $106 million related to certain dispositions and a goodwill impairment loss of $65 million. See Notes 3 and 11.
See “— Variable Interest Entities” for discussion of CSEs.
Gains (losses) from foreign currency transactions included within net investment gains (losses) were $171 million, ($112) million and $37 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Sales or Disposals and Impairments of Fixed Maturity and Equity Securities
Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) are as shown in the table below. Investment gains and losses on sales of securities are determined on a specific identification basis.
	Years Ended December 31,
	2013				2012				2011				2013				2012				2011				2013			2012			2011
	Fixed Maturity Securities												Equity Securities												Total
	(In millions)
Proceeds	$	76,070			$	59,219			$	67,449			$	746			$	1,648			$	1,241			$	76,816		$	60,867		$	68,690
Gross investment gains	$	1,326			$	944			$	892			$	56			$	73			$	108			$	1,382		$	1,017		$	1,000
Gross investment losses	(765		)		(691		)		(867		)		(25		)		(35		)		(71		)		(790		)	(726		)	(938		)
Total OTTI losses:
Credit-related	(147		)		(223		)		(645		)		—				—				—				(147		)	(223		)	(645		)
Other (1)	(19		)		(94		)		(310		)		(26		)		(34		)		(60		)		(45		)	(128		)	(370		)
Total OTTI losses	(166		)		(317		)		(955		)		(26		)		(34		)		(60		)		(192		)	(351		)	(1,015		)
Net investment gains (losses)	$	395			$	(64	)		$	(930	)		$	5			$	4			$	(23	)		$	400		$	(60	)	$	(953	)
______________
-1	Other OTTI losses recognized in earnings include impairments on (i) equity securities, (ii) perpetual hybrid securities classified within fixed maturity securities where the primary reason for the impairment was the severity and/or the duration of an unrealized loss position and (iii) fixed maturity securities where there is an intent to sell or it is more likely than not that the Company will be required to sell the security before recovery of the decline in estimated fair value.
Credit Loss Rollforward
The table below presents a rollforward of the cumulative credit loss component of OTTI loss recognized in earnings on fixed maturity securities still held for which a portion of the OTTI loss was recognized in OCI:
	Years Ended December 31,
	2013				2012
	(In millions)
Balance at January 1,	$	392			$	471
Additions:
Initial impairments — credit loss OTTI recognized on securities not previously impaired	6				46
Additional impairments — credit loss OTTI recognized on securities previously impaired	69				70
Reductions:
Sales (maturities, pay downs or prepayments) during the period of securities previously impaired as credit loss OTTI	(87		)		(176		)
Securities impaired to net present value of expected future cash flows	—				(17		)
Increases in cash flows — accretion of previous credit loss OTTI	(2		)		(2		)
Balance at December 31,	$	378			$	392

Derivatives

Derivatives	12 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivatives	'
	9. Derivatives
	Accounting for Derivatives
	See Note 1 for a description of the Company’s accounting policies for derivatives and Note 10 for information about the fair value hierarchy for derivatives.
	Derivative Strategies
	The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives.
	Derivatives are financial instruments whose values are derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. To a lesser extent, the Company uses credit default swaps and structured interest rate swaps to synthetically replicate investment risks and returns which are not readily available in the cash market.
	Interest Rate Derivatives
	The Company uses a variety of interest rate derivatives to reduce its exposure to changes in interest rates, including interest rate swaps, caps, floors, swaptions, futures and forwards.
	Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest amounts as calculated by reference to an agreed notional amount. The Company utilizes interest rate swaps in fair value, cash flow and non-qualifying hedging relationships.
	The Company uses structured interest rate swaps to synthetically create investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and a cash instrument such as a U.S. Treasury, agency, or other fixed maturity security. Structured interest rate swaps are included in interest rate swaps. Structured interest rate swaps are not designated as hedging instruments.
	The Company purchases interest rate caps and floors primarily to protect its floating rate liabilities against rises in interest rates above a specified level, and against interest rate exposure arising from mismatches between assets and liabilities, as well as to protect its minimum rate guarantee liabilities against declines in interest rates below a specified level, respectively. In certain instances, the Company locks in the economic impact of existing purchased caps and floors by entering into offsetting written caps and floors. The Company utilizes interest rate caps and floors in non-qualifying hedging relationships.
	In exchange-traded interest rate (Treasury and swap) futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of interest rate securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded interest rate (Treasury and swap) futures are used primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring and to hedge against changes in interest rates on anticipated liability issuances by replicating Treasury or swap curve performance. The Company utilizes exchange-traded interest rate futures in non-qualifying hedging relationships.
	Swaptions are used by the Company to hedge interest rate risk associated with the Company’s long-term liabilities and invested assets. A swaption is an option to enter into a swap with a forward starting effective date. In certain instances, the Company locks in the economic impact of existing purchased swaptions by entering into offsetting written swaptions. The Company pays a premium for purchased swaptions and receives a premium for written swaptions. The Company utilizes swaptions in non-qualifying hedging relationships. Swaptions are included in interest rate options.
	The Company enters into interest rate forwards to buy and sell securities. The price is agreed upon at the time of the contract and payment for such a contract is made at a specified future date. The Company utilizes interest rate forwards in cash flow hedging relationships.
	Foreign Currency Exchange Rate Derivatives
	The Company uses foreign currency exchange rate derivatives including foreign currency swaps, foreign currency forwards and currency options, to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. The Company also uses foreign currency derivatives to hedge the foreign currency exchange rate risk associated with certain of its net investments in foreign operations.
	In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in fair value, cash flow and non-qualifying hedging relationships.
	In a foreign currency forward transaction, the Company agrees with another party to deliver a specified amount of an identified currency at a specified future date. The price is agreed upon at the time of the contract and payment for such a contract is made at the specified future date. The Company utilizes foreign currency forwards in fair value, net investment in foreign operations and non-qualifying hedging relationships.
	The Company enters into currency options that give it the right, but not the obligation, to sell the foreign currency amount in exchange for a functional currency amount within a limited time at a contracted price. The contracts may also be net settled in cash, based on differentials in the foreign exchange rate and the strike price. The Company uses currency options to hedge against the foreign currency exposure inherent in certain of its variable annuity products. The Company also uses currency options as an economic hedge of foreign currency exposure related to the Company’s international subsidiaries. The Company utilizes currency options in net investment in foreign operations and non-qualifying hedging relationships.
	The Company uses certain of its foreign currency denominated funding agreements to hedge portions of its net investments in foreign operations against adverse movements in exchange rates. Such contracts are included in non-derivative hedging instruments.
	To a lesser extent, the Company uses exchange-traded currency futures to hedge currency mismatches between assets and liabilities. The Company utilizes exchange-traded currency futures in non-qualifying hedging relationships.
	Credit Derivatives
	The Company enters into purchased credit default swaps to hedge against credit-related changes in the value of its investments. In a credit default swap transaction, the Company agrees with another party to pay, at specified intervals, a premium to hedge credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the delivery of par quantities of the referenced investment equal to the specified swap notional in exchange for the payment of cash amounts by the counterparty equal to the par value of the investment surrendered. Credit events vary by type of issuer but typically include bankruptcy, failure to pay debt obligations, repudiation, moratorium, or involuntary restructuring. In each case, payout on a credit default swap is triggered only after the Credit Derivatives Determinations Committee of the International Swaps and Derivatives Association, Inc. (“ISDA”) deems that a credit event has occurred. The Company utilizes credit default swaps in non-qualifying hedging relationships.
	The Company enters into written credit default swaps to synthetically create credit investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and one or more cash instruments, such as U.S. Treasury securities, agency securities or other fixed maturity securities. These credit default swaps are not designated as hedging instruments.
	The Company also enters into certain purchased and written credit default swaps held in relation to trading portfolios for the purpose of generating profits on short-term differences in price. These credit default swaps are not designated as hedging instruments.
	The Company enters into forwards to lock in the price to be paid for forward purchases of certain securities. The price is agreed upon at the time of the contract and payment for the contract is made at a specified future date. When the primary purpose of entering into these transactions is to hedge against the risk of changes in purchase price due to changes in credit spreads, the Company designates these as credit forwards. The Company utilizes credit forwards in cash flow hedging relationships.
	Equity Derivatives
	The Company uses a variety of equity derivatives to reduce its exposure to equity market risk, including equity index options, variance swaps, exchange-traded equity futures and total rate of return swaps (“TRRs”).
	Equity index options are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. To hedge against adverse changes in equity indices, the Company enters into contracts to sell the equity index within a limited time at a contracted price. The contracts will be net settled in cash based on differentials in the indices at the time of exercise and the strike price. Certain of these contracts may also contain settlement provisions linked to interest rates. In certain instances, the Company may enter into a combination of transactions to hedge adverse changes in equity indices within a pre-determined range through the purchase and sale of options. The Company utilizes equity index options in non-qualifying hedging relationships.
	Equity variance swaps are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. In an equity variance swap, the Company agrees with another party to exchange amounts in the future, based on changes in equity volatility over a defined period. The Company utilizes equity variance swaps in non-qualifying hedging relationships.
	In exchange-traded equity futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of equity securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded equity futures are used primarily to hedge liabilities embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded equity futures in non-qualifying hedging relationships.
	TRRs are swaps whereby the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and the LIBOR, calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. The Company uses TRRs to hedge its equity market guarantees in certain of its insurance products. TRRs can be used as hedges or to synthetically create investments. The Company utilizes TRRs in non-qualifying hedging relationships.
	Primary Risks Managed by Derivatives
	The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company’s derivatives, excluding embedded derivatives, held at:
		Primary Underlying Risk Exposure		December 31,
				2013												2012
								Estimated Fair Value												Estimated Fair Value
				Notional				Assets				Liabilities				Notional				Assets			Liabilities
				Amount												Amount
				(In millions)
	Derivatives Designated as Hedging Instruments
	Fair value hedges:
	Interest rate swaps	Interest rate		$	6,419			$	1,282			$	78			$	5,397			$	1,921		$	90
	Foreign currency swaps	Foreign currency exchange rate		2,713				252				135				3,187				332			85
	Foreign currency forwards	Foreign currency exchange rate		2,935				—				77				—				—			—
	Subtotal			12,067				1,534				290				8,584				2,253			175
	Cash flow hedges:
	Interest rate swaps	Interest rate		3,121				83				141				3,642				705			—
	Interest rate forwards	Interest rate		450				7				7				675				139			—
	Foreign currency swaps	Foreign currency exchange rate		12,452				401				660				9,038				219			355
	Subtotal			16,023				491				808				13,355				1,063			355
	Foreign operations hedges:
	Foreign currency forwards	Foreign currency exchange rate		3,182				82				47				2,552				43			61
	Currency options	Foreign currency exchange rate		7,362				318				—				4,375				43			3
	Subtotal			10,544				400				47				6,927				86			64
	Total qualifying hedges			38,634				2,425				1,145				28,866				3,402			594
	Derivatives Not Designated or Not Qualifying as Hedging Instruments
	Interest rate swaps	Interest rate		107,354				3,330				1,767				83,250				5,201			2,043
	Interest rate floors	Interest rate		63,064				451				346				56,246				1,174			837
	Interest rate caps	Interest rate		39,460				177				—				49,465				74			—
	Interest rate futures	Interest rate		6,011				9				9				11,684				1			38
	Interest rate options	Interest rate		40,978				255				243				16,328				640			60
	Synthetic GICs	Interest rate		4,409				—				—				4,162				—			—
Foreign currency swaps	Foreign currency exchange rate		9,307				133				684				8,208				199			736
Foreign currency forwards	Foreign currency exchange rate		11,311				69				359				9,202				26			288
Currency futures	Foreign currency exchange rate		1,316				1				1				1,408				4			—
Currency options	Foreign currency exchange rate		2,265				53				48				129				1			—
Credit default swaps - purchased	Credit		3,725				7				51				3,674				11			34
Credit default swaps - written	Credit		9,055				166				1				8,879				79			5
Equity futures	Equity market		5,157				1				43				7,008				14			132
Equity options	Equity market		37,411				1,344				1,068				22,920				2,825			356
Variance swaps	Equity market		21,636				174				577				19,830				122			310
TRRs	Equity market		3,802				—				179				3,092				4			103
Total non-designated or non-qualifying derivatives			366,261				6,170				5,376				305,485				10,375			4,942
Total			$	404,895			$	8,595			$	6,521			$	334,351			$	13,777		$	5,536
Based on notional amounts, a substantial portion of the Company’s derivatives was not designated or did not qualify as part of a hedging relationship at both December 31, 2013 and 2012. The Company’s use of derivatives includes (i) derivatives that serve as macro hedges of the Company’s exposure to various risks and that generally do not qualify for hedge accounting due to the criteria required under the portfolio hedging rules; (ii) derivatives that economically hedge insurance liabilities that contain mortality or morbidity risk and that generally do not qualify for hedge accounting because the lack of these risks in the derivatives cannot support an expectation of a highly effective hedging relationship; (iii) derivatives that economically hedge embedded derivatives that do not qualify for hedge accounting because the changes in estimated fair value of the embedded derivatives are already recorded in net income; and (iv) written credit default swaps that are used to synthetically create credit investments and that do not qualify for hedge accounting because they do not involve a hedging relationship. For these non-qualified derivatives, changes in market factors can lead to the recognition of fair value changes in the consolidated statement of operations without an offsetting gain or loss recognized in earnings for the item being hedged.
Net Derivative Gains (Losses)
The components of net derivative gains (losses) were as follows:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Derivatives and hedging gains (losses) (1)	$	(8,343	)		$	(3,158	)		$	6,108
Embedded derivatives	5,104				1,239				(1,284		)
Total net derivative gains (losses)	$	(3,239	)		$	(1,919	)		$	4,824
______________
-1	Includes foreign currency transaction gains (losses) on hedged items in cash flow and non-qualifying hedging relationships, which are not presented elsewhere in this note.
The following table presents earned income on derivatives:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Qualifying hedges:
Net investment income	$	135			$	111			$	98
Interest credited to policyholder account balances	150				164				214
Other expenses	(6		)		(5		)		(4		)
Non-qualifying hedges:
Net investment income	(6		)		(6		)		(8		)
Other revenues	—				47				75
Net derivative gains (losses)	328				476				411
Policyholder benefits and claims	(292		)		(120		)		17
Total	$	309			$	667			$	803
Non-Qualifying Derivatives and Derivatives for Purposes Other Than Hedging
The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or qualifying as hedging instruments:
	Net				Net				Policyholder				Other
	Derivative				Investment				Benefits and				Revenues (3)
	Gains (Losses)				Income (1)				Claims (2)
	(In millions)
Year Ended December 31, 2013:
Interest rate derivatives	$	(3,458	)		$	—			$	(27	)		$	—
Foreign currency exchange rate derivatives	(1,716		)		—				—				—
Credit derivatives — purchased	(21		)		(14		)		—
Credit derivatives — written	130				1				—				—
Equity derivatives	(3,663		)		(25		)		(727		)		—
Total	$	(8,728	)		$	(38	)		$	(754	)		$	—
Year Ended December 31, 2012:
Interest rate derivatives	$	(296	)		$	—			$	—			$	28
Foreign currency exchange rate derivatives	(660		)		—				—				—
Credit derivatives — purchased	(298		)		(14		)		—				—
Credit derivatives — written	150				—				—				—
Equity derivatives	(2,556		)		(9		)		(419		)		—
Total	$	(3,660	)		$	(23	)		$	(419	)		$	28
Year Ended December 31, 2011:
Interest rate derivatives	$	3,940			$	(1	)		$	—			$	236
Foreign currency exchange rate derivatives	343				(9		)		—				—
Credit derivatives — purchased	250				6				—				—
Credit derivatives — written	(75		)		(1		)		—				—
Equity derivatives	1,178				(35		)		(87		)		—
Total	$	5,636			$	(40	)		$	(87	)		$	236
______________
-1	Changes in estimated fair value related to economic hedges of equity method investments in joint ventures; changes in estimated fair value related to derivatives held in relation to trading portfolios; and changes in estimated fair value related to derivatives held within contractholder-directed unit-linked investments.
-2	Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits.
-3	Changes in estimated fair value related to derivatives held in connection with the Company’s mortgage banking activities prior to the MetLife Bank Divestiture.
Fair Value Hedges
The Company designates and accounts for the following as fair value hedges when they have met the requirements of fair value hedging: (i) interest rate swaps to convert fixed rate assets and liabilities to floating rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated assets and liabilities; and (iii) foreign currency forwards to hedge the foreign currency fair value exposure of foreign currency denominated investments.
The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges within net derivative gains (losses). The following table presents the amount of such net derivative gains (losses):
Derivatives in Fair Value		Hedged Items in Fair Value		Net Derivative				Net Derivative				Ineffectiveness
Hedging Relationships		Hedging Relationships		Gains (Losses)				Gains (Losses)				Recognized in
				Recognized				Recognized for				Net Derivative
				for Derivatives				Hedged Items				Gains (Losses)
				(In millions)
Year Ended December 31, 2013:
Interest rate swaps:		Fixed maturity securities		$	42			$	(43	)		$	(1	)
		Policyholder liabilities (1)		(830		)		835				5
Foreign currency swaps:		Foreign-denominated fixed maturity securities		13				(12		)		1
		Foreign-denominated PABs (2)		(97		)		110				13
Foreign currency forwards:		Foreign-denominated fixed maturity securities		(109		)		102				(7		)
Total				$	(981	)		$	992			$	11
Year Ended December 31, 2012:
Interest rate swaps:		Fixed maturity securities		$	(4	)		$	—			$	(4	)
		Policyholder liabilities (1)		(82		)		96				14
Foreign currency swaps:		Foreign-denominated fixed maturity securities		(1		)		1				—
		Foreign-denominated PABs (2)		3				(20		)		(17		)
Foreign currency forwards:		Foreign-denominated fixed maturity securities		(51		)		50				(1		)
Total				$	(135	)		$	127			$	(8	)
Year Ended December 31, 2011:
Interest rate swaps:		Fixed maturity securities		$	(25	)		$	22			$	(3	)
		Policyholder liabilities (1)		1,054				(1,030		)		24
Foreign currency swaps:		Foreign-denominated fixed maturity securities		1				3				4
		Foreign-denominated PABs (2)		(24		)		(25		)		(49		)
Foreign currency forwards:		Foreign-denominated fixed maturity securities		(25		)		25				—
Total				$	981			$	(1,005	)		$	(24	)
______________
-1	Fixed rate liabilities reported in PABs or future policy benefits.
-2	Fixed rate or floating rate liabilities.
For the Company’s foreign currency forwards, the change in the fair value of the derivative related to the changes in the difference between the spot price and the forward price is excluded from the assessment of hedge effectiveness. For all other derivatives, all components of each derivative’s gain or loss were included in the assessment of hedge effectiveness. For the years ended December 31, 2013, 2012 and 2011, the component of the change in fair value of derivatives that was excluded from the assessment of hedge effectiveness was ($2) million, ($4) million and ($3) million, respectively.
Cash Flow Hedges
The Company designates and accounts for the following as cash flow hedges when they have met the requirements of cash flow hedging: (i) interest rate swaps to convert floating rate assets and liabilities to fixed rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated assets and liabilities; (iii) interest rate forwards and credit forwards to lock in the price to be paid for forward purchases of investments; (iv) interest rate swaps and interest rate forwards to hedge the forecasted purchases of fixed-rate investments; and (v) interest rate swaps and interest rate forwards to hedge forecasted fixed-rate borrowings.
In certain instances, the Company discontinued cash flow hedge accounting because the forecasted transactions were no longer probable of occurring. Because certain of the forecasted transactions also were not probable of occurring within two months of the anticipated date, the Company reclassified certain amounts from AOCI into net derivative gains (losses). These amounts were ($1) million, $1 million and ($13) million for the years ended December 31, 2013, 2012 and 2011, respectively.
At December 31, 2013 and 2012, the maximum length of time over which the Company was hedging its exposure to variability in future cash flows for forecasted transactions did not exceed seven years and eight years, respectively.
At December 31, 2013 and 2012, the balance in AOCI associated with cash flow hedges was $375 million and $1.3 billion, respectively.
The following table presents the effects of derivatives in cash flow hedging relationships on the consolidated statements of operations and the consolidated statements of equity:
Derivatives in Cash Flow		Amount of Gains				Amount and Location												Amount and Location
Hedging Relationships		(Losses)Deferred in				of Gains (Losses)												of Gains (Losses)Recognized in Income
		AOCI on Derivatives				Reclassified from												(Loss) on Derivatives
						AOCI into Income (Loss)
		(Effective Portion)				(Effective Portion)												(Ineffective Portion)
						Net Derivative				Net Investment				Other				Net Derivative
						Gains (Losses)				Income				Expenses				Gains (Losses)
		(In millions)
Year Ended December 31, 2013:
Interest rate swaps		$	(635	)		$	20			$	8			$	—			$	(3	)
Interest rate forwards		(59		)		10				3				(1		)		1
Foreign currency swaps		(165		)		(3		)		(3		)		1				3
Credit forwards		(4		)		—				1				—				—
Total		$	(863	)		$	27			$	9			$	—			$	1
Year Ended December 31, 2012:
Interest rate swaps		$	(34	)		$	1			$	4			$	(3	)		$	2
Interest rate forwards		(17		)		1				2				(1		)		—
Foreign currency swaps		(164		)		23				(5		)		1				(6		)
Credit forwards		—				—				1				—				—
Total		$	(215	)		$	25			$	2			$	(3	)		$	(4	)
Year Ended December 31, 2011:
Interest rate swaps		$	1,023			$	(42	)		$	1			$	(10	)		$	1
Interest rate forwards		336				31				1				(1		)		2
Foreign currency swaps		175				—				(6		)		2				2
Credit forwards		18				2				1				—				—
Total		$	1,552			$	(9	)		$	(3	)		$	(9	)		$	5
All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.
At December 31, 2013, ($23) million of deferred net gains (losses) on derivatives in AOCI was expected to be reclassified to earnings within the next 12 months.
Hedges of Net Investments in Foreign Operations
The Company uses foreign currency exchange rate derivatives, which may include foreign currency forwards and currency options, to hedge portions of its net investments in foreign operations against adverse movements in exchange rates. The Company measures ineffectiveness on these derivatives based upon the change in forward rates. In addition, the Company may also use non-derivative financial instruments to hedge portions of its net investments in foreign operations against adverse movements in exchange rates. The Company measures ineffectiveness on non-derivative financial instruments based upon the change in spot rates.
When net investments in foreign operations are sold or substantially liquidated, the amounts in AOCI are reclassified to the consolidated statements of operations.
The following table presents the effects of derivatives and non‑derivative financial instruments in net investment hedging relationships in the consolidated statements of operations and the consolidated statements of equity:
Derivatives and Non‑Derivative Hedging Instruments in Net Investment		Amount of Gains (Losses) Deferred in
Hedging Relationships (1), (2)		AOCI (Effective Portion)
		Years Ended December 31,
		2013				2012				2011
		(In millions)
Foreign currency forwards		$	69			$	(50	)		$	62
Currency options		262				36				—
Non‑derivative hedging instruments		—				—				6
Total		$	331			$	(14	)		$	68
______________
-1	During the years ended December 31, 2013 and 2012, there were no sales or substantial liquidations of net investments in foreign operations that would have required the reclassification of gains or losses from AOCI into earnings. During the year ended December 31, 2011, the Company sold its interest in MSI MetLife, which was a hedged item in a net investment hedging relationship. As a result, the Company released losses of $71 million from AOCI upon the sale. This release did not impact net income for the year ended December 31, 2011 as such losses were considered in the overall impairment evaluation of the investment prior to sale. See Note 3.
-2	There was no ineffectiveness recognized for the Company’s hedges of net investments in foreign operations. All components of each derivative and non‑derivative hedging instrument’s gain or loss were included in the assessment of hedge effectiveness.
At December 31, 2013 and 2012, the cumulative foreign currency translation gain (loss) recorded in AOCI related to hedges of net investments in foreign operations was $233 million and ($98) million, respectively.
Credit Derivatives
In connection with synthetically created credit investment transactions and credit default swaps held in relation to the trading portfolio, the Company writes credit default swaps for which it receives a premium to insure credit risk. Such credit derivatives are included within the non-qualifying derivatives and derivatives for purposes other than hedging table. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The Company’s maximum amount at risk, assuming the value of all referenced credit obligations is zero, was $9.1 billion and $8.9 billion at December 31, 2013 and 2012, respectively. The Company can terminate these contracts at any time through cash settlement with the counterparty at an amount equal to the then current fair value of the credit default swaps. At December 31, 2013 and 2012, the Company would have received $165 million and $74 million, respectively, to terminate all of these contracts.
The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:
		December 31,
		2013											2012
Rating Agency Designation of Referenced		Estimated				Maximum				Weighted			Estimated				Maximum				Weighted
Credit Obligations (1)		Fair Value				Amount of Future				Average			Fair Value				Amount of Future				Average
		of Credit				Payments under				Years to			of Credit				Payments under				Years to
		Default				Credit Default				Maturity (3)			Default				Credit Default				Maturity (3)
		Swaps				Swaps (2)							Swaps				Swaps (2)
		(In millions)											(In millions)
Aaa/Aa/A
Single name credit default swaps (corporate)		$	10			$	545			2.6			$	10			$	777			2.7
Credit default swaps referencing indices		26				2,739				1.5			42				2,713				2.1
Subtotal		36				3,284				1.6			52				3,490				2.2
Baa
Single name credit default swaps (corporate)		24				1,320				3.1			8				1,314				3.4
Credit default swaps referencing indices		73				4,071				4.7			11				3,750				4.9
Subtotal		97				5,391				4.3			19				5,064				4.5
Ba
Single name credit default swaps (corporate)		—				5				3.8			—				25				2.7
Credit default swaps referencing indices		—				—				—			—				—				—
Subtotal		—				5				3.8			—				25				2.7
B
Single name credit default swaps (corporate)		—				—				—			—				—				—
Credit default swaps referencing indices		32				375				4.9			3				300				4.9
Subtotal		32				375				4.9			3				300				4.9
Total		$	165			$	9,055			3.4			$	74			$	8,879			3.6
______________
-1	The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), S&P and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.
-2	Assumes the value of the referenced credit obligations is zero.
-3	The weighted average years to maturity of the credit default swaps is calculated based on weighted average notional amounts.
The Company has also entered into credit default swaps to purchase credit protection on certain of the referenced credit obligations in the table above. As a result, the maximum amounts of potential future recoveries available to offset the $9.1 billion and $8.9 billion from the table above were $90 million and $150 million at December 31, 2013 and 2012, respectively.
Written credit default swaps held in relation to the trading portfolio amounted to $10 million in notional and $0 in fair value at both December 31, 2013 and 2012.
Credit Risk on Freestanding Derivatives
The Company may be exposed to credit-related losses in the event of nonperformance by counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.
The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company’s OTC-bilateral derivative transactions are generally governed by ISDA Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set-off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company’s ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives.
The Company’s OTC-cleared derivatives are effected through central clearing counterparties and its exchange-traded derivatives are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis, and the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to such derivatives.
See Note 10 for a description of the impact of credit risk on the valuation of derivatives.
The estimated fair value of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral was as follows at:
		31-Dec-13								31-Dec-12
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement		Assets				Liabilities				Assets				Liabilities
		(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)		$	8,537			$	6,367			$	14,048			$	5,480
OTC-cleared (1)		302				129				—				—
Exchange-traded		11				53				19				170
Total gross estimated fair value of derivatives (1)		8,850				6,549				14,067				5,650
Amounts offset in the consolidated balance sheets		—				—				—				—
Estimated fair value of derivatives presented in the consolidated balance sheets (1)		8,850				6,549				14,067				5,650
Gross amounts not offset in the consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral		(4,631		)		(4,631		)		(4,562		)		(4,562		)
OTC-cleared		(122		)		(122		)		—				—
Exchange-traded		(5		)		(5		)		(19		)		(19		)
Cash collateral: (3)
OTC-bilateral		(1,679		)		(3		)		(5,960		)		(1		)
OTC-cleared		(169		)		(7		)		—				—
Exchange-traded		—				(44		)		—				(151		)
Securities collateral: (4)
OTC-bilateral		(2,105		)		(1,464		)		(3,526		)		(875		)
OTC-cleared		—				—				—				—
Exchange-traded		—				(4		)		—				—
Net amount after application of master netting agreements and collateral		$	139			$	269			$	—			$	42
__________________
-1	At December 31, 2013 and 2012, derivative assets include income or expense accruals reported in accrued investment income or in other liabilities of $255 million and $290 million, respectively, and derivative liabilities include income or expense accruals reported in accrued investment income or in other liabilities of $28 million and $114 million, respectively.
-2	Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
-3	Cash collateral received is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions in the consolidated balance sheets. The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables in the consolidated balance sheets. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At December 31, 2013 and 2012, the Company received excess cash collateral of $104 million and $0, respectively, and provided excess cash collateral of $236 million and $290 million, respectively, which is not included in the table above due to the foregoing limitation.
-4	Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the consolidated balance sheets. Subject to certain constraints, the Company is permitted by contract to sell or repledge this collateral, but at December 31, 2013 none of the collateral had been sold or repledged. Securities collateral pledged by the Company is reported in fixed maturity securities in the consolidated balance sheets. Subject to certain constraints, the counterparties are permitted by contract to sell or repledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At December 31, 2013 and 2012, the Company received excess securities collateral with an estimated fair value of $238 million and $161 million, respectively, for its OTC-bilateral derivatives which are not included in the table above due to the foregoing limitation. At December 31, 2013 and 2012, the Company provided excess securities collateral with an estimated fair value of $66 million and $0, respectively, for its OTC-bilateral derivatives, $141 million and $0, respectively, for its OTC-cleared derivatives, and $81 million and $40 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
The Company’s collateral arrangements for its OTC-bilateral derivatives generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the fair value of that counterparty’s derivatives reaches a pre-determined threshold. Certain of these arrangements also include credit-contingent provisions that provide for a reduction of these thresholds (on a sliding scale that converges toward zero) in the event of downgrades in the credit ratings of the Company and/or the counterparty. In addition, certain of the Company’s netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade credit rating from each of Moody’s and S&P. If a party’s credit ratings were to fall below that specific investment grade credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party’s reasonable valuation of the derivatives.
The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The table also presents the incremental collateral that the Company would be required to provide if there was a one notch downgrade in the Company’s credit rating at the reporting date or if the Company’s credit rating sustained a downgrade to a level that triggered full overnight collateralization or termination of the derivative position at the reporting date. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table.
					Estimated Fair Value of								Fair Value of Incremental
					Collateral Provided:								Collateral Provided Upon:
	Estimated				Fixed Maturity				Cash				One Notch				Downgrade in the Company’s
	Fair Value of Derivatives in				Securities								Downgrade in				Credit Rating to a Level
	Net Liability												the Company’s				that Triggers Full Overnight
	Position (1)												Credit Rating				Collateralization or Termination
																	of the Derivative Position
	(In millions)
December 31, 2013:
Derivatives subject to credit-contingent provisions	$	1,674			$	1,530			$	—			$	27			$	34
Derivatives not subject to credit-contingent provisions	20				—				3				—				—
Total	$	1,694			$	1,530			$	3			$	27			$	34
December 31, 2012:
Derivatives subject to credit-contingent provisions	$	771			$	775			$	—			$	35			$	73
Derivatives not subject to credit-contingent provisions	79				100				1				—				—
Total	$	850			$	875			$	1			$	35			$	73
______________
-1	After taking into consideration the existence of netting agreements.
Embedded Derivatives
The Company issues certain products or purchases certain investments that contain embedded derivatives that are required to be separated from their host contracts and accounted for as freestanding derivatives. These host contracts principally include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; ceded reinsurance of guaranteed minimum benefits related to certain GMIBs; assumed reinsurance of guaranteed minimum benefits related to GMWBs and GMABs; funding agreements with equity or bond indexed crediting rates; funds withheld on assumed and ceded reinsurance; and certain debt and equity securities.
The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
			December 31,
	Balance Sheet Location		2013				2012
			(In millions)
Net embedded derivatives within asset host contracts:
Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables		$	247			$	439
Funds withheld on assumed reinsurance	Other invested assets		38				66
Options embedded in debt or equity securities	Investments		(145		)		(88		)
Other	Other invested assets		—				1
Net embedded derivatives within asset host contracts			$	140			$	418
Net embedded derivatives within liability host contracts:
Direct guaranteed minimum benefits	PABs		$	(2,296	)		$	923
Assumed guaranteed minimum benefits	PABs		1,262				2,582
Funds withheld on ceded reinsurance	Other liabilities		60				162
Other	PABs		5				17
Net embedded derivatives within liability host contracts			$	(969	)		$	3,684
The following table presents changes in estimated fair value related to embedded derivatives:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Net derivative gains (losses) (1)	$	5,104			$	1,239			$	(1,284	)
Policyholder benefits and claims	$	(139	)		$	75			$	86
______________
-1	The valuation of guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses), in connection with this adjustment, were ($952) million, ($1.7) billion and $1.8 billion for the years ended December 31, 2013, 2012 and 2011, respectively.

Fair_Value

Fair Value	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Fair Value	'
	10. Fair Value
	When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows:
	Level 1	Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities.
	Level 2	Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3	Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.
	Financial markets are susceptible to severe events evidenced by rapid depreciation in asset values accompanied by a reduction in asset liquidity. The Company’s ability to sell securities, or the price ultimately realized for these securities, depends upon the demand and liquidity in the market and increases the use of judgment in determining the estimated fair value of certain securities.
	Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.
	Recurring Fair Value Measurements
	The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below.
		December 31, 2013
		Fair Value Hierarchy
		Level 1				Level 2				Level 3			Total Estimated
													Fair Value
		(In millions)
	Assets
	Fixed maturity securities:
	U.S. corporate	$	—			$	99,321			$	7,148		$	106,469
	Foreign corporate	—				56,448				6,704			63,152
	Foreign government	—				52,202				2,235			54,437
	U.S. Treasury and agency	25,061				20,000				62			45,123
	RMBS	—				32,098				2,957			35,055
	CMBS	—				15,578				972			16,550
	ABS	—				11,361				4,210			15,571
	State and political subdivision	—				13,820				10			13,830
	Total fixed maturity securities	25,061				300,828				24,298			350,187
	Equity securities:
	Common stock	1,186				990				177			2,353
	Non-redeemable preferred stock	—				654				395			1,049
	Total equity securities	1,186				1,644				572			3,402
	FVO and trading securities:
	Actively Traded Securities	2				648				12			662
	FVO general account securities	518				80				29			627
	FVO contractholder-directed unit-linked investments	10,702				4,806				603			16,111
	FVO securities held by CSEs	—				23				—			23
	Total FVO and trading securities	11,222				5,557				644			17,423
	Short-term investments (1)	5,915				6,943				254			13,112
	Mortgage loans:
	Residential mortgage loans — FVO	—				—				338			338
	Commercial mortgage loans held by CSEs — FVO	—				1,598				—			1,598
	Mortgage loans held-for-sale (2)	—				—				—			—
	Total mortgage loans	—				1,598				338			1,936
	Other invested assets:
	Other investments	188				71				—			259
	Derivative assets: (3)
	Interest rate	10				5,557				27			5,594
	Foreign currency exchange rate	1				1,280				28			1,309
	Credit	—				144				29			173
	Equity market	1				1,233				285			1,519
	Total derivative assets	12				8,214				369			8,595
	Total other invested assets	200				8,285				369			8,854
	Net embedded derivatives within asset host contracts (4)	—				—				285			285
	Separate account assets (5)	89,960				225,776				1,465			317,201
	Total assets	$	133,544			$	550,631			$	28,225		$	712,400
	Liabilities
	Derivative liabilities: (3)
	Interest rate	$	9			$	2,568			$	14		$	2,591
	Foreign currency exchange rate	1				1,971				39			2,011
	Credit	—				52				—			52
	Equity market	43				1,222				602			1,867
	Total derivative liabilities	53				5,813				655			6,521
	Net embedded derivatives within liability host contracts (4)	—				4				(973		)	(969		)
	Long-term debt of CSEs — FVO	—				1,427				28			1,455
	Trading liabilities (6)	260				2				—			262
Total liabilities	$	313			$	7,246			$	(290	)	$	7,269
	December 31, 2012
	Fair Value Hierarchy
	Level 1				Level 2				Level 3			Total Estimated Fair Value
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—			$	106,693			$	7,433		$	114,126
Foreign corporate	—				60,976				6,208			67,184
Foreign government	—				55,522				1,814			57,336
U.S. Treasury and agency	27,441				20,455				71			47,967
RMBS	—				35,442				2,037			37,479
CMBS	—				17,982				1,147			19,129
ABS	—				12,341				3,656			15,997
State and political subdivision	—				14,994				54			15,048
Total fixed maturity securities	27,441				324,405				22,420			374,266
Equity securities:
Common stock	932				1,040				190			2,162
Non-redeemable preferred stock	—				310				419			729
Total equity securities	932				1,350				609			2,891
FVO and trading securities:
Actively Traded Securities	7				646				6			659
FVO general account securities	—				151				32			183
FVO contractholder-directed unit-linked investments	9,103				5,425				937			15,465
FVO securities held by CSEs	—				41				—			41
Total FVO and trading securities	9,110				6,263				975			16,348
Short-term investments (1)	9,426				6,295				429			16,150
Mortgage loans:
Residential mortgage loans — FVO	—				—				—			—
Commercial mortgage loans held by CSEs — FVO	—				2,666				—			2,666
Mortgage loans held-for-sale (2)	—				—				49			49
Total mortgage loans	—				2,666				49			2,715
Other invested assets:
Other investments	303				123				—			426
Derivative assets: (3)
Interest rate	1				9,648				206			9,855
Foreign currency exchange rate	4				819				44			867
Credit	—				47				43			90
Equity market	14				2,478				473			2,965
Total derivative assets	19				12,992				766			13,777
Total other invested assets	322				13,115				766			14,203
Net embedded derivatives within asset host contracts (4)	—				1				505			506
Separate account assets (5)	31,620				202,568				1,205			235,393
Total assets	$	78,851			$	556,663			$	26,958		$	662,472
Liabilities
Derivative liabilities: (3)
Interest rate	$	38			$	3,001			$	29		$	3,068
Foreign currency exchange rate	—				1,521				7			1,528
Credit	—				39				—			39
Equity market	132				424				345			901
Total derivative liabilities	170				4,985				381			5,536
Net embedded derivatives within liability host contracts (4)	—				17				3,667			3,684
Long-term debt of CSEs — FVO	—				2,483				44			2,527
Trading liabilities (6)	163				—				—			163
Total liabilities	$	333			$	7,485			$	4,092		$	11,910
______________
-1	Short-term investments as presented in the tables above differ from the amounts presented in the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.
-2	See “— Fair Value Option” for additional information on mortgage loans held-for-sale. The amounts in the preceding tables differ from the amounts presented in the consolidated balance sheets as these tables do not include mortgage loans that are stated at lower of amortized cost or estimated fair value.
-3	Derivative assets are presented within other invested assets in the consolidated balance sheets and derivative liabilities are presented within other liabilities in the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation in the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.
-4	Net embedded derivatives within asset host contracts are presented primarily within premiums, reinsurance and other receivables in the consolidated balance sheets. Net embedded derivatives within liability host contracts are presented primarily within PABs in the consolidated balance sheets. At December 31, 2013 and 2012, equity securities also included embedded derivatives of ($145) million and ($88) million, respectively.
-5	Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets.
-6	Trading liabilities are presented within other liabilities in the consolidated balance sheets.
The following describes the valuation methodologies used to measure assets and liabilities at fair value. The description includes the valuation techniques and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy.
Investments
Valuation Controls and Procedures
On behalf of the Company’s Chief Investment Officer and Chief Financial Officer, a pricing and valuation committee that is independent of the trading and investing functions and comprised of senior management, provides oversight of control systems and valuation policies for securities, mortgage loans and derivatives. On a quarterly basis, this committee reviews and approves new transaction types and markets, ensures that observable market prices and market-based parameters are used for valuation, wherever possible, and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. This committee also provides oversight of the selection of independent third party pricing providers and the controls and procedures to evaluate third party pricing. Periodically, the Chief Accounting Officer reports to the Audit Committee of MetLife, Inc.’s Board of Directors regarding compliance with fair value accounting standards.
The Company reviews its valuation methodologies on an ongoing basis and revises those methodologies when necessary based on changing market conditions. Assurance is gained on the overall reasonableness and consistent application of input assumptions, valuation methodologies and compliance with fair value accounting standards through controls designed to ensure valuations represent an exit price. Several controls are utilized, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, comparing fair value estimates to management’s knowledge of the current market, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. The Company ensures that prices received from independent brokers, also referred to herein as “consensus pricing,” represent a reasonable estimate of fair value by considering such pricing relative to the Company’s knowledge of the current market dynamics and current pricing for similar financial instruments. While independent non-binding broker quotations are utilized, they are not used for a significant portion of the portfolio. For example, fixed maturity securities priced using independent non-binding broker quotations represent less than 1% of the total estimated fair value of fixed maturity securities and 13% of the total estimated fair value of Level 3 fixed maturity securities.
The Company also applies a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained, or an internally developed valuation is prepared. Internally developed valuations of current estimated fair value, which reflect internal estimates of liquidity and nonperformance risks, compared with pricing received from the independent pricing services, did not produce material differences in the estimated fair values for the majority of the portfolio; accordingly, overrides were not material. This is, in part, because internal estimates of liquidity and nonperformance risks are generally based on available market evidence and estimates used by other market participants. In the absence of such market-based evidence, management’s best estimate is used.
Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities
When available, the estimated fair value of these financial instruments is based on quoted prices in active markets that are readily and regularly obtainable. Generally, these are the most liquid of the Company’s securities holdings and valuation of these securities does not involve management’s judgment.
When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, giving priority to observable inputs. The significant inputs to the market standard valuation methodologies for certain types of securities with reasonable levels of price transparency are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. When observable inputs are not available, the market standard valuation methodologies rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs can be based in large part on management’s judgment or estimation and cannot be supported by reference to market activity. Even though these inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such securities and are considered appropriate given the circumstances.
The estimated fair value of FVO securities held by CSEs, other investments, long-term debt of CSEs — FVO and trading liabilities is determined on a basis consistent with the methodologies described herein for securities.
Level 2 Valuation Techniques and Key Inputs:
This level includes securities priced principally by independent pricing services using observable inputs. FVO and trading securities, short-term investments and other investments within this level are of a similar nature and class to the Level 2 fixed maturity securities and equity securities. Contractholder-directed unit-linked investments reported within FVO and trading securities include mutual fund interests without readily determinable fair values given prices are not published publicly. Valuation of these mutual funds is based upon quoted prices or reported NAV provided by the fund managers, which were based on observable inputs.
U.S. corporate and foreign corporate securities
These securities are principally valued using the market and income approaches. Valuations are based primarily on quoted prices in markets that are not active, or using matrix pricing or other similar techniques that use standard market observable inputs such as benchmark yields, spreads off benchmark yields, new issuances, issuer rating, duration, and trades of identical or comparable securities. Privately-placed securities are valued using matrix pricing methodologies using standard market observable inputs, and inputs derived from, or corroborated by, market observable data including market yield curve, duration, call provisions, observable prices and spreads for similar publicly traded or privately traded issues that incorporate the credit quality and industry sector of the issuer, and in certain cases, delta spread adjustments to reflect specific credit-related issues.
Foreign government and state and political subdivision securities
These securities are principally valued using the market approach. Valuations are based primarily on matrix pricing or other similar techniques using standard market observable inputs, including a benchmark U.S. Treasury yield or other yields, issuer ratings, broker-dealer quotes, issuer spreads and reported trades of similar securities, including those within the same sub-sector or with a similar maturity or credit rating.
U.S. Treasury and agency securities
These securities are principally valued using the market approach. Valuations are based primarily on quoted prices in markets that are not active, or using matrix pricing or other similar techniques using standard market observable inputs such as a benchmark U.S. Treasury yield curve, the spread off the U.S. Treasury yield curve for the identical security and comparable securities that are actively traded.
Structured securities comprised of RMBS, CMBS and ABS
These securities are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques using standard market inputs, including spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, rating, weighted average coupon, weighted average maturity, average delinquency rates, geographic region, debt-service coverage ratios and issuance-specific information, including, but not limited to: collateral type, payment terms of the underlying assets, payment priority within the tranche, structure of the security, deal performance and vintage of loans.
Common and non-redeemable preferred stock
These securities are principally valued using the market approach. Valuations are based principally on observable inputs, including quoted prices in markets that are not considered active.
Level 3 Valuation Techniques and Key Inputs:
In general, securities classified within Level 3 use many of the same valuation techniques and inputs as described previously for Level 2. However, if key inputs are unobservable, or if the investments are less liquid and there is very limited trading activity, the investments are generally classified as Level 3. The use of independent non-binding broker quotations to value investments generally indicates there is a lack of liquidity or a lack of transparency in the process to develop the valuation estimates, generally causing these investments to be classified in Level 3.
FVO and trading securities and short-term investments within this level are of a similar nature and class to the Level 3 securities described below; accordingly, the valuation techniques and significant market standard observable inputs used in their valuation are also similar to those described below.
U.S. corporate and foreign corporate securities
These securities, including financial services industry hybrid securities classified within fixed maturity securities, are principally valued using the market approach. Valuations are based primarily on matrix pricing or other similar techniques that utilize unobservable inputs or inputs that cannot be derived principally from, or corroborated by, observable market data, including illiquidity premium, delta spread adjustments to reflect specific credit-related issues, credit spreads; and inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain valuations are based on independent non-binding broker quotations.
Foreign government and state and political subdivision securities
These securities are principally valued using the market approach. Valuations are based primarily on independent non-binding broker quotations and inputs, including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain valuations are based on matrix pricing that utilize inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data, including credit spreads.
Structured securities comprised of RMBS, CMBS and ABS
These securities are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques that utilize inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data, including credit spreads. Below investment grade securities and sub-prime RMBS included in this level are valued based on inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2. Certain of these valuations are based on independent non-binding broker quotations.
Common and non-redeemable preferred stock
These securities, including privately-held securities and financial services industry hybrid securities classified within equity securities, are principally valued using the market and income approaches. Valuations are based primarily on matrix pricing, discounted cash flow methodologies or other similar techniques using inputs such as comparable credit rating and issuance structure. Certain of these securities are valued based on inputs including quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2 and independent non-binding broker quotations.
Mortgage Loans
The Company has elected the FVO for certain residential mortgage loans held-for-investment, commercial mortgage loans held by CSEs and certain residential mortgage loans held-for-sale.
Level 2 Valuation Techniques and Key Inputs:
Commercial mortgage loans held by CSEs — FVO
These investments are principally valued using the market approach. The principal market for these investments is the securitization market. The Company uses the quoted securitization market price of the obligations of the CSEs to determine the estimated fair value of these commercial loan portfolios. These market prices are determined principally by independent pricing services using observable inputs.
Level 3 Valuation Techniques and Key Inputs:
Residential mortgage loans — FVO
For these investments, the estimated fair values are based primarily on matrix pricing or other similar techniques that utilize inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data.
Mortgage loans held-for-sale
For these investments, when pricing for securities backed by similar adjustable-rate loans is not observable, the estimated fair value is determined using unobservable independent broker quotations or valuation models using significant unobservable inputs.
Separate Account Assets
Separate account assets are carried at estimated fair value and reported as a summarized total on the consolidated balance sheets. The estimated fair value of separate account assets is based on the estimated fair value of the underlying assets. Separate account assets include: mutual funds, fixed maturity securities, equity securities, derivatives, hedge funds, other limited partnership interests, short-term investments and cash and cash equivalents.
Level 2 Valuation Techniques and Key Inputs:
These assets are comprised of investments that are similar in nature to the instruments described under “— Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities” and “— Derivatives — Freestanding Derivatives.” Also included are certain mutual funds and hedge funds without readily determinable fair values as prices are not published publicly. Valuation of the mutual funds and hedge funds is based upon quoted prices or reported NAV provided by the fund managers.
Level 3 Valuation Techniques and Key Inputs:
These assets are comprised of investments that are similar in nature to the instruments described under “— Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities” and “— Derivatives — Freestanding Derivatives.” Also included are other limited partnership interests, which are valued giving consideration to the value of the underlying holdings of the partnerships and by applying a premium or discount, if appropriate, for factors such as liquidity, bid/ask spreads, the performance record of the fund manager or other relevant variables that may impact the exit value of the particular partnership interest.
Derivatives
The estimated fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives, or through the use of pricing models for OTC-bilateral and OTC-cleared derivatives. The determination of estimated fair value, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments. Derivative valuations can be affected by changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, nonperformance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models. The valuation controls and procedures for derivatives are described in “— Investments.”
The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Significant inputs that are observable generally include: interest rates, foreign currency exchange rates, interest rate curves, credit curves and volatility. However, certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant inputs that are unobservable generally include references to emerging market currencies and inputs that are outside the observable portion of the interest rate curve, credit curve, volatility or other relevant market measure. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.
Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income.
The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.
Freestanding Derivatives
Level 2 Valuation Techniques and Key Inputs:
This level includes all types of derivatives utilized by the Company with the exception of exchange-traded derivatives included within Level 1 and those derivatives with unobservable inputs as described in Level 3. These derivatives are principally valued using the income approach.
Interest rate
Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve and basis curves.
Option-based. Valuations are based on option pricing models, which utilize significant inputs that may include the swap yield curve, basis curves and interest rate volatility.
Foreign currency exchange rate
Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, basis curves, currency spot rates and cross currency basis curves.
Option-based. Valuations are based on option pricing models, which utilize significant inputs that may include the swap yield curve, basis curves, currency spot rates, cross currency basis curves and currency volatility.
Credit
Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, credit curves and recovery rates.
Equity market
Non-option-based. Valuations are based on present value techniques, which utilize significant inputs that may include the swap yield curve, spot equity index levels and dividend yield curves.
Option-based. Valuations are based on option pricing models, which utilize significant inputs that may include the swap yield curve, spot equity index levels, dividend yield curves and equity volatility.
Level 3 Valuation Techniques and Key Inputs:
These derivatives are principally valued using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models. These valuation methodologies generally use the same inputs as described in the corresponding sections above for Level 2 measurements of derivatives. However, these derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data.
Interest rate
Non-option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of the swap yield curve and basis curves.
Option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of the swap yield curve, basis curves and interest rate volatility.
Foreign currency exchange rate
Non-option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of the swap yield curve, basis curves, cross currency basis curves and currency correlation.
Option-based. Significant unobservable inputs may include currency correlation and the extrapolation beyond observable limits of the swap yield curve, basis curves, cross currency basis curves and currency volatility.
Credit
Non-option-based. Significant unobservable inputs may include credit spreads, repurchase rates and the extrapolation beyond observable limits of the swap yield curve and credit curves. Certain of these derivatives are valued based on independent non-binding broker quotations.
Equity market
Non-option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of dividend yield curves and equity volatility.
Option-based. Significant unobservable inputs may include the extrapolation beyond observable limits of dividend yield curves, equity volatility and unobservable correlation between model inputs.
Embedded Derivatives
Embedded derivatives principally include certain direct, assumed and ceded variable annuity guarantees and equity or bond indexed crediting rates within certain funding agreements. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.
The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within PABs in the consolidated balance sheets.
The fair value of these embedded derivatives, estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior, is calculated by the Company’s actuarial department. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk free rates.
Capital market assumptions, such as risk free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.
The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife, Inc.’s debt, including related credit default swaps. These observable spreads are then adjusted, as necessary, to reflect the priority of these liabilities and the claims paying ability of the issuing insurance subsidiaries compared to MetLife, Inc.
Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income.
The Company ceded the risk associated with certain of the GMIBs previously described. These reinsurance agreements contain embedded derivatives which are included within premiums, reinsurance and other receivables in the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses) or policyholder benefits and claims depending on the statement of operations classification of the direct risk. The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously for the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer.
The estimated fair value of the embedded derivatives within funds withheld related to certain ceded reinsurance is determined based on the change in estimated fair value of the underlying assets held by the Company in a reference portfolio backing the funds withheld liability. The estimated fair value of the underlying assets is determined as previously described in “— Investments — Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities.” The estimated fair value of these embedded derivatives is included, along with their funds withheld hosts, in other liabilities in the consolidated balance sheets with changes in estimated fair value recorded in net derivative gains (losses). Changes in the credit spreads on the underlying assets, interest rates and market volatility may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income.
The estimated fair value of the embedded equity and bond indexed derivatives contained in certain funding agreements is determined using market standard swap valuation models and observable market inputs, including a nonperformance risk adjustment. The estimated fair value of these embedded derivatives are included, along with their funding agreements host, within PABs with changes in estimated fair value recorded in net derivative gains (losses). Changes in equity and bond indices, interest rates and the Company’s credit standing may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income.
Embedded Derivatives Within Asset and Liability Host Contracts
Level 3 Valuation Techniques and Key Inputs:
Direct and assumed guaranteed minimum benefits
These embedded derivatives are principally valued using the income approach. Valuations are based on option pricing techniques, which utilize significant inputs that may include swap yield curve, currency exchange rates and implied volatilities. These embedded derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant unobservable inputs generally include: the extrapolation beyond observable limits of the swap yield curve and implied volatilities, actuarial assumptions for policyholder behavior and mortality and the potential variability in policyholder behavior and mortality, nonperformance risk and cost of capital for purposes of calculating the risk margin.
Reinsurance ceded on certain guaranteed minimum benefits
These embedded derivatives are principally valued using the income approach. The valuation techniques and significant market standard unobservable inputs used in their valuation are similar to those described above in “— Direct and Assumed Guaranteed Minimum Benefits” and also include counterparty credit spreads.
Transfers between Levels
Overall, transfers between levels occur when there are changes in the observability of inputs and market activity. Transfers into or out of any level are assumed to occur at the beginning of the period.
Transfers between Levels 1 and 2:
For assets and liabilities measured at estimated fair value and still held at December 31, 2013, transfers between Levels 1 and 2 were $101 million. For assets and liabilities measured at estimated fair value and still held at December 31, 2012, transfers between Levels 1 and 2 were not significant.
Transfers into or out of Level 3:
Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.
Transfers into Level 3 for fixed maturity securities, FVO and trading securities, mortgage loans, and separate account assets were due primarily to a lack of trading activity, decreased liquidity and credit ratings downgrades (e.g., from investment grade to below investment grade) which have resulted in decreased transparency of valuations and an increased use of independent non-binding broker quotations and unobservable inputs, such as illiquidity premiums, delta spread adjustments or credit spreads.
Transfers out of Level 3 for fixed maturity securities, equity securities, FVO and trading securities and separate account assets resulted primarily from increased transparency of both new issuances that, subsequent to issuance and establishment of trading activity, became priced by independent pricing services and existing issuances that, over time, the Company was able to obtain pricing from, or corroborate pricing received from, independent pricing services with observable inputs (such as observable spreads used in pricing securities) or increases in market activity and upgraded credit ratings.
Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)
The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:
							31-Dec-13					31-Dec-12					Impact of
																	Increase in Input
																	on Estimated
	Valuation			Significant			Range				Weighted	Range			Weighted		Fair Value (2)
	Techniques			Unobservable Inputs							Average (1)				Average (1)
Fixed maturity securities: (3)
U.S. corporate and foreign corporate	•	Matrix pricing		•	Delta spread adjustments (4)		-10	-	240		46	-50	-	500	90		Decrease
				•	Illiquidity premium (4)		30	-	30		30	30	-	30	30		Decrease
				•	Credit spreads (4)		-1,489	-	876		174	-1,416	-	876	272		Decrease
				•	Offered quotes (5)		4	-	145		100	—	-	348	115		Increase
	•	Consensus pricing		•	Offered quotes (5)		33	-	145		95	—	-	555	92		Increase
Foreign government	•	Matrix pricing		•	Credit spreads (4)		4	-	72		32	-58	-	150	72		Decrease
	•	Market pricing		•	Quoted prices (5)		64	-	156		100	77	-	146	99		Increase
	•	Consensus pricing		•	Offered quotes (5)		84	-	156		107	82	-	200	117		Increase
RMBS	•	Matrix pricing and		•	Credit spreads (4)		-136	-	3,609		288	9	-	2,980	521		Decrease (6)
		discounted cash flow
	•	Market pricing		•	Quoted prices (5)		10	-	109		98	13	-	109	100		Increase (6)
	•	Consensus pricing		•	Offered quotes (5)		69	-	101		93	28	-	100	75		Increase (6)
CMBS	•	Matrix pricing and		•	Credit spreads (4)		215	-	2,025		409	1	-	9,164	374		Decrease (6)
		discounted cash flow
	•	Market pricing		•	Quoted prices (5)		70	-	104		97	1	-	106	99		Increase (6)
	•	Consensus pricing		•	Offered quotes (5)		90	-	101		95						Increase (6)
ABS	•	Matrix pricing and		•	Credit spreads (4)		30	-	1,878		145	—	-	1,829	109		Decrease (6)
		discounted cash flow
	•	Market pricing		•	Quoted prices (5)		—	-	110		101	40	-	105	100		Increase (6)
	•	Consensus pricing		•	Offered quotes (5)		56	-	106		98	—	-	111	97		Increase (6)
Derivatives:
Interest rate	•	Present value techniques		•	Swap yield (7)		248	-	450			186	-	353			Increase (12)
Foreign currency exchange rate	•	Present value techniques		•	Swap yield (7)		97	-	767			228	-	795			Increase (12)
				•	Correlation (8)		38%	-	47%			43%	-	57%
Credit	•	Present value techniques		•	Credit spreads (9)		98	-	101			100	-	100			Decrease (9)
	•	Consensus pricing		•	Offered quotes (10)
Equity market	•	Present value techniques		•	Volatility (11)		13%	-	28%			13%	-	32%			Increase (12)
		or option pricing models
				•	Correlation (8)		60%	-	60%			65%	-	65%
Embedded derivatives:
Direct and assumed guaranteed minimum benefits	•	Option pricing		•	Mortality rates:
		techniques
					Ages 0 - 40		0%	-	0.14%			0%	-	0.14%			Decrease (13)
					Ages 41 - 60		0.04%	-	0.88%			0.05%	-	0.88%			Decrease (13)
					Ages 61 - 115		0.26%	-	100%			0.26%	-	100%			Decrease (13)
				•	Lapse rates:
					Durations 1 - 10		0.50%	-	100%			0.50%	-	100%			Decrease (14)
					Durations 11 - 20		2%	-	100%			2%	-	100%			Decrease (14)
					Durations 21 - 116		2%	-	100%			2%	-	100%			Decrease (14)
				•	Utilization rates		20%	-	50%			20%	-	50%			Increase (15)
				•	Withdrawal rates		0%	-	40%			0.07%	-	20%			-16
				•	Long-term equity volatilities		9.14%	-	40%			15.18%	-	40%			Increase (17)
				•	Nonperformance risk spread		-1.08%	-	0.83%			0.10%	-	1.72%			Decrease (18)
______________
-1	The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.
-2	The impact of a decrease in input would have the opposite impact on the estimated fair value. For embedded derivatives, changes are based on liability positions.
-3	Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.
-4	Range and weighted average are presented in basis points.
-5	Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.
-6	Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.
-7	Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curve is utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
-8	Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.
-9	Represents the risk quoted in basis points of a credit default event on the underlying instrument. The range being provided is a single quoted spread in the valuation model. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.
-10	At both December 31, 2013 and 2012, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value.
-11	Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
-12	Changes are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.
-13	Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-14	Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-15	The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-16	The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.
-17	Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-18	Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.
The following is a summary of the valuation techniques and significant unobservable inputs used in the fair value measurement of assets and liabilities classified within Level 3 that are not included in the preceding table. Generally, all other classes of securities classified within Level 3, including those within separate account assets, use the same valuation techniques and significant unobservable inputs as previously described for Level 3 securities. This includes matrix pricing and discounted cash flow methodologies, inputs such as quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2, as well as independent non-binding broker quotations. The residential mortgage loans — FVO and long-term debt of CSEs — FVO are valued using independent non-binding broker quotations and internal models including matrix pricing and discounted cash flow methodologies using current interest rates. The sensitivity of the estimated fair value to changes in the significant unobservable inputs for these other assets and liabilities is similar in nature to that described in the preceding table. The valuation techniques and significant unobservable inputs used in the fair value measurement for the more significant assets measured at estimated fair value on a nonrecurring basis and determined using significant unobservable inputs (Level 3) are summarized in “— Nonrecurring Fair Value Measurements.”
The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities:
	U.S.				Foreign				Foreign			U.S.			RMBS			CMBS			ABS			State and
	Corporate				Corporate				Government			Treasury												Political
												and Agency												Subdivision
	(In millions)
Year Ended December 31, 2013:
Balance at January 1,	$	7,433			$	6,208			$	1,814		$	71		$	2,037		$	1,147		$	3,656		$	54
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	10				9				9			—			31			5			8			—
Net investment gains (losses)	(31		)		(33		)		8			—			(3		)	(14		)	5			—
Net derivative gains (losses)	—				—				—			—			—			—			—			—
Other revenues	—				—				—			—			—			—			—			—
Policyholder benefits and claims	—				—				—			—			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—
OCI	(94		)		(75		)		(84		)	(3		)	155			(45		)	(70		)	(1		)
Purchases (3)	1,555				1,972				734			—			1,155			546			1,870			—
Sales (3)	(1,178		)		(999		)		(128		)	(6		)	(399		)	(450		)	(814		)	(7		)
Issuances (3)	—				—				—			—			—			—			—			—
Settlements (3)	—				—				—			—			—			—			—			—
Transfers into Level 3 (4)	1,092				310				81			—			56			114			33			—
Transfers out of Level 3 (4)	(1,639		)		(688		)		(199		)	—			(75		)	(331		)	(478		)	(36		)
Balance at December 31,	$	7,148			$	6,704			$	2,235		$	62		$	2,957		$	972		$	4,210		$	10
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	8			$	8			$	9		$	—		$	36		$	3		$	1		$	—
Net investment gains (losses)	$	(39	)		$	(3	)		$	—		$	—		$	(3	)	$	(12	)	$	—		$	—
Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Equity Securities:								FVO and Trading Securities:												Mortgage Loans:
	Common				Non-				Actively			FVO			FVO			Short-term			Residential			Mortgage
	Stock				redeemable				Traded			General			Contractholder-			Investments			Mortgage			Loans Held-
					Preferred				Securities			Account			directed						Loans - FVO			for-sale
					Stock							Securities			Unit-linked
															Investments
	(In millions)
Year Ended December 31, 2013:
Balance at January 1,	$	190			$	419			$	6		$	32		$	937		$	429		$	—		$	49
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	—				—				—			6			(8		)	3			1			—
Net investment gains (losses)	26				(32		)		—			6			—			(23		)	—			—
Net derivative gains (losses)	—				—				—			—			—			—			—			—
Other revenues	—				—				—			—			—			—			—			—
Policyholder benefits and claims	—				—				—			—			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—
OCI	—				100				—			—			—			17			—			—
Purchases (3)	9				21				9			—			340			256			339			—
Sales (3)	(45		)		(113		)		—			(30		)	(608		)	(427		)	(2		)	(45		)
Issuances (3)	—				—				—			—			—			—			—			—
Settlements (3)	—				—				—			—			—			—			—			(4		)
Transfers into Level 3 (4)	1				—				—			15			235			—			—			—
Transfers out of Level 3 (4)	(4		)		—				(3		)	—			(293		)	(1		)	—			—
Balance at December 31,	$	177			$	395			$	12		$	29		$	603		$	254		$	338		$	—
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	—			$	—			$	—		$	5		$	(1	)	$	2		$	1		$	—
Net investment gains (losses)	$	(3	)		$	(20	)		$	—		$	—		$	—		$	—		$	—		$	—
Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Net Derivatives: (6)
	Interest				Foreign				Credit			Equity			Net			Separate			Long-term
	Rate				Currency							Market			Embedded			Account			Debt of
					Exchange										Derivatives (7)			Assets (8)			CSEs - FVO
					Rate
	(In millions)
Year Ended December 31, 2013:
Balance at January 1,	$	177			$	37			$	43		$	128		$	(3,162	)	$	1,205		$	(44	)
Total realized/unrealized gains(losses) included in:
Net income (loss): (1), (2)
Net investment income	—				—				—			—			—			—			—
Net investment gains (losses)	—				—				—			—			—			35			(2		)
Net derivative gains (losses)	(16		)		(49		)		(12		)	(479		)	5,041			—			—
Other revenues	—				—				—			—			—			—			—
Policyholder benefits and claims	—				—				—			19			(139		)	—			—
Other expenses	—				—				—			—			—			—			—
OCI	(102		)		(1		)		—			—			300			—			—
Purchases (3)	—				—				—			14			—			294			—
Sales (3)	—				—				—			—			—			(319		)	—
Issuances (3)	—				—				(1		)	—			—			72			—
Settlements (3)	(31		)		2				(1		)	1			(782		)	—			18
Transfers into Level 3 (4)	—				—				—			—			—			240			—
Transfers out of Level 3 (4)	(15		)		—				—			—			—			(62		)	—
Balance at December 31,	$	13			$	(11	)		$	29		$	(317	)	$	1,258		$	1,465		$	(28	)
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	—			$	—			$	—		$	—		$	—		$	—		$	—
Net investment gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—
Net derivative gains (losses)	$	(8	)		$	(46	)		$	(10	)	$	(463	)	$	5,022		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	19		$	(135	)	$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities:
	U.S.				Foreign				Foreign			U.S			RMBS			CMBS			ABS			State and
	Corporate				Corporate				Government			Treasury												Political
												and Agency												Subdivision
	(In millions)
Year Ended December 31, 2012:
Balance at January 1,	$	6,784			$	4,370			$	2,322		$	31		$	1,602		$	753		$	1,850		$	53
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	14				20				14			—			27			8			18			—
Net investment gains (losses)	4				(78		)		(3		)	—			(7		)	(42		)	2			—
Net derivative gains (losses)	—				—				—			—			—			—			—			—
Other revenues	—				—				—			—			—			—			—			—
Policyholder benefits and claims	—				—				—			—			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—
OCI	328				294				45			—			275			(4		)	(2		)	3
Purchases (3)	1,718				2,654				431			48			952			682			2,007			5
Sales (3)	(1,207		)		(855		)		(673		)	(8		)	(704		)	(397		)	(177		)	(7		)
Issuances (3)	—				—				—			—			—			—			—			—
Settlements (3)	—				—				—			—			—			—			—			—
Transfers into Level 3 (4)	661				186				28			—			161			177			6			—
Transfers out of Level 3 (4)	(869		)		(383		)		(350		)	—			(269		)	(30		)	(48		)	—
Balance at December 31,	$	7,433			$	6,208			$	1,814		$	71		$	2,037		$	1,147		$	3,656		$	54
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	12			$	19			$	16		$	—		$	27		$	2		$	18		$	—
Net investment gains (losses)	$	(4	)		$	(30	)		$	—		$	—		$	(4	)	$	(1	)	$	—		$	—
Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Equity Securities:								FVO and Trading Securities:												Mortgage Loans:
	Common				Non-				Actively			FVO			FVO			Short-term			Residential			Mortgage Loans Held-
	Stock				redeemable				Traded			General			Contractholder-			Investments			Mortgage			for-sale
					Preferred				Securities			Account			directed						Loans - FVO
					Stock							Securities			Unit-linked
															Investments
	(In millions)
Year Ended December 31, 2012:
Balance at January 1,	$	281			$	438			$	—		$	23		$	1,386		$	590		$	—		$	1,414
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	—				—				—			18			25			2			—			—
Net investment gains (losses)	(1		)		2				—			—			—			—			—			—
Net derivative gains (losses)	—				—				—			—			—			—			—			—
Other revenues	—				—				—			—			—			—			—			(35		)
Policyholder benefits and claims	—				—				—			—			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—
OCI	13				40				—			—			—			(26		)	—			—
Purchases (3)	99				5				6			—			604			425			—			1
Sales (3)	(140		)		(66		)		—			(9		)	(1,040		)	(559		)	—			(1,348		)
Issuances (3)	—				—				—			—			—			—			—			7
Settlements (3)	—				—				—			—			—			—			—			(43		)
Transfers into Level 3 (4)	3				—				—			—			—			5			—			56
Transfers out of Level 3 (4)	(65		)		—				—			—			(38		)	(8		)	—			(3		)
Balance at December 31,	$	190			$	419			$	6		$	32		$	937		$	429		$	—		$	49
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	—			$	—			$	—		$	14		$	25		$	1		$	—		$	—
Net investment gains (losses)	$	(11	)		$	—			$	—		$	—		$	—		$	—		$	—		$	—
Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	(29	)
Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Net Derivatives: (6)
	Interest				Foreign				Credit			Equity			Net			Separate			Long-term			MSRs (9)			Liability Related
	Rate				Currency							Market			Embedded			Account			Debt of						to Securitized
					Exchange										Derivatives (7)			Assets (8)			CSEs - FVO						Reverse Mortgage
					Rate																						Loans (9)
	(In millions)
Year Ended December 31, 2012:
Balance at January 1,	$	300			$	44			$	1		$	889		$	(4,203	)	$	1,325		$	(116	)	$	666		$	(1,175	)
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	—				—				—			—			—			—			—			—			—
Net investment gains (losses)	—				—				—			—			—			99			(7		)	—			—
Net derivative gains (losses)	15				10				48			(606		)	1,305			—			—			—			—
Other revenues	(67		)		—				—			—			—			—			—			(83		)	1
Policyholder benefits and claims	—				—				—			29			75			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—			—
OCI	—				—				—			(3		)	259			—			—			—			—
Purchases (3)	—				—				—			19			—			244			—			—			—
Sales (3)	—				—				—			—			—			(443		)	—			(485		)	1,149
Issuances (3)	—				—				(3		)	(44		)	—			2			—			43			—
Settlements (3)	(71		)		(17		)		(3		)	(156		)	(598		)	(1		)	79			(141		)	23
Transfers into Level 3 (4)	—				—				—			—			—			24			—			—			—
Transfers out of Level 3 (4)	—				—				—			—			—			(45		)	—			—			2
Balance at December 31,	$	177			$	37			$	43		$	128		$	(3,162	)	$	1,205		$	(44	)	$	—		$	—
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Net investment gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	(7	)	$	—		$	—
Net derivative gains (losses)	$	—			$	(12	)		$	47		$	(593	)	$	1,275		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	29		$	78		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities:
	U.S.				Foreign				Foreign			U.S.			RMBS			CMBS			ABS			State and			Other
	Corporate				Corporate				Government			Treasury												Political
												and Agency												Subdivision
	(In millions)
Year Ended December 31, 2011:
Balance at January 1,	$	7,149			$	5,726			$	3,134		$	79		$	2,541		$	1,011		$	3,026		$	46		$	4
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	11				27				18			—			10			25			24			—			—
Net investment gains (losses)	17				(9		)		—			—			(41		)	(16		)	(18		)	—			—
Net derivative gains (losses)	—				—				—			—			—			—			—			—			—
Other revenues	—				—				—			—			—			—			—			—			—
Policyholder benefits and claims	—				—				—			—			—			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—			—
OCI	327				(66		)		—			3			(5		)	71			81			(8		)	—
Purchases (3)	912				1,740				529			6			393			283			1,033			11			—
Sales (3)	(887		)		(2,094		)		(179		)	(1		)	(213		)	(178		)	(659		)	(4		)	(4		)
Issuances (3)	—				—				—			—			—			—			—			—			—
Settlements (3)	—				—				—			—			—			—			—			—			—
Transfers into Level 3 (4)	169				211				123			—			20			52			14			10			—
Transfers out of Level 3 (4)	(914		)		(1,165		)		(1,303		)	(56		)	(1,103		)	(495		)	(1,651		)	(2		)	—
Balance at December 31,	$	6,784			$	4,370			$	2,322		$	31		$	1,602		$	753		$	1,850		$	53		$	—
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	10			$	19			$	18		$	—		$	11		$	24		$	20		$	—		$	—
Net investment gains (losses)	$	(27	)		$	(31	)		$	(3	)	$	—		$	(41	)	$	(14	)	$	(10	)	$	—		$	—
Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Equity Securities:								FVO and Trading Securities:												Mortgage Loans:
	Common				Non-				Actively			FVO			FVO			Short-term			Residential			Mortgage
	Stock				redeemable				Traded			General			Contractholder-			Investments			Mortgage			Loans Held-
					Preferred				Securities			Account			directed						Loans - FVO			for-sale
					Stock							Securities			Unit-linked
															Investments
	(In millions)
Year Ended December 31, 2011:
Balance at January 1,	$	268			$	905			$	10		$	77		$	735		$	858		$	—		$	24
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	—				—				—			(7		)	5			3			—			—
Net investment gains (losses)	14				(71		)		—			—			—			(2		)	—			—
Net derivative gains (losses)	—				—				—			—			—			—			—			—
Other revenues	—				—				—			—			—			—			—			5
Policyholder benefits and claims	—				—				—			—			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—
OCI	5				5				—			—			—			2			—			—
Purchases (3)	106				3				—			—			1,246			600			—			3
Sales (3)	(46		)		(416		)		(8		)	(33		)	(478		)	(870		)	—			—
Issuances (3)	—				—				—			—			—			—			—			1,361
Settlements (3)	—				—				—			—			—			—			—			(87		)
Transfers into Level 3 (4)	—				12				—			—			121			—			—			109
Transfers out of Level 3 (4)	(66		)		—				(2		)	(14		)	(243		)	(1		)	—			(1		)
Balance at December 31,	$	281			$	438			$	—		$	23		$	1,386		$	590		$	—		$	1,414
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	—			$	—			$	—		$	(8	)	$	(4	)	$	—		$	—		$	—
Net investment gains (losses)	$	(6	)		$	(19	)		$	—		$	—		$	—		$	(1	)	$	—		$	—
Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	5
Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Net Derivatives: (6)
	Interest				Foreign				Credit			Equity			Net			Separate			Long-term			MSRs (9)			Liability Related
	Rate				Currency							Market			Embedded			Account			Debt of						to Securitized
					Exchange										Derivatives (7)			Assets (8)			CSEs - FVO						Reverse Mortgage
					Rate																						Loans (9)
	(In millions)
Year Ended December 31, 2011:
Balance at January 1,	$	(86	)		$	73			$	44		$	142		$	(2,438	)	$	1,983		$	(184	)	$	950		$	—
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	—				—				—			(3		)	—			—			—			—			—
Net investment gains (losses)	—				—				—			—			—			39			(8		)	—			—
Net derivative gains (losses)	41				(28		)		(43		)	601			(1,277		)	—			—			—			—
Other revenues	62				—				—			—			—			—			—			(314		)	—
Policyholder benefits and claims	—				—				—			7			86			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—			—
OCI	329				—				14			1			(119		)	—			—			—			—
Purchases (3)	(1		)		—				1			228			—			284			—			—			—
Sales (3)	—				—				—			—			—			(743		)	—			—			—
Issuances (3)	—				—				(3		)	(4		)	—			—			—			173			(1,175		)
Settlements (3)	(44		)		(1		)		(12		)	(8		)	(455		)	—			76			(143		)	—
Transfers into Level 3 (4)	(1		)		—				—			—			—			19			—			—			—
Transfers out of Level 3 (4)	—				—				—			(75		)	—			(257		)	—			—			—
Balance at December 31,	$	300			$	44			$	1		$	889		$	(4,203	)	$	1,325		$	(116	)	$	666		$	(1,175	)
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Net investment gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	(8	)	$	—		$	—
Net derivative gains (losses)	$	24			$	(24	)		$	(42	)	$	601		$	(1,303	)	$	—		$	—		$	—		$	—
Other revenues	$	68			$	—			$	—		$	—		$	—		$	—		$	—		$	(282	)	$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	7		$	94		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
______________
-1	Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities and certain mortgage loans are included in net investment gains (losses) while changes in the estimated fair value of certain mortgage loans and MSRs are included in other revenues. Lapses associated with net embedded derivatives are included in net derivative gains (losses).
-2	Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.
-3	Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.
-4	Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.
-5	Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods.
-6	Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.
-7	Embedded derivative assets and liabilities are presented net for purposes of the rollforward.
-8	Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income. For the purpose of this disclosure, these changes are presented within net investment gains (losses).
-9	See Note 3 for a discussion of the MetLife Bank Divestiture. Other revenues related to MSRs represent the changes in estimated fair value due to changes in valuation model inputs or assumptions.
Fair Value Option
The following table presents information for certain assets and liabilities accounted for under the FVO. These assets and liabilities were initially measured at fair value.
		Residential Mortgage								Certain Assets
		Loans — FVO (1)								and Liabilities
										of CSEs (2)
		December 31,								December 31,
		2013				2012				2013			2012
		(In millions)
Assets
Unpaid principal balance		$	508			$	—			$	1,528		$	2,539
Difference between estimated fair value and unpaid principal balance		(170		)		—				70			127
Carrying value at estimated fair value		$	338			$	—			$	1,598		$	2,666
Loans in non-accrual status		$	—			$	—			$	—		$	—
Loans more than 90 days past due		$	81			$	—			$	—		$	—
Loans in non-accrual status or more than 90 days past due, or both — difference between aggregate estimated fair value and unpaid principal balance		$	(82	)		$	—			$	—		$	—
Liabilities
Contractual principal balance										$	1,445		$	2,430
Difference between estimated fair value and contractual principal balance										10			97
Carrying value at estimated fair value										$	1,455		$	2,527
______________
-1	Interest income, changes in estimated fair value and gains or losses on sales are recognized in net investment income. Changes in estimated fair value for these loans were due to the following:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Instrument-specific credit risk based on changes in credit spreads for non-agency loans and adjustments in individual loan quality	$	(1	)		$	—			$	—
Other changes in estimated fair value	1				—				—
Total gains (losses) recognized in net investment income	$	—			$	—			$	—
-2	These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs — FVO is recognized in net investment income. Interest expense from long-term debt of CSEs — FVO is recognized in other expenses.
The Company also held $49 million of mortgage loans held-for-sale — FVO at December 31, 2012. Changes in estimated fair value are recognized as gains in other revenues. Changes in fair value due to instrument-specific credit risk were less than ($1) million, ($1) million, and ($3) million for the years ended December 31, 2013, 2012 and 2011, respectively. Other changes in estimated fair value were less than $1 million, $68 million and $511 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Nonrecurring Fair Value Measurements
The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates; that is, they are not measured at fair value on a recurring basis but are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).
	At December 31,											Years Ended December 31,
	2013				2012				2011			2013			2012			2011
	Carrying Value After Measurement											Gains (Losses)
	(In millions)
Mortgage loans: (1)
Held-for-investment	$	211			$	428			$	151		$	20		$	(11	)	$	(15	)
Held-for-sale	$	3			$	319			$	58		$	—		$	(31	)	$	(3	)
Other limited partnership interests (2)	$	77			$	54			$	13		$	(46	)	$	(33	)	$	(5	)
Real estate joint ventures (3)	$	3			$	10			$	—		$	(2	)	$	(6	)	$	—
Goodwill (4)	$	—			$	—			$	—		$	—		$	(1,868	)	$	(65	)
Other assets (5)	$	—			$	32			$	—		$	—		$	(77	)	$	—
______________
-1	Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows.
-2	For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both December 31, 2013 and 2012 were not significant.
-3	For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include several real estate funds that typically invest primarily in commercial real estate and mezzanine debt. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next one to 10 years. Unfunded commitments for these investments at both December 31, 2013 and 2012 were not significant.
-4	As discussed in Note 11, in 2012, the Company recorded an impairment of goodwill associated with the Retail Annuities reporting unit. In addition, in 2011, the Company recorded an impairment of goodwill associated with MetLife Bank. This impairment has been categorized as Level 3 due to the significant unobservable inputs used in the determination of the estimated fair value.
-5	As discussed in Note 5, in 2012, the Company recorded an impairment of VOCRA, which is included in other assets.
Fair Value of Financial Instruments Carried at Other Than Fair Value
The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income, payables for collateral under securities loaned and other transactions, short-term debt and those short-term investments that are not securities, such as time deposits, and therefore are not included in the three level hierarchy table disclosed in the “— Recurring Fair Value Measurements” section. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2 and, to a lesser extent, in Level 1, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the table below are not considered financial instruments subject to this disclosure.
The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:
	December 31, 2013
					Fair Value Hierarchy
	Carrying				Level 1				Level 2			Level 3			Total
	Value														Estimated
															Fair Value
	(In millions)
Assets
Mortgage loans:
Held-for-investment	$	55,767			$	—			$	—		$	57,921		$	57,921
Held-for-sale	3				—				—			3			3
Mortgage loans, net	$	55,770			$	—			$	—		$	57,924		$	57,924
Policy loans	$	11,764			$	—			$	1,694		$	11,512		$	13,206
Real estate joint ventures	$	102			$	—			$	—		$	169		$	169
Other limited partnership interests	$	950			$	—			$	—		$	1,109		$	1,109
Other invested assets	$	844			$	322			$	163		$	359		$	844
Premiums, reinsurance and other receivables	$	3,116			$	—			$	728		$	2,382		$	3,110
Other assets	$	324			$	—			$	210		$	142		$	352
Liabilities
PABs	$	139,735			$	—			$	—		$	144,631		$	144,631
Bank deposits	$	—			$	—			$	—		$	—		$	—
Long-term debt	$	17,170			$	—			$	18,564		$	—		$	18,564
Collateral financing arrangements	$	4,196			$	—			$	—		$	3,984		$	3,984
Junior subordinated debt securities	$	3,193			$	—			$	3,789		$	—		$	3,789
Other liabilities	$	2,239			$	—			$	948		$	1,292		$	2,240
Separate account liabilities	$	117,562			$	—			$	117,562		$	—		$	117,562
	December 31, 2012
					Fair Value Hierarchy
	Carrying				Level 1				Level 2			Level 3			Total
	Value														Estimated
															Fair Value
	(In millions)
Assets
Mortgage loans:
Held-for-investment	$	53,926			$	—			$	—		$	57,381		$	57,381
Held-for-sale	365				—				—			365			365
Mortgage loans, net	$	54,291			$	—			$	—		$	57,746		$	57,746
Policy loans	$	11,884			$	—			$	1,690		$	12,567		$	14,257
Real estate joint ventures	$	113			$	—			$	—		$	171		$	171
Other limited partnership interests	$	1,154			$	—			$	—		$	1,277		$	1,277
Other invested assets	$	815			$	305			$	144		$	366		$	815
Premiums, reinsurance and other receivables	$	3,287			$	—			$	745		$	2,960		$	3,705
Other assets	$	260			$	—			$	214		$	78		$	292
Liabilities
PABs	$	149,928			$	—			$	—		$	158,040		$	158,040
Bank deposits	$	6,416			$	—			$	2,018		$	4,398		$	6,416
Long-term debt	$	16,502			$	—			$	18,978		$	—		$	18,978
Collateral financing arrangements	$	4,196			$	—			$	—		$	3,839		$	3,839
Junior subordinated debt securities	$	3,192			$	—			$	3,984		$	—		$	3,984
Other liabilities	$	1,913			$	—			$	673		$	1,243		$	1,916
Separate account liabilities	$	58,726			$	—			$	58,726		$	—		$	58,726
The methods, assumptions and significant valuation techniques and inputs used to estimate the fair value of financial instruments are summarized as follows:
Mortgage Loans
Mortgage loans held-for-investment
For mortgage loans held-for-investment, estimated fair value is primarily determined by estimating expected future cash flows and discounting them using current interest rates for similar mortgage loans with similar credit risk, or is determined from pricing for similar loans.
Mortgage loans held-for-sale
For mortgage loans held-for-sale, estimated fair value is determined using independent non-binding broker quotations or internal valuation models using significant unobservable inputs.
Policy Loans
Policy loans with fixed interest rates are classified within Level 3. The estimated fair values for these loans are determined using a discounted cash flow model applied to groups of similar policy loans determined by the nature of the underlying insurance liabilities. Cash flow estimates are developed by applying a weighted-average interest rate to the outstanding principal balance of the respective group of policy loans and an estimated average maturity determined through experience studies of the past performance of policyholder repayment behavior for similar loans. These cash flows are discounted using current risk-free interest rates with no adjustment for borrower credit risk as these loans are fully collateralized by the cash surrender value of the underlying insurance policy. Policy loans with variable interest rates are classified within Level 2 and the estimated fair value approximates carrying value due to the absence of borrower credit risk and the short time period between interest rate resets, which presents minimal risk of a material change in estimated fair value due to changes in market interest rates.
Real Estate Joint Ventures and Other Limited Partnership Interests
The estimated fair values of these cost method investments are generally based on the Company’s share of the NAV as provided in the financial statements of the investees. In certain circumstances, management may adjust the NAV by a premium or discount when it has sufficient evidence to support applying such adjustments.
Other Invested Assets
These other invested assets are principally comprised of various interest-bearing assets held in foreign subsidiaries and certain amounts due under contractual indemnifications. For the various interest-bearing assets held in foreign subsidiaries, the Company evaluates the specific facts and circumstances of each instrument to determine the appropriate estimated fair values. These estimated fair values were not materially different from the recognized carrying values.
Premiums, Reinsurance and Other Receivables
Premiums, reinsurance and other receivables are principally comprised of certain amounts recoverable under reinsurance agreements, amounts on deposit with financial institutions to facilitate daily settlements related to certain derivatives and amounts receivable for securities sold but not yet settled.
Amounts recoverable under ceded reinsurance agreements, which the Company has determined do not transfer significant risk such that they are accounted for using the deposit method of accounting, have been classified as Level 3. The valuation is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using interest rates determined to reflect the appropriate credit standing of the assuming counterparty.
The amounts on deposit for derivative settlements, classified within Level 2, essentially represent the equivalent of demand deposit balances and amounts due for securities sold are generally received over short periods such that the estimated fair value approximates carrying value.
Other Assets
These other assets are principally comprised of a receivable for cash paid to an unaffiliated financial institution under the MetLife Reinsurance Company of Charleston (“MRC”) collateral financing arrangement described in Note 13. The estimated fair value of the receivable for the cash paid to the unaffiliated financial institution under the MRC collateral financing arrangement is determined by discounting the expected future cash flows using a discount rate that reflects the credit rating of the unaffiliated financial institution.
PABs
These PABs include investment contracts. Embedded derivatives on investment contracts and certain variable annuity guarantees accounted for as embedded derivatives are excluded from this caption in the preceding tables as they are separately presented in “— Recurring Fair Value Measurements.”
The investment contracts primarily include certain funding agreements, fixed deferred annuities, modified guaranteed annuities, fixed term payout annuities and total control accounts. The valuation of these investment contracts is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using current market risk-free interest rates adding a spread to reflect the nonperformance risk in the liability.
Bank Deposits
Due to the frequency of interest rate resets on customer bank deposits held in money market accounts, the Company believes that there is minimal risk of a material change in interest rates such that the estimated fair value approximates carrying value. For time deposits, the Company has taken into consideration the sale price for the disposition of the depository business of MetLife Bank to determine the estimated fair value of bank deposits. See Note 3.
Long-term Debt, Collateral Financing Arrangements and Junior Subordinated Debt Securities
The estimated fair values of long-term debt and junior subordinated debt securities are principally determined using market standard valuation methodologies. Capital leases, which are not required to be disclosed at estimated fair value are excluded from the preceding tables.
Valuations classified as Level 2 are based primarily on quoted prices in markets that are not active or using matrix pricing that use standard market observable inputs such as quoted prices in markets that are not active and observable yields and spreads in the market. Instruments valued using discounted cash flow methodologies use standard market observable inputs including market yield curve, duration, call provisions, observable prices and spreads for similar publicly traded or privately traded issues.
Valuations classified as Level 3 are based primarily on discounted cash flow methodologies that utilize unobservable discount rates that can vary significantly based upon the specific terms of each individual arrangement. The determination of estimated fair values of collateral financing arrangements incorporates valuations obtained from the counterparties to the arrangements, as part of the collateral management process.
Other Liabilities
Other liabilities consist primarily of interest and dividends payable, amounts due for securities purchased but not yet settled, funds withheld amounts payable, which are contractually withheld by the Company in accordance with the terms of the reinsurance agreements, and amounts payable under certain assumed reinsurance agreements, which are recorded using the deposit method of accounting. The Company evaluates the specific terms, facts and circumstances of each instrument to determine the appropriate estimated fair values, which are not materially different from the carrying values, with the exception of certain deposit type reinsurance payables. For such payables, the estimated fair value is determined as the present value of expected future cash flows, which are discounted using an interest rate determined to reflect the appropriate credit standing of the assuming counterparty.
Separate Account Liabilities
Separate account liabilities represent those balances due to policyholders under contracts that are classified as investment contracts.
Separate account liabilities classified as investment contracts primarily represent variable annuities with no significant mortality risk to the Company such that the death benefit is equal to the account balance, funding agreements related to group life contracts and certain contracts that provide for benefit funding.
Since separate account liabilities are fully funded by cash flows from the separate account assets which are recognized at estimated fair value as described in the section “— Recurring Fair Value Measurements,” the value of those assets approximates the estimated fair value of the related separate account liabilities. The valuation techniques and inputs for separate account liabilities are similar to those described for separate account assets.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill	'
	11. Goodwill
	Goodwill is the excess of cost over the estimated fair value of net assets acquired. Goodwill is not amortized but is tested for impairment at least annually or more frequently if events or circumstances, such as adverse changes in the business climate, indicate that there may be justification for conducting an interim test. Step 1 of the goodwill impairment process requires a comparison of the fair value of a reporting unit to its carrying value. In performing the Company’s goodwill impairment tests, the estimated fair values of the reporting units are first determined using a market multiple valuation approach. When further corroboration is required, the Company uses a discounted cash flow valuation approach. For reporting units which are particularly sensitive to market assumptions, the Company may use additional valuation methodologies to estimate the reporting units’ fair values.
	The market multiple valuation approach utilizes market multiples of companies with similar businesses and the projected operating earnings of the reporting unit. The discounted cash flow valuation approach requires judgments about revenues, operating earnings projections, capital market assumptions and discount rates. The key inputs, judgments and assumptions necessary in determining estimated fair value of the reporting units include projected operating earnings, current book value, the level of economic capital required to support the mix of business, long-term growth rates, comparative market multiples, the account value of in-force business, projections of new and renewal business, as well as margins on such business, the level of interest rates, credit spreads, equity market levels, and the discount rate that the Company believes is appropriate for the respective reporting unit.
	When testing goodwill for impairment, the Company also considers its market capitalization in relation to the aggregate estimated fair value of its reporting units. The Company applies significant judgment when determining the estimated fair value of the Company’s reporting units and when assessing the relationship of market capitalization to the aggregate estimated fair value of its reporting units.
	The valuation methodologies utilized are subject to key judgments and assumptions that are sensitive to change. Estimates of fair value are inherently uncertain and represent only management’s reasonable expectation regarding future developments. These estimates and the judgments and assumptions upon which the estimates are based will, in all likelihood, differ in some respects from actual future results. Declines in the estimated fair value of the Company’s reporting units could result in goodwill impairments in future periods which could materially adversely affect the Company’s results of operations or financial position.
	During the 2013 annual goodwill impairment tests, the Company concluded that the fair values of all reporting units were in excess of their carrying values and, therefore, goodwill was not impaired.
	Information regarding goodwill by segment, as well as Corporate & Other, was as follows:
		Retail			Group,		Corporate		Latin			Asia (1)			EMEA			Corporate			Unallocated			Total
					Voluntary &		Benefit		America									& Other (2)			Goodwill
					Worksite		Funding
					Benefits
		(In millions)
	Balance at January 1, 2011
	Goodwill	$	3,125		$	138	$	900	$	229		$	72		$	38		$	470		$	6,809		$	11,781
	Accumulated impairment	—			—		—		—			—			—			—			—			—
	Total goodwill, net	3,125			138		900		229			72			38			470			6,809			11,781
	Goodwill allocation (3)	—			—		—		312			5,163			1,334			—			(6,809		)	—
	Acquisitions (4)	—			—		—		—			39			—			—			—			39
	Impairments (5)	—			—		—		—			—			—			(65		)	—			(65		)
	Effect of foreign currency translation and other	—			—		—		(40		)	259			(39		)	—			—			180
	Balance at December 31, 2011
	Goodwill	3,125			138		900		501			5,533			1,333			470			—			12,000
	Accumulated impairment	—			—		—		—			—			—			(65		)	—			(65		)
	Total goodwill, net	3,125			138		900		501			5,533			1,333			405			—			11,935
	Acquisitions	—			—		—		—			—			1			—			—			1
	Impairments (6)	(1,692		)	—		—		—			—			—			(176		)	—			(1,868		)
	Effect of foreign currency translation and other	—			—		—		26			(146		)	5			—			—			(115		)
	Balance at December 31, 2012
	Goodwill	3,125			138		900		527			5,387			1,339			470			—			11,886
	Accumulated impairment	(1,692		)	—		—		—			—			—			(241		)	—			(1,933		)
	Total goodwill, net	1,433			138		900		527			5,387			1,339			229			—			9,953
	Acquisitions (7)	—			—		—		1,140			—			1			—			—			1,141
	Dispositions	—			—		—		—			—			(8		)	—			—			(8		)
	Reduction of goodwill (5)	—			—		—		—			—			—			(65		)	—			(65		)
	Reduction of accumulated impairment (5)	—			—		—		—			—			—			65			—			65
	Effect of foreign currency translation and other	—			—		—		(79		)	(489		)	24			—			—			(544		)
	Balance at December 31, 2013
	Goodwill	3,125			138		900		1,588			4,898			1,356			405			—			12,410
	Accumulated impairment	(1,692		)	—		—		—			—			—			(176		)	—			(1,868		)
	Total goodwill, net	$	1,433		$	138	$	900	$	1,588		$	4,898		$	1,356		$	229		$	—		$	10,542
	______________
	-1	Includes goodwill of $4.7 billion, $5.2 billion and $5.4 billion from the Japan operations at December 31, 2013, 2012 and 2011, respectively.
	-2	For purposes of goodwill impairment testing, the $229 million of net goodwill in Corporate & Other at December 31, 2012, which resulted from goodwill acquired as part of the 2005 Travelers acquisition, was allocated to business units of the Retail; Group, Voluntary & Worksite Benefits; and Corporate Benefit Funding segments in the amounts of $34 million, $9 million and $186 million, respectively.
	-3	Goodwill associated with the ALICO Acquisition was allocated among the Company’s segments in the first quarter of 2011.
	-4	As of November 1, 2011, American Life’s current and deferred income taxes were affected by measurement period adjustments, which resulted in a $39 million increase to the goodwill recorded as part of the ALICO Acquisition related to Japan which is included in the Asia segment.
	-5	In 2011, the Company performed a goodwill impairment test on MetLife Bank, which was a separate reporting unit in Corporate & Other. A comparison of the fair value of the reporting unit, using a market multiple approach, to its carrying value indicated a potential for goodwill impairment. A further comparison of the implied fair value of the reporting unit’s goodwill with its carrying amount indicated that the entire amount of goodwill associated with MetLife Bank was impaired. Consequently, the Company recorded a $65 million goodwill impairment charge that is reflected as a net investment loss for the year ended December 31, 2011. In connection with the MetLife Bank Divestiture, goodwill and the related accumulated impairment were reduced by $65 million for the year ended December 31, 2013. See Note 3.
	-6	In connection with its annual goodwill impairment testing in 2012, the market multiple and discounted cash flow valuation approaches indicated that the fair value of the Retail Annuities reporting unit was below its carrying value. As a result, an actuarial appraisal, which estimates the net worth of the reporting unit, the value of existing business and the value of new business, was also performed. This appraisal also resulted in a fair value of the Retail Annuities reporting unit that was less than the carrying value, indicating a potential for goodwill impairment. A further comparison of the implied fair value of its goodwill with the reporting unit’s carrying amount indicated that the entire amount of goodwill associated with the Retail Annuities reporting unit was impaired. Consequently, the Company recorded a non-cash charge of $1.9 billion ($1.6 billion, net of income tax) for the impairment of the entire goodwill balance in the consolidated statements of operations for the year ended December 31, 2012. Of this amount, $1.4 billion was impaired at MetLife, Inc. There was no impact on income taxes.
	-7	See Note 3 for a discussion of the acquisition of ProVida, which is included in the Latin America segment.

Longterm_and_Shortterm_Debt

Long-term and Short-term Debt	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Long-term and Short-term Debt	'
	12. Long-term and Short-term Debt
	Long-term and short-term debt outstanding was as follows:
		Interest Rates (1)				Maturity		December 31,
		Range		Weighted				2013			2012
				Average
								(In millions)
	Senior notes	1.52% - 7.72%		4.96%		2014 - 2045		$	15,938		$	15,669
	Surplus notes	7.63% - 7.88%		7.84%		2015 - 2025		701			700
	Other notes	1.39% - 8.00%		4.04%		2014 - 2030		531			133
	Capital lease obligations							28			33
	Total long-term debt (2)							17,198			16,535
	Total short-term debt							175			100
	Total							$	17,373		$	16,635
	______________
	-1	Range of interest rates and weighted average interest rates are for the year ended December 31, 2013.
	-2	Excludes $1.5 billion and $2.5 billion of long-term debt relating to CSEs — FVO at December 31, 2013 and 2012, respectively. See Note 8.
	The aggregate maturities of long-term debt at December 31, 2013 for the next five years and thereafter are $1.4 billion in 2014, $1.2 billion in 2015, $1.3 billion in 2016, $502 million in 2017, $1.5 billion in 2018 and $11.3 billion thereafter.
	Capital lease obligations are collateralized and rank highest in priority, followed by unsecured senior debt which consists of senior notes and other notes, followed by subordinated debt which consists of junior subordinated debt securities (see Note 14). Payments of interest and principal on the Company’s surplus notes, which are subordinate to all other obligations at the operating company level and are senior to obligations at MetLife, Inc., may be made only with the prior approval of the insurance department of the state of domicile. Collateral financing arrangements (see Note 13) are supported by either surplus notes of subsidiaries or financing arrangements with MetLife, Inc. and, accordingly, have priority consistent with other such obligations.
	Certain of the Company’s debt instruments, credit facilities and committed facilities contain various administrative, reporting, legal and financial covenants. The Company believes it was in compliance with all such covenants at December 31, 2013.
	Senior Notes — Senior Debt Securities Underlying Common Equity Units
	In connection with the financing of the ALICO Acquisition in November 2010, MetLife, Inc. issued to AM Holdings $3.0 billion (estimated fair value of $3.0 billion) of three series of debt securities (the “Series C Debt Securities,” the “Series D Debt Securities,” and the “Series E Debt Securities,” collectively, the “Debt Securities”), which constitute a part of the common equity units more fully described in Note 15.
	In both September 2013 and October 2012, MetLife, Inc. closed the successful remarketing of senior debt securities underlying the common equity units. The Series D Debt Securities were remarketed in September 2013 as 4.368% senior debt securities due September 2023. The Series C Debt Securities were remarketed in October 2012 as 1.756% Series C senior debt securities Tranche 1 and 3.048% Series C senior debt securities Tranche 2, due December 2017 and December 2022, respectively. MetLife, Inc. did not receive any proceeds from the remarketings.
	The Series E Debt Securities initially bear interest at 2.46%, initially mature in June 2045, and are subject to remarketing. The interest rates will be reset in connection with the successful remarketing of the Series E Debt Securities. Prior to the first scheduled attempted remarketing of the Series E Debt Securities, such Debt Securities will be divided into two tranches equal in principal amount with maturity dates of June 2018 and June 2045.
	Senior Notes — Other Issuances
	In November 2013, MetLife, Inc. issued $1.0 billion of senior notes due in November 2043. The senior notes bear interest at a fixed rate of 4.875%, payable semi-annually. In connection with the issuance, MetLife, Inc. incurred $10 million of related costs which have been capitalized and included in other assets. These costs are being amortized over the term of the senior notes.
	In August 2012, MetLife, Inc. issued $750 million of senior notes due in August 2042. The senior notes bear interest at a fixed rate of 4.125%, payable semi-annually. In connection with the issuance, MetLife, Inc. incurred $7 million of related costs which have been capitalized and included in other assets. These costs are being amortized over the term of the senior notes.
	Advances from the Federal Home Loan Bank of New York
	MetLife Bank has been a member of the FHLB of NY and, in connection with such membership, entered into advances agreements with the FHLB of NY under which MetLife Bank received cash advances, which were reflected in long-term debt or short-term debt according to the tenor of the advances. In January 2012, MetLife Bank discontinued taking advances from the FHLB of NY. In April 2012, MetLife Bank transferred cash to MLIC related to $3.8 billion of outstanding advances which had been included in long-term debt, and MLIC assumed the associated obligations under terms similar to those of the transferred advances by issuing funding agreements for which the liability was included in PABs. During the years ended December 31, 2013 and 2012, MetLife Bank did not receive advances. During the year ended December 31, 2011, MetLife Bank received advances totaling $1.3 billion. During the years ended December 31, 2012 and 2011, MetLife Bank made repayments totaling $374 million and $750 million, respectively, related to long-term borrowings under the advances agreements. MetLife Bank did not make repayments in 2013. There was no long-term debt or short-term debt liability for advances at December 31, 2013 and 2012.
	Short-term Debt
	Short-term debt with maturities of one year or less was as follows:
		December 31,
		2013				2012
		(In millions)
	Commercial paper	$	175			$	100
	Average daily balance	$	103			$	119
	Average days outstanding	55 days				40 days
	During the years ended December 31, 2013, 2012 and 2011, the weighted average interest rate on short-term debt was 0.12%, 0.17% and 0.33%, respectively.
	Interest Expense
	Interest expense related to long-term and short-term debt included in other expenses was $854 million, $871 million and $975 million for the years ended December 31, 2013, 2012 and 2011, respectively. Such amounts do not include interest expense on long-term debt related to CSEs — FVO, collateral financing arrangements, junior subordinated debt securities, or common equity units. See Notes 8, 13, 14 and 15.
	Credit and Committed Facilities
	The Company maintains unsecured credit facilities and committed facilities, which aggregated $4.0 billion and $12.4 billion, respectively, at December 31, 2013. When drawn upon, these facilities bear interest at varying rates in accordance with the respective agreements.
	Credit Facilities
	The unsecured credit facilities are used for general corporate purposes, to support the borrowers’ commercial paper programs and for the issuance of letters of credit. Total fees expensed associated with these credit facilities were $24 million, $30 million and $35 million for the years ended December 31, 2013, 2012 and 2011, respectively, and are included in other expenses. Information on these credit facilities at December 31, 2013 was as follows:
	Borrower(s)		Expiration		Capacity				Letters of			Drawdowns		Unused Commitments
									Credit
									Issued
					(In millions)
	MetLife, Inc. and MetLife Funding, Inc.		September 2017 (1)		$	1,000			$	59		$	—	$	941
	MetLife, Inc. and MetLife Funding, Inc.		August 2016 (2)		3,000				133			—		2,867
	Total				$	4,000			$	192		$	—	$	3,808
	______________
	-1	In September 2012, MetLife, Inc. and MetLife Funding, Inc. entered into a $1.0 billion five-year credit agreement which amended and restated the three-year agreement dated October 2010. All borrowings under the 2012 five-year credit agreement must be repaid by September 2017, except that letters of credit outstanding on that date may remain outstanding until no later than September 2018. MetLife, Inc. incurred costs of $4 million related to the amended and restated credit facility, which were capitalized and included in other assets. These costs are being amortized over the remaining term of the amended and restated credit facility.
	-2	In connection with the October 2013 re-domestication of Exeter to Delaware in anticipation of the Mergers and the related redistribution of assets held in trust at Exeter, $1.9 billion of outstanding letters of credit were no longer required and therefore canceled by the Company. Accordingly, remaining availability under the unsecured credit facilities increased by $1.9 billion in October 2013. See Note 8 for further information on the Mergers.
	Committed Facilities
	The committed facilities are used for collateral for certain of the Company’s affiliated reinsurance liabilities. Total fees expensed associated with these committed facilities were $103 million, $96 million and $93 million for the years ended December 31, 2013, 2012 and 2011, respectively, and are included in other expenses. Information on these committed facilities at December 31, 2013 was as follows:
	Account Party/Borrower(s)		Expiration		Capacity				Letters of			Drawdowns		Unused
									Credit					Commitments
									Issued
					(In millions)
	MetLife, Inc.		Aug-14		$	300			$	300		$	—	$	—
	Exeter Reassurance Company, Ltd., MetLife, Inc. & Missouri Reinsurance, Inc.		Jun-16		500				490			—		10
	MetLife Reinsurance Company of Vermont & MetLife, Inc.		December 2020 (1)		350				350			—		—
	Exeter Reassurance Company, Ltd.		December 2027 (1)		650				600			—		50
MetLife Reinsurance Company of South Carolina & MetLife, Inc.		June 2037 (2)		3,500				—			2,797		703
MetLife Reinsurance Company of Vermont & MetLife, Inc.		December 2037 (1)		2,896				1,937			—		959
MetLife Reinsurance Company of Vermont & MetLife, Inc.		September 2038 (1)		4,250				3,062			—		1,188
Total				$	12,446			$	6,739		$	2,797	$	2,910
______________
-1	MetLife, Inc. is guarantor under this agreement.
-2	The drawdown on this facility is associated with a collateral financing arrangement described more fully in Note 13.

Collateral_Financing_Arrangeme

Collateral Financing Arrangements	12 Months Ended
	Dec. 31, 2013
Secured Debt [Abstract]	'
Collateral Financing Arrangements	'
	13. Collateral Financing Arrangements
	Associated with the Closed Block
	In December 2007, MLIC reinsured a portion of its closed block liabilities to MRC, a wholly-owned subsidiary of MetLife, Inc. In connection with this transaction, MRC issued, to investors placed by an unaffiliated financial institution, $2.5 billion in aggregate principal amount of 35-year surplus notes to provide statutory reserve support for the assumed closed block liabilities. Interest on the surplus notes accrues at an annual rate of three-month LIBOR plus 0.55%, payable quarterly. The ability of MRC to make interest and principal payments on the surplus notes is contingent upon South Carolina regulatory approval.
	Simultaneous with the issuance of the surplus notes, MetLife, Inc. entered into an agreement with the unaffiliated financial institution, under which MetLife, Inc. is entitled to the interest paid by MRC on the surplus notes of three-month LIBOR plus 0.55% in exchange for the payment of three-month LIBOR plus 1.12%, payable quarterly on such amount as adjusted, as described below. MetLife, Inc. may also be required to pledge collateral or make payments to the unaffiliated financial institution related to any decline in the estimated fair value of the surplus notes. Any such payments would be accounted for as a receivable and included in other assets on the Company’s consolidated balance sheets and would not reduce the principal amount outstanding of the surplus notes. Such payments would, however, reduce the amount of interest payments due from MetLife, Inc. under the agreement. Any payment received from the unaffiliated financial institution would reduce the receivable by an amount equal to such payment and would also increase the amount of interest payments due from MetLife, Inc. under the agreement. In addition, the unaffiliated financial institution may be required to pledge collateral to MetLife, Inc. related to any increase in the estimated fair value of the surplus notes. MetLife, Inc. may also be required to make a payment to the unaffiliated financial institution in connection with any early termination of this agreement.
	In June 2012 and December 2011, following regulatory approval, MRC repurchased and canceled $451 million and $650 million, respectively, in aggregate principal amount of the surplus notes. Payments made by the Company in June 2012 and December 2011 associated with the partial repurchases, which also included payments made to the unaffiliated financial institution, totaled $451 million and $650 million, respectively, exclusive of accrued interest on the surplus notes. In connection with the partial repurchases, in June 2012 and December 2011, the amount of the receivable from the unaffiliated financial institution decreased $59 million and $84 million, respectively.
	In addition, in June 2011, MetLife, Inc. received $100 million from the unaffiliated financial institution related to an increase in the estimated fair value of the surplus notes. No such payments were made or received by MetLife, Inc. during 2013 and 2012.
	At both December 31, 2013 and 2012, the amount of the surplus notes outstanding was $1.4 billion. At both December 31, 2013 and 2012, the amount of the receivable from the unaffiliated financial institution was $182 million.
	In addition, at December 31, 2013 and 2012, MetLife, Inc. had pledged collateral with an estimated fair value of $23 million and $120 million, respectively, to the unaffiliated financial institution.
	A majority of the proceeds from the offering of the surplus notes was placed in a trust, which is consolidated by the Company, to support MRC’s statutory obligations associated with the assumed closed block liabilities. At December 31, 2013 and 2012, the estimated fair value of assets held in trust by the Company was $1.7 billion and $1.6 billion, respectively. The assets are principally invested in fixed maturity securities and are presented as such within the Company’s consolidated balance sheets, with the related income included within net investment income in the Company’s consolidated statements of operations. Interest expense on the collateral financing arrangement is included as a component of other expenses.
	Interest expense related to this collateral financing arrangement was $20 million, $26 million and $35 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	Associated with Secondary Guarantees
	In May 2007, MetLife, Inc. and MRSC, a wholly-owned subsidiary of MetLife, Inc., entered into a 30-year collateral financing arrangement with an unaffiliated financial institution that provides up to $3.5 billion of statutory reserve support for MRSC associated with reinsurance obligations under intercompany reinsurance agreements. Such statutory reserves are associated with universal life secondary guarantees and are required under U.S. Valuation of Life Policies Model Regulation (commonly referred to as Regulation A-XXX). At both December 31, 2013 and 2012, $2.8 billion had been drawn upon under the collateral financing arrangement. Proceeds from the collateral financing arrangement were placed in trusts to support MRSC’s statutory obligations associated with the reinsurance of secondary guarantees. The trusts are VIEs which are consolidated by the Company. The unaffiliated financial institution is entitled to the return on the investment portfolio held by the trusts. At both December 31, 2013 and 2012, the Company held assets in trust with an estimated fair value of $3.4 billion, associated with the collateral financing arrangement. The assets are principally invested in fixed maturity securities and are presented as such within the Company’s consolidated balance sheets, with the related income included within net investment income in the Company’s consolidated statements of operations. Interest expense on the collateral financing arrangement is included as a component of other expenses. The collateral financing arrangement may be extended by agreement of MetLife, Inc. and the unaffiliated financial institution on each anniversary of the closing.
	In connection with the collateral financing arrangement, MetLife, Inc. entered into an agreement with the same unaffiliated financial institution under which MetLife, Inc. is entitled to the return on the investment portfolio held by the trusts established in connection with this collateral financing arrangement in exchange for the payment of a stated rate of return to the unaffiliated financial institution of three-month LIBOR plus 0.70%, payable quarterly. MetLife, Inc. may also be required to make payments to the unaffiliated financial institution, for deposit into the trusts, related to any decline in the estimated fair value of the assets held by the trusts, as well as amounts outstanding upon maturity or early termination of the collateral financing arrangement. During 2013, 2012 and 2011, no payments were made or received by MetLife, Inc. Cumulatively, since May 2007, MetLife, Inc. has contributed a total of $680 million as a result of declines in the estimated fair value of the assets in the trusts, all of which was deposited into the trusts.
	In addition, MetLife, Inc. may be required to pledge collateral to the unaffiliated financial institution under this agreement. At December 31, 2013, MetLife, Inc. had no pledged collateral under this agreement. At December 31, 2012, MetLife, Inc. had pledged $78 million under this agreement.
	Interest expense related to this collateral financing arrangement was $28 million, $33 million and $29 million for the years ended December 31, 2013, 2012 and 2011, respectively.

Junior_Subordinated_Debt_Secur

Junior Subordinated Debt Securities

12 Months Ended

Dec. 31, 2013

Junior Subordinated Notes [Abstract]

'

Junior Subordinated Debt Securities

'

14. Junior Subordinated Debt Securities

Outstanding Junior Subordinated Debt Securities

Outstanding junior subordinated debt securities and trust securities which MetLife, Inc. will exchange for junior subordinated debt securities prior to redemption or repayment were as follows:

Carrying Value at December 31,

Issuer

Issue Date

Face Value

Interest Rate (2)

Scheduled

Interest Rate

Final

2013

2012

Redemption

Subsequent to

Maturity

Date

Scheduled

Redemption

Date (3)

(In millions)

(In millions)

MetLife, Inc.

Jul-09

$

500

10.75

%

Aug-39

LIBOR + 7.548%

Aug-69

$

500

$

500

MetLife Capital Trust X (1)

Apr-08

$

750

9.25

%

Apr-38

LIBOR + 5.540%

Apr-68

750

750

MetLife Capital Trust IV (1)

Dec-07

$

700

7.875

%

Dec-37

LIBOR + 3.960%

Dec-67

695

694

MetLife, Inc.

Dec-06

$

1,250

6.4

%

Dec-36

LIBOR + 2.205%

Dec-66

1,248

1,248

$

3,193

$

3,192

______________

-1

MetLife Capital Trust X and MetLife Capital Trust IV are VIEs which are consolidated in the financial statements of the Company. The securities issued by these entities are exchangeable surplus trust securities, which will be exchanged for a like amount of MetLife, Inc.’s junior subordinated debt securities on the scheduled redemption date; mandatorily under certain circumstances, and at any time upon MetLife, Inc. exercising its option to redeem the securities. The exchangeable surplus trust securities are classified as junior subordinated debt securities for purposes of financial statement presentation.

-2

Prior to the scheduled redemption date, interest is payable semiannually in arrears.

-3

In the event the securities are not redeemed on or before the scheduled redemption date, interest will accrue after such date at an annual rate of three-month LIBOR plus the indicated margin, payable quarterly in arrears.

In connection with each of the securities described above, MetLife, Inc. may redeem or may cause the redemption of the securities (i) in whole or in part, at any time on or after the date five years prior to the scheduled redemption date at their principal amount plus accrued and unpaid interest to, but excluding, the date of redemption, or (ii) in certain circumstances, in whole or in part, prior to the date five years prior to the scheduled redemption date at their principal amount plus accrued and unpaid interest to, but excluding, the date of redemption or, if greater, a make-whole price. MetLife, Inc. also has the right to, and in certain circumstances the requirement to, defer interest payments on the securities for a period up to 10 years. Interest compounds during such periods of deferral. If interest is deferred for more than five consecutive years, MetLife, Inc. is required to use proceeds from the sale of its common stock or warrants on common stock to satisfy this interest payment obligation. In connection with each of the securities described above, MetLife, Inc. entered into a separate replacement capital covenant (“RCC”). As part of each RCC, MetLife, Inc. agreed that it will not repay, redeem, or purchase the securities on or before a date 10 years prior to the final maturity date of each issuance, unless, subject to certain limitations, it has received cash proceeds during a specified period from the sale of specified replacement securities. Each RCC will terminate upon the occurrence of certain events, including an acceleration of the applicable securities due to the occurrence of an event of default. The RCCs are not intended for the benefit of holders of the securities and may not be enforced by them. Rather, each RCC is for the benefit of the holders of a designated series of MetLife, Inc.’s other indebtedness (the “Covered Debt”). Initially, the Covered Debt for each of the securities described above was MetLife, Inc.’s 5.70% senior notes due 2035 (the “Senior Notes”). As a result of the issuance of MetLife, Inc.’s 10.750% Fixed-to-Floating Rate Junior Subordinated Debentures due 2069 (the “10.750% JSDs”), the 10.750% JSDs became the Covered Debt with respect to, and in accordance with, the terms of the RCC relating to MetLife, Inc.’s 6.40% Fixed-to-Floating Rate Junior Subordinated Debentures due 2066. The Senior Notes continue to be the Covered Debt with respect to, and in accordance with, the terms of the RCCs relating to each of MetLife Capital Trust IV’s 7.875% Fixed-to-Floating Rate Exchangeable Surplus Trust Securities, MetLife Capital Trust X’s 9.250% Fixed-to-Floating Rate Exchangeable Surplus Trust Securities and the 10.750% JSDs. MetLife, Inc. also entered into a replacement capital obligation which will commence during the six month period prior to the scheduled redemption date of each of the securities described above and under which MetLife, Inc. must use reasonable commercial efforts to raise replacement capital to permit repayment of the securities through the issuance of certain qualifying capital securities.

Interest expense on outstanding junior subordinated debt securities was $258 million for each of the years ended December 31, 2013, 2012 and 2011.

Common_Equity_Units

Common Equity Units	12 Months Ended
	Dec. 31, 2013
Temporary Equity Disclosure [Abstract]	'
Common Equity Units [Text Block]	'
	15. Common Equity Units
	Acquisition of ALICO
	In connection with the financing of the ALICO Acquisition in November 2010, MetLife, Inc. issued to AM Holdings 40.0 million common equity units with an aggregate stated amount at issuance of $3.0 billion and an estimated fair value of $3.2 billion. Each common equity unit has an initial stated amount of $75 per unit and initially consists of: (i) three purchase contracts (the “Series C Purchase Contracts,” the “Series D Purchase Contracts” and the “Series E Purchase Contracts” and, together, the “Purchase Contracts”), obligating the holder to purchase, on a subsequent settlement date, a variable number of shares of MetLife, Inc. common stock, par value $0.01 per share, for a purchase price of $25 ($75 in the aggregate); and (ii) a 1/40 undivided beneficial ownership interest in each of three series of Debt Securities issued by MetLife, Inc., each series of Debt Securities having an aggregate principal amount of $1.0 billion. Distributions on the common equity units will be made quarterly, and will consist of contract payments on the Purchase Contracts and interest payments on the Debt Securities, at an aggregate annual rate of 5.00% of the stated amount at any time. The excess of the estimated fair value of the common equity units over the estimated fair value of the Debt Securities (see Note 12), after accounting for the present value of future contract payments recorded in other liabilities, resulted in a net decrease to additional paid-in capital of $69 million, representing the fair value of the Purchase Contracts discussed below. On March 8, 2011, AM Holdings sold, in a public offering, all the common equity units it received as consideration from MetLife in connection with the ALICO Acquisition. The common equity units are listed on the New York Stock Exchange (“NYSE”).
	Purchase Contracts
	Settlement of the Purchase Contracts of each series occurs upon the successful remarketing of the related series of Debt Securities, or upon a final failed remarketing of the related series, as described below under “—Debt Securities.” On each settlement date subsequent to a successful remarketing, the holder will pay $25 per common equity unit and MetLife, Inc. will issue to such holder a variable number of shares of its common stock in settlement of the applicable Purchase Contract. The number of shares to be issued will depend on the average of the daily volume-weighted average prices of MetLife, Inc.’s common stock during the 20 trading day periods ending on, and including, the third day prior to the initial scheduled settlement date for each series of Purchase Contracts. The Series C Purchase Contracts and Series D Purchase Contracts have been settled as described in “— Remarketing of Debt Securities and Settlement of Purchase Contracts.” The initially-scheduled settlement date for the remaining Series E Purchase Contracts is October 8, 2014. If the average value of MetLife, Inc.’s common stock as calculated pursuant to the stock purchase agreement dated as of March 7, 2010, as amended, by and among MetLife, Inc., AIG and AM Holdings (the “Stock Purchase Agreement”) during the applicable 20 trading day period is less than or equal to $35.15, as such amount may be adjusted (the “Reference Price”), the number of shares to be issued in settlement of the Series E Purchase Contract will equal $25 divided by the Reference Price, as calculated pursuant to the Stock Purchase Agreement (the “Maximum Settlement Rate”). If the market value of MetLife, Inc.’s common stock is greater than or equal to $43.93, as such amount may be adjusted (the “Threshold Appreciation Price”), the number of shares to be issued in settlement of the Series E Purchase Contract will equal $25 divided by the Threshold Appreciation Price, as so calculated (the “Minimum Settlement Rate”). If the market value of MetLife, Inc.’s common stock is greater than the Reference Price and less than the Threshold Appreciation Price, the number of shares to be issued will equal $25 divided by the applicable market value, as so calculated. In the event of an unsuccessful remarketing of any series of Debt Securities and the postponement of settlement to a later date, the average market value used to calculate the settlement rate for a particular series will not be recalculated, although certain corporate events may require adjustments to the settlement rate. After settlement of the remaining Series E Purchase Contracts, MetLife, Inc. will receive proceeds of $1.0 billion and issue between 22.8 million and 28.5 million shares of its common stock, subject to certain adjustments, in addition to the proceeds received and shares issued upon settlement of the Series C Purchase Contracts in October 2012 and Series D Purchase Contracts in September 2013. The holder of a common equity unit may, at its option, settle the related Series E Purchase Contracts before the applicable settlement date. However, upon early settlement, the holder will receive the Minimum Settlement Rate.
	Distributions on the Purchase Contracts will be made quarterly at an average annual rate of 3.02%. The value of all Purchase Contracts at issuance of $247 million was calculated as the present value of the future contract payments and was recorded in other liabilities with an offsetting decrease in additional paid-in capital. The other liabilities balance will be reduced as contract payments are made. Contract payments of $48 million and $84 million were made for the years ended December 31, 2013 and 2012, respectively.
	Debt Securities
	The Debt Securities are senior, unsecured notes of MetLife, Inc. which, in the aggregate, pay quarterly distributions at an initial average annual rate of 1.98% and are included in long-term debt (see Note 12 for further discussion of terms). The Debt Securities are pledged as collateral to secure the obligations of each common equity unit holder under the related Purchase Contracts. Each series of the Debt Securities will be subject to a remarketing and sold on behalf of participating holders to investors. The proceeds of a remarketing, net of any related fees, will be applied on behalf of participating holders who so elect to settle any obligation of the holder to pay cash under the related Purchase Contract on the applicable settlement dates. The Series C Purchase Contracts and Series D Purchase Contracts have been settled as described in “— Remarketing of Debt Securities and Settlement of Purchase Contracts.” The initially-scheduled settlement date for the remaining contracts is October 8, 2014 for the Series E Debt Securities, subject to delay if there are one or more unsuccessful remarketings. If the initial attempted remarketing of the series is unsuccessful, up to two additional remarketing attempts will occur. At the remarketing date, the remarketing agent may reset the interest rate on the Debt Securities, subject to a reset cap for each of the first two attempted remarketings of each series. If a remarketing is successful, the reset rate will apply to all outstanding Debt Securities of the applicable tranche of the remarketed series, whether or not the holder participated in the remarketing and will become effective on the settlement date of such remarketing. If the first remarketing attempt with respect to a series is unsuccessful, the Series E Purchase Contract settlement date will be delayed for three calendar months, at which time a second remarketing attempt will occur in connection with settlement. If the second remarketing attempt is unsuccessful, one additional delay may occur on the same basis. If both additional remarketing attempts are unsuccessful, a “final failed remarketing” will have occurred, and the interest rate on such series of Debt Securities will not be reset and the holder may put such series of Debt Securities to MetLife, Inc. at a price equal to its principal amount plus accrued and unpaid interest, if any, and apply the principal amount against the holder’s obligations under the related Series E Purchase Contract.
	Remarketing of Senior Debt Securities and Settlement of Stock Purchase Contracts
	In both September 2013 and October 2012, MetLife, Inc. closed the successful remarketings of senior debt securities underlying the common equity units. The Series D Debt Securities were remarketed in September 2013 as 4.368% senior debt securities due September 2023. The Series C Debt Securities were remarketed as 1.756% Series C senior debt securities Tranche 1 and 3.048% Series C senior debt securities Tranche 2, due December 2017 and December 2022, respectively. MetLife, Inc. did not receive any proceeds from the remarketings. Most holders of common equity units used the remarketing proceeds to settle their payment obligations under the applicable stock purchase contracts. The subsequent settlement of the stock purchase contracts provided proceeds to MetLife, Inc. of $1.0 billion in each of September 2013 and October 2012 in exchange for shares of MetLife, Inc.’s common stock. In September 2013 and October 2012, MetLife, Inc. delivered 22,679,955 and 28,231,956 shares, respectively, of its newly issued common stock to settle the stock purchase contracts.

Equity

Equity	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Equity	'
	16. Equity
	Preferred Stock
	There are 200,000,000 authorized shares of preferred stock, of which 6,857,000 shares were designated for issuance of Series B Contingent Convertible Junior Participating Non-Cumulative Perpetual Preferred Stock (“Convertible Preferred Stock”) in connection with the financing of the ALICO Acquisition in 2010. See “— Convertible Preferred Stock” below.
	MetLife, Inc. has outstanding 24 million shares of Floating Rate Non-Cumulative Preferred Stock, Series A (the “Series A preferred shares”) with a $0.01 par value per share, and a liquidation preference of $25 per share.
	MetLife, Inc. has outstanding 60 million shares of 6.50% Non-Cumulative Preferred Stock, Series B (the “Series B preferred shares”), with a $0.01 par value per share, and a liquidation preference of $25 per share.
	The preferred stock ranks senior to the common stock with respect to dividends and liquidation rights. Dividends on the preferred stock are not cumulative. Holders of the preferred stock will be entitled to receive dividend payments only when, as and if declared by MetLife, Inc.’s Board of Directors or a duly authorized committee of the Board. If dividends are declared on the Series A preferred shares, they will be payable quarterly, in arrears, at an annual rate of the greater of: (i) 1.00% above three-month LIBOR on the related LIBOR determination date; or (ii) 4.00%. Any dividends declared on the Series B preferred shares will be payable quarterly, in arrears, at an annual fixed rate of 6.50%. Accordingly, in the event that dividends are not declared on the preferred stock for payment on any dividend payment date, then those dividends will cease to accrue and be payable. If a dividend is not declared before the dividend payment date, MetLife, Inc. has no obligation to pay dividends accrued for that dividend period whether or not dividends are declared and paid in future periods. No dividends may, however, be paid or declared on MetLife, Inc.’s common stock — or any other securities ranking junior to the preferred stock — unless the full dividends for the latest completed dividend period on all preferred stock, and any parity stock, have been declared and paid or provided for.
	MetLife, Inc. is prohibited from declaring dividends on the preferred stock if it fails to meet specified capital adequacy, net income and equity levels. See “— Dividend Restrictions.”
	The preferred stock does not have voting rights except in certain circumstances where the dividends have not been paid for an equivalent of six or more dividend payment periods whether or not those periods are consecutive. Under such circumstances, the holders of the preferred stock have certain voting rights with respect to members of the Board of Directors of MetLife, Inc.
	The preferred stock is not subject to any mandatory redemption, sinking fund, retirement fund, purchase fund or similar provisions. The preferred stock is redeemable at MetLife, Inc.’s option in whole or in part, at a redemption price of $25 per share of preferred stock, plus declared and unpaid dividends.
	In December 2008, MetLife, Inc. entered into an RCC related to the preferred stock. As part of such RCC, MetLife, Inc. agreed that it will not repay, redeem or purchase the preferred shares on or before December 31, 2018, unless, subject to certain limitations, it has received proceeds during a specified period from the sale of specified replacement securities. The RCC is for the benefit of the holders of the related Covered Debt, which was initially the Senior Notes. As a result of the issuance of the 10.750% JSDs, the 10.750% JSDs became the Covered Debt with respect to, and in accordance with, the terms of the RCC relating to the preferred shares. The RCC will terminate upon the occurrence of certain events, including the date on which MetLife, Inc. has no series of outstanding eligible debt securities.
	Information on the declaration, record and payment dates, as well as per share and aggregate dividend amounts, for the Series A and Series B preferred shares was as follows:
							Dividend
	Declaration Date		Record Date		Payment Date		Series A				Series A				Series B				Series B
							Per Share				Aggregate				Per Share				Aggregate
							(In millions, except per share data)
	November 15, 2013		November 30, 2013		December 16, 2013		$	0.253			$	7			$	0.406			$	24
	August 15, 2013		August 31, 2013		September 16, 2013		$	0.256			6				$	0.406			24
	May 15, 2013		May 31, 2013		June 17, 2013		$	0.256			7				$	0.406			24
	March 5, 2013		February 28, 2013		March 15, 2013		$	0.25			6				$	0.406			24
											$	26							$	96
	November 15, 2012		November 30, 2012		December 17, 2012		$	0.253			$	7			$	0.406			$	24
	August 15, 2012		August 31, 2012		September 17, 2012		$	0.256			6				$	0.406			24
	May 15, 2012		May 31, 2012		June 15, 2012		$	0.256			7				$	0.406			24
	March 5, 2012		February 29, 2012		March 15, 2012		$	0.253			6				$	0.406			24
											$	26							$	96
	November 15, 2011		November 30, 2011		December 15, 2011		$	0.253			$	7			$	0.406			$	24
	August 15, 2011		August 31, 2011		September 15, 2011		$	0.256			6				$	0.406			24
	May 16, 2011		May 31, 2011		June 15, 2011		$	0.256			7				$	0.406			24
	March 7, 2011		February 28, 2011		March 15, 2011		$	0.25			6				$	0.406			24
											$	26							$	96
	See Note 23 for information on subsequent dividends declared.
	Convertible Preferred Stock
	In connection with the financing of the ALICO Acquisition in November 2010, MetLife, Inc. issued to AM Holdings 6,857,000 shares of Convertible Preferred Stock with a $0.01 par value per share, a liquidation preference of $0.01 per share and a fair value of $2.8 billion. On March 8, 2011, MetLife, Inc. repurchased and canceled all of the Convertible Preferred Stock for $3.0 billion in cash, which resulted in a preferred stock redemption premium of $146 million.
	Common Stock
	Issuances
	In September 2013, MetLife, Inc. issued 22,679,955 new shares of its common stock for $1.0 billion. The issuance was made in connection with the settlement of the Series D Purchase Contracts. See Note 15 .
	In October 2012, MetLife, Inc. issued 28,231,956 new shares of its common stock for $1.0 billion. The issuance was made in connection with the settlement of the Series C Purchase Contracts. See Note 15.
	In March 2011, MetLife, Inc. issued 68,570,000 new shares of its common stock in a public offering at a price of $43.25 per share for gross proceeds of $3.0 billion. In connection with this offering of common stock, $16 million of issuance costs were incurred which have been recorded as a reduction of additional paid-in capital. The proceeds were used to repurchase the Convertible Preferred Stock issued to AM Holdings in November 2010.
	During the years ended December 31, 2013, 2012 and 2011, 7,663,446, 5,497,752 and 3,549,211 new shares of common stock were issued for $250 million, $171 million and $115 million, respectively, to satisfy various stock option exercises and other stock-based awards. There were no shares of common stock issued from treasury stock during each of the years ended December 31, 2013, 2012 and 2011.
	Repurchase Programs
	At December 31, 2013, MetLife, Inc. had $1.3 billion remaining under its common stock repurchase program authorizations. During the years ended December 31, 2013, 2012 and 2011, no shares of common stock were repurchased under these repurchase program authorizations.
	Under the aforementioned authorizations, MetLife, Inc. may purchase its common stock from the MetLife Policyholder Trust, in the open market (including pursuant to the terms of a pre-set trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934) and in privately negotiated transactions. Any future common stock repurchases will be dependent upon several factors, including the Company’s capital position, its liquidity, its financial strength and credit ratings, general market conditions and the market price of MetLife, Inc.’s common stock compared to management’s assessment of the stock’s underlying value and applicable regulatory approvals, as well as other legal and accounting factors.
	Dividends
	The table below presents declaration, record and payment dates, as well as per share and aggregate dividend amounts, for common stock:
							Dividend
	Declaration Date		Record Date		Payment Date		Per Share				Aggregate
							(In millions, except per share data)
	October 22, 2013		November 8, 2013		December 13, 2013		$	0.275			$	311
	June 25, 2013		August 9, 2013		September 13, 2013		$	0.275			303
	April 23, 2013		May 9, 2013		June 13, 2013		$	0.275			302
	January 4, 2013		February 6, 2013		March 13, 2013		$	0.185			203
											$	1,119
	October 23, 2012		November 9, 2012		December 14, 2012		$	0.74			$	811
	October 25, 2011		November 9, 2011		December 14, 2011		$	0.74			$	787
	See Note 23 for information on subsequent dividends declared.
	The funding of the cash dividends and operating expenses of MetLife, Inc. is primarily provided by cash dividends from MetLife, Inc.’s insurance subsidiaries. The statutory capital and surplus, or net assets, of MetLife, Inc.’s insurance subsidiaries are subject to regulatory restrictions except to the extent that dividends are allowed to be paid in a given year without prior regulatory approval. Dividends exceeding these limitations can generally be made subject to regulatory approval. The nature and amount of these dividend restrictions, as well as the statutory capital and surplus of MetLife, Inc.’s U.S. insurance subsidiaries, are disclosed in “— Statutory Equity and Income” and “— Dividend Restrictions — Insurance Operations.” MetLife, Inc.’s principal non-U.S. insurance operations are branches or subsidiaries of American Life, a U.S. insurance subsidiary of the Company. In addition, the payment of dividends by MetLife, Inc. to its shareholders is also subject to restrictions. See “— Dividend Restrictions — MetLife, Inc.”
	Stock-Based Compensation Plans
	Description of Plans for Employees and Agents — General Terms
	The MetLife, Inc. 2000 Stock Incentive Plan, as amended (the “2000 Stock Plan”) authorized the granting of awards to employees and agents in the form of options (“Stock Options”) to buy shares of MetLife, Inc. common stock (“Shares”) that either qualify as incentive Stock Options under Section 422A of the Code or are non-qualified. By December 31, 2009, all awards under the 2000 Stock Plan had either vested or been forfeited. No awards have been made under the 2000 Stock Plan since 2005.
	Under the MetLife, Inc. 2005 Stock and Incentive Compensation Plan (the “2005 Stock Plan”), awards granted to employees and agents may be in the form of Stock Options, Stock Appreciation Rights, Restricted Stock or Restricted Stock Units, Performance Shares or Performance Share Units, Cash-Based Awards and Stock-Based Awards (each as defined in the 2005 Stock Plan with reference to Shares).
	The aggregate number of shares authorized for issuance under the 2005 Stock Plan is 68,000,000, plus those shares available but not utilized under the 2000 Stock Plan and those shares utilized under the 2000 Stock Plan that are recovered due to forfeiture of Stock Options. Each share issued under the 2005 Stock Plan in connection with a Stock Option or Stock Appreciation Right reduces the number of Shares remaining for issuance under that plan by one, and each Share issued under the 2005 Stock Plan in connection with awards other than Stock Options or Stock Appreciation Rights reduces the number of Shares remaining for issuance under that plan by 1.179 Shares. At December 31, 2013, the aggregate number of Shares remaining available for issuance pursuant to the 2005 Stock Plan was 20,098,440. Stock Option exercises and other awards settled in Shares are satisfied through the issuance of Shares held in treasury by the Company or by the issuance of new Shares.
	Compensation expense related to awards under the 2005 Stock Plan is recognized based on the number of awards expected to vest, which represents the awards granted less expected forfeitures over the life of the award, as estimated at the date of grant. Unless a material deviation from the assumed forfeiture rate is observed during the term in which the awards are expensed, any adjustment necessary to reflect differences in actual experience is recognized in the period the award becomes payable or exercisable.
	Compensation expense related to awards under the 2005 Stock Plan is principally related to the issuance of Stock Options, Performance Shares and Restricted Stock Units. The majority of the awards granted each year under the 2005 Stock Plan are made in the first quarter of each year.
Certain stock-based awards provide solely for cash settlement based on changes in the price of Shares and other factors (“Phantom Stock-Based Awards”). Such awards have been made under the MetLife, Inc. International Unit Option Incentive Plan, the MetLife International Performance Unit Incentive Plan, and the MetLife International Restricted Unit Incentive Plan.
Description of Plans for Non-Management Directors — General Terms
Under the MetLife, Inc. 2005 Non-Management Director Stock Compensation Plan (the “2005 Directors Stock Plan”), awards granted may be in the form of non-qualified Stock Options, Stock Appreciation Rights, Restricted Stock or Restricted Stock Units, or Stock-Based Awards (each as defined in the 2005 Directors Stock Plan with reference to Shares) to non-management Directors of MetLife, Inc. The number of Shares authorized for issuance under the 2005 Directors Stock Plan is 2,000,000. There were no Shares carried forward from any prior MetLife, Inc. directors stock plan to the 2005 Directors Stock Plan. At December 31, 2013, the aggregate number of Shares remaining available for issuance pursuant to the 2005 Directors Stock Plan was 1,695,352. Stock Option exercises and other awards settled in Shares are satisfied through the issuance of Shares held in treasury by the Company or by the issuance of new Shares.
Compensation expense related to awards under the 2005 Directors Plan is recognized based on the number of Shares awarded. The only awards made to date under the 2005 Directors Stock Plan have been Stock-Based Awards that have vested immediately. The majority of the awards granted each year under the 2005 Directors Stock Plan are made in the second quarter of each year.
Compensation Expense Related to Stock-Based Compensation
The components of compensation expense related to stock-based compensation includes compensation expense related to Phantom Stock-Based Awards, and excludes the insignificant compensation expense related to the 2005 Directors Stock Plan. Those components were:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Stock Options and Unit Options	$	39			$	61			$	58
Performance Shares and Units (1)	91				80				68
Restricted Stock Units and Restricted Units	45				27				18
Total compensation expense	$	175			$	168			$	144
Income tax benefit	$	61			$	59			$	50
______________
-1	Performance Shares expected to vest and the related compensation expenses may be further adjusted by the performance factor most likely to be achieved, as estimated by management, at the end of the performance period.
The following table presents the total unrecognized compensation expense related to stock-based compensation and the expected weighted average period over which these expenses will be recognized at:
	31-Dec-13
	Expense				Weighted Average
					Period
	(In millions)				(Years)
Stock Options	$	25			1.27
Performance Shares	$	61			1.71
Restricted Stock Units	$	42			1.88
Equity Awards
Stock Options
Stock Options are the contingent right of award holders to purchase Shares at a stated price for a limited time. All Stock Options have an exercise price equal to the closing price of a Share reported on the NYSE on the date of grant, and have a maximum term of 10 years. The vast majority of Stock Options granted have become or will become exercisable at a rate of one-third of each award on each of the first three anniversaries of the grant date. Other Stock Options have become or will become exercisable on the third anniversary of the grant date. Vesting is subject to continued service, except for employees who are retirement eligible and in certain other limited circumstances.
A summary of the activity related to Stock Options was as follows:
	Shares			Weighted				Weighted		Aggregate
	Under			Average				Average		Intrinsic
	Option			Exercise				Remaining		Value (1)
				Price				Contractual
								Term
								(Years)		(In millions)
Outstanding at January 1, 2013	35,153,071			$	40.89			5.5		$	51
Granted	1,310,019			$	35.96
Exercised	(6,357,522	)		$	31.8
Expired	(183,662	)		$	50.46
Forfeited	(170,530	)		$	39.86
Outstanding at December 31, 2013	29,751,376			$	42.56			5.19		$	379
Expected to vest at a future date as of December 31, 2013	29,536,674			$	42.6			5.16		$	376
Exercisable at December 31, 2013	22,786,277			$	43.56			4.32		$	277
______________
-1	The aggregate intrinsic value was computed using the closing Share price on December 31, 2013 of $53.92 and December 31, 2012 of $32.94, as applicable.
The fair value of Stock Options is estimated on the date of grant using a binomial lattice model. Significant assumptions used in the Company’s binomial lattice model are further described below. The assumptions include: expected volatility of the price of Shares; risk-free rate of return; dividend yield on Shares; exercise multiple; and the post-vesting termination rate.
Expected volatility is based upon an analysis of historical prices of Shares and call options on Shares traded on the open market. The Company uses a weighted-average of the implied volatility for publicly-traded call options with the longest remaining maturity nearest to the money as of each valuation date and the historical volatility, calculated using monthly closing prices of Shares. The Company chose a monthly measurement interval for historical volatility as this interval reflects the Company’s view that employee option exercise decisions are based on longer-term trends in the price of the underlying Shares rather than on daily price movements.
The binomial lattice model used by the Company incorporates different risk-free rates based on the imputed forward rates for U.S. Treasury Strips for each year over the contractual term of the option. The table below presents the full range of rates that were used for options granted during the respective periods.
Dividend yield is determined based on historical dividend distributions compared to the price of the underlying Shares as of the valuation date and held constant over the life of the Stock Option.
The binomial lattice model used by the Company incorporates the contractual term of the Stock Options. The model also factors in expected exercise behavior and a post-vesting termination rate, or the rate at which vested options are exercised or expire prematurely due to termination of employment. From these factors, the model derives an expected life of the Stock Option. The exercise behavior in the model is a multiple that reflects the ratio of exercise price to the strike price of the Stock Option at which holders are expected to exercise. The exercise multiple is derived from actual historical exercise activity. The post-vesting termination rate is determined from actual historical exercise experience and expiration activity under the Incentive Plans.
The following table presents the weighted average assumptions, with the exception of risk-free rate, which is expressed as a range, used to determine the fair value of Stock Options issued:
	Years Ended December 31,
	2013				2012				2011
Dividend yield	2.13%				1.95%				1.65%
Risk-free rate of return	0.16%-3.89%				0.21%-4.17%				0.29%-5.51%
Expected volatility	32.98%				35.59%				32.64%
Exercise multiple	1.51				1.58				1.69
Post-vesting termination rate	3.16%				3.14%				3.36%
Contractual term (years)	10				10				10
Expected life (years)	7				7				7
Weighted average exercise price of stock options granted	$	35.96			$	37.91			$	45.16
Weighted average fair value of stock options granted	$	9.88			$	11.33			$	14.27
The following table presents a summary of Stock Option exercise activity:
	Years Ended December 31,
	2013				2012				2011
	(In millions)
Total intrinsic value of stock options exercised	$	79			$	29			$	41
Cash received from exercise of stock options	$	202			$	109			$	88
Income tax benefit realized from stock options exercised	$	28			$	10			$	14
Performance Shares
Performance Shares are units that, if they vest, are multiplied by a performance factor to produce a number of final Performance Shares which are payable in Shares. Performance Shares are accounted for as equity awards, but are not credited with dividend-equivalents for actual dividends paid on Shares during the performance period. Performance Share awards normally vest in their entirety at the end of the three-year performance period. Vesting is subject to continued service, except for employees who are retirement eligible and in certain other limited circumstances.
For awards granted prior to the January 1, 2013 – December 31, 2015 performance period, vested Performance Shares are multiplied by a performance factor of 0.0 to 2.0 based on MetLife, Inc.’s adjusted income, total shareholder return, and performance in change in annual net operating earnings and total shareholder return compared to the performance of its competitors, each measured with respect to the applicable three-year performance period or portions thereof. The estimated fair value of Performance Shares is based upon the closing price of a Share on the date of grant, reduced by the present value of estimated dividends to be paid on that stock during the performance period. The performance factor for the January 1, 2010 – December 31, 2012 performance period was 0.92.
For the January 1, 2013 – December 31, 2015 performance period, the vested Performance Shares will be multiplied by a performance factor of 0.00 to 1.75. Assuming that MetLife, Inc. has met threshold performance goals related to its adjusted income or total shareholder return, the MetLife, Inc. Compensation Committee will determine the performance factor in its discretion. In doing so, the Compensation Committee may consider MetLife, Inc.’s total shareholder return relative to the performance of its competitors and MetLife, Inc.’s operating return on equity relative to its financial plan. The estimated fair value of Performance Shares will be remeasured each quarter until they become payable.
Restricted Stock Units
Restricted Stock Units are units that, if they vest, are payable in an equal number of Shares. Restricted Stock Units are accounted for as equity awards and are not credited with dividend-equivalents for dividends paid on Shares. Accordingly, the estimated fair value of Restricted Stock Units is based upon the closing price of Shares on the date of grant, reduced by the present value of estimated dividends to be paid on that stock.
The vast majority of Restricted Stock Units normally vest in their entirety on the third anniversary of their grant date. Other Restricted Stock Units normally vest in thirds on the first three anniversaries of their grant date, and others vest in their entirety on the fifth anniversary of their grant date. Vesting is subject to continued service, except for employees who are retirement eligible and in certain other limited circumstances.
The following table presents a summary of Performance Share and Restricted Stock Unit activity:
	Performance Shares							Restricted Stock Units
	Shares			Weighted				Units			Weighted
				Average							Average
				Grant Date							Grant Date
				Fair Value							Fair Value
Outstanding at January 1, 2013	4,822,028			$	36.93			2,080,148			$	36.55
Granted	1,749,212			$	50.86			2,182,213			$	32.34
Forfeited	(151,075	)		$	40.87			(395,365	)		$	33.97
Payable (1)	(1,346,025	)		$	32.24			(538,480	)		$	33.17
Outstanding at December 31, 2013	5,074,140			$	42.86			3,328,516			$	33.35
Expected to vest at a future date as of December 31, 2013	5,067,337			$	38.6			2,995,664			$	33.34
______________
-1	Includes both Shares paid and Shares deferred for later payment.
Performance Share amounts above represent aggregate initial target awards and do not reflect potential increases or decreases resulting from the performance factor determined after the end of the respective performance periods. At December 31, 2013, the three year performance period for the 2011 Performance Share grants was completed, but the performance factor had not yet been calculated. Included in the immediately preceding table are 1,545,020 outstanding Performance Shares to which the 2011 – 2013 performance factor will be applied. The factor will be determined in the second quarter of 2014.
Liability Awards (Phantom Stock-Based Awards)
Certain MetLife international subsidiaries have a liability for Phantom Stock-Based Awards in the form of Unit Options, Restricted Units, and/or Performance Units. These Share-based cash settled awards are recorded as liabilities until payout is made. Unlike Share-settled awards, which have a fixed grant-date fair value, the fair value of unsettled or unvested liability awards is remeasured at the end of each reporting period based on the change in fair value of one Share. The liability and corresponding expense are adjusted accordingly until the award is settled.
Unit Options
Each Unit Option is the contingent right of the holder to receive a cash payment equal to the closing price of a Share on the surrender date, less the closing price on the grant date, if the difference is greater than zero. The vast majority of Unit Options have become or will become eligible for surrender at a rate of one-third of each award on each of the first three anniversaries of the grant date. Other Unit Options have become or will become eligible for surrender on the third anniversary of the grant date. Vesting is subject to continued service, except for employees who are retirement eligible and in certain other limited circumstances.
Restricted Units
Restricted Units are units that, if they vest, are payable in cash equal to the closing price of a Share on the last day of the restriction period. The vast majority of Restricted Units normally vest in their entirety on the third anniversary of their grant date. Vesting is subject to continued service, except for employees who are retirement eligible and in certain other limited circumstances.
Performance Units
Performance Units are units that, if they vest, are multiplied by a performance factor to produce a number of final Performance Units which are payable in cash equal to the closing price of a Share on a date following the last day of the three-year performance period. The performance factor for the Performance Units for any given period is determined on the identical basis as the performance factor for Performance Shares for the same performance period. Performance Units are accounted for as liability awards, but are not credited with dividend-equivalents for actual dividends paid on Shares during the performance period. Accordingly, the estimated fair value of Performance Units is based upon the closing price of a Share on the date of grant, reduced by the present value of estimated dividends to be paid on that stock during the performance period.
See “— Performance Shares” for a discussion of the Performance Shares vesting period and award calculation, which is also used for Performance Units.
The following table presents a summary of Liability Awards activity:
	Unit			Restricted			Performance
	Options			Units			Units
Outstanding at January 1, 2013	1,370,317			740,436			305,164
Granted	48,301			445,740			297,834
Exercised	(127,386	)		—			—
Forfeited	(69,606	)		(127,329	)		(15,761	)
Paid	—			(79,325	)		(55,349	)
Outstanding at December 31, 2013	1,221,626			979,522			531,888
Expected to vest at a future date as of December 31, 2013	1,137,832			881,570			478,699
Statutory Equity and Income
Each of MetLife, Inc.’s U.S. insurance company’s state of domicile imposes risk-based capital (“RBC”) requirements that were developed by the National Association of Insurance Commissioners (“NAIC”). American Life does not write business in Delaware or any other domestic state and, as such, is exempt from RBC requirements by Delaware law. As Exeter prepares financial statements on a modified GAAP basis, as approved by the Delaware Commissioner of Insurance (the “Delaware Commissioner”), they are also not subject to the RBC requirements that generally apply to insurers that prepare statutory-basis financial statements. Regulatory compliance is determined by a ratio of a company’s total adjusted capital, calculated in the manner prescribed by the NAIC (“TAC”) to its authorized control level RBC, calculated in the manner prescribed by the NAIC (“ACL RBC”). Companies below specific trigger points or ratios are classified within certain levels, each of which requires specified corrective action. The minimum level of TAC before corrective action commences is twice ACL RBC (“Company Action RBC”). While not required by or filed with insurance regulators, the Company also calculates an internally defined combined RBC ratio (“Combined RBC Ratio”), which is determined by dividing the sum of TAC for MetLife, Inc.’s principal U.S. insurance subsidiaries, excluding American Life, by the sum of Company Action RBC for such subsidiaries. The Company’s Combined RBC Ratio was in excess of 400% for all periods presented. In addition, all non-exempted U.S. insurance subsidiaries individually exceeded Company Action RBC for all periods presented.
MetLife, Inc.’s foreign operations are regulated by applicable authorities of the countries in which each entity operates and are subject to minimum capital and solvency requirements in those countries before corrective action commences. At December 31, 2013 and 2012, the adjusted capital of American Life’s insurance subsidiary in Japan, the Company’s largest foreign operation, was in excess of four times the 200% solvency margin ratio that would require corrective action. Excluding Japan, the aggregate required capital and surplus of the Company’s other foreign insurance operations was $2.4 billion and the aggregate actual regulatory capital and surplus of such operations was $8.4 billion as of the date of the most recent required capital adequacy calculation for each jurisdiction. Each of those other foreign insurance operations exceeded minimum capital and solvency requirements of their respective countries for all periods presented.
MetLife, Inc.’s insurance subsidiaries prepare statutory-basis financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of the state of domicile or applicable foreign jurisdiction. The NAIC has adopted the Codification of Statutory Accounting Principles (“Statutory Codification”). Statutory Codification is intended to standardize regulatory accounting and reporting to state insurance departments. However, statutory accounting principles continue to be established by individual state laws and permitted practices. Modifications by the various state insurance departments may impact the effect of Statutory Codification on the statutory capital and surplus of MetLife, Inc.’s U.S. insurance subsidiaries.
Statutory accounting principles differ from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions, reporting surplus notes as surplus instead of debt and valuing securities on a different basis.
In addition, certain assets are not admitted under statutory accounting principles and are charged directly to surplus. The most significant assets not admitted by the Company are net deferred income tax assets resulting from temporary differences between statutory accounting principles basis and tax basis not expected to reverse and become recoverable within three years. Further, statutory accounting principles do not give recognition to purchase accounting adjustments.
MetLife, Inc.’s U.S. insurance subsidiaries have no material state prescribed accounting practices, except for American Life. American Life calculates its policyholder reserves on insurance written in each foreign jurisdiction in accordance with the reserve standards required by such jurisdiction. American Life is not required to quantify the impact to its statutory capital and surplus as a result of applying this prescribed practice to its branch operations. Additionally, American Life’s insurance subsidiaries are valued based on each respective subsidiary’s underlying local statutory equity, adjusted in a manner consistent with the reporting prescribed for its branch operations, which resulted in higher statutory capital and surplus of $20 million and $413 million for the years ended December 31, 2013 and 2012, respectively.
The tables below present amounts from MetLife, Inc.’s primary insurance subsidiaries, which are derived from the statutory–basis financial statements as filed with the insurance regulators.
Statutory net income (loss) was as follows:
				Years Ended December 31,
Company		State of Domicile		2013				2012				2011
				(In millions)
Metropolitan Life Insurance Company		New York		$	369			$	1,320			$	1,970
American Life Insurance Company		Delaware		$	631			$	317			$	334
MetLife Insurance Company of Connecticut		Connecticut		$	790			$	848			$	46
Metropolitan Property and Casualty Insurance Company		Rhode Island		$	282			$	235			$	41
Metropolitan Tower Life Insurance Company		Delaware		$	52			$	61			$	63
Statutory capital and surplus was as follows at:
		December 31,
Company		2013				2012
		(In millions)
Metropolitan Life Insurance Company		$	12,428			$	14,295
American Life Insurance Company		$	2,711			$	3,044
MetLife Insurance Company of Connecticut		$	4,795			$	5,331
Metropolitan Property and Casualty Insurance Company		$	2,225			$	1,987
Metropolitan Tower Life Insurance Company		$	735			$	781
As derived from the most recent annual statutory basis financial statements filed with insurance regulators, the aggregate statutory net income and aggregate statutory capital and surplus of the Company’s foreign insurance subsidiaries not owned directly or indirectly by the Company’s primary insurance subsidiaries set forth in the table above was $423 million and $4.5 billion, respectively.
The Company’s domestic captive life reinsurance subsidiaries, which reinsure risks including the closed block, level premium term life and universal life with secondary guarantees assumed from other MetLife subsidiaries, have no material state prescribed accounting practices, except for MetLife Reinsurance Company of Vermont (“MRV”). MRV, with the explicit permission of the Commissioner of Insurance of the State of Vermont, has included, as admitted assets, the value of letters of credit serving as collateral for reinsurance credit taken by various affiliated cedants, in connection with reinsurance agreements entered into between MRV and the various affiliated cedants, which resulted in higher statutory capital and surplus of $5.5 billion and $5.1 billion for the years ended December 31, 2013 and 2012, respectively. MRV’s RBC would have triggered a regulatory event without the use of the state prescribed practice. The statutory net income (loss) of MetLife, Inc.’s domestic captive life reinsurance subsidiaries was ($612) million, ($154) million and ($130) million for the years ended December 2013, 2012 and 2011, respectively, and the statutory capital and surplus, including the aforementioned prescribed practice, was $4.3 billion and $4.2 billion at December 31, 2013 and 2012, respectively.
Dividend Restrictions
Insurance Operations
The table below sets forth the dividends permitted to be paid by the respective insurance subsidiary without insurance regulatory approval and the respective dividends paid:
		2014				2013									2012
Company		Permitted w/o				Paid (2)					Permitted w/o				Paid (2)				Permitted w/o
		Approval (1)									Approval (3)								Approval (3)
		(In millions)
Metropolitan Life Insurance Company		$	1,116			$	1,428				$	1,428			$	1,023			$	1,350
American Life Insurance Company		$	—			$	—				$	523			$	1,300		-4	$	168
MetLife Insurance Company of Connecticut		$	1,061			$	1,000				$	1,330			$	706		-5	$	504
Metropolitan Property and Casualty Insurance Company		$	218			$	100				$	74			$	100			$	—
Metropolitan Tower Life Insurance Company		$	73			$	109		(6	)	$	77			$	82			$	82
MetLife Investors Insurance Company		$	99			$	129				$	129			$	18			$	18
Delaware American Life Insurance Company		$	16			$	—				$	7			$	—			$	12
______________
-1	Reflects dividend amounts that may be paid during 2014 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2014, some or all of such dividends may require regulatory approval.
-2	Reflects all amounts paid, including those requiring regulatory approval.
-3	Reflects dividend amounts that could have been paid during the relevant year without prior regulatory approval.
-4	During May 2012, American Life received regulatory approval to pay an extraordinary dividend for an amount up to the funds remitted in connection with the restructuring of American Life’s business in Japan. Subsequently, $1.5 billion was remitted to American Life. See Note 3. Of this approved amount, $1.3 billion was paid to MetLife, Inc. as an extraordinary dividend.
-5	During June 2012, MICC distributed shares of an affiliate to its stockholders as an in-kind extraordinary dividend of $202 million as calculated on a statutory basis. Regulatory approval for this extraordinary dividend was obtained due to the timing of payment. During December 2012, MICC paid a dividend to its stockholders in the amount of $504 million, which represented its ordinary dividend capacity at December 31, 2012. Due to the June 2012 in-kind dividend, a portion of this was extraordinary and regulatory approval was obtained.
-6	During October 2013, Metropolitan Tower Life Insurance Company (“MTL”) distributed shares of an affiliate to MetLife, Inc. as an in-kind dividend of $32 million. Also during October 2013, MTL paid a dividend to MetLife, Inc. in the amount of $77 million in cash, which represented its dividend capacity without regulatory approval at December 31, 2013. Regulatory approval for these dividends was obtained due to the amount and timing of the payments.
Under New York State Insurance Law, MLIC is permitted, without prior insurance regulatory clearance, to pay stockholder dividends to MetLife, Inc. as long as the aggregate amount of all such dividends in any calendar year does not exceed the lesser of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains). MLIC will be permitted to pay a dividend to MetLife, Inc. in excess of the lesser of such two amounts only if it files notice of its intention to declare such a dividend and the amount thereof with the New York Superintendent of Financial Services (the “Superintendent”) and the Superintendent either approves the distribution of the dividend or does not disapprove the dividend within 30 days of its filing. Under New York State Insurance Law, the Superintendent has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders.
Under Delaware State Insurance Law, each of American Life, DelAm and MTL is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend to MetLife, Inc. as long as the amount of the dividend, when aggregated with all other dividends in the preceding 12 months, does not exceed the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) its net statutory gain from operations for the immediately preceding calendar year (excluding realized capital gains). Each of American Life, DelAm and MTL will be permitted to pay a dividend to MetLife, Inc. in excess of the greater of such two amounts only if it files notice of the declaration of such a dividend and the amount thereof with the Delaware Commissioner and the Delaware Commissioner either approves the distribution of the dividend or does not disapprove the distribution within 30 days of its filing. In addition, any dividend that exceeds earned surplus (defined as “unassigned funds (surplus)”) as of the immediately preceding calendar year requires insurance regulatory approval. Under Delaware State Insurance Law, the Delaware Commissioner has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders.
Under Connecticut State Insurance Law, MICC is permitted, without prior insurance regulatory clearance, to pay stockholder dividends to its stockholders as long as the amount of such dividends, when aggregated with all other dividends in the preceding 12 months, does not exceed the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) its statutory net gain from operations for the immediately preceding calendar year. MICC will be permitted to pay a dividend in excess of the greater of such two amounts only if it files notice of its declaration of such a dividend and the amount thereof with the Connecticut Commissioner of Insurance (the “Connecticut Commissioner”) and the Connecticut Commissioner either approves the distribution of the dividend or does not disapprove the payment within 30 days after notice. In addition, any dividend that exceeds earned surplus (defined as “unassigned funds (surplus)”, reduced by 25% of unrealized appreciation in value or revaluation of assets or unrealized profits on investments) as of the last filed annual statutory statement requires insurance regulatory approval. Under Connecticut State Insurance Law, the Connecticut Commissioner has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders.
Under the Rhode Island Insurance Code, Metropolitan Property and Casualty Insurance Company (“MPC”) is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend to MetLife, Inc. as long as the aggregate amount of all such dividends in any 12 month period does not exceed the lesser of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) net income, not including realized capital gains, for the immediately preceding calendar year, not including pro rata distributions of MPC’s own securities. In determining whether a dividend is extraordinary, MPC may include carry forward net income from the previous two calendar years, excluding realized capital gains less dividends paid in the second and immediately preceding calendar years. MPC will be permitted to pay a dividend to MetLife, Inc. in excess of the lesser of such two amounts only if it files notice of its intention to declare such a dividend and the amount thereof with the Rhode Island Commissioner of Insurance (the “Rhode Island Commissioner”) and the Rhode Island Commissioner either approves the distribution of the dividend or does not disapprove the distribution within 30 days of its filing. Under the Rhode Island Insurance Code, the Rhode Island Commissioner has broad discretion in determining whether the financial condition of a stock property and casualty insurance company would support the payment of such dividends to its stockholders.
Under Missouri State Insurance Law, MLIIC is permitted, without prior insurance regulatory clearance, to pay a stockholder dividend to MetLife, Inc. as long as the amount of the dividend when aggregated with all other dividends in the preceding 12 months does not exceed the greater of: (i) 10% of its surplus to policyholders as of the end of the immediately preceding calendar year; or (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding net realized capital gains). MLIIC will be permitted to pay a dividend to its parent in excess of the greater of such two amounts only if it files notice of the declaration of such a dividend and the amount thereof with the Missouri Director of Insurance (the “Missouri Director”) and the Missouri Director either approves the distribution of the dividend or does not disapprove the distribution within 30 days of its filing. In addition, any dividend that exceeds earned surplus (defined by the Company as “unassigned funds (surplus)”) as of the last filed annual statutory statement requires insurance regulatory approval. Under Missouri State Insurance Law, the Missouri Director has broad discretion in determining whether the financial condition of a stock life insurance company would support the payment of such dividends to its stockholders.
MetLife, Inc.
In addition to regulatory restrictions on the payment of dividends by its subsidiaries to MetLife, Inc., the payment of dividends by MetLife, Inc. to its stockholders is also subject to restrictions. The declaration and payment of dividends is subject to the discretion of MetLife, Inc.’s Board of Directors, and will depend on its financial condition, results of operations, cash requirements, future prospects and other factors deemed relevant by the board. In addition, the payment of dividends on MetLife, Inc.’s common stock, and MetLife, Inc.’s ability to repurchase its common stock, may be subject to restrictions arising out of regulation by the Federal Reserve Bank of New York (collectively, with the Federal Reserve Board, the “Federal Reserve”) if, in the future, MetLife, Inc. is designated by the Financial Stability Oversight Council (“FSOC”) as a non-bank systemically important financial institution (“non-bank SIFI”), as described below. They are also subject to restrictions under the terms of MetLife, Inc.’s preferred stock, junior subordinated debentures and trust securities in situations where MetLife, Inc. may be experiencing financial stress, as described below. For purposes of this discussion, “junior subordinated debentures” are deemed to include MetLife, Inc.’s Fixed-to-Floating Rate Exchangeable Surplus Trust Securities, which are exchangeable at the option of MetLife, Inc., or in the future upon the occurrence of certain events, for junior subordinated debentures, and which contain terms with the same substantive effects described in this discussion as the terms in MetLife’s junior subordinated debentures.
Regulatory Restrictions. As discussed in Note 3, MetLife, Inc. has de-registered as a bank holding company. As a result, MetLife, Inc. is no longer regulated as a bank holding company or subject to enhanced supervision and prudential standards as a bank holding company with assets of $50 billion or more. However, if, in the future, MetLife, Inc. is designated by the FSOC as a non-bank SIFI, it could once again be subject to regulation by the Federal Reserve and enhanced supervision and prudential standards. While the Federal Reserve has proposed a set of prudential standards that would apply to non-bank SIFIs, as well as bank holding companies with assets of $50 billion or more, it has not yet adopted final rules for most of these standards. The Federal Reserve has stated its intention to take a tailored approach to applying the prudential standards to non-bank SIFIs, but has not provided any details on how it intends to do so. If MetLife, Inc. were designated as a non-bank SIFI by the FSOC, the associated enhanced prudential standards imposed could adversely affect MetLife, Inc.’s ability to pay dividends to its stockholders, as well as repurchase its common stock. MetLife, Inc. has been designated as a global systemically important insurer by the Financial Stability Board. As such, it could be subject to policy measures which could include higher capital requirements and more intensive regulation. These policy measures would need to be implemented by regulation or legislation in relevant jurisdictions but could limit MetLife, Inc.’s ability to pay dividends to its stockholders and repurchase its common stock.
“Dividend Stopper” Provisions in the Preferred Stock and Junior Subordinated Debentures. Certain terms of MetLife, Inc.’s preferred stock and junior subordinated debentures (sometimes referred to as “dividend stoppers”) may prevent it from repurchasing its common or preferred stock or paying dividends on its common or preferred stock in certain circumstances. Under the preferred stock, if, for any reason, including due to a determination by the MetLife, Inc. Board of Directors, MetLife, Inc. has not paid the full dividends on its preferred stock for a dividend period (i.e., the period from and including a preferred stock dividend payment date to, but excluding the next preferred stock dividend payment date), it may not repurchase or pay dividends on its common stock for that period. Under the junior subordinated debentures, if MetLife, Inc. has not paid in full the accrued interest on its junior subordinated debentures through the most recent interest payment date, it may not repurchase or pay dividends on its common stock or other capital stock (including the preferred stock), subject to certain exceptions. The junior subordinated debentures provide that MetLife may, at its option and provided that certain conditions are met, defer payment of interest without giving rise to an event of default for periods of up to 10 years (although after five years MetLife, Inc. would be obligated to use commercially reasonable efforts to sell equity securities to raise proceeds to pay the interest), with no limitation on the number of deferral periods that MetLife, Inc. may begin, so long as all accrued and unpaid interest is paid with respect to prior deferral periods. If MetLife, Inc. were to elect to defer payments of interest, the “dividend stopper” provisions in the junior subordinated debentures would thus prevent MetLife, Inc. from repurchasing or paying dividends on its common stock or other capital stock (including the preferred stock) during the period of deferral, subject to exceptions.
In addition, the preferred stock and the junior subordinated debentures contain provisions that would automatically suspend the payment of preferred stock dividends and junior subordinated debenture interest payments if MetLife, Inc. fails to meet certain risk based capital ratio, net income and stockholders’ equity tests at specified times. In such cases, however, MetLife would be permitted to make the payments if it were able to utilize a prescribed alternative payment mechanism. As a result of the suspension of these payments, the “dividend stopper” provisions would come into effect.
MetLife, Inc. is a party to certain RCCs which limit its ability to eliminate these restrictions through the repayment, redemption or purchase of preferred stock or junior subordinated debentures by requiring MetLife, subject to certain limitations, to receive cash proceeds during a specified period from the sale of specified replacement securities prior to any such repayment, redemption or purchase. See “— Preferred Stock” for a description of such covenants in effect with respect to the preferred stock, and Note 14 for a description of such covenants in effect with respect to junior subordinated debentures.
Accumulated Other Comprehensive Income (Loss)
Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc., net of income tax, was as follows:
	Unrealized				Unrealized				Foreign				Defined				Total
	Investment Gains				Gains (Losses)				Currency				Benefit
	(Losses), Net of				on Derivatives				Translation				Plans
	Related Offsets (1)								Adjustments				Adjustment
	(In millions)
Balance at December 31, 2010	$	3,161			$	(39	)		$	(528	)		$	(1,449	)		$	1,145
OCI before reclassifications	7,637				1,595				42				(893		)		8,381
Income tax expense (benefit)	(2,604		)		(557		)		(162		)		312				(3,011		)
OCI before reclassifications, net of income tax	8,194				999				(648		)		(2,030		)		6,515
Amounts reclassified from AOCI	(766		)		(21		)		—				133				(654		)
Income tax expense (benefit)	261				7				—				(46		)		222
Amounts reclassified from AOCI, net of income tax	(505		)		(14		)		—				87				(432		)
Balance at December 31, 2011	7,689				985				(648		)		(1,943		)		6,083
OCI before reclassifications	9,321				(262		)		(134		)		(996		)		7,929
Income tax expense (benefit)	(3,457		)		92				249				350				(2,766		)
OCI before reclassifications, net of income tax	13,553				815				(533		)		(2,589		)		11,246
Amounts reclassified from AOCI	58				24				—				154				236
Income tax expense (benefit)	(23		)		(8		)		—				(54		)		(85		)
Amounts reclassified from AOCI, net of income tax	35				16				—				100				151
Balance at December 31, 2012	13,588				831				(533		)		(2,489		)		11,397
OCI before reclassifications	(8,487		)		(937		)		(937		)		1,078				(9,283		)
Income tax expense (benefit)	2,807				312				(189		)		(379		)		2,551
OCI before reclassifications, net of income tax	7,908				206				(1,659		)		(1,790		)		4,665
Amounts reclassified from AOCI	411				36				—				214				661
Income tax expense (benefit)	(136		)		(11		)		—				(75		)		(222		)
Amounts reclassified from AOCI, net of income tax	275				25				—				139				439
Balance at December 31, 2013	$	8,183			$	231			$	(1,659	)		$	(1,651	)		$	5,104
__________________
-1	See Note 8 for information on offsets to investments related to insurance liabilities, DAC and VOBA and the policyholder dividend obligation.
Information regarding amounts reclassified out of each component of AOCI, was as follows:
AOCI Components		Amounts Reclassified from AOCI												Statement of Operations and
														Comprehensive Income (Loss) Location
		Years Ended December 31,
		2013				2012				2011
		(In millions)
Net unrealized investment gains (losses):
Net unrealized investment gains (losses)		$	404			$	(34	)		$	(952	)		Other net investment gains (losses)
Net unrealized investment gains (losses)		93				73				73				Net investment income
Net unrealized investment gains (losses)		(26		)		(10		)		144				Net derivative gains (losses)
OTTI		(60		)		29				(31		)		OTTI on fixed maturity securities
Net unrealized investment gains (losses), before income tax		411				58				(766		)
Income tax (expense) benefit		(136		)		(23		)		261
Net unrealized investment gains (losses), net of income tax		$	275			$	35			$	(505	)
Unrealized gains (losses) on derivatives - cash flow hedges:
Interest rate swaps		$	20			$	1			$	(42	)		Net derivative gains (losses)
Interest rate swaps		8				4				1				Net investment income
Interest rate swaps		—				(3		)		(10		)		Other expenses
Interest rate forwards		10				1				31				Net derivative gains (losses)
Interest rate forwards		3				2				1				Net investment income
Interest rate forwards		(1		)		(1		)		(1		)		Other expenses
Foreign currency swaps		(3		)		23				—				Net derivative gains (losses)
Foreign currency swaps		(3		)		(5		)		(6		)		Net investment income
Foreign currency swaps		1				1				2				Other expenses
Credit forwards		—				—				2				Net derivative gains (losses)
Credit forwards		1				1				1				Net investment income
Gains (losses) on cash flow hedges, before income tax		36				24				(21		)
Income tax (expense) benefit		(11		)		(8		)		7
Gains (losses) on cash flow hedges, net of income tax		$	25			$	16			$	(14	)
Defined benefit plans adjustment: (1)
Amortization of net actuarial gains (losses)		$	283			$	252			$	237
Amortization of prior service (costs) credit		(69		)		(98		)		(104		)
Amortization of defined benefit plan items, before		214				154				133
income tax
Income tax (expense) benefit		(75		)		(54		)		(46		)
Amortization of defined benefit plan items, net of income tax		$	139			$	100			$	87
Total reclassifications, net of income tax		$	439			$	151			$	(432	)
__________________
-1	These AOCI components are included in the computation of net periodic benefit costs. See Note 18.

Other_Expenses

Other Expenses	12 Months Ended
	Dec. 31, 2013
Other Income and Expenses [Abstract]	'
Other Expenses	'
	17. Other Expenses
	Information on other expenses was as follows:
		Years Ended December 31,
		2013			2012			2011
		(In millions)
	Compensation	$	5,108		$	5,562		$	5,287
	Pension, postretirement and postemployment benefit costs	488			428			463
	Commissions	5,428			5,909			6,378
	Volume-related costs	842			599			335
	Interest credited to bank deposits	2			78			95
	Capitalization of DAC	(4,786		)	(5,289		)	(5,558		)
	Amortization of DAC and VOBA	3,550			4,199			4,898
	Amortization of negative VOBA	(579		)	(622		)	(697		)
	Interest expense on debt and debt issuance costs	1,282			1,356			1,629
	Premium taxes, licenses and fees	658			677			633
	Professional services	1,454			1,664			1,597
	Rent and related expenses, net of sublease income	376			422			426
	Other (1)	2,779			2,772			3,051
	Total other expenses	$	16,602		$	17,755		$	18,537
	__________________
	-1	See Note 19 for information on the Japan income tax refund included in other expenses for the year ended December 31, 2013.
	Capitalization of DAC and Amortization of DAC and VOBA
	See Note 5 for additional information on DAC and VOBA including impacts of capitalization and amortization. See also Note 7 for a description of the DAC amortization impact associated with the closed block.
	Interest Expense on Debt and Debt Issuance Costs
	See Notes 12, 13, 14 and 15 for attribution of interest expense by debt issuance. Interest expense on debt and debt issuance costs includes interest expense related to CSEs. See Note 8.
	Restructuring Charges
	The Company commenced in 2012 an enterprise-wide strategic initiative. This global strategy focuses on leveraging the Company’s scale to improve the value it provides to customers and shareholders in order to reduce costs, enhance revenues, achieve efficiencies and reinvest in its technology, platforms and functionality to improve its current operations and develop new capabilities.
	These restructuring charges are included in other expenses. As the expenses relate to an enterprise-wide initiative, they are reported in Corporate & Other. Estimated restructuring costs may change as management continues to execute this enterprise-wide strategic initiative. Such restructuring charges were as follows:
		Years Ended December 31,
		2013									2012
		Severance			Lease and			Total			Severance			Lease and			Total
					Asset									Asset
					Impairment									Impairment
		(In millions)
	Balance at January 1,	$	23		$	—		$	23		$	—		$	—		$	—
	Restructuring charges	99			16			115			141			18			159
	Cash payments	(82		)	(10		)	(92		)	(118		)	(18		)	(136		)
	Balance at December 31,	$	40		$	6		$	46		$	23		$	—		$	23
	Total restructuring charges incurred since inception of initiative	$	240		$	34		$	274		$	141		$	18		$	159
	Management anticipates further restructuring charges including severance, as well as lease and asset impairments, through the year ending December 31, 2015. However, such restructuring plans were not sufficiently developed to enable management to make an estimate of such restructuring charges at December 31, 2013.
	ALICO Acquisition Integration-Related Expenses
	Integration-related costs were $138 million, $305 million and $362 million for the years ended December 31, 2013, 2012 and 2011, respectively. Integration-related costs represent costs directly related to integrating ALICO, including expenses for consulting and the integration of information systems. Such costs have been expensed as incurred and, as the integration of ALICO is an enterprise-wide initiative, these expenses are reported in Corporate & Other. The Company does not expect future ALICO integration-related costs to be material.
	See Note 3 for discussion of costs related to other acquisitions.

Employee_Benefit_Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Employee Benefit Plans	'
	18. Employee Benefit Plans
	Pension and Other Postretirement Benefit Plans
	The Subsidiaries sponsor and/or administer various U.S. qualified and non-qualified defined benefit pension plans and other postretirement employee benefit plans covering employees and sales representatives who meet specified eligibility requirements. U.S. pension benefits are provided utilizing either a traditional formula or cash balance formula. The traditional formula provides benefits that are primarily based upon years of credited service and either final average or career average earnings. The cash balance formula utilizes hypothetical or notional accounts which credit participants with benefits equal to a percentage of eligible pay, as well as earnings credits, determined annually based upon the average annual rate of interest on 30-year U.S. Treasury securities, for each account balance. At December 31, 2013, the majority of active participants were accruing benefits under the cash balance formula; however, 90% of the Subsidiaries’ obligations result from benefits calculated with the traditional formula. The U.S. non-qualified pension plans provide supplemental benefits in excess of limits applicable to a qualified plan. The non-U.S. pension plans generally provide benefits based upon either years of credited service and earnings preceding-retirement or points earned on job grades and other factors in years of service.
	The Subsidiaries also provide certain postemployment benefits and certain postretirement medical and life insurance benefits for retired employees. Employees of the Subsidiaries who were hired prior to 2003 (or, in certain cases, rehired during or after 2003) and meet age and service criteria while working for one of the Subsidiaries may become eligible for these other postretirement benefits, at various levels, in accordance with the applicable plans. Virtually all retirees, or their beneficiaries, contribute a portion of the total costs of postretirement medical benefits. Employees hired after 2003 are not eligible for any employer subsidy for postretirement medical benefits.
	Obligations and Funded Status
		Pension Benefits																Other Postretirement Benefits
		U.S. Plans (1)								Non-U.S. Plans								U.S. Plans							Non-U.S. Plans
		December 31,
		2013				2012				2013				2012				2013				2012			2013			2012
		(In millions)
	Change in benefit obligations:
	Benefit obligations at January 1,	$	9,480			$	8,327			$	823			$	773			$	2,375			$	2,093		$	43		$	39
	Service costs	236				224				67				75				20				21			2			1
	Interest costs	389				406				14				17				92				103			2			2
	Plan participants’ contributions	—				—				—				—				30				29			—			—
	Net actuarial (gains) losses	(1,050		)		999				34				32				(551		)		261			(1		)	4
	Acquisition, divestitures and curtailments	—				—				(19		)		(12		)		—				—			(3		)	(3		)
	Change in benefits	—				—				—				(1		)		—				—			—			—
	Benefits paid	(464		)		(476		)		(41		)		(41		)		(132		)		(132		)	(2		)	(2		)
	Effect of foreign currency translation and other	—				—				(134		)		(20		)		—				—			—			2
	Benefit obligations at December 31,	8,591				9,480				744				823				1,834				2,375			41			43
	Change in plan assets:
	Fair value of plan assets at January 1,	7,879				7,108				224				185				1,320				1,240			15			13
	Actual return on plan assets	(22		)		740				34				20				58				105			(1		)	2
	Acquisition, divestitures and settlements	—				—				(19		)		(11		)		—				—			(3		)	(3		)
	Plan participants’ contributions	—				—				—				—				30				29			—			—
	Employer contributions	383				507				83				74				76				78			5			4
	Benefits paid	(464		)		(476		)		(41		)		(41		)		(132		)		(132		)	(2		)	(2		)
	Effect of foreign currency translation	—				—				(33		)		(3		)		—				—			—			1
	Fair value of plan assets at December 31,	7,776				7,879				248				224				1,352				1,320			14			15
	Over (under) funded status at December 31,	$	(815	)		$	(1,601	)		$	(496	)		$	(599	)		$	(482	)		$	(1,055	)	$	(27	)	$	(28	)
	Amounts recognized in the consolidated balance sheets consist of:
	Other assets	$	223			$	—			$	7			$	6			$	—			$	—		$	—		$	—
	Other liabilities	(1,038		)		(1,601		)		(503		)		(605		)		(482		)		(1,055		)	(27		)	(28		)
	Net amount recognized	$	(815	)		$	(1,601	)		$	(496	)		$	(599	)		$	(482	)		$	(1,055	)	$	(27	)	$	(28	)
	AOCI:
	Net actuarial (gains) losses	$	2,274			$	3,047			$	28			$	27			$	211			$	799		$	2		$	3
	Prior service costs (credit)	18				24				2				2				1				(74		)	1			1
	AOCI, before income tax	$	2,292			$	3,071			$	30			$	29			$	212			$	725		$	3		$	4
	Accumulated benefit obligation	$	8,104			$	8,866			$	636			$	724			N/A				N/A			N/A			N/A
	_____________
	-1	Includes non-qualified unfunded plans, for which the aggregate projected benefit obligation was $1.0 billion and $1.1 billion at December 31, 2013 and 2012, respectively.
	The aggregate pension accumulated benefit obligation and aggregate fair value of plan assets for pension benefit plans with accumulated benefit obligations in excess of plan assets was as follows:
		Pension Benefits
		U.S. Plans								Non-U.S. Plans
		December 31,
		2013				2012				2013				2012
		(In millions)
	Projected benefit obligations	$	1,037			$	1,323			$	644			$	690
	Accumulated benefit obligations	$	927			$	1,166			$	579			$	651
	Fair value of plan assets	$	—			$	157			$	167			$	144
	Information for pension and other postretirement benefit plans with a projected benefit obligation in excess of plan assets were as follows:
		Pension Benefits																Other Postretirement Benefits
		U.S. Plans								Non-U.S. Plans								U.S. Plans							Non-U.S. Plans
		December 31,
		2013				2012				2013				2012				2013				2012			2013			2012
		(In millions)
	Projected benefit obligations	$	1,170			$	9,480			$	701			$	763			$	1,834			$	2,375		$	41		$	43
	Fair value of plan assets	$	133			$	7,879			$	199			$	188			$	1,352			$	1,320		$	14		$	15
	Net Periodic Benefit Costs
	Net periodic benefit costs are determined using management estimates and actuarial assumptions to derive service costs, interest costs and expected return on plan assets for a particular year. Net periodic benefit costs also includes the applicable amortization of net actuarial gains (losses) and amortization of any prior service costs (credit).
	The obligations and expenses associated with these plans require an extensive use of assumptions such as the discount rate, expected rate of return on plan assets, rate of future compensation increases, healthcare cost trend rates, as well as assumptions regarding participant demographics such as rate and age of retirements, withdrawal rates and mortality. Management, in consultation with its external consulting actuarial firms, determines these assumptions based upon a variety of factors such as historical performance of the plan and its assets, currently available market and industry data and expected benefit payout streams. The assumptions used may differ materially from actual results due to, among other factors, changing market and economic conditions and changes in participant demographics. These differences may have a significant effect on the Company’s consolidated financial statements and liquidity.
	Net periodic pension costs and net periodic other postretirement benefit plan costs are comprised of the following:
•	Service Costs — Service costs are the increase in the projected (expected) PBO resulting from benefits payable to employees of the Subsidiaries on service rendered during the current year.
•	Interest Costs — Interest costs are the time value adjustment on the projected (expected) PBO at the end of each year.
•	Settlement and Curtailment Costs — The aggregate amount of net gains (losses) recognized in net periodic benefit costs due to settlements and curtailments. Settlements result from actions that relieve/eliminate the plan’s responsibility for benefit obligations or risks associated with the obligations or assets used for the settlement. Curtailments result from an event that significantly reduces/eliminates plan participants’ expected years of future services or benefit accruals.
•	Expected Return on Plan Assets — Expected return on plan assets is the assumed return earned by the accumulated pension and other postretirement fund assets in a particular year.
•	Amortization of Net Actuarial Gains (Losses) — Actuarial gains and losses result from differences between the actual experience and the expected experience on pension and other postretirement plan assets or projected (expected) PBO during a particular period. These gains and losses are accumulated and, to the extent they exceed 10% of the greater of the PBO or the fair value of plan assets, the excess is amortized into pension and other postretirement benefit costs over the expected service years of the employees.
•	Amortization of Prior Service Costs (Credit) — These costs relate to the recognition of increases or decreases in pension and other postretirement benefit obligation due to amendments in plans or initiation of new plans. These increases or decreases in obligation are recognized in AOCI at the time of the amendment. These costs are then amortized to pension and other postretirement benefit costs over the expected service years of the employees affected by the change.
The components of net periodic benefit costs and other changes in plan assets and benefit obligations recognized in OCI were as follows:
	Pension Benefits																							Other Postretirement Benefits
	U.S. Plans												Non-U.S. Plans											U.S. Plans									Non-U.S. Plans
	Years Ended December 31,
	2013				2012				2011				2013				2012				2011			2013			2012			2011			2013			2012			2011
	(In millions)
Net periodic benefit costs:
Service costs	$	236			$	224			$	187			$	67			$	75			$	64		$	20		$	21		$	16		$	2		$	1		$	1
Interest costs	389				406				404				14				17				16			92			103			106			2			2			2
Settlement and curtailment costs	—				—				—				(2		)		—				—			—			—			—			1			1			1
Expected return on plan assets	(483		)		(484		)		(448		)		(6		)		(6		)		(6		)	(75		)	(77		)	(76		)	(1		)	(1		)	(1		)
Amortization of net actuarial (gains) losses	228				195				194				—				—				—			55			57			43			—			—			—
Amortization of prior service costs (credit)	6				6				4				—				—				—			(75		)	(104		)	(108		)	—			—			—
Total net periodic benefit costs (credit)	376				347				341				73				86				74			17			—			(19		)	4			3			3
Other changes in plan assets and benefit obligations recognized in OCI:
Net actuarial (gains) losses	(545		)		744				575				1				18				34			(533		)	234			262			1			2			5
Prior service costs (credit)	—				—				17				—				(1		)		—			—			—			—			—			(1		)	—
Amortization of net actuarial gains (losses)	(228		)		(195		)		(194		)		—				—				—			(55		)	(57		)	(43		)	(2		)	—			—
Amortization of prior service (costs) credit	(6		)		(6		)		(4		)		—				—				—			75			104			108			—			—			—
Total recognized in OCI	(779		)		543				394				1				17				34			(513		)	281			327			(1		)	1			5
Total recognized in net periodic benefit costs and OCI	$	(403	)		$	890			$	735			$	74			$	103			$	108		$	(496	)	$	281		$	308		$	3		$	4		$	8
For the year ended December 31, 2013, included within OCI were other changes in plan assets and benefit obligations associated with pension benefits of ($779) million for the U.S. plans and $1 million for the non-U.S. plans and other postretirement benefits of ($513) million for the U.S. plans and ($1) million for the non-U.S. plans for an aggregate increase in OCI of $1.3 billion before income tax and $838 million, net of income tax.
The estimated net actuarial (gains) losses and prior service costs (credit) for the U.S. pension plans and the U.S. defined benefit other postretirement benefit plans that will be amortized from AOCI into net periodic benefit costs over the next year are $151 million and $5 million, and $6 million and ($1) million, respectively.
Assumptions
Assumptions used in determining benefit obligations were as follows:
	Pension Benefits										Other Postretirement Benefits
	U.S. Plans					Non-U.S. Plans (1)					U.S. Plans		Non-U.S. Plans (1)
December 31, 2013:
Weighted average discount rate	5.15%					1.94%					5.15%		6.47%
Rate of compensation increase	3.5	%	-	7.50%		2	%	-	5.50%		N/A		N/A
December 31, 2012:
Weighted average discount rate	4.20%					1.98%					4.20%		4.94%
Rate of compensation increase	3.5	%	-	7.50%		2.01	%	-	5.50%		N/A		N/A
______________
-1	Reflects those assumptions that were most appropriate for the local economic environments of each of the Subsidiaries providing such benefits.
Assumptions used in determining net periodic benefit costs were as follows:
	Pension Benefits										Other Postretirement Benefits
	U.S. Plans					Non-U.S. Plans (1)					U.S. Plans		Non-U.S. Plans (1)
Year Ended December 31, 2013:
Weighted average discount rate	4.20%					1.98%					4.20%		5.01%
Weighted average expected rate of return on plan assets	6.25%					2.07%					5.76%		7.25%
Rate of compensation increase	3.5	%	-	7.50%		1.5	%	-	5.50%		N/A		N/A
Year Ended December 31, 2012:
Weighted average discount rate	4.95%					2.35%					4.95%		5.78%
Weighted average expected rate of return on plan assets	7.00%					3.35%					6.26%		6.54%
Rate of compensation increase	3.5	%	-	7.50%		2	%	-	4.00%		N/A		N/A
Year Ended December 31, 2011:
Weighted average discount rate	5.80%					2.40%					5.80%		6.34%
Weighted average expected rate of return on plan assets	7.25%					3.19%					7.25%		7.01%
Rate of compensation increase	3.5	%	-	7.50%		3	%	-	5.50%		N/A		N/A
______________
-1	Reflects those assumptions that were most appropriate for the local economic environments of each of the Subsidiaries providing such benefits.
The weighted average discount rate for the U.S. plans is determined annually based on the yield, measured on a yield to worst basis, of a hypothetical portfolio constructed of high quality debt instruments available on the valuation date, which would provide the necessary future cash flows to pay the aggregate projected benefit obligation when due.
The weighted average discount rate for non-U.S. pension plans is based on the duration of liabilities on a country by country basis. The rate was selected by reference to high quality corporate bonds in developed markets or local government bonds where markets were less robust or nonexistent.
The weighted average expected rate of return on plan assets for the U.S. plans is based on anticipated performance of the various asset sectors in which the plans invest, weighted by target allocation percentages. Anticipated future performance is based on long-term historical returns of the plan assets by sector, adjusted for the Subsidiaries’ long-term expectations on the performance of the markets. While the precise expected rate of return derived using this approach will fluctuate from year to year, the policy of most of the Subsidiaries’ is to hold this long-term assumption constant as long as it remains within reasonable tolerance from the derived rate.
The weighted average expected long-term rate of return for the non-U.S. pension plans is an aggregation of each country’s expected rate of return within each asset class. For each country, the rate of return with respect to each asset class was developed based on a building block approach that considers historical returns, current market conditions, asset volatility and the expectations for future market returns. While the assessment of the expected rate of return is long-term and not expected to change annually, significant changes in investment strategy or economic conditions may warrant such a change. The expected rate of return within each asset class, together with any contributions made, are expected to maintain the plans’ ability to meet all required benefit obligations.
The weighted average expected rate of return on plan assets for use in that plan’s valuation in 2014 is currently anticipated to be 6.24% for U.S. pension benefits and 5.64% for U.S. other postretirement benefits. The weighted average expected rate of return on plan assets for use in that plan’s valuation in 2014 is currently anticipated to be 3.01% for non-U.S. pension benefits and 7.25% for non-U.S. other postretirement benefits.
The assumed healthcare costs trend rates used in measuring the APBO and net periodic benefit costs were as follows:
	December 31,
	2013		2012
Pre-and Post-Medicare eligible claims	6.4% in 2014, gradually decreasing each year until 2094 reaching the ultimate rate of 4.4% for Pre-Medicare and 4.6% for Post-Medicare.		7.8% in 2013, gradually decreasing each year until 2094 reaching the ultimate rate of 4.4% for Pre-Medicare and 4.6% for Post-Medicare.
Assumed healthcare costs trend rates may have a significant effect on the amounts reported for healthcare plans. A 1% change in assumed healthcare costs trend rates would have the following effects as of December 31, 2013:
	U.S. Plans								Non-U.S. Plans
	One Percent				One Percent				One Percent				One Percent
	Increase				Decrease				Increase				Decrease
	(In millions)
Effect on total of service and interest costs components	$	16			$	(13	)		$	—			$	—
Effect of accumulated postretirement benefit obligations	$	235			$	(193	)		$	1			$	(1	)
Plan Assets
The pension and other postretirement benefit plan assets are categorized into a three-level fair value hierarchy, as defined in Note 10, based upon the significant input with the lowest level in its valuation. The following summarizes the types of assets included within the three-level fair value hierarchy presented below.
Level 1		This category includes separate accounts that are invested in fixed maturity securities, equity securities, derivative assets and short-term investments which have unadjusted quoted market prices in active markets for identical assets and liabilities.
Level 2		This category includes certain separate accounts that are primarily invested in liquid and readily marketable securities. The estimated fair value of such separate account is based upon reported NAV provided by fund managers and this value represents the amount at which transfers into and out of the respective separate account are effected. These separate accounts provide reasonable levels of price transparency and can be corroborated through observable market data.
		Certain separate accounts are invested in investment partnerships designated as hedge funds. The values for these separate accounts is determined monthly based on the NAV of the underlying hedge fund investment. Additionally, such hedge funds generally contain lock out or other waiting period provisions for redemption requests to be filled. While the reporting and redemption restrictions may limit the frequency of trading activity in separate accounts invested in hedge funds, the reported NAV, and thus the referenced value of the separate account, provides a reasonable level of price transparency that can be corroborated through observable market data.
		Directly held investments are primarily invested in U.S. and foreign government and corporate securities.
Level 3		This category includes separate accounts that are invested in fixed maturity securities, equity securities, derivative assets and other investments that provide little or no price transparency due to the infrequency with which the underlying assets trade and generally require additional time to liquidate in an orderly manner. Accordingly, the values for separate accounts invested in these alternative asset classes are based on inputs that cannot be readily derived from or corroborated by observable market data.
U.S. Plans
The U.S. Subsidiaries provide employees with benefits under various Employee Retirement Income Security Act of 1974 (“ERISA”) benefit plans. These include qualified pension plans, postretirement medical plans and certain retiree life insurance coverage. The assets of the U.S. Subsidiaries’ qualified pension plans are held in insurance group annuity contracts, and the vast majority of the assets of the postretirement medical plan and backing the retiree life coverage are held in insurance contracts. All of these contracts are issued by Company insurance affiliates, and the assets under the contracts are held in insurance separate accounts that have been established by the Company. The underlying assets of the separate accounts are principally comprised of cash and cash equivalents, short-term investments, fixed maturity and equity securities, derivatives, real estate, private equity investments and hedge fund investments.
The insurance contract provider engages investment management firms (“Managers”) to serve as sub-advisors for the separate accounts based on the specific investment needs and requests identified by the plan fiduciary. These Managers have portfolio management discretion over the purchasing and selling of securities and other investment assets pursuant to the respective investment management agreements and guidelines established for each insurance separate account. The assets of the qualified pension plans and postretirement medical plans (the “Invested Plans”) are well diversified across multiple asset categories and across a number of different Managers, with the intent of minimizing risk concentrations within any given asset category or with any given Manager.
The Invested Plans, other than those held in participant directed investment accounts, are managed in accordance with investment policies consistent with the longer-term nature of related benefit obligations and within prudent risk parameters. Specifically, investment policies are oriented toward (i) maximizing the Invested Plan’s funded status; (ii) minimizing the volatility of the Invested Plan’s funded status; (iii) generating asset returns that exceed liability increases; and (iv) targeting rates of return in excess of a custom benchmark and industry standards over appropriate reference time periods. These goals are expected to be met through identifying appropriate and diversified asset classes and allocations, ensuring adequate liquidity to pay benefits and expenses when due and controlling the costs of administering and managing the Invested Plan’s investments. Independent investment consultants are periodically used to evaluate the investment risk of Invested Plan’s assets relative to liabilities, analyze the economic and portfolio impact of various asset allocations and management strategies and to recommend asset allocations.
Derivative contracts may be used to reduce investment risk, to manage duration and to replicate the risk/return profile of an asset or asset class. Derivatives may not be used to leverage a portfolio in any manner, such as to magnify exposure to an asset, asset class, interest rates or any other financial variable. Derivatives are also prohibited for use in creating exposures to securities, currencies, indices or any other financial variable that is otherwise restricted.
The table below summarizes the actual weighted average allocation of the fair value of total plan assets by asset class at December 31 for the years indicated and the approved target allocation by major asset class at December 31, 2013 for the Invested Plans:
	Pension									Postretirement Medical									Postretirement Life
	Target			Actual Allocation						Target			Actual Allocation						Target			Actual Allocation
				2013			2012						2013			2012						2013		2012
Asset Class:
Fixed maturity securities (1)	75	%		64	%		69	%		70	%		52	%		63	%		—	%		—	%	—	%
Equity securities (2)	12	%		23	%		21	%		30	%		47	%		37	%		—	%		—	%	—	%
Alternative securities (3)	13	%		13	%		10	%		—	%		1	%		—	%		100	%		100	%	100	%
Total assets				100	%		100	%					100	%		100	%					100	%	100	%
______________
-1	Fixed maturity securities include primarily ABS, collateralized mortgage obligations, corporate, federal agency, foreign bonds, mortgage-backed securities, municipals, preferred stocks and U.S. government bonds.
-2	Equity securities primarily include common stock of U.S. companies.
-3	Alternative securities primarily include derivative assets, money market securities, short-term investments and other investments. Postretirement life’s target and actual allocation of plan assets are all in short-term investments.
The pension and postretirement plan assets measured at estimated fair value on a recurring basis were determined as described in “— Plan Assets.” These estimated fair values and their corresponding placement in the fair value hierarchy are summarized as follows:
	December 31, 2013
	Pension Benefits																Other Postretirement Benefits
	Fair Value Hierarchy																Fair Value Hierarchy
	Level 1				Level 2				Level 3				Total				Level 1				Level 2			Level 3			Total
													Estimated														Estimated
													Fair														Fair
													Value														Value
	(In millions)
Assets
Fixed maturity securities:
Corporate	$	—			$	2,073			$	59			$	2,132			$	—			$	170		$	1		$	171
U.S. government bonds	924				166				—				1,090				135				5			—			140
Foreign bonds	—				718				11				729				—				63			—			63
Federal agencies	—				292				—				292				—				33			—			33
Municipals	—				219				—				219				—				15			—			15
Other (1)	—				490				19				509				—				54			—			54
Total fixed maturity securities	924				3,958				89				4,971				135				340			1			476
Equity securities:
Common stock - domestic	1,133				22				148				1,303				328				—			—			328
Common stock - foreign	460				—				—				460				102				—			—			102
Total equity securities	1,593				22				148				1,763				430				—			—			430
Other investments	—				—				600				600				—				—			—			—
Short-term investments	53				309				—				362				—				439			—			439
Money market securities	1				12				—				13				4				—			—			4
Derivative assets	17				15				35				67				—				3			—			3
Total assets	$	2,588			$	4,316			$	872			$	7,776			$	569			$	782		$	1		$	1,352
	31-Dec-12
	Pension Benefits																Other Postretirement Benefits
	Fair Value Hierarchy																Fair Value Hierarchy
	Level 1				Level 2				Level 3				Total				Level 1				Level 2			Level 3			Total
													Estimated														Estimated
													Fair														Fair
													Value														Value
	(In millions)
Assets
Fixed maturity securities:
Corporate	$	—			$	2,260			$	19			$	2,279			$	—			$	165		$	4		$	169
U.S. government bonds	1,153				160				—				1,313				175				3			—			178
Foreign bonds	—				761				8				769				—				51			—			51
Federal agencies	1				335				—				336				—				26			—			26
Municipals	—				258				—				258				—				70			1			71
Other (1)	—				490				7				497				—				55			3			58
Total fixed maturity securities	1,154				4,264				34				5,452				175				370			8			553
Equity securities:
Common stock - domestic	1,092				38				137				1,267				249				1			—			250
Common stock - foreign	362				—				—				362				83				—			—			83
Total equity securities	1,454				38				137				1,629				332				1			—			333
Other investments	—				117				447				564				—				—			—			—
Short-term investments	—				214				—				214				—				432			—			432
Money market securities	2				10				—				12				1				—			—			1
Derivative assets	—				7				1				8				—				1			—			1
Total assets	$	2,610			$	4,650			$	619			$	7,879			$	508			$	804		$	8		$	1,320
______________
-1	Other primarily includes mortgage-backed securities, collateralized mortgage obligations and ABS.
A rollforward of all pension and other postretirement benefit plan assets measured at estimated fair value on a recurring basis using significant unobservable (Level 3) inputs was as follows:
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Pension Benefits
	Fixed Maturity												Equity
	Securities:												Securities:
	Corporate				Foreign				Other (1)				Common				Other				Derivative
					Bonds								Stock -				Investments				Assets
													Domestic
	(In millions)
Year Ended December 31, 2013:
Balance at January 1,	$	19			$	8			$	7			$	137			$	447			$	1
Realized gains (losses)	—				—				—				(1		)		—				(3		)
Unrealized gains (losses)	(2		)		1				—				9				59				(18		)
Purchases, sales, issuances and settlements, net	19				(3		)		11				3				(62		)		55
Transfers into and/or out of Level 3	23				5				1				—				156				—
Balance at December 31,	$	59			$	11			$	19			$	148			$	600			$	35
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Other Postretirement Benefits
	Fixed Maturity
	Securities:
	Corporate				Municipals				Other (1)
	(In millions)
Year Ended December 31, 2013:
Balance at January 1,	$	4			$	1			$	3
Realized gains (losses)	—				—				(3		)
Unrealized gains (losses)	—				—				4
Purchases, sales, issuances and settlements, net	(3		)		(1		)		(4		)
Transfers into and/or out of Level 3	—				—				—
Balance at December 31,	$	1			$	—			$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Pension Benefits
	Fixed Maturity												Equity
	Securities:												Securities:
	Corporate				Foreign				Other (1)				Common				Other				Derivative
					Bonds								Stock -				Investments				Assets
													Domestic
	(In millions)
Year Ended December 31, 2012:
Balance at January 1,	$	32			$	5			$	2			$	206			$	531			$	4
Realized gains (losses)	—				—				—				(27		)		55				6
Unrealized gains (losses)	(1		)		8				—				10				(36		)		(7		)
Purchases, sales, issuances and settlements, net	(12		)		(5		)		5				(52		)		(103		)		(2		)
Transfers into and/or out of Level 3	—				—				—				—				—				—
Balance at December 31,	$	19			$	8			$	7			$	137			$	447			$	1
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Other Postretirement Benefits
	Fixed Maturity
	Securities:
	Corporate				Municipals				Other (1)				Derivative
													Assets
	(In millions)
Year Ended December 31, 2012:
Balance at January 1,	$	4			$	1			$	5			$	1
Realized gains (losses)	—				—				(2		)		2
Unrealized gains (losses)	—				—				2				(2		)
Purchases, sales, issuances and settlements, net	—				—				(2		)		(1		)
Transfers into and/or out of Level 3	—				—				—				—
Balance at December 31,	$	4			$	1			$	3			$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Pension Benefits
	Fixed Maturity												Equity
	Securities:												Securities:
	Corporate				Foreign				Other (1)				Common				Other				Derivative
					Bonds								Stock -				Investments				Assets
													Domestic
	(In millions)
Year Ended December 31, 2011:
Balance at January 1,	$	49			$	4			$	2			$	240			$	471			$	—
Realized gains (losses)	—				—				(1		)		(59		)		85				2
Unrealized gains (losses)	(4		)		(1		)		1				118				45				4
Purchases, sales, issuances and settlements, net	(13		)		2				(1		)		(93		)		(70		)		(2		)
Transfers into and/or out of Level 3	—				—				1				—				—				—
Balance at December 31,	$	32			$	5			$	2			$	206			$	531			$	4
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Other Postretirement Benefits
	Fixed Maturity
	Securities:
	Corporate				Municipals				Other (1)				Derivative
													Assets
	(In millions)
Year Ended December 31, 2011:
Balance at January 1,	$	4			$	1			$	6			$	—
Realized gains (losses)	—				—				(1		)		—
Unrealized gains (losses)	—				—				1				1
Purchases, sales, issuances and settlements, net	—				—				(1		)		—
Transfers into and/or out of Level 3	—				—				—				—
Balance at December 31,	$	4			$	1			$	5			$	1
______________
-1	Other includes ABS and collateralized mortgage obligations.
Non-U.S. Plans
Pension benefits are provided utilizing either a traditional formula or cash balance formula, similar to the U.S. plans. The investment objectives are also similar, subject to local regulations. Generally, these international pension plans invest directly in high quality equity and fixed maturity securities. The assets of the non-U.S. pension plans are comprised of short-term investments, equity and fixed maturity securities, real estate and hedge fund investments.
The assets of the non-U.S. pension plans, other than those held in participant directed investment accounts, are managed in accordance with investment policies consistent with the longer-term nature of related benefit obligations and within prudent risk parameters and consistent with the policies, goals and derivative instrument risk management guidelines described above for the U.S. plans.
The table below summarizes the actual weighted average allocation of the fair value of total plan assets by asset class at December 31 for the years indicated and the approved target allocation by major asset class at December 31, 2013 for the plans:
	Pension									Other Postretirement
				Actual Allocation									Actual Allocation
	Target			2013			2012			Target			2013			2012
Asset Class:
Fixed maturity securities (1)	76	%		50	%		54	%		100	%		100	%		100	%
Equity securities (2)	17	%		33	%		24	%		—	%		—	%		—	%
Alternative securities (3)	7	%		17	%		22	%		—	%		—	%		—	%
Total assets				100	%		100	%					100	%		100	%
______________
-1	Fixed maturity securities include corporate and foreign bonds.
-2	Equity securities primarily include common stock of non-U.S. companies.
-3	Alternative securities include derivative assets, real estate, short-term investments, and other investments.
The pension and postretirement plan assets measured at estimated fair value on a recurring basis were determined as described in “— Plan Assets.” These estimated fair values and their corresponding placement in the fair value hierarchy are summarized as follows:
	31-Dec-13
	Pension Benefits																Other Postretirement Benefits
	Fair Value Hierarchy																Fair Value Hierarchy
	Level 1				Level 2				Level 3				Total				Level 1				Level 2			Level 3			Total
													Estimated														Estimated
													Fair														Fair
													Value														Value
	(In millions)
Assets
Fixed maturity securities:
Corporate	$	—			$	27			$	—			$	27			$	—			$	—		$	—		$	—
Foreign bonds	—				96				—				96				—				14			—			14
Total fixed maturity securities	—				123				—				123				—				14			—			14
Equity securities:
Common stock - foreign	—				83				—				83				—				—			—			—
Other investments	32				—				—				32				—				—			—			—
Derivative assets	—				—				2				2				—				—			—			—
Real estate	—				—				2				2				—				—			—			—
Short-term investments	—				6				—				6				—				—			—			—
Total assets	$	32			$	212			$	4			$	248			$	—			$	14		$	—		$	14
	31-Dec-12
	Pension Benefits																Other Postretirement Benefits
	Fair Value Hierarchy																Fair Value Hierarchy
	Level 1				Level 2				Level 3				Total				Level 1				Level 2			Level 3			Total
													Estimated														Estimated
													Fair														Fair
													Value														Value
	(In millions)
Assets
Fixed maturity securities:
Foreign bonds	$	—			$	120			$	—			$	120			$	—			$	15		$	—		$	15
Equity securities:
Common stock - foreign	—				54				—				54				—				—			—			—
Other investments	24				—				—				24				—				—			—			—
Derivative assets	—				—				13				13				—				—			—			—
Real estate	—				—				7				7				—				—			—			—
Short-term investments	—				6				—				6				—				—			—			—
Total assets	$	24			$	180			$	20			$	224			$	—			$	15		$	—		$	15
A rollforward of all pension benefit plan assets measured at estimated fair value on a recurring basis using significant unobservable (Level 3) inputs was as follows:
		Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
		Pension Benefits
		Years Ended December 31,
		2013								2012								2011
		Derivative				Real				Derivative				Real				Derivative				Real
		Assets				Estate				Assets				Estate				Assets				Estate
		(In millions)
Balance at January 1,		$	13			$	7			$	13			$	8			$	11			$	8
Realized gains (losses)		(2		)		(1		)		(1		)		(1		)		—				—
Unrealized gains (losses)		3				1				1				—				2				—
Purchases, sales, issuances, and settlements, net		(12		)		(5		)		—				—				—				—
Balance at December 31,		$	2			$	2			$	13			$	7			$	13			$	8
Expected Future Contributions and Benefit Payments
It is the Subsidiaries’ practice to make contributions to the U.S. qualified pension plan to comply with minimum funding requirements of ERISA. In accordance with such practice, no contributions are required for 2014. The Subsidiaries expect to make discretionary contributions to the qualified pension plan of $230 million in 2014. For information on employer contributions, see “— Obligations and Funded Status.”
Benefit payments due under the U.S. non-qualified pension plans are primarily funded from the Subsidiaries’ general assets as they become due under the provision of the plans, therefore benefit payments equal employer contributions. The U.S. Subsidiaries expect to make contributions of $70 million to fund the benefit payments in 2014.
U.S. and non-U.S. postretirement benefits are either: (i) not vested under law; (ii) a non-funded obligation of the Subsidiaries; or (iii) both. Current regulations do not require funding for these benefits. The Subsidiaries use their general assets, net of participant’s contributions, to pay postretirement medical claims as they come due in lieu of utilizing any plan assets. The U.S. Subsidiaries expect to make contributions of $50 million towards benefit obligations in 2014 to pay postretirement medical claims.
Gross benefit payments for the next 10 years, which reflect expected future service where appropriate, are expected to be as follows:
	Pension Benefits								Other Postretirement Benefits
	U.S. Plans				Non-U.S. Plans				U.S. Plans				Non-U.S. Plans
	(In millions)
2014	$	461			$	35			$	84			$	4
2015	$	474			$	38			$	86			$	4
2016	$	487			$	42			$	86			$	4
2017	$	515			$	42			$	89			$	4
2018	$	524			$	45			$	93			$	4
2019-2023	$	2,928			$	263			$	522			$	16
Additional Information
As previously discussed, most of the assets of the U.S. pension and other postretirement benefit plans are held in group annuity and life insurance contracts issued by the Subsidiaries. Total revenues from these contracts recognized in the consolidated statements of operations were $49 million, $54 million and $47 million for the years ended December 31, 2013, 2012 and 2011, respectively, and included policy charges and net investment income from investments backing the contracts and administrative fees. Total investment income (loss), including realized and unrealized gains (losses), credited to the account balances was $20 million, $867 million and $885 million for the years ended December 31, 2013, 2012 and 2011, respectively. The terms of these contracts are consistent in all material respects with those the Subsidiaries offer to unaffiliated parties that are similarly situated.
Defined Contribution Plans
The Subsidiaries sponsor defined contribution plans for substantially all U.S. employees under which a portion of employee contributions are matched. The Subsidiaries contributed $93 million, $96 million and $95 million for the years ended December 31, 2013, 2012 and 2011, respectively.

Income_Tax

Income Tax	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Tax	'
	19. Income Tax
	The provision for income tax from continuing operations was as follows:
		Years Ended December 31,
		2013			2012				2011
		(In millions)
	Current:
	Federal	$	85		$	(29	)		$	(200	)
	State and local	2			6				(1		)
	Foreign	422			846				614
	Subtotal	509			823				413
	Deferred:
	Federal	(250		)	(244		)		2,241
	State and local	(11		)	(1		)		(3		)
	Foreign	413			(450		)		142
	Subtotal	152			(695		)		2,380
	Provision for income tax expense (benefit)	$	661		$	128			$	2,793
	The Company’s income (loss) from continuing operations before income tax expense (benefit) from domestic and foreign operations were as follows:
		Years Ended December 31,
		2013			2012				2011
		(In millions)
	Income (loss) from continuing operations:
	Domestic	$	1,186		$	(1,496	)		$	6,869
	Foreign	2,866			2,938				2,315
	Total	$	4,052		$	1,442			$	9,184
	The reconciliation of the income tax provision at the U.S. statutory rate to the provision for income tax as reported for continuing operations was as follows:
		Years Ended December 31,
		2013			2012				2011
		(In millions)
	Tax provision at U.S. statutory rate	$	1,418		$	505			$	3,215
	Tax effect of:
	Dividend received deduction	(166		)	(162		)		(160		)
	Tax-exempt income	(96		)	(94		)		(86		)
	Prior year tax	75			23				(4		)
	Low income housing tax credits	(194		)	(150		)		(102		)
	Other tax credits	(54		)	(28		)		(36		)
	Foreign tax rate differential (1)	(340		)	(45		)		(41		)
	Change in valuation allowance	30			15				16
	Goodwill impairment	—			408				—
	Deferred tax effects of branch conversions	4			(324		)		—
	Other, net	(16		)	(20		)		(9		)
	Provision for income tax expense (benefit)	$	661		$	128			$	2,793
	______________
	-1	For the year ended December 31, 2013, foreign tax rate differential includes one-time tax benefits of $119 million related to the receipt of a Japan tax refund, $69 million related to the estimated reversal of Japan temporary differences, and $65 million related to the change in repatriation assumptions for foreign earnings of certain European operations.
	Deferred income tax represents the tax effect of the differences between the book and tax basis of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at:
		December 31,
		2013			2012
		(In millions)
	Deferred income tax assets:
	Policyholder liabilities and receivables	$	1,014		$	6,233
	Investments, including derivatives	86			—
	Net operating loss carryforwards	1,808			1,408
	Employee benefits	737			1,234
	Capital loss carryforwards	32			160
	Tax credit carryforwards	1,653			545
	Litigation-related and government mandated	232			197
	Other	471			484
	Total gross deferred income tax assets	6,033			10,261
	Less: Valuation allowance	357			368
	Total net deferred income tax assets	5,676			9,893
	Deferred income tax liabilities:
	Investments, including derivatives	—			3,149
	Intangibles	2,081			2,668
	Net unrealized investment gains	4,883			7,854
DAC	5,133			4,775
Other	222			140
Total deferred income tax liabilities	12,319			18,586
Net deferred income tax asset (liability)	$	(6,643	)	$	(8,693	)
The following table sets forth the domestic, state, and foreign net operating and capital loss carryforwards for tax purposes at December 31, 2013.
	Net Operating Loss Carryforwards					Capital Loss Carryforwards
	Amount			Expiration		Amount				Expiration
	(In millions)					(In millions)
Domestic	$	4,153		Beginning in 2018		$	52			Beginning in 2018
State	$	153		Beginning in 2014		$	—			N/A
Foreign	$	1,576		Beginning in 2014		$	40			Beginning in 2014
Foreign tax credit carryforwards of $991 million at December 31, 2013 will expire beginning in 2015, of which $12 million will expire before 2020. General business credits of $662 million will expire beginning in 2025.
The Company also has recorded valuation allowance charges of $36 million related to certain state and foreign net operating loss carryforwards, $4 million related to branch restructuring and a benefit of $6 million related to certain foreign capital loss carryforwards. In addition a $45 million reduction was recorded as a balance sheet reclassification with other deferred tax assets primarily related to branch restructuring. The valuation allowance reflects management’s assessment, based on available information, that it is more likely than not that the deferred income tax asset for certain foreign net operating and capital loss carryforwards, certain state net operating loss carryforwards, certain foreign unrealized losses and certain foreign other assets will not be realized. The tax benefit will be recognized when management believes that it is more likely than not that these deferred income tax assets are realizable.
In accordance with the Closing Agreement, the Company completed its plan to transfer foreign branch assets to various MetLife foreign subsidiaries during 2013.
As a result of these asset transfers and the filing of various foreign branch and U.S. income tax returns, the Company revised the estimate of the valuation allowance required for U.S. deferred tax assets relating to the restructuring of American Life’s non-U.S. branches. The net reduction in the valuation allowance was primarily due to the following factors:
•	Additional U.S. deferred tax assets that more likely than not will not be realizable;
•	A reduction in both the gross deferred tax asset and the valuation allowance related to the completion of the Company’s transfer of its foreign branch assets to wholly-owned subsidiaries.
The following table provides a rollforward of the deferred tax asset valuation allowance associated with the 2013 branch restructurings:
	Amount
	(In millions)
Balance at January 1, 2012	$	23
Income tax expense (benefit)	12
Deferred income tax expense (benefit) related to unrealized investment gains (losses)	(10		)
Offsetting reduction in gross deferred tax asset related to the branch transfer of assets to foreign subsidies	—
Balance at December 31, 2012	25
Income tax expense (benefit)	4
Deferred income tax expense (benefit) related to unrealized investment gains (losses)	2
Offsetting reduction in gross deferred tax asset related to the branch transfer of assets to foreign subsidies	(31		)
Balance at December 31, 2013	$	—
See Note 3 for a discussion of branch restructuring in accordance with the Closing Agreement. In December 2012, the Tokyo District Court ruled in favor of the Japan branch of American Life in a tax case related to the deduction of unrealized foreign exchange losses on certain securities held by American Life prior to its acquisition by MetLife. During the first quarter of 2013, American Life received a refund of ¥16 billion ($176 million) related to income tax, interest and penalties. Under the indemnification provisions of the stock purchase agreement dated March 7, 2010, as amended, by and among MetLife, Inc., AIG and AM Holdings, MetLife, Inc. has remitted the refund to AIG, net of certain amounts it can retain as a counter claim. The receipt of the refund, net of obligations to AIG with related foreign currency exchange impact and corresponding U.S. tax effects, resulted in a net charge of $16 million in the consolidated statements of operations for the year ended December 31, 2013, which was comprised of a $154 million charge included in other expenses, a $19 million gain included in other net investment gains (losses) and a $119 million benefit included in provision for income tax expense (benefit).
The Company has not provided U.S. deferred taxes on cumulative earnings of certain non-U.S. affiliates and associated companies that have been reinvested indefinitely. These earnings relate to ongoing operations and have been reinvested in active non-U.S. business operations. The Company does not intend to repatriate these earnings to fund U.S. operations. Deferred taxes are provided for earnings of non-U.S. affiliates and associated companies when the Company plans to remit those earnings. At December 31, 2013, the Company had not made a provision for U.S. taxes on approximately $3.3 billion of the excess of the amount for financial reporting over the tax basis of investments in foreign subsidiaries that are essentially permanent in duration. It is not practicable to estimate the amount of deferred tax liability related to investments in these foreign subsidiaries.
The Company considers the earnings of Japan, Argentina and the Middle East (excluding Turkey) to be available for repatriation. Earnings from the remaining foreign countries are considered to be permanently reinvested. In 2013, the Company changed its repatriation assumptions related to certain of its European operations and now considers these foreign earnings to be permanently reinvested.
The Company files income tax returns with the U.S. federal government and various state and local jurisdictions, as well as foreign jurisdictions. The Company is under continuous examination by the IRS and other tax authorities in jurisdictions in which the Company has significant business operations. The income tax years under examination vary by jurisdiction and subsidiary. The Company is no longer subject to U.S. federal, state, or local income tax examinations for years prior to 2003, except for 2000 through 2002 where the IRS has disallowed certain tax credits claimed and the Company continues to protest. The IRS audit cycle for the years 2003 through 2006, which began in April 2010, is expected to conclude in 2014. In material foreign jurisdictions, the Company is no longer subject to income tax examination for years prior to 2008.
The Company’s liability for unrecognized tax benefits may increase or decrease in the next 12 months. A reasonable estimate of the increase or decrease cannot be made at this time. However, the Company continues to believe that the ultimate resolution of the pending issues will not result in a material change to its consolidated financial statements, although the resolution of income tax matters could impact the Company’s effective tax rate for a particular future period.
A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows:
	Years Ended December 31,
	2013			2012				2011
	(In millions)
Balance at January 1,	$	708		$	679			$	810
Additions for tax positions of prior years	117			105				30
Reductions for tax positions of prior years	(37		)	(82		)		(161		)
Additions for tax positions of current year	39			32				13
Reductions for tax positions of current year	(1		)	(9		)		(8		)
Settlements with tax authorities	(52		)	(15		)		(5		)
Lapses of statutes of limitations	—			(2		)		—
Balance at December 31,	$	774		$	708			$	679
Unrecognized tax benefits that, if recognized would impact the effective rate	$	661		$	566			$	527
The Company classifies interest accrued related to unrecognized tax benefits in interest expense, included within other expenses, while penalties are included in income tax expense.
Interest was as follows:
	Years Ended December 31,
	2013			2012				2011
	(In millions)
Interest recognized in the consolidated statements of operations	$	20		$	2			$	31
				December 31,
				2013				2012
				(In millions)
Interest included in other liabilities in the consolidated balance sheets				$	257			$	237
The Company had penalties of $3 million which were included in the unrecognized tax benefits for the year ended December 31, 2013. The Company had no penalties for the years ended December 31, 2012 and 2011.
The U.S. Treasury Department and the IRS have indicated that they intend to address through regulations the methodology to be followed in determining the dividends received deduction (“DRD”), related to variable life insurance and annuity contracts. The DRD reduces the amount of dividend income subject to tax and is a significant component of the difference between the actual tax expense and expected amount determined using the federal statutory tax rate of 35%. Any regulations that the IRS ultimately proposes for issuance in this area will be subject to public notice and comment, at which time insurance companies and other interested parties will have the opportunity to raise legal and practical questions about the content, scope and application of such regulations. As a result, the ultimate timing and substance of any such regulations are unknown at this time. For the years ended December 31, 2013 and 2012, the Company recognized an income tax benefit of $164 million and $152 million, respectively, related to the separate account DRD. The 2013 benefit included a benefit of $6 million related to a true-up of the 2012 tax return. The 2012 benefit included a benefit of less than $1 million related to a true-up of the 2011 tax return.

Earnings_Per_Common_Share

Earnings Per Common Share	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Earnings Per Common Share	'
	20. Earnings Per Common Share
	The following table presents the weighted average shares used in calculating basic earnings per common share and those used in calculating diluted earnings per common share for each income category presented below:
		Years Ended December 31,
		2013		2012		2011
		(In millions, except share and per share data)
	Weighted Average Shares:
	Weighted average common stock outstanding for basic earnings per common share	1,105,579,693		1,070,755,561		1,059,580,442
	Incremental common shares from assumed:
	Stock purchase contracts underlying common equity units (1)	1,164,018		—		1,641,444
	Exercise or issuance of stock-based awards	9,458,999		6,084,078		6,872,474
	Weighted average common stock outstanding for diluted earnings per common share	1,116,202,710		1,076,839,639		1,068,094,360
	Income (Loss) from Continuing Operations:
	Income (loss) from continuing operations, net of income tax	$	3,391	$	1,314	$	6,391
	Less: Income (loss) from continuing operations, net of income tax, attributable to noncontrolling interests	25		38		(8		)
	Less: Preferred stock dividends	122		122		122
	Preferred stock redemption premium	—		—		146
	Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	3,244	$	1,154	$	6,131
	Basic	$	2.94	$	1.08	$	5.79
	Diluted	$	2.91	$	1.08	$	5.74
	Income (Loss) from Discontinued Operations:
	Income (loss) from discontinued operations, net of income tax	$	2	$	48	$	24
	Less: Income (loss) from discontinued operations, net of income tax, attributable to noncontrolling interests	—		—		—
	Income (loss) from discontinued operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	2	$	48	$	24
	Basic	$	—	$	0.04	$	0.02
	Diluted	$	—	$	0.04	$	0.02
	Net Income (Loss):
	Net income (loss)	$	3,393	$	1,362	$	6,415
	Less: Net income (loss) attributable to noncontrolling interests	25		38		(8		)
	Less: Preferred stock dividends	122		122		122
	Preferred stock redemption premium	—		—		146
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	3,246	$	1,202	$	6,155
	Basic	$	2.94	$	1.12	$	5.81
	Diluted	$	2.91	$	1.12	$	5.76
	______________
	-1	See Note 15 for a description of the Company’s common equity units. For the year ended December 31, 2012, all shares related to the assumed issuance of shares in settlement of the applicable purchase contracts have been excluded from the calculation of diluted earnings per common share as these assumed shares are anti-dilutive.

Contingencies_Commitments_and_

Contingencies, Commitments and Guarantees	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Contingencies, Commitments and Guarantees	'
	21. Contingencies, Commitments and Guarantees
	Contingencies
	Litigation
	The Company is a defendant in a large number of litigation matters. In some of the matters, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value.
	Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law.
	The Company establishes liabilities for litigation and regulatory loss contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Liabilities have been established for a number of the matters noted below. It is possible that some of the matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be estimated at December 31, 2013. While the potential future charges could be material in the particular quarterly or annual periods in which they are recorded, based on information currently known to management, management does not believe any such charges are likely to have a material effect on the Company’s financial position.
	Matters as to Which an Estimate Can Be Made
	For some of the matters disclosed below, the Company is able to estimate a reasonably possible range of loss. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. As of December 31, 2013, the Company estimates the aggregate range of reasonably possible losses in excess of amounts accrued for these matters to be $0 to $520 million.
	Matters as to Which an Estimate Cannot Be Made
	For other matters disclosed below, the Company is not currently able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews.
	Asbestos-Related Claims
	MLIC is and has been a defendant in a large number of asbestos-related suits filed primarily in state courts. These suits principally allege that the plaintiff or plaintiffs suffered personal injury resulting from exposure to asbestos and seek both actual and punitive damages. MLIC has never engaged in the business of manufacturing, producing, distributing or selling asbestos or asbestos-containing products nor has MLIC issued liability or workers’ compensation insurance to companies in the business of manufacturing, producing, distributing or selling asbestos or asbestos-containing products. The lawsuits principally have focused on allegations with respect to certain research, publication and other activities of one or more of MLIC’s employees during the period from the 1920’s through approximately the 1950’s and allege that MLIC learned or should have learned of certain health risks posed by asbestos and, among other things, improperly publicized or failed to disclose those health risks. MLIC believes that it should not have legal liability in these cases. The outcome of most asbestos litigation matters, however, is uncertain and can be impacted by numerous variables, including differences in legal rulings in various jurisdictions, the nature of the alleged injury and factors unrelated to the ultimate legal merit of the claims asserted against MLIC. MLIC employs a number of resolution strategies to manage its asbestos loss exposure, including seeking resolution of pending litigation by judicial rulings and settling individual or groups of claims or lawsuits under appropriate circumstances.
	Claims asserted against MLIC have included negligence, intentional tort and conspiracy concerning the health risks associated with asbestos. MLIC’s defenses (beyond denial of certain factual allegations) include that: (i) MLIC owed no duty to the plaintiffs — it had no special relationship with the plaintiffs and did not manufacture, produce, distribute or sell the asbestos products that allegedly injured plaintiffs; (ii) plaintiffs did not rely on any actions of MLIC; (iii) MLIC’s conduct was not the cause of the plaintiffs’ injuries; (iv) plaintiffs’ exposure occurred after the dangers of asbestos were known; and (v) the applicable time with respect to filing suit has expired. During the course of the litigation, certain trial courts have granted motions dismissing claims against MLIC, while other trial courts have denied MLIC’s motions. There can be no assurance that MLIC will receive favorable decisions on motions in the future. While most cases brought to date have settled, MLIC intends to continue to defend aggressively against claims based on asbestos exposure, including defending claims at trials.
	The approximate total number of asbestos personal injury claims pending against MLIC as of the dates indicated, the approximate number of new claims during the years ended on those dates and the approximate total settlement payments made to resolve asbestos personal injury claims at or during those years are set forth in the following table:
		December 31,
		2013		2012		2011
		(In millions, except number of claims)
	Asbestos personal injury claims at year end	67,983		65,812		66,747
	Number of new claims during the year	5,898		5,303		4,972
	Settlement payments during the year (1)	$	37	$	36.4	$	34.2
	______________
	-1	Settlement payments represent payments made by MLIC during the year in connection with settlements made in that year and in prior years. Amounts do not include MLIC’s attorneys’ fees and expenses and do not reflect amounts received from insurance carriers.
	The number of asbestos cases that may be brought, the aggregate amount of any liability that MLIC may incur, and the total amount paid in settlements in any given year are uncertain and may vary significantly from year to year.
	The ability of MLIC to estimate its ultimate asbestos exposure is subject to considerable uncertainty, and the conditions impacting its liability can be dynamic and subject to change. The availability of reliable data is limited and it is difficult to predict the numerous variables that can affect liability estimates, including the number of future claims, the cost to resolve claims, the disease mix and severity of disease in pending and future claims, the impact of the number of new claims filed in a particular jurisdiction and variations in the law in the jurisdictions in which claims are filed, the possible impact of tort reform efforts, the willingness of courts to allow plaintiffs to pursue claims against MLIC when exposure to asbestos took place after the dangers of asbestos exposure were well known, and the impact of any possible future adverse verdicts and their amounts.
	The ability to make estimates regarding ultimate asbestos exposure declines significantly as the estimates relate to years further in the future. In the Company’s judgment, there is a future point after which losses cease to be probable and reasonably estimable. It is reasonably possible that the Company’s total exposure to asbestos claims may be materially greater than the asbestos liability currently accrued and that future charges to income may be necessary. While the potential future charges could be material in the particular quarterly or annual periods in which they are recorded, based on information currently known by management, management does not believe any such charges are likely to have a material effect on the Company’s financial position.
	The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for asbestos-related claims. MLIC’s recorded asbestos liability is based on its estimation of the following elements, as informed by the facts presently known to it, its understanding of current law and its past experiences: (i) the probable and reasonably estimable liability for asbestos claims already asserted against MLIC, including claims settled but not yet paid; (ii) the probable and reasonably estimable liability for asbestos claims not yet asserted against MLIC, but which MLIC believes are reasonably probable of assertion; and (iii) the legal defense costs associated with the foregoing claims. Significant assumptions underlying MLIC’s analysis of the adequacy of its recorded liability with respect to asbestos litigation include: (i) the number of future claims; (ii) the cost to resolve claims; and (iii) the cost to defend claims.
	MLIC reevaluates on a quarterly and annual basis its exposure from asbestos litigation, including studying its claims experience, reviewing external literature regarding asbestos claims experience in the United States, assessing relevant trends impacting asbestos liability and considering numerous variables that can affect its asbestos liability exposure on an overall or per claim basis. These variables include bankruptcies of other companies involved in asbestos litigation, legislative and judicial developments, the number of pending claims involving serious disease, the number of new claims filed against it and other defendants and the jurisdictions in which claims are pending. Based upon its reevaluation of its exposure from asbestos litigation, MLIC has updated its liability analysis for asbestos-related claims through December 31, 2013. The frequency of severe claims relating to asbestos has not declined as expected, and MLIC has reflected this in its provisions. Accordingly, MLIC increased its recorded liability for asbestos-related claims from $417 million to $572 million at December 31, 2013.
	Regulatory Matters
	The Company receives and responds to subpoenas or other inquiries from state regulators, including state insurance commissioners; state attorneys general or other state governmental authorities; federal regulators, including the U.S. Securities and Exchange Commission (“SEC”); federal governmental authorities, including congressional committees; and the Financial Industry Regulatory Authority (“FINRA”) seeking a broad range of information. The issues involved in information requests and regulatory matters vary widely. The Company cooperates in these inquiries.
	Mortgage Regulatory and Law Enforcement Authorities’ Inquiries
	MetLife, through its affiliate, MetLife Bank, was engaged in the origination, sale and servicing of forward and reverse residential mortgage loans since 2008. In 2012, MetLife Bank exited the business of originating residential mortgage loans. In 2012 and 2013, MetLife Bank sold its residential mortgage servicing portfolios, and in 2013 wound down its mortgage servicing business. See Note 3 for information regarding the MetLife Bank Divestiture. In August 2013, MetLife Bank merged with and into MLHL, its former subsidiary, with MLHL as the surviving non-bank entity.
	On April 13, 2011, the Office of the Comptroller of the Currency (the “OCC”) entered into a consent order with MetLife Bank (the “OCC consent order”). The OCC consent order required an independent review of foreclosure practices and set forth new residential mortgage servicing standards. In February 2013, MetLife Bank entered into an agreement with the OCC to amend the OCC consent order, and paid approximately $46 million to settle its obligations and end the foreclosure review. In addition, the Federal Reserve Board entered into a consent order with MetLife, Inc. in 2011 (the “Federal Reserve Board consent order”), to enhance its supervision of the mortgage servicing activities of MetLife Bank. On August 6, 2012, the Federal Reserve Board and MetLife, Inc. entered into an Order of Assessment of a Civil Monetary Penalty Issued Upon Consent that imposes a penalty of up to $3.2 million for the alleged deficiencies in MetLife, Inc.’s oversight of MetLife Bank’s servicing of residential mortgage loans and processing foreclosures that were the subject of the Federal Reserve Board consent order.
	In May 2013, MetLife Bank received a subpoena from the U.S. Department of Justice requiring production of documents relating to MetLife Bank’s payment of certain foreclosure-related expenses to law firms and business entities affiliated with law firms and relating to MetLife Bank’s supervision of such payments, including expenses submitted to the Federal National Mortgage Association, the Federal Home Loan Mortgage Corp. and the U.S. Department of Housing and Urban Development (“HUD”) for reimbursement. It is possible that various state or federal regulatory and law enforcement authorities may seek monetary penalties from MLHL relating to foreclosure practices.
	MetLife Bank has also responded to a subpoena issued by the Department of Financial Services regarding hazard insurance and flood insurance that MetLife Bank obtained to protect the lienholder’s interest when the borrower’s insurance has lapsed.
	In April and May 2012, MetLife Bank received two subpoenas issued by the Office of Inspector General for HUD regarding Federal Housing Administration (“FHA”) insured loans. In June and September 2012, MetLife Bank received two Civil Investigative Demands that the U.S. Department of Justice issued as part of a False Claims Act investigation of allegations that MetLife Bank had improperly originated and/or underwritten loans insured by the FHA. MetLife Bank has met with the U.S. Department of Justice to discuss the allegations and possible resolution of the FHA False Claims Act investigation. The Company has included what it currently believes to be the probable and estimable amount of such loss in the Company’s consolidated financial statements and is continuing to investigate matters raised during the meeting.
	The consent decrees, as well as the inquiries or investigations referred to above, could adversely affect MetLife’s reputation or result in significant fines, penalties, equitable remedies or other enforcement actions, and result in significant legal costs in responding to governmental investigations or other litigation. The MetLife Bank Divestiture may not relieve MetLife from complying with the consent decrees, or protect it from inquiries and investigations relating to residential mortgage servicing and foreclosure activities, or any fines, penalties, equitable remedies or enforcement actions that may result, the costs of responding to any such governmental investigations, or other litigation. Management believes that the Company’s consolidated financial statements as a whole will not be materially affected by these regulatory matters.
	In the Matter of Chemform, Inc. Site, Pompano Beach, Broward County, Florida
	In July 2010, the Environmental Protection Agency (“EPA”) advised MLIC that it believed payments were due under two settlement agreements, known as “Administrative Orders on Consent,” that New England Mutual Life Insurance Company (“New England Mutual”) signed in 1989 and 1992 with respect to the cleanup of a Superfund site in Florida (the “Chemform Site”). The EPA originally contacted MLIC (as successor to New England Mutual) and a third party in 2001, and advised that they owed additional clean-up costs for the Chemform Site. The matter was not resolved at that time. The EPA is requesting payment of an amount under $1 million from MLIC and such third party for past costs and an additional amount for future environmental testing costs at the Chemform Site. In June 2012, the EPA, MLIC and the third party executed an Administrative Order on Consent under which MLIC and the third party have agreed to be responsible for certain environmental testing at the Chemform site. The Company estimates that its costs for the environmental testing will not exceed $100,000. The June 2012 Administrative Order on Consent does not resolve the EPA’s claim for past clean-up costs. The EPA may seek additional costs if the environmental testing identifies issues. The Company estimates that the aggregate cost to resolve this matter will not exceed $1 million.
	Metco Site, Hicksville, Nassau County, New York
	On February 22, 2012, the New York State Department of Environmental Conservation (“Department of Environmental Conservation”) issued a notice to MLIC, as purported successor in interest to New England Mutual, that it is a potentially responsible party with respect to hazardous substances and hazardous waste located on a property that New England Mutual owned for a time in 1978. MLIC has responded to the Department of Environmental Conservation and asserted that it is not a potentially responsible party under the law.
	New York Licensing Inquiry
	The Company continues to work with the Department of Financial Services and the Manhattan District Attorney’s Office regarding their inquiries into whether from January 2007 to the present American Life and DelAm conducted insurance business in New York without a license and whether representatives acting on behalf of these companies solicited, sold or negotiated insurance products in New York without a license. Additionally, the New York State Office of the Attorney General Taxpayer Protection Bureau is inquiring concerning American Life and DelAm’s New York State premium and franchise tax filings. The Company is cooperating with all regulators.
	Sales Practices Regulatory Matters
	Regulatory authorities in a small number of states and FINRA, and occasionally the SEC, have had investigations or inquiries relating to sales of individual life insurance policies or annuities or other products by MLIC, MICC, New England Life Insurance Company (“NELICO”) and General American Life Insurance Company (“GALIC”), and broker-dealers MetLife Securities, Inc. and New England Securities Corporation. These investigations often focus on the conduct of particular financial services representatives and the sale of unregistered or unsuitable products or the misuse of client assets. Over the past several years, these and a number of investigations by other regulatory authorities were resolved for monetary payments and certain other relief, including restitution payments. The Company may continue to resolve investigations in a similar manner. The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for these sales practices-related investigations or inquiries.
	Unclaimed Property Litigation and Inquiries
	In 2012, the Company reached agreements with representatives of the U.S. jurisdictions that were conducting audits of MetLife, Inc. and certain of its affiliates for compliance with unclaimed property laws, and with state insurance regulators directly involved in a multistate targeted market conduct examination relating to claim-payment practices and compliance with unclaimed property laws. In the first quarter of 2012, the Company recorded a $52 million after tax charge for the multistate examination payment and the expected acceleration of benefit payments to policyholders under the settlements. On September 20, 2012, the West Virginia Treasurer filed an action against MLIC in West Virginia state court (West Virginia ex rel. John D. Perdue v. Metropolitan Life Insurance Company, Circuit Court of Putnam County, Civil Action No. 12-C-295) alleging that the Company violated the West Virginia Uniform Unclaimed Property Act, seeking to compel compliance with the Act, and seeking payment of unclaimed property, interest, and penalties. On November 14, 2012, November 21, 2012, December 28, 2012, and January 9, 2013, the Treasurer filed substantially identical suits against MLI-USA, NELICO, MICC and GALIC, respectively. On December 30, 2013, the court granted defendants’ motions to dismiss all of the West Virginia Treasurer’s actions. The Treasurer has filed a notice to appeal the dismissal order. At least one other jurisdiction is pursuing a market conduct examination concerning compliance with unclaimed property statutes. It is possible that other jurisdictions may pursue similar examinations, audits, or lawsuits and that such actions may result in additional payments to beneficiaries, additional escheatment of funds deemed abandoned under state laws, administrative penalties, interest, and/or further changes to the Company’s procedures. The Company is not currently able to estimate these additional possible costs.
	Total Asset Recovery Services, LLC on behalf of the State of Florida v. MetLife, Inc., et. al. (Cir. Ct. Leon County, FL, filed October 27, 2010)
	Alleging that MetLife, Inc. and another company have violated the Florida Disposition of Unclaimed Property law by failing to escheat to Florida benefits of 9,022 life insurance contracts, Total Asset Recovery Services, LLC (“the Relator”) has brought an action under the Florida False Claims Act seeking to recover damages on behalf of Florida. The action had been sealed by court order until December 17, 2012. The Relator alleges that the aggregate damages attributable to MetLife, Inc., including statutory damages and treble damages, are $767 million. The Relator also bases its damage calculation in part on its assumption that the average face amount of the subject policies is $120,000. MetLife, Inc. strongly disputes this assumption, the Relator’s alleged damages amounts, and other allegations in the complaint. On December 14, 2012, the Florida Attorney General apprised the court that the State of Florida declined to intervene in the action and noted that the allegations in the complaint “. . . are very similar (if not identical) to those raised in regulatory investigations of the defendants that predated the filing of the action” and that those regulatory investigations have been resolved. On August 20, 2013, the court granted defendants’ motion to dismiss the action. The Relator has appealed the dismissal.
	City of Westland Police and Fire Retirement System v. MetLife, Inc., et. al. (S.D.N.Y., filed January 12, 2012)
	Seeking to represent a class of persons who purchased MetLife, Inc. common shares between February 2, 2010, and October 6, 2011, the plaintiff filed a second amended complaint alleging that MetLife, Inc. and several current and former executive officers of MetLife, Inc. violated the Securities Act of 1933 as well as the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by issuing, or causing MetLife, Inc. to issue, materially false and misleading statements concerning MetLife, Inc.’s potential liability for millions of dollars in insurance benefits that should have been paid to beneficiaries or escheated to the states. Plaintiff seeks unspecified compensatory damages and other relief. The defendants intend to defend this action vigorously.
	City of Birmingham Retirement and Relief System v. MetLife, Inc., et al. (N.D. Alabama, filed in state court on July 5, 2012 and removed to federal court on August 3, 2012)
	Seeking to represent a class of persons who purchased MetLife, Inc. common equity units in or traceable to a public offering in March 2011, the plaintiff filed an action alleging that MetLife, Inc., certain current and former directors and executive officers of MetLife, Inc., and various underwriters violated several provisions of the Securities Act of 1933 related to the filing of the registration statement by issuing, or causing MetLife, Inc. to issue, materially false and misleading statements and/or omissions concerning MetLife, Inc.’s potential liability for millions of dollars in insurance benefits that should have been paid to beneficiaries or escheated to the states. Plaintiff seeks unspecified compensatory damages and other relief. Defendants removed this action to federal court, and plaintiff has moved to remand the action to state court. The magistrate judge recommended granting the motion to remand to state court and the defendants have objected to that recommendation. The defendants intend to defend this action vigorously.
	Derivative Actions and Demands
	Seeking to sue derivatively on behalf of MetLife, Inc., four shareholders commenced separate actions against members of the MetLife, Inc. Board of Directors, alleging that they breached their fiduciary and other duties to the Company. Plaintiffs allege that the defendants failed to ensure that the Company complied with state unclaimed property laws and to ensure that the Company accurately reported its earnings. Plaintiffs allege that because of the defendant’s breaches of duty, MetLife, Inc. has incurred damage to its reputation and has suffered other unspecified damages. The two state court actions (Fishbaum v. Kandarian, et al. (Sup. Ct., New York County, filed January 27, 2012); Batchelder v. Burwell, et al. (Sup. Ct., New York County, filed March 6, 2012)), have been consolidated under the caption In re: MetLife Shareholder Derivative Action. On January 22, 2014, the state court issued an order granting defendants’ motion to dismiss on the basis that plaintiffs had not established that their failure to make the required pre-suit demand to the Board of Directors should be excused. Plaintiffs have moved for leave to reargue the order dismissing its claim or for leave to file an amended complaint. The two actions filed in federal court (Mallon v. Kandarian, et al. (S.D.N.Y., filed March 28, 2012); and Martino v. Kandarian, et al. (S.D.N.Y., filed April 19, 2012)) have been consolidated and stayed pending further order of the court. The defendants intend to continue to defend these actions vigorously. A fifth shareholder, Western Pennsylvania Electrical Workers Pension Fund, has written to the MetLife, Inc. Board of Directors demanding that MetLife, Inc. take action against current and former Board members, executive officers, and MetLife, Inc.’ s independent auditor, for similar alleged breaches of duty with respect to the Company’s compliance with unclaimed property laws and financial disclosures. The MetLife, Inc. Board of Directors appointed a Special Committee to investigate these allegations. On September 24, 2012, counsel for the Special Committee apprised this shareholder that the Board of Directors had reviewed the issues and rejected the demand.
	Total Control Accounts Litigation
	MLIC is a defendant in a consolidated lawsuit related to its use of retained asset accounts, known as Total Control Accounts (“TCA”), as a settlement option for death benefits.
	Keife, et al. v. Metropolitan Life Insurance Company (D. Nev., filed in state court on July 30, 2010 and removed to federal court on September 7, 2010); and Simon v. Metropolitan Life Insurance Company (D. Nev., filed November 3, 2011)
	These putative class action lawsuits, which have been consolidated, raise breach of contract claims arising from MLIC’s use of the TCA to pay life insurance benefits under the Federal Employees’ Group Life Insurance program. On March 8, 2013, the court granted MLIC’s motion for summary judgment. Plaintiffs have appealed that decision to the United States Court of Appeals for the Ninth Circuit.
	Other Litigation
	Merrill Haviland, et al. v. Metropolitan Life Insurance Company (E.D. Mich., removed to federal court on July 22, 2011)
	This lawsuit was filed by 45 retired General Motors (“GM”) employees against MLIC and the amended complaint includes claims for conversion, unjust enrichment, breach of contract, fraud, intentional infliction of emotional distress, fraudulent insurance acts, unfair trade practices, and ERISA claims based upon GM’s 2009 reduction of the employees’ life insurance coverage under GM’s ERISA-governed plan. The complaint includes a count seeking class action status. MLIC is the insurer of GM’s group life insurance plan and administers claims under the plan. According to the complaint, MLIC had previously provided plaintiffs with a “written guarantee” that their life insurance benefits under the GM plan would not be reduced for the rest of their lives. On June 26, 2012, the district court granted MLIC’s motion to dismiss the complaint. Plaintiffs appealed and the United States Court of Appeals for the Sixth Circuit affirmed the dismissal of the action on September 12, 2013.
	McGuire v. Metropolitan Life Insurance Company (E.D. Mich., filed February 22, 2012)
	This lawsuit was filed by the fiduciary for the Union Carbide Employees’ Pension Plan and alleges that MLIC, which issued annuity contracts to fund some of the benefits the Plan provides, engaged in transactions that ERISA prohibits and violated duties under ERISA and federal common law by determining that no dividends were payable with respect to the contracts from and after 1999. On September 26, 2012, the court denied MLIC’s motion to dismiss the complaint. The trial has been scheduled for June 2014.
Sun Life Assurance Company of Canada Indemnity Claim
In 2006, Sun Life Assurance Company of Canada (“Sun Life”), as successor to the purchaser of MLIC’s Canadian operations, filed a lawsuit in Toronto, seeking a declaration that MLIC remains liable for “market conduct claims” related to certain individual life insurance policies sold by MLIC and that have been transferred to Sun Life. Sun Life had asked that the court require MLIC to indemnify Sun Life for these claims pursuant to indemnity provisions in the sale agreement for the sale of MLIC’s Canadian operations entered into in June of 1998. In January 2010, the court found that Sun Life had given timely notice of its claim for indemnification but, because it found that Sun Life had not yet incurred an indemnifiable loss, granted MLIC’s motion for summary judgment. Both parties appealed but subsequently agreed to withdraw the appeal and consider the indemnity claim through arbitration. In September 2010, Sun Life notified MLIC that a purported class action lawsuit was filed against Sun Life in Toronto, Fehr v. Sun Life Assurance Co. (Super. Ct., Ontario, September 2010), alleging sales practices claims regarding the same individual policies sold by MLIC and transferred to Sun Life. An amended class action complaint in that case was served on Sun Life, again without naming MLIC as a party. On August 30, 2011, Sun Life notified MLIC that a purported class action lawsuit was filed against Sun Life in Vancouver, Alamwala v. Sun Life Assurance Co. (Sup. Ct., British Columbia, August 2011), alleging sales practices claims regarding certain of the same policies sold by MLIC and transferred to Sun Life. Sun Life contends that MLIC is obligated to indemnify Sun Life for some or all of the claims in these lawsuits. These sales practices cases against Sun Life are ongoing and the Company is unable to estimate the reasonably possible loss or range of loss arising from this litigation.
C-Mart, Inc. v. Metropolitan Life Ins. Co., et al. (S.D. Fla., January 10, 2013). Cadenasso v. Metropolitan Life Insurance Co., et al. (N.D. Cal., November 26, 2013).
Plaintiffs filed these lawsuits against defendants, including MLIC and a former MetLife financial services representative, alleging that the defendants sent unsolicited fax advertisements to plaintiff and others in violation of the Telephone Consumer Protection Act, as amended by the Junk Fax Prevention Act, 47 U.S.C. § 227 (“TCPA”). In the C-Mart case, the court granted plaintiff’s motion to certify a class of approximately 36,000 persons in Missouri who, during the period of August 7, 2012 through September 6, 2012, were allegedly sent an unsolicited fax in violation of the TCPA. Trial is set for April 2014. In the Cadenasso case, plaintiff seeks certification of a nationwide class of persons (except for Missouri residents) who were allegedly sent millions of unsolicited faxes in violation of the TCPA. In both cases, plaintiffs seek an award of statutory damages under the TCPA in the amount of $500 for each violation and to have such damages trebled.
Sales Practices Claims
Over the past several years, the Company has faced numerous claims, including class action lawsuits, alleging improper marketing or sales of individual life insurance policies, annuities, mutual funds or other products. Some of the current cases seek substantial damages, including punitive and treble damages and attorneys’ fees. The Company continues to vigorously defend against the claims in these matters. The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for sales practices matters.
Summary
Putative or certified class action litigation and other litigation and claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company’s consolidated financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, mortgage lending bank, employer, investor, investment advisor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations.
It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Although in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s consolidated net income or cash flows in particular quarterly or annual periods.
Insolvency Assessments
Most of the jurisdictions in which the Company is admitted to transact business require insurers doing business within the jurisdiction to participate in guaranty associations, which are organized to pay contractual benefits owed pursuant to insurance policies issued by impaired, insolvent or failed insurers. These associations levy assessments, up to prescribed limits, on all member insurers in a particular state on the basis of the proportionate share of the premiums written by member insurers in the lines of business in which the impaired, insolvent or failed insurer engaged. Some states permit member insurers to recover assessments paid through full or partial premium tax offsets. In addition, Japan has established the Life Insurance Policyholders Protection Corporation of Japan as a contingency to protect policyholders against the insolvency of life insurance companies in Japan through assessments to companies licensed to provide life insurance.
Assets and liabilities held for insolvency assessments were as follows:
	December 31,
	2013		2012
	(In millions)
Other Assets:
Premium tax offset for future undiscounted assessments	$	60	$	114
Premium tax offsets currently available for paid assessments	69		14
Receivable for reimbursement of paid assessments (1)	5		6
	$	134	$	134
Other Liabilities:
Insolvency assessments	$	93	$	205
______________
-1	The Company holds a receivable from the seller of a prior acquisition in accordance with the purchase agreement.
On September 1, 2011, the Department of Financial Services filed a liquidation plan for Executive Life Insurance Company of New York (“ELNY”), which had been under rehabilitation by the Liquidation Bureau since 1991. The plan involves the satisfaction of insurers’ financial obligations under a number of state life and health insurance guaranty associations and also provides additional industry support for certain ELNY policyholders. The Company recorded a net charge (benefit) of ($31) million, $38 million and $40 million, net of income tax, during the years ended December 31, 2013, 2012 and 2011, respectively, related to ELNY.
Commitments
Leases
The Company, as lessee, has entered into various lease and sublease agreements for office space, information technology and other equipment. Future minimum gross rental payments relating to these lease arrangements are as follows:
	Amount
	(In millions)
2014	$	320
2015	259
2016	212
2017	161
2018	141
Thereafter	794
Total	$	1,887
Total minimum rentals to be received in the future under non-cancelable subleases are $139 million as of December 31, 2013.
Commitments to Fund Partnership Investments
The Company makes commitments to fund partnership investments in the normal course of business. The amounts of these unfunded commitments were $4.4 billion and $3.4 billion at December 31, 2013 and 2012, respectively. The Company anticipates that these amounts will be invested in partnerships over the next five years.
Mortgage Loan Commitments
The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $3.4 billion and $3.0 billion at December 31, 2013 and 2012, respectively.
Commitments to Fund Bank Credit Facilities, Bridge Loans and Private Corporate Bond Investments
The Company commits to lend funds under bank credit facilities, bridge loans and private corporate bond investments. The amounts of these unfunded commitments were $925 million and $1.2 billion at December 31, 2013 and 2012, respectively.
Guarantees
In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from less than $1 million to $800 million, with a cumulative maximum of $1.4 billion, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments.
In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future.
The Company has also minimum fund yield requirements on certain international pension funds in accordance with local laws. Since these guarantees are not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future.
The Company’s recorded liabilities were $5 million at both December 31, 2013 and 2012, for indemnities, guarantees and commitments.

Quarterly_Results_of_Operation

Quarterly Results of Operations (Unaudited)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Quarterly Results of Operations (Unaudited)	'
	22. Quarterly Results of Operations (Unaudited)
	The unaudited quarterly results of operations for 2013 and 2012 are summarized in the table below:
		Three Months Ended
		March 31,			June 30,		September 30,			December 31,
		(In millions, except per share data)
	2013:00:00
	Total revenues	$	17,683		$	15,721	$	16,337		$	18,458
	Total expenses	$	16,436		$	15,160	$	15,361		$	17,190
	Income (loss) from continuing operations, net of income tax	$	995		$	508	$	973		$	915
	Income (loss) from discontinued operations, net of income tax	$	(3	)	$	2	$	2		$	1
	Net income (loss)	$	992		$	510	$	975		$	916
	Less: Net income (loss) attributable to noncontrolling interests	$	6		$	8	$	3		$	8
	Net income (loss) attributable to MetLife, Inc.	$	986		$	502	$	972		$	908
	Less: Preferred stock dividends	$	30		$	31	$	30		$	31
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	956		$	471	$	942		$	877
	Basic earnings per common share:
	Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	0.87		$	0.43	$	0.85		$	0.78
	Income (loss) from discontinued operations, net of income tax, attributable to MetLife, Inc.	$	—		$	—	$	—		$	—
	Net income (loss) attributable to MetLife, Inc.	$	0.9		$	0.46	$	0.88		$	0.81
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	0.87		$	0.43	$	0.85		$	0.78
	Diluted earnings per common share:
	Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	0.87		$	0.43	$	0.84		$	0.77
	Income (loss) from discontinued operations, net of income tax, attributable to MetLife, Inc.	$	—		$	—	$	—		$	—
	Net income (loss) attributable to MetLife, Inc.	$	0.89		$	0.45	$	0.87		$	0.8
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	0.87		$	0.43	$	0.84		$	0.77
	2012:00:00
	Total revenues	$	15,916		$	18,398	$	16,503		$	17,333
	Total expenses	$	16,325		$	15,060	$	17,513		$	17,810
	Income (loss) from continuing operations, net of income tax	$	(134	)	$	2,300	$	(957	)	$	105
	Income (loss) from discontinued operations, net of income tax	$	14		$	3	$	—		$	31
	Net income (loss)	$	(120	)	$	2,303	$	(957	)	$	136
	Less: Net income (loss) attributable to noncontrolling interests	$	24		$	8	$	(3	)	$	9
	Net income (loss) attributable to MetLife, Inc.	$	(144	)	$	2,295	$	(954	)	$	127
	Less: Preferred stock dividends	$	30		$	31	$	30		$	31
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	(174	)	$	2,264	$	(984	)	$	96
	Basic earnings per common share:
	Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	(0.17	)	$	2.13	$	(0.92	)	$	0.06
	Income (loss) from discontinued operations, net of income tax, attributable to MetLife, Inc.	$	0.01		$	—	$	—		$	0.03
	Net income (loss) attributable to MetLife, Inc.	$	(0.14	)	$	2.16	$	(0.90	)	$	0.12
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	(0.16	)	$	2.13	$	(0.92	)	$	0.09
	Diluted earnings per common share:
	Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	(0.17	)	$	2.12	$	(0.92	)	$	0.06
	Income (loss) from discontinued operations, net of income tax, attributable to MetLife, Inc.	$	0.01		$	—	$	—		$	0.03
	Net income (loss) attributable to MetLife, Inc.	$	(0.14	)	$	2.14	$	(0.90	)	$	0.12
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	(0.16	)	$	2.12	$	(0.92	)	$	0.09

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Event	'
	23. Subsequent Events
	Dividends
	Preferred Stock
	On February 18, 2014, MetLife, Inc. announced dividends of $0.250 per share, for a total of $6 million, on its Series A preferred shares, and $0.406 per share, for a total of $24 million, on its Series B preferred shares, subject to the final confirmation that it has met the financial tests specified in the Series A and Series B preferred shares, which the Company anticipates will be made on or about March 5, 2014. Both dividends will be payable March 17, 2014 to shareholders of record as of February 28, 2014.
	Common Stock
	On January 6, 2014, MetLife, Inc.’s Board of Directors declared a first quarter 2014 common stock dividend of $0.275 per share payable on March 13, 2014 to shareholders of record as of February 6, 2014. The Company estimates the aggregate dividend payment to be $310 million.
	Disposition
	On February 14, 2014, the Company entered into a definitive agreement to sell its wholly-owned subsidiary, MetLife Assurance Limited. The Company expects to record a charge of between $350 million and $390 million, net of income tax, reflecting the estimated loss on sale, in the first quarter of 2014. The transaction is expected to close in the second quarter of 2014, subject to regulatory approvals and satisfaction of other closing conditions.

Consolidated_Summary_of_Invest

Consolidated Summary of Investments - Other Than Investments in Related Parties	12 Months Ended
	Dec. 31, 2013
Summary of Investments, Other than Investments in Related Parties [Abstract]	'
Consolidated Summary of Investments - Other Than Investments in Related Parties	'
	MetLife, Inc.
	Schedule I
	Consolidated Summary of Investments —
	Other Than Investments in Related Parties
	December 31, 2013
	(In millions)
	Types of Investments	Cost or Amortized Cost (1)		Estimated Fair Value		Amount at Which Shown on Balance Sheet
	Fixed maturity securities:
	Bonds:
	Foreign government securities	$	50,717	$	54,437	$	54,437
	U.S. Treasury and agency securities	43,928		45,123		45,123
	Public utilities	27,512		29,897		29,897
	State and political subdivision securities	13,233		13,830		13,830
	All other corporate bonds	130,469		137,682		137,682
	Total bonds	265,859		280,969		280,969
	Mortgage-backed and asset-backed securities	65,740		67,176		67,176
	Redeemable preferred stock	2,000		2,042		2,042
	Total fixed maturity securities	333,599		350,187		350,187
	Fair value option and trading securities	16,403		17,423		17,423
	Equity securities:
	Common stock:
	Industrial, miscellaneous and all other	1,760		2,143		2,143
	Banks, trust and insurance companies	167		210		210
	Non-redeemable preferred stock	1,085		1,049		1,049
	Total equity securities	3,012		3,402		3,402
	Mortgage loans:
	Held-for-investment	57,703				57,703
	Held-for-sale	3				3
	Mortgage loans, net	57,706				57,706
	Policy loans	11,764				11,764
	Real estate and real estate joint ventures	10,267				10,267
	Real estate acquired in satisfaction of debt	445				445
	Other limited partnership interests	7,401				7,401
	Short-term investments	13,955				13,955
	Other invested assets	16,229				16,229
	Total investments	$	470,781			$	488,779
	______________
	-1	The Company’s fair value option and trading securities portfolio is mainly comprised of fixed maturity and equity securities, including mutual funds and, to a lesser extent, short-term investments and cash and cash equivalents. Cost or amortized cost for fixed maturity securities and mortgage loans held-for-investment represents original cost reduced by repayments, valuation allowances and impairments from other-than-temporary declines in estimated fair value that are charged to earnings and adjusted for amortization of premiums or accretion of discounts; for equity securities, cost represents original cost reduced by impairments from other-than-temporary declines in estimated fair value; for real estate, cost represents original cost reduced by impairments and adjusted for valuation allowances and depreciation; for real estate joint ventures and other limited partnership interests cost represents original cost reduced for impairments or original cost adjusted for equity in earnings and distributions.

Condensed_Financial_Informatio

Condensed Financial Information (Parent Company)	12 Months Ended
	Dec. 31, 2013
Condensed Financial Information of Parent Company Only Disclosure [Abstract]	'
Condensed Financial Information (Parent Company)	'
	MetLife, Inc.
	Schedule II
	Condensed Financial Information
	(Parent Company Only)
	December 31, 2013 and 2012
	(In millions, except share and per share data)
		2013			2012
	Condensed Balance Sheets
	Assets
	Investments:
	Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $4,497 and $4,867, respectively)	$	4,531		$	4,967
	Equity securities available-for-sale, at estimated fair value (cost: $0 and $15, respectively)	—			13
	Short-term investments, principally at estimated fair value	560			295
	Other invested assets, at estimated fair value	557			155
	Total investments	5,648			5,430
	Cash and cash equivalents	648			188
	Accrued investment income	40			37
	Investment in subsidiaries	76,871			81,769
	Loans to subsidiaries	2,333			750
	Receivables from subsidiaries	—			7
	Other assets	1,677			1,369
	Total assets	$	87,217		$	89,550
	Liabilities and Stockholders’ Equity
	Liabilities
	Payables for collateral under securities loaned and other transactions	$	85		$	—
	Long-term debt — unaffiliated	15,938			15,669
	Long-term debt — affiliated	3,600			3,250
	Collateral financing arrangements	2,797			2,797
	Junior subordinated debt securities	1,748			1,748
	Payables to subsidiaries	13			—
	Other liabilities	1,483			1,633
	Total liabilities	25,664			25,097
	Stockholders’ Equity
	Preferred stock, par value $0.01 per share; 200,000,000 shares authorized: 84,000,000 shares issued and outstanding; $2,100 aggregate liquidation preference	1			1
	Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,125,224,024 and 1,094,880,623 shares issued at December 31, 2013 and 2012, respectively; 1,122,030,137 and 1,091,686,736 shares outstanding at December 31, 2013 and 2012, respectively	11			11
	Additional paid-in capital	29,277			28,011
	Retained earnings	27,332			25,205
	Treasury stock, at cost; 3,193,887 shares at December 31, 2013 and 2012	(172		)	(172		)
	Accumulated other comprehensive income (loss)	5,104			11,397
	Total stockholders’ equity	61,553			64,453
	Total liabilities and stockholders’ equity	$	87,217		$	89,550
	See accompanying notes to the condensed financial information.
	MetLife, Inc.
	Schedule II
	Condensed Financial Information — (Continued)
	(Parent Company Only)
	For the Years Ended December 31, 2013, 2012 and 2011
	(In millions)
		2013			2012				2011
	Condensed Statements of Operations
	Revenues
	Equity in earnings of subsidiaries	$	4,163		$	3,444			$	6,979
	Net investment income	304			94				121
	Other revenues	155			159				155
	Net investment gains (losses)	(80		)	29				(146		)
	Net derivative gains (losses)	(99		)	(259		)		82
	Total revenues	4,443			3,467				7,191
	Expenses
	Interest expense	1,122			985				1,007
	Goodwill impairment	—			1,384				—
	Other expenses	373			167				149
	Total expenses	1,495			2,536				1,156
	Income (loss) before provision for income tax	2,948			931				6,035
Provision for income tax expense (benefit)	(420		)	(393		)		(388		)
Net income (loss)	3,368			1,324				6,423
Less: Preferred stock dividends	122			122				122
Preferred stock redemption premium	—			—				146
Net income (loss) available to common shareholders	$	3,246		$	1,202			$	6,155
Comprehensive income (loss)	$	(2,925	)	$	6,638			$	11,361
See accompanying notes to the condensed financial information.
MetLife, Inc.
Schedule II
Condensed Financial Information — (Continued)
(Parent Company Only)
For the Years Ended December 31, 2013, 2012 and 2011
(In millions)
	2013			2012				2011
Condensed Statements of Cash Flows
Cash flows from operating activities
Net income (loss)	$	3,368		$	1,324			$	6,423
Earnings of subsidiaries	(4,163		)	(3,444		)		(6,979		)
Dividends from subsidiaries	2,734			3,177				2,578
Goodwill impairment	—			1,384				—
Other, net	(74		)	177				697
Net cash provided by (used in) operating activities	1,865			2,618				2,719
Cash flows from investing activities
Sales of fixed maturity securities	5,108			5,645				3,265
Purchases of fixed maturity securities	(4,795		)	(6,200		)		(4,787		)
Sales of equity securities	13			2				1
Cash received in connection with freestanding derivatives	424			197				257
Cash paid in connection with freestanding derivatives	(465		)	(203		)		(276		)
Sales of businesses	17			—				180
Expense paid on behalf of subsidiaries	(85		)	(80		)		(75		)
Repayments of loans to subsidiaries	645			175				1,275
Issuances of loans to subsidiaries	(1,942		)	(175		)		—
Redemption of preferred stock of subsidiary	300			—				—
Investment in preferred stock of subsidiary	—			—				(250		)
Returns of capital from subsidiaries	267			9				591
Capital contributions to subsidiaries	(748		)	(1,223		)		(1,439		)
Net change in short-term investments	(265		)	372				(620		)
Other, net	(49		)	(48		)		(10		)
Net cash provided by (used in) investing activities	(1,575		)	(1,529		)		(1,888		)
Cash flows from financing activities
Net change in payables for collateral under securities loaned and other transactions	85			(1,180		)		520
Long-term debt issued	994			750				—
Long-term debt repaid	(750		)	(797		)		(750		)
Cash received (paid) in connection with collateral financing arrangements	—			(44		)		37
Common stock issued, net of issuance costs	1,000			1,000				2,950
Redemption of convertible preferred stock	—			—				(2,805		)
Preferred stock redemption premium	—			—				(146		)
Dividends on preferred stock	(122		)	(122		)		(122		)
Dividends on common stock	(1,119		)	(811		)		(787		)
Other, net	82			(6		)		(43		)
Net cash provided by (used in) financing activities	170			(1,210		)		(1,146		)
Change in cash and cash equivalents	460			(121		)		(315		)
Cash and cash equivalents, beginning of year	188			309				624
Cash and cash equivalents, end of year	$	648		$	188			$	309
MetLife, Inc.
Schedule II
Condensed Financial Information — (Continued)
(Parent Company Only)
For the Years Ended December 31, 2013, 2012 and 2011
(In millions)
	2013			2012				2011
Supplemental disclosures of cash flow information:
Net cash paid (received) for:
Interest	$	1,100		$	937			$	997
Income tax	$	69		$	24			$	(659	)
Non-cash transactions:
Dividends from subsidiaries	$	32		$	203			$	170
Returns of capital from subsidiaries	$	—		$	356			$	47
Capital contributions to subsidiaries	$	121		$	559			$	316
Assumption of long-term debt from subsidiary	$	—		$	2,000			$	—
Investment in preferred stock of subsidiary	$	—		$	2,000			$	—
Issuance of long-term debt to subsidiary	$	350		$	750			$	—
Issuance of loan to subsidiary	$	350		$	750			$	—
Allocation of interest expense to subsidiary	$	28		$	33			$	29
Allocation of interest income to subsidiary	$	68		$	76			$	68
MetLife, Inc.
Schedule II
Notes to the Condensed Financial Information
(Parent Company Only)
1. Basis of Presentation
The condensed financial information of MetLife, Inc. (the “Parent Company”) should be read in conjunction with the consolidated financial statements of MetLife, Inc. and its subsidiaries and the notes thereto (the “Consolidated Financial Statements”). These condensed unconsolidated financial statements reflect the results of operations, financial position and cash flows for MetLife, Inc. Investments in subsidiaries are accounted for using the equity method of accounting.
The preparation of these condensed unconsolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to adopt accounting policies and make certain estimates and assumptions. The most important of these estimates and assumptions relate to the fair value measurements, the accounting for goodwill and identifiable intangible assets and the provision for potential losses that may arise from litigation and regulatory proceedings and tax audits, which may affect the amounts reported in the condensed unconsolidated financial statements and accompanying notes. Actual results could differ from these estimates.
[Placeholder for Provida Acquisition and MetLife Bank disposition. Will remove this section if it is not required to disclose neither.]
2. Investment in Subsidiaries
During 2012, MetLife, Inc. assumed debt from Exeter Reassurance Company, Ltd. (“Exeter”), a subsidiary, as described in Note 5, in exchange for $2.0 billion of preferred stock of Exeter. In September 2012, MetLife, Inc. subscribed to 75,000 shares of Exeter’s Series A Non-Cumulative Perpetual Preferred Shares which bears an annual rate of 7.69% that is payable semi-annually. In December 2012, MetLife, Inc. subscribed to 125,000 shares of Exeter’s Series B Non-Cumulative Perpetual Preferred Shares which bears an annual rate of 7.75% that is payable semi-annually.
3. Loans to Subsidiaries
MetLife, Inc. lends funds, as necessary, to its subsidiaries, some of which are regulated, to meet their capital requirements. Payments of interest and principal on surplus notes of regulated subsidiaries, which are subordinate to all other obligations of the issuing company, may be made only with the prior approval of the insurance department of the state of domicile.
In December 2013, MetLife Reinsurance Company of Delaware (“MRD”), issued a $350 million surplus note to MetLife, Inc. due December 2033. The surplus note bears interest at a fixed rate of 6.00% payable semi-annually. MetLife, Inc. issued a $350 million senior note to MRD in exchange for the surplus note (see Note 4).
In July, 2013, MetLife Ireland Treasury Limited (“MITL”) borrowed the Chilean peso equivalent of $1.5 billion from MetLife, Inc., which is due July 2023. The loan bears interest at a fixed rate of 8.5%, payable annually. In December 2013, MITL repaid $245 million of the loan to MetLife, Inc.
In December 2012, MRD issued a $750 million surplus note to MetLife, Inc. due September 30, 2032. The surplus note bears interest at a fixed rate of 5.13% payable semi-annually. In December 2012, MetLife, Inc. issued a $750 million senior note to MRD in exchange for the surplus note (see Note 4).
In December 2011, Metropolitan Life Insurance Company (“MLIC”) repaid in cash the $500 million capital notes issued to MetLife, Inc. In April 2011, MLIC repaid in cash a $775 million surplus note issued to MetLife, Inc. and due December 2011. The early redemption was approved by the New York Superintendent of Insurance.
Interest income earned on loans to subsidiaries of $103 million, $1 million and $40 million for the years ended December 31, 2013, 2012 and 2011, respectively, is included in net investment income.
4. Long-term Debt
Long-term debt outstanding was as follows:
	Interest Rates (1)					December 31,
	Range		Weighted	Maturity		2013				2012
			Average
						(In millions)
Senior notes — unaffiliated	1.52% - 7.72%		4.96%	2014 - 2045		$	15,938			$	15,669
Senior notes — affiliated	3.57% - 7.44%		5.43%	2014 - 2033		3,100				2,750
Other affiliated debt	0.95% - 1.01%		0.98%	2015 - 2016		500				500
Total						$	19,538			$	18,919
______________
-1	Range of interest rates and weighted average interest rates are for the year ended December 31, 2013.
See Note 12 of the Notes to the Consolidated Financial Statements for information about the issuances of senior notes - unaffiliated in 2013 and 2012.
The aggregate maturities of long-term debt at December 31, 2013 for the next five years and thereafter are $1.9 billion in 2014, $1.3 billion in 2015, $1.7 billion in 2016, $500 million in 2017, $1.5 billion in 2018 and $12.6 billion thereafter.
Senior Notes – Affiliated
In December 2013, MetLife, Inc. issued a $350 million senior note to MRD due December 31, 2033. The senior note bears interest at a fixed rate of 5.10%, payable semi-annually. MRD issued a $350 million surplus note to MetLife, Inc. in exchange for the senior note.
In December 2012, $1.25 billion of senior notes issued by Exeter, payable to affiliates and comprised of three notes, were reassigned to MetLife, Inc. MetLife, Inc. received $1.25 billion of preferred stock of Exeter in exchange for the assumption of this affiliated debt (see Note 3). A $250 million senior note matures on September 30, 2016 and bears interest at a fixed rate of 7.44%, payable semi-annually. A $500 million senior note matures on July 15, 2021 and bears interest at a fixed rate of 5.64%, payable semi-annually. A $500 million senior note matures on December 16, 2021 and bears interest at a fixed rate of 5.86%, payable semi-annually.
In December 2012, MetLife, Inc. issued a $750 million senior note to MRD due September 30, 2032. The senior note bears interest at a fixed rate of 4.21%, payable semi-annually. MRD issued a $750 million surplus note to MetLife, Inc. in exchange for the senior note.
In September 2012, $750 million of senior notes issued by Exeter payable to MLIC were reassigned to MetLife, Inc. MetLife, Inc. received $750 million of preferred stock of Exeter in exchange for the assumption of this affiliated debt (see Note 3). On September 30, 2012, $250 million of the assumed senior notes matured and, subsequently, in October 2012, a $250 million senior note was issued by MetLife, Inc. to MLIC. The $250 million senior note matures on October 1, 2019 and bears interest at a fixed rate of 3.57%, payable semi-annually. The remaining $500 million senior note matures on June 30, 2014 and bears interest at a fixed rate of 6.44%, payable semi-annually.
Interest Expense
Interest expense was comprised of the following:
	Years Ended December 31,
	2013			2012				2011
	(In millions)
Long-term debt — unaffiliated	$	790		$	779			$	806
Long-term debt — affiliated	163			28				16
Collateral financing arrangements	35			42				43
Junior subordinated debt securities	134			134				134
Stock purchase contracts	—			2				8
Total	$	1,122		$	985			$	1,007
5. Support Agreements
MetLife, Inc. is party to various capital support commitments and guarantees with certain of its subsidiaries. Under these arrangements, MetLife, Inc. has agreed to cause each such entity to meet specified capital and surplus levels or has guaranteed certain contractual obligations.
In October 2013, MetLife, Inc. guaranteed two-year notes issued by Exeter to affiliates, MetLife Insurance Company of Connecticut and MetLife Investors USA Insurance Company, totaling $500 million that bear interest at 2.47%.
In January 2013, MetLife, Inc. entered into an 18-month agreement with MetLife Bank, National Association’s (“MetLife Bank”) to lend up to $500 million to MetLife Bank on a revolving basis. In February 2013, the agreement was amended to reduce borrowing capacity to $100 million. MetLife Bank's rights and obligations under the agreement succeeded to MetLife Home Loans LLC (“MLHL”) upon the merger of MetLife Bank with and into MLHL. On October 29, 2013, MetLife, Inc. and MLHL agreed to terminate the agreement. There were no loans outstanding at such date.
In July 2012, in connection with an operating agreement with the Comptroller of the Currency (the “OCC”) governing MetLife Bank operations during its wind-down process, MetLife Bank and MetLife, Inc. entered into a capital support agreement with the OCC and MetLife, Inc. and MetLife Bank entered into an indemnification and capital maintenance agreement under which agreements MetLife, Inc. provided financial and other support to MetLife Bank to ensure that MetLife Bank could wind down its operations in a safe and sound manner. Pursuant to the agreements, MetLife, Inc. was required to ensure that MetLife Bank meets or exceeds certain minimum capital and liquidity requirements and make indemnification payments to MetLife Bank in connection with MetLife Bank’s obligation under the April 2011 consent decree between MetLife Bank and the OCC. During the years ended December 31, 2013 and 2012, MetLife, Inc. invested $21 million and $34 million, respectively, in cash in MetLife Bank in connection with these agreements. On August 30, 2013, MetLife Bank merged with and into MLHL, with MLHL as the surviving, non-bank entity. The obligations of MetLife, Inc. and MetLife Bank under the capital support agreement with the OCC and the obligations of MetLife, Inc. under the indemnification and capital maintenance agreement ceased in all material respects upon the merger of MetLife Bank with and into MLHL.
MetLife, Inc., in connection with MRD’s reinsurance of certain universal life and term life risks, entered into a capital maintenance agreement pursuant to which MetLife, Inc. agreed, without limitation as to amount, to cause the initial protected cell of MRD to maintain total adjusted capital equal to or greater than 200% of such protected cell’s company action level risk-based capital (“RBC”), as defined in state insurance statutes.
MetLife, Inc. guarantees the obligations of its subsidiary, DelAm, under a stop loss reinsurance agreement with RGA Reinsurance (Barbados) Inc. (“RGARe”), pursuant to which RGARe retrocedes to DelAm a portion of the whole life medical insurance business that RGARe assumed from American Life on behalf of its Japan operations. Also, MetLife, Inc. guarantees the obligations of its subsidiary, Missouri Reinsurance, Inc. (“MoRe”), under a retrocession agreement with RGARe, pursuant to which MoRe retrocedes certain group term life insurance liabilities and a portion of the closed block liabilities associated with industrial life and ordinary life insurance policies that it assumed from MLIC.
Prior to the sale in April 2011 of its 50% interest in Mitsui Sumitomo MetLife Insurance Co., Ltd. (‘MSI MetLife’) to a third party, MetLife, Inc. guaranteed the obligations of its subsidiary, Exeter, under a reinsurance agreement with MSI MetLife, under which Exeter reinsures variable annuity business written by MSI MetLife. This guarantee will remain in place until such time as the reinsurance agreement between Exeter and MSI MetLife is terminated, notwithstanding the April 2011 disposition of MetLife, Inc.’s interest in MSI MetLife as described in Note 3 of the Notes to the Consolidated Financial Statements.
MetLife, Inc. guarantees the obligations of Exeter in an aggregate amount up to $1.0 billion, under a reinsurance agreement with MetLife Europe Limited (“MEL”), under which Exeter reinsures the guaranteed living benefits and guaranteed death benefits associated with certain unit-linked annuity contracts issued by MEL.
MetLife, Inc., in connection with MetLife Reinsurance Company of Vermont’s (“MRV”) reinsurance of certain universal life and term life insurance risks, committed to the Vermont Department of Banking, Insurance, Securities and Health Care Administration to take necessary action to cause the three protected cells of MRV to maintain total adjusted capital in an amount that is equal to or greater than 200% of each such protected cell’s authorized control level RBC, as defined in Vermont state insurance statutes. See Note 12 of the Notes to the Consolidated Financial Statements.
MetLife, Inc., in connection with the collateral financing arrangement associated with MetLife Reinsurance Company of Charleston’s (“MRC”) reinsurance of a portion of the liabilities associated with the closed block, committed to the South Carolina Department of Insurance to make capital contributions, if necessary, to MRC so that MRC may at all times maintain its total adjusted capital in an amount that is equal to or greater than 200% of the company action level RBC, as defined in South Carolina state insurance statutes as in effect on the date of determination or December 31, 2007, whichever calculation produces the greater capital requirement, or as otherwise required by the South Carolina Department of Insurance. See Note 13 of the Notes to the Consolidated Financial Statements.
MetLife, Inc., in connection with the collateral financing arrangement associated with MetLife Reinsurance Company of South Carolina’s (“MRSC”) reinsurance of universal life secondary guarantees, committed to the South Carolina Department of Insurance to take necessary action to cause MRSC to maintain the greater of capital and surplus of $250,000 or total adjusted capital in an amount that is equal to or greater than 100% of authorized control level RBC, as defined in South Carolina state insurance statutes. See Note 13 of the Notes to the Consolidated Financial Statements.
MetLife, Inc. has net worth maintenance agreements with two of its insurance subsidiaries, MetLife Investors Insurance Company and First MetLife Investors Insurance Company. Under these agreements, as amended, MetLife, Inc. agreed, without limitation as to the amount, to cause each of these subsidiaries to have capital and surplus of $10 million, total adjusted capital in an amount that is equal to or greater than 150% of the company action level RBC, as defined by applicable state insurance statutes, and liquidity necessary to enable it to meet its current obligations on a timely basis.
MetLife, Inc. guarantees obligations arising from derivatives of the following subsidiaries: Exeter, MetLife International Holdings, Inc. and MetLife Worldwide Holdings, Inc. These subsidiaries are exposed to various risks relating to their ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. These subsidiaries use a variety of strategies to manage these risks, including the use of derivatives. Further, all of the subsidiaries’ derivatives are subject to industry standard netting agreements and collateral agreements that limit the unsecured portion of any open derivative position. On a net counterparty basis at December 31, 2013 and 2012, derivative transactions with positive mark-to-market values (in-the-money) were $568 million and $3.2 billion, respectively, and derivative transactions with negative mark-to-market values (out-of-the-money) were $734 million and $22 million, respectively. To secure the obligations represented by the out of-the-money transactions, the subsidiaries had provided collateral to their counterparties with an estimated fair value of $651 million and $12 million at December 31, 2013 and 2012, respectively. Accordingly, unsecured derivative liabilities guaranteed by MetLife, Inc. were $83 million and $10 million at December 31, 2013 and 2012, respectively.
MetLife, Inc. also guarantees the obligations of certain of its subsidiaries under committed facilities with third-party banks. See Note 12 of the Notes to the Consolidated Financial Statements.

Consolidated_Supplementary_Ins

Consolidated Supplementary Insurance Information	12 Months Ended
	Dec. 31, 2013
Supplementary Insurance Information [Abstract]	'
Consolidated Supplementary Insurance Information	'
	MetLife, Inc.
	Schedule III
	Consolidated Supplementary Insurance Information
	December 31, 2013, 2012 and 2011
	(In millions)
	Segment		DAC		Future Policy Benefits,		Policyholder		Policyholder		Unearned		Unearned
			and		Other Policy-Related		Account		Dividends		Premiums (1), (2)		Revenue (1)
			VOBA		Balances and		Balances		Payable
					Policyholder Dividend
					Obligation
	2013
	Retail		$	12,882	$	73,953	$	62,733	$	601	$	918	$	860
	Group, Voluntary & Worksite Benefits		382		20,946		8,575		—		886		—
	Corporate Benefit Funding		99		50,548		62,043		—		—		32
	Latin America		2,201		8,985		7,177		—		499		678
	Asia		9,077		35,863		57,203		65		1,895		1,035
	EMEA		2,039		7,704		13,953		9		196		260
	Corporate & Other		26		6,928		1,201		—		9		—
	Total		$	26,706	$	204,927	$	212,885	$	675	$	4,403	$	2,865
	2012
	Retail		$	11,500	$	74,887	$	67,023	$	610	$	873	$	911
	Group, Voluntary & Worksite Benefits		382		21,078		8,918		—		852		—
	Corporate Benefit Funding		96		53,542		63,523		—		—		39
	Latin America		1,231		8,856		7,199		—		428		627
	Asia		9,554		39,061		64,003		65		1,554		831
	EMEA		1,998		7,521		12,679		53		215		270
	Corporate & Other		—		6,697		2,476		—		9		—
	Total		$	24,761	$	211,642	$	225,821	$	728	$	3,931	$	2,678
	2011
	Retail		$	11,681	$	72,238	$	69,553	$	659	$	791	$	995
	Group, Voluntary & Worksite Benefits		377		19,626		9,273		—		822		—
	Corporate Benefit Funding		89		49,858		56,367		—		—		49
	Latin America		1,050		7,731		6,159		4		284		514
	Asia		9,554		38,528		59,739		53		1,267		655
	EMEA		1,866		8,113		14,235		58		200		103
	Corporate & Other		2		6,699		2,374		—		10		—
	Total		$	24,619	$	202,793	$	217,700	$	774	$	3,374	$	2,316
	______________
	-1	Amounts are included within the future policy benefits, other policy-related balances and policyholder dividend obligation column.
	-2	Includes premiums received in advance.
	MetLife, Inc.
	Schedule III
	Consolidated Supplementary Insurance Information — (Continued)
	December 31, 2013, 2012 and 2011
	(In millions)
	Segment		Premium		Net		Policyholder		Amortization of		Other
			Revenue		Investment		Benefits and		DAC and		Operating
			and		Income		Claims and		VOBA		Expenses (1)
			Policy				Interest Credited		Charged to
			Charges				to Policyholder		Other
							Account Balances		Expenses
	2013
	Retail		$	11,783	$	7,427	$	11,460	$	850	$	5,006
	Group, Voluntary & Worksite Benefits		15,938		1,684		14,381		140		2,241
	Corporate Benefit Funding		3,106		5,805		6,604		23		505
	Latin America		3,820		1,326		2,793		310		1,182
	Asia		9,525		4,335		9,200		1,527		1,825
	EMEA		2,698		1,164		1,743		699		1,035
	Corporate & Other		255		491		105		1		2,517
	Total		$	47,125	$	22,232	$	46,286	$	3,550	$	14,311
	2012
	Retail		$	11,411	$	7,275	$	11,247	$	1,603	$	4,941
	Group, Voluntary & Worksite Benefits		15,456		1,628		13,858		133		2,215
Corporate Benefit Funding		3,462		5,765		7,105		22		457
Latin America		3,438		1,354		3,014		228		1,047
Asia		9,835		3,421		8,246		1,567		1,933
EMEA		2,718		1,348		2,088		644		1,060
Corporate & Other		211		1,193		158		2		3,272
Total		$	46,531	$	21,984	$	45,716	$	4,199	$	14,925
2011
Retail		$	11,077	$	7,156	$	10,447	$	2,365	$	4,902
Group, Voluntary & Worksite Benefits		14,579		1,631		13,193		186		2,022
Corporate Benefit Funding		3,080		5,639		6,664		17		497
Latin America		3,371		1,105		2,899		211		1,056
Asia		9,059		1,954		6,360		1,505		1,862
EMEA		2,792		535		1,385		613		1,119
Corporate & Other		209		1,565		126		1		3,627
Total		$	44,167	$	19,585	$	41,074	$	4,898	$	15,085
______________
-1	Includes other expenses and policyholder dividends, excluding amortization of deferred policy acquisition costs (“DAC”) and value of business acquired (“VOBA”) charged to other expenses.

Consolidated_Reinsurance

Consolidated Reinsurance	12 Months Ended
	Dec. 31, 2013
Supplemental Schedule of Reinsurance Premiums for Insurance Companies [Abstract]	'
Consolidated Reinsurance	'
	MetLife, Inc.
	Schedule IV
	Consolidated Reinsurance
	December 31, 2013, 2012 and 2011
	(In millions)
		Gross Amount		Ceded		Assumed		Net Amount		% Amount Assumed to Net
	2013
	Life insurance in-force	$	4,517,797	$	763,754	$	607,591	$	4,361,634	13.9	%
	Insurance premium
	Life insurance	$	22,206	$	1,862	$	1,269	$	21,613	5.9	%
	Accident and health insurance	12,957		333		196		12,820		1.5	%
	Property and casualty insurance	3,313		79		7		3,241		0.2	%
	Total insurance premium	$	38,476	$	2,274	$	1,472	$	37,674	3.9	%
	2012
	Life insurance in-force	$	4,432,178	$	761,993	$	594,062	$	4,264,247	13.9	%
	Insurance premium
	Life insurance	$	22,006	$	1,550	$	1,268	$	21,724	5.8	%
	Accident and health insurance	13,567		605		211		13,173		1.6	%
	Property and casualty insurance	3,146		77		9		3,078		0.3	%
	Total insurance premium	$	38,719	$	2,232	$	1,488	$	37,975	3.9	%
	2011
	Life insurance in-force	$	4,263,421	$	754,781	$	604,555	$	4,113,195	14.7	%
	Insurance premium
	Life insurance	$	21,930	$	1,670	$	1,198	$	21,458	5.6	%
	Accident and health insurance	12,186		568		275		11,893		2.3	%
	Property and casualty insurance	3,069		70		11		3,010		0.4	%
	Total insurance premium	$	37,185	$	2,308	$	1,484	$	36,361	4.1	%

Business_Basis_of_Presentation1

Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Use of Estimates	'
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from estimates.
Consolidation of Subsidiaries	'
	The accompanying consolidated financial statements include the accounts of MetLife, Inc. and its subsidiaries, as well as partnerships and joint ventures in which the Company has control, and variable interest entities (“VIEs”) for which the Company is the primary beneficiary. Intercompany accounts and transactions have been eliminated.
	Closed block assets, liabilities, revenues and expenses are combined on a line-by-line basis with the assets, liabilities, revenues and expenses outside the closed block based on the nature of the particular item.
Fiscal Period	'
	Certain international subsidiaries have a fiscal year-end of November 30. Accordingly, the Company’s consolidated financial statements reflect the assets and liabilities of such subsidiaries as of November 30, 2013 and 2012 and the operating results of such subsidiaries for the years ended November 30, 2013, 2012 and 2011.
Discontinued Operations	'
	Discontinued Operations
	The results of operations of a component of the Company that has either been disposed of or is classified as held-for-sale are reported in discontinued operations if certain criteria are met. In order to qualify for a discontinued operation, the operations and cash flows of the component have been or will be eliminated from the ongoing operations of the Company, and the Company will not have any significant continuing involvement in the operations of the component after the disposal transaction.
Separate Accounts	'
	Separate Accounts
	Separate accounts are established in conformity with insurance laws and are generally not chargeable with liabilities that arise from any other business of the Company. Separate account assets are subject to general account claims only to the extent the value of such assets exceeds the separate account liabilities. The Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if:
	•	such separate accounts are legally recognized;
	•	assets supporting the contract liabilities are legally insulated from the Company’s general account liabilities;
	•	investments are directed by the contractholder; and
	•	all investment performance, net of contract fees and assessments, is passed through to the contractholder.
	The Company reports separate account assets at their fair value which is based on the estimated fair values of the underlying assets comprising the individual separate account portfolios. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line in the statements of operations. Separate accounts credited with a contractual investment return are combined on a line-by-line basis with the Company’s general account assets, liabilities, revenues and expenses and the accounting for these investments is consistent with the methodologies described herein for similar financial instruments held within the general account. Unit-linked separate account investments that are directed by contractholders but do not meet one or more of the other above criteria are included in fair value option (“FVO”) and trading securities.
	The Company’s revenues reflect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Such fees are included in universal life and investment-type product policy fees in the statements of operations.
Future Policy Benefit Liabilities and Policyholder Account Balances	'
	Future Policy Benefit Liabilities and Policyholder Account Balances
	The Company establishes liabilities for amounts payable under insurance policies. Generally, amounts are payable over an extended period of time and related liabilities are calculated as the present value of future expected benefits to be paid reduced by the present value of future expected premiums. Such liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy benefits are mortality, morbidity, policy lapse, renewal, retirement, disability incidence, disability terminations, investment returns, inflation, expenses and other contingent events as appropriate to the respective product type and geographical area. These assumptions are established at the time the policy is issued and are intended to estimate the experience for the period the policy benefits are payable. Utilizing these assumptions, liabilities are established on a block of business basis. For long duration insurance contracts, assumptions such as mortality, morbidity and interest rates are “locked in” upon the issuance of new business. However, significant adverse changes in experience on such contracts may require the establishment of premium deficiency reserves. Such reserves are determined based on the then current assumptions and do not include a provision for adverse deviation.
	Premium deficiency reserves may also be established for short duration contracts to provide for expected future losses. These reserves are based on actuarial estimates of the amount of loss inherent in that period, including losses incurred for which claims have not been reported. The provisions for unreported claims are calculated using studies that measure the historical length of time between the incurred date of a claim and its eventual reporting to the Company. Anticipated investment income is considered in the calculation of premium deficiency losses for short duration contracts.
	Liabilities for universal and variable life secondary guarantees and paid-up guarantees are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the accumulation period based on total expected assessments. The assumptions used in estimating the secondary and paid-up guarantee liabilities are consistent with those used for amortizing deferred policy acquisition costs (“DAC”), and are thus subject to the same variability and risk as further discussed herein. The assumptions of investment performance and volatility for variable products are consistent with historical experience of appropriate underlying equity indices, such as the Standard & Poor’s Ratings Services (“S&P”) 500 Index. The benefits used in calculating the liabilities are based on the average benefits payable over a range of scenarios.
	The Company regularly reviews its estimates of liabilities for future policy benefits and compares them with its actual experience. Differences result in changes to the liability balances with related charges or credits to benefit expenses in the period in which the changes occur.
	Policyholder account balances (“PABs”) relate to contract or contract features where the Company has no significant insurance risk.
	Future policy benefits are measured as follows:
	Product Type:	Measurement Assumptions:
	Participating life	Aggregate of (i) net level premium reserves for death and endowment policy benefits (calculated based upon the non-forfeiture interest rate, ranging from 3% to 7% for domestic business and 1% to 13% for international business, and mortality rates guaranteed in calculating the cash surrender values described in such contracts); and (ii) the liability for terminal dividends for domestic business.
	Nonparticipating life	Aggregate of the present value of expected future benefit payments and related expenses less the present value of expected future net premiums. Assumptions as to mortality and persistency are based upon the Company’s experience when the basis of the liability is established. Interest rate assumptions for the aggregate future policy benefit liabilities range from 2% to 10% for domestic business and 1% to 13% for international business.
	Individual and group	Present value of expected future payments. Interest rate assumptions used in establishing such liabilities range from 1% to 11% for domestic business and 1% to 12% for international business.
	traditional fixed annuities
	after annuitization
	Non-medical health	The net level premium method and assumptions as to future morbidity, withdrawals and interest, which provide a margin for adverse deviation. Interest rate assumptions used in establishing such liabilities range from 4% to 7% (primarily related to domestic business).
	insurance
	Disabled lives	Present value of benefits method and experience assumptions as to claim terminations, expenses and interest. Interest rate assumptions used in establishing such liabilities range from 2% to 8% for domestic business and 1% to 9% for international business.
	Property and casualty	The amount estimated for claims that have been reported but not settled and claims incurred but not reported are based upon the Company’s historical experience and other actuarial assumptions that consider the effects of current developments, anticipated trends and risk management programs, reduced for anticipated salvage and subrogation.
	insurance
	PABs are equal to: (i) policy account values, which consist of an accumulation of gross premium payments and investment performance; (ii) credited interest, ranging from 1% to 13% for domestic business and 1% to 12% for international business, less expenses, mortality charges and withdrawals; and (iii) fair value adjustments relating to business combinations.
Variable Annuity Guaranteed Minimum Benefits	'
	The Company issues directly and assumes through reinsurance certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (i.e., the benefit base) less withdrawals. These guarantees are accounted for as insurance liabilities or as embedded derivatives depending on how and when the benefit is paid. Specifically, a guarantee is accounted for as an embedded derivative if a guarantee is paid without requiring (i) the occurrence of specific insurable event, or (ii) the policyholder to annuitize. Alternatively, a guarantee is accounted for as an insurance liability if the guarantee is paid only upon either (i) the occurrence of a specific insurable event, or (ii) annuitization. In certain cases, a guarantee may have elements of both an insurance liability and an embedded derivative and in such cases the guarantee is split and accounted for under both models.
	Guarantees accounted for as insurance liabilities in future policy benefits include guaranteed minimum death benefits (“GMDBs”), the portion of guaranteed minimum income benefits (“GMIBs”) that require annuitization, and the life-contingent portion of guaranteed minimum withdrawal benefits (“GMWBs”).
	Guarantees accounted for as embedded derivatives in PABs include the non life-contingent portion of GMWBs, guaranteed minimum accumulation benefits (“GMABs”) and the portion of GMIBs that do not require annuitization. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent “excess” fees and are reported in universal life and investment-type product policy fees.
	The Company issues variable annuity products with guaranteed minimum benefits. The non-life contingent portion of GMWBs and the portion of certain GMIBs that does not require annuitization are accounted for as embedded derivatives in PABs and are further discussed in Note 9. Guarantees accounted for as insurance liabilities include:
	Guarantee:			Measurement Assumptions:
	GMDBs	Ÿ	A return of purchase payment upon death even if the account value is reduced to zero.	Ÿ	Present value of expected death benefits in excess of the projected account balance recognizing the excess ratably over the accumulation period based on the present value of total expected assessments.
		Ÿ	An enhanced death benefit may be available for an additional fee.	Ÿ	Assumptions are consistent with those used for amortizing DAC, and are thus subject to the same variability and risk.
				Ÿ	Investment performance and volatility assumptions are consistent with the historical experience of the appropriate underlying equity index, such as the S&P 500 Index.
				Ÿ	Benefit assumptions are based on the average benefits payable over a range of scenarios.
	GMIBs	Ÿ	After a specified period of time determined at the time of issuance of the variable annuity contract, a minimum accumulation of purchase payments, even if the account value is reduced to zero, that can be annuitized to receive a monthly income stream that is not less than a specified amount.	Ÿ	Present value of expected income benefits in excess of the projected account balance at any future date of annuitization and recognizing the excess ratably over the accumulation period based on present value of total expected assessments.
		Ÿ	Certain contracts also provide for a guaranteed lump sum return of purchase premium in lieu of the annuitization benefit.	Ÿ	Assumptions are consistent with those used for estimating GMDB liabilities.
				Ÿ	Calculation incorporates an assumption for the percentage of the potential annuitizations that may be elected by the contractholder.
	GMWBs	Ÿ	A return of purchase payment via partial withdrawals, even if the account value is reduced to zero, provided that cumulative withdrawals in a contract year do not exceed a certain limit.	Ÿ	Expected value of the life contingent payments and expected assessments using assumptions consistent with those used for estimating the GMDB liabilities.
		Ÿ	Certain contracts include guaranteed withdrawals that are life contingent.
	The Company also issues annuity contracts that apply a lower rate on funds deposited if the contractholder elects to surrender the contract for cash and a higher rate if the contractholder elects to annuitize (“two tier annuities”). These guarantees include benefits that are payable in the event of death, maturity or at annuitization. Additionally, the Company issues universal and variable life contracts where the Company contractually guarantees to the contractholder a secondary guarantee or a guaranteed paid-up benefit.
	The Company ceded the risk associated with certain of the GMIBs previously described. These reinsurance agreements contain embedded derivatives which are included within premiums, reinsurance and other receivables in the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses) or policyholder benefits and claims depending on the statement of operations classification of the direct risk. The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously for the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer.
	Embedded derivatives principally include certain direct, assumed and ceded variable annuity guarantees and equity or bond indexed crediting rates within certain funding agreements. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.
	The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within PABs in the consolidated balance sheets.
	The fair value of these embedded derivatives, estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior, is calculated by the Company’s actuarial department. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk free rates.
	Capital market assumptions, such as risk free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.
	The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife, Inc.’s debt, including related credit default swaps. These observable spreads are then adjusted, as necessary, to reflect the priority of these liabilities and the claims paying ability of the issuing insurance subsidiaries compared to MetLife, Inc.
	Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income.
Other Policy-Related Balances	'
	Other Policy-Related Balances
	Other policy-related balances include policy and contract claims, unearned revenue liabilities, premiums received in advance, policyholder dividends due and unpaid, policyholder dividends left on deposit and negative value of business acquired.
	The liability for policy and contract claims generally relates to incurred but not reported death, disability, long-term care (“LTC”) and dental claims, as well as claims which have been reported but not yet settled. The liability for these claims is based on the Company’s estimated ultimate cost of settling all claims. The Company derives estimates for the development of incurred but not reported claims principally from analyses of historical patterns of claims by business line. The methods used to determine these estimates are continually reviewed. Adjustments resulting from this continuous review process and differences between estimates and payments for claims are recognized in policyholder benefits and claims expense in the period in which the estimates are changed or payments are made.
	The unearned revenue liability relates to universal life-type and investment-type products and represents policy charges for services to be provided in future periods. The charges are deferred as unearned revenue and amortized using the product’s estimated gross profits and margins, similar to DAC as discussed further herein. Such amortization is recorded in universal life and investment-type product policy fees.
	The Company accounts for the prepayment of premiums on its individual life, group life and health contracts as premium received in advance and applies the cash received to premiums when due.
	For certain acquired blocks of business, the estimated fair value of the in-force contract obligations exceeded the book value of assumed in-force insurance policy liabilities, resulting in negative VOBA, which is presented separately from VOBA as an additional insurance liability. The fair value of the in-force contract obligations is based on projections by each block of business. Negative VOBA is amortized over the policy period in proportion to the approximate consumption of losses included in the liability usually expressed in terms of insurance in-force or account value. Such amortization is recorded as a contra-expense in other expenses.
Recognition of Insurance Revenues and Deposits	'
	Recognition of Insurance Revenues and Deposits
	Premiums related to traditional life, annuity policies with life contingencies, long-duration accident and health, and credit insurance policies are recognized as revenues when due from policyholders. Policyholder benefits and expenses are provided to recognize profits over the estimated lives of the insurance policies. When premiums are due over a significantly shorter period than the period over which benefits are provided, any excess profit is deferred and recognized into earnings in a constant relationship to insurance in-force or, for annuities, the amount of expected future policy benefit payments.
	Premiums related to short-duration non-medical health and disability, accident and health, and certain credit insurance contracts are recognized on a pro rata basis over the applicable contract term.
	Deposits related to universal life-type and investment-type products are credited to PABs. Revenues from such contracts consist of fees for mortality, policy administration and surrender charges and are recorded in universal life and investment-type product policy fees in the period in which services are provided. Amounts that are charged to earnings include interest credited and benefit claims incurred in excess of related PABs.
	Premiums related to property and casualty contracts are recognized as revenue on a pro rata basis over the applicable contract term. Unearned premiums, representing the portion of premium written related to the unexpired coverage, are also included in future policy benefits.
	Premiums, policy fees, policyholder benefits and expenses are presented net of reinsurance.
Deferred Policy Acquisition Costs and Value of Business Acquired	'
	Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles
	The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. Such costs include:
	•	incremental direct costs of contract acquisition, such as commissions;
	•	the portion of an employee’s total compensation and benefits related to time spent selling, underwriting or processing the issuance of new and renewal insurance business only with respect to actual policies acquired or renewed;
	•	other essential direct costs that would not have been incurred had a policy not been acquired or renewed; and
	•	in limited circumstances, the costs of direct-response advertising, the primary purpose of which is to elicit sales to customers who could be shown to have responded specifically to the advertising and that results in probable future benefits.
	All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred.
	Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity, and investment-type contracts in-force at the acquisition date. The estimated fair value of the acquired liabilities is based on projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns, nonperformance risk adjustment and other factors. Actual experience on the purchased business may vary from these projections.
	DAC and VOBA are amortized as follows:
	Products:			In proportion to the following over estimated lives of the contracts:
	•	Nonparticipating and non-dividend-paying traditional contracts:			Historic actual and expected future gross premiums.
		•	Term insurance
		•	Nonparticipating whole life insurance
		•	Traditional group life insurance
		•	Non-medical health insurance
		•	Accident and health insurance
	•	Participating, dividend-paying traditional contracts			Actual and expected future gross margins.
	•	Fixed and variable universal life contracts			Actual and expected future gross profits.
	•	Fixed and variable deferred annuity contracts
	•	Credit insurance contracts			Historic and future earned premium.
	•	Property and casualty insurance contracts
	•	Other short-duration contracts
	See Note 5 for additional information on DAC and VOBA amortization.
	The recovery of DAC and VOBA is dependent upon the future profitability of the related business. DAC and VOBA are aggregated in the financial statements for reporting purposes.
	Nonparticipating and Non-Dividend-Paying Traditional Contracts
	The Company amortizes DAC and VOBA related to these contracts (term insurance, nonparticipating whole life insurance, traditional group life insurance, non-medical health insurance, and accident and health insurance) over the appropriate premium paying period in proportion to the historic actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, morbidity, persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policyholder benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. Absent a premium deficiency, variability in amortization after policy issuance or acquisition is caused only by variability in premium volumes.
	Participating, Dividend-Paying Traditional Contracts
	The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross margins. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The future gross margins are dependent principally on investment returns, policyholder dividend scales, mortality, persistency, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inflation. For participating contracts within the closed block (dividend-paying traditional contracts) future gross margins are also dependent upon changes in the policyholder dividend obligation. See Note 7. Of these factors, the Company anticipates that investment returns, expenses, persistency and other factor changes, as well as policyholder dividend scales are reasonably likely to impact significantly the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross margins with the actual gross margins for that period. When the actual gross margins change from previously estimated gross margins, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross margins exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross margins are below the previously estimated gross margins. Each reporting period, the Company also updates the actual amount of business in-force, which impacts expected future gross margins. When expected future gross margins are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross margins are above the previously estimated expected future gross margins. Each period, the Company also reviews the estimated gross margins for each block of business to determine the recoverability of DAC and VOBA balances.
	Fixed and Variable Universal Life Contracts and Fixed and Variable Deferred Annuity Contracts
	The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties, the effect of any hedges used and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses and persistency are reasonably likely to impact significantly the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. Each period, the Company also reviews the estimated gross profits for each block of business to determine the recoverability of DAC and VOBA balances.
	Credit Insurance, Property and Casualty Insurance and Other Short-Duration Contracts
	The Company amortizes DAC for these contracts, which is primarily composed of commissions and certain underwriting expenses, in proportion to historic and future earned premium over the applicable contract term.
	Factors Impacting Amortization
	Separate account rates of return on variable universal life contracts and variable deferred annuity contracts affect in-force account balances on such contracts each reporting period, which can result in significant fluctuations in amortization of DAC and VOBA. Returns that are higher than the Company’s long-term expectation produce higher account balances, which increases the Company’s future fee expectations and decreases future benefit payment expectations on minimum death and living benefit guarantees, resulting in higher expected future gross profits. The opposite result occurs when returns are lower than the Company’s long-term expectation. The Company’s practice to determine the impact of gross profits resulting from returns on separate accounts assumes that long-term appreciation in equity markets is not changed by short-term market fluctuations, but is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes.
	The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These assumptions primarily relate to investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC and VOBA amortization will decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease.
	Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If such modification, referred to as an internal replacement, substantially changes the contract, the associated DAC or VOBA is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed.
	Amortization of DAC and VOBA is attributed to net investment gains (losses) and net derivative gains (losses), and to other expenses for the amount of gross margins or profits originating from transactions other than investment gains and losses. Unrealized investment gains and losses represent the amount of DAC and VOBA that would have been amortized if such gains and losses had been recognized.
Deferred Policy Acquisition Costs and Value of Business Acquired	'
	Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles
	The Company incurs significant costs in connection with acquiring new and renewal insurance business. Costs that are related directly to the successful acquisition or renewal of insurance contracts are capitalized as DAC. Such costs include:
	•	incremental direct costs of contract acquisition, such as commissions;
	•	the portion of an employee’s total compensation and benefits related to time spent selling, underwriting or processing the issuance of new and renewal insurance business only with respect to actual policies acquired or renewed;
	•	other essential direct costs that would not have been incurred had a policy not been acquired or renewed; and
	•	in limited circumstances, the costs of direct-response advertising, the primary purpose of which is to elicit sales to customers who could be shown to have responded specifically to the advertising and that results in probable future benefits.
	All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred.
	Value of business acquired (“VOBA”) is an intangible asset resulting from a business combination that represents the excess of book value over the estimated fair value of acquired insurance, annuity, and investment-type contracts in-force at the acquisition date. The estimated fair value of the acquired liabilities is based on projections, by each block of business, of future policy and contract charges, premiums, mortality and morbidity, separate account performance, surrenders, operating expenses, investment returns, nonperformance risk adjustment and other factors. Actual experience on the purchased business may vary from these projections.
	DAC and VOBA are amortized as follows:
	Products:			In proportion to the following over estimated lives of the contracts:
	•	Nonparticipating and non-dividend-paying traditional contracts:			Historic actual and expected future gross premiums.
		•	Term insurance
		•	Nonparticipating whole life insurance
		•	Traditional group life insurance
		•	Non-medical health insurance
		•	Accident and health insurance
	•	Participating, dividend-paying traditional contracts			Actual and expected future gross margins.
	•	Fixed and variable universal life contracts			Actual and expected future gross profits.
	•	Fixed and variable deferred annuity contracts
	•	Credit insurance contracts			Historic and future earned premium.
	•	Property and casualty insurance contracts
	•	Other short-duration contracts
	See Note 5 for additional information on DAC and VOBA amortization.
	The recovery of DAC and VOBA is dependent upon the future profitability of the related business. DAC and VOBA are aggregated in the financial statements for reporting purposes.
	Nonparticipating and Non-Dividend-Paying Traditional Contracts
	The Company amortizes DAC and VOBA related to these contracts (term insurance, nonparticipating whole life insurance, traditional group life insurance, non-medical health insurance, and accident and health insurance) over the appropriate premium paying period in proportion to the historic actual and expected future gross premiums that were set at contract issue. The expected premiums are based upon the premium requirement of each policy and assumptions for mortality, morbidity, persistency and investment returns at policy issuance, or policy acquisition (as it relates to VOBA), include provisions for adverse deviation, and are consistent with the assumptions used to calculate future policyholder benefit liabilities. These assumptions are not revised after policy issuance or acquisition unless the DAC or VOBA balance is deemed to be unrecoverable from future expected profits. Absent a premium deficiency, variability in amortization after policy issuance or acquisition is caused only by variability in premium volumes.
	Participating, Dividend-Paying Traditional Contracts
	The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross margins. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The future gross margins are dependent principally on investment returns, policyholder dividend scales, mortality, persistency, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inflation. For participating contracts within the closed block (dividend-paying traditional contracts) future gross margins are also dependent upon changes in the policyholder dividend obligation. See Note 7. Of these factors, the Company anticipates that investment returns, expenses, persistency and other factor changes, as well as policyholder dividend scales are reasonably likely to impact significantly the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross margins with the actual gross margins for that period. When the actual gross margins change from previously estimated gross margins, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross margins exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross margins are below the previously estimated gross margins. Each reporting period, the Company also updates the actual amount of business in-force, which impacts expected future gross margins. When expected future gross margins are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross margins are above the previously estimated expected future gross margins. Each period, the Company also reviews the estimated gross margins for each block of business to determine the recoverability of DAC and VOBA balances.
	Fixed and Variable Universal Life Contracts and Fixed and Variable Deferred Annuity Contracts
	The Company amortizes DAC and VOBA related to these contracts over the estimated lives of the contracts in proportion to actual and expected future gross profits. The amortization includes interest based on rates in effect at inception or acquisition of the contracts. The amount of future gross profits is dependent principally upon returns in excess of the amounts credited to policyholders, mortality, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties, the effect of any hedges used and certain economic variables, such as inflation. Of these factors, the Company anticipates that investment returns, expenses and persistency are reasonably likely to impact significantly the rate of DAC and VOBA amortization. Each reporting period, the Company updates the estimated gross profits with the actual gross profits for that period. When the actual gross profits change from previously estimated gross profits, the cumulative DAC and VOBA amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. When actual gross profits exceed those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the actual gross profits are below the previously estimated gross profits. Each reporting period, the Company also updates the actual amount of business remaining in-force, which impacts expected future gross profits. When expected future gross profits are below those previously estimated, the DAC and VOBA amortization will increase, resulting in a current period charge to earnings. The opposite result occurs when the expected future gross profits are above the previously estimated expected future gross profits. Each period, the Company also reviews the estimated gross profits for each block of business to determine the recoverability of DAC and VOBA balances.
	Credit Insurance, Property and Casualty Insurance and Other Short-Duration Contracts
	The Company amortizes DAC for these contracts, which is primarily composed of commissions and certain underwriting expenses, in proportion to historic and future earned premium over the applicable contract term.
	Factors Impacting Amortization
	Separate account rates of return on variable universal life contracts and variable deferred annuity contracts affect in-force account balances on such contracts each reporting period, which can result in significant fluctuations in amortization of DAC and VOBA. Returns that are higher than the Company’s long-term expectation produce higher account balances, which increases the Company’s future fee expectations and decreases future benefit payment expectations on minimum death and living benefit guarantees, resulting in higher expected future gross profits. The opposite result occurs when returns are lower than the Company’s long-term expectation. The Company’s practice to determine the impact of gross profits resulting from returns on separate accounts assumes that long-term appreciation in equity markets is not changed by short-term market fluctuations, but is only changed when sustained interim deviations are expected. The Company monitors these events and only changes the assumption when its long-term expectation changes.
	The Company also periodically reviews other long-term assumptions underlying the projections of estimated gross margins and profits. These assumptions primarily relate to investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency and expenses to administer business. Management annually updates assumptions used in the calculation of estimated gross margins and profits which may have significantly changed. If the update of assumptions causes expected future gross margins and profits to increase, DAC and VOBA amortization will decrease, resulting in a current period increase to earnings. The opposite result occurs when the assumption update causes expected future gross margins and profits to decrease.
	Periodically, the Company modifies product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. If such modification, referred to as an internal replacement, substantially changes the contract, the associated DAC or VOBA is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC or VOBA amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed.
	Amortization of DAC and VOBA is attributed to net investment gains (losses) and net derivative gains (losses), and to other expenses for the amount of gross margins or profits originating from transactions other than investment gains and losses. Unrealized investment gains and losses represent the amount of DAC and VOBA that would have been amortized if such gains and losses had been recognized.
Deferred Sales Inducements	'
	The Company generally has two different types of sales inducements which are included in other assets: (i) the policyholder receives a bonus whereby the policyholder’s initial account balance is increased by an amount equal to a specified percentage of the customer’s deposit; and (ii) the policyholder receives a higher interest rate using a dollar cost averaging method than would have been received based on the normal general account interest rate credited. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. The amortization of sales inducements is included in policyholder benefits and claims. Each year, or more frequently if circumstances indicate a potential recoverability issue exists, the Company reviews deferred sales inducements to determine the recoverability of the asset.
Value of Distribution Agreements and Customer Relationships Acquired	'
	Value of distribution agreements acquired (“VODA”) is reported in other assets and represents the present value of expected future profits associated with the expected future business derived from the distribution agreements acquired as part of a business combination. Value of customer relationships acquired (“VOCRA”) is also reported in other assets and represents the present value of the expected future profits associated with the expected future business acquired through existing customers of the acquired company or business. The VODA and VOCRA associated with past business combinations are amortized over useful lives ranging from 10 to 40 years and such amortization is included in other expenses. Each year, or more frequently if circumstances indicate a possible impairment exists, the Company reviews VODA and VOCRA to determine whether the asset is impaired.
Reinsurance	'
	Reinsurance
	For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The Company reviews all contractual features, including those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims.
	For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid (received), and the liabilities ceded (assumed) related to the underlying contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is recorded as an adjustment to DAC and recognized as a component of other expenses on a basis consistent with the way the acquisition costs on the underlying reinsured contracts would be recognized. Subsequent amounts paid (received) on the reinsurance of in-force blocks, as well as amounts paid (received) related to new business, are recorded as ceded (assumed) premiums; and ceded (assumed) premiums, reinsurance and other receivables (future policy benefits) are established.
	For prospective reinsurance of short-duration contracts that meet the criteria for reinsurance accounting, amounts paid (received) are recorded as ceded (assumed) premiums and ceded (assumed) unearned premiums. Unearned premiums are reflected as a component of premiums, reinsurance and other receivables (future policy benefits). Such amounts are amortized through earned premiums over the remaining contract period in proportion to the amount of insurance protection provided. For retroactive reinsurance of short-duration contracts that meet the criteria of reinsurance accounting, amounts paid (received) in excess of the related insurance liabilities ceded (assumed) are recognized immediately as a loss and are reported in the appropriate line item within the statement of operations. Any gain on such retroactive agreement is deferred and is amortized as part of DAC, primarily using the recovery method.
	Amounts currently recoverable under reinsurance agreements are included in premiums, reinsurance and other receivables and amounts currently payable are included in other liabilities. Assets and liabilities relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance.
	Premiums, fees and policyholder benefits and claims include amounts assumed under reinsurance agreements and are net of reinsurance ceded. Amounts received from reinsurers for policy administration are reported in other revenues. With respect to GMIBs, a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. These embedded derivatives are included in premiums, reinsurance and other receivables with changes in estimated fair value reported in policyholder benefits and claims.
	If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. Periodically, the Company evaluates the adequacy of the expected payments or recoveries and adjusts the deposit asset or liability through other revenues or other expenses, as appropriate.
	The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products and also as a provider of reinsurance for some insurance products issued by third parties.
	Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the financial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed in Note 8.
Investments	'
	Investments
	Net Investment Income and Net Investment Gains (Losses)
	Income on investments is reported within net investment income, unless otherwise stated herein. Gains and losses on sales of investments, impairment losses and changes in valuation allowances are reported within net investment gains (losses), unless otherwise stated herein.
	Fixed Maturity and Equity Securities
	The majority of the Company’s fixed maturity and equity securities are classified as available-for-sale (“AFS”) and are reported at their estimated fair value. Unrealized investment gains and losses on these securities are recorded as a separate component of other comprehensive income (loss) (“OCI”), net of policyholder-related amounts and deferred income taxes. All security transactions are recorded on a trade date basis. Investment gains and losses on sales are determined on a specific identification basis.
	Interest income on fixed maturity securities is recognized when earned using an effective yield method giving effect to amortization of premiums and accretion of discounts. Prepayment fees are recognized when earned. Dividends on equity securities are recognized when declared.
	The Company periodically evaluates fixed maturity and equity securities for impairment. The assessment of whether impairments have occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in estimated fair value, as well as an analysis of the gross unrealized losses by severity and/or age as described in Note 8 “— Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities.”
	For fixed maturity securities in an unrealized loss position, an other-than-temporary impairment (“OTTI”) is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exist, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings (“credit loss”). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors (“noncredit loss”) is recorded in OCI.
	With respect to equity securities, the Company considers in its OTTI analysis its intent and ability to hold a particular equity security for a period of time sufficient to allow for the recovery of its estimated fair value to an amount equal to or greater than cost. If a sale decision is made for an equity security and recovery to an amount at least equal to cost prior to the sale is not expected, the security will be deemed to be other-than-temporarily impaired in the period that the sale decision was made and an OTTI loss will be recorded in earnings. The OTTI loss recognized is the entire difference between the security’s cost and its estimated fair value.
	FVO and Trading Securities
	FVO and trading securities are stated at estimated fair value and include investments for which the FVO has been elected (“FVO Securities”) and investments that are actively purchased and sold (“Actively Traded Securities”). FVO Securities include:
	•	fixed maturity and equity securities held-for-investment by the general account to support asset and liability management strategies for certain insurance products and investments in certain separate accounts (“FVO general account securities”);
	•	contractholder-directed investments supporting unit-linked variable annuity type liabilities which do not qualify for presentation and reporting as separate account summary total assets and liabilities. These investments are primarily mutual funds and, to a lesser extent, fixed maturity and equity securities, short-term investments and cash and cash equivalents. The investment returns on these investments inure to contractholders and are offset by a corresponding change in PABs through interest credited to policyholder account balances (“FVO contractholder-directed unit-linked investments”); and
	•	securities held by consolidated securitization entities (“CSEs”) (“FVO securities held by CSEs”).
	Actively Traded Securities principally include fixed maturity securities and short sale agreement liabilities, which are included in other liabilities.
	Changes in estimated fair value of these securities are included in net investment income, except for certain securities included in FVO Securities where changes are included in net investment gains (losses).
	Mortgage Loans
	The Company disaggregates its mortgage loan investments into three portfolio segments: commercial, agricultural, and residential. The accounting policies that are applicable to all portfolio segments are presented below and the accounting policies related to each of the portfolio segments are included in Note 8.
	Mortgage Loans Held-For-Investment
	Mortgage loans held-for-investment are stated at unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses, and are net of valuation allowances. Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts.
	Also included in mortgage loans held-for-investment are commercial mortgage loans held by CSEs and residential mortgage loans for which the FVO was elected. These mortgage loans are stated at estimated fair value. Changes in estimated fair value are recognized in net investment gains (losses) for commercial mortgage loans held by CSEs — FVO, and net investment income for residential mortgage loans.
	Mortgage Loans Held-For-Sale
	Mortgage loans held-for-sale that were previously designated as held-for-investment, but now are designated as held-for-sale and mortgage loans originated with the intent to sell for which FVO was not elected, are stated at the lower of amortized cost or estimated fair value.
	Policy Loans
	Policy loans are stated at unpaid principal balances. Interest income on such loans is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy’s anniversary date. Valuation allowances are not established for policy loans, as they are fully collateralized by the cash surrender value of the underlying insurance policies. Any unpaid principal or interest on the loan is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy.
	Real Estate
	Real estate held-for-investment is stated at cost less accumulated depreciation. Depreciation is provided on a straight-line basis over the estimated useful life of the asset (typically 20 to 55 years). Rental income associated with such real estate is recognized on a straight-line basis over the term of the respective leases. The Company periodically reviews its real estate held-for-investment for impairment and tests for recoverability whenever events or changes in circumstances indicate the carrying value may not be recoverable and exceeds its estimated fair value. Properties whose carrying values are greater than their undiscounted cash flows are written down to their estimated fair value, which is generally computed using the present value of expected future cash flows discounted at a rate commensurate with the underlying risks.
	Real estate for which the Company commits to a plan to sell within one year and actively markets in its current condition for a reasonable price in comparison to its estimated fair value is classified as held-for-sale. Real estate held-for-sale is stated at the lower of depreciated cost or estimated fair value less expected disposition costs and is not depreciated.
	Real Estate Joint Ventures and Other Limited Partnership Interests
	The Company uses the equity method of accounting for investments in equity securities when it has significant influence or at least 20% interest and for investments in real estate joint ventures and other limited partnership interests (“investees”) when it has more than a minor ownership interest or more than a minor influence over the investee’s operations, but does not have a controlling financial interest. The Company generally recognizes its share of the investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period.
	The Company uses the cost method of accounting for investments in which it has virtually no influence over the investee’s operations. The Company recognizes distributions on cost method investments as earned or received. Because of the nature and structure of these cost method investments, they do not meet the characteristics of an equity security in accordance with applicable accounting standards.
	The Company routinely evaluates its equity method and cost method investments for impairment. For equity method investees, the Company considers financial and other information provided by the investee, other known information and inherent risks in the underlying investments, as well as future capital commitments, in determining whether an impairment has occurred. The Company considers its cost method investments for impairment when the carrying value of such investments exceeds the net asset value (“NAV”). The Company takes into consideration the severity and duration of this excess when determining whether the cost method investment is impaired.
	Short-term Investments
	Short-term investments include securities and other investments with remaining maturities of one year or less, but greater than three months, at the time of purchase and are stated at estimated fair value or amortized cost, which approximates estimated fair value.
	Other Invested Assets
	Other invested assets consist principally of the following:
	•	Freestanding derivatives with positive estimated fair values are described in “— Derivatives” below.
	•	Tax credit and renewable energy partnerships derive a significant source of investment return in the form of income tax credits or other tax incentives. Where tax credits are guaranteed by a creditworthy third party, the investment is accounted for under the effective yield method. Otherwise, the investment is accounted for under the equity method.
	•	Leveraged leases are recorded net of non-recourse debt. Income on leveraged leases is recognized by applying the leveraged lease’s estimated rate of return to the net investment in the lease. The Company regularly reviews residual values for impairment.
	•	Funds withheld represent a receivable for amounts contractually withheld by ceding companies in accordance with reinsurance agreements. The Company recognizes interest on funds withheld at rates defined by the terms of the agreement which may be contractually specified or directly related to the underlying investments.
	•	Investments in joint ventures that engage in insurance underwriting activities are accounted for under the equity method.
	Securities Lending Program
	Securities lending transactions, whereby blocks of securities are loaned to third parties, primarily brokerage firms and commercial banks, are treated as financing arrangements and the associated liability is recorded at the amount of cash received. The Company obtains collateral at the inception of the loan, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned, and maintains it at a level greater than or equal to 100% for the duration of the loan. The Company is liable to return to the counterparties the cash collateral received. Security collateral on deposit from counterparties in connection with the securities lending transactions may not be sold or repledged, unless the counterparty is in default, and is not reflected in the financial statements. The Company monitors the estimated fair value of the securities loaned on a daily basis and additional collateral is obtained as necessary. Income and expenses associated with securities lending transactions are reported as investment income and investment expense, respectively, within net investment income.
	Amortization of premium and accretion of discount on structured securities considers the estimated timing and amount of prepayments of the underlying loans. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the originally anticipated and the actual prepayments received and currently anticipated. Prepayment assumptions for single class and multi-class mortgage-backed and ABS are estimated using inputs obtained from third-party specialists and based on management’s knowledge of the current market. For credit-sensitive mortgage-backed and ABS and certain prepayment-sensitive securities, the effective yield is recalculated on a prospective basis. For all other mortgage-backed and ABS, the effective yield is recalculated on a retrospective basis.
	Investment Risks and Uncertainties
	Investments are exposed to the following primary sources of risk: credit, interest rate, liquidity, market valuation, currency and real estate risk. The financial statement risks, stemming from such investment risks, are those associated with the determination of estimated fair values, the diminished ability to sell certain investments in times of strained market conditions, the recognition of impairments, the recognition of income on certain investments and the potential consolidation of VIEs. The use of different methodologies, assumptions and inputs relating to these financial statement risks may have a material effect on the amounts presented within the consolidated financial statements.
	The determination of valuation allowances and impairments is highly subjective and is based upon periodic evaluations and assessments of known and inherent risks associated with the respective asset class. Such evaluations and assessments are revised as conditions change and new information becomes available.
	The recognition of income on certain investments (e.g. structured securities, including mortgage-backed securities, asset-backed securities (“ABS”), certain structured investment transactions and FVO and trading securities) is dependent upon certain factors such as prepayments and defaults, and changes in such factors could result in changes in amounts to be earned.
	Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. RMBS, CMBS and ABS are shown separately, as they are not due at a single maturity.
	Evaluation and Measurement Methodologies
	Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below cost or amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) with respect to fixed maturity securities, whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to structured securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; and (viii) other subjective factors, including concentrations and information obtained from regulators and rating agencies.
	The methodology and significant inputs used to determine the amount of credit loss on fixed maturity securities are as follows:
	•	The Company calculates the recovery value by performing a discounted cash flow analysis based on the present value of future cash flows. The discount rate is generally the effective interest rate of the security prior to impairment.
	•	When determining collectability and the period over which value is expected to recover, the Company applies considerations utilized in its overall impairment evaluation process which incorporates information regarding the specific security, fundamentals of the industry and geographic area in which the security issuer operates, and overall macroeconomic conditions. Projected future cash flows are estimated using assumptions derived from management’s best estimates of likely scenario-based outcomes after giving consideration to a variety of variables that include, but are not limited to: payment terms of the security; the likelihood that the issuer can service the interest and principal payments; the quality and amount of any credit enhancements; the security’s position within the capital structure of the issuer; possible corporate restructurings or asset sales by the issuer; and changes to the rating of the security or the issuer by rating agencies.
	•	Additional considerations are made when assessing the unique features that apply to certain structured securities including, but not limited to: the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying loans or assets backing a particular security, and the payment priority within the tranche structure of the security.
	•	When determining the amount of the credit loss for U.S. and foreign corporate securities, foreign government securities and state and political subdivision securities, the estimated fair value is considered the recovery value when available information does not indicate that another value is more appropriate. When information is identified that indicates a recovery value other than estimated fair value, management considers in the determination of recovery value the same considerations utilized in its overall impairment evaluation process as described above, as well as any private and public sector programs to restructure such securities.
	With respect to securities that have attributes of debt and equity (perpetual hybrid securities), consideration is given in the OTTI analysis as to whether there has been any deterioration in the credit of the issuer and the likelihood of recovery in value of the securities that are in a severe and extended unrealized loss position. Consideration is also given as to whether any perpetual hybrid securities, with an unrealized loss, regardless of credit rating, have deferred any dividend payments. When an OTTI loss has occurred, the OTTI loss is the entire difference between the perpetual hybrid security’s cost and its estimated fair value with a corresponding charge to earnings.
	The cost or amortized cost of fixed maturity and equity securities is adjusted for OTTI in the period in which the determination is made. The Company does not change the revised cost basis for subsequent recoveries in value.
	In periods subsequent to the recognition of OTTI on a fixed maturity security, the Company accounts for the impaired security as if it had been purchased on the measurement date of the impairment. Accordingly, the discount (or reduced premium) based on the new cost basis is accreted over the remaining term of the fixed maturity security in a prospective manner based on the amount and timing of estimated future cash flows.
	Valuation Allowance Methodology
	Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for all three portfolio segments as the excess carrying value of a loan over either (i) the present value of expected future cash flows discounted at the loan’s original effective interest rate, (ii) the estimated fair value of the loan’s underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan’s observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for all loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company’s experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.
	Commercial and Agricultural Mortgage Loan Portfolio Segments
	The Company typically uses several years of historical experience in establishing non-specific valuation allowances which captures multiple economic cycles. For evaluations of commercial mortgage loans, in addition to historical experience, management considers factors that include the impact of a rapid change to the economy, which may not be reflected in the loan portfolio, and recent loss and recovery trend experience as compared to historical loss and recovery experience. For evaluations of agricultural mortgage loans, in addition to historical experience, management considers factors that include increased stress in certain sectors, which may be evidenced by higher delinquency rates, or a change in the number of higher risk loans. On a quarterly basis, management incorporates the impact of these current market events and conditions on historical experience in determining the non-specific valuation allowance established for commercial and agricultural mortgage loans.
All commercial mortgage loans are reviewed on an ongoing basis which may include an analysis of the property financial statements and rent roll, lease rollover analysis, property inspections, market analysis, estimated valuations of the underlying collateral, loan-to-value ratios, debt service coverage ratios, and tenant creditworthiness. All agricultural mortgage loans are monitored on an ongoing basis. The monitoring process focuses on higher risk loans, which include those that are classified as restructured, delinquent or in foreclosure, as well as loans with higher loan-to-value ratios and lower debt service coverage ratios. The monitoring process for agricultural mortgage loans is generally similar to the commercial mortgage loan monitoring process, with a focus on higher risk loans, including reviews on a geographic and property-type basis. Higher risk loans are reviewed individually on an ongoing basis for potential credit loss and specific valuation allowances are established using the methodology described above. Quarterly, the remaining loans are reviewed on a pool basis by aggregating groups of loans that have similar risk characteristics for potential credit loss, and non-specific valuation allowances are established as described above using inputs that are unique to each segment of the loan portfolio.
For commercial mortgage loans, the primary credit quality indicator is the debt service coverage ratio, which compares a property’s net operating income to amounts needed to service the principal and interest due under the loan. Generally, the lower the debt service coverage ratio, the higher the risk of experiencing a credit loss. The Company also reviews the loan-to-value ratio of its commercial mortgage loan portfolio. Loan-to-value ratios compare the unpaid principal balance of the loan to the estimated fair value of the underlying collateral. Generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss. The debt service coverage ratio and loan-to-value ratio, as well as the values utilized in calculating these ratios, are updated annually, on a rolling basis, with a portion of the loan portfolio updated each quarter.
For agricultural mortgage loans, the Company’s primary credit quality indicator is the loan-to-value ratio. The values utilized in calculating this ratio are developed in connection with the ongoing review of the agricultural mortgage loan portfolio and are routinely updated.
Residential Mortgage Loan Portfolio Segment
The Company’s residential mortgage loan portfolio is comprised primarily of closed end, amortizing residential mortgage loans. For evaluations of residential mortgage loans, the key inputs of expected frequency and expected loss reflect current market conditions, with expected frequency adjusted, when appropriate, for differences from market conditions and the Company’s historical experience. In contrast to the commercial and agricultural mortgage loan portfolios, residential mortgage loans are smaller-balance homogeneous loans that are collectively evaluated for impairment. Non-specific valuation allowances are established using the evaluation framework described above for pools of loans with similar risk characteristics from inputs that are unique to the residential segment of the loan portfolio. Loan specific valuation allowances are only established on residential mortgage loans when they have been restructured and are established using the methodology described above for all loan portfolio segments.
For residential mortgage loans, the Company’s primary credit quality indicator is whether the loan is performing or nonperforming. The Company generally defines nonperforming residential mortgage loans as those that are 60 or more days past due and/or in non-accrual status which is assessed monthly. Generally, nonperforming residential mortgage loans have a higher risk of experiencing a credit loss.
Mortgage Loans Modified in a Troubled Debt Restructuring
For a small portion of the mortgage loan portfolio, classified as troubled debt restructurings, concessions are granted related to borrowers experiencing financial difficulties. Generally, the types of concessions include: reduction of the contractual interest rate, extension of the maturity date at an interest rate lower than current market interest rates, and/or a reduction of accrued interest. The amount, timing and extent of the concession granted is considered in determining any impairment or changes in the specific valuation allowance recorded with the restructuring. Through the continuous monitoring process, a specific valuation allowance may have been recorded prior to the quarter when the mortgage loan is modified in a troubled debt restructuring. Accordingly, the carrying value (after specific valuation allowance) before and after modification through a troubled debt restructuring may not change significantly, or may increase if the expected recovery is higher than the pre-modification recovery assessment.
Past Due and Interest Accrual Status of Mortgage Loans
The Company has a high quality, well performing mortgage loan portfolio, with 99% of all mortgage loans classified as performing at both December 31, 2013 and 2012. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days.
Rental receivables are generally due in periodic installments. The payment periods range from one to 15 years but in certain circumstances can be over 30 years. For rental receivables, the primary credit quality indicator is whether the rental receivable is performing or nonperforming, which is assessed monthly. The Company generally defines nonperforming rental receivables as those that are 90 days or more past due.
Purchased Credit Impaired Investments
Investments acquired with evidence of credit quality deterioration since origination and for which it is probable at the acquisition date that the Company will be unable to collect all contractually required payments are classified as purchased credit impaired (“PCI”) investments. For each investment, the excess of the cash flows expected to be collected as of the acquisition date over its acquisition date fair value is referred to as the accretable yield and is recognized as net investment income on an effective yield basis. If subsequently, based on current information and events, it is probable that there is a significant increase in cash flows previously expected to be collected or if actual cash flows are significantly greater than cash flows previously expected to be collected, the accretable yield is adjusted prospectively. The excess of the contractually required payments (including interest) as of the acquisition date over the cash flows expected to be collected as of the acquisition date is referred to as the nonaccretable difference, and this amount is not expected to be realized as net investment income. Decreases in cash flows expected to be collected can result in OTTI or the recognition of mortgage loan valuation allowances.
Variable Interest Entities
The Company has invested in certain structured transactions (including CSEs), formed trusts to invest proceeds from certain collateral financing arrangements and has insurance operations that are VIEs. In certain instances, the Company holds both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, is deemed to be the primary beneficiary or consolidator of the entity.
The determination of the VIE’s primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party’s relationship with or involvement in the entity, an estimate of the entity’s expected losses and expected residual returns and the allocation of such estimates to each party involved in the entity. The Company generally uses a qualitative approach to determine whether it is the primary beneficiary. However, for VIEs that are investment companies or apply measurement principles consistent with those utilized by investment companies, the primary beneficiary is based on a risks and rewards model and is defined as the entity that will absorb a majority of a VIE’s expected losses, receive a majority of a VIE’s expected residual returns if no single entity absorbs a majority of expected losses, or both. The Company reassesses its involvement with VIEs on a quarterly basis. The use of different methodologies, assumptions and inputs in the determination of the primary beneficiary could have a material effect on the amounts presented within the consolidated financial statements.
Derivatives	'
	Derivatives
	Freestanding Derivatives
	Freestanding derivatives are carried in the Company’s balance sheets either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.
	Accruals on derivatives are generally recorded in accrued investment income or within other liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in other invested assets or other liabilities.
	If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses) except as follows:
	Statement of Operations Presentation:	Derivative:
	Policyholder benefits and claims	•	Economic hedges of variable annuity guarantees included in future policy benefits
	Net investment income	•	Economic hedges of equity method investments in joint ventures
		•	All derivatives held in relation to trading portfolios
		•	Derivatives held within contractholder-directed unit-linked investments
	Other revenues	•	Derivatives held in connection with the Company’s previous mortgage banking activities
	Hedge Accounting
	To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. Hedge designation and financial statement presentation of changes in estimated fair value of the hedging derivatives are as follows:
	•	Fair value hedge (a hedge of the estimated fair value of a recognized asset or liability) - in net derivative gains (losses), consistent with the change in fair value of the hedged item attributable to the designated risk being hedged.
	•	Cash flow hedge (a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability) - effectiveness in OCI (deferred gains or losses on the derivative are reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item); ineffectiveness in net derivative gains (losses).
	•	Net investment in a foreign operation hedge - effectiveness in OCI, consistent with the translation adjustment for the hedged net investment in the foreign operation; ineffectiveness in net derivative gains (losses).
	The changes in estimated fair values of the hedging derivatives are exclusive of any accruals that are separately reported in the statement of operations within interest income or interest expense to match the location of the hedged item. Accruals on derivatives in net investment hedges are recognized in OCI.
	In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. Assessments of hedge effectiveness and measurements of ineffectiveness are also subject to interpretation and estimation and different interpretations or estimates may have a material effect on the amount reported in net income.
	The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.
	When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried in the balance sheets at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statements of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.
	When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date or within two months of that date, the derivative continues to be carried in the balance sheets at its estimated fair value, with changes in estimated fair value recognized currently in net derivative gains (losses). Deferred gains and losses of a derivative recorded in OCI pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in net derivative gains (losses).
	In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value in the balance sheets, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).
	Embedded Derivatives
	The Company sells variable annuities and issues certain insurance products and investment contracts and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if:
	•	the combined instrument is not accounted for in its entirety at fair value with changes in fair value recorded in earnings;
	•	the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and
	•	a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument.
	Such embedded derivatives are carried in the balance sheets at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses) except for those in policyholder benefits and claims related to ceded reinsurance of GMIB. If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income. Additionally, the Company may elect to carry an entire contract on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income if that contract contains an embedded derivative that requires bifurcation. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent “excess” fees and are reported in universal life and investment-type product policy fees.
	Derivatives are financial instruments whose values are derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. To a lesser extent, the Company uses credit default swaps and structured interest rate swaps to synthetically replicate investment risks and returns which are not readily available in the cash market.
	The Company designates and accounts for the following as fair value hedges when they have met the requirements of fair value hedging: (i) interest rate swaps to convert fixed rate assets and liabilities to floating rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated assets and liabilities; and (iii) foreign currency forwards to hedge the foreign currency fair value exposure of foreign currency denominated investments.
	The Company designates and accounts for the following as cash flow hedges when they have met the requirements of cash flow hedging: (i) interest rate swaps to convert floating rate assets and liabilities to fixed rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated assets and liabilities; (iii) interest rate forwards and credit forwards to lock in the price to be paid for forward purchases of investments; (iv) interest rate swaps and interest rate forwards to hedge the forecasted purchases of fixed-rate investments; and (v) interest rate swaps and interest rate forwards to hedge forecasted fixed-rate borrowings.
	The Company uses foreign currency exchange rate derivatives, which may include foreign currency forwards and currency options, to hedge portions of its net investments in foreign operations against adverse movements in exchange rates. The Company measures ineffectiveness on these derivatives based upon the change in forward rates. In addition, the Company may also use non-derivative financial instruments to hedge portions of its net investments in foreign operations against adverse movements in exchange rates. The Company measures ineffectiveness on non-derivative financial instruments based upon the change in spot rates.
	When net investments in foreign operations are sold or substantially liquidated, the amounts in AOCI are reclassified to the consolidated statements of operations.
	The Company may be exposed to credit-related losses in the event of nonperformance by counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.
Fair Value	'
	Fair Value
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In most cases, the exit price and the transaction (or entry) price will be the same at initial recognition.
	Subsequent to initial recognition, fair values are based on unadjusted quoted prices for identical assets or liabilities in active markets that are readily and regularly obtainable. When such quoted prices are not available, fair values are based on quoted prices in markets that are not active, quoted prices for similar but not identical assets or liabilities, or other observable inputs. If these inputs are not available, or observable inputs are not determinable, unobservable inputs and/or adjustments to observable inputs requiring management judgment are used to determine the estimated fair value of assets and liabilities.
	When developing estimated fair values, the Company considers three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given what is being measured and the availability of sufficient inputs, giving priority to observable inputs. The Company categorizes its assets and liabilities measured at estimated fair value into a three-level hierarchy, based on the significant input with the lowest level in its valuation. The input levels are as follows:
	Level 1	Unadjusted quoted prices in active markets for identical assets or liabilities. The Company defines active markets based on average trading volume for equity securities. The size of the bid/ask spread is used as an indicator of market activity for fixed maturity securities.
	Level 2	Quoted prices in markets that are not active or inputs that are observable either directly or indirectly. These inputs can include quoted prices for similar assets or liabilities other than quoted prices in Level 1, quoted prices in markets that are not active, or other significant inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3	Unobservable inputs that are supported by little or no market activity and are significant to the determination of estimated fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.
	Financial markets are susceptible to severe events evidenced by rapid depreciation in asset values accompanied by a reduction in asset liquidity. The Company’s ability to sell securities, or the price ultimately realized for these securities, depends upon the demand and liquidity in the market and increases the use of judgment in determining the estimated fair value of certain securities.
	Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.
Goodwill	'
	Goodwill
	Goodwill represents the future economic benefits arising from net assets acquired in a business combination that are not individually identified and recognized. Goodwill is calculated as the excess of cost over the estimated fair value of such net assets acquired, is not amortized, and is tested for impairment based on a fair value approach at least annually or more frequently if events or circumstances indicate that there may be justification for conducting an interim test. The Company performs its annual goodwill impairment testing during the third quarter of each year based upon data as of the close of the second quarter. Goodwill associated with a business acquisition is not tested for impairment during the year the business is acquired unless there is a significant identified impairment event.
	The impairment test is performed at the reporting unit level, which is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level. For purposes of goodwill impairment testing, if the carrying value of a reporting unit exceeds its estimated fair value, there may be an indication of impairment. In such instances, the implied fair value of the goodwill is determined in the same manner as the amount of goodwill that would be determined in a business combination. The excess of the carrying value of goodwill over the implied fair value of goodwill would be recognized as an impairment and recorded as a charge against net income.
	On an ongoing basis, the Company evaluates potential triggering events that may affect the estimated fair value of the Company’s reporting units to assess whether any goodwill impairment exists. Deteriorating or adverse market conditions for certain reporting units may have a significant impact on the estimated fair value of these reporting units and could result in future impairments of goodwill.
	Goodwill is the excess of cost over the estimated fair value of net assets acquired. Goodwill is not amortized but is tested for impairment at least annually or more frequently if events or circumstances, such as adverse changes in the business climate, indicate that there may be justification for conducting an interim test. Step 1 of the goodwill impairment process requires a comparison of the fair value of a reporting unit to its carrying value. In performing the Company’s goodwill impairment tests, the estimated fair values of the reporting units are first determined using a market multiple valuation approach. When further corroboration is required, the Company uses a discounted cash flow valuation approach. For reporting units which are particularly sensitive to market assumptions, the Company may use additional valuation methodologies to estimate the reporting units’ fair values.
	The market multiple valuation approach utilizes market multiples of companies with similar businesses and the projected operating earnings of the reporting unit. The discounted cash flow valuation approach requires judgments about revenues, operating earnings projections, capital market assumptions and discount rates. The key inputs, judgments and assumptions necessary in determining estimated fair value of the reporting units include projected operating earnings, current book value, the level of economic capital required to support the mix of business, long-term growth rates, comparative market multiples, the account value of in-force business, projections of new and renewal business, as well as margins on such business, the level of interest rates, credit spreads, equity market levels, and the discount rate that the Company believes is appropriate for the respective reporting unit.
	When testing goodwill for impairment, the Company also considers its market capitalization in relation to the aggregate estimated fair value of its reporting units. The Company applies significant judgment when determining the estimated fair value of the Company’s reporting units and when assessing the relationship of market capitalization to the aggregate estimated fair value of its reporting units.
	The valuation methodologies utilized are subject to key judgments and assumptions that are sensitive to change. Estimates of fair value are inherently uncertain and represent only management’s reasonable expectation regarding future developments. These estimates and the judgments and assumptions upon which the estimates are based will, in all likelihood, differ in some respects from actual future results. Declines in the estimated fair value of the Company’s reporting units could result in goodwill impairments in future periods which could materially adversely affect the Company’s results of operations or financial position.
Employee Benefit Plans	'
	Employee Benefit Plans
	Certain subsidiaries of MetLife, Inc. (the “Subsidiaries”) sponsor and/or administer various plans that provide defined benefit pension and other postretirement benefits covering eligible employees and sales representatives. Measurement dates used for all of the Subsidiaries’ defined benefit pension and other postretirement benefit plans correspond with the fiscal year ends of sponsoring Subsidiaries, which are December 31 for U.S. Subsidiaries and November 30 for most non-U.S. Subsidiaries.
	The Company recognizes the funded status of the projected benefit obligation (“PBO”) for pension benefits and the accumulated postretirement benefit obligation (“APBO”) for other postretirement benefits for each of its plans. The Company recognizes an expense for differences between actual experience and estimates over the average future service period of participants. The actuarial gains (losses), prior service costs (credit) and the remaining net transition asset or obligation not yet included in net periodic benefit costs are charged to accumulated OCI (“AOCI”), net of income tax.
	The Subsidiaries also sponsor defined contribution plans for substantially all U.S. employees under which a portion of employee contributions is matched. Applicable matching contributions are made each payroll period. Accordingly, the Company recognizes compensation cost for current matching contributions. As all contributions are transferred currently as earned to the defined contribution plans, no liability for matching contributions is recognized in the balance sheets.
	The Subsidiaries sponsor and/or administer various U.S. qualified and non-qualified defined benefit pension plans and other postretirement employee benefit plans covering employees and sales representatives who meet specified eligibility requirements. U.S. pension benefits are provided utilizing either a traditional formula or cash balance formula. The traditional formula provides benefits that are primarily based upon years of credited service and either final average or career average earnings. The cash balance formula utilizes hypothetical or notional accounts which credit participants with benefits equal to a percentage of eligible pay, as well as earnings credits, determined annually based upon the average annual rate of interest on 30-year U.S. Treasury securities, for each account balance. At December 31, 2013, the majority of active participants were accruing benefits under the cash balance formula; however, 90% of the Subsidiaries’ obligations result from benefits calculated with the traditional formula. The U.S. non-qualified pension plans provide supplemental benefits in excess of limits applicable to a qualified plan. The non-U.S. pension plans generally provide benefits based upon either years of credited service and earnings preceding-retirement or points earned on job grades and other factors in years of service.
	The Subsidiaries also provide certain postemployment benefits and certain postretirement medical and life insurance benefits for retired employees. Employees of the Subsidiaries who were hired prior to 2003 (or, in certain cases, rehired during or after 2003) and meet age and service criteria while working for one of the Subsidiaries may become eligible for these other postretirement benefits, at various levels, in accordance with the applicable plans. Virtually all retirees, or their beneficiaries, contribute a portion of the total costs of postretirement medical benefits. Employees hired after 2003 are not eligible for any employer subsidy for postretirement medical benefits.
	Net periodic benefit costs are determined using management estimates and actuarial assumptions to derive service costs, interest costs and expected return on plan assets for a particular year. Net periodic benefit costs also includes the applicable amortization of net actuarial gains (losses) and amortization of any prior service costs (credit).
	The obligations and expenses associated with these plans require an extensive use of assumptions such as the discount rate, expected rate of return on plan assets, rate of future compensation increases, healthcare cost trend rates, as well as assumptions regarding participant demographics such as rate and age of retirements, withdrawal rates and mortality. Management, in consultation with its external consulting actuarial firms, determines these assumptions based upon a variety of factors such as historical performance of the plan and its assets, currently available market and industry data and expected benefit payout streams. The assumptions used may differ materially from actual results due to, among other factors, changing market and economic conditions and changes in participant demographics. These differences may have a significant effect on the Company’s consolidated financial statements and liquidity.
	Net periodic pension costs and net periodic other postretirement benefit plan costs are comprised of the following:
	•	Service Costs — Service costs are the increase in the projected (expected) PBO resulting from benefits payable to employees of the Subsidiaries on service rendered during the current year.
	•	Interest Costs — Interest costs are the time value adjustment on the projected (expected) PBO at the end of each year.
	•	Settlement and Curtailment Costs — The aggregate amount of net gains (losses) recognized in net periodic benefit costs due to settlements and curtailments. Settlements result from actions that relieve/eliminate the plan’s responsibility for benefit obligations or risks associated with the obligations or assets used for the settlement. Curtailments result from an event that significantly reduces/eliminates plan participants’ expected years of future services or benefit accruals.
	•	Expected Return on Plan Assets — Expected return on plan assets is the assumed return earned by the accumulated pension and other postretirement fund assets in a particular year.
	•	Amortization of Net Actuarial Gains (Losses) — Actuarial gains and losses result from differences between the actual experience and the expected experience on pension and other postretirement plan assets or projected (expected) PBO during a particular period. These gains and losses are accumulated and, to the extent they exceed 10% of the greater of the PBO or the fair value of plan assets, the excess is amortized into pension and other postretirement benefit costs over the expected service years of the employees.
	•	Amortization of Prior Service Costs (Credit) — These costs relate to the recognition of increases or decreases in pension and other postretirement benefit obligation due to amendments in plans or initiation of new plans. These increases or decreases in obligation are recognized in AOCI at the time of the amendment. These costs are then amortized to pension and other postretirement benefit costs over the expected service years of the employees affected by the change.
Income Tax	'
	Income Tax
	MetLife, Inc. and its includable life insurance and non-life insurance subsidiaries file a consolidated U.S. federal income tax return in accordance with the provisions of the Internal Revenue Code of 1986, as amended (the “Code”). Non-includable subsidiaries file either separate individual corporate tax returns or separate consolidated tax returns.
	The Company’s accounting for income taxes represents management’s best estimate of various events and transactions.
	Deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities are measured at the balance sheet date using enacted tax rates expected to apply to taxable income in the years the temporary differences are expected to reverse.
	The realization of deferred tax assets depends upon the existence of sufficient taxable income within the carryback or carryforward periods under the tax law in the applicable tax jurisdiction. Valuation allowances are established when management determines, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Factors in management’s determination include the performance of the business and its ability to generate capital gains. Significant judgment is required in determining whether valuation allowances should be established, as well as the amount of such allowances. When making such determination, consideration is given to, among other things, the following:
	•	future taxable income exclusive of reversing temporary differences and carryforwards;
	•	future reversals of existing taxable temporary differences;
	•	taxable income in prior carryback years; and
	•	tax planning strategies.
	The Company may be required to change its provision for income taxes in certain circumstances. Examples of such circumstances include when estimates used in determining valuation allowances on deferred tax assets significantly change or when receipt of new information indicates the need for adjustment in valuation allowances. Additionally, future events, such as changes in tax laws, tax regulations, or interpretations of such laws or regulations, could have an impact on the provision for income tax and the effective tax rate. Any such changes could significantly affect the amounts reported in the financial statements in the year these changes occur.
	The Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. Unrecognized tax benefits due to tax uncertainties that do not meet the threshold are included within other liabilities and are charged to earnings in the period that such determination is made.
	The Company classifies interest recognized as interest expense and penalties recognized as a component of income tax.
Litigation Contingencies	'
	Litigation Contingencies
	The Company is a party to a number of legal actions and is involved in a number of regulatory investigations. Given the inherent unpredictability of these matters, it is difficult to estimate the impact on the Company’s financial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Except as otherwise disclosed in Note 21, legal costs are recognized as incurred. On a quarterly and annual basis, the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reflected in the Company’s financial statements.
Redeemable Noncontrolling Interests	'
	Redeemable Noncontrolling Interests
	Redeemable noncontrolling interests associated with certain joint ventures and partially-owned consolidated subsidiaries are reported in the temporary section of the balance sheet.
Stock-based Compensation	'
	Stock-Based Compensation
	The Company grants certain employees and directors stock-based compensation awards under various plans that are subject to specific vesting conditions. With the exception of performance shares granted in 2013 which are remeasured quarterly, the cost of all stock-based transactions is measured at fair value at grant date and recognized over the period during which a grantee is required to provide services in exchange for the award. Although the terms of the Company’s stock-based plans do not accelerate vesting upon retirement, or the attainment of retirement eligibility, the requisite service period subsequent to attaining such eligibility is considered nonsubstantive. Accordingly, the Company recognizes compensation expense related to stock-based awards over the shorter of the requisite service period or the period to attainment of retirement eligibility. An estimation of future forfeitures of stock-based awards is incorporated into the determination of compensation expense when recognizing expense over the requisite service period.
	The fair value of Stock Options is estimated on the date of grant using a binomial lattice model. Significant assumptions used in the Company’s binomial lattice model are further described below. The assumptions include: expected volatility of the price of Shares; risk-free rate of return; dividend yield on Shares; exercise multiple; and the post-vesting termination rate.
	Expected volatility is based upon an analysis of historical prices of Shares and call options on Shares traded on the open market. The Company uses a weighted-average of the implied volatility for publicly-traded call options with the longest remaining maturity nearest to the money as of each valuation date and the historical volatility, calculated using monthly closing prices of Shares. The Company chose a monthly measurement interval for historical volatility as this interval reflects the Company’s view that employee option exercise decisions are based on longer-term trends in the price of the underlying Shares rather than on daily price movements.
	The binomial lattice model used by the Company incorporates different risk-free rates based on the imputed forward rates for U.S. Treasury Strips for each year over the contractual term of the option. The table below presents the full range of rates that were used for options granted during the respective periods.
	Dividend yield is determined based on historical dividend distributions compared to the price of the underlying Shares as of the valuation date and held constant over the life of the Stock Option.
	The binomial lattice model used by the Company incorporates the contractual term of the Stock Options. The model also factors in expected exercise behavior and a post-vesting termination rate, or the rate at which vested options are exercised or expire prematurely due to termination of employment. From these factors, the model derives an expected life of the Stock Option. The exercise behavior in the model is a multiple that reflects the ratio of exercise price to the strike price of the Stock Option at which holders are expected to exercise. The exercise multiple is derived from actual historical exercise activity. The post-vesting termination rate is determined from actual historical exercise experience and expiration activity under the Incentive Plans.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at amortized cost, which approximates estimated fair value.
Property, Equipment, Leasehold Improvements and Computer Software	'
	Property, Equipment, Leasehold Improvements and Computer Software
	Property, equipment and leasehold improvements, which are included in other assets, are stated at cost, less accumulated depreciation and amortization. Depreciation is determined using the straight-line method over the estimated useful lives of the assets, as appropriate. The estimated life is generally 40 years for company occupied real estate property, from one to 25 years for leasehold improvements, and from three to seven years for all other property and equipment. The cost basis of the property, equipment and leasehold improvements was $2.0 billion and $2.5 billion at December 31, 2013 and 2012, respectively. Accumulated depreciation and amortization of property, equipment and leasehold improvements was $1.0 billion and $1.3 billion at December 31, 2013 and 2012, respectively. Related depreciation and amortization expense was $183 million, $208 million and $199 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	Computer software, which is included in other assets, is stated at cost, less accumulated amortization. Purchased software costs, as well as certain internal and external costs incurred to develop internal-use computer software during the application development stage, are capitalized. Such costs are amortized generally over a four-year period using the straight-line method. The cost basis of computer software was $1.7 billion and $1.5 billion at December 31, 2013 and 2012, respectively. Accumulated amortization of capitalized software was $1.1 billion and $932 million at December 31, 2013 and 2012, respectively. Related amortization expense was $216 million, $221 million and $217 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Other Revenues	'
	Other Revenues
	Other revenues include, in addition to items described elsewhere herein, advisory fees, broker-dealer commissions and fees, administrative service fees, and changes in account value relating to corporate-owned life insurance (“COLI”). Such fees and commissions are recognized in the period in which services are performed. Under certain COLI contracts, if the Company reports certain unlikely adverse results in its financial statements, withdrawals would not be immediately available and would be subject to market value adjustment, which could result in a reduction of the account value.
Policyholder Dividends	'
	Policyholder Dividends
	Policyholder dividends are approved annually by the insurance subsidiaries’ boards of directors. The aggregate amount of policyholder dividends is related to actual interest, mortality, morbidity and expense experience for the year, as well as management’s judgment as to the appropriate level of statutory surplus to be retained by the insurance subsidiaries.
Foreign Currency	'
	Foreign Currency
	Assets, liabilities and operations of foreign affiliates and subsidiaries are recorded based on the functional currency of each entity. The determination of the functional currency is made based on the appropriate economic and management indicators. With the exception of certain foreign operations, primarily Japan, where multiple functional currencies exist, the local currencies of foreign operations are the functional currencies. Assets and liabilities of foreign affiliates and subsidiaries are translated from the functional currency to U.S. dollars at the exchange rates in effect at each year-end and income and expense accounts are translated at the average exchange rates during the year. The resulting translation adjustments are charged or credited directly to OCI, net of applicable taxes. Gains and losses from foreign currency transactions, including the effect of re-measurement of monetary assets and liabilities to the appropriate functional currency, are reported as part of net investment gains (losses) in the period in which they occur.
Earnings Per Common Share	'
	Earnings Per Common Share
	Basic earnings per common share are computed based on the weighted average number of common shares, or their equivalent, outstanding during the period. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares. Diluted earnings per common share include the dilutive effect of the assumed: (i) exercise or issuance of stock-based awards using the treasury stock method; (ii) settlement of stock purchase contracts underlying common equity units using the treasury stock method; and (iii) settlement of accelerated common stock repurchase contracts. Under the treasury stock method, exercise or issuance of stock-based awards and settlement of the stock purchase contracts underlying common equity units is assumed to occur with the proceeds used to purchase common stock at the average market price for the period.
Closed Block	'
	On April 7, 2000 (the “Demutualization Date”), MLIC converted from a mutual life insurance company to a stock life insurance company and became a wholly-owned subsidiary of MetLife, Inc. The conversion was pursuant to an order by the New York Superintendent of Insurance approving MLIC’s plan of reorganization, as amended (the “Plan”). On the Demutualization Date, MLIC established a closed block for the benefit of holders of certain individual life insurance policies of MLIC. Assets have been allocated to the closed block in an amount that has been determined to produce cash flows which, together with anticipated revenues from the policies included in the closed block, are reasonably expected to be sufficient to support obligations and liabilities relating to these policies, including, but not limited to, provisions for the payment of claims and certain expenses and taxes, and to provide for the continuation of policyholder dividend scales in effect for 1999, if the experience underlying such dividend scales continues, and for appropriate adjustments in such scales if the experience changes. At least annually, the Company compares actual and projected experience against the experience assumed in the then-current dividend scales. Dividend scales are adjusted periodically to give effect to changes in experience.
	The closed block assets, the cash flows generated by the closed block assets and the anticipated revenues from the policies in the closed block will benefit only the holders of the policies in the closed block. To the extent that, over time, cash flows from the assets allocated to the closed block and claims and other experience related to the closed block are, in the aggregate, more or less favorable than what was assumed when the closed block was established, total dividends paid to closed block policyholders in the future may be greater than or less than the total dividends that would have been paid to these policyholders if the policyholder dividend scales in effect for 1999 had been continued. Any cash flows in excess of amounts assumed will be available for distribution over time to closed block policyholders and will not be available to stockholders. If the closed block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from assets outside of the closed block. The closed block will continue in effect as long as any policy in the closed block remains in-force. The expected life of the closed block is over 100 years.
	The Company uses the same accounting principles to account for the participating policies included in the closed block as it used prior to the Demutualization Date. However, the Company establishes a policyholder dividend obligation for earnings that will be paid to policyholders as additional dividends as described below. The excess of closed block liabilities over closed block assets at the Demutualization Date (adjusted to eliminate the impact of related amounts in AOCI) represents the estimated maximum future earnings from the closed block expected to result from operations attributed to the closed block after income taxes. Earnings of the closed block are recognized in income over the period the policies and contracts in the closed block remain in-force. Management believes that over time the actual cumulative earnings of the closed block will approximately equal the expected cumulative earnings due to the effect of dividend changes. If, over the period the closed block remains in existence, the actual cumulative earnings of the closed block are greater than the expected cumulative earnings of the closed block, the Company will pay the excess of the actual cumulative earnings of the closed block over the expected cumulative earnings to closed block policyholders as additional policyholder dividends unless offset by future unfavorable experience of the closed block and, accordingly, will recognize only the expected cumulative earnings in income with the excess recorded as a policyholder dividend obligation. If over such period, the actual cumulative earnings of the closed block are less than the expected cumulative earnings of the closed block, the Company will recognize only the actual earnings in income. However, the Company may change policyholder dividend scales in the future, which would be intended to increase future actual earnings until the actual cumulative earnings equal the expected cumulative earnings.
	Experience within the closed block, in particular mortality and investment yields, as well as realized and unrealized gains and losses, directly impact the policyholder dividend obligation. Amortization of the closed block DAC, which resides outside of the closed block, is based upon cumulative actual and expected earnings within the closed block. Accordingly, the Company’s net income continues to be sensitive to the actual performance of the closed block.

Segment_Information_Tables

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Segment Reporting Information, by Segment	'
			Operating Earnings
			Americas
	Year Ended December 31, 2013		Retail				Group,				Corporate			Latin			Total			Asia			EMEA			Corporate			Total			Adjustments			Total
							Voluntary				Benefit			America												& Other									Consolidated
							& Worksite				Funding
							Benefits
			(In millions)
	Revenues
	Premiums		$	6,528			$	15,250			$	2,859		$	2,824		$	27,461		$	7,801		$	2,297		$	116		$	37,675		$	(1	)	$	37,674
	Universal life and investment-type product policy fees		4,912				688				247			991			6,838			1,722			386			139			9,085			366			9,451
	Net investment income		7,898				1,856				5,790			1,246			16,790			2,915			498			381			20,584			1,648			22,232
	Other revenues		1,018				418				278			23			1,737			92			97			28			1,954			(34		)	1,920
	Net investment gains (losses)		—				—				—			—			—			—			—			—			—			161			161
	Net derivative gains (losses)		—				—				—			—			—			—			—			—			—			(3,239		)	(3,239		)
	Total revenues		20,356				18,212				9,174			5,084			52,826			12,530			3,278			664			69,298			(1,099		)	68,199
	Expenses
	Policyholder benefits and claims and policyholder dividends		9,028				14,227				5,402			2,454			31,111			5,755			1,039			63			37,968			1,398			39,366
	Interest credited to policyholder account balances		2,331				155				1,233			417			4,136			1,690			147			42			6,015			2,164			8,179
	Goodwill impairment		—				—				—			—			—			—			—			—			—			—			—
	Capitalization of DAC		(1,309		)		(141		)		(27		)	(424		)	(1,901		)	(2,143		)	(714		)	(28		)	(4,786		)	—			(4,786		)
	Amortization of DAC and VOBA		1,384				140				23			310			1,857			1,542			683			1			4,083			(533		)	3,550
	Amortization of negative VOBA		—				—				—			(2		)	(2		)	(427		)	(95		)	—			(524		)	(55		)	(579		)
	Interest expense on debt		—				1				9			—			10			—			1			1,148			1,159			123			1,282
	Other expenses		5,084				2,380				523			1,612			9,599			4,312			1,810			894			16,615			520			17,135
	Total expenses		16,518				16,762				7,163			4,367			44,810			10,729			2,871			2,120			60,530			3,617			64,147
	Provision for income tax expense (benefit)		1,314				488				704			143			2,649			557			78			(925		)	2,359			(1,698		)	661
	Operating earnings		$	2,524			$	962			$	1,307		$	574		$	5,367		$	1,244		$	329		$	(531	)	6,409
	Adjustments to:
	Total revenues																												(1,099		)
	Total expenses																												(3,617		)
	Provision for income tax (expense) benefit																												1,698
	Income (loss) from continuing operations, net of income tax																												$	3,391					$	3,391
	At December 31, 2013		Retail				Group,				Corporate			Latin			Asia (1)			EMEA			Corporate			Total
							Voluntary				Benefit			America									& Other
							& Worksite				Funding
							Benefits
			(In millions)
	Total assets		$	349,516			$	43,404			$	220,612		$	69,874		$	119,717		$	33,382		$	48,791		$	885,296
	Separate account assets		$	172,382			$	644			$	77,023		$	49,660		$	8,996		$	8,496		$	—		$	317,201
	Separate account liabilities		$	172,382			$	644			$	77,023		$	49,660		$	8,996		$	8,496		$	—		$	317,201
	______________
	-1	Total assets includes $98.4 billion of assets from the Japan operations which represents 11% of total consolidated assets.
			Operating Earnings
			Americas
	Year Ended December 31, 2012		Retail				Group,				Corporate			Latin			Total			Asia			EMEA			Corporate			Total			Adjustments			Total
							Voluntary				Benefit			America												& Other									Consolidated
							& Worksite				Funding
							Benefits
			(In millions)
	Revenues
	Premiums		$	6,532			$	14,794			$	3,237		$	2,578		$	27,141		$	8,344		$	2,370		$	56		$	37,911		$	64		$	37,975
	Universal life and investment-type product policy fees		4,561				662				225			785			6,233			1,491			333			155			8,212			344			8,556
	Net investment income		7,670				1,768				5,703			1,198			16,339			2,895			535			703			20,472			1,512			21,984
	Other revenues		879				422				259			16			1,576			26			121			33			1,756			150			1,906
	Net investment gains (losses)		—				—				—			—			—			—			—			—			—			(352		)	(352		)
	Net derivative gains (losses)		—				—				—			—			—			—			—			—			—			(1,919		)	(1,919		)
	Total revenues		19,642				17,646				9,424			4,577			51,289			12,756			3,359			947			68,351			(201		)	68,150
	Expenses
	Policyholder benefits and claims and policyholder dividends		9,010				13,691				5,704			2,231			30,636			5,819			1,196			119			37,770			1,586			39,356
	Interest credited to policyholder account balances		2,375				167				1,358			393			4,293			1,784			126			39			6,242			1,487			7,729
	Goodwill impairment		—				—				—			—			—			—			—			—			—			1,868			1,868
	Capitalization of DAC		(1,753		)		(138		)		(29		)	(353		)	(2,273		)	(2,288		)	(723		)	—			(5,284		)	(5		)	(5,289		)
	Amortization of DAC and VOBA		1,607				133				22			224			1,986			1,563			626			2			4,177			22			4,199
Amortization of negative VOBA		—				—				—			(5		)	(5		)	(456		)	(94		)	—			(555		)	(67		)	(622		)
Interest expense on debt		—				1				8			(1		)	8			5			1			1,176			1,190			166			1,356
Other expenses		5,369				2,351				478			1,375			9,573			4,738			1,810			559			16,680			1,431			18,111
Total expenses		16,608				16,205				7,541			3,864			44,218			11,165			2,942			1,895			60,220			6,488			66,708
Provision for income tax expense (benefit)		1,032				481				659			130			2,302			554			146			(679		)	2,323			(2,195		)	128
Operating earnings		$	2,002			$	960			$	1,224		$	583		$	4,769		$	1,037		$	271		$	(269	)	5,808
Adjustments to:
Total revenues																												(201		)
Total expenses																												(6,488		)
Provision for income tax (expense) benefit																												2,195
Income (loss) from continuing operations, net of income tax																												$	1,314					$	1,314
At December 31, 2012		Retail				Group,				Corporate			Latin			Asia (1)			EMEA			Corporate			Total
						Voluntary				Benefit			America									& Other
						& Worksite				Funding
						Benefits
		(In millions)
Total assets		$	332,387			$	44,138			$	217,352		$	23,272		$	131,138		$	23,474		$	65,020		$	836,781
Separate account assets		$	150,513			$	532			$	71,875		$	4,200		$	8,273		$	—		$	—		$	235,393
Separate account liabilities		$	150,513			$	532			$	71,875		$	4,200		$	8,273		$	—		$	—		$	235,393
______________
-1	Total assets includes $111.0 billion of assets from the Japan operations which represents 13% of total consolidated assets.
		Operating Earnings
		Americas
Year Ended December 31, 2011		Retail				Group,				Corporate			Latin			Total			Asia			EMEA			Corporate			Total			Adjustments			Total
						Voluntary				Benefit			America												& Other									Consolidated
						& Worksite Benefits				Funding
		(In millions)
Revenues
Premiums		$	6,711			$	13,949			$	2,848		$	2,514		$	26,022		$	7,716		$	2,477		$	54		$	36,269		$	92		$	36,361
Universal life and investment-type product policy fees		4,096				630				232			757			5,715			1,343			315			155			7,528			278			7,806
Net investment income		7,414				1,768				5,506			1,025			15,713			2,475			562			888			19,638			(53		)	19,585
Other revenues		779				390				249			15			1,433			36			123			60			1,652			880			2,532
Net investment gains (losses)		—				—				—			—			—			—			—			—			—			(867		)	(867		)
Net derivative gains (losses)		—				—				—			—			—			—			—			—			—			4,824			4,824
Total revenues		19,000				16,737				8,835			4,311			48,883			11,570			3,477			1,157			65,087			5,154			70,241
Expenses
Policyholder benefits and claims and policyholder dividends		9,220				13,015				5,287			2,064			29,586			5,239			1,290			126			36,241			676			36,917
Interest credited to policyholder account balances		2,412				178				1,323			371			4,284			1,607			166			—			6,057			(454		)	5,603
Goodwill impairment		—				—				—			—			—			—			—			—			—			—			—
Capitalization of DAC		(2,339		)		(176		)		(25		)	(295		)	(2,835		)	(2,045		)	(669		)	—			(5,549		)	(9		)	(5,558		)
Amortization of DAC and VOBA		1,845				186				17			207			2,255			1,486			613			1			4,355			543			4,898
Amortization of negative VOBA		—				—				—			(6		)	(6		)	(560		)	(53		)	—			(619		)	(78		)	(697		)
Interest expense on debt		1				—				9			1			11			—			—			1,293			1,304			325			1,629
Other expenses		5,854				2,198				513			1,305			9,870			4,522			1,723			505			16,620			1,645			18,265
Total expenses		16,993				15,401				7,124			3,647			43,165			10,249			3,070			1,925			58,409			2,648			61,057
Provision for income tax expense (benefit)		672				445				599			150			1,866			441			156			(584		)	1,879			914			2,793
Operating earnings		$	1,335			$	891			$	1,112		$	514		$	3,852		$	880		$	251		$	(184	)	4,799
Adjustments to:
Total revenues																												5,154
Total expenses																												(2,648		)
Provision for income tax (expense) benefit																												(914		)
Income (loss) from continuing operations, net of income tax																												$	6,391					$	6,391
Premiums, Universal Life and Investment-Type Policy Fees and Other Revenue by Product Groups for Reportable Segment	'
	The following table presents total premiums, universal life and investment-type product policy fees and other revenues by major product groups of the Company’s segments, as well as Corporate & Other:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Life insurance (1)	$	32,176			$	31,723			$	30,486
	Accident and health insurance	13,214				13,255				12,269
	Property and casualty insurance	3,270				3,117				3,043
	Non-insurance	385				342				901
	Total	$	49,045			$	48,437			$	46,699
	______________
	-1	Includes annuities and corporate benefit funding products.
Total premiums, universal life & investment-type product policy fees and other revenues associated with the Company's U.S. and foreign operations	'
	The following table presents total premiums, universal life and investment-type product policy fees and other revenues associated with the Company’s U.S. and foreign operations:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	U.S.	$	32,529			$	31,500			$	30,108
	Foreign:
	Japan	7,373				7,833				7,184
	Other	9,143				9,104				9,407
	Total	$	49,045			$	48,437			$	46,699

Acquisitions_and_Dispositions_

Acquisitions and Dispositions (Tables)	12 Months Ended
	Dec. 31, 2013
Business Combinations [Abstract]	'
Discontinued Operations in Consolidated Financial Statements	'
	The following table summarizes the amounts that have been reflected as discontinued operations in the consolidated statements of operations. Income (loss) from discontinued operations includes real estate classified as held-for-sale or sold.
		Years Ended December 31,
		2013		2012		2011
		(In millions)
	Total revenues	$	3	$	74	$	484
	Total expenses	—		—		363
	Income (loss) before provision for income tax	3		74		121
	Provision for income tax expense (benefit)	1		26		33
	Income (loss) from operations of discontinued operations, net of income tax	2		48		88
	Gain (loss) on disposal of operations, net of income tax	—		—		(64		)
	Income (loss) from discontinued operations, net of income tax	$	2	$	48	$	24

Insurance_Tables

Insurance (Tables)	12 Months Ended
	Dec. 31, 2013
Insurance [Abstract]	'
Insurance Liabilities	'
	Insurance liabilities are comprised of future policy benefits, PABs and other policy-related balances. Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at:
		December 31,
		2013			2012
		(In millions)
	Retail	$	134,915		$	138,082
	Group, Voluntary & Worksite Benefits	29,521			29,996
	Corporate Benefit Funding	112,591			117,065
	Latin America	16,162			16,055
	Asia	93,066			103,064
	EMEA	21,657			20,200
	Corporate & Other	8,129			9,173
	Total	$	416,041		$	433,635
Liabilities for Guarantees	'
	Information regarding the liabilities for guarantees (excluding base policy liabilities and embedded derivatives) relating to annuity and universal and variable life contracts was as follows:
		Annuity Contracts						Universal and Variable
								Life Contracts
		GMDBs			GMIBs			Secondary				Paid-Up			Total
								Guarantees				Guarantees
		(In millions)
	Direct and Assumed
	Balance at January 1, 2011	$	272		$	623		$	3,991			$	198		$	5,084
	Incurred guaranteed benefits (1)	273			269			496				23			1,061
	Paid guaranteed benefits	(113		)	(10		)	(24		)		—			(147		)
	Balance at December 31, 2011	432			882			4,463				221			5,998
	Incurred guaranteed benefits (1)	252			771			348				25			1,396
	Paid guaranteed benefits	(117		)	(18		)	(26		)		—			(161		)
	Balance at December 31, 2012	567			1,635			4,785				246			7,233
	Incurred guaranteed benefits (1)	200			229			(64		)		20			385
	Paid guaranteed benefits	(82		)	(13		)	(23		)		—			(118		)
	Balance at December 31, 2013	$	685		$	1,851		$	4,698			$	266		$	7,500
	Ceded
	Balance at January 1, 2011	$	39		$	(1	)	$	594			$	139		$	771
	Incurred guaranteed benefits	35			9			20				16			80
	Paid guaranteed benefits	(20		)	—			—				—			(20		)
	Balance at December 31, 2011	54			8			614				155			831
	Incurred guaranteed benefits	22			1			139				18			180
	Paid guaranteed benefits	(20		)	—			—				—			(20		)
	Balance at December 31, 2012	56			9			753				173			991
	Incurred guaranteed benefits	(5		)	—			175				14			184
	Paid guaranteed benefits	(10		)	(2		)	—				—			(12		)
	Balance at December 31, 2013	$	41		$	7		$	928			$	187		$	1,163
	Net
	Balance at January 1, 2011	$	233		$	624		$	3,397			$	59		$	4,313
	Incurred guaranteed benefits	238			260			476				7			981
	Paid guaranteed benefits	(93		)	(10		)	(24		)		—			(127		)
	Balance at December 31, 2011	378			874			3,849				66			5,167
	Incurred guaranteed benefits	230			770			209				7			1,216
	Paid guaranteed benefits	(97		)	(18		)	(26		)		—			(141		)
	Balance at December 31, 2012	511			1,626			4,032				73			6,242
	Incurred guaranteed benefits	205			229			(239		)		6			201
	Paid guaranteed benefits	(72		)	(11		)	(23		)		—			(106		)
	Balance at December 31, 2013	$	644		$	1,844		$	3,770			$	79		$	6,337
	______________
	-1	Secondary guarantees include the effects of foreign currency translation of ($597) million, ($39) million and $231 million at December 31, 2013, 2012 and 2011, respectively.
Fund Groupings	'
	Account balances of contracts with insurance guarantees were invested in separate account asset classes as follows at:
		December 31,
		2013			2012
		(In millions)
	Fund Groupings:
	Equity	$	79,036		$	66,469
	Balanced	75,928			67,230
	Bond	10,632			11,188
	Money Market	1,157			1,291
	Total	$	166,753		$	146,178
Guarantees related to Annuity, Universal and Variable Life Contracts	'
	Information regarding the types of guarantees relating to annuity contracts and universal and variable life contracts was as follows at:
		December 31,
		2013						2012
		In the			At			In the				At
		Event of Death			Annuitization			Event of Death				Annuitization
		(In millions)
	Annuity Contracts (1)
	Variable Annuity Guarantees
	Total contract account value (2)	$	201,395		$	100,527		$	184,095			$	89,137
	Separate account value	$	164,500		$	96,459		$	143,893			$	84,354
	Net amount at risk	$	4,203		$	1,219		$	9,501			$	4,593
	Average attained age of contractholders	63 years			63 years			62 years				62 years
	Two Tier Annuities
	General account value	N/A			$	880		N/A				$	848
	Net amount at risk	N/A			$	234		N/A				$	232
	Average attained age of contractholders	N/A			50 years			N/A				51 years
		December 31,
		2013						2012
		Secondary			Paid-Up			Secondary				Paid-Up
		Guarantees			Guarantees			Guarantees				Guarantees
		(In millions)
	Universal and Variable Life Contracts (1)
	Account value (general and separate account)	$	16,048		$	3,700		$	14,256			$	3,828
	Net amount at risk	$	185,920		$	21,737		$	189,197			$	23,276
	Average attained age of policyholders	55 years			60 years			54 years				60 years
	______________
	-1	The Company’s annuity and life contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.
	-2	Includes amounts, which are not reported in the consolidated balance sheets, from assumed reinsurance of certain variable annuity products from the Company’s former operating joint venture in Japan.
Schedule of Federal Home Loan Bank, common stock holdings, by branch of FHLB Bank	'
	Certain of the Company’s subsidiaries are members of regional banks in the FHLB system (“FHLBanks”). Holdings of common stock of FHLBanks, included in equity securities, were as follows at:
		December 31,
		2013			2012
		(In millions)
	FHLB of NY	$	700		$	736
	FHLB of Des Moines	$	76		$	83
	FHLB of Boston	$	64		$	67
	FHLB of Pittsburgh	$	30		$	14
Schedule of liability recorded and collateral pledged for funding agreements	'
	Such subsidiaries have also entered into funding agreements with FHLBanks and the Federal Agricultural Mortgage Corporation, a federally chartered instrumentality of the U.S. (“Farmer Mac”). The liability for such funding agreements is included in PABs. Information related to such funding agreements was as follows at:
		Liability						Collateral
		December 31,
		2013			2012			2013					2012
		(In millions)
	FHLB of NY (1)	$	12,770		$	13,512		$	14,287		-2		$	14,611	-2
	Farmer Mac (3)	$	2,750		$	2,750		$	3,159				$	3,159
	FHLB of Des Moines (1)	$	1,405		$	1,405		$	1,596		-2		$	1,902	-2
	FHLB of Boston (1)	$	450		$	450		$	808		-2		$	537	-2
	FHLB of Pittsburgh (1)	$	375		$	—		$	976		-2		$	810	-2
	______________
	-1	Represents funding agreements issued to the applicable FHLBank in exchange for cash and for which such FHLBank has been granted a lien on certain assets, some of which are in the custody of such FHLBank, including residential mortgage-backed securities (“RMBS”), to collateralize obligations under advances evidenced by funding agreements. The Company is permitted to withdraw any portion of the collateral in the custody of such FHLBank as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by the Company, such FHLBank’s recovery on the collateral is limited to the amount of the Company’s liability to such FHLBank.
	-2	Advances are collateralized by mortgage-backed securities. The amount of collateral presented is at estimated fair value.
	-3	Represents funding agreements issued to certain SPEs that have issued debt securities for which payment of interest and principal is secured by such funding agreements, and such debt securities are also guaranteed as to payment of interest and principal by Farmer Mac. The obligations under these funding agreements are secured by a pledge of certain eligible agricultural real estate mortgage loans and may, under certain circumstances, be secured by other qualified collateral. The amount of collateral presented is at carrying value.
Liabilities for Unpaid Claims and Claim Expenses	'
	Information regarding the liabilities for unpaid claims and claim expenses relating to property and casualty, group accident and non-medical health policies and contracts, which are reported in future policy benefits and other policy-related balances, was as follows:
		Years Ended December 31,
		2013			2012			2011
		(In millions)
	Balance at January 1,	$	10,436		$	10,117		$	10,708
	Less: Reinsurance recoverables	1,581			1,436			2,198
	Net balance at January 1,	8,855			8,681			8,510
	Incurred related to:
	Current year	8,660			8,399			9,028
	Prior years (1)	(86		)	(69		)	(199		)
	Total incurred	8,574			8,330			8,829
	Paid related to:
	Current year	(6,083		)	(5,689		)	(6,238		)
	Prior years	(2,377		)	(2,467		)	(2,420		)
	Total paid	(8,460		)	(8,156		)	(8,658		)
	Net balance at December 31,	8,969			8,855			8,681
	Add: Reinsurance recoverables	1,661			1,581			1,436
	Balance at December 31,	$	10,630		$	10,436		$	10,117
	______________
	-1	During 2013, 2012 and 2011, as a result of changes in estimates of insured events in the respective prior year, claims and claim adjustment expenses associated with prior years decreased due to a reduction in prior year automobile bodily injury and homeowners’ severity and improved loss ratio for non-medical health claim liabilities.

Deferred_Policy_Acquisition_Co1

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (Tables)	12 Months Ended
	Dec. 31, 2013
Deferred Policy Acquisition Costs and Value of Business Acquired [Abstract]	'
Schedule of Deferred Policy Acquisition Costs and Value of Business Acquired	'
	Information regarding DAC and VOBA was as follows:
		Years Ended December 31,
		2013			2012			2011
		(In millions)
	DAC
	Balance at January 1,	$	17,150		$	15,240		$	13,377
	Capitalizations	4,786			5,289			5,558
	Amortization related to:
	Net investment gains (losses) and net derivative gains (losses)	192			(40		)	(478		)
	Other expenses	(2,812		)	(2,875		)	(2,614		)
	Total amortization	(2,620		)	(2,915		)	(3,092		)
	Unrealized investment gains (losses)	924			(516		)	(427		)
	Effect of foreign currency translation and other	(466		)	52			(176		)
	Balance at December 31,	19,774			17,150			15,240
	VOBA
	Balance at January 1,	7,611			9,379			11,088
	Acquisitions (1)	947			55			11
	Amortization related to:
	Net investment gains (losses) and net derivative gains (losses)	3			(1		)	(49		)
	Other expenses	(933		)	(1,283		)	(1,757		)
	Total amortization	(930		)	(1,284		)	(1,806		)
	Unrealized investment gains (losses)	358			(197		)	(361		)
	Effect of foreign currency translation and other	(1,054		)	(342		)	447
	Balance at December 31,	6,932			7,611			9,379
	Total DAC and VOBA
	Balance at December 31,	$	26,706		$	24,761		$	24,619
	______________
	(1) See Note 3 for a description of acquisitions.
Information regarding Deferred Policy Acquisition Costs and Value of Business Acquired by Segment	'
	Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at:
		December 31,
		2013			2012
		(In millions)
	Retail	$	12,882		$	11,500
	Group, Voluntary & Worksite Benefits	382			382
	Corporate Benefit Funding	99			96
	Latin America	2,201			1,231
	Asia	9,077			9,554
	EMEA	2,039			1,998
	Corporate & Other	26			—
	Total	$	26,706		$	24,761
Deferred Sales Inducements, Value of Distribution Agreements and Customer Relationships Acquired and Negative Value of Business Acquired	'
	Information regarding other policy-related intangibles was as follows:
		Years Ended December 31,
		2013			2012			2011
		(In millions)
	Deferred Sales Inducements
	Balance at January 1,	$	930		$	926		$	918
	Capitalization	58			81			140
	Amortization	(36		)	(77		)	(132		)
	Effect of foreign currency translation	(2		)	—			—
	Balance at December 31,	$	950		$	930		$	926
	VODA and VOCRA
	Balance at January 1,	$	1,108		$	1,264		$	1,094
	Acquisitions	—			—			213
	Amortization (1)	(84		)	(150		)	(60		)
	Effect of foreign currency translation	(49		)	(6		)	17
	Balance at December 31,	$	975		$	1,108		$	1,264
	Accumulated amortization	$	418		$	334		$	184
	Negative VOBA
	Balance at January 1,	$	2,916		$	3,657		$	4,287
	Acquisitions	—			10			7
	Amortization	(579		)	(622		)	(697		)
	Effect of foreign currency translation	(175		)	(129		)	60
	Balance at December 31,	$	2,162		$	2,916		$	3,657
	Accumulated amortization	$	1,962		$	1,383		$	761
	____________
	-1	In connection with the Company’s annual impairment testing of VOCRA, it was determined that the VOCRA included in the Group, Voluntary & Worksite Benefits segment, associated with a previously acquired dental business, was impaired as the undiscounted future cash flows associated with the asset were lower than its current carrying value. This shortfall in undiscounted future cash flows is primarily the result of actual persistency experience being less favorable than what was assumed when the asset was acquired. As a result of this impairment, the Company wrote the asset down to its estimated fair value, which was determined using the discounted cash flow valuation approach. The Company recorded a non-cash charge of $77 million ($50 million, net of income tax) for the impairment of the VOCRA balance to other expenses in the consolidated statement of operations for the year ended December 31, 2012.
Estimated Future Amortization Expense (Credit)	'
	The estimated future amortization expense (credit) to be reported in other expenses for the next five years is as follows:
		VOBA			VODA and VOCRA			Negative VOBA
		(In millions)
	2014	$	846		$	80		$	(438	)
	2015	$	700		$	79		$	(353	)
	2016	$	596		$	75		$	(271	)
	2017	$	516		$	71		$	(154	)
	2018	$	448		$	66		$	(68	)

Reinsurance_Tables

Reinsurance (Tables)	12 Months Ended
	Dec. 31, 2013
Reinsurance Disclosures [Abstract]	'
Effect of reinsurance	'
	The amounts in the consolidated statements of operations include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows:
		Years Ended December 31,
		2013			2012			2011
		(In millions)
	Premiums
	Direct premiums	$	38,476		$	38,719		$	37,185
	Reinsurance assumed	1,472			1,488			1,484
	Reinsurance ceded	(2,274		)	(2,232		)	(2,308		)
	Net premiums	$	37,674		$	37,975		$	36,361
	Universal life and investment-type product policy fees
	Direct universal life and investment-type product policy fees	$	10,197		$	9,216		$	8,455
	Reinsurance assumed	139			155			154
	Reinsurance ceded	(885		)	(815		)	(803		)
	Net universal life and investment-type product policy fees	$	9,451		$	8,556		$	7,806
	Policyholder benefits and claims
	Direct policyholder benefits and claims	$	40,211		$	39,262		$	37,588
	Reinsurance assumed	1,047			1,167			1,101
	Reinsurance ceded	(3,151		)	(2,442		)	(3,218		)
	Net policyholder benefits and claims	$	38,107		$	37,987		$	35,471
	Other expenses
	Direct other expenses	$	16,712		$	17,848		$	18,672
	Reinsurance assumed	147			228			168
	Reinsurance ceded	(257		)	(321		)	(303		)
	Net other expenses	$	16,602		$	17,755		$	18,537
	The amounts in the consolidated balance sheets include the impact of reinsurance. Information regarding the significant effects of reinsurance was as follows at:
		December 31,
		2013											2012
		Direct			Assumed			Ceded			Total		Direct		Assumed		Ceded			Total
											Balance									Balance
											Sheet									Sheet
		(In millions)
	Assets
	Premiums, reinsurance and other receivables	$	6,248		$	593		$	15,018		$	21,859	$	6,286	$	548	$	14,800		$	21,634
	Deferred policy acquisition costs and value of business acquired	26,954			104			(352		)	26,706		24,789		92		(120		)	24,761
	Total assets	$	33,202		$	697		$	14,666		$	48,565	$	31,075	$	640	$	14,680		$	46,395
	Liabilities
	Future policy benefits	$	185,908		$	2,034		$	—		$	187,942	$	190,321	$	2,031	$	(1	)	$	192,351
	Policyholder account balances	211,610			1,277			(2		)	212,885		223,229		2,594		(2		)	225,821
	Other policy-related balances	14,838			353			23			15,214		15,142		313		8			15,463
	Other liabilities	19,591			533			3,044			23,168		18,925		543		3,024			22,492
	Total liabilities	$	431,947		$	4,197		$	3,065		$	439,209	$	447,617	$	5,481	$	3,029		$	456,127

Closed_Block_Tables

Closed Block (Tables)	12 Months Ended
	Dec. 31, 2013
Closed Block Disclosure [Abstract]	'
Closed block liabilities and assets	'
	Information regarding the closed block liabilities and assets designated to the closed block was as follows at:
		December 31,
		2013				2012
		(In millions)
	Closed Block Liabilities
	Future policy benefits	$	42,076			$	42,586
	Other policy-related balances	298				298
	Policyholder dividends payable	456				466
	Policyholder dividend obligation	1,771				3,828
	Current income tax payable	18				—
	Other liabilities	582				602
	Total closed block liabilities	45,201				47,780
	Assets Designated to the Closed Block
	Investments:
	Fixed maturity securities available-for-sale, at estimated fair value	28,374				30,546
	Equity securities available-for-sale, at estimated fair value	86				41
	Mortgage loans	6,155				6,192
	Policy loans	4,669				4,670
	Real estate and real estate joint ventures	492				459
	Other invested assets	814				953
	Total investments	40,590				42,861
	Cash and cash equivalents	238				381
	Accrued investment income	477				481
	Premiums, reinsurance and other receivables	98				107
	Current income tax recoverable	—				2
	Deferred income tax assets	293				319
	Total assets designated to the closed block	41,696				44,151
	Excess of closed block liabilities over assets designated to the closed block	3,505				3,629
	Amounts included in AOCI:
	Unrealized investment gains (losses), net of income tax	1,502				2,891
	Unrealized gains (losses) on derivatives, net of income tax	(3		)		9
	Allocated to policyholder dividend obligation, net of income tax	(1,151		)		(2,488		)
	Total amounts included in AOCI	348				412
	Maximum future earnings to be recognized from closed block assets and liabilities	$	3,853			$	4,041
Closed block policyholder dividend obligation	'
	Information regarding the closed block policyholder dividend obligation was as follows:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Balance at January 1,	$	3,828			$	2,919			$	876
	Change in unrealized investment and derivative gains (losses)	(2,057		)		909				2,043
	Balance at December 31,	$	1,771			$	3,828			$	2,919
Closed block revenues and expenses	'
	Information regarding the closed block revenues and expenses was as follows:
			Years Ended December 31,
			2013				2012				2011
			(In millions)
	Revenues
	Premiums		$	1,987			$	2,139			$	2,306
	Net investment income		2,130				2,188				2,231
	Net investment gains (losses)		25				61				32
	Net derivative gains (losses)		(6		)		(12		)		8
	Total revenues		4,136				4,376				4,577
	Expenses
	Policyholder benefits and claims		2,702				2,783				2,991
	Policyholder dividends		979				1,072				1,137
	Other expenses		165				179				193
	Total expenses		3,846				4,034				4,321
	Revenues, net of expenses before provision for income tax expense (benefit)		290				342				256
	Provision for income tax expense (benefit)		101				120				89
	Revenues, net of expenses and provision for income tax expense (benefit) from continuing operations		189				222				167
	Revenues, net of expenses and provision for income tax expense (benefit) from discontinued operations		—				10				1
	Revenues, net of expenses and provision for income tax expense (benefit)		$	189			$	232			$	168

Investments_Tables

Investments (Tables)	12 Months Ended
	Dec. 31, 2013																																				Dec. 31, 2012
Investments, Debt and Equity Securities [Abstract]	'																																				'
Fixed Maturity and Equity Securities Available-for-Sale	'																																				'
																																					The following table presents the fixed maturity and equity securities AFS by sector. Redeemable preferred stock is reported within U.S. corporate and foreign corporate fixed maturity securities and non-redeemable preferred stock is reported within equity securities. Included within fixed maturity securities are structured securities including RMBS, commercial mortgage-backed securities (“CMBS”) and ABS.
																																						December 31, 2013										December 31, 2012
																																						Cost or		Gross Unrealized						Estimated		Cost or		Gross Unrealized							Estimated
																																						Amortized								Fair		Amortized									Fair
																																						Cost		Gains		Temporary		OTTI		Value		Cost		Gains		Temporary		OTTI			Value
																																										Losses		Losses								Losses		Losses
																																														(In millions)
																																					Fixed maturity securities
																																					U.S. corporate	$	100,203	$	7,495	$	1,229	$	—	$	106,469	$	102,669	$	11,887	$	430	$	—		$	114,126
																																					Foreign corporate (1)	59,778		3,939		565		—		63,152		61,806		5,654		277		(1		)	67,184
																																					Foreign government	50,717		4,107		387		—		54,437		51,967		5,440		71		—			57,336
																																					U.S. Treasury and agency	43,928		2,251		1,056		—		45,123		41,874		6,104		11		—			47,967
																																					RMBS	34,167		1,584		490		206		35,055		35,666		2,477		315		349			37,479
																																					CMBS	16,115		605		170		—		16,550		18,177		1,009		57		—			19,129
																																					ABS	15,458		296		171		12		15,571		15,762		404		156		13			15,997
																																					State and political subdivision	13,233		903		306		—		13,830		12,949		2,169		70		—			15,048
																																					Total fixed maturity securities	$	333,599	$	21,180	$	4,374	$	218	$	350,187	$	340,870	$	35,144	$	1,387	$	361		$	374,266
																																					Equity securities
																																					Common stock	$	1,927	$	431	$	5	$	—	$	2,353	$	2,034	$	147	$	19	$	—		$	2,162
																																					Non-redeemable preferred stock	1,085		76		112		—		1,049		804		65		140		—			729
																																					Total equity securities	$	3,012	$	507	$	117	$	—	$	3,402	$	2,838	$	212	$	159	$	—		$	2,891
																																					______________
																																					-1	The noncredit loss component of OTTI losses for foreign corporate securities was in an unrealized gain position of $1 million at December 31, 2012, due to increases in estimated fair value subsequent to initial recognition of noncredit losses on such securities. See also “— Net Unrealized Investment Gains (Losses).”
Available-for-sale fixed maturity securities by contractual maturity date	'																																				'
	The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at:
		December 31,
		2013								2012
		Amortized				Estimated				Amortized				Estimated
		Cost				Fair				Cost				Fair
						Value								Value
		(In millions)
	Due in one year or less	$	15,828			$	16,030			$	24,177			$	24,394
	Due after one year through five years	70,467				74,229				66,973				70,759
	Due after five years through ten years	78,159				83,223				82,376				91,975
	Due after ten years	103,405				109,529				97,739				114,533
	Subtotal	267,859				283,011				271,265				301,661
	Structured securities (RMBS, CMBS and ABS)	65,740				67,176				69,605				72,605
	Total fixed maturity securities	$	333,599			$	350,187			$	340,870			$	374,266
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'																																				'
	The following table presents the estimated fair value and gross unrealized losses of fixed maturity and equity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position.
		31-Dec-13																December 31, 2012
		Less than 12 Months								Equal to or Greater than 12 Months								Less than 12 Months								Equal to or Greater than 12 Months
		Estimated				Gross				Estimated				Gross				Estimated				Gross				Estimated			Gross
		Fair				Unrealized				Fair				Unrealized				Fair				Unrealized				Fair			Unrealized
		Value				Losses				Value				Losses				Value				Losses				Value			Losses
		(In millions, except number of securities)
	Fixed maturity securities
	U.S. corporate	$	13,889			$	808			$	3,807			$	421			$	3,799			$	88			$	3,695		$	342
	Foreign corporate	9,019				402				2,320				163				2,783				96				2,873			180
	Foreign government	5,052				336				1,846				51				1,431				22				543			49
	U.S. Treasury and agency	15,225				1,037				357				19				1,951				11				—			—
	RMBS	10,754				363				2,302				333				735				31				4,098			633
	CMBS	3,696				142				631				28				842				11				577			46
	ABS	3,772				59				978				124				1,920				30				1,410			139
	State and political subdivision	3,109				225				351				81				260				4				251			66
	Total fixed maturity securities	$	64,516			$	3,372			$	12,592			$	1,220			$	13,721			$	293			$	13,447		$	1,455
	Equity securities
	Common stock	$	81			$	4			$	16			$	1			$	201			$	18			$	14		$	1
	Non-redeemable preferred stock	364				65				191				47				—				—				295			140
	Total equity securities	$	445			$	69			$	207			$	48			$	201			$	18			$	309		$	141
	Total number of securities in an	4,480								1,571								1,941								1,335
	unrealized loss position
Disclosure of Mortgage Loans Net of Valuation Allowance	'																																				'
	Mortgage loans are summarized as follows at:
		December 31,
		2013							2012
		Carrying				% of			Carrying				% of
		Value				Total			Value				Total
		(In millions)							(In millions)
	Mortgage loans held-for-investment:
	Commercial	$	40,926			70.9	%		$	40,472			71	%
	Agricultural	12,391				21.5			12,843				22.5
	Residential	2,772				4.8			958				1.7
	Subtotal (1)	56,089				97.2			54,273				95.2
	Valuation allowances	(322		)		(0.6	)		(347		)		(0.6	)
	Subtotal mortgage loans held-for-investment, net	55,767				96.6			53,926				94.6
	Residential — FVO	338				0.6			—				—
	Commercial mortgage loans held by CSEs — FVO	1,598				2.8			2,666				4.7
	Total mortgage loans held-for-investment, net	57,703				100			56,592				99.3
	Mortgage loans held-for-sale	3				—			414				0.7
	Total mortgage loans, net	$	57,706			100	%		$	57,006			100	%
	______________
	-1	Purchases of mortgage loans were $2.2 billion and $205 million for the years ended December 31, 2013 and 2012, respectively.
Disclosure of mortgage loans held-for-investment and valuation allowances by method of evaluation for credit loss	'																																				'
	The carrying value prior to valuation allowance (“recorded investment”) in mortgage loans held-for-investment, by portfolio segment, by method of evaluation of credit loss, and the related valuation allowances, by type of credit loss, were as follows at:
		December 31,
		2013																2012
		Commercial				Agricultural				Residential				Total				Commercial				Agricultural				Residential			Total
		(In millions)
	Mortgage loans:
	Evaluated individually for credit losses	$	506			$	100			$	16			$	622			$	539			$	181			$	13		$	733
	Evaluated collectively for credit losses	40,420				12,291				2,756				55,467				39,933				12,662				945			53,540
	Total mortgage loans	40,926				12,391				2,772				56,089				40,472				12,843				958			54,273
	Valuation allowances:
	Specific credit losses	58				7				1				66				94				21				2			117
	Non-specifically identified credit losses	200				37				19				256				199				31				—			230
	Total valuation allowances	258				44				20				322				293				52				2			347
	Mortgage loans, net of valuation allowance	$	40,668			$	12,347			$	2,752			$	55,767			$	40,179			$	12,791			$	956		$	53,926
Allowance for Loan and Lease Losses, Provision for Loss, Net	'																																				'
	The changes in the valuation allowance, by portfolio segment, were as follows:
		Commercial				Agricultural				Residential				Total
		(In millions)
	Balance at January 1, 2011	$	562			$	88			$	14			$	664
	Provision (release)	(152		)		(3		)		10				(145		)
	Charge-offs, net of recoveries	(12		)		(4		)		(3		)		(19		)
	Transfers to held-for-sale (1)	—				—				(19		)		(19		)
	Balance at December 31, 2011	398				81				2				481
	Provision (release)	(92		)		—				6				(86		)
	Charge-offs, net of recoveries	(13		)		(24		)		—				(37		)
	Transfers to held-for-sale (1)	—				(5		)		(6		)		(11		)
	Balance at December 31, 2012	293				52				2				347
	Provision (release)	(35		)		4				18				(13		)
	Charge-offs, net of recoveries	—				(12		)		—				(12		)
	Transfers to held-for-sale	—				—				—				—
	Balance at December 31, 2013	$	258			$	44			$	20			$	322
	______________
	-1	The valuation allowance on and the related carrying value of certain residential mortgage loans held-for-investment were transferred to mortgage loans held-for-sale in connection with the MetLife Bank Divestiture. See Note 3.
Schedule of Financing Receivables, Non Accrual Status	'																																				'
	The Company has a high quality, well performing mortgage loan portfolio, with 99% of all mortgage loans classified as performing at both December 31, 2013 and 2012. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days. The past due and accrual status of mortgage loans at recorded investment, prior to valuation allowances, by portfolio segment, were as follows at:
		Past Due								Greater than 90 Days Past Due								Nonaccrual Status
										and Still Accruing Interest
		31-Dec-13				31-Dec-12				31-Dec-13				31-Dec-12				31-Dec-13				31-Dec-12
		(In millions)
	Commercial	$	12			$	2			$	12			$	—			$	191			$	84
	Agricultural	44				116				—				53				47				67
	Residential	79				29				—				—				65				18
	Total	$	135			$	147			$	12			$	53			$	303			$	169
Impaired mortgage loans held-for-investment	'																																				'
	Impaired mortgage loans held-for-investment, including those modified in a troubled debt restructuring, by portfolio segment, were as follows at and for the years ended:
		Loans with a Valuation Allowance																Loans without a Valuation Allowance								All Impaired Loans
		Unpaid				Recorded				Valuation				Carrying				Unpaid				Recorded				Unpaid			Carrying			Average			Interest
		Principal				Investment				Allowances				Value				Principal				Investment				Principal			Value			Recorded			Income
		Balance																Balance								Balance						Investment
		(In millions)
	December 31, 2013:
	Commercial	$	214			$	210			$	58			$	152			$	299			$	296			$	513		$	448		$	526		$	15
	Agricultural	68				66				7				59				35				34				103			93			153			9
	Residential	12				12				1				11				5				4				17			15			14			—
	Total	$	294			$	288			$	66			$	222			$	339			$	334			$	633		$	556		$	693		$	24
	December 31, 2012:
	Commercial	$	445			$	436			$	94			$	342			$	103			$	103			$	548		$	445		$	464		$	14
	Agricultural	110				107				21				86				79				74				189			160			204			8
	Residential	13				13				2				11				—				—				13			11			13			—
	Total	$	568			$	556			$	117			$	439			$	182			$	177			$	750		$	616		$	681		$	22
Mortgage loans modified in a troubled debt restructuring	'																																				'
	For a small portion of the mortgage loan portfolio, classified as troubled debt restructurings, concessions are granted related to borrowers experiencing financial difficulties. Generally, the types of concessions include: reduction of the contractual interest rate, extension of the maturity date at an interest rate lower than current market interest rates, and/or a reduction of accrued interest. The amount, timing and extent of the concession granted is considered in determining any impairment or changes in the specific valuation allowance recorded with the restructuring. Through the continuous monitoring process, a specific valuation allowance may have been recorded prior to the quarter when the mortgage loan is modified in a troubled debt restructuring. Accordingly, the carrying value (after specific valuation allowance) before and after modification through a troubled debt restructuring may not change significantly, or may increase if the expected recovery is higher than the pre-modification recovery assessment. The number of mortgage loans and carrying value after specific valuation allowance of mortgage loans modified during the period in a troubled debt restructuring were as follows:
		Years Ended December 31,
		2013											2012
		Number of			Carrying Value after Specific								Number of			Carrying Value after Specific
		Mortgage Loans			Valuation Allowance								Mortgage Loans			Valuation Allowance
					Pre-Modification				Post-Modification							Pre-Modification				Post-Modification
					(In millions)											(In millions)
	Commercial	1			$	49			$	49			1			$	222			$	199
	Agricultural	3			28				28				5			17				16
	Residential	27			5				5				—			—				—
	Total	31			$	82			$	82			6			$	239			$	215
Investment in leveraged leases	'																																				'
	Investment in leveraged leases consisted of the following at:
		December 31,
		2013				2012
		(In millions)
	Rental receivables, net	$	1,491			$	1,564
	Estimated residual values	1,325				1,474
	Subtotal	2,816				3,038
	Unearned income	(870		)		(1,040		)
	Investment in leveraged leases, net of non-recourse debt	$	1,946			$	1,998
Net income from investment in leveraged leases	'																																				'
	The components of income from investment in leveraged leases, excluding net investment gains (losses), were as follows:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Income from investment in leveraged leases	$	82			$	57			$	125
	Less: Income tax expense on leveraged leases	29				20				44
	Investment income after income tax from investment in leveraged leases	$	53			$	37			$	81
Components of net unrealized investment gains (losses) included in accumulated other comprehensive income (loss)	'																																				'
	The components of net unrealized investment gains (losses), included in AOCI, were as follows:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Fixed maturity securities	$	16,672			$	33,641			$	21,096
	Fixed maturity securities with noncredit OTTI losses in AOCI	(218		)		(361		)		(724		)
	Total fixed maturity securities	16,454				33,280				20,372
	Equity securities	390				97				(167		)
	Derivatives	375				1,274				1,514
	Other	(73		)		(30		)		72
	Subtotal	17,146				34,621				21,791
	Amounts allocated from:
	Insurance liability loss recognition	(898		)		(6,049		)		(3,996		)
	DAC and VOBA related to noncredit OTTI losses recognized in AOCI	6				19				47
	DAC and VOBA	(1,190		)		(2,485		)		(1,800		)
	Policyholder dividend obligation	(1,771		)		(3,828		)		(2,919		)
	Subtotal	(3,853		)		(12,343		)		(8,668		)
	Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	73				119				236
	Deferred income tax benefit (expense)	(4,956		)		(7,973		)		(4,694		)
	Net unrealized investment gains (losses)	8,410				14,424				8,665
	Net unrealized investment gains (losses) attributable to noncontrolling interests	4				(5		)		9
	Net unrealized investment gains (losses) attributable to MetLife, Inc.	$	8,414			$	14,419			$	8,674
	The changes in net unrealized investment gains (losses) were as follows:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Balance at January 1,	$	14,419			$	8,674			$	3,122
	Fixed maturity securities on which noncredit OTTI losses have been recognized	143				363				(123		)
	Unrealized investment gains (losses) during the year	(17,618		)		12,467				14,823
	Unrealized investment gains (losses) of subsidiary at the date of disposal	—				—				(105		)
	Unrealized investment gains (losses) relating to:
	Insurance liability gain (loss) recognition	5,151				(2,053		)		(3,406		)
	Insurance liability gain (loss) recognition of subsidiary at the date of disposal	—				—				82
	DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(13		)		(28		)		9
	DAC and VOBA	1,295				(685		)		(808		)
	DAC and VOBA of subsidiary at date of disposal	—				—				11
	Policyholder dividend obligation	2,057				(909		)		(2,043		)
	Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	(46		)		(117		)		39
	Deferred income tax benefit (expense)	3,017				(3,279		)		(2,936		)
	Deferred income tax benefit (expense) of subsidiary at date of disposal	—				—				4
	Net unrealized investment gains (losses)	8,405				14,433				8,669
	Net unrealized investment gains (losses) attributable to noncontrolling interests	9				(14		)		5
	Balance at December 31,	$	8,414			$	14,419			$	8,674
	Change in net unrealized investment gains (losses)	$	(6,014	)		$	5,759			$	5,547
	Change in net unrealized investment gains (losses) attributable to noncontrolling interests	9				(14		)		5
	Change in net unrealized investment gains (losses) attributable to MetLife, Inc.	$	(6,005	)		$	5,745			$	5,552
Other than temporary impairment, credit losses recongnized earnings	'																																				'
	The changes in fixed maturity securities with noncredit OTTI losses included in AOCI were as follows:
		Years Ended December 31,
		2013				2012
		(In millions)
	Balance at January 1,	$	(361	)		$	(724	)
	Noncredit OTTI losses and subsequent changes recognized (1)	60				(29		)
	Securities sold with previous noncredit OTTI loss	149				177
	Subsequent changes in estimated fair value	(66		)		215
	Balance at December 31,	$	(218	)		$	(361	)
	______________
	-1	Noncredit OTTI losses and subsequent changes recognized, net of DAC, were $52 million and ($21) million for the years ended December 31, 2013 and 2012, respectively.
Securities Lending	'																																				'
	Elements of the securities lending program are presented below at:
		December 31,
		2013				2012
		(In millions)
	Securities on loan: (1)
	Amortized cost	$	27,094			$	23,380
	Estimated fair value	$	27,595			$	27,077
	Cash collateral on deposit from counterparties (2)	$	28,319			$	27,727
	Security collateral on deposit from counterparties (3)	$	—			$	104
	Reinvestment portfolio — estimated fair value	$	28,481			$	28,112
	______________
	-1	Included within fixed maturity securities, short-term investments, equity securities and cash and cash equivalents.
	-2	Included within payables for collateral under securities loaned and other transactions.
	-3	Security collateral on deposit from counterparties may not be sold or repledged, unless the counterparty is in default, and is not reflected in the consolidated financial statements.
Invested Assets on Deposit, Held in Trust and Pledged as Collateral	'																																				'
	Invested assets on deposit, held in trust and pledged as collateral are presented below at estimated fair value for cash and cash equivalents, short-term investments, fixed maturity and equity securities, and FVO and trading securities, and at carrying value for mortgage loans at:
		December 31,
		2013				2012
		(In millions)
	Invested assets on deposit (regulatory deposits)	$	2,153			$	2,362
	Invested assets held in trust (collateral financing arrangements and reinsurance agreements)	11,004				12,434
	Invested assets pledged as collateral (1)	23,770				23,251
	Total invested assets on deposit, held in trust and pledged as collateral	$	36,927			$	38,047
	______________
	-1	The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Notes 4 and 12), collateral financing arrangements (see Note 13) and derivative transactions (see Note 9).
Purchased credit impaired investments, by invested asset class, held	'																																				'
	The following table presents information about PCI investments acquired during the periods indicated:
		Years Ended December 31,
		2013				2012				2013				2012
		Fixed Maturity Securities								Mortgage Loans
		(In millions)
	Contractually required payments (including interest)	$	1,872			$	2,083			$	—			$	—
	Cash flows expected to be collected (1)	$	1,446			$	1,524			$	—			$	—
	Fair value of investments acquired	$	978			$	991			$	—			$	—
	______________
	-1	Represents undiscounted principal and interest cash flow expectations, at the date of acquisition.
	The Company’s PCI investments, by invested asset class, were as follows at:
		December 31,
		2013				2012				2013				2012
		Fixed Maturity Securities								Mortgage Loans
		(In millions)
	Outstanding principal and interest balance (1)	$	5,319			$	4,905			$	291			$	440
	Carrying value (2)	$	4,109			$	3,900			$	138			$	199
	______________
	-1	Represents the contractually required payments, which is the sum of contractual principal, whether or not currently due, and accrued interest.
	-2	Estimated fair value plus accrued interest for fixed maturity securities and amortized cost, plus accrued interest, less any valuation allowances, for mortgage loans.
	The following table presents activity for the accretable yield on PCI investments:
		Years Ended December 31,
		2013				2012				2013				2012
		Fixed Maturity Securities								Mortgage Loans
		(In millions)
	Accretable yield, January 1,	$	2,665			$	2,311			$	184			$	254
	Investments purchased	468				533				—				—
	Accretion recognized in earnings	(260		)		(203		)		(87		)		(71		)
	Disposals	(152		)		(102		)		—				—
	Reclassification (to) from nonaccretable difference	25				126				(23		)		1
	Accretable yield, December 31,	$	2,746			$	2,665			$	74			$	184
The Components of Net Investment Income	'																																				'
	The components of net investment income were as follows:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Investment income:
	Fixed maturity securities	$	15,071			$	15,218			$	15,037
	Equity securities	127				133				141
	FVO and trading securities — Actively Traded Securities and FVO general account securities (1)	65				88				31
	Mortgage loans	3,020				3,191				3,164
	Policy loans	620				626				641
	Real estate and real estate joint ventures	909				834				688
	Other limited partnership interests	955				845				681
	Cash, cash equivalents and short-term investments	181				163				167
	International joint ventures	10				19				(12		)
	Other	165				131				178
	Subtotal	21,123				21,248				20,716
	Less: Investment expenses	1,198				1,090				1,019
	Subtotal, net	19,925				20,158				19,697
	FVO and trading securities — FVO contractholder-directed unit-linked investments (1)	2,172				1,473				(453		)
	Securitized reverse residential mortgage loans	—				177				—
	FVO CSEs - interest income:
	Commercial mortgage loans	132				172				332
	Securities	3				4				9
	Subtotal	2,307				1,826				(112		)
	Net investment income	$	22,232			$	21,984			$	19,585
	______________
	-1	Changes in estimated fair value subsequent to purchase for securities still held as of the end of the respective years included in net investment income were as follows:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Actively Traded Securities and FVO general account securities	$	18			$	51			$	(3	)
	FVO contractholder-directed unit-linked investments	$	1,579			$	1,170			$	(647	)
The components of net investment gains (losses)	'																																				'
	The components of net investment gains (losses) were as follows:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Total gains (losses) on fixed maturity securities:
	Total OTTI losses recognized — by sector and industry:
	U.S. and foreign corporate securities — by industry:
	Utility	$	(48	)		$	(61	)		$	(10	)
	Consumer	(11		)		(19		)		(50		)
	Finance	(10		)		(32		)		(56		)
	Transportation	(3		)		(17		)		—
	Communications	(2		)		(19		)		(41		)
	Technology	—				(6		)		(1		)
	Industrial	—				(5		)		(11		)
	Total U.S. and foreign corporate securities	(74		)		(159		)		(169		)
	RMBS	(80		)		(97		)		(214		)
	CMBS	(12		)		(51		)		(32		)
	ABS	—				(9		)		(54		)
	State and political subdivision	—				(1		)		—
	Foreign government	—				—				(486		)
	OTTI losses on fixed maturity securities recognized in earnings	(166		)		(317		)		(955		)
	Fixed maturity securities — net gains (losses) on sales and disposals	561				253				25
	Total gains (losses) on fixed maturity securities (1)	395				(64		)		(930		)
	Total gains (losses) on equity securities:
	Total OTTI losses recognized — by sector:
	Non-redeemable preferred stock	(20		)		—				(38		)
	Common stock	(6		)		(34		)		(22		)
	OTTI losses on equity securities recognized in earnings	(26		)		(34		)		(60		)
	Equity securities — net gains (losses) on sales and disposals	31				38				37
	Total gains (losses) on equity securities	5				4				(23		)
	FVO and trading securities — FVO general account securities	15				17				(2		)
	Mortgage loans (1)	22				57				175
	Real estate and real estate joint ventures	(19		)		(36		)		134
	Other limited partnership interests	(48		)		(36		)		4
	Other investment portfolio gains (losses)	22				(151		)		(7		)
	Subtotal — investment portfolio gains (losses) (1)	392				(209		)		(649		)
	FVO CSEs:
	Commercial mortgage loans	(52		)		7				(84		)
	Securities	2				—				—
	Long-term debt — related to commercial mortgage loans	85				25				97
	Long-term debt — related to securities	(2		)		(7		)		(8		)
	Non-investment portfolio gains (losses) (2)	(264		)		(168		)		(223		)
	Subtotal FVO CSEs and non-investment portfolio gains (losses)	(231		)		(143		)		(218		)
	Total net investment gains (losses)	$	161			$	(352	)		$	(867	)
	______________
	-1	Investment portfolio gains (losses) for the years ended December 31, 2012 and 2011 includes a net gain (loss) of $37 million and ($153) million, respectively, as a result of the MetLife Bank Divestiture, which is comprised of gains (losses) on investments sold of $78 million and $1 million, respectively, and impairments on mortgage loans of ($41) million and ($154) million, respectively. See Note 3.
	-2	Non-investment portfolio gains (losses) for the years ended December 31, 2013 and 2012 includes a gain of $30 million and $33 million, respectively, related to certain dispositions as more fully described in Note 3. Non-investment portfolio gains (losses) for the year ended December 31, 2011 includes a loss of $106 million related to certain dispositions and a goodwill impairment loss of $65 million. See Notes 3 and 11.
Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains and losses	'																																				'
	Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) are as shown in the table below. Investment gains and losses on sales of securities are determined on a specific identification basis.
		Years Ended December 31,
		2013				2012				2011				2013				2012				2011				2013			2012			2011
		Fixed Maturity Securities												Equity Securities												Total
		(In millions)
	Proceeds	$	76,070			$	59,219			$	67,449			$	746			$	1,648			$	1,241			$	76,816		$	60,867		$	68,690
	Gross investment gains	$	1,326			$	944			$	892			$	56			$	73			$	108			$	1,382		$	1,017		$	1,000
	Gross investment losses	(765		)		(691		)		(867		)		(25		)		(35		)		(71		)		(790		)	(726		)	(938		)
	Total OTTI losses:
	Credit-related	(147		)		(223		)		(645		)		—				—				—				(147		)	(223		)	(645		)
	Other (1)	(19		)		(94		)		(310		)		(26		)		(34		)		(60		)		(45		)	(128		)	(370		)
	Total OTTI losses	(166		)		(317		)		(955		)		(26		)		(34		)		(60		)		(192		)	(351		)	(1,015		)
	Net investment gains (losses)	$	395			$	(64	)		$	(930	)		$	5			$	4			$	(23	)		$	400		$	(60	)	$	(953	)
	______________
	-1	Other OTTI losses recognized in earnings include impairments on (i) equity securities, (ii) perpetual hybrid securities classified within fixed maturity securities where the primary reason for the impairment was the severity and/or the duration of an unrealized loss position and (iii) fixed maturity securities where there is an intent to sell or it is more likely than not that the Company will be required to sell the security before recovery of the decline in estimated fair value.
Rollforward of the Cumulative Credit Loss Component of OTTI income (loss)	'																																				'
	The table below presents a rollforward of the cumulative credit loss component of OTTI loss recognized in earnings on fixed maturity securities still held for which a portion of the OTTI loss was recognized in OCI:
		Years Ended December 31,
		2013				2012
		(In millions)
	Balance at January 1,	$	392			$	471
	Additions:
	Initial impairments — credit loss OTTI recognized on securities not previously impaired	6				46
	Additional impairments — credit loss OTTI recognized on securities previously impaired	69				70
	Reductions:
	Sales (maturities, pay downs or prepayments) during the period of securities previously impaired as credit loss OTTI	(87		)		(176		)
	Securities impaired to net present value of expected future cash flows	—				(17		)
	Increases in cash flows — accretion of previous credit loss OTTI	(2		)		(2		)
	Balance at December 31,	$	378			$	392
Variable Interest Entity, Primary Beneficiary [Member]	'																																				'
Variable Interest Entity [Line Items]	'																																				'
Schedule of Variable Interest Entities [Table Text Block]	'																																				'
	The following table presents the total assets and total liabilities relating to VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at December 31, 2013 and 2012. Creditors or beneficial interest holders of VIEs where the Company is the primary beneficiary have no recourse to the general credit of the Company, as the Company’s obligation to the VIEs is limited to the amount of its committed investment.
		December 31,
		2013								2012
		Total				Total				Total				Total
		Assets				Liabilities				Assets				Liabilities
		(In millions)
	MRSC (collateral financing arrangement (primarily securities)) (1)	$	3,440			$	—			$	3,439			$	—
	Operating joint venture (2)	2,095				1,777				—				—
	CSEs (assets (primarily loans) and liabilities (primarily debt)) (3)	1,630				1,457				2,730				2,545
	Investments:
	Real estate joint ventures (4)	1,181				443				11				14
	Other invested assets	82				7				85				—
	FVO and trading securities	69				—				71				—
	Other limited partnership interests	61				—				356				8
	Total	$	8,558			$	3,684			$	6,692			$	2,567
	______________
	-1	See Note 13 for a description of the MetLife Reinsurance Company of South Carolina (“MRSC”) collateral financing arrangement.
	-2	Assets of the operating joint venture are primarily fixed maturity securities and separate account assets. Liabilities of the operating joint venture are primarily future policy benefits, other policyholder funds and separate account liabilities. The assets and liabilities of the operating joint venture were consolidated in earlier periods; however, as a result of the quarterly reassessment in the first quarter of 2013, it was determined to be a consolidated VIE.
	-3	The Company consolidates entities that are structured as CMBS and as collateralized debt obligations. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company’s exposure was limited to that of its remaining investment in these entities of $154 million and $168 million at estimated fair value at December 31, 2013 and 2012, respectively. The long-term debt bears interest primarily at fixed rates ranging from 2.25% to 5.57%, payable primarily on a monthly basis. Interest expense related to these obligations, included in other expenses, was $122 million, $163 million and $324 million for the years ended December 31, 2013, 2012 and 2011 respectively.
	-4	The Company consolidated an open ended core real estate fund formed in the fourth quarter of 2013, which represented the majority of the balances at December 31, 2013. Assets of the real estate fund are a real estate investment trust which holds primarily traditional core income-producing real estate which has associated liabilities that are primarily non-recourse debt secured by certain real estate assets of the fund. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company’s exposure was limited to that of its investment in the real estate fund of $178 million at carrying value at December 31, 2013. The long-term debt bears interest primarily at fixed rates ranging from 1.39% to 4.45%, payable primarily on a monthly basis. Interest expense related to these obligations, included in other expenses, was less than $1 million for the year ended December 31, 2013.
Variable Interest Entity, Not Primary Beneficiary [Member]	'																																				'
Variable Interest Entity [Line Items]	'																																				'
Schedule of Variable Interest Entities [Table Text Block]	'																																				'
	The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at:
		December 31,
		2013								2012
		Carrying				Maximum				Carrying				Maximum
		Amount				Exposure				Amount				Exposure
						to Loss (1)								to Loss (1)
		(In millions)
	Fixed maturity securities AFS:
	Structured securities (RMBS, CMBS and ABS) (2)	$	67,176			$	67,176			$	72,605			$	72,605
	U.S. and foreign corporate	3,966				3,966				5,287				5,287
	Other limited partnership interests	5,041				6,994				4,436				5,908
	Other invested assets	1,509				1,897				1,117				1,431
	FVO and trading securities	619				619				563				563
	Mortgage loans	106				106				351				351
	Real estate joint ventures	70				71				150				157
	Equity securities AFS:
	Non-redeemable preferred stock	35				35				32				32
	Total	$	78,522			$	80,864			$	84,541			$	86,334
	______________
	-1	The maximum exposure to loss relating to fixed maturity securities AFS, FVO and trading securities and equity securities AFS is equal to their carrying amounts or the carrying amounts of retained interests. The maximum exposure to loss relating to other limited partnership interests, mortgage loans and real estate joint ventures is equal to the carrying amounts plus any unfunded commitments of the Company. For certain of its investments in other invested assets, the Company’s return is in the form of income tax credits which are guaranteed by creditworthy third parties. For such investments, the maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments, reduced by income tax credits guaranteed by third parties of $257 million and $318 million at December 31, 2013 and 2012, respectively. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee.
	-2	For these variable interests, the Company’s involvement is limited to that of a passive investor.
Commercial mortgage loans portfolio segment [Member]	'																																				'
Mortgage Loans on Real Estate [Line Items]	'																																				'
Disclosure of the mortgage loans portfolio segment by the recorded investment, prior to valuation allowances, by credit quality indicator categories	'																																				'
	The credit quality of commercial mortgage loans held-for-investment, were as follows at:
		Recorded Investment																			Estimated				% of
		Debt Service Coverage Ratios												Total				% of			Fair				Total
		> 1.20x				1.00x - 1.20x				< 1.00x								Total			Value
		(In millions)																			(In millions)
	December 31, 2013:
	Loan-to-value ratios:
	Less than 65%	$	30,552			$	614			$	841			$	32,007			78.2	%		$	33,519			78.9	%
	65% to 75%	6,360				438				149				6,947				17			7,039				16.6
	76% to 80%	525				192				189				906				2.2			892				2.1
	Greater than 80%	661				242				163				1,066				2.6			1,006				2.4
	Total	$	38,098			$	1,486			$	1,342			$	40,926			100	%		$	42,456			100	%
	December 31, 2012:
	Loan-to-value ratios:
	Less than 65%	$	29,839			$	730			$	722			$	31,291			77.3	%		$	33,730			78.3	%
	65% to 75%	5,057				672				153				5,882				14.6			6,129				14.2
	76% to 80%	938				131				316				1,385				3.4			1,436				3.3
	Greater than 80%	1,085				552				277				1,914				4.7			1,787				4.2
	Total	$	36,919			$	2,085			$	1,468			$	40,472			100	%		$	43,082			100	%
Agricultural Portfolio Segment [Member]	'																																				'
Mortgage Loans on Real Estate [Line Items]	'																																				'
Disclosure of the mortgage loans portfolio segment by the recorded investment, prior to valuation allowances, by credit quality indicator categories	'																																				'
	The credit quality of agricultural mortgage loans held-for-investment, were as follows at:
		December 31,
		2013							2012
		Recorded				% of			Recorded				% of
		Investment				Total			Investment				Total
		(In millions)							(In millions)
	Loan-to-value ratios:
	Less than 65%	$	11,461			92.5	%		$	11,908			92.7	%
	65% to 75%	729				5.9			590				4.6
	76% to 80%	84				0.7			92				0.7
	Greater than 80%	117				0.9			253				2
	Total	$	12,391			100	%		$	12,843			100	%
Residential mortgage loans portfolio segment [Member]	'																																				'
Mortgage Loans on Real Estate [Line Items]	'																																				'
Disclosure of the mortgage loans portfolio segment by the recorded investment, prior to valuation allowances, by credit quality indicator categories	'																																				'
	The credit quality of residential mortgage loans held-for-investment, were as follows at:
		December 31,
		2013							2012
		Recorded				% of			Recorded				% of
		Investment				Total			Investment				Total
		(In millions)							(In millions)
	Performance indicators:
	Performing	$	2,693			97.1	%		$	929			97	%
	Nonperforming	79				2.9			29				3
	Total	$	2,772			100	%		$	958			100	%

Derivatives_Tables

Derivatives (Tables)	12 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location	'
	The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company’s derivatives, excluding embedded derivatives, held at:
		Primary Underlying Risk Exposure		December 31,
				2013												2012
								Estimated Fair Value												Estimated Fair Value
				Notional				Assets				Liabilities				Notional				Assets			Liabilities
				Amount												Amount
				(In millions)
	Derivatives Designated as Hedging Instruments
	Fair value hedges:
	Interest rate swaps	Interest rate		$	6,419			$	1,282			$	78			$	5,397			$	1,921		$	90
	Foreign currency swaps	Foreign currency exchange rate		2,713				252				135				3,187				332			85
	Foreign currency forwards	Foreign currency exchange rate		2,935				—				77				—				—			—
	Subtotal			12,067				1,534				290				8,584				2,253			175
	Cash flow hedges:
	Interest rate swaps	Interest rate		3,121				83				141				3,642				705			—
	Interest rate forwards	Interest rate		450				7				7				675				139			—
	Foreign currency swaps	Foreign currency exchange rate		12,452				401				660				9,038				219			355
	Subtotal			16,023				491				808				13,355				1,063			355
	Foreign operations hedges:
	Foreign currency forwards	Foreign currency exchange rate		3,182				82				47				2,552				43			61
	Currency options	Foreign currency exchange rate		7,362				318				—				4,375				43			3
	Subtotal			10,544				400				47				6,927				86			64
	Total qualifying hedges			38,634				2,425				1,145				28,866				3,402			594
	Derivatives Not Designated or Not Qualifying as Hedging Instruments
	Interest rate swaps	Interest rate		107,354				3,330				1,767				83,250				5,201			2,043
	Interest rate floors	Interest rate		63,064				451				346				56,246				1,174			837
	Interest rate caps	Interest rate		39,460				177				—				49,465				74			—
	Interest rate futures	Interest rate		6,011				9				9				11,684				1			38
	Interest rate options	Interest rate		40,978				255				243				16,328				640			60
	Synthetic GICs	Interest rate		4,409				—				—				4,162				—			—
	Foreign currency swaps	Foreign currency exchange rate		9,307				133				684				8,208				199			736
	Foreign currency forwards	Foreign currency exchange rate		11,311				69				359				9,202				26			288
	Currency futures	Foreign currency exchange rate		1,316				1				1				1,408				4			—
	Currency options	Foreign currency exchange rate		2,265				53				48				129				1			—
	Credit default swaps - purchased	Credit		3,725				7				51				3,674				11			34
	Credit default swaps - written	Credit		9,055				166				1				8,879				79			5
	Equity futures	Equity market		5,157				1				43				7,008				14			132
	Equity options	Equity market		37,411				1,344				1,068				22,920				2,825			356
	Variance swaps	Equity market		21,636				174				577				19,830				122			310
	TRRs	Equity market		3,802				—				179				3,092				4			103
	Total non-designated or non-qualifying derivatives			366,261				6,170				5,376				305,485				10,375			4,942
	Total			$	404,895			$	8,595			$	6,521			$	334,351			$	13,777		$	5,536
Components of Net Derivatives Gains (Losses)	'
	The components of net derivative gains (losses) were as follows:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Derivatives and hedging gains (losses) (1)	$	(8,343	)		$	(3,158	)		$	6,108
	Embedded derivatives	5,104				1,239				(1,284		)
	Total net derivative gains (losses)	$	(3,239	)		$	(1,919	)		$	4,824
	______________
	-1	Includes foreign currency transaction gains (losses) on hedged items in cash flow and non-qualifying hedging relationships, which are not presented elsewhere in this note.
Earned Income On Derivatives And Income Statement Location	'
	The following table presents earned income on derivatives:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Qualifying hedges:
	Net investment income	$	135			$	111			$	98
	Interest credited to policyholder account balances	150				164				214
	Other expenses	(6		)		(5		)		(4		)
	Non-qualifying hedges:
	Net investment income	(6		)		(6		)		(8		)
	Other revenues	—				47				75
	Net derivative gains (losses)	328				476				411
	Policyholder benefits and claims	(292		)		(120		)		17
	Total	$	309			$	667			$	803
Amount and location of gains (losses) recognized in income for derivatives that are not designated or qualifying as hedging instruments	'
	The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or qualifying as hedging instruments:
		Net				Net				Policyholder				Other
		Derivative				Investment				Benefits and				Revenues (3)
		Gains (Losses)				Income (1)				Claims (2)
		(In millions)
	Year Ended December 31, 2013:
	Interest rate derivatives	$	(3,458	)		$	—			$	(27	)		$	—
	Foreign currency exchange rate derivatives	(1,716		)		—				—				—
	Credit derivatives — purchased	(21		)		(14		)		—
	Credit derivatives — written	130				1				—				—
	Equity derivatives	(3,663		)		(25		)		(727		)		—
	Total	$	(8,728	)		$	(38	)		$	(754	)		$	—
	Year Ended December 31, 2012:
	Interest rate derivatives	$	(296	)		$	—			$	—			$	28
	Foreign currency exchange rate derivatives	(660		)		—				—				—
	Credit derivatives — purchased	(298		)		(14		)		—				—
	Credit derivatives — written	150				—				—				—
	Equity derivatives	(2,556		)		(9		)		(419		)		—
	Total	$	(3,660	)		$	(23	)		$	(419	)		$	28
	Year Ended December 31, 2011:
	Interest rate derivatives	$	3,940			$	(1	)		$	—			$	236
	Foreign currency exchange rate derivatives	343				(9		)		—				—
	Credit derivatives — purchased	250				6				—				—
	Credit derivatives — written	(75		)		(1		)		—				—
	Equity derivatives	1,178				(35		)		(87		)		—
	Total	$	5,636			$	(40	)		$	(87	)		$	236
	______________
	-1	Changes in estimated fair value related to economic hedges of equity method investments in joint ventures; changes in estimated fair value related to derivatives held in relation to trading portfolios; and changes in estimated fair value related to derivatives held within contractholder-directed unit-linked investments.
	-2	Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits.
	-3	Changes in estimated fair value related to derivatives held in connection with the Company’s mortgage banking activities prior to the MetLife Bank Divestiture.
Net derivatives gains (losses) recognized on fair value derivatives and the related hedged items	'
	The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges within net derivative gains (losses). The following table presents the amount of such net derivative gains (losses):
	Derivatives in Fair Value		Hedged Items in Fair Value		Net Derivative				Net Derivative				Ineffectiveness
	Hedging Relationships		Hedging Relationships		Gains (Losses)				Gains (Losses)				Recognized in
					Recognized				Recognized for				Net Derivative
					for Derivatives				Hedged Items				Gains (Losses)
					(In millions)
	Year Ended December 31, 2013:
	Interest rate swaps:		Fixed maturity securities		$	42			$	(43	)		$	(1	)
			Policyholder liabilities (1)		(830		)		835				5
	Foreign currency swaps:		Foreign-denominated fixed maturity securities		13				(12		)		1
			Foreign-denominated PABs (2)		(97		)		110				13
	Foreign currency forwards:		Foreign-denominated fixed maturity securities		(109		)		102				(7		)
	Total				$	(981	)		$	992			$	11
	Year Ended December 31, 2012:
	Interest rate swaps:		Fixed maturity securities		$	(4	)		$	—			$	(4	)
			Policyholder liabilities (1)		(82		)		96				14
	Foreign currency swaps:		Foreign-denominated fixed maturity securities		(1		)		1				—
			Foreign-denominated PABs (2)		3				(20		)		(17		)
	Foreign currency forwards:		Foreign-denominated fixed maturity securities		(51		)		50				(1		)
	Total				$	(135	)		$	127			$	(8	)
	Year Ended December 31, 2011:
	Interest rate swaps:		Fixed maturity securities		$	(25	)		$	22			$	(3	)
			Policyholder liabilities (1)		1,054				(1,030		)		24
	Foreign currency swaps:		Foreign-denominated fixed maturity securities		1				3				4
			Foreign-denominated PABs (2)		(24		)		(25		)		(49		)
	Foreign currency forwards:		Foreign-denominated fixed maturity securities		(25		)		25				—
	Total				$	981			$	(1,005	)		$	(24	)
	______________
	-1	Fixed rate liabilities reported in PABs or future policy benefits.
	-2	Fixed rate or floating rate liabilities.
Derivatives and Non-Derivative Hedging Instruments in Net Investment Hedging Relationships	'
	The following table presents the effects of derivatives and non‑derivative financial instruments in net investment hedging relationships in the consolidated statements of operations and the consolidated statements of equity:
	Derivatives and Non‑Derivative Hedging Instruments in Net Investment		Amount of Gains (Losses) Deferred in
	Hedging Relationships (1), (2)		AOCI (Effective Portion)
			Years Ended December 31,
			2013				2012				2011
			(In millions)
	Foreign currency forwards		$	69			$	(50	)		$	62
	Currency options		262				36				—
	Non‑derivative hedging instruments		—				—				6
	Total		$	331			$	(14	)		$	68
	______________
	-1	During the years ended December 31, 2013 and 2012, there were no sales or substantial liquidations of net investments in foreign operations that would have required the reclassification of gains or losses from AOCI into earnings. During the year ended December 31, 2011, the Company sold its interest in MSI MetLife, which was a hedged item in a net investment hedging relationship. As a result, the Company released losses of $71 million from AOCI upon the sale. This release did not impact net income for the year ended December 31, 2011 as such losses were considered in the overall impairment evaluation of the investment prior to sale. See Note 3.
	-2	There was no ineffectiveness recognized for the Company’s hedges of net investments in foreign operations. All components of each derivative and non‑derivative hedging instrument’s gain or loss were included in the assessment of hedge effectiveness.
Schedule of estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps	'
	The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:
			December 31,
			2013											2012
	Rating Agency Designation of Referenced		Estimated				Maximum				Weighted			Estimated				Maximum				Weighted
	Credit Obligations (1)		Fair Value				Amount of Future				Average			Fair Value				Amount of Future				Average
			of Credit				Payments under				Years to			of Credit				Payments under				Years to
			Default				Credit Default				Maturity (3)			Default				Credit Default				Maturity (3)
			Swaps				Swaps (2)							Swaps				Swaps (2)
			(In millions)											(In millions)
	Aaa/Aa/A
	Single name credit default swaps (corporate)		$	10			$	545			2.6			$	10			$	777			2.7
	Credit default swaps referencing indices		26				2,739				1.5			42				2,713				2.1
	Subtotal		36				3,284				1.6			52				3,490				2.2
	Baa
	Single name credit default swaps (corporate)		24				1,320				3.1			8				1,314				3.4
	Credit default swaps referencing indices		73				4,071				4.7			11				3,750				4.9
	Subtotal		97				5,391				4.3			19				5,064				4.5
	Ba
	Single name credit default swaps (corporate)		—				5				3.8			—				25				2.7
	Credit default swaps referencing indices		—				—				—			—				—				—
	Subtotal		—				5				3.8			—				25				2.7
	B
	Single name credit default swaps (corporate)		—				—				—			—				—				—
	Credit default swaps referencing indices		32				375				4.9			3				300				4.9
	Subtotal		32				375				4.9			3				300				4.9
	Total		$	165			$	9,055			3.4			$	74			$	8,879			3.6
	______________
	-1	The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), S&P and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.
	-2	Assumes the value of the referenced credit obligations is zero.
	-3	The weighted average years to maturity of the credit default swaps is calculated based on weighted average notional amounts.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral	'
	The estimated fair value of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral was as follows at:
			31-Dec-13								31-Dec-12
	Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement		Assets				Liabilities				Assets				Liabilities
			(In millions)
	Gross estimated fair value of derivatives:
	OTC-bilateral (1)		$	8,537			$	6,367			$	14,048			$	5,480
	OTC-cleared (1)		302				129				—				—
	Exchange-traded		11				53				19				170
	Total gross estimated fair value of derivatives (1)		8,850				6,549				14,067				5,650
	Amounts offset in the consolidated balance sheets		—				—				—				—
	Estimated fair value of derivatives presented in the consolidated balance sheets (1)		8,850				6,549				14,067				5,650
	Gross amounts not offset in the consolidated balance sheets:
	Gross estimated fair value of derivatives: (2)
	OTC-bilateral		(4,631		)		(4,631		)		(4,562		)		(4,562		)
	OTC-cleared		(122		)		(122		)		—				—
	Exchange-traded		(5		)		(5		)		(19		)		(19		)
	Cash collateral: (3)
	OTC-bilateral		(1,679		)		(3		)		(5,960		)		(1		)
	OTC-cleared		(169		)		(7		)		—				—
	Exchange-traded		—				(44		)		—				(151		)
	Securities collateral: (4)
	OTC-bilateral		(2,105		)		(1,464		)		(3,526		)		(875		)
	OTC-cleared		—				—				—				—
	Exchange-traded		—				(4		)		—				—
	Net amount after application of master netting agreements and collateral		$	139			$	269			$	—			$	42
	__________________
	-1	At December 31, 2013 and 2012, derivative assets include income or expense accruals reported in accrued investment income or in other liabilities of $255 million and $290 million, respectively, and derivative liabilities include income or expense accruals reported in accrued investment income or in other liabilities of $28 million and $114 million, respectively.
	-2	Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
	-3	Cash collateral received is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions in the consolidated balance sheets. The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables in the consolidated balance sheets. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At December 31, 2013 and 2012, the Company received excess cash collateral of $104 million and $0, respectively, and provided excess cash collateral of $236 million and $290 million, respectively, which is not included in the table above due to the foregoing limitation.
	-4	Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the consolidated balance sheets. Subject to certain constraints, the Company is permitted by contract to sell or repledge this collateral, but at December 31, 2013 none of the collateral had been sold or repledged. Securities collateral pledged by the Company is reported in fixed maturity securities in the consolidated balance sheets. Subject to certain constraints, the counterparties are permitted by contract to sell or repledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At December 31, 2013 and 2012, the Company received excess securities collateral with an estimated fair value of $238 million and $161 million, respectively, for its OTC-bilateral derivatives which are not included in the table above due to the foregoing limitation. At December 31, 2013 and 2012, the Company provided excess securities collateral with an estimated fair value of $66 million and $0, respectively, for its OTC-bilateral derivatives, $141 million and $0, respectively, for its OTC-cleared derivatives, and $81 million and $40 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
Derivative Instruments, Gain (Loss) [Line Items]	'
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location	'
	The following table presents the effects of derivatives in cash flow hedging relationships on the consolidated statements of operations and the consolidated statements of equity:
	Derivatives in Cash Flow		Amount of Gains				Amount and Location												Amount and Location
	Hedging Relationships		(Losses)Deferred in				of Gains (Losses)												of Gains (Losses)Recognized in Income
			AOCI on Derivatives				Reclassified from												(Loss) on Derivatives
							AOCI into Income (Loss)
			(Effective Portion)				(Effective Portion)												(Ineffective Portion)
							Net Derivative				Net Investment				Other				Net Derivative
							Gains (Losses)				Income				Expenses				Gains (Losses)
			(In millions)
	Year Ended December 31, 2013:
	Interest rate swaps		$	(635	)		$	20			$	8			$	—			$	(3	)
	Interest rate forwards		(59		)		10				3				(1		)		1
	Foreign currency swaps		(165		)		(3		)		(3		)		1				3
	Credit forwards		(4		)		—				1				—				—
	Total		$	(863	)		$	27			$	9			$	—			$	1
	Year Ended December 31, 2012:
	Interest rate swaps		$	(34	)		$	1			$	4			$	(3	)		$	2
	Interest rate forwards		(17		)		1				2				(1		)		—
	Foreign currency swaps		(164		)		23				(5		)		1				(6		)
	Credit forwards		—				—				1				—				—
	Total		$	(215	)		$	25			$	2			$	(3	)		$	(4	)
	Year Ended December 31, 2011:
	Interest rate swaps		$	1,023			$	(42	)		$	1			$	(10	)		$	1
	Interest rate forwards		336				31				1				(1		)		2
	Foreign currency swaps		175				—				(6		)		2				2
	Credit forwards		18				2				1				—				—
	Total		$	1,552			$	(9	)		$	(3	)		$	(9	)		$	5
Schedule of Derivative Instruments	'
	The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The table also presents the incremental collateral that the Company would be required to provide if there was a one notch downgrade in the Company’s credit rating at the reporting date or if the Company’s credit rating sustained a downgrade to a level that triggered full overnight collateralization or termination of the derivative position at the reporting date. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table.
						Estimated Fair Value of								Fair Value of Incremental
						Collateral Provided:								Collateral Provided Upon:
		Estimated				Fixed Maturity				Cash				One Notch				Downgrade in the Company’s
		Fair Value of Derivatives in				Securities								Downgrade in				Credit Rating to a Level
		Net Liability												the Company’s				that Triggers Full Overnight
		Position (1)												Credit Rating				Collateralization or Termination
																		of the Derivative Position
		(In millions)
	December 31, 2013:
	Derivatives subject to credit-contingent provisions	$	1,674			$	1,530			$	—			$	27			$	34
	Derivatives not subject to credit-contingent provisions	20				—				3				—				—
	Total	$	1,694			$	1,530			$	3			$	27			$	34
	December 31, 2012:
	Derivatives subject to credit-contingent provisions	$	771			$	775			$	—			$	35			$	73
	Derivatives not subject to credit-contingent provisions	79				100				1				—				—
	Total	$	850			$	875			$	1			$	35			$	73
	______________
	-1	After taking into consideration the existence of netting agreements.
Embedded Derivative Financial Instruments [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location	'
	The following table presents changes in estimated fair value related to embedded derivatives:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Net derivative gains (losses) (1)	$	5,104			$	1,239			$	(1,284	)
	Policyholder benefits and claims	$	(139	)		$	75			$	86
	______________
	-1	The valuation of guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses), in connection with this adjustment, were ($952) million, ($1.7) billion and $1.8 billion for the years ended December 31, 2013, 2012 and 2011, respectively.
Schedule of Derivative Instruments	'
	The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
				December 31,
		Balance Sheet Location		2013				2012
				(In millions)
	Net embedded derivatives within asset host contracts:
	Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables		$	247			$	439
	Funds withheld on assumed reinsurance	Other invested assets		38				66
	Options embedded in debt or equity securities	Investments		(145		)		(88		)
	Other	Other invested assets		—				1
	Net embedded derivatives within asset host contracts			$	140			$	418
	Net embedded derivatives within liability host contracts:
	Direct guaranteed minimum benefits	PABs		$	(2,296	)		$	923
	Assumed guaranteed minimum benefits	PABs		1,262				2,582
	Funds withheld on ceded reinsurance	Other liabilities		60				162
	Other	PABs		5				17
	Net embedded derivatives within liability host contracts			$	(969	)		$	3,684

Fair_Value_Tables

Fair Value (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Recurring Fair Value Measurements	'
	The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below.
		December 31, 2013
		Fair Value Hierarchy
		Level 1				Level 2				Level 3			Total Estimated
													Fair Value
		(In millions)
	Assets
	Fixed maturity securities:
	U.S. corporate	$	—			$	99,321			$	7,148		$	106,469
	Foreign corporate	—				56,448				6,704			63,152
	Foreign government	—				52,202				2,235			54,437
	U.S. Treasury and agency	25,061				20,000				62			45,123
	RMBS	—				32,098				2,957			35,055
	CMBS	—				15,578				972			16,550
	ABS	—				11,361				4,210			15,571
	State and political subdivision	—				13,820				10			13,830
	Total fixed maturity securities	25,061				300,828				24,298			350,187
	Equity securities:
	Common stock	1,186				990				177			2,353
	Non-redeemable preferred stock	—				654				395			1,049
	Total equity securities	1,186				1,644				572			3,402
	FVO and trading securities:
	Actively Traded Securities	2				648				12			662
	FVO general account securities	518				80				29			627
	FVO contractholder-directed unit-linked investments	10,702				4,806				603			16,111
	FVO securities held by CSEs	—				23				—			23
	Total FVO and trading securities	11,222				5,557				644			17,423
	Short-term investments (1)	5,915				6,943				254			13,112
	Mortgage loans:
	Residential mortgage loans — FVO	—				—				338			338
	Commercial mortgage loans held by CSEs — FVO	—				1,598				—			1,598
	Mortgage loans held-for-sale (2)	—				—				—			—
	Total mortgage loans	—				1,598				338			1,936
	Other invested assets:
	Other investments	188				71				—			259
	Derivative assets: (3)
	Interest rate	10				5,557				27			5,594
	Foreign currency exchange rate	1				1,280				28			1,309
	Credit	—				144				29			173
	Equity market	1				1,233				285			1,519
	Total derivative assets	12				8,214				369			8,595
	Total other invested assets	200				8,285				369			8,854
	Net embedded derivatives within asset host contracts (4)	—				—				285			285
	Separate account assets (5)	89,960				225,776				1,465			317,201
	Total assets	$	133,544			$	550,631			$	28,225		$	712,400
	Liabilities
	Derivative liabilities: (3)
	Interest rate	$	9			$	2,568			$	14		$	2,591
	Foreign currency exchange rate	1				1,971				39			2,011
	Credit	—				52				—			52
	Equity market	43				1,222				602			1,867
	Total derivative liabilities	53				5,813				655			6,521
	Net embedded derivatives within liability host contracts (4)	—				4				(973		)	(969		)
	Long-term debt of CSEs — FVO	—				1,427				28			1,455
	Trading liabilities (6)	260				2				—			262
	Total liabilities	$	313			$	7,246			$	(290	)	$	7,269
		December 31, 2012
		Fair Value Hierarchy
		Level 1				Level 2				Level 3			Total Estimated Fair Value
		(In millions)
	Assets
	Fixed maturity securities:
	U.S. corporate	$	—			$	106,693			$	7,433		$	114,126
Foreign corporate	—				60,976				6,208			67,184
Foreign government	—				55,522				1,814			57,336
U.S. Treasury and agency	27,441				20,455				71			47,967
RMBS	—				35,442				2,037			37,479
CMBS	—				17,982				1,147			19,129
ABS	—				12,341				3,656			15,997
State and political subdivision	—				14,994				54			15,048
Total fixed maturity securities	27,441				324,405				22,420			374,266
Equity securities:
Common stock	932				1,040				190			2,162
Non-redeemable preferred stock	—				310				419			729
Total equity securities	932				1,350				609			2,891
FVO and trading securities:
Actively Traded Securities	7				646				6			659
FVO general account securities	—				151				32			183
FVO contractholder-directed unit-linked investments	9,103				5,425				937			15,465
FVO securities held by CSEs	—				41				—			41
Total FVO and trading securities	9,110				6,263				975			16,348
Short-term investments (1)	9,426				6,295				429			16,150
Mortgage loans:
Residential mortgage loans — FVO	—				—				—			—
Commercial mortgage loans held by CSEs — FVO	—				2,666				—			2,666
Mortgage loans held-for-sale (2)	—				—				49			49
Total mortgage loans	—				2,666				49			2,715
Other invested assets:
Other investments	303				123				—			426
Derivative assets: (3)
Interest rate	1				9,648				206			9,855
Foreign currency exchange rate	4				819				44			867
Credit	—				47				43			90
Equity market	14				2,478				473			2,965
Total derivative assets	19				12,992				766			13,777
Total other invested assets	322				13,115				766			14,203
Net embedded derivatives within asset host contracts (4)	—				1				505			506
Separate account assets (5)	31,620				202,568				1,205			235,393
Total assets	$	78,851			$	556,663			$	26,958		$	662,472
Liabilities
Derivative liabilities: (3)
Interest rate	$	38			$	3,001			$	29		$	3,068
Foreign currency exchange rate	—				1,521				7			1,528
Credit	—				39				—			39
Equity market	132				424				345			901
Total derivative liabilities	170				4,985				381			5,536
Net embedded derivatives within liability host contracts (4)	—				17				3,667			3,684
Long-term debt of CSEs — FVO	—				2,483				44			2,527
Trading liabilities (6)	163				—				—			163
Total liabilities	$	333			$	7,485			$	4,092		$	11,910
______________
-1	Short-term investments as presented in the tables above differ from the amounts presented in the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.
-2	See “— Fair Value Option” for additional information on mortgage loans held-for-sale. The amounts in the preceding tables differ from the amounts presented in the consolidated balance sheets as these tables do not include mortgage loans that are stated at lower of amortized cost or estimated fair value.
-3	Derivative assets are presented within other invested assets in the consolidated balance sheets and derivative liabilities are presented within other liabilities in the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation in the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.
-4	Net embedded derivatives within asset host contracts are presented primarily within premiums, reinsurance and other receivables in the consolidated balance sheets. Net embedded derivatives within liability host contracts are presented primarily within PABs in the consolidated balance sheets. At December 31, 2013 and 2012, equity securities also included embedded derivatives of ($145) million and ($88) million, respectively.
-5	Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets.
-6	Trading liabilities are presented within other liabilities in the consolidated balance sheets.
Fair Value Inputs, Quantitative Information	'
	The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:
								31-Dec-13					31-Dec-12					Impact of
																		Increase in Input
																		on Estimated
		Valuation			Significant			Range				Weighted	Range			Weighted		Fair Value (2)
		Techniques			Unobservable Inputs							Average (1)				Average (1)
	Fixed maturity securities: (3)
	U.S. corporate and foreign corporate	•	Matrix pricing		•	Delta spread adjustments (4)		-10	-	240		46	-50	-	500	90		Decrease
					•	Illiquidity premium (4)		30	-	30		30	30	-	30	30		Decrease
					•	Credit spreads (4)		-1,489	-	876		174	-1,416	-	876	272		Decrease
					•	Offered quotes (5)		4	-	145		100	—	-	348	115		Increase
		•	Consensus pricing		•	Offered quotes (5)		33	-	145		95	—	-	555	92		Increase
	Foreign government	•	Matrix pricing		•	Credit spreads (4)		4	-	72		32	-58	-	150	72		Decrease
		•	Market pricing		•	Quoted prices (5)		64	-	156		100	77	-	146	99		Increase
		•	Consensus pricing		•	Offered quotes (5)		84	-	156		107	82	-	200	117		Increase
	RMBS	•	Matrix pricing and		•	Credit spreads (4)		-136	-	3,609		288	9	-	2,980	521		Decrease (6)
			discounted cash flow
		•	Market pricing		•	Quoted prices (5)		10	-	109		98	13	-	109	100		Increase (6)
		•	Consensus pricing		•	Offered quotes (5)		69	-	101		93	28	-	100	75		Increase (6)
	CMBS	•	Matrix pricing and		•	Credit spreads (4)		215	-	2,025		409	1	-	9,164	374		Decrease (6)
			discounted cash flow
		•	Market pricing		•	Quoted prices (5)		70	-	104		97	1	-	106	99		Increase (6)
		•	Consensus pricing		•	Offered quotes (5)		90	-	101		95						Increase (6)
	ABS	•	Matrix pricing and		•	Credit spreads (4)		30	-	1,878		145	—	-	1,829	109		Decrease (6)
			discounted cash flow
		•	Market pricing		•	Quoted prices (5)		—	-	110		101	40	-	105	100		Increase (6)
		•	Consensus pricing		•	Offered quotes (5)		56	-	106		98	—	-	111	97		Increase (6)
	Derivatives:
	Interest rate	•	Present value techniques		•	Swap yield (7)		248	-	450			186	-	353			Increase (12)
	Foreign currency exchange rate	•	Present value techniques		•	Swap yield (7)		97	-	767			228	-	795			Increase (12)
					•	Correlation (8)		38%	-	47%			43%	-	57%
	Credit	•	Present value techniques		•	Credit spreads (9)		98	-	101			100	-	100			Decrease (9)
		•	Consensus pricing		•	Offered quotes (10)
	Equity market	•	Present value techniques		•	Volatility (11)		13%	-	28%			13%	-	32%			Increase (12)
			or option pricing models
					•	Correlation (8)		60%	-	60%			65%	-	65%
	Embedded derivatives:
	Direct and assumed guaranteed minimum benefits	•	Option pricing		•	Mortality rates:
			techniques
						Ages 0 - 40		0%	-	0.14%			0%	-	0.14%			Decrease (13)
						Ages 41 - 60		0.04%	-	0.88%			0.05%	-	0.88%			Decrease (13)
						Ages 61 - 115		0.26%	-	100%			0.26%	-	100%			Decrease (13)
					•	Lapse rates:
						Durations 1 - 10		0.50%	-	100%			0.50%	-	100%			Decrease (14)
						Durations 11 - 20		2%	-	100%			2%	-	100%			Decrease (14)
						Durations 21 - 116		2%	-	100%			2%	-	100%			Decrease (14)
					•	Utilization rates		20%	-	50%			20%	-	50%			Increase (15)
					•	Withdrawal rates		0%	-	40%			0.07%	-	20%			-16
					•	Long-term equity volatilities		9.14%	-	40%			15.18%	-	40%			Increase (17)
					•	Nonperformance risk spread		-1.08%	-	0.83%			0.10%	-	1.72%			Decrease (18)
	______________
	-1	The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.
	-2	The impact of a decrease in input would have the opposite impact on the estimated fair value. For embedded derivatives, changes are based on liability positions.
	-3	Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.
	-4	Range and weighted average are presented in basis points.
	-5	Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.
	-6	Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.
	-7	Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curve is utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
	-8	Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.
	-9	Represents the risk quoted in basis points of a credit default event on the underlying instrument. The range being provided is a single quoted spread in the valuation model. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.
	-10	At both December 31, 2013 and 2012, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value.
	-11	Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
	-12	Changes are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.
-13	Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-14	Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-15	The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-16	The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.
-17	Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-18	Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.
Fair Value Inputs, Quantitative Information	'
	The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:
								31-Dec-13					31-Dec-12					Impact of
																		Increase in Input
																		on Estimated
		Valuation			Significant			Range				Weighted	Range			Weighted		Fair Value (2)
		Techniques			Unobservable Inputs							Average (1)				Average (1)
	Fixed maturity securities: (3)
	U.S. corporate and foreign corporate	•	Matrix pricing		•	Delta spread adjustments (4)		-10	-	240		46	-50	-	500	90		Decrease
					•	Illiquidity premium (4)		30	-	30		30	30	-	30	30		Decrease
					•	Credit spreads (4)		-1,489	-	876		174	-1,416	-	876	272		Decrease
					•	Offered quotes (5)		4	-	145		100	—	-	348	115		Increase
		•	Consensus pricing		•	Offered quotes (5)		33	-	145		95	—	-	555	92		Increase
	Foreign government	•	Matrix pricing		•	Credit spreads (4)		4	-	72		32	-58	-	150	72		Decrease
		•	Market pricing		•	Quoted prices (5)		64	-	156		100	77	-	146	99		Increase
		•	Consensus pricing		•	Offered quotes (5)		84	-	156		107	82	-	200	117		Increase
	RMBS	•	Matrix pricing and		•	Credit spreads (4)		-136	-	3,609		288	9	-	2,980	521		Decrease (6)
			discounted cash flow
		•	Market pricing		•	Quoted prices (5)		10	-	109		98	13	-	109	100		Increase (6)
		•	Consensus pricing		•	Offered quotes (5)		69	-	101		93	28	-	100	75		Increase (6)
	CMBS	•	Matrix pricing and		•	Credit spreads (4)		215	-	2,025		409	1	-	9,164	374		Decrease (6)
			discounted cash flow
		•	Market pricing		•	Quoted prices (5)		70	-	104		97	1	-	106	99		Increase (6)
		•	Consensus pricing		•	Offered quotes (5)		90	-	101		95						Increase (6)
	ABS	•	Matrix pricing and		•	Credit spreads (4)		30	-	1,878		145	—	-	1,829	109		Decrease (6)
			discounted cash flow
		•	Market pricing		•	Quoted prices (5)		—	-	110		101	40	-	105	100		Increase (6)
		•	Consensus pricing		•	Offered quotes (5)		56	-	106		98	—	-	111	97		Increase (6)
	Derivatives:
	Interest rate	•	Present value techniques		•	Swap yield (7)		248	-	450			186	-	353			Increase (12)
	Foreign currency exchange rate	•	Present value techniques		•	Swap yield (7)		97	-	767			228	-	795			Increase (12)
					•	Correlation (8)		38%	-	47%			43%	-	57%
	Credit	•	Present value techniques		•	Credit spreads (9)		98	-	101			100	-	100			Decrease (9)
		•	Consensus pricing		•	Offered quotes (10)
	Equity market	•	Present value techniques		•	Volatility (11)		13%	-	28%			13%	-	32%			Increase (12)
			or option pricing models
					•	Correlation (8)		60%	-	60%			65%	-	65%
	Embedded derivatives:
	Direct and assumed guaranteed minimum benefits	•	Option pricing		•	Mortality rates:
			techniques
						Ages 0 - 40		0%	-	0.14%			0%	-	0.14%			Decrease (13)
						Ages 41 - 60		0.04%	-	0.88%			0.05%	-	0.88%			Decrease (13)
						Ages 61 - 115		0.26%	-	100%			0.26%	-	100%			Decrease (13)
					•	Lapse rates:
						Durations 1 - 10		0.50%	-	100%			0.50%	-	100%			Decrease (14)
						Durations 11 - 20		2%	-	100%			2%	-	100%			Decrease (14)
						Durations 21 - 116		2%	-	100%			2%	-	100%			Decrease (14)
					•	Utilization rates		20%	-	50%			20%	-	50%			Increase (15)
					•	Withdrawal rates		0%	-	40%			0.07%	-	20%			-16
					•	Long-term equity volatilities		9.14%	-	40%			15.18%	-	40%			Increase (17)
					•	Nonperformance risk spread		-1.08%	-	0.83%			0.10%	-	1.72%			Decrease (18)
	______________
	-1	The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.
	-2	The impact of a decrease in input would have the opposite impact on the estimated fair value. For embedded derivatives, changes are based on liability positions.
	-3	Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.
	-4	Range and weighted average are presented in basis points.
	-5	Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.
	-6	Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.
	-7	Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curve is utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
	-8	Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.
	-9	Represents the risk quoted in basis points of a credit default event on the underlying instrument. The range being provided is a single quoted spread in the valuation model. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.
	-10	At both December 31, 2013 and 2012, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value.
	-11	Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.
	-12	Changes are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.
-13	Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-14	Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-15	The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-16	The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.
-17	Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.
-18	Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.
Fair Value, Measured on Recurring Basis, Unobservable Input Reconciliation	'
	The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):
		Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
		Fixed Maturity Securities:
		U.S.				Foreign				Foreign			U.S.			RMBS			CMBS			ABS			State and
		Corporate				Corporate				Government			Treasury												Political
													and Agency												Subdivision
		(In millions)
	Year Ended December 31, 2013:
	Balance at January 1,	$	7,433			$	6,208			$	1,814		$	71		$	2,037		$	1,147		$	3,656		$	54
	Total realized/unrealized gains (losses) included in:
	Net income (loss): (1), (2)
	Net investment income	10				9				9			—			31			5			8			—
	Net investment gains (losses)	(31		)		(33		)		8			—			(3		)	(14		)	5			—
	Net derivative gains (losses)	—				—				—			—			—			—			—			—
	Other revenues	—				—				—			—			—			—			—			—
	Policyholder benefits and claims	—				—				—			—			—			—			—			—
	Other expenses	—				—				—			—			—			—			—			—
	OCI	(94		)		(75		)		(84		)	(3		)	155			(45		)	(70		)	(1		)
	Purchases (3)	1,555				1,972				734			—			1,155			546			1,870			—
	Sales (3)	(1,178		)		(999		)		(128		)	(6		)	(399		)	(450		)	(814		)	(7		)
	Issuances (3)	—				—				—			—			—			—			—			—
	Settlements (3)	—				—				—			—			—			—			—			—
	Transfers into Level 3 (4)	1,092				310				81			—			56			114			33			—
	Transfers out of Level 3 (4)	(1,639		)		(688		)		(199		)	—			(75		)	(331		)	(478		)	(36		)
	Balance at December 31,	$	7,148			$	6,704			$	2,235		$	62		$	2,957		$	972		$	4,210		$	10
	Changes in unrealized gains (losses) included in net income (loss): (5)
	Net investment income	$	8			$	8			$	9		$	—		$	36		$	3		$	1		$	—
	Net investment gains (losses)	$	(39	)		$	(3	)		$	—		$	—		$	(3	)	$	(12	)	$	—		$	—
	Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
		Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
		Equity Securities:								FVO and Trading Securities:												Mortgage Loans:
		Common				Non-				Actively			FVO			FVO			Short-term			Residential			Mortgage
		Stock				redeemable				Traded			General			Contractholder-			Investments			Mortgage			Loans Held-
						Preferred				Securities			Account			directed						Loans - FVO			for-sale
						Stock							Securities			Unit-linked
																Investments
		(In millions)
	Year Ended December 31, 2013:
	Balance at January 1,	$	190			$	419			$	6		$	32		$	937		$	429		$	—		$	49
	Total realized/unrealized gains (losses) included in:
	Net income (loss): (1), (2)
	Net investment income	—				—				—			6			(8		)	3			1			—
	Net investment gains (losses)	26				(32		)		—			6			—			(23		)	—			—
	Net derivative gains (losses)	—				—				—			—			—			—			—			—
	Other revenues	—				—				—			—			—			—			—			—
	Policyholder benefits and claims	—				—				—			—			—			—			—			—
	Other expenses	—				—				—			—			—			—			—			—
	OCI	—				100				—			—			—			17			—			—
	Purchases (3)	9				21				9			—			340			256			339			—
	Sales (3)	(45		)		(113		)		—			(30		)	(608		)	(427		)	(2		)	(45		)
	Issuances (3)	—				—				—			—			—			—			—			—
	Settlements (3)	—				—				—			—			—			—			—			(4		)
	Transfers into Level 3 (4)	1				—				—			15			235			—			—			—
	Transfers out of Level 3 (4)	(4		)		—				(3		)	—			(293		)	(1		)	—			—
	Balance at December 31,	$	177			$	395			$	12		$	29		$	603		$	254		$	338		$	—
	Changes in unrealized gains (losses) included in net income (loss): (5)
	Net investment income	$	—			$	—			$	—		$	5		$	(1	)	$	2		$	1		$	—
	Net investment gains (losses)	$	(3	)		$	(20	)		$	—		$	—		$	—		$	—		$	—		$	—
	Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Net Derivatives: (6)
	Interest				Foreign				Credit			Equity			Net			Separate			Long-term
	Rate				Currency							Market			Embedded			Account			Debt of
					Exchange										Derivatives (7)			Assets (8)			CSEs - FVO
					Rate
	(In millions)
Year Ended December 31, 2013:
Balance at January 1,	$	177			$	37			$	43		$	128		$	(3,162	)	$	1,205		$	(44	)
Total realized/unrealized gains(losses) included in:
Net income (loss): (1), (2)
Net investment income	—				—				—			—			—			—			—
Net investment gains (losses)	—				—				—			—			—			35			(2		)
Net derivative gains (losses)	(16		)		(49		)		(12		)	(479		)	5,041			—			—
Other revenues	—				—				—			—			—			—			—
Policyholder benefits and claims	—				—				—			19			(139		)	—			—
Other expenses	—				—				—			—			—			—			—
OCI	(102		)		(1		)		—			—			300			—			—
Purchases (3)	—				—				—			14			—			294			—
Sales (3)	—				—				—			—			—			(319		)	—
Issuances (3)	—				—				(1		)	—			—			72			—
Settlements (3)	(31		)		2				(1		)	1			(782		)	—			18
Transfers into Level 3 (4)	—				—				—			—			—			240			—
Transfers out of Level 3 (4)	(15		)		—				—			—			—			(62		)	—
Balance at December 31,	$	13			$	(11	)		$	29		$	(317	)	$	1,258		$	1,465		$	(28	)
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	—			$	—			$	—		$	—		$	—		$	—		$	—
Net investment gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—
Net derivative gains (losses)	$	(8	)		$	(46	)		$	(10	)	$	(463	)	$	5,022		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	19		$	(135	)	$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities:
	U.S.				Foreign				Foreign			U.S			RMBS			CMBS			ABS			State and
	Corporate				Corporate				Government			Treasury												Political
												and Agency												Subdivision
	(In millions)
Year Ended December 31, 2012:
Balance at January 1,	$	6,784			$	4,370			$	2,322		$	31		$	1,602		$	753		$	1,850		$	53
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	14				20				14			—			27			8			18			—
Net investment gains (losses)	4				(78		)		(3		)	—			(7		)	(42		)	2			—
Net derivative gains (losses)	—				—				—			—			—			—			—			—
Other revenues	—				—				—			—			—			—			—			—
Policyholder benefits and claims	—				—				—			—			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—
OCI	328				294				45			—			275			(4		)	(2		)	3
Purchases (3)	1,718				2,654				431			48			952			682			2,007			5
Sales (3)	(1,207		)		(855		)		(673		)	(8		)	(704		)	(397		)	(177		)	(7		)
Issuances (3)	—				—				—			—			—			—			—			—
Settlements (3)	—				—				—			—			—			—			—			—
Transfers into Level 3 (4)	661				186				28			—			161			177			6			—
Transfers out of Level 3 (4)	(869		)		(383		)		(350		)	—			(269		)	(30		)	(48		)	—
Balance at December 31,	$	7,433			$	6,208			$	1,814		$	71		$	2,037		$	1,147		$	3,656		$	54
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	12			$	19			$	16		$	—		$	27		$	2		$	18		$	—
Net investment gains (losses)	$	(4	)		$	(30	)		$	—		$	—		$	(4	)	$	(1	)	$	—		$	—
Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Equity Securities:								FVO and Trading Securities:												Mortgage Loans:
	Common				Non-				Actively			FVO			FVO			Short-term			Residential			Mortgage Loans Held-
	Stock				redeemable				Traded			General			Contractholder-			Investments			Mortgage			for-sale
					Preferred				Securities			Account			directed						Loans - FVO
					Stock							Securities			Unit-linked
															Investments
	(In millions)
Year Ended December 31, 2012:
Balance at January 1,	$	281			$	438			$	—		$	23		$	1,386		$	590		$	—		$	1,414
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	—				—				—			18			25			2			—			—
Net investment gains (losses)	(1		)		2				—			—			—			—			—			—
Net derivative gains (losses)	—				—				—			—			—			—			—			—
Other revenues	—				—				—			—			—			—			—			(35		)
Policyholder benefits and claims	—				—				—			—			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—
OCI	13				40				—			—			—			(26		)	—			—
Purchases (3)	99				5				6			—			604			425			—			1
Sales (3)	(140		)		(66		)		—			(9		)	(1,040		)	(559		)	—			(1,348		)
Issuances (3)	—				—				—			—			—			—			—			7
Settlements (3)	—				—				—			—			—			—			—			(43		)
Transfers into Level 3 (4)	3				—				—			—			—			5			—			56
Transfers out of Level 3 (4)	(65		)		—				—			—			(38		)	(8		)	—			(3		)
Balance at December 31,	$	190			$	419			$	6		$	32		$	937		$	429		$	—		$	49
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	—			$	—			$	—		$	14		$	25		$	1		$	—		$	—
Net investment gains (losses)	$	(11	)		$	—			$	—		$	—		$	—		$	—		$	—		$	—
Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	(29	)
Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Net Derivatives: (6)
	Interest				Foreign				Credit			Equity			Net			Separate			Long-term			MSRs (9)			Liability Related
	Rate				Currency							Market			Embedded			Account			Debt of						to Securitized
					Exchange										Derivatives (7)			Assets (8)			CSEs - FVO						Reverse Mortgage
					Rate																						Loans (9)
	(In millions)
Year Ended December 31, 2012:
Balance at January 1,	$	300			$	44			$	1		$	889		$	(4,203	)	$	1,325		$	(116	)	$	666		$	(1,175	)
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	—				—				—			—			—			—			—			—			—
Net investment gains (losses)	—				—				—			—			—			99			(7		)	—			—
Net derivative gains (losses)	15				10				48			(606		)	1,305			—			—			—			—
Other revenues	(67		)		—				—			—			—			—			—			(83		)	1
Policyholder benefits and claims	—				—				—			29			75			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—			—
OCI	—				—				—			(3		)	259			—			—			—			—
Purchases (3)	—				—				—			19			—			244			—			—			—
Sales (3)	—				—				—			—			—			(443		)	—			(485		)	1,149
Issuances (3)	—				—				(3		)	(44		)	—			2			—			43			—
Settlements (3)	(71		)		(17		)		(3		)	(156		)	(598		)	(1		)	79			(141		)	23
Transfers into Level 3 (4)	—				—				—			—			—			24			—			—			—
Transfers out of Level 3 (4)	—				—				—			—			—			(45		)	—			—			2
Balance at December 31,	$	177			$	37			$	43		$	128		$	(3,162	)	$	1,205		$	(44	)	$	—		$	—
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Net investment gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	(7	)	$	—		$	—
Net derivative gains (losses)	$	—			$	(12	)		$	47		$	(593	)	$	1,275		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	29		$	78		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities:
	U.S.				Foreign				Foreign			U.S.			RMBS			CMBS			ABS			State and			Other
	Corporate				Corporate				Government			Treasury												Political
												and Agency												Subdivision
	(In millions)
Year Ended December 31, 2011:
Balance at January 1,	$	7,149			$	5,726			$	3,134		$	79		$	2,541		$	1,011		$	3,026		$	46		$	4
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	11				27				18			—			10			25			24			—			—
Net investment gains (losses)	17				(9		)		—			—			(41		)	(16		)	(18		)	—			—
Net derivative gains (losses)	—				—				—			—			—			—			—			—			—
Other revenues	—				—				—			—			—			—			—			—			—
Policyholder benefits and claims	—				—				—			—			—			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—			—
OCI	327				(66		)		—			3			(5		)	71			81			(8		)	—
Purchases (3)	912				1,740				529			6			393			283			1,033			11			—
Sales (3)	(887		)		(2,094		)		(179		)	(1		)	(213		)	(178		)	(659		)	(4		)	(4		)
Issuances (3)	—				—				—			—			—			—			—			—			—
Settlements (3)	—				—				—			—			—			—			—			—			—
Transfers into Level 3 (4)	169				211				123			—			20			52			14			10			—
Transfers out of Level 3 (4)	(914		)		(1,165		)		(1,303		)	(56		)	(1,103		)	(495		)	(1,651		)	(2		)	—
Balance at December 31,	$	6,784			$	4,370			$	2,322		$	31		$	1,602		$	753		$	1,850		$	53		$	—
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	10			$	19			$	18		$	—		$	11		$	24		$	20		$	—		$	—
Net investment gains (losses)	$	(27	)		$	(31	)		$	(3	)	$	—		$	(41	)	$	(14	)	$	(10	)	$	—		$	—
Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Equity Securities:								FVO and Trading Securities:												Mortgage Loans:
	Common				Non-				Actively			FVO			FVO			Short-term			Residential			Mortgage
	Stock				redeemable				Traded			General			Contractholder-			Investments			Mortgage			Loans Held-
					Preferred				Securities			Account			directed						Loans - FVO			for-sale
					Stock							Securities			Unit-linked
															Investments
	(In millions)
Year Ended December 31, 2011:
Balance at January 1,	$	268			$	905			$	10		$	77		$	735		$	858		$	—		$	24
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	—				—				—			(7		)	5			3			—			—
Net investment gains (losses)	14				(71		)		—			—			—			(2		)	—			—
Net derivative gains (losses)	—				—				—			—			—			—			—			—
Other revenues	—				—				—			—			—			—			—			5
Policyholder benefits and claims	—				—				—			—			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—
OCI	5				5				—			—			—			2			—			—
Purchases (3)	106				3				—			—			1,246			600			—			3
Sales (3)	(46		)		(416		)		(8		)	(33		)	(478		)	(870		)	—			—
Issuances (3)	—				—				—			—			—			—			—			1,361
Settlements (3)	—				—				—			—			—			—			—			(87		)
Transfers into Level 3 (4)	—				12				—			—			121			—			—			109
Transfers out of Level 3 (4)	(66		)		—				(2		)	(14		)	(243		)	(1		)	—			(1		)
Balance at December 31,	$	281			$	438			$	—		$	23		$	1,386		$	590		$	—		$	1,414
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	—			$	—			$	—		$	(8	)	$	(4	)	$	—		$	—		$	—
Net investment gains (losses)	$	(6	)		$	(19	)		$	—		$	—		$	—		$	(1	)	$	—		$	—
Net derivative gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other revenues	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	5
Policyholder benefits and claims	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Net Derivatives: (6)
	Interest				Foreign				Credit			Equity			Net			Separate			Long-term			MSRs (9)			Liability Related
	Rate				Currency							Market			Embedded			Account			Debt of						to Securitized
					Exchange										Derivatives (7)			Assets (8)			CSEs - FVO						Reverse Mortgage
					Rate																						Loans (9)
	(In millions)
Year Ended December 31, 2011:
Balance at January 1,	$	(86	)		$	73			$	44		$	142		$	(2,438	)	$	1,983		$	(184	)	$	950		$	—
Total realized/unrealized gains (losses) included in:
Net income (loss): (1), (2)
Net investment income	—				—				—			(3		)	—			—			—			—			—
Net investment gains (losses)	—				—				—			—			—			39			(8		)	—			—
Net derivative gains (losses)	41				(28		)		(43		)	601			(1,277		)	—			—			—			—
Other revenues	62				—				—			—			—			—			—			(314		)	—
Policyholder benefits and claims	—				—				—			7			86			—			—			—			—
Other expenses	—				—				—			—			—			—			—			—			—
OCI	329				—				14			1			(119		)	—			—			—			—
Purchases (3)	(1		)		—				1			228			—			284			—			—			—
Sales (3)	—				—				—			—			—			(743		)	—			—			—
Issuances (3)	—				—				(3		)	(4		)	—			—			—			173			(1,175		)
Settlements (3)	(44		)		(1		)		(12		)	(8		)	(455		)	—			76			(143		)	—
Transfers into Level 3 (4)	(1		)		—				—			—			—			19			—			—			—
Transfers out of Level 3 (4)	—				—				—			(75		)	—			(257		)	—			—			—
Balance at December 31,	$	300			$	44			$	1		$	889		$	(4,203	)	$	1,325		$	(116	)	$	666		$	(1,175	)
Changes in unrealized gains (losses) included in net income (loss): (5)
Net investment income	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
Net investment gains (losses)	$	—			$	—			$	—		$	—		$	—		$	—		$	(8	)	$	—		$	—
Net derivative gains (losses)	$	24			$	(24	)		$	(42	)	$	601		$	(1,303	)	$	—		$	—		$	—		$	—
Other revenues	$	68			$	—			$	—		$	—		$	—		$	—		$	—		$	(282	)	$	—
Policyholder benefits and claims	$	—			$	—			$	—		$	7		$	94		$	—		$	—		$	—		$	—
Other expenses	$	—			$	—			$	—		$	—		$	—		$	—		$	—		$	—		$	—
______________
-1	Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities and certain mortgage loans are included in net investment gains (losses) while changes in the estimated fair value of certain mortgage loans and MSRs are included in other revenues. Lapses associated with net embedded derivatives are included in net derivative gains (losses).
-2	Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.
-3	Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.
-4	Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.
-5	Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods.
-6	Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.
-7	Embedded derivative assets and liabilities are presented net for purposes of the rollforward.
-8	Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income. For the purpose of this disclosure, these changes are presented within net investment gains (losses).
-9	See Note 3 for a discussion of the MetLife Bank Divestiture. Other revenues related to MSRs represent the changes in estimated fair value due to changes in valuation model inputs or assumptions.
Fair Value Option	'
	The following table presents information for certain assets and liabilities accounted for under the FVO. These assets and liabilities were initially measured at fair value.
			Residential Mortgage								Certain Assets
			Loans — FVO (1)								and Liabilities
											of CSEs (2)
			December 31,								December 31,
			2013				2012				2013			2012
			(In millions)
	Assets
	Unpaid principal balance		$	508			$	—			$	1,528		$	2,539
	Difference between estimated fair value and unpaid principal balance		(170		)		—				70			127
	Carrying value at estimated fair value		$	338			$	—			$	1,598		$	2,666
	Loans in non-accrual status		$	—			$	—			$	—		$	—
	Loans more than 90 days past due		$	81			$	—			$	—		$	—
	Loans in non-accrual status or more than 90 days past due, or both — difference between aggregate estimated fair value and unpaid principal balance		$	(82	)		$	—			$	—		$	—
	Liabilities
	Contractual principal balance										$	1,445		$	2,430
	Difference between estimated fair value and contractual principal balance										10			97
	Carrying value at estimated fair value										$	1,455		$	2,527
	______________
	-1	Interest income, changes in estimated fair value and gains or losses on sales are recognized in net investment income. Changes in estimated fair value for these loans were due to the following:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Instrument-specific credit risk based on changes in credit spreads for non-agency loans and adjustments in individual loan quality	$	(1	)		$	—			$	—
	Other changes in estimated fair value	1				—				—
	Total gains (losses) recognized in net investment income	$	—			$	—			$	—
	-2	These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs — FVO is recognized in net investment income. Interest expense from long-term debt of CSEs — FVO is recognized in other expenses.
Nonrecurring Fair Value Measurements	'
	The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates; that is, they are not measured at fair value on a recurring basis but are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).
		At December 31,											Years Ended December 31,
		2013				2012				2011			2013			2012			2011
		Carrying Value After Measurement											Gains (Losses)
		(In millions)
	Mortgage loans: (1)
	Held-for-investment	$	211			$	428			$	151		$	20		$	(11	)	$	(15	)
	Held-for-sale	$	3			$	319			$	58		$	—		$	(31	)	$	(3	)
	Other limited partnership interests (2)	$	77			$	54			$	13		$	(46	)	$	(33	)	$	(5	)
	Real estate joint ventures (3)	$	3			$	10			$	—		$	(2	)	$	(6	)	$	—
	Goodwill (4)	$	—			$	—			$	—		$	—		$	(1,868	)	$	(65	)
	Other assets (5)	$	—			$	32			$	—		$	—		$	(77	)	$	—
	______________
	-1	Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows.
	-2	For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both December 31, 2013 and 2012 were not significant.
	-3	For these cost method investments, estimated fair value is determined from information provided in the financial statements of the underlying entities including NAV data. These investments include several real estate funds that typically invest primarily in commercial real estate and mezzanine debt. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next one to 10 years. Unfunded commitments for these investments at both December 31, 2013 and 2012 were not significant.
	-4	As discussed in Note 11, in 2012, the Company recorded an impairment of goodwill associated with the Retail Annuities reporting unit. In addition, in 2011, the Company recorded an impairment of goodwill associated with MetLife Bank. This impairment has been categorized as Level 3 due to the significant unobservable inputs used in the determination of the estimated fair value.
	-5	As discussed in Note 5, in 2012, the Company recorded an impairment of VOCRA, which is included in other assets.
Fair Value of Financial Instruments Carried at Other Than Fair Value	'
	The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:
		December 31, 2013
						Fair Value Hierarchy
		Carrying				Level 1				Level 2			Level 3			Total
		Value														Estimated
																Fair Value
		(In millions)
	Assets
	Mortgage loans:
	Held-for-investment	$	55,767			$	—			$	—		$	57,921		$	57,921
	Held-for-sale	3				—				—			3			3
	Mortgage loans, net	$	55,770			$	—			$	—		$	57,924		$	57,924
	Policy loans	$	11,764			$	—			$	1,694		$	11,512		$	13,206
	Real estate joint ventures	$	102			$	—			$	—		$	169		$	169
	Other limited partnership interests	$	950			$	—			$	—		$	1,109		$	1,109
	Other invested assets	$	844			$	322			$	163		$	359		$	844
	Premiums, reinsurance and other receivables	$	3,116			$	—			$	728		$	2,382		$	3,110
	Other assets	$	324			$	—			$	210		$	142		$	352
	Liabilities
	PABs	$	139,735			$	—			$	—		$	144,631		$	144,631
	Bank deposits	$	—			$	—			$	—		$	—		$	—
	Long-term debt	$	17,170			$	—			$	18,564		$	—		$	18,564
	Collateral financing arrangements	$	4,196			$	—			$	—		$	3,984		$	3,984
	Junior subordinated debt securities	$	3,193			$	—			$	3,789		$	—		$	3,789
	Other liabilities	$	2,239			$	—			$	948		$	1,292		$	2,240
	Separate account liabilities	$	117,562			$	—			$	117,562		$	—		$	117,562
		December 31, 2012
						Fair Value Hierarchy
		Carrying				Level 1				Level 2			Level 3			Total
		Value														Estimated
																Fair Value
		(In millions)
	Assets
	Mortgage loans:
	Held-for-investment	$	53,926			$	—			$	—		$	57,381		$	57,381
	Held-for-sale	365				—				—			365			365
	Mortgage loans, net	$	54,291			$	—			$	—		$	57,746		$	57,746
	Policy loans	$	11,884			$	—			$	1,690		$	12,567		$	14,257
	Real estate joint ventures	$	113			$	—			$	—		$	171		$	171
	Other limited partnership interests	$	1,154			$	—			$	—		$	1,277		$	1,277
	Other invested assets	$	815			$	305			$	144		$	366		$	815
	Premiums, reinsurance and other receivables	$	3,287			$	—			$	745		$	2,960		$	3,705
	Other assets	$	260			$	—			$	214		$	78		$	292
	Liabilities
	PABs	$	149,928			$	—			$	—		$	158,040		$	158,040
	Bank deposits	$	6,416			$	—			$	2,018		$	4,398		$	6,416
	Long-term debt	$	16,502			$	—			$	18,978		$	—		$	18,978
	Collateral financing arrangements	$	4,196			$	—			$	—		$	3,839		$	3,839
	Junior subordinated debt securities	$	3,192			$	—			$	3,984		$	—		$	3,984
	Other liabilities	$	1,913			$	—			$	673		$	1,243		$	1,916
	Separate account liabilities	$	58,726			$	—			$	58,726		$	—		$	58,726

Goodwill_Tables

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill Rollforward and by Segment	'
	Information regarding goodwill by segment, as well as Corporate & Other, was as follows:
		Retail			Group,		Corporate		Latin			Asia (1)			EMEA			Corporate			Unallocated			Total
					Voluntary &		Benefit		America									& Other (2)			Goodwill
					Worksite		Funding
					Benefits
		(In millions)
	Balance at January 1, 2011
	Goodwill	$	3,125		$	138	$	900	$	229		$	72		$	38		$	470		$	6,809		$	11,781
	Accumulated impairment	—			—		—		—			—			—			—			—			—
	Total goodwill, net	3,125			138		900		229			72			38			470			6,809			11,781
	Goodwill allocation (3)	—			—		—		312			5,163			1,334			—			(6,809		)	—
	Acquisitions (4)	—			—		—		—			39			—			—			—			39
	Impairments (5)	—			—		—		—			—			—			(65		)	—			(65		)
	Effect of foreign currency translation and other	—			—		—		(40		)	259			(39		)	—			—			180
	Balance at December 31, 2011
	Goodwill	3,125			138		900		501			5,533			1,333			470			—			12,000
	Accumulated impairment	—			—		—		—			—			—			(65		)	—			(65		)
	Total goodwill, net	3,125			138		900		501			5,533			1,333			405			—			11,935
	Acquisitions	—			—		—		—			—			1			—			—			1
	Impairments (6)	(1,692		)	—		—		—			—			—			(176		)	—			(1,868		)
	Effect of foreign currency translation and other	—			—		—		26			(146		)	5			—			—			(115		)
	Balance at December 31, 2012
	Goodwill	3,125			138		900		527			5,387			1,339			470			—			11,886
	Accumulated impairment	(1,692		)	—		—		—			—			—			(241		)	—			(1,933		)
	Total goodwill, net	1,433			138		900		527			5,387			1,339			229			—			9,953
	Acquisitions (7)	—			—		—		1,140			—			1			—			—			1,141
	Dispositions	—			—		—		—			—			(8		)	—			—			(8		)
	Reduction of goodwill (5)	—			—		—		—			—			—			(65		)	—			(65		)
	Reduction of accumulated impairment (5)	—			—		—		—			—			—			65			—			65
	Effect of foreign currency translation and other	—			—		—		(79		)	(489		)	24			—			—			(544		)
	Balance at December 31, 2013
	Goodwill	3,125			138		900		1,588			4,898			1,356			405			—			12,410
	Accumulated impairment	(1,692		)	—		—		—			—			—			(176		)	—			(1,868		)
	Total goodwill, net	$	1,433		$	138	$	900	$	1,588		$	4,898		$	1,356		$	229		$	—		$	10,542
	______________
	-1	Includes goodwill of $4.7 billion, $5.2 billion and $5.4 billion from the Japan operations at December 31, 2013, 2012 and 2011, respectively.
	-2	For purposes of goodwill impairment testing, the $229 million of net goodwill in Corporate & Other at December 31, 2012, which resulted from goodwill acquired as part of the 2005 Travelers acquisition, was allocated to business units of the Retail; Group, Voluntary & Worksite Benefits; and Corporate Benefit Funding segments in the amounts of $34 million, $9 million and $186 million, respectively.
	-3	Goodwill associated with the ALICO Acquisition was allocated among the Company’s segments in the first quarter of 2011.
	-4	As of November 1, 2011, American Life’s current and deferred income taxes were affected by measurement period adjustments, which resulted in a $39 million increase to the goodwill recorded as part of the ALICO Acquisition related to Japan which is included in the Asia segment.
	-5	In 2011, the Company performed a goodwill impairment test on MetLife Bank, which was a separate reporting unit in Corporate & Other. A comparison of the fair value of the reporting unit, using a market multiple approach, to its carrying value indicated a potential for goodwill impairment. A further comparison of the implied fair value of the reporting unit’s goodwill with its carrying amount indicated that the entire amount of goodwill associated with MetLife Bank was impaired. Consequently, the Company recorded a $65 million goodwill impairment charge that is reflected as a net investment loss for the year ended December 31, 2011. In connection with the MetLife Bank Divestiture, goodwill and the related accumulated impairment were reduced by $65 million for the year ended December 31, 2013. See Note 3.
	-6	In connection with its annual goodwill impairment testing in 2012, the market multiple and discounted cash flow valuation approaches indicated that the fair value of the Retail Annuities reporting unit was below its carrying value. As a result, an actuarial appraisal, which estimates the net worth of the reporting unit, the value of existing business and the value of new business, was also performed. This appraisal also resulted in a fair value of the Retail Annuities reporting unit that was less than the carrying value, indicating a potential for goodwill impairment. A further comparison of the implied fair value of its goodwill with the reporting unit’s carrying amount indicated that the entire amount of goodwill associated with the Retail Annuities reporting unit was impaired. Consequently, the Company recorded a non-cash charge of $1.9 billion ($1.6 billion, net of income tax) for the impairment of the entire goodwill balance in the consolidated statements of operations for the year ended December 31, 2012. Of this amount, $1.4 billion was impaired at MetLife, Inc. There was no impact on income taxes.
	-7	See Note 3 for a discussion of the acquisition of ProVida, which is included in the Latin America segment.

Longterm_and_Shortterm_Debt_Ta

Long-term and Short-term Debt (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Long-term and Short-term debt outstanding	'
	Long-term and short-term debt outstanding was as follows:
		Interest Rates (1)				Maturity		December 31,
		Range		Weighted				2013			2012
				Average
								(In millions)
	Senior notes	1.52% - 7.72%		4.96%		2014 - 2045		$	15,938		$	15,669
	Surplus notes	7.63% - 7.88%		7.84%		2015 - 2025		701			700
	Other notes	1.39% - 8.00%		4.04%		2014 - 2030		531			133
	Capital lease obligations							28			33
	Total long-term debt (2)							17,198			16,535
	Total short-term debt							175			100
	Total							$	17,373		$	16,635
	______________
	-1	Range of interest rates and weighted average interest rates are for the year ended December 31, 2013.
	-2	Excludes $1.5 billion and $2.5 billion of long-term debt relating to CSEs — FVO at December 31, 2013 and 2012, respectively. See Note 8.
Schedule of Short-term Debt	'
	Short-term debt with maturities of one year or less was as follows:
		December 31,
		2013				2012
		(In millions)
	Commercial paper	$	175			$	100
	Average daily balance	$	103			$	119
	Average days outstanding	55 days				40 days
Schedule of Line of Credit Facilities	'
	The unsecured credit facilities are used for general corporate purposes, to support the borrowers’ commercial paper programs and for the issuance of letters of credit. Total fees expensed associated with these credit facilities were $24 million, $30 million and $35 million for the years ended December 31, 2013, 2012 and 2011, respectively, and are included in other expenses. Information on these credit facilities at December 31, 2013 was as follows:
	Borrower(s)		Expiration		Capacity				Letters of			Drawdowns		Unused Commitments
									Credit
									Issued
					(In millions)
	MetLife, Inc. and MetLife Funding, Inc.		September 2017 (1)		$	1,000			$	59		$	—	$	941
	MetLife, Inc. and MetLife Funding, Inc.		August 2016 (2)		3,000				133			—		2,867
	Total				$	4,000			$	192		$	—	$	3,808
	______________
	-1	In September 2012, MetLife, Inc. and MetLife Funding, Inc. entered into a $1.0 billion five-year credit agreement which amended and restated the three-year agreement dated October 2010. All borrowings under the 2012 five-year credit agreement must be repaid by September 2017, except that letters of credit outstanding on that date may remain outstanding until no later than September 2018. MetLife, Inc. incurred costs of $4 million related to the amended and restated credit facility, which were capitalized and included in other assets. These costs are being amortized over the remaining term of the amended and restated credit facility.
	-2	In connection with the October 2013 re-domestication of Exeter to Delaware in anticipation of the Mergers and the related redistribution of assets held in trust at Exeter, $1.9 billion of outstanding letters of credit were no longer required and therefore canceled by the Company. Accordingly, remaining availability under the unsecured credit facilities increased by $1.9 billion in October 2013. See Note 8 for further information on the Mergers.
Committed Facilities	'
	The committed facilities are used for collateral for certain of the Company’s affiliated reinsurance liabilities. Total fees expensed associated with these committed facilities were $103 million, $96 million and $93 million for the years ended December 31, 2013, 2012 and 2011, respectively, and are included in other expenses. Information on these committed facilities at December 31, 2013 was as follows:
	Account Party/Borrower(s)		Expiration		Capacity				Letters of			Drawdowns		Unused
									Credit					Commitments
									Issued
					(In millions)
	MetLife, Inc.		Aug-14		$	300			$	300		$	—	$	—
	Exeter Reassurance Company, Ltd., MetLife, Inc. & Missouri Reinsurance, Inc.		Jun-16		500				490			—		10
	MetLife Reinsurance Company of Vermont & MetLife, Inc.		December 2020 (1)		350				350			—		—
	Exeter Reassurance Company, Ltd.		December 2027 (1)		650				600			—		50
	MetLife Reinsurance Company of South Carolina & MetLife, Inc.		June 2037 (2)		3,500				—			2,797		703
	MetLife Reinsurance Company of Vermont & MetLife, Inc.		December 2037 (1)		2,896				1,937			—		959
	MetLife Reinsurance Company of Vermont & MetLife, Inc.		September 2038 (1)		4,250				3,062			—		1,188
	Total				$	12,446			$	6,739		$	2,797	$	2,910
	______________
	-1	MetLife, Inc. is guarantor under this agreement.
	-2	The drawdown on this facility is associated with a collateral financing arrangement described more fully in Note 13.

Junior_Subordinated_Debt_Secur1

Junior Subordinated Debt Securities (Tables)	12 Months Ended
	Dec. 31, 2013
Junior Subordinated Notes [Abstract]	'
Outstanding Junior Subordinated Debt Securities	'
	Outstanding junior subordinated debt securities and trust securities which MetLife, Inc. will exchange for junior subordinated debt securities prior to redemption or repayment were as follows:
												Carrying Value at December 31,
	Issuer		Issue Date		Face Value		Interest Rate (2)		Scheduled	Interest Rate	Final	2013		2012
									Redemption	Subsequent to	Maturity
									Date	Scheduled
										Redemption
										Date (3)
				(In millions)								(In millions)
	MetLife, Inc.		Jul-09		$	500	10.75	%	Aug-39	LIBOR + 7.548%	Aug-69	$	500	$	500
	MetLife Capital Trust X (1)		Apr-08		$	750	9.25	%	Apr-38	LIBOR + 5.540%	Apr-68	750		750
	MetLife Capital Trust IV (1)		Dec-07		$	700	7.875	%	Dec-37	LIBOR + 3.960%	Dec-67	695		694
	MetLife, Inc.		Dec-06		$	1,250	6.4	%	Dec-36	LIBOR + 2.205%	Dec-66	1,248		1,248
												$	3,193	$	3,192
	______________
	-1	MetLife Capital Trust X and MetLife Capital Trust IV are VIEs which are consolidated in the financial statements of the Company. The securities issued by these entities are exchangeable surplus trust securities, which will be exchanged for a like amount of MetLife, Inc.’s junior subordinated debt securities on the scheduled redemption date; mandatorily under certain circumstances, and at any time upon MetLife, Inc. exercising its option to redeem the securities. The exchangeable surplus trust securities are classified as junior subordinated debt securities for purposes of financial statement presentation.
	-2	Prior to the scheduled redemption date, interest is payable semiannually in arrears.
	-3	In the event the securities are not redeemed on or before the scheduled redemption date, interest will accrue after such date at an annual rate of three-month LIBOR plus the indicated margin, payable quarterly in arrears.

Equity_Tables

Equity (Tables)	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Schedule of Dividends Paid, Preferred Stock	'
	Information on the declaration, record and payment dates, as well as per share and aggregate dividend amounts, for the Series A and Series B preferred shares was as follows:
							Dividend
	Declaration Date		Record Date		Payment Date		Series A				Series A				Series B				Series B
							Per Share				Aggregate				Per Share				Aggregate
							(In millions, except per share data)
	November 15, 2013		November 30, 2013		December 16, 2013		$	0.253			$	7			$	0.406			$	24
	August 15, 2013		August 31, 2013		September 16, 2013		$	0.256			6				$	0.406			24
	May 15, 2013		May 31, 2013		June 17, 2013		$	0.256			7				$	0.406			24
	March 5, 2013		February 28, 2013		March 15, 2013		$	0.25			6				$	0.406			24
											$	26							$	96
	November 15, 2012		November 30, 2012		December 17, 2012		$	0.253			$	7			$	0.406			$	24
	August 15, 2012		August 31, 2012		September 17, 2012		$	0.256			6				$	0.406			24
	May 15, 2012		May 31, 2012		June 15, 2012		$	0.256			7				$	0.406			24
	March 5, 2012		February 29, 2012		March 15, 2012		$	0.253			6				$	0.406			24
											$	26							$	96
	November 15, 2011		November 30, 2011		December 15, 2011		$	0.253			$	7			$	0.406			$	24
	August 15, 2011		August 31, 2011		September 15, 2011		$	0.256			6				$	0.406			24
	May 16, 2011		May 31, 2011		June 15, 2011		$	0.256			7				$	0.406			24
	March 7, 2011		February 28, 2011		March 15, 2011		$	0.25			6				$	0.406			24
											$	26							$	96
Schedule of Dividends Paid, Common Stock	'
	The table below presents declaration, record and payment dates, as well as per share and aggregate dividend amounts, for common stock:
							Dividend
	Declaration Date		Record Date		Payment Date		Per Share				Aggregate
							(In millions, except per share data)
	October 22, 2013		November 8, 2013		December 13, 2013		$	0.275			$	311
	June 25, 2013		August 9, 2013		September 13, 2013		$	0.275			303
	April 23, 2013		May 9, 2013		June 13, 2013		$	0.275			302
	January 4, 2013		February 6, 2013		March 13, 2013		$	0.185			203
											$	1,119
	October 23, 2012		November 9, 2012		December 14, 2012		$	0.74			$	811
	October 25, 2011		November 9, 2011		December 14, 2011		$	0.74			$	787
Components of compensation expense related to stock based compensation	'
	The components of compensation expense related to stock-based compensation includes compensation expense related to Phantom Stock-Based Awards, and excludes the insignificant compensation expense related to the 2005 Directors Stock Plan. Those components were:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Stock Options and Unit Options	$	39			$	61			$	58
	Performance Shares and Units (1)	91				80				68
	Restricted Stock Units and Restricted Units	45				27				18
	Total compensation expense	$	175			$	168			$	144
	Income tax benefit	$	61			$	59			$	50
	______________
	-1	Performance Shares expected to vest and the related compensation expenses may be further adjusted by the performance factor most likely to be achieved, as estimated by management, at the end of the performance period.
Total unrecognized compensation expense related to stock based compensation and the expected weighted average period over which the expenses will be recognized	'
	The following table presents the total unrecognized compensation expense related to stock-based compensation and the expected weighted average period over which these expenses will be recognized at:
		31-Dec-13
		Expense				Weighted Average
						Period
		(In millions)				(Years)
	Stock Options	$	25			1.27
	Performance Shares	$	61			1.71
	Restricted Stock Units	$	42			1.88
Activity related to Stock Options	'
	A summary of the activity related to Stock Options was as follows:
		Shares			Weighted				Weighted		Aggregate
		Under			Average				Average		Intrinsic
		Option			Exercise				Remaining		Value (1)
					Price				Contractual
									Term
									(Years)		(In millions)
	Outstanding at January 1, 2013	35,153,071			$	40.89			5.5		$	51
	Granted	1,310,019			$	35.96
	Exercised	(6,357,522	)		$	31.8
	Expired	(183,662	)		$	50.46
	Forfeited	(170,530	)		$	39.86
	Outstanding at December 31, 2013	29,751,376			$	42.56			5.19		$	379
	Expected to vest at a future date as of December 31, 2013	29,536,674			$	42.6			5.16		$	376
	Exercisable at December 31, 2013	22,786,277			$	43.56			4.32		$	277
	______________
	-1	The aggregate intrinsic value was computed using the closing Share price on December 31, 2013 of $53.92 and December 31, 2012 of $32.94, as applicable.
Weighted average assumptions used to determine the fair value of Stock Options issued	'
	The following table presents the weighted average assumptions, with the exception of risk-free rate, which is expressed as a range, used to determine the fair value of Stock Options issued:
		Years Ended December 31,
		2013				2012				2011
	Dividend yield	2.13%				1.95%				1.65%
	Risk-free rate of return	0.16%-3.89%				0.21%-4.17%				0.29%-5.51%
	Expected volatility	32.98%				35.59%				32.64%
	Exercise multiple	1.51				1.58				1.69
	Post-vesting termination rate	3.16%				3.14%				3.36%
	Contractual term (years)	10				10				10
	Expected life (years)	7				7				7
	Weighted average exercise price of stock options granted	$	35.96			$	37.91			$	45.16
	Weighted average fair value of stock options granted	$	9.88			$	11.33			$	14.27
Stock Option exercise activity	'
	The following table presents a summary of Stock Option exercise activity:
		Years Ended December 31,
		2013				2012				2011
		(In millions)
	Total intrinsic value of stock options exercised	$	79			$	29			$	41
	Cash received from exercise of stock options	$	202			$	109			$	88
	Income tax benefit realized from stock options exercised	$	28			$	10			$	14
Performance Share and Restricted Stock Unit Activity	'
	The following table presents a summary of Performance Share and Restricted Stock Unit activity:
		Performance Shares							Restricted Stock Units
		Shares			Weighted				Units			Weighted
					Average							Average
					Grant Date							Grant Date
					Fair Value							Fair Value
	Outstanding at January 1, 2013	4,822,028			$	36.93			2,080,148			$	36.55
	Granted	1,749,212			$	50.86			2,182,213			$	32.34
	Forfeited	(151,075	)		$	40.87			(395,365	)		$	33.97
	Payable (1)	(1,346,025	)		$	32.24			(538,480	)		$	33.17
	Outstanding at December 31, 2013	5,074,140			$	42.86			3,328,516			$	33.35
	Expected to vest at a future date as of December 31, 2013	5,067,337			$	38.6			2,995,664			$	33.34
	______________
	-1	Includes both Shares paid and Shares deferred for later payment.
Liability Award Unit Activity	'
	The following table presents a summary of Liability Awards activity:
		Unit			Restricted			Performance
		Options			Units			Units
	Outstanding at January 1, 2013	1,370,317			740,436			305,164
	Granted	48,301			445,740			297,834
	Exercised	(127,386	)		—			—
	Forfeited	(69,606	)		(127,329	)		(15,761	)
	Paid	—			(79,325	)		(55,349	)
	Outstanding at December 31, 2013	1,221,626			979,522			531,888
	Expected to vest at a future date as of December 31, 2013	1,137,832			881,570			478,699
Schedules of statutory net income, and capital and surplus by subsidiary	'
	Statutory net income (loss) was as follows:
					Years Ended December 31,
	Company		State of Domicile		2013				2012				2011
					(In millions)
	Metropolitan Life Insurance Company		New York		$	369			$	1,320			$	1,970
	American Life Insurance Company		Delaware		$	631			$	317			$	334
	MetLife Insurance Company of Connecticut		Connecticut		$	790			$	848			$	46
	Metropolitan Property and Casualty Insurance Company		Rhode Island		$	282			$	235			$	41
	Metropolitan Tower Life Insurance Company		Delaware		$	52			$	61			$	63
	Statutory capital and surplus was as follows at:
			December 31,
	Company		2013				2012
			(In millions)
	Metropolitan Life Insurance Company		$	12,428			$	14,295
	American Life Insurance Company		$	2,711			$	3,044
	MetLife Insurance Company of Connecticut		$	4,795			$	5,331
	Metropolitan Property and Casualty Insurance Company		$	2,225			$	1,987
	Metropolitan Tower Life Insurance Company		$	735			$	781
Dividend Payment Restrictions	'
	The table below sets forth the dividends permitted to be paid by the respective insurance subsidiary without insurance regulatory approval and the respective dividends paid:
			2014				2013									2012
	Company		Permitted w/o				Paid (2)					Permitted w/o				Paid (2)				Permitted w/o
			Approval (1)									Approval (3)								Approval (3)
			(In millions)
	Metropolitan Life Insurance Company		$	1,116			$	1,428				$	1,428			$	1,023			$	1,350
	American Life Insurance Company		$	—			$	—				$	523			$	1,300		-4	$	168
	MetLife Insurance Company of Connecticut		$	1,061			$	1,000				$	1,330			$	706		-5	$	504
	Metropolitan Property and Casualty Insurance Company		$	218			$	100				$	74			$	100			$	—
	Metropolitan Tower Life Insurance Company		$	73			$	109		(6	)	$	77			$	82			$	82
	MetLife Investors Insurance Company		$	99			$	129				$	129			$	18			$	18
	Delaware American Life Insurance Company		$	16			$	—				$	7			$	—			$	12
	______________
	-1	Reflects dividend amounts that may be paid during 2014 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2014, some or all of such dividends may require regulatory approval.
	-2	Reflects all amounts paid, including those requiring regulatory approval.
	-3	Reflects dividend amounts that could have been paid during the relevant year without prior regulatory approval.
	-4	During May 2012, American Life received regulatory approval to pay an extraordinary dividend for an amount up to the funds remitted in connection with the restructuring of American Life’s business in Japan. Subsequently, $1.5 billion was remitted to American Life. See Note 3. Of this approved amount, $1.3 billion was paid to MetLife, Inc. as an extraordinary dividend.
	-5	During June 2012, MICC distributed shares of an affiliate to its stockholders as an in-kind extraordinary dividend of $202 million as calculated on a statutory basis. Regulatory approval for this extraordinary dividend was obtained due to the timing of payment. During December 2012, MICC paid a dividend to its stockholders in the amount of $504 million, which represented its ordinary dividend capacity at December 31, 2012. Due to the June 2012 in-kind dividend, a portion of this was extraordinary and regulatory approval was obtained.
	-6	During October 2013, Metropolitan Tower Life Insurance Company (“MTL”) distributed shares of an affiliate to MetLife, Inc. as an in-kind dividend of $32 million. Also during October 2013, MTL paid a dividend to MetLife, Inc. in the amount of $77 million in cash, which represented its dividend capacity without regulatory approval at December 31, 2013. Regulatory approval for these dividends was obtained due to the amount and timing of the payments.
Components of Accumulated Other Comprehensive Income (Loss)	'
	Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc., net of income tax, was as follows:
		Unrealized				Unrealized				Foreign				Defined				Total
		Investment Gains				Gains (Losses)				Currency				Benefit
		(Losses), Net of				on Derivatives				Translation				Plans
		Related Offsets (1)								Adjustments				Adjustment
		(In millions)
	Balance at December 31, 2010	$	3,161			$	(39	)		$	(528	)		$	(1,449	)		$	1,145
	OCI before reclassifications	7,637				1,595				42				(893		)		8,381
	Income tax expense (benefit)	(2,604		)		(557		)		(162		)		312				(3,011		)
	OCI before reclassifications, net of income tax	8,194				999				(648		)		(2,030		)		6,515
	Amounts reclassified from AOCI	(766		)		(21		)		—				133				(654		)
	Income tax expense (benefit)	261				7				—				(46		)		222
	Amounts reclassified from AOCI, net of income tax	(505		)		(14		)		—				87				(432		)
	Balance at December 31, 2011	7,689				985				(648		)		(1,943		)		6,083
	OCI before reclassifications	9,321				(262		)		(134		)		(996		)		7,929
	Income tax expense (benefit)	(3,457		)		92				249				350				(2,766		)
	OCI before reclassifications, net of income tax	13,553				815				(533		)		(2,589		)		11,246
	Amounts reclassified from AOCI	58				24				—				154				236
	Income tax expense (benefit)	(23		)		(8		)		—				(54		)		(85		)
	Amounts reclassified from AOCI, net of income tax	35				16				—				100				151
	Balance at December 31, 2012	13,588				831				(533		)		(2,489		)		11,397
	OCI before reclassifications	(8,487		)		(937		)		(937		)		1,078				(9,283		)
	Income tax expense (benefit)	2,807				312				(189		)		(379		)		2,551
	OCI before reclassifications, net of income tax	7,908				206				(1,659		)		(1,790		)		4,665
	Amounts reclassified from AOCI	411				36				—				214				661
	Income tax expense (benefit)	(136		)		(11		)		—				(75		)		(222		)
	Amounts reclassified from AOCI, net of income tax	275				25				—				139				439
	Balance at December 31, 2013	$	8,183			$	231			$	(1,659	)		$	(1,651	)		$	5,104
	__________________
	-1	See Note 8 for information on offsets to investments related to insurance liabilities, DAC and VOBA and the policyholder dividend obligation.
Reclassification out of Accumulated Other Comprehensive Income (Loss)	'
	Information regarding amounts reclassified out of each component of AOCI, was as follows:
	AOCI Components		Amounts Reclassified from AOCI												Statement of Operations and
															Comprehensive Income (Loss) Location
			Years Ended December 31,
			2013				2012				2011
			(In millions)
	Net unrealized investment gains (losses):
	Net unrealized investment gains (losses)		$	404			$	(34	)		$	(952	)		Other net investment gains (losses)
	Net unrealized investment gains (losses)		93				73				73				Net investment income
	Net unrealized investment gains (losses)		(26		)		(10		)		144				Net derivative gains (losses)
	OTTI		(60		)		29				(31		)		OTTI on fixed maturity securities
	Net unrealized investment gains (losses), before income tax		411				58				(766		)
	Income tax (expense) benefit		(136		)		(23		)		261
	Net unrealized investment gains (losses), net of income tax		$	275			$	35			$	(505	)
	Unrealized gains (losses) on derivatives - cash flow hedges:
	Interest rate swaps		$	20			$	1			$	(42	)		Net derivative gains (losses)
	Interest rate swaps		8				4				1				Net investment income
	Interest rate swaps		—				(3		)		(10		)		Other expenses
	Interest rate forwards		10				1				31				Net derivative gains (losses)
	Interest rate forwards		3				2				1				Net investment income
	Interest rate forwards		(1		)		(1		)		(1		)		Other expenses
	Foreign currency swaps		(3		)		23				—				Net derivative gains (losses)
	Foreign currency swaps		(3		)		(5		)		(6		)		Net investment income
	Foreign currency swaps		1				1				2				Other expenses
	Credit forwards		—				—				2				Net derivative gains (losses)
	Credit forwards		1				1				1				Net investment income
	Gains (losses) on cash flow hedges, before income tax		36				24				(21		)
	Income tax (expense) benefit		(11		)		(8		)		7
	Gains (losses) on cash flow hedges, net of income tax		$	25			$	16			$	(14	)
	Defined benefit plans adjustment: (1)
	Amortization of net actuarial gains (losses)		$	283			$	252			$	237
	Amortization of prior service (costs) credit		(69		)		(98		)		(104		)
	Amortization of defined benefit plan items, before		214				154				133
	income tax
	Income tax (expense) benefit		(75		)		(54		)		(46		)
	Amortization of defined benefit plan items, net of income tax		$	139			$	100			$	87
	Total reclassifications, net of income tax		$	439			$	151			$	(432	)
	__________________
	-1	These AOCI components are included in the computation of net periodic benefit costs. See Note 18.

Other_Expenses_Tables

Other Expenses (Tables)	12 Months Ended
	Dec. 31, 2013
Other Income and Expenses [Abstract]	'
Other Expenses	'
	Information on other expenses was as follows:
		Years Ended December 31,
		2013			2012			2011
		(In millions)
	Compensation	$	5,108		$	5,562		$	5,287
	Pension, postretirement and postemployment benefit costs	488			428			463
	Commissions	5,428			5,909			6,378
	Volume-related costs	842			599			335
	Interest credited to bank deposits	2			78			95
	Capitalization of DAC	(4,786		)	(5,289		)	(5,558		)
	Amortization of DAC and VOBA	3,550			4,199			4,898
	Amortization of negative VOBA	(579		)	(622		)	(697		)
	Interest expense on debt and debt issuance costs	1,282			1,356			1,629
	Premium taxes, licenses and fees	658			677			633
	Professional services	1,454			1,664			1,597
	Rent and related expenses, net of sublease income	376			422			426
	Other (1)	2,779			2,772			3,051
	Total other expenses	$	16,602		$	17,755		$	18,537
	__________________
	-1	See Note 19 for information on the Japan income tax refund included in other expenses for the year ended December 31, 2013.
Restructuring charges	'
	These restructuring charges are included in other expenses. As the expenses relate to an enterprise-wide initiative, they are reported in Corporate & Other. Estimated restructuring costs may change as management continues to execute this enterprise-wide strategic initiative. Such restructuring charges were as follows:
		Years Ended December 31,
		2013									2012
		Severance			Lease and			Total			Severance			Lease and			Total
					Asset									Asset
					Impairment									Impairment
		(In millions)
	Balance at January 1,	$	23		$	—		$	23		$	—		$	—		$	—
	Restructuring charges	99			16			115			141			18			159
	Cash payments	(82		)	(10		)	(92		)	(118		)	(18		)	(136		)
	Balance at December 31,	$	40		$	6		$	46		$	23		$	—		$	23
	Total restructuring charges incurred since inception of initiative	$	240		$	34		$	274		$	141		$	18		$	159

Employee_Benefit_Plans_Tables

Employee Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Benefit Plan Obligations, Assets, Funded Status, Accumulated Other Comprehensive Income (Loss) and Accumulated Benefit Obligation	'
		Pension Benefits																Other Postretirement Benefits
		U.S. Plans (1)								Non-U.S. Plans								U.S. Plans							Non-U.S. Plans
		December 31,
		2013				2012				2013				2012				2013				2012			2013			2012
		(In millions)
	Change in benefit obligations:
	Benefit obligations at January 1,	$	9,480			$	8,327			$	823			$	773			$	2,375			$	2,093		$	43		$	39
	Service costs	236				224				67				75				20				21			2			1
	Interest costs	389				406				14				17				92				103			2			2
	Plan participants’ contributions	—				—				—				—				30				29			—			—
	Net actuarial (gains) losses	(1,050		)		999				34				32				(551		)		261			(1		)	4
	Acquisition, divestitures and curtailments	—				—				(19		)		(12		)		—				—			(3		)	(3		)
	Change in benefits	—				—				—				(1		)		—				—			—			—
	Benefits paid	(464		)		(476		)		(41		)		(41		)		(132		)		(132		)	(2		)	(2		)
	Effect of foreign currency translation and other	—				—				(134		)		(20		)		—				—			—			2
	Benefit obligations at December 31,	8,591				9,480				744				823				1,834				2,375			41			43
	Change in plan assets:
	Fair value of plan assets at January 1,	7,879				7,108				224				185				1,320				1,240			15			13
	Actual return on plan assets	(22		)		740				34				20				58				105			(1		)	2
	Acquisition, divestitures and settlements	—				—				(19		)		(11		)		—				—			(3		)	(3		)
	Plan participants’ contributions	—				—				—				—				30				29			—			—
	Employer contributions	383				507				83				74				76				78			5			4
	Benefits paid	(464		)		(476		)		(41		)		(41		)		(132		)		(132		)	(2		)	(2		)
	Effect of foreign currency translation	—				—				(33		)		(3		)		—				—			—			1
	Fair value of plan assets at December 31,	7,776				7,879				248				224				1,352				1,320			14			15
	Over (under) funded status at December 31,	$	(815	)		$	(1,601	)		$	(496	)		$	(599	)		$	(482	)		$	(1,055	)	$	(27	)	$	(28	)
	Amounts recognized in the consolidated balance sheets consist of:
	Other assets	$	223			$	—			$	7			$	6			$	—			$	—		$	—		$	—
	Other liabilities	(1,038		)		(1,601		)		(503		)		(605		)		(482		)		(1,055		)	(27		)	(28		)
	Net amount recognized	$	(815	)		$	(1,601	)		$	(496	)		$	(599	)		$	(482	)		$	(1,055	)	$	(27	)	$	(28	)
	AOCI:
	Net actuarial (gains) losses	$	2,274			$	3,047			$	28			$	27			$	211			$	799		$	2		$	3
	Prior service costs (credit)	18				24				2				2				1				(74		)	1			1
	AOCI, before income tax	$	2,292			$	3,071			$	30			$	29			$	212			$	725		$	3		$	4
	Accumulated benefit obligation	$	8,104			$	8,866			$	636			$	724			N/A				N/A			N/A			N/A
	_____________
	-1	Includes non-qualified unfunded plans, for which the aggregate projected benefit obligation was $1.0 billion and $1.1 billion at December 31, 2013 and 2012, respectively.
Benefit Plan Obligations, Assets, Funded Status, Accumulated Other Comprehensive Income (Loss) and Accumulated Benefit Obligation	'
		Pension Benefits																Other Postretirement Benefits
		U.S. Plans (1)								Non-U.S. Plans								U.S. Plans							Non-U.S. Plans
		December 31,
		2013				2012				2013				2012				2013				2012			2013			2012
		(In millions)
	Change in benefit obligations:
	Benefit obligations at January 1,	$	9,480			$	8,327			$	823			$	773			$	2,375			$	2,093		$	43		$	39
	Service costs	236				224				67				75				20				21			2			1
	Interest costs	389				406				14				17				92				103			2			2
	Plan participants’ contributions	—				—				—				—				30				29			—			—
	Net actuarial (gains) losses	(1,050		)		999				34				32				(551		)		261			(1		)	4
	Acquisition, divestitures and curtailments	—				—				(19		)		(12		)		—				—			(3		)	(3		)
	Change in benefits	—				—				—				(1		)		—				—			—			—
	Benefits paid	(464		)		(476		)		(41		)		(41		)		(132		)		(132		)	(2		)	(2		)
	Effect of foreign currency translation and other	—				—				(134		)		(20		)		—				—			—			2
	Benefit obligations at December 31,	8,591				9,480				744				823				1,834				2,375			41			43
	Change in plan assets:
	Fair value of plan assets at January 1,	7,879				7,108				224				185				1,320				1,240			15			13
	Actual return on plan assets	(22		)		740				34				20				58				105			(1		)	2
	Acquisition, divestitures and settlements	—				—				(19		)		(11		)		—				—			(3		)	(3		)
	Plan participants’ contributions	—				—				—				—				30				29			—			—
	Employer contributions	383				507				83				74				76				78			5			4
	Benefits paid	(464		)		(476		)		(41		)		(41		)		(132		)		(132		)	(2		)	(2		)
	Effect of foreign currency translation	—				—				(33		)		(3		)		—				—			—			1
	Fair value of plan assets at December 31,	7,776				7,879				248				224				1,352				1,320			14			15
	Over (under) funded status at December 31,	$	(815	)		$	(1,601	)		$	(496	)		$	(599	)		$	(482	)		$	(1,055	)	$	(27	)	$	(28	)
	Amounts recognized in the consolidated balance sheets consist of:
	Other assets	$	223			$	—			$	7			$	6			$	—			$	—		$	—		$	—
	Other liabilities	(1,038		)		(1,601		)		(503		)		(605		)		(482		)		(1,055		)	(27		)	(28		)
	Net amount recognized	$	(815	)		$	(1,601	)		$	(496	)		$	(599	)		$	(482	)		$	(1,055	)	$	(27	)	$	(28	)
	AOCI:
	Net actuarial (gains) losses	$	2,274			$	3,047			$	28			$	27			$	211			$	799		$	2		$	3
	Prior service costs (credit)	18				24				2				2				1				(74		)	1			1
	AOCI, before income tax	$	2,292			$	3,071			$	30			$	29			$	212			$	725		$	3		$	4
	Accumulated benefit obligation	$	8,104			$	8,866			$	636			$	724			N/A				N/A			N/A			N/A
	_____________
	-1	Includes non-qualified unfunded plans, for which the aggregate projected benefit obligation was $1.0 billion and $1.1 billion at December 31, 2013 and 2012, respectively.
Benefit Plan Obligations, Assets, Funded Status, Accumulated Other Comprehensive Income (Loss) and Accumulated Benefit Obligation	'
		Pension Benefits																Other Postretirement Benefits
		U.S. Plans (1)								Non-U.S. Plans								U.S. Plans							Non-U.S. Plans
		December 31,
		2013				2012				2013				2012				2013				2012			2013			2012
		(In millions)
	Change in benefit obligations:
	Benefit obligations at January 1,	$	9,480			$	8,327			$	823			$	773			$	2,375			$	2,093		$	43		$	39
	Service costs	236				224				67				75				20				21			2			1
	Interest costs	389				406				14				17				92				103			2			2
	Plan participants’ contributions	—				—				—				—				30				29			—			—
	Net actuarial (gains) losses	(1,050		)		999				34				32				(551		)		261			(1		)	4
	Acquisition, divestitures and curtailments	—				—				(19		)		(12		)		—				—			(3		)	(3		)
	Change in benefits	—				—				—				(1		)		—				—			—			—
	Benefits paid	(464		)		(476		)		(41		)		(41		)		(132		)		(132		)	(2		)	(2		)
	Effect of foreign currency translation and other	—				—				(134		)		(20		)		—				—			—			2
	Benefit obligations at December 31,	8,591				9,480				744				823				1,834				2,375			41			43
	Change in plan assets:
	Fair value of plan assets at January 1,	7,879				7,108				224				185				1,320				1,240			15			13
	Actual return on plan assets	(22		)		740				34				20				58				105			(1		)	2
	Acquisition, divestitures and settlements	—				—				(19		)		(11		)		—				—			(3		)	(3		)
	Plan participants’ contributions	—				—				—				—				30				29			—			—
	Employer contributions	383				507				83				74				76				78			5			4
	Benefits paid	(464		)		(476		)		(41		)		(41		)		(132		)		(132		)	(2		)	(2		)
	Effect of foreign currency translation	—				—				(33		)		(3		)		—				—			—			1
	Fair value of plan assets at December 31,	7,776				7,879				248				224				1,352				1,320			14			15
	Over (under) funded status at December 31,	$	(815	)		$	(1,601	)		$	(496	)		$	(599	)		$	(482	)		$	(1,055	)	$	(27	)	$	(28	)
	Amounts recognized in the consolidated balance sheets consist of:
	Other assets	$	223			$	—			$	7			$	6			$	—			$	—		$	—		$	—
	Other liabilities	(1,038		)		(1,601		)		(503		)		(605		)		(482		)		(1,055		)	(27		)	(28		)
	Net amount recognized	$	(815	)		$	(1,601	)		$	(496	)		$	(599	)		$	(482	)		$	(1,055	)	$	(27	)	$	(28	)
	AOCI:
	Net actuarial (gains) losses	$	2,274			$	3,047			$	28			$	27			$	211			$	799		$	2		$	3
	Prior service costs (credit)	18				24				2				2				1				(74		)	1			1
	AOCI, before income tax	$	2,292			$	3,071			$	30			$	29			$	212			$	725		$	3		$	4
	Accumulated benefit obligation	$	8,104			$	8,866			$	636			$	724			N/A				N/A			N/A			N/A
	_____________
	-1	Includes non-qualified unfunded plans, for which the aggregate projected benefit obligation was $1.0 billion and $1.1 billion at December 31, 2013 and 2012, respectively.
Accumulated benefit obligations in excess of fair value of plan assets	'
	The aggregate pension accumulated benefit obligation and aggregate fair value of plan assets for pension benefit plans with accumulated benefit obligations in excess of plan assets was as follows:
		Pension Benefits
		U.S. Plans								Non-U.S. Plans
		December 31,
		2013				2012				2013				2012
		(In millions)
	Projected benefit obligations	$	1,037			$	1,323			$	644			$	690
	Accumulated benefit obligations	$	927			$	1,166			$	579			$	651
	Fair value of plan assets	$	—			$	157			$	167			$	144
Defined benefit plan pension plans with projected benefit obligations in excess of plan assets	'
	Information for pension and other postretirement benefit plans with a projected benefit obligation in excess of plan assets were as follows:
		Pension Benefits																Other Postretirement Benefits
		U.S. Plans								Non-U.S. Plans								U.S. Plans							Non-U.S. Plans
		December 31,
		2013				2012				2013				2012				2013				2012			2013			2012
		(In millions)
	Projected benefit obligations	$	1,170			$	9,480			$	701			$	763			$	1,834			$	2,375		$	41		$	43
	Fair value of plan assets	$	133			$	7,879			$	199			$	188			$	1,352			$	1,320		$	14		$	15
Net periodic benefit costs and other changes in plan assets and benefit obligations recognized in other comprehensive income (loss)	'
	The components of net periodic benefit costs and other changes in plan assets and benefit obligations recognized in OCI were as follows:
		Pension Benefits																							Other Postretirement Benefits
		U.S. Plans												Non-U.S. Plans											U.S. Plans									Non-U.S. Plans
		Years Ended December 31,
		2013				2012				2011				2013				2012				2011			2013			2012			2011			2013			2012			2011
		(In millions)
	Net periodic benefit costs:
	Service costs	$	236			$	224			$	187			$	67			$	75			$	64		$	20		$	21		$	16		$	2		$	1		$	1
	Interest costs	389				406				404				14				17				16			92			103			106			2			2			2
	Settlement and curtailment costs	—				—				—				(2		)		—				—			—			—			—			1			1			1
	Expected return on plan assets	(483		)		(484		)		(448		)		(6		)		(6		)		(6		)	(75		)	(77		)	(76		)	(1		)	(1		)	(1		)
	Amortization of net actuarial (gains) losses	228				195				194				—				—				—			55			57			43			—			—			—
	Amortization of prior service costs (credit)	6				6				4				—				—				—			(75		)	(104		)	(108		)	—			—			—
	Total net periodic benefit costs (credit)	376				347				341				73				86				74			17			—			(19		)	4			3			3
	Other changes in plan assets and benefit obligations recognized in OCI:
	Net actuarial (gains) losses	(545		)		744				575				1				18				34			(533		)	234			262			1			2			5
	Prior service costs (credit)	—				—				17				—				(1		)		—			—			—			—			—			(1		)	—
	Amortization of net actuarial gains (losses)	(228		)		(195		)		(194		)		—				—				—			(55		)	(57		)	(43		)	(2		)	—			—
	Amortization of prior service (costs) credit	(6		)		(6		)		(4		)		—				—				—			75			104			108			—			—			—
	Total recognized in OCI	(779		)		543				394				1				17				34			(513		)	281			327			(1		)	1			5
	Total recognized in net periodic benefit costs and OCI	$	(403	)		$	890			$	735			$	74			$	103			$	108		$	(496	)	$	281		$	308		$	3		$	4		$	8
Net periodic benefit costs and other changes in plan assets and benefit obligations recognized in other comprehensive income (loss)	'
	The components of net periodic benefit costs and other changes in plan assets and benefit obligations recognized in OCI were as follows:
		Pension Benefits																							Other Postretirement Benefits
		U.S. Plans												Non-U.S. Plans											U.S. Plans									Non-U.S. Plans
		Years Ended December 31,
		2013				2012				2011				2013				2012				2011			2013			2012			2011			2013			2012			2011
		(In millions)
	Net periodic benefit costs:
	Service costs	$	236			$	224			$	187			$	67			$	75			$	64		$	20		$	21		$	16		$	2		$	1		$	1
	Interest costs	389				406				404				14				17				16			92			103			106			2			2			2
	Settlement and curtailment costs	—				—				—				(2		)		—				—			—			—			—			1			1			1
	Expected return on plan assets	(483		)		(484		)		(448		)		(6		)		(6		)		(6		)	(75		)	(77		)	(76		)	(1		)	(1		)	(1		)
	Amortization of net actuarial (gains) losses	228				195				194				—				—				—			55			57			43			—			—			—
	Amortization of prior service costs (credit)	6				6				4				—				—				—			(75		)	(104		)	(108		)	—			—			—
	Total net periodic benefit costs (credit)	376				347				341				73				86				74			17			—			(19		)	4			3			3
	Other changes in plan assets and benefit obligations recognized in OCI:
	Net actuarial (gains) losses	(545		)		744				575				1				18				34			(533		)	234			262			1			2			5
	Prior service costs (credit)	—				—				17				—				(1		)		—			—			—			—			—			(1		)	—
	Amortization of net actuarial gains (losses)	(228		)		(195		)		(194		)		—				—				—			(55		)	(57		)	(43		)	(2		)	—			—
	Amortization of prior service (costs) credit	(6		)		(6		)		(4		)		—				—				—			75			104			108			—			—			—
	Total recognized in OCI	(779		)		543				394				1				17				34			(513		)	281			327			(1		)	1			5
	Total recognized in net periodic benefit costs and OCI	$	(403	)		$	890			$	735			$	74			$	103			$	108		$	(496	)	$	281		$	308		$	3		$	4		$	8
Assumptions used in determining benefit obligations and net periodic benefit costs	'
	Assumptions used in determining benefit obligations were as follows:
		Pension Benefits										Other Postretirement Benefits
		U.S. Plans					Non-U.S. Plans (1)					U.S. Plans		Non-U.S. Plans (1)
	December 31, 2013:
	Weighted average discount rate	5.15%					1.94%					5.15%		6.47%
	Rate of compensation increase	3.5	%	-	7.50%		2	%	-	5.50%		N/A		N/A
	December 31, 2012:
	Weighted average discount rate	4.20%					1.98%					4.20%		4.94%
	Rate of compensation increase	3.5	%	-	7.50%		2.01	%	-	5.50%		N/A		N/A
	______________
	-1	Reflects those assumptions that were most appropriate for the local economic environments of each of the Subsidiaries providing such benefits.
	Assumptions used in determining net periodic benefit costs were as follows:
		Pension Benefits										Other Postretirement Benefits
		U.S. Plans					Non-U.S. Plans (1)					U.S. Plans		Non-U.S. Plans (1)
	Year Ended December 31, 2013:
	Weighted average discount rate	4.20%					1.98%					4.20%		5.01%
	Weighted average expected rate of return on plan assets	6.25%					2.07%					5.76%		7.25%
	Rate of compensation increase	3.5	%	-	7.50%		1.5	%	-	5.50%		N/A		N/A
	Year Ended December 31, 2012:
	Weighted average discount rate	4.95%					2.35%					4.95%		5.78%
	Weighted average expected rate of return on plan assets	7.00%					3.35%					6.26%		6.54%
	Rate of compensation increase	3.5	%	-	7.50%		2	%	-	4.00%		N/A		N/A
	Year Ended December 31, 2011:
	Weighted average discount rate	5.80%					2.40%					5.80%		6.34%
	Weighted average expected rate of return on plan assets	7.25%					3.19%					7.25%		7.01%
	Rate of compensation increase	3.5	%	-	7.50%		3	%	-	5.50%		N/A		N/A
	______________
	-1	Reflects those assumptions that were most appropriate for the local economic environments of each of the Subsidiaries providing such benefits.
Assumed healthcare costs trend rates	'
	The assumed healthcare costs trend rates used in measuring the APBO and net periodic benefit costs were as follows:
		December 31,
		2013		2012
	Pre-and Post-Medicare eligible claims	6.4% in 2014, gradually decreasing each year until 2094 reaching the ultimate rate of 4.4% for Pre-Medicare and 4.6% for Post-Medicare.		7.8% in 2013, gradually decreasing each year until 2094 reaching the ultimate rate of 4.4% for Pre-Medicare and 4.6% for Post-Medicare.
One-percentage point change in assumed healthcare cost trend rates	'
	Assumed healthcare costs trend rates may have a significant effect on the amounts reported for healthcare plans. A 1% change in assumed healthcare costs trend rates would have the following effects as of December 31, 2013:
		U.S. Plans								Non-U.S. Plans
		One Percent				One Percent				One Percent				One Percent
		Increase				Decrease				Increase				Decrease
		(In millions)
	Effect on total of service and interest costs components	$	16			$	(13	)		$	—			$	—
	Effect of accumulated postretirement benefit obligations	$	235			$	(193	)		$	1			$	(1	)
Plan Assets	'
	The table below summarizes the actual weighted average allocation of the fair value of total plan assets by asset class at December 31 for the years indicated and the approved target allocation by major asset class at December 31, 2013 for the plans:
		Pension									Other Postretirement
					Actual Allocation									Actual Allocation
		Target			2013			2012			Target			2013			2012
	Asset Class:
	Fixed maturity securities (1)	76	%		50	%		54	%		100	%		100	%		100	%
	Equity securities (2)	17	%		33	%		24	%		—	%		—	%		—	%
	Alternative securities (3)	7	%		17	%		22	%		—	%		—	%		—	%
	Total assets				100	%		100	%					100	%		100	%
	______________
	-1	Fixed maturity securities include corporate and foreign bonds.
	-2	Equity securities primarily include common stock of non-U.S. companies.
	-3	Alternative securities include derivative assets, real estate, short-term investments, and other investments.
	The pension and postretirement plan assets measured at estimated fair value on a recurring basis were determined as described in “— Plan Assets.” These estimated fair values and their corresponding placement in the fair value hierarchy are summarized as follows:
		31-Dec-13
		Pension Benefits																Other Postretirement Benefits
		Fair Value Hierarchy																Fair Value Hierarchy
		Level 1				Level 2				Level 3				Total				Level 1				Level 2			Level 3			Total
														Estimated														Estimated
														Fair														Fair
														Value														Value
		(In millions)
	Assets
	Fixed maturity securities:
	Corporate	$	—			$	27			$	—			$	27			$	—			$	—		$	—		$	—
	Foreign bonds	—				96				—				96				—				14			—			14
	Total fixed maturity securities	—				123				—				123				—				14			—			14
	Equity securities:
	Common stock - foreign	—				83				—				83				—				—			—			—
	Other investments	32				—				—				32				—				—			—			—
	Derivative assets	—				—				2				2				—				—			—			—
	Real estate	—				—				2				2				—				—			—			—
	Short-term investments	—				6				—				6				—				—			—			—
	Total assets	$	32			$	212			$	4			$	248			$	—			$	14		$	—		$	14
		31-Dec-12
		Pension Benefits																Other Postretirement Benefits
		Fair Value Hierarchy																Fair Value Hierarchy
		Level 1				Level 2				Level 3				Total				Level 1				Level 2			Level 3			Total
														Estimated														Estimated
														Fair														Fair
														Value														Value
		(In millions)
	Assets
	Fixed maturity securities:
	Foreign bonds	$	—			$	120			$	—			$	120			$	—			$	15		$	—		$	15
	Equity securities:
	Common stock - foreign	—				54				—				54				—				—			—			—
	Other investments	24				—				—				24				—				—			—			—
	Derivative assets	—				—				13				13				—				—			—			—
	Real estate	—				—				7				7				—				—			—			—
	Short-term investments	—				6				—				6				—				—			—			—
	Total assets	$	24			$	180			$	20			$	224			$	—			$	15		$	—		$	15
	The table below summarizes the actual weighted average allocation of the fair value of total plan assets by asset class at December 31 for the years indicated and the approved target allocation by major asset class at December 31, 2013 for the Invested Plans:
		Pension									Postretirement Medical									Postretirement Life
		Target			Actual Allocation						Target			Actual Allocation						Target			Actual Allocation
					2013			2012						2013			2012						2013		2012
	Asset Class:
	Fixed maturity securities (1)	75	%		64	%		69	%		70	%		52	%		63	%		—	%		—	%	—	%
	Equity securities (2)	12	%		23	%		21	%		30	%		47	%		37	%		—	%		—	%	—	%
	Alternative securities (3)	13	%		13	%		10	%		—	%		1	%		—	%		100	%		100	%	100	%
	Total assets				100	%		100	%					100	%		100	%					100	%	100	%
	______________
	-1	Fixed maturity securities include primarily ABS, collateralized mortgage obligations, corporate, federal agency, foreign bonds, mortgage-backed securities, municipals, preferred stocks and U.S. government bonds.
-2	Equity securities primarily include common stock of U.S. companies.
-3	Alternative securities primarily include derivative assets, money market securities, short-term investments and other investments. Postretirement life’s target and actual allocation of plan assets are all in short-term investments.
The pension and postretirement plan assets measured at estimated fair value on a recurring basis were determined as described in “— Plan Assets.” These estimated fair values and their corresponding placement in the fair value hierarchy are summarized as follows:
	December 31, 2013
	Pension Benefits																Other Postretirement Benefits
	Fair Value Hierarchy																Fair Value Hierarchy
	Level 1				Level 2				Level 3				Total				Level 1				Level 2			Level 3			Total
													Estimated														Estimated
													Fair														Fair
													Value														Value
	(In millions)
Assets
Fixed maturity securities:
Corporate	$	—			$	2,073			$	59			$	2,132			$	—			$	170		$	1		$	171
U.S. government bonds	924				166				—				1,090				135				5			—			140
Foreign bonds	—				718				11				729				—				63			—			63
Federal agencies	—				292				—				292				—				33			—			33
Municipals	—				219				—				219				—				15			—			15
Other (1)	—				490				19				509				—				54			—			54
Total fixed maturity securities	924				3,958				89				4,971				135				340			1			476
Equity securities:
Common stock - domestic	1,133				22				148				1,303				328				—			—			328
Common stock - foreign	460				—				—				460				102				—			—			102
Total equity securities	1,593				22				148				1,763				430				—			—			430
Other investments	—				—				600				600				—				—			—			—
Short-term investments	53				309				—				362				—				439			—			439
Money market securities	1				12				—				13				4				—			—			4
Derivative assets	17				15				35				67				—				3			—			3
Total assets	$	2,588			$	4,316			$	872			$	7,776			$	569			$	782		$	1		$	1,352
	31-Dec-12
	Pension Benefits																Other Postretirement Benefits
	Fair Value Hierarchy																Fair Value Hierarchy
	Level 1				Level 2				Level 3				Total				Level 1				Level 2			Level 3			Total
													Estimated														Estimated
													Fair														Fair
													Value														Value
	(In millions)
Assets
Fixed maturity securities:
Corporate	$	—			$	2,260			$	19			$	2,279			$	—			$	165		$	4		$	169
U.S. government bonds	1,153				160				—				1,313				175				3			—			178
Foreign bonds	—				761				8				769				—				51			—			51
Federal agencies	1				335				—				336				—				26			—			26
Municipals	—				258				—				258				—				70			1			71
Other (1)	—				490				7				497				—				55			3			58
Total fixed maturity securities	1,154				4,264				34				5,452				175				370			8			553
Equity securities:
Common stock - domestic	1,092				38				137				1,267				249				1			—			250
Common stock - foreign	362				—				—				362				83				—			—			83
Total equity securities	1,454				38				137				1,629				332				1			—			333
Other investments	—				117				447				564				—				—			—			—
Short-term investments	—				214				—				214				—				432			—			432
Money market securities	2				10				—				12				1				—			—			1
Derivative assets	—				7				1				8				—				1			—			1
Total assets	$	2,610			$	4,650			$	619			$	7,879			$	508			$	804		$	8		$	1,320
______________
-1	Other primarily includes mortgage-backed securities, collateralized mortgage obligations and ABS.
Rollforward fair value measurement using significant unobservable outputs (level 3)	'
	A rollforward of all pension benefit plan assets measured at estimated fair value on a recurring basis using significant unobservable (Level 3) inputs was as follows:
			Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
			Pension Benefits
			Years Ended December 31,
			2013								2012								2011
			Derivative				Real				Derivative				Real				Derivative				Real
			Assets				Estate				Assets				Estate				Assets				Estate
			(In millions)
	Balance at January 1,		$	13			$	7			$	13			$	8			$	11			$	8
	Realized gains (losses)		(2		)		(1		)		(1		)		(1		)		—				—
	Unrealized gains (losses)		3				1				1				—				2				—
	Purchases, sales, issuances, and settlements, net		(12		)		(5		)		—				—				—				—
	Balance at December 31,		$	2			$	2			$	13			$	7			$	13			$	8
	A rollforward of all pension and other postretirement benefit plan assets measured at estimated fair value on a recurring basis using significant unobservable (Level 3) inputs was as follows:
		Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
		Pension Benefits
		Fixed Maturity												Equity
		Securities:												Securities:
		Corporate				Foreign				Other (1)				Common				Other				Derivative
						Bonds								Stock -				Investments				Assets
														Domestic
		(In millions)
	Year Ended December 31, 2013:
	Balance at January 1,	$	19			$	8			$	7			$	137			$	447			$	1
	Realized gains (losses)	—				—				—				(1		)		—				(3		)
	Unrealized gains (losses)	(2		)		1				—				9				59				(18		)
	Purchases, sales, issuances and settlements, net	19				(3		)		11				3				(62		)		55
	Transfers into and/or out of Level 3	23				5				1				—				156				—
	Balance at December 31,	$	59			$	11			$	19			$	148			$	600			$	35
		Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
		Other Postretirement Benefits
		Fixed Maturity
		Securities:
		Corporate				Municipals				Other (1)
		(In millions)
	Year Ended December 31, 2013:
	Balance at January 1,	$	4			$	1			$	3
	Realized gains (losses)	—				—				(3		)
	Unrealized gains (losses)	—				—				4
	Purchases, sales, issuances and settlements, net	(3		)		(1		)		(4		)
	Transfers into and/or out of Level 3	—				—				—
	Balance at December 31,	$	1			$	—			$	—
		Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
		Pension Benefits
		Fixed Maturity												Equity
		Securities:												Securities:
		Corporate				Foreign				Other (1)				Common				Other				Derivative
						Bonds								Stock -				Investments				Assets
														Domestic
		(In millions)
	Year Ended December 31, 2012:
	Balance at January 1,	$	32			$	5			$	2			$	206			$	531			$	4
	Realized gains (losses)	—				—				—				(27		)		55				6
	Unrealized gains (losses)	(1		)		8				—				10				(36		)		(7		)
	Purchases, sales, issuances and settlements, net	(12		)		(5		)		5				(52		)		(103		)		(2		)
	Transfers into and/or out of Level 3	—				—				—				—				—				—
	Balance at December 31,	$	19			$	8			$	7			$	137			$	447			$	1
		Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
		Other Postretirement Benefits
		Fixed Maturity
		Securities:
		Corporate				Municipals				Other (1)				Derivative
														Assets
	(In millions)
Year Ended December 31, 2012:
Balance at January 1,	$	4			$	1			$	5			$	1
Realized gains (losses)	—				—				(2		)		2
Unrealized gains (losses)	—				—				2				(2		)
Purchases, sales, issuances and settlements, net	—				—				(2		)		(1		)
Transfers into and/or out of Level 3	—				—				—				—
Balance at December 31,	$	4			$	1			$	3			$	—
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Pension Benefits
	Fixed Maturity												Equity
	Securities:												Securities:
	Corporate				Foreign				Other (1)				Common				Other				Derivative
					Bonds								Stock -				Investments				Assets
													Domestic
	(In millions)
Year Ended December 31, 2011:
Balance at January 1,	$	49			$	4			$	2			$	240			$	471			$	—
Realized gains (losses)	—				—				(1		)		(59		)		85				2
Unrealized gains (losses)	(4		)		(1		)		1				118				45				4
Purchases, sales, issuances and settlements, net	(13		)		2				(1		)		(93		)		(70		)		(2		)
Transfers into and/or out of Level 3	—				—				1				—				—				—
Balance at December 31,	$	32			$	5			$	2			$	206			$	531			$	4
	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Other Postretirement Benefits
	Fixed Maturity
	Securities:
	Corporate				Municipals				Other (1)				Derivative
													Assets
	(In millions)
Year Ended December 31, 2011:
Balance at January 1,	$	4			$	1			$	6			$	—
Realized gains (losses)	—				—				(1		)		—
Unrealized gains (losses)	—				—				1				1
Purchases, sales, issuances and settlements, net	—				—				(1		)		—
Transfers into and/or out of Level 3	—				—				—				—
Balance at December 31,	$	4			$	1			$	5			$	1
______________
-1	Other includes ABS and collateralized mortgage obligations.
Defined benefit plan estimated future benefit payments	'
	Gross benefit payments for the next 10 years, which reflect expected future service where appropriate, are expected to be as follows:
		Pension Benefits								Other Postretirement Benefits
		U.S. Plans				Non-U.S. Plans				U.S. Plans				Non-U.S. Plans
		(In millions)
	2014	$	461			$	35			$	84			$	4
	2015	$	474			$	38			$	86			$	4
	2016	$	487			$	42			$	86			$	4
	2017	$	515			$	42			$	89			$	4
	2018	$	524			$	45			$	93			$	4
	2019-2023	$	2,928			$	263			$	522			$	16

Income_Tax_Tables

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Provision for income tax from continuing operations	'
	The provision for income tax from continuing operations was as follows:
		Years Ended December 31,
		2013			2012				2011
		(In millions)
	Current:
	Federal	$	85		$	(29	)		$	(200	)
	State and local	2			6				(1		)
	Foreign	422			846				614
	Subtotal	509			823				413
	Deferred:
	Federal	(250		)	(244		)		2,241
	State and local	(11		)	(1		)		(3		)
	Foreign	413			(450		)		142
	Subtotal	152			(695		)		2,380
	Provision for income tax expense (benefit)	$	661		$	128			$	2,793
Income (loss) from continuing operations before income tax expense (benefit) from domestic and foreign operations	'
	The Company’s income (loss) from continuing operations before income tax expense (benefit) from domestic and foreign operations were as follows:
		Years Ended December 31,
		2013			2012				2011
		(In millions)
	Income (loss) from continuing operations:
	Domestic	$	1,186		$	(1,496	)		$	6,869
	Foreign	2,866			2,938				2,315
	Total	$	4,052		$	1,442			$	9,184
Income tax for continuing operations effective rate reconciliation	'
	The reconciliation of the income tax provision at the U.S. statutory rate to the provision for income tax as reported for continuing operations was as follows:
		Years Ended December 31,
		2013			2012				2011
		(In millions)
	Tax provision at U.S. statutory rate	$	1,418		$	505			$	3,215
	Tax effect of:
	Dividend received deduction	(166		)	(162		)		(160		)
	Tax-exempt income	(96		)	(94		)		(86		)
	Prior year tax	75			23				(4		)
	Low income housing tax credits	(194		)	(150		)		(102		)
	Other tax credits	(54		)	(28		)		(36		)
	Foreign tax rate differential (1)	(340		)	(45		)		(41		)
	Change in valuation allowance	30			15				16
	Goodwill impairment	—			408				—
	Deferred tax effects of branch conversions	4			(324		)		—
	Other, net	(16		)	(20		)		(9		)
	Provision for income tax expense (benefit)	$	661		$	128			$	2,793
	______________
	-1	For the year ended December 31, 2013, foreign tax rate differential includes one-time tax benefits of $119 million related to the receipt of a Japan tax refund, $69 million related to the estimated reversal of Japan temporary differences, and $65 million related to the change in repatriation assumptions for foreign earnings of certain European operations.
Components of deferred tax assets and liabilities	'
	Deferred income tax represents the tax effect of the differences between the book and tax basis of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following at:
		December 31,
		2013			2012
		(In millions)
	Deferred income tax assets:
	Policyholder liabilities and receivables	$	1,014		$	6,233
	Investments, including derivatives	86			—
	Net operating loss carryforwards	1,808			1,408
	Employee benefits	737			1,234
	Capital loss carryforwards	32			160
	Tax credit carryforwards	1,653			545
	Litigation-related and government mandated	232			197
	Other	471			484
	Total gross deferred income tax assets	6,033			10,261
	Less: Valuation allowance	357			368
	Total net deferred income tax assets	5,676			9,893
	Deferred income tax liabilities:
	Investments, including derivatives	—			3,149
	Intangibles	2,081			2,668
	Net unrealized investment gains	4,883			7,854
	DAC	5,133			4,775
	Other	222			140
	Total deferred income tax liabilities	12,319			18,586
	Net deferred income tax asset (liability)	$	(6,643	)	$	(8,693	)
Summary of net operating loss carryforwards for tax purposes	'
	The following table sets forth the domestic, state, and foreign net operating and capital loss carryforwards for tax purposes at December 31, 2013.
		Net Operating Loss Carryforwards					Capital Loss Carryforwards
		Amount			Expiration		Amount				Expiration
		(In millions)					(In millions)
	Domestic	$	4,153		Beginning in 2018		$	52			Beginning in 2018
	State	$	153		Beginning in 2014		$	—			N/A
	Foreign	$	1,576		Beginning in 2014		$	40			Beginning in 2014
Rollforward of the deferred tax asset valuation allowance associated with branch restructuring	'
	The following table provides a rollforward of the deferred tax asset valuation allowance associated with the 2013 branch restructurings:
		Amount
		(In millions)
	Balance at January 1, 2012	$	23
	Income tax expense (benefit)	12
	Deferred income tax expense (benefit) related to unrealized investment gains (losses)	(10		)
	Offsetting reduction in gross deferred tax asset related to the branch transfer of assets to foreign subsidies	—
	Balance at December 31, 2012	25
	Income tax expense (benefit)	4
	Deferred income tax expense (benefit) related to unrealized investment gains (losses)	2
	Offsetting reduction in gross deferred tax asset related to the branch transfer of assets to foreign subsidies	(31		)
	Balance at December 31, 2013	$	—
Reconciliation of unrecognized tax benefits	'
	Interest was as follows:
		Years Ended December 31,
		2013			2012				2011
		(In millions)
	Interest recognized in the consolidated statements of operations	$	20		$	2			$	31
					December 31,
					2013				2012
					(In millions)
	Interest included in other liabilities in the consolidated balance sheets				$	257			$	237
	A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows:
		Years Ended December 31,
		2013			2012				2011
		(In millions)
	Balance at January 1,	$	708		$	679			$	810
	Additions for tax positions of prior years	117			105				30
	Reductions for tax positions of prior years	(37		)	(82		)		(161		)
	Additions for tax positions of current year	39			32				13
	Reductions for tax positions of current year	(1		)	(9		)		(8		)
	Settlements with tax authorities	(52		)	(15		)		(5		)
	Lapses of statutes of limitations	—			(2		)		—
	Balance at December 31,	$	774		$	708			$	679
	Unrecognized tax benefits that, if recognized would impact the effective rate	$	661		$	566			$	527

Earnings_Per_Common_Share_Tabl

Earnings Per Common Share (Tables)	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Earnings Per Common Share	'
	The following table presents the weighted average shares used in calculating basic earnings per common share and those used in calculating diluted earnings per common share for each income category presented below:
		Years Ended December 31,
		2013		2012		2011
		(In millions, except share and per share data)
	Weighted Average Shares:
	Weighted average common stock outstanding for basic earnings per common share	1,105,579,693		1,070,755,561		1,059,580,442
	Incremental common shares from assumed:
	Stock purchase contracts underlying common equity units (1)	1,164,018		—		1,641,444
	Exercise or issuance of stock-based awards	9,458,999		6,084,078		6,872,474
	Weighted average common stock outstanding for diluted earnings per common share	1,116,202,710		1,076,839,639		1,068,094,360
	Income (Loss) from Continuing Operations:
	Income (loss) from continuing operations, net of income tax	$	3,391	$	1,314	$	6,391
	Less: Income (loss) from continuing operations, net of income tax, attributable to noncontrolling interests	25		38		(8		)
	Less: Preferred stock dividends	122		122		122
	Preferred stock redemption premium	—		—		146
	Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	3,244	$	1,154	$	6,131
	Basic	$	2.94	$	1.08	$	5.79
	Diluted	$	2.91	$	1.08	$	5.74
	Income (Loss) from Discontinued Operations:
	Income (loss) from discontinued operations, net of income tax	$	2	$	48	$	24
	Less: Income (loss) from discontinued operations, net of income tax, attributable to noncontrolling interests	—		—		—
	Income (loss) from discontinued operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	2	$	48	$	24
	Basic	$	—	$	0.04	$	0.02
	Diluted	$	—	$	0.04	$	0.02
	Net Income (Loss):
	Net income (loss)	$	3,393	$	1,362	$	6,415
	Less: Net income (loss) attributable to noncontrolling interests	25		38		(8		)
	Less: Preferred stock dividends	122		122		122
	Preferred stock redemption premium	—		—		146
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	3,246	$	1,202	$	6,155
	Basic	$	2.94	$	1.12	$	5.81
	Diluted	$	2.91	$	1.12	$	5.76
	______________
	-1	See Note 15 for a description of the Company’s common equity units. For the year ended December 31, 2012, all shares related to the assumed issuance of shares in settlement of the applicable purchase contracts have been excluded from the calculation of diluted earnings per common share as these assumed shares are anti-dilutive.

Contingencies_Commitments_and_1

Contingencies, Commitments and Guarantees (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments - Leases	'
	The Company, as lessee, has entered into various lease and sublease agreements for office space, information technology and other equipment. Future minimum gross rental payments relating to these lease arrangements are as follows:
		Amount
		(In millions)
	2014	$	320
	2015	259
	2016	212
	2017	161
	2018	141
	Thereafter	794
	Total	$	1,887
Asbestos Related Claims [Member]	'
Loss Contingencies [Line Items]	'
Schedule of Loss Contingencies by Contingency	'
	The approximate total number of asbestos personal injury claims pending against MLIC as of the dates indicated, the approximate number of new claims during the years ended on those dates and the approximate total settlement payments made to resolve asbestos personal injury claims at or during those years are set forth in the following table:
		December 31,
		2013		2012		2011
		(In millions, except number of claims)
	Asbestos personal injury claims at year end	67,983		65,812		66,747
	Number of new claims during the year	5,898		5,303		4,972
	Settlement payments during the year (1)	$	37	$	36.4	$	34.2
	______________
	-1	Settlement payments represent payments made by MLIC during the year in connection with settlements made in that year and in prior years. Amounts do not include MLIC’s attorneys’ fees and expenses and do not reflect amounts received from insurance carriers.
Insurance-related Assessments [Member]	'
Loss Contingencies [Line Items]	'
Schedule of Loss Contingencies by Contingency	'
	Assets and liabilities held for insolvency assessments were as follows:
		December 31,
		2013		2012
		(In millions)
	Other Assets:
	Premium tax offset for future undiscounted assessments	$	60	$	114
	Premium tax offsets currently available for paid assessments	69		14
	Receivable for reimbursement of paid assessments (1)	5		6
		$	134	$	134
	Other Liabilities:
	Insolvency assessments	$	93	$	205
	______________
	-1	The Company holds a receivable from the seller of a prior acquisition in accordance with the purchase agreement.

Quarterly_Results_of_Operation1

Quarterly Results of Operations (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Quarterly Results of Operations (Unaudited)	'
	The unaudited quarterly results of operations for 2013 and 2012 are summarized in the table below:
		Three Months Ended
		March 31,			June 30,		September 30,			December 31,
		(In millions, except per share data)
	2013:00:00
	Total revenues	$	17,683		$	15,721	$	16,337		$	18,458
	Total expenses	$	16,436		$	15,160	$	15,361		$	17,190
	Income (loss) from continuing operations, net of income tax	$	995		$	508	$	973		$	915
	Income (loss) from discontinued operations, net of income tax	$	(3	)	$	2	$	2		$	1
	Net income (loss)	$	992		$	510	$	975		$	916
	Less: Net income (loss) attributable to noncontrolling interests	$	6		$	8	$	3		$	8
	Net income (loss) attributable to MetLife, Inc.	$	986		$	502	$	972		$	908
	Less: Preferred stock dividends	$	30		$	31	$	30		$	31
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	956		$	471	$	942		$	877
	Basic earnings per common share:
	Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	0.87		$	0.43	$	0.85		$	0.78
	Income (loss) from discontinued operations, net of income tax, attributable to MetLife, Inc.	$	—		$	—	$	—		$	—
	Net income (loss) attributable to MetLife, Inc.	$	0.9		$	0.46	$	0.88		$	0.81
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	0.87		$	0.43	$	0.85		$	0.78
	Diluted earnings per common share:
	Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	0.87		$	0.43	$	0.84		$	0.77
	Income (loss) from discontinued operations, net of income tax, attributable to MetLife, Inc.	$	—		$	—	$	—		$	—
	Net income (loss) attributable to MetLife, Inc.	$	0.89		$	0.45	$	0.87		$	0.8
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	0.87		$	0.43	$	0.84		$	0.77
	2012:00:00
	Total revenues	$	15,916		$	18,398	$	16,503		$	17,333
	Total expenses	$	16,325		$	15,060	$	17,513		$	17,810
	Income (loss) from continuing operations, net of income tax	$	(134	)	$	2,300	$	(957	)	$	105
	Income (loss) from discontinued operations, net of income tax	$	14		$	3	$	—		$	31
	Net income (loss)	$	(120	)	$	2,303	$	(957	)	$	136
	Less: Net income (loss) attributable to noncontrolling interests	$	24		$	8	$	(3	)	$	9
	Net income (loss) attributable to MetLife, Inc.	$	(144	)	$	2,295	$	(954	)	$	127
	Less: Preferred stock dividends	$	30		$	31	$	30		$	31
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	(174	)	$	2,264	$	(984	)	$	96
	Basic earnings per common share:
	Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	(0.17	)	$	2.13	$	(0.92	)	$	0.06
	Income (loss) from discontinued operations, net of income tax, attributable to MetLife, Inc.	$	0.01		$	—	$	—		$	0.03
	Net income (loss) attributable to MetLife, Inc.	$	(0.14	)	$	2.16	$	(0.90	)	$	0.12
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	(0.16	)	$	2.13	$	(0.92	)	$	0.09
	Diluted earnings per common share:
	Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders	$	(0.17	)	$	2.12	$	(0.92	)	$	0.06
	Income (loss) from discontinued operations, net of income tax, attributable to MetLife, Inc.	$	0.01		$	—	$	—		$	0.03
	Net income (loss) attributable to MetLife, Inc.	$	(0.14	)	$	2.14	$	(0.90	)	$	0.12
	Net income (loss) available to MetLife, Inc.’s common shareholders	$	(0.16	)	$	2.12	$	(0.92	)	$	0.09

Business_Basis_of_Presentation2

Business, Basis of Presentation and Summary of Significant Accounting Policies (Narrative) (Details) (USD $)

12 Months Ended

3 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Segment

Accounting Standards Update 2011-06 [Member]

Building [Member]

Computer Software, Intangible Asset [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Subsequent Event [Member]

Other Capitalized Property Plant and Equipment [Member]

Leasehold Improvements [Member]

VODA and VOCRA [Member]

Other Capitalized Property Plant and Equipment [Member]

Leasehold Improvements [Member]

VODA and VOCRA [Member]

Organization, Consolidation and Presentation of Financial Statements [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of segments

6

'

'

'

'

'

'

'

'

'

'

'

'

'

Property, Plant and Equipment [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cost basis of property, equipment and leasehold improvements

$2,000,000,000

$2,500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Accumulated depreciation and amortization of property, equipment and leasehold improvements

1,000,000,000

1,300,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Depreciation and amortization expense

183,000,000

208,000,000

199,000,000

'

'

'

'

'

'

'

'

'

'

'

Cost basis of computer software

1,700,000,000

1,500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Accumulated amortization of computer software

1,100,000,000

932,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Amortization expense related to computer software

216,000,000

221,000,000

217,000,000

'

'

'

'

'

'

'

'

'

'

'

Real Estate Held-for-investment And Accumulated Depreciation [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Real Estate Held-for-investment And Accumulated Depreciation Life Used For Depreciation

'

'

'

'

'

'

'20 years

'

'

'

'55 years

'

'

'

Finite-Lived Intangible Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization period

'

'

'

'

'

'4 years

'

'

'

'10 years

'

'

'

'40 years

Property, Plant and Equipment [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property, Plant and Equipment, Useful Life

'

'

'

'

'40 years

'

'

'3 years

'1 year

'

'

'7 years

'25 years

'

New Accounting Pronouncements or Change in Accounting Principle [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Adoption of the new accounting pronouncement

'

'

'

$57,000,000

'

'

'

'

'

'

'

'

'

'

Segment_Information_Earnings_D

Segment Information (Earnings) (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenues	'	'	'	'	'	'	'	'	'	'	'
Premiums	'	'	'	'	'	'	'	'	$37,674	$37,975	$36,361
Universal life and investment-type product policy fees	'	'	'	'	'	'	'	'	9,451	8,556	7,806
Net investment income	'	'	'	'	'	'	'	'	22,232	21,984	19,585
Other revenues	'	'	'	'	'	'	'	'	1,920	1,906	2,532
Net investment gains (losses)	'	'	'	'	'	'	'	'	161	-352	-867
Net derivative gains (losses)	'	'	'	'	'	'	'	'	-3,239	-1,919	4,824
Total revenues	18,458	16,337	15,721	17,683	17,333	16,503	18,398	15,916	68,199	68,150	70,241
Expenses	'	'	'	'	'	'	'	'	'	'	'
Policyholder benefits and claims and policyholder dividends	'	'	'	'	'	'	'	'	39,366	39,356	36,917
Interest credited to policyholder account balances	'	'	'	'	'	'	'	'	8,179	7,729	5,603
Goodwill impairment	'	'	'	'	'	'	'	'	0	1,868	0
Capitalization of DAC	'	'	'	'	'	'	'	'	-4,786	-5,289	-5,558
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	3,550	4,199	4,898
Amortization of negative VOBA	'	'	'	'	'	'	'	'	-579	-622	-697
Interest expense on debt	'	'	'	'	'	'	'	'	1,282	1,356	1,629
Other expenses	'	'	'	'	'	'	'	'	17,135	18,111	18,265
Total expenses	17,190	15,361	15,160	16,436	17,810	17,513	15,060	16,325	64,147	66,708	61,057
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	661	128	2,793
Income (loss) from continuing operations, net of income tax	915	973	508	995	105	-957	2,300	-134	3,391	1,314	6,391
Retail [Member]	'	'	'	'	'	'	'	'	'	'	'
Expenses	'	'	'	'	'	'	'	'	'	'	'
Goodwill impairment	'	'	'	'	'	'	'	'	'	1,692	0
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	850	1,603	2,365
Group, Voluntary & Worksite Benefits [Member]	'	'	'	'	'	'	'	'	'	'	'
Expenses	'	'	'	'	'	'	'	'	'	'	'
Goodwill impairment	'	'	'	'	'	'	'	'	'	0	0
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	140	133	186
Corporate Benefit Funding [Member]	'	'	'	'	'	'	'	'	'	'	'
Expenses	'	'	'	'	'	'	'	'	'	'	'
Goodwill impairment	'	'	'	'	'	'	'	'	'	0	0
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	23	22	17
Latin America [Member]	'	'	'	'	'	'	'	'	'	'	'
Expenses	'	'	'	'	'	'	'	'	'	'	'
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	310	228	211
Asia [Member]	'	'	'	'	'	'	'	'	'	'	'
Expenses	'	'	'	'	'	'	'	'	'	'	'
Goodwill impairment	'	'	'	'	'	'	'	'	'	0	0
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	1,527	1,567	1,505
Europe, the Middle East and Africa [Member]	'	'	'	'	'	'	'	'	'	'	'
Expenses	'	'	'	'	'	'	'	'	'	'	'
Goodwill impairment	'	'	'	'	'	'	'	'	'	0	0
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	699	644	613
Corporate & Other [Member]	'	'	'	'	'	'	'	'	'	'	'
Expenses	'	'	'	'	'	'	'	'	'	'	'
Goodwill impairment	'	'	'	'	'	'	'	'	'	176	65
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	1	2	1
Operating Segments [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Premiums	'	'	'	'	'	'	'	'	37,675	37,911	36,269
Universal life and investment-type product policy fees	'	'	'	'	'	'	'	'	9,085	8,212	7,528
Net investment income	'	'	'	'	'	'	'	'	20,584	20,472	19,638
Other revenues	'	'	'	'	'	'	'	'	1,954	1,756	1,652
Net investment gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Net derivative gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Total revenues	'	'	'	'	'	'	'	'	69,298	68,351	65,087
Expenses	'	'	'	'	'	'	'	'	'	'	'
Policyholder benefits and claims and policyholder dividends	'	'	'	'	'	'	'	'	37,968	37,770	36,241
Interest credited to policyholder account balances	'	'	'	'	'	'	'	'	6,015	6,242	6,057
Goodwill impairment	'	'	'	'	'	'	'	'	0	0	0
Capitalization of DAC	'	'	'	'	'	'	'	'	-4,786	-5,284	-5,549
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	4,083	4,177	4,355
Amortization of negative VOBA	'	'	'	'	'	'	'	'	-524	-555	-619
Interest expense on debt	'	'	'	'	'	'	'	'	1,159	1,190	1,304
Other expenses	'	'	'	'	'	'	'	'	16,615	16,680	16,620
Total expenses	'	'	'	'	'	'	'	'	60,530	60,220	58,409
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	2,359	2,323	1,879
Operating earnings	'	'	'	'	'	'	'	'	6,409	5,808	4,799
Operating Segments [Member] | Americas [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Premiums	'	'	'	'	'	'	'	'	27,461	27,141	26,022
Universal life and investment-type product policy fees	'	'	'	'	'	'	'	'	6,838	6,233	5,715
Net investment income	'	'	'	'	'	'	'	'	16,790	16,339	15,713
Other revenues	'	'	'	'	'	'	'	'	1,737	1,576	1,433
Net investment gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Net derivative gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Total revenues	'	'	'	'	'	'	'	'	52,826	51,289	48,883
Expenses	'	'	'	'	'	'	'	'	'	'	'
Policyholder benefits and claims and policyholder dividends	'	'	'	'	'	'	'	'	31,111	30,636	29,586
Interest credited to policyholder account balances	'	'	'	'	'	'	'	'	4,136	4,293	4,284
Goodwill impairment	'	'	'	'	'	'	'	'	0	0	0
Capitalization of DAC	'	'	'	'	'	'	'	'	-1,901	-2,273	-2,835
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	1,857	1,986	2,255
Amortization of negative VOBA	'	'	'	'	'	'	'	'	-2	-5	-6
Interest expense on debt	'	'	'	'	'	'	'	'	10	8	11
Other expenses	'	'	'	'	'	'	'	'	9,599	9,573	9,870
Total expenses	'	'	'	'	'	'	'	'	44,810	44,218	43,165
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	2,649	2,302	1,866
Operating earnings	'	'	'	'	'	'	'	'	5,367	4,769	3,852
Operating Segments [Member] | Retail [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Premiums	'	'	'	'	'	'	'	'	6,528	6,532	6,711
Universal life and investment-type product policy fees	'	'	'	'	'	'	'	'	4,912	4,561	4,096
Net investment income	'	'	'	'	'	'	'	'	7,898	7,670	7,414
Other revenues	'	'	'	'	'	'	'	'	1,018	879	779
Net investment gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Net derivative gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Total revenues	'	'	'	'	'	'	'	'	20,356	19,642	19,000
Expenses	'	'	'	'	'	'	'	'	'	'	'
Policyholder benefits and claims and policyholder dividends	'	'	'	'	'	'	'	'	9,028	9,010	9,220
Interest credited to policyholder account balances	'	'	'	'	'	'	'	'	2,331	2,375	2,412
Goodwill impairment	'	'	'	'	'	'	'	'	0	0	0
Capitalization of DAC	'	'	'	'	'	'	'	'	-1,309	-1,753	-2,339
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	1,384	1,607	1,845
Amortization of negative VOBA	'	'	'	'	'	'	'	'	0	0	0
Interest expense on debt	'	'	'	'	'	'	'	'	0	0	1
Other expenses	'	'	'	'	'	'	'	'	5,084	5,369	5,854
Total expenses	'	'	'	'	'	'	'	'	16,518	16,608	16,993
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	1,314	1,032	672
Operating earnings	'	'	'	'	'	'	'	'	2,524	2,002	1,335
Operating Segments [Member] | Group, Voluntary & Worksite Benefits [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Premiums	'	'	'	'	'	'	'	'	15,250	14,794	13,949
Universal life and investment-type product policy fees	'	'	'	'	'	'	'	'	688	662	630
Net investment income	'	'	'	'	'	'	'	'	1,856	1,768	1,768
Other revenues	'	'	'	'	'	'	'	'	418	422	390
Net investment gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Net derivative gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Total revenues	'	'	'	'	'	'	'	'	18,212	17,646	16,737
Expenses	'	'	'	'	'	'	'	'	'	'	'
Policyholder benefits and claims and policyholder dividends	'	'	'	'	'	'	'	'	14,227	13,691	13,015
Interest credited to policyholder account balances	'	'	'	'	'	'	'	'	155	167	178
Goodwill impairment	'	'	'	'	'	'	'	'	0	0	0
Capitalization of DAC	'	'	'	'	'	'	'	'	-141	-138	-176
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	140	133	186
Amortization of negative VOBA	'	'	'	'	'	'	'	'	0	0	0
Interest expense on debt	'	'	'	'	'	'	'	'	1	1	0
Other expenses	'	'	'	'	'	'	'	'	2,380	2,351	2,198
Total expenses	'	'	'	'	'	'	'	'	16,762	16,205	15,401
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	488	481	445
Operating earnings	'	'	'	'	'	'	'	'	962	960	891
Operating Segments [Member] | Corporate Benefit Funding [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Premiums	'	'	'	'	'	'	'	'	2,859	3,237	2,848
Universal life and investment-type product policy fees	'	'	'	'	'	'	'	'	247	225	232
Net investment income	'	'	'	'	'	'	'	'	5,790	5,703	5,506
Other revenues	'	'	'	'	'	'	'	'	278	259	249
Net investment gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Net derivative gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Total revenues	'	'	'	'	'	'	'	'	9,174	9,424	8,835
Expenses	'	'	'	'	'	'	'	'	'	'	'
Policyholder benefits and claims and policyholder dividends	'	'	'	'	'	'	'	'	5,402	5,704	5,287
Interest credited to policyholder account balances	'	'	'	'	'	'	'	'	1,233	1,358	1,323
Goodwill impairment	'	'	'	'	'	'	'	'	0	0	0
Capitalization of DAC	'	'	'	'	'	'	'	'	-27	-29	-25
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	23	22	17
Amortization of negative VOBA	'	'	'	'	'	'	'	'	0	0	0
Interest expense on debt	'	'	'	'	'	'	'	'	9	8	9
Other expenses	'	'	'	'	'	'	'	'	523	478	513
Total expenses	'	'	'	'	'	'	'	'	7,163	7,541	7,124
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	704	659	599
Operating earnings	'	'	'	'	'	'	'	'	1,307	1,224	1,112
Operating Segments [Member] | Latin America [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Premiums	'	'	'	'	'	'	'	'	2,824	2,578	2,514
Universal life and investment-type product policy fees	'	'	'	'	'	'	'	'	991	785	757
Net investment income	'	'	'	'	'	'	'	'	1,246	1,198	1,025
Other revenues	'	'	'	'	'	'	'	'	23	16	15
Net investment gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Net derivative gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Total revenues	'	'	'	'	'	'	'	'	5,084	4,577	4,311
Expenses	'	'	'	'	'	'	'	'	'	'	'
Policyholder benefits and claims and policyholder dividends	'	'	'	'	'	'	'	'	2,454	2,231	2,064
Interest credited to policyholder account balances	'	'	'	'	'	'	'	'	417	393	371
Goodwill impairment	'	'	'	'	'	'	'	'	0	0	0
Capitalization of DAC	'	'	'	'	'	'	'	'	-424	-353	-295
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	310	224	207
Amortization of negative VOBA	'	'	'	'	'	'	'	'	-2	-5	-6
Interest expense on debt	'	'	'	'	'	'	'	'	0	-1	1
Other expenses	'	'	'	'	'	'	'	'	1,612	1,375	1,305
Total expenses	'	'	'	'	'	'	'	'	4,367	3,864	3,647
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	143	130	150
Operating earnings	'	'	'	'	'	'	'	'	574	583	514
Operating Segments [Member] | Asia [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Premiums	'	'	'	'	'	'	'	'	7,801	8,344	7,716
Universal life and investment-type product policy fees	'	'	'	'	'	'	'	'	1,722	1,491	1,343
Net investment income	'	'	'	'	'	'	'	'	2,915	2,895	2,475
Other revenues	'	'	'	'	'	'	'	'	92	26	36
Net investment gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Net derivative gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Total revenues	'	'	'	'	'	'	'	'	12,530	12,756	11,570
Expenses	'	'	'	'	'	'	'	'	'	'	'
Policyholder benefits and claims and policyholder dividends	'	'	'	'	'	'	'	'	5,755	5,819	5,239
Interest credited to policyholder account balances	'	'	'	'	'	'	'	'	1,690	1,784	1,607
Goodwill impairment	'	'	'	'	'	'	'	'	0	0	0
Capitalization of DAC	'	'	'	'	'	'	'	'	-2,143	-2,288	-2,045
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	1,542	1,563	1,486
Amortization of negative VOBA	'	'	'	'	'	'	'	'	-427	-456	-560
Interest expense on debt	'	'	'	'	'	'	'	'	0	5	0
Other expenses	'	'	'	'	'	'	'	'	4,312	4,738	4,522
Total expenses	'	'	'	'	'	'	'	'	10,729	11,165	10,249
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	557	554	441
Operating earnings	'	'	'	'	'	'	'	'	1,244	1,037	880
Operating Segments [Member] | Europe, the Middle East and Africa [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Premiums	'	'	'	'	'	'	'	'	2,297	2,370	2,477
Universal life and investment-type product policy fees	'	'	'	'	'	'	'	'	386	333	315
Net investment income	'	'	'	'	'	'	'	'	498	535	562
Other revenues	'	'	'	'	'	'	'	'	97	121	123
Net investment gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Net derivative gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Total revenues	'	'	'	'	'	'	'	'	3,278	3,359	3,477
Expenses	'	'	'	'	'	'	'	'	'	'	'
Policyholder benefits and claims and policyholder dividends	'	'	'	'	'	'	'	'	1,039	1,196	1,290
Interest credited to policyholder account balances	'	'	'	'	'	'	'	'	147	126	166
Goodwill impairment	'	'	'	'	'	'	'	'	0	0	0
Capitalization of DAC	'	'	'	'	'	'	'	'	-714	-723	-669
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	683	626	613
Amortization of negative VOBA	'	'	'	'	'	'	'	'	-95	-94	-53
Interest expense on debt	'	'	'	'	'	'	'	'	1	1	0
Other expenses	'	'	'	'	'	'	'	'	1,810	1,810	1,723
Total expenses	'	'	'	'	'	'	'	'	2,871	2,942	3,070
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	78	146	156
Operating earnings	'	'	'	'	'	'	'	'	329	271	251
Operating Segments [Member] | Corporate & Other [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Premiums	'	'	'	'	'	'	'	'	116	56	54
Universal life and investment-type product policy fees	'	'	'	'	'	'	'	'	139	155	155
Net investment income	'	'	'	'	'	'	'	'	381	703	888
Other revenues	'	'	'	'	'	'	'	'	28	33	60
Net investment gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Net derivative gains (losses)	'	'	'	'	'	'	'	'	0	0	0
Total revenues	'	'	'	'	'	'	'	'	664	947	1,157
Expenses	'	'	'	'	'	'	'	'	'	'	'
Policyholder benefits and claims and policyholder dividends	'	'	'	'	'	'	'	'	63	119	126
Interest credited to policyholder account balances	'	'	'	'	'	'	'	'	42	39	0
Goodwill impairment	'	'	'	'	'	'	'	'	0	0	0
Capitalization of DAC	'	'	'	'	'	'	'	'	-28	0	0
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	1	2	1
Amortization of negative VOBA	'	'	'	'	'	'	'	'	0	0	0
Interest expense on debt	'	'	'	'	'	'	'	'	1,148	1,176	1,293
Other expenses	'	'	'	'	'	'	'	'	894	559	505
Total expenses	'	'	'	'	'	'	'	'	2,120	1,895	1,925
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	-925	-679	-584
Operating earnings	'	'	'	'	'	'	'	'	-531	-269	-184
Significant Reconciling Items [Member]	'	'	'	'	'	'	'	'	'	'	'
Revenues	'	'	'	'	'	'	'	'	'	'	'
Premiums	'	'	'	'	'	'	'	'	-1	64	92
Universal life and investment-type product policy fees	'	'	'	'	'	'	'	'	366	344	278
Net investment income	'	'	'	'	'	'	'	'	1,648	1,512	-53
Other revenues	'	'	'	'	'	'	'	'	-34	150	880
Net investment gains (losses)	'	'	'	'	'	'	'	'	161	-352	-867
Net derivative gains (losses)	'	'	'	'	'	'	'	'	-3,239	-1,919	4,824
Total revenues	'	'	'	'	'	'	'	'	-1,099	-201	5,154
Expenses	'	'	'	'	'	'	'	'	'	'	'
Policyholder benefits and claims and policyholder dividends	'	'	'	'	'	'	'	'	1,398	1,586	676
Interest credited to policyholder account balances	'	'	'	'	'	'	'	'	2,164	1,487	-454
Goodwill impairment	'	'	'	'	'	'	'	'	0	1,868	0
Capitalization of DAC	'	'	'	'	'	'	'	'	0	-5	-9
Amortization of DAC and VOBA	'	'	'	'	'	'	'	'	-533	22	543
Amortization of negative VOBA	'	'	'	'	'	'	'	'	-55	-67	-78
Interest expense on debt	'	'	'	'	'	'	'	'	123	166	325
Other expenses	'	'	'	'	'	'	'	'	520	1,431	1,645
Total expenses	'	'	'	'	'	'	'	'	3,617	6,488	2,648
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	($1,698)	($2,195)	$914

Segment_Information_Total_Asse

Segment Information (Total Assets) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Segment Reporting Information [Line Items]	'	'
Total assets	$885,296	$836,781
Separate account assets	317,201	235,393
Separate account liabilities	317,201	235,393
Retail [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total assets	349,516	332,387
Separate account assets	172,382	150,513
Separate account liabilities	172,382	150,513
Group, Voluntary & Worksite Benefits [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total assets	43,404	44,138
Separate account assets	644	532
Separate account liabilities	644	532
Corporate Benefit Funding [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total assets	220,612	217,352
Separate account assets	77,023	71,875
Separate account liabilities	77,023	71,875
Latin America [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total assets	69,874	23,272
Separate account assets	49,660	4,200
Separate account liabilities	49,660	4,200
Asia [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total assets	119,717	131,138
Separate account assets	8,996	8,273
Separate account liabilities	8,996	8,273
Europe, the Middle East and Africa [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total assets	33,382	23,474
Separate account assets	8,496	0
Separate account liabilities	8,496	0
Corporate & Other [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total assets	48,791	65,020
Separate account assets	0	0
Separate account liabilities	$0	$0

Segment_Information_Premiums_U

Segment Information (Premiums, Universal Life and Investment-Type Policy Fees and Other Revenues by Major Product Groups) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Segment Reporting Information [Line Items]	'	'	'
Total premiums, universal life and investment-type product policy fees and other revenues	$49,045	$48,437	$46,699
Life Insurance [Member]	'	'	'
Segment Reporting Information [Line Items]	'	'	'
Total premiums, universal life and investment-type product policy fees and other revenues	32,176	31,723	30,486
Accident and Health Insurance [Member]	'	'	'
Segment Reporting Information [Line Items]	'	'	'
Total premiums, universal life and investment-type product policy fees and other revenues	13,214	13,255	12,269
Property and Casualty Insurance [Member]	'	'	'
Segment Reporting Information [Line Items]	'	'	'
Total premiums, universal life and investment-type product policy fees and other revenues	3,270	3,117	3,043
Non-Insurance [Member]	'	'	'
Segment Reporting Information [Line Items]	'	'	'
Total premiums, universal life and investment-type product policy fees and other revenues	$385	$342	$901

Segment_Information_Premiums_U1

Segment Information (Premiums, Universal Life and Investment-Type Policy Fees and Other Revenues by US and Foreign Operations) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Segment Reporting Information [Line Items]	'	'	'
Total premiums, universal life and investment-type product policy fees and other revenues	$49,045	$48,437	$46,699
U.S. [Member]	'	'	'
Segment Reporting Information [Line Items]	'	'	'
Total premiums, universal life and investment-type product policy fees and other revenues	32,529	31,500	30,108
Japan [Member]	'	'	'
Segment Reporting Information [Line Items]	'	'	'
Total premiums, universal life and investment-type product policy fees and other revenues	7,373	7,833	7,184
Other Foreign [Member]	'	'	'
Segment Reporting Information [Line Items]	'	'	'
Total premiums, universal life and investment-type product policy fees and other revenues	$9,143	$9,104	$9,407

Segment_Information_Narrative_

Segment Information (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
	Segment
Segment Reporting [Abstract]	'	'
Number of segments	6	'
Segment Reporting Information [Line Items]	'	'
Total assets	$885,296	$836,781
Japan [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Total assets	$98,400	$111,000
Percent of total assets from Japan operations	11.00%	13.00%

Acquisitions_and_Dispositions_1

Acquisitions and Dispositions (Discontinued Operations) (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Discontinued Operations in Consolidated Statements of Operations	'	'	'	'	'	'	'	'	'	'	'
Total revenues	'	'	'	'	'	'	'	'	$3	$74	$484
Total expenses	'	'	'	'	'	'	'	'	0	0	363
Income (loss) before provision for income tax	'	'	'	'	'	'	'	'	3	74	121
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	1	26	33
Income (loss) from operations of discontinued operations, net of income tax	'	'	'	'	'	'	'	'	2	48	88
Gain (loss) on disposal of operations, net of income tax	'	'	'	'	'	'	'	'	0	0	-64
Income (loss) from discontinued operations, net of income tax	$1	$2	$2	($3)	$31	$0	$3	$14	$2	$48	$24

Acquisitions_and_Dispositions_2

Acquisitions and Dispositions (Acquisitions - Narrative) (Details) (USD $)

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

3 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2013

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Nov. 01, 2010

Acquisition of Administradora de Fondos de Pensiones ProVida SA [Member]

Acquisition of Administradora de Fondos de Pensiones ProVida SA [Member]

Acquisition of Administradora de Fondos de Pensiones ProVida SA [Member]

Acquisition of Administradora de Fondos de Pensiones ProVida SA [Member]

Acquisition of Administradora de Fondos de Pensiones ProVida SA [Member]

Acquisition of Administradora de Fondos de Pensiones ProVida SA [Member]

Acquisition of Administradora de Fondos de Pensiones ProVida SA [Member]

Acquisition of Administradora de Fondos de Pensiones ProVida SA [Member]

Acquisition of Administradora de Fondos de Pensiones ProVida SA [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

Service Marks [Member]

Encaje Investment Fund A [Member]

Encaje Investment Fund B [Member]

Encaje Investment Fund C [Member]

Encaje Investment Fund D [Member]

Encaje Investment Fund E [Member]

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Name of Acquired Entity

'

'

'American Life Insurance Company ("American Life") and Delaware American Life Insurance Company ("DelAm"), (American Life, together with DelAm, collectively, "ALICO")

'

'

'Administradora de Fondos de Pensiones Provida S.A. (bProVidab)

'

'

'

'

'

'

'

'

'

'

'

'

'

Liability recognized in purchase accounting for the anticipated and estimated costs associated with restructuring foreign branches into subsidiaries

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$11,000,000

'

'

'

$277,000,000

Business Acquisition, Percentage of Voting Interests Acquired Directly From Seller

'

'

'

'

'

'

64.32%

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Percentage of Voting Interests Acquired Directly From Publicly Traded Shares

'

'

'

'

'

'

27.06%

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Percentage of Voting Interests Acquired

'

'

'

'

'

'

91.38%

'

'

'

'

'

'

'

'

'

'

'

'

Payments to Acquire Businesses, Gross

'

'

'

'

'

1,900,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity Method Investment, Ownership Percentage

'

'

'

'

'

'

'

'

1.00%

1.00%

1.00%

1.00%

1.00%

'

'

'

'

'

'

Business Acquisition, Effective Date of Acquisition

'

'

'

1-Nov-10

'

'

'

'

'

'

'

'

'

1-Nov-10

'

'

'

1-Nov-10

'

Business Combination, Consideration Transferred

'

'

'

'

'

'

'

'

'

'

'

'

'

16,400,000,000

'

'

'

'

'

Business Combination, Reason for Business Combination

'

'

'

'

'

'

'

'

'

'

'

'

'

'The ALICO Acquisition significantly broadened the Companybs diversification by product, distribution and geography, meaningfully accelerated MetLifebs global growth strategy, and provides the opportunity to build an international franchise leveraging the key strengths of ALICO.

'

'

'

'

'

Fair value of assets assumed

'

'

'

'

'

'

631,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of liabilities assumed

'

'

'

'

'

'

159,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Acquisitions of VOBA

947,000,000

55,000,000

11,000,000

'

941,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Finite-Lived Intangible Asset, Useful Life

'

'

'

'

'15 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquired trade name value

0

0

213,000,000

'

'

'

'

179,000,000

'

'

'

'

'

'

'

'

'

'

'

Goodwill acquired

1,141,000,000

1,000,000

39,000,000

'

1,100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of future service liability

'

'

'

'

'

'

589,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Total revenues from acquiree included in MetLife's total revenues

'

'

'

'

100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Income (loss) from continuing operations, net of income tax, from Acquisition included in MetLife's 2013 results

'

'

'

'

42,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Transaction Costs

'

'

'

'

18,000,000

18,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Combination, Integration Related Costs

'

'

'

'

12,000,000

'

'

'

'

'

'

'

'

'

138,000,000

305,000,000

362,000,000

'

'

Separate account assets

317,201,000,000

235,393,000,000

'

'

'

'

45,200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Separate account liabilities

317,201,000,000

235,393,000,000

'

'

'

'

45,200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets

'

'

'

'

'

'

451,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Deferred income tax assets

6,033,000,000

10,261,000,000

'

'

'

'

118,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Deferred income tax liabilities

12,319,000,000

18,586,000,000

'

'

'

'

224,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Goodwill, Expected Tax Deductible Amount

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value

'

'

'

'

'

'

176,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Liability For Tax Restructuring Costs, Change in Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$29,000,000

'

'

'

'

Acquisitions_and_Dispositions_3

Acquisitions and Dispositions (Dispositions - Narrative) (Details)

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2013

Jan. 11, 2013

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Nov. 01, 2011

USD ($)

USD ($)

USD ($)

Caribbean Business [Member]

Caribbean Business [Member]

Caribbean Business [Member]

MetLife Bank [Member]

MetLife Bank [Member]

MetLife Bank [Member]

MetLife Bank [Member]

MetLife Bank [Member]

MetLife Bank [Member]

Ceded Assumption Reinsurance of Certain Closed Blocks of Business [Member]

Ceded Assumption Reinsurance of Certain Closed Blocks of Business [Member]

Mitsui Sumitomo MetLife Insurance Co Ltd (MSI MetLife) [Member]

Mitsui Sumitomo MetLife Insurance Co Ltd (MSI MetLife) [Member]

MetLife Taiwan Insurance Company Limited [Member]

MetLife Taiwan Insurance Company Limited [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Minimum [Member]

Maximum [Member]

USD ($)

USD ($)

USD ($)

JPY (¥)

USD ($)

USD ($)

USD ($)

USD ($)

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity Method Investment, Net Sales Proceeds

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$269

¥ 22,500

'

'

Equity Method Investment, Ownership Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50.00%

50.00%

'

'

Additional charges expected related to the exit of business

'

'

'

'

'

'

'

'

'

'

20

45

'

'

'

'

'

'

Net consideration

'

'

'

'

'

'

'

'

6,400

'

'

'

'

'

'

'

180

'

Net assets sold

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

282

Gain (loss) on disposal

'

'

'

2

-5

21

163

115

'

212

'

'

'

-25

'

'

'

'

Assets related to sale of business

'

'

'

'

'

'

7,800

446

6,400

'

'

'

'

4,100

'

'

'

'

Liabilities related to sale of business

'

'

'

'

'

'

6,800

282

'

'

'

'

4,100

'

'

'

'

'

Expense For Reimbursement Of Transaction Costs Related To Disposal Of Joint Venture

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4

310

'

'

Foreign Operation Hedge Gain (Loss) Reclassified, Net of tax

'

'

'

'

'

'

'

'

'

'

'

'

'

'

46

'

'

'

Equity Method Investment, Realized Gain (Loss) on Disposal

-48

-36

4

'

'

'

'

'

'

'

'

'

'

'

-57

'

'

'

Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax

0

0

-64

'

'

'

'

'

'

'

'

'

'

'

'

'

-64

'

Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax

2

48

88

'

'

'

'

'

'

'

'

'

'

'

'

'

20

'

Liabilities of business transferred to subsidiary under funding agreements that are included in policyholder account balances

$0

$3,806

$0

'

'

'

$3,800

'

'

'

'

'

'

'

'

'

'

'

Insurance_Insurance_Liabilitie

Insurance (Insurance Liabilities) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Insurance Liabilities [Line Items]	'	'
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	$416,041	$433,635
Retail [Member]	'	'
Insurance Liabilities [Line Items]	'	'
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	134,915	138,082
Group, Voluntary & Worksite Benefits [Member]	'	'
Insurance Liabilities [Line Items]	'	'
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	29,521	29,996
Corporate Benefit Funding [Member]	'	'
Insurance Liabilities [Line Items]	'	'
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	112,591	117,065
Latin America [Member]	'	'
Insurance Liabilities [Line Items]	'	'
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	16,162	16,055
Asia [Member]	'	'
Insurance Liabilities [Line Items]	'	'
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	93,066	103,064
Europe, the Middle East and Africa [Member]	'	'
Insurance Liabilities [Line Items]	'	'
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	21,657	20,200
Corporate & Other [Member]	'	'
Insurance Liabilities [Line Items]	'	'
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	$8,129	$9,173

Insurance_Liabilities_for_Guar

Insurance (Liabilities for Guarantees) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	$7,233	$5,998	$5,084
Incurred guaranteed benefits	385	1,396	1,061
Paid guaranteed benefits	-118	-161	-147
Balance at December 31,	7,500	7,233	5,998
Ceded [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	991	831	771
Incurred guaranteed benefits	184	180	80
Paid guaranteed benefits	-12	-20	-20
Balance at December 31,	1,163	991	831
Net [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	6,242	5,167	4,313
Incurred guaranteed benefits	201	1,216	981
Paid guaranteed benefits	-106	-141	-127
Balance at December 31,	6,337	6,242	5,167
Variable Annuity Guarantees [Member] | Guaranteed Minimum Death Benefit [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	567	432	272
Incurred guaranteed benefits	200	252	273
Paid guaranteed benefits	-82	-117	-113
Balance at December 31,	685	567	432
Variable Annuity Guarantees [Member] | Guaranteed Minimum Income Benefit [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	1,635	882	623
Incurred guaranteed benefits	229	771	269
Paid guaranteed benefits	-13	-18	-10
Balance at December 31,	1,851	1,635	882
Variable Annuity Guarantees [Member] | Ceded [Member] | Guaranteed Minimum Death Benefit [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	56	54	39
Incurred guaranteed benefits	-5	22	35
Paid guaranteed benefits	-10	-20	-20
Balance at December 31,	41	56	54
Variable Annuity Guarantees [Member] | Ceded [Member] | Guaranteed Minimum Income Benefit [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	9	8	-1
Incurred guaranteed benefits	0	1	9
Paid guaranteed benefits	-2	0	0
Balance at December 31,	7	9	8
Variable Annuity Guarantees [Member] | Net [Member] | Guaranteed Minimum Death Benefit [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	511	378	233
Incurred guaranteed benefits	205	230	238
Paid guaranteed benefits	-72	-97	-93
Balance at December 31,	644	511	378
Variable Annuity Guarantees [Member] | Net [Member] | Guaranteed Minimum Income Benefit [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	1,626	874	624
Incurred guaranteed benefits	229	770	260
Paid guaranteed benefits	-11	-18	-10
Balance at December 31,	1,844	1,626	874
Universal And Variable Life Contracts [Member] | Secondary Guarantees [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	4,785	4,463	3,991
Incurred guaranteed benefits	-64	348	496
Paid guaranteed benefits	-23	-26	-24
Balance at December 31,	4,698	4,785	4,463
Universal And Variable Life Contracts [Member] | Secondary Guarantees [Member] | Foreign Currency Translation [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Incurred guaranteed benefits	-597	-39	231
Universal And Variable Life Contracts [Member] | Paid-Up Guarantees [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	246	221	198
Incurred guaranteed benefits	20	25	23
Paid guaranteed benefits	0	0	0
Balance at December 31,	266	246	221
Universal And Variable Life Contracts [Member] | Ceded [Member] | Secondary Guarantees [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	753	614	594
Incurred guaranteed benefits	175	139	20
Paid guaranteed benefits	0	0	0
Balance at December 31,	928	753	614
Universal And Variable Life Contracts [Member] | Ceded [Member] | Paid-Up Guarantees [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	173	155	139
Incurred guaranteed benefits	14	18	16
Paid guaranteed benefits	0	0	0
Balance at December 31,	187	173	155
Universal And Variable Life Contracts [Member] | Net [Member] | Secondary Guarantees [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	4,032	3,849	3,397
Incurred guaranteed benefits	-239	209	476
Paid guaranteed benefits	-23	-26	-24
Balance at December 31,	3,770	4,032	3,849
Universal And Variable Life Contracts [Member] | Net [Member] | Paid-Up Guarantees [Member]	'	'	'
Movement In Guaranteed Benefit Liability Gross Rollforward	'	'	'
Balance at January 1,	73	66	59
Incurred guaranteed benefits	6	7	7
Paid guaranteed benefits	0	0	0
Balance at December 31,	$79	$73	$66

Insurance_Fund_Groupings_Detai

Insurance (Fund Groupings) (Details) (Variable Annuity and Variable Life [Member], USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Fund Groupings	'	'
Fund Groupings	$166,753	$146,178
Balanced Funds [Member]	'	'
Fund Groupings	'	'
Fund Groupings	75,928	67,230
Equity Funds [Member]	'	'
Fund Groupings	'	'
Fund Groupings	79,036	66,469
Bond Funds [Member]	'	'
Fund Groupings	'	'
Fund Groupings	10,632	11,188
Money Market Funds [Member]	'	'
Fund Groupings	'	'
Fund Groupings	$1,157	$1,291

Insurance_Guarantees_Related_t

Insurance (Guarantees Related to Annuity Contracts) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Variable Annuity Guarantees [Member] | Guaranteed Death Benefits [Member]	'	'
Net Amount at Risk by Product and Guarantee [Line Items]	'	'
Account value	$201,395	$184,095
Separate account value in event of death	164,500	143,893
Net amount at risk in event of death	4,203	9,501
Average attained age of contractholders	'63 years	'62 years
Variable Annuity Guarantees [Member] | Guaranteed Annuitization Benefits [Member]	'	'
Net Amount at Risk by Product and Guarantee [Line Items]	'	'
Account value	100,527	89,137
Separate account value at annuitization	96,459	84,354
Net amount at risk at annuitization	1,219	4,593
Average attained age of contractholders	'63 years	'62 years
Two Tier Annuities [Member] | Guaranteed Annuitization Benefits [Member]	'	'
Net Amount at Risk by Product and Guarantee [Line Items]	'	'
Account value	880	848
Net amount at risk at annuitization	$234	$232
Average attained age of contractholders	'50 years	'51 years

Insurance_Guarantees_Related_t1

Insurance (Guarantees Related to Universal and Variable Life Contracts) (Details) (Universal And Variable Life Contracts [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Secondary Guarantees [Member]	'	'
Net Amount at Risk by Product and Guarantee [Line Items]	'	'
Account value (general and separate account)	$16,048	$14,256
Net amount at risk	185,920	189,197
Average attained age of policyholders	'55 years	'54 years
Paid-Up Guarantees [Member]	'	'
Net Amount at Risk by Product and Guarantee [Line Items]	'	'
Account value (general and separate account)	3,700	3,828
Net amount at risk	$21,737	$23,276
Average attained age of policyholders	'60 years	'60 years

Insurance_Obligations_Under_Fu

Insurance (Obligations Under Funding Agreements - FHLB Common Stock) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Federal Home Loan Bank of New York [Member]	'	'
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]	'	'
Federal Home Loan Bank Stock	$700	$736
Federal Home Loan Bank of Boston [Member]	'	'
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]	'	'
Federal Home Loan Bank Stock	64	67
Federal Home Loan Bank of Des Moines [Member]	'	'
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]	'	'
Federal Home Loan Bank Stock	76	83
Federal Home Loan Bank of Pittsburgh [Member]	'	'
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]	'	'
Federal Home Loan Bank Stock	$30	$14

Insurance_Obligations_Under_Fu1

Insurance (Obligations Under Funding Agreements - Liability and Collateral) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Fixed and Floating Rate Funding Agreements by Type [Line Items]	'	'
Outstanding funding agreements to certain SPEs	$31,200,000,000	$30,000,000,000
Invested Assets Pledged As Collateral	23,770,000,000	23,251,000,000
Funding agreements - Federal Agricultural Mortgage Corporation [Member]	'	'
Fixed and Floating Rate Funding Agreements by Type [Line Items]	'	'
Outstanding funding agreements to certain SPEs	2,750,000,000	2,750,000,000
Invested Assets Pledged As Collateral	3,159,000,000	3,159,000,000
Federal Home Loan Bank of New York [Member]	'	'
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]	'	'
Federal Home Loan Bank amount of advances by branch for funding agreements	12,770,000,000	13,512,000,000
Collateral pledged relating to obligations under funding agreements	14,287,000,000	14,611,000,000
Federal Home Loan Bank of Boston [Member]	'	'
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]	'	'
Federal Home Loan Bank amount of advances by branch for funding agreements	450,000,000	450,000,000
Collateral pledged relating to obligations under funding agreements	808,000,000	537,000,000
Federal Home Loan Bank of Des Moines [Member]	'	'
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]	'	'
Federal Home Loan Bank amount of advances by branch for funding agreements	1,405,000,000	1,405,000,000
Collateral pledged relating to obligations under funding agreements	1,596,000,000	1,902,000,000
Federal Home Loan Bank of Pittsburgh [Member]	'	'
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]	'	'
Federal Home Loan Bank amount of advances by branch for funding agreements	375,000,000	0
Collateral pledged relating to obligations under funding agreements	$976,000,000	$810,000,000

Insurance_Liabilities_for_Unpa

Insurance (Liabilities for Unpaid Claims and Claim Expense) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Liabilities for Unpaid Claims and Claim Expenses	'	'	'
Balance at January 1,	$10,436	$10,117	$10,708
Less: Reinsurance recoverables	1,581	1,436	2,198
Net balance at January 1,	8,855	8,681	8,510
Incurred related to:	'	'	'
Current year	8,660	8,399	9,028
Prior years	-86	-69	-199
Total incurred	8,574	8,330	8,829
Paid related to:	'	'	'
Current year	-6,083	-5,689	-6,238
Prior years	-2,377	-2,467	-2,420
Total paid	-8,460	-8,156	-8,658
Net balance at December 31,	8,969	8,855	8,681
Add: Reinsurance recoverables	1,661	1,581	1,436
Balance at December 31,	$10,630	$10,436	$10,117

Insurance_Insurance_Liabilitie1

Insurance (Insurance Liabilities Assumptions and Ratios - Narrative) (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Liability for Future Policy Benefits and Policyholder Account Balances [Abstract]	'	'	'
Participating business as a percentage of gross life insurance policies in-force	5.00%	6.00%	'
Participating business as a percentage of the gross life insurance premiums	19.00%	20.00%	21.00%
Domestic Business [Member] | Minimum [Member]	'	'	'
Liability for Future Policy Benefit, by Product Segment [Line Items]	'	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for individual and group traditional fixed annuities after annuitization	1.00%	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for non-medical health insurance	4.00%	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for disabled lives	2.00%	'	'
Interest rate range credited to policyholder account balances	1.00%	'	'
Domestic Business [Member] | Maximum [Member]	'	'	'
Liability for Future Policy Benefit, by Product Segment [Line Items]	'	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for individual and group traditional fixed annuities after annuitization	11.00%	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for non-medical health insurance	7.00%	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for disabled lives	8.00%	'	'
Interest rate range credited to policyholder account balances	13.00%	'	'
Domestic Business [Member] | Participating Life Insurance Policies [Member]	'	'	'
Liability for Future Policy Benefit, by Product Segment [Line Items]	'	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for traditional life insurance policies, low end	3.00%	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for traditional life insurance policies, high end	7.00%	'	'
Domestic Business [Member] | Nonparticipating Life Insurance Policies [Member]	'	'	'
Liability for Future Policy Benefit, by Product Segment [Line Items]	'	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for traditional life insurance policies, low end	2.00%	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for traditional life insurance policies, high end	10.00%	'	'
International Business [Member] | Minimum [Member]	'	'	'
Liability for Future Policy Benefit, by Product Segment [Line Items]	'	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for individual and group traditional fixed annuities after annuitization	1.00%	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for disabled lives	1.00%	'	'
Interest rate range credited to policyholder account balances	1.00%	'	'
International Business [Member] | Maximum [Member]	'	'	'
Liability for Future Policy Benefit, by Product Segment [Line Items]	'	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for individual and group traditional fixed annuities after annuitization	12.00%	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for disabled lives	9.00%	'	'
Interest rate range credited to policyholder account balances	12.00%	'	'
International Business [Member] | Participating Life Insurance Policies [Member]	'	'	'
Liability for Future Policy Benefit, by Product Segment [Line Items]	'	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for traditional life insurance policies, low end	1.00%	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for traditional life insurance policies, high end	13.00%	'	'
International Business [Member] | Nonparticipating Life Insurance Policies [Member]	'	'	'
Liability for Future Policy Benefit, by Product Segment [Line Items]	'	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for traditional life insurance policies, low end	1.00%	'	'
Interest rate assumptions for the aggregate future policy benefit liabilities for traditional life insurance policies, high end	13.00%	'	'

Insurance_Obligations_Under_Fu2

Insurance (Obligations Under Funding Agreements - Narrative) (Details) (USD $)	12 Months Ended
In Billions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Insurance [Abstract]	'	'	'
Funding agreements issued to certain SPEs	$37.70	$35.10	$39.90
Funding agreements repaid to certain SPEs	36.8	31.1	41.6
Outstanding funding agreements to certain SPEs	$31.20	$30	'

Insurance_Separate_Accounts_Na

Insurance (Separate Accounts - Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Insurance [Abstract]	'	'	'
Pass-through separate accounts	$265,400,000,000	$185,900,000,000	'
Separate accounts with a guaranteed minimum return or account value	51,800,000,000	49,500,000,000	'
Gain (losses) on transfers of assets from the general account to the separate accounts	$0	$0	$0
Funding Agreements and Participating Close Out Contracts Included in Separate Accounts with a Guaranteed Minimum Return or Account Value [Member]	'	'	'
Schedule Separate Accounts [Line Items]	'	'	'
Average interest rate credited on separate accounts with a guaranteed minimum return or account value	2.23%	2.80%	'

Deferred_Policy_Acquisition_Co2

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (DAC and VOBA) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Deferred Policy Acquisition Costs and Value of Business Acquired [Abstract]	'	'	'
Beginning Balance of DAC	$17,150	$15,240	$13,377
Beginning Balance of VOBA	7,611	9,379	11,088
Capitalizations of DAC	4,786	5,289	5,558
Acquisitions of VOBA	947	55	11
Net investment gains (losses) of DAC and net derivative gains (losses) of DAC	192	-40	-478
Net investment gains (losses) of VOBA and net derivative gains (losses) of VOBA	3	-1	-49
Other expenses of DAC	-2,812	-2,875	-2,614
Other expenses of VOBA	-933	-1,283	-1,757
Total amortization of DAC	-2,620	-2,915	-3,092
Total amortization of VOBA	-930	-1,284	-1,806
Unrealized investment gains (losses) of DAC	924	-516	-427
Unrealized investment gains (losses) of VOBA	358	-197	-361
Effect of foreign currency translation and other of DAC	-466	52	-176
Effect of foreign currency translation and other of VOBA	-1,054	-342	447
Ending Balance of DAC	19,774	17,150	15,240
Ending Balance of VOBA	6,932	7,611	9,379
Balance, end of period	$26,706	$24,761	$24,619

Deferred_Policy_Acquisition_Co3

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (DAC and VOBA by Segment) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Millions, unless otherwise specified
Deferred Policy Acquisition Costs and Present Value of Future Profits [Abstract]	'	'	'
DAC & VOBA	$26,706	$24,761	$24,619
Retail [Member]	'	'	'
Deferred Policy Acquisition Costs and Present Value of Future Profits [Abstract]	'	'	'
DAC & VOBA	12,882	11,500	11,681
Group, Voluntary & Worksite Benefits [Member]	'	'	'
Deferred Policy Acquisition Costs and Present Value of Future Profits [Abstract]	'	'	'
DAC & VOBA	382	382	377
Corporate Benefit Funding [Member]	'	'	'
Deferred Policy Acquisition Costs and Present Value of Future Profits [Abstract]	'	'	'
DAC & VOBA	99	96	89
Latin America [Member]	'	'	'
Deferred Policy Acquisition Costs and Present Value of Future Profits [Abstract]	'	'	'
DAC & VOBA	2,201	1,231	1,050
Asia [Member]	'	'	'
Deferred Policy Acquisition Costs and Present Value of Future Profits [Abstract]	'	'	'
DAC & VOBA	9,077	9,554	9,554
Europe, the Middle East and Africa [Member]	'	'	'
Deferred Policy Acquisition Costs and Present Value of Future Profits [Abstract]	'	'	'
DAC & VOBA	2,039	1,998	1,866
Corporate & Other [Member]	'	'	'
Deferred Policy Acquisition Costs and Present Value of Future Profits [Abstract]	'	'	'
DAC & VOBA	$26	$0	$2

Deferred_Policy_Acquisition_Co4

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (Deferred Sales Inducements) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Deferred Sales Inducements	'	'	'
Balance at January 1,	$930	$926	$918
Capitalization	58	81	140
Amortization	-36	-77	-132
Effect of foreign currency translation	-2	0	0
Balance at December 31,	$950	$930	$926

Deferred_Policy_Acquisition_Co5

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (VODA and VOCRA) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Insurance [Abstract]	'	'	'
Balance at January 1,	$1,108	$1,264	$1,094
Acquisitions	0	0	213
Amortization	-84	-150	-60
Effect of foreign currency translation	-49	-6	17
Balance at December 31,	975	1,108	1,264
Accumulated Amortization	$418	$334	$184

Deferred_Policy_Acquisition_Co6

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (Negative VOBA) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Finite Lived Intangible Liabilities	'	'	'
Balance at January 1,	$2,916	$3,657	$4,287
Acquisitions	0	10	7
Amortization of negative VOBA	-579	-622	-697
Effect of foreign currency translation	-175	-129	60
Balance at December 31,	2,162	2,916	3,657
Accumulated Amortization	$1,962	$1,383	$761

Deferred_Policy_Acquisition_Co7

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (Estimated Future Amortization) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Estimated future amortization expense allocated to other expenses for VOBA [Abstract]	'
VOBA 2014	$846
VOBA 2015	700
VOBA 2016	596
VOBA 2017	516
VOBA 2018	448
Value of Distribution Agreements and Customer Relationships Acquired [Abstract]	'
VODA and VOCRA 2014	80
VODA and VOCRA 2015	79
VODA and VOCRA 2016	75
VODA and VOCRA 2017	71
VODA and VOCRA 2018	66
Negative Value of Business Acquired [Abstract]	'
Negative VOBA 2014	-438
Negative VOBA 2015	-353
Negative VOBA 2016	-271
Negative VOBA 2017	-154
Negative VOBA 2018	($68)

Deferred_Policy_Acquisition_Co8

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2012
Deferred Policy Acquisition Costs and Value of Business Acquired [Abstract]	'
VOCRA impairment	$77
VOCRA impairment, net of income tax	$50

Reinsurance_Effects_of_Reinsur

Reinsurance (Effects of Reinsurance on Earnings) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Premiums:	'	'	'
Direct premiums	$38,476	$38,719	$37,185
Reinsurance assumed	1,472	1,488	1,484
Reinsurance ceded	-2,274	-2,232	-2,308
Net premiums	37,674	37,975	36,361
Universal life and investment-type product policy fees:	'	'	'
Direct universal life and investment-type product policy fees	10,197	9,216	8,455
Reinsurance assumed	139	155	154
Reinsurance ceded	-885	-815	-803
Net universal life and investment-type product policy fees	9,451	8,556	7,806
Policyholder benefits and claims:	'	'	'
Direct policyholder benefits and claims	40,211	39,262	37,588
Reinsurance assumed	1,047	1,167	1,101
Reinsurance ceded	-3,151	-2,442	-3,218
Net policyholder benefits and claims	38,107	37,987	35,471
Other expenses:	'	'	'
Direct other expenses	16,712	17,848	18,672
Reinsurance assumed	147	228	168
Reinsurance ceded	-257	-321	-303
Total other expenses	$16,602	$17,755	$18,537

Reinsurance_Effects_of_Reinsur1

Reinsurance (Effects of Reinsurance on Balance Sheet) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Millions, unless otherwise specified
Assets:	'	'	'
Premiums and Other Receivables, Net	$21,859	$21,634	'
Deferred Policy Acquisition Costs and Value of Business Acquired	26,706	24,761	24,619
Total assets	48,565	46,395	'
Liabilities:	'	'	'
Future policy benefits (includes $516 and $0, respectively, relating to variable interest entities)	187,942	192,351	'
Policyholder account balances	212,885	225,821	217,700
Other policy-related balances (includes $123 and $0, respectively, relating to variable interest entities)	15,214	15,463	'
Other Liabilities	23,168	22,492	'
Total liabilities	439,209	456,127	'
Assumed Reinsurance [Member]	'	'	'
Assets:	'	'	'
Premiums and Other Receivables, Net	593	548	'
Deferred Policy Acquisition Costs and Value of Business Acquired	104	92	'
Total assets	697	640	'
Liabilities:	'	'	'
Future policy benefits (includes $516 and $0, respectively, relating to variable interest entities)	2,034	2,031	'
Policyholder account balances	1,277	2,594	'
Other policy-related balances (includes $123 and $0, respectively, relating to variable interest entities)	353	313	'
Other Liabilities	533	543	'
Total liabilities	4,197	5,481	'
Ceded Reinsurance [Member]	'	'	'
Assets:	'	'	'
Premiums and Other Receivables, Net	15,018	14,800	'
Deferred Policy Acquisition Costs and Value of Business Acquired	-352	-120	'
Total assets	14,666	14,680	'
Liabilities:	'	'	'
Future policy benefits (includes $516 and $0, respectively, relating to variable interest entities)	0	-1	'
Policyholder account balances	-2	-2	'
Other policy-related balances (includes $123 and $0, respectively, relating to variable interest entities)	23	8	'
Other Liabilities	3,044	3,024	'
Total liabilities	3,065	3,029	'
Direct Reinsurance [Member]	'	'	'
Assets:	'	'	'
Premiums and Other Receivables, Net	6,248	6,286	'
Deferred Policy Acquisition Costs and Value of Business Acquired	26,954	24,789	'
Total assets	33,202	31,075	'
Liabilities:	'	'	'
Future policy benefits (includes $516 and $0, respectively, relating to variable interest entities)	185,908	190,321	'
Policyholder account balances	211,610	223,229	'
Other policy-related balances (includes $123 and $0, respectively, relating to variable interest entities)	14,838	15,142	'
Other Liabilities	19,591	18,925	'
Total liabilities	$431,947	$447,617	'

Reinsurance_Narrative_Details

Reinsurance (Narrative) (Details) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Mortality Risk [Member]

Mortality Risk on Case by Case Basis [Member]

Quota Share Reinsurance for Certain Disability Business [Member]

Mortality Risk on Yearly Renewable Term Basis [Member]

Modified Coinsurance of Closed Block [Member]

Ceded Credit Risk, Unsecured [Member]

Ceded Credit Risk, Unsecured [Member]

Five Largest Ceded Reinsurers [Member]

Five Largest Ceded Reinsurers [Member]

Five Largest Ceded Reinsurers [Member]

Five Largest Ceded Reinsurers [Member]

Ceded Credit Risk, Unsecured [Member]

Ceded Credit Risk, Unsecured [Member]

Reinsurance Disclosures [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

Deposit assets in premiums, reinsurance, and other receivables or secondary guarantee risk for reinsurance

$2,300,000,000

$2,300,000,000

'

'

'

'

'

'

'

'

'

'

'

Deposit liabilities in other liabilities for reinsurance

37,000,000

45,000,000

'

'

'

'

'

'

'

'

'

'

'

Ceded Credit Risk [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Reinsurance recoverables

14,400,000,000

14,100,000,000

'

'

'

'

'

5,600,000,000

5,700,000,000

'

'

'

'

Five largest reinsurers, reinsurance recoverables amount

'

'

'

'

'

'

'

'

'

10,600,000,000

10,400,000,000

2,600,000,000

2,800,000,000

Five largest reinsurers, reinsurance recoverables percentage

'

'

'

'

'

'

'

'

'

74.00%

74.00%

'

'

Reinsurance Retention Policy [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Reinsured risk percentage

'

'

90.00%

'

100.00%

'

59.25%

'

'

'

'

'

'

Percentage of reinsured risk in excess of stated amount

'

'

90.00%

100.00%

'

'

'

'

'

'

'

'

'

Retention amount

'

'

$2,000,000

$20,000,000

'

$5,000,000

'

'

'

'

'

'

'

Closed_Block_Liabilities_and_A

Closed Block (Liabilities and Assets) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Millions, unless otherwise specified
Closed Block Liabilities	'	'	'	'
Future policy benefits	$42,076	$42,586	'	'
Other policy-related balances	298	298	'	'
Policyholder dividends payable	456	466	'	'
Policyholder dividend obligation	1,771	3,828	2,919	876
Current income tax payable	18	0	'	'
Other liabilities	582	602	'	'
Total closed block liabilities	45,201	47,780	'	'
Assets Designated to the Closed Block	'	'	'	'
Fixed maturity securities available-for-sale, at estimated fair value	28,374	30,546	'	'
Equity securities available-for-sale, at estimated fair value	86	41	'	'
Mortgage loans	6,155	6,192	'	'
Policy loans	4,669	4,670	'	'
Real estate and real estate joint ventures	492	459	'	'
Other invested assets	814	953	'	'
Total investments	40,590	42,861	'	'
Cash and cash equivalents	238	381	'	'
Accrued investment income	477	481	'	'
Premiums, reinsurance and other receivables	98	107	'	'
Current income tax recoverable	0	2	'	'
Deferred income tax assets	293	319	'	'
Total assets designated to the closed block	41,696	44,151	'	'
Excess of closed block liabilities over assets designated to the closed block	3,505	3,629	'	'
Amounts included in AOCI:	'	'	'	'
Unrealized investment gains (losses), net of income tax	1,502	2,891	'	'
Unrealized gains (losses) on derivatives, net of income tax	-3	9	'	'
Allocated to policyholder dividend obligation, net of income tax	-1,151	-2,488	'	'
Total amounts included in AOCI	348	412	'	'
Maximum future earnings to be recognized from closed block assets and liabilities	$3,853	$4,041	'	'

Closed_Block_Policyholder_Divi

Closed Block (Policyholder Dividend Obligation) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Closed block policyholder dividend obligation	'	'	'
Balance at January 1,	$3,828	$2,919	$876
Change in unrealized investment and derivative gains (losses)	-2,057	909	2,043
Balance at December 31,	$1,771	$3,828	$2,919

Closed_Block_Revenues_and_Expe

Closed Block (Revenues and Expenses) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenues	'	'	'
Premiums	$1,987	$2,139	$2,306
Net investment income	2,130	2,188	2,231
Net investment gains (losses)	25	61	32
Net derivative gains (losses)	-6	-12	8
Total revenues	4,136	4,376	4,577
Expenses	'	'	'
Policyholder benefits and claims	2,702	2,783	2,991
Policyholder dividends	979	1,072	1,137
Other expenses	165	179	193
Total expenses	3,846	4,034	4,321
Revenues, net of expenses before provision for income tax expense (benefit)	290	342	256
Provision for income tax expense (benefit)	101	120	89
Revenues, net of expenses and provision for income tax expense (benefit) from continuing operations	189	222	167
Revenues, net of expenses and provision for income tax expense (benefit) from discontinued operations	0	10	1
Revenues, net of expenses and provision for income tax expense (benefit)	$189	$232	$168

Investments_Fixed_Maturity_and

Investments (Fixed Maturity and Equity Securities Available-For-Sale by Sector) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Millions, unless otherwise specified
Available-for-sale Securities [Abstract]	'	'	'
Amortized Cost	$333,599	$340,870	'
Cost or Amortized Cost	3,012	2,838	'
Gross Unrealized OTTI Loss	218	361	724
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	350,187	374,266	'
Equity securities	3,402	2,891	'
Fixed maturity securities [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Amortized Cost	333,599	340,870	'
Gross Unrealized Gain	21,180	35,144	'
Gross Unrealized Temporary Loss	4,374	1,387	'
Gross Unrealized OTTI Loss	218	361	'
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	350,187	374,266	'
U.S. corporate securities [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Amortized Cost	100,203	102,669	'
Gross Unrealized Gain	7,495	11,887	'
Gross Unrealized Temporary Loss	1,229	430	'
Gross Unrealized OTTI Loss	0	0	'
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	106,469	114,126	'
Foreign corporate securities [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Amortized Cost	59,778	61,806	'
Gross Unrealized Gain	3,939	5,654	'
Gross Unrealized Temporary Loss	565	277	'
Gross Unrealized OTTI Loss	0	-1	'
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	63,152	67,184	'
Foreign government debt securities [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Amortized Cost	50,717	51,967	'
Gross Unrealized Gain	4,107	5,440	'
Gross Unrealized Temporary Loss	387	71	'
Gross Unrealized OTTI Loss	0	0	'
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	54,437	57,336	'
RMBS [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Amortized Cost	34,167	35,666	'
Gross Unrealized Gain	1,584	2,477	'
Gross Unrealized Temporary Loss	490	315	'
Gross Unrealized OTTI Loss	206	349	'
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	35,055	37,479	'
U.S. Treasury and agency securities [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Amortized Cost	43,928	41,874	'
Gross Unrealized Gain	2,251	6,104	'
Gross Unrealized Temporary Loss	1,056	11	'
Gross Unrealized OTTI Loss	0	0	'
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	45,123	47,967	'
CMBS [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Amortized Cost	16,115	18,177	'
Gross Unrealized Gain	605	1,009	'
Gross Unrealized Temporary Loss	170	57	'
Gross Unrealized OTTI Loss	0	0	'
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	16,550	19,129	'
ABS [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Amortized Cost	15,458	15,762	'
Gross Unrealized Gain	296	404	'
Gross Unrealized Temporary Loss	171	156	'
Gross Unrealized OTTI Loss	12	13	'
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	15,571	15,997	'
State and political subdivision securities [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Amortized Cost	13,233	12,949	'
Gross Unrealized Gain	903	2,169	'
Gross Unrealized Temporary Loss	306	70	'
Gross Unrealized OTTI Loss	0	0	'
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	13,830	15,048	'
Equity Securities [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Cost or Amortized Cost	3,012	2,838	'
Gross Unrealized Gain	507	212	'
Gross Unrealized Temporary Loss	117	159	'
Gross Unrealized OTTI Loss	0	0	'
Equity securities	3,402	2,891	'
Common Stock [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Cost or Amortized Cost	1,927	2,034	'
Gross Unrealized Gain	431	147	'
Gross Unrealized Temporary Loss	5	19	'
Gross Unrealized OTTI Loss	0	0	'
Equity securities	2,353	2,162	'
Non-redeemable preferred stock [Member]	'	'	'
Available-for-sale Securities [Abstract]	'	'	'
Cost or Amortized Cost	1,085	804	'
Gross Unrealized Gain	76	65	'
Gross Unrealized Temporary Loss	112	140	'
Gross Unrealized OTTI Loss	0	0	'
Equity securities	$1,049	$729	'

Investments_Maturities_of_Fixe

Investments (Maturities of Fixed Maturity Securities) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Available-for-sale Securities, Debt Maturities [Abstract]	'	'
Amortized Cost, Due in one year or less	$15,828	$24,177
Amortized Cost, Due after one year through five years	70,467	66,973
Amortized Cost, Due after five years through ten years	78,159	82,376
Amortized Cost, Due after ten years	103,405	97,739
Amortized Cost, Subtotal	267,859	271,265
Amortized Cost, RMBS, CMBS and ABS	65,740	69,605
Amortized cost of fixed maturity securities available-for-sale	333,599	340,870
Estimated Fair Value, Due in one year or less	16,030	24,394
Estimated Fair Value, Due after one year through five years	74,229	70,759
Estimated Fair Value, Due after five years through ten years	83,223	91,975
Estimated Fair Value, Due after ten years	109,529	114,533
Estimated Fair Value, Subtotal	283,011	301,661
Estimated fair value, Mortgage-backed and asset-backed securities	67,176	72,605
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $333,599 and $340,870, respectively; includes $4,005 and $3,378, respectively, relating to variable interest entities)	$350,187	$374,266

Investments_Continuous_Gross_U

Investments (Continuous Gross Unrealized Losses for Fixed Maturity and Equity Securities Available-For-Sale) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Total number of securities in an unrealized loss position less than 12 months	4,480	1,941
Total number of securities in an unrealized loss position equal to or greater than 12 months	1,571	1,335
Fixed maturity securities [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	$64,516	$13,721
Less than 12 Months Gross Unrealized Loss	3,372	293
Equal to or Greater than 12 Months Estimated Fair Value	12,592	13,447
Equal to or Greater than 12 Months Gross Unrealized Loss	1,220	1,455
U.S. corporate securities [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	13,889	3,799
Less than 12 Months Gross Unrealized Loss	808	88
Equal to or Greater than 12 Months Estimated Fair Value	3,807	3,695
Equal to or Greater than 12 Months Gross Unrealized Loss	421	342
Foreign corporate securities [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	9,019	2,783
Less than 12 Months Gross Unrealized Loss	402	96
Equal to or Greater than 12 Months Estimated Fair Value	2,320	2,873
Equal to or Greater than 12 Months Gross Unrealized Loss	163	180
Foreign government debt securities [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	5,052	1,431
Less than 12 Months Gross Unrealized Loss	336	22
Equal to or Greater than 12 Months Estimated Fair Value	1,846	543
Equal to or Greater than 12 Months Gross Unrealized Loss	51	49
RMBS [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	10,754	735
Less than 12 Months Gross Unrealized Loss	363	31
Equal to or Greater than 12 Months Estimated Fair Value	2,302	4,098
Equal to or Greater than 12 Months Gross Unrealized Loss	333	633
U.S. Treasury, agency and government guaranteed securities [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	15,225	1,951
Less than 12 Months Gross Unrealized Loss	1,037	11
Equal to or Greater than 12 Months Estimated Fair Value	357	0
Equal to or Greater than 12 Months Gross Unrealized Loss	19	0
CMBS [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	3,696	842
Less than 12 Months Gross Unrealized Loss	142	11
Equal to or Greater than 12 Months Estimated Fair Value	631	577
Equal to or Greater than 12 Months Gross Unrealized Loss	28	46
ABS [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	3,772	1,920
Less than 12 Months Gross Unrealized Loss	59	30
Equal to or Greater than 12 Months Estimated Fair Value	978	1,410
Equal to or Greater than 12 Months Gross Unrealized Loss	124	139
State and political subdivision securities [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	3,109	260
Less than 12 Months Gross Unrealized Loss	225	4
Equal to or Greater than 12 Months Estimated Fair Value	351	251
Equal to or Greater than 12 Months Gross Unrealized Loss	81	66
Equity Securities [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	445	201
Less than 12 Months Gross Unrealized Loss	69	18
Equal to or Greater than 12 Months Estimated Fair Value	207	309
Equal to or Greater than 12 Months Gross Unrealized Loss	48	141
Common Stock [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	81	201
Less than 12 Months Gross Unrealized Loss	4	18
Equal to or Greater than 12 Months Estimated Fair Value	16	14
Equal to or Greater than 12 Months Gross Unrealized Loss	1	1
Non-redeemable preferred stock [Member]	'	'
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale	'	'
Less than 12 months Estimated Fair Value	364	0
Less than 12 Months Gross Unrealized Loss	65	0
Equal to or Greater than 12 Months Estimated Fair Value	191	295
Equal to or Greater than 12 Months Gross Unrealized Loss	$47	$140

Investments_Mortgage_Loans_by_

Investments (Mortgage Loans by Portfolio Segment) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Millions, unless otherwise specified
Company-held mortgage loans held-for-investment, net	'	'	'	'
Commercial mortgage loans	$40,926	$40,472	'	'
Percentage of loans receivable on commercial mortgage loans	70.90%	71.00%	'	'
Agricultural mortgage loans	12,391	12,843	'	'
Percentage of loans receivable on agricultural mortgage loans	21.50%	22.50%	'	'
Residential mortgage loans	2,772	958	'	'
Percentage of loans receivable on residential mortgage loans	4.80%	1.70%	'	'
Subtotal	56,089	54,273	'	'
Percentage of loans receivable on subtotal	97.20%	95.20%	'	'
Valuation allowances	-322	-347	-481	-664
Percentage of loans receivable on valuation allowances	0.60%	0.60%	'	'
Subtotal mortgage loans held-for-investment, net	55,767	53,926	'	'
Percentage of loans receivable on subtotal mortgage loans held-for-investment, net	96.60%	94.60%	'	'
Residential - FVO	338	0	'	'
Percentage of residential mortgage loans - FVO	0.60%	0.00%	'	'
Commercial mortgage loans held by consolidated securitization entities - fair value option	1,598	2,666	'	'
Percentage of loans receivable on commercial mortgage loans held by consolidated securitization entities - fair value option	2.80%	4.70%	'	'
Mortgage Loans on Real Estate, Commercial and Consumer, Net	57,703	56,592	'	'
Percentage of loans receivable on mortgage loans, at estimated fair value	100.00%	99.30%	'	'
Mortgage loans held-for-sale	'	'	'	'
Held-for-sale, principally at estimated fair value (includes $0 and $49, respectively, under the fair value option)	3	414	'	'
Percentage of loans held for sale on held-for-sale, principally at estimated fair value	0.00%	0.70%	'	'
Total mortgage loans, net	$57,706	$57,006	'	'
Percentage of loans held for sale on total mortgage loans, net	100.00%	100.00%	'	'

Investments_Mortgage_Loans_and

Investments (Mortgage Loans and Valuation Allowance by Portfolio Segment) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Millions, unless otherwise specified
Mortgage Loans on Real Estate [Line Items]	'	'	'	'
Evaluated individually for credit losses	$622	$733	'	'
Evaluated collectively for credit losses	55,467	53,540	'	'
Total mortgage loans	56,089	54,273	'	'
Specific credit losses	66	117	'	'
Non-specifically identified credit losses	256	230	'	'
Valuation allowances	322	347	481	664
Mortgage loan, net of valuation allowance	55,767	53,926	'	'
Commercial mortgage loans portfolio segment [Member]	'	'	'	'
Mortgage Loans on Real Estate [Line Items]	'	'	'	'
Evaluated individually for credit losses	506	539	'	'
Evaluated collectively for credit losses	40,420	39,933	'	'
Total mortgage loans	40,926	40,472	'	'
Specific credit losses	58	94	'	'
Non-specifically identified credit losses	200	199	'	'
Valuation allowances	258	293	398	562
Mortgage loan, net of valuation allowance	40,668	40,179	'	'
Agricultural [Member]	'	'	'	'
Mortgage Loans on Real Estate [Line Items]	'	'	'	'
Evaluated individually for credit losses	100	181	'	'
Evaluated collectively for credit losses	12,291	12,662	'	'
Total mortgage loans	12,391	12,843	'	'
Specific credit losses	7	21	'	'
Non-specifically identified credit losses	37	31	'	'
Valuation allowances	44	52	81	88
Mortgage loan, net of valuation allowance	12,347	12,791	'	'
Residential [Member]	'	'	'	'
Mortgage Loans on Real Estate [Line Items]	'	'	'	'
Evaluated individually for credit losses	16	13	'	'
Evaluated collectively for credit losses	2,756	945	'	'
Total mortgage loans	2,772	958	'	'
Specific credit losses	1	2	'	'
Non-specifically identified credit losses	19	0	'	'
Valuation allowances	20	2	2	14
Mortgage loan, net of valuation allowance	$2,752	$956	'	'

Investments_Valuation_Allowanc

Investments (Valuation Allowance Rollforward by Portfolio Segment) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Mortgage Loans on Real Estate [Line Items]	'	'	'
Beginning Balance	$347	$481	$664
Provision (release)	-13	-86	-145
Charge-offs, net of recoveries	-12	-37	-19
Transfers to held-for-sale	0	-11	-19
Ending Balance	322	347	481
Commercial mortgage loans portfolio segment [Member]	'	'	'
Mortgage Loans on Real Estate [Line Items]	'	'	'
Beginning Balance	293	398	562
Provision (release)	-35	-92	-152
Charge-offs, net of recoveries	0	-13	-12
Transfers to held-for-sale	0	0	0
Ending Balance	258	293	398
Agricultural [Member]	'	'	'
Mortgage Loans on Real Estate [Line Items]	'	'	'
Beginning Balance	52	81	88
Provision (release)	4	0	-3
Charge-offs, net of recoveries	-12	-24	-4
Transfers to held-for-sale	0	-5	0
Ending Balance	44	52	81
Residential [Member]	'	'	'
Mortgage Loans on Real Estate [Line Items]	'	'	'
Beginning Balance	2	2	14
Provision (release)	18	6	10
Charge-offs, net of recoveries	0	0	-3
Transfers to held-for-sale	0	-6	-19
Ending Balance	$20	$2	$2

Investments_Credit_Quality_of_

Investments (Credit Quality of Commercial Mortgage Loans) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	$40,926	$40,472
% of Total	100.00%	100.00%
Estimated Fair Value	42,456	43,082
% of Total	100.00%	100.00%
Less than 65% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	32,007	31,291
% of Total	78.20%	77.30%
Estimated Fair Value	33,519	33,730
% of Total	78.90%	78.30%
65% to 75% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	6,947	5,882
% of Total	17.00%	14.60%
Estimated Fair Value	7,039	6,129
% of Total	16.60%	14.20%
76% to 80% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	906	1,385
% of Total	2.20%	3.40%
Estimated Fair Value	892	1,436
% of Total	2.10%	3.30%
Greater than 80% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	1,066	1,914
% of Total	2.60%	4.70%
Estimated Fair Value	1,006	1,787
% of Total	2.40%	4.20%
Greater than 1.20x [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	38,098	36,919
Greater than 1.20x [Member] | Less than 65% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	30,552	29,839
Greater than 1.20x [Member] | 65% to 75% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	6,360	5,057
Greater than 1.20x [Member] | 76% to 80% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	525	938
Greater than 1.20x [Member] | Greater than 80% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	661	1,085
1.00x - 1.20x [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	1,486	2,085
1.00x - 1.20x [Member] | Less than 65% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	614	730
1.00x - 1.20x [Member] | 65% to 75% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	438	672
1.00x - 1.20x [Member] | 76% to 80% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	192	131
1.00x - 1.20x [Member] | Greater than 80% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	242	552
Less than 1.00x [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	1,342	1,468
Less than 1.00x [Member] | Less than 65% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	841	722
Less than 1.00x [Member] | 65% to 75% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	149	153
Less than 1.00x [Member] | 76% to 80% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	189	316
Less than 1.00x [Member] | Greater than 80% [Member]	'	'
Mortgage Loans on Real Estate [Line Items]	'	'
Commercial mortgage loans	$163	$277

Investments_Credit_Quality_of_1

Investments (Credit Quality of Agricultural and Residential Mortgage Loans) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Agricultural Mortgage Loans - by Credit Quality Indicator:	'	'
Recorded investment in Mortgage Loan	$12,391	$12,843
% of Total	100.00%	100.00%
Residential Mortgage Loans - by Credit Quality Indicator:	'	'
Recorded investment in Mortgage Loan	2,772	958
% of Total	100.00%	100.00%
Less than 65% [Member]	'	'
Agricultural Mortgage Loans - by Credit Quality Indicator:	'	'
Recorded investment in Mortgage Loan	11,461	11,908
% of Total	92.50%	92.70%
65% to 75% [Member]	'	'
Agricultural Mortgage Loans - by Credit Quality Indicator:	'	'
Recorded investment in Mortgage Loan	729	590
% of Total	5.90%	4.60%
76% to 80% [Member]	'	'
Agricultural Mortgage Loans - by Credit Quality Indicator:	'	'
Recorded investment in Mortgage Loan	84	92
% of Total	0.70%	0.70%
Greater than 80% [Member]	'	'
Agricultural Mortgage Loans - by Credit Quality Indicator:	'	'
Recorded investment in Mortgage Loan	117	253
% of Total	0.90%	2.00%
Performing [Member]	'	'
Residential Mortgage Loans - by Credit Quality Indicator:	'	'
Recorded investment in Mortgage Loan	2,693	929
% of Total	97.10%	97.00%
Nonperforming [Member]	'	'
Residential Mortgage Loans - by Credit Quality Indicator:	'	'
Recorded investment in Mortgage Loan	$79	$29
% of Total	2.90%	3.00%

Investments_Past_Due_and_Inter

Investments (Past Due and Interest Accrual Status of Mortgage Loans) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Past Due and Interest Accrual Status of Mortgage Loans	'	'
Past Due Status of Mortgage Loans	$135	$147
Interest Accrual Status of Mortgage Loans	12	53
Mortgage loans that were in non accrual status	303	169
Commercial mortgage loans portfolio segment [Member]	'	'
Past Due and Interest Accrual Status of Mortgage Loans	'	'
Past Due Status of Mortgage Loans	12	2
Interest Accrual Status of Mortgage Loans	12	0
Mortgage loans that were in non accrual status	191	84
Agricultural [Member]	'	'
Past Due and Interest Accrual Status of Mortgage Loans	'	'
Past Due Status of Mortgage Loans	44	116
Interest Accrual Status of Mortgage Loans	0	53
Mortgage loans that were in non accrual status	47	67
Residential [Member]	'	'
Past Due and Interest Accrual Status of Mortgage Loans	'	'
Past Due Status of Mortgage Loans	79	29
Interest Accrual Status of Mortgage Loans	0	0
Mortgage loans that were in non accrual status	$65	$18

Investments_Impaired_Mortgage_

Investments (Impaired Mortgage Loans) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	$633	$750	'	'
Valuation allowances	322	347	481	664
Recorded Investment	556	616	'	'
Average Investment	693	681	'	'
Interest Income	24	22	'	'
Loans with a Valuation Allowance [Member]	'	'	'	'
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	294	568	'	'
Recorded Investment	288	556	'	'
Valuation allowances	66	117	'	'
Recorded Investment	222	439	'	'
Loans Without Valuation Allowances [Member]	'	'	'	'
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	339	182	'	'
Recorded Investment	334	177	'	'
Commercial mortgage loans portfolio segment [Member]	'	'	'	'
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	513	548	'	'
Valuation allowances	258	293	398	562
Recorded Investment	448	445	'	'
Average Investment	526	464	'	'
Interest Income	15	14	'	'
Commercial mortgage loans portfolio segment [Member] | Loans with a Valuation Allowance [Member]	'	'	'	'
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	214	445	'	'
Recorded Investment	210	436	'	'
Valuation allowances	58	94	'	'
Recorded Investment	152	342	'	'
Commercial mortgage loans portfolio segment [Member] | Loans Without Valuation Allowances [Member]	'	'	'	'
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	299	103	'	'
Recorded Investment	296	103	'	'
Agricultural [Member]	'	'	'	'
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	103	189	'	'
Valuation allowances	44	52	81	88
Recorded Investment	93	160	'	'
Average Investment	153	204	'	'
Interest Income	9	8	'	'
Agricultural [Member] | Loans with a Valuation Allowance [Member]	'	'	'	'
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	68	110	'	'
Recorded Investment	66	107	'	'
Valuation allowances	7	21	'	'
Recorded Investment	59	86	'	'
Agricultural [Member] | Loans Without Valuation Allowances [Member]	'	'	'	'
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	35	79	'	'
Recorded Investment	34	74	'	'
Residential [Member]	'	'	'	'
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	17	13	'	'
Valuation allowances	20	2	2	14
Recorded Investment	15	11	'	'
Average Investment	14	13	'	'
Interest Income	0	0	'	'
Residential [Member] | Loans with a Valuation Allowance [Member]	'	'	'	'
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	12	13	'	'
Recorded Investment	12	13	'	'
Valuation allowances	1	2	'	'
Recorded Investment	11	11	'	'
Residential [Member] | Loans Without Valuation Allowances [Member]	'	'	'	'
Impaired Mortgage Loans	'	'	'	'
Unpaid Principal Balance	5	0	'	'
Recorded Investment	$4	$0	'	'

Investments_Mortgage_Loans_Mod

Investments (Mortgage Loans Modified in a Troubled Debt Restructuring) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
	Contracts	Contracts
Financing Receivable, Modifications [Line Items]	'	'
Number of Mortgage Loans	31	6
Carrying Value after Specific Valuation Allowance, Pre-Modification	$82	$239
Carrying Value after Specific Valuation Allowance, Post-Modification	82	215
Commercial [Member]	'	'
Financing Receivable, Modifications [Line Items]	'	'
Number of Mortgage Loans	1	1
Carrying Value after Specific Valuation Allowance, Pre-Modification	49	222
Carrying Value after Specific Valuation Allowance, Post-Modification	49	199
Agricultural [Member]	'	'
Financing Receivable, Modifications [Line Items]	'	'
Number of Mortgage Loans	3	5
Carrying Value after Specific Valuation Allowance, Pre-Modification	28	17
Carrying Value after Specific Valuation Allowance, Post-Modification	28	16
Residential [Member]	'	'
Financing Receivable, Modifications [Line Items]	'	'
Number of Mortgage Loans	27	0
Carrying Value after Specific Valuation Allowance, Pre-Modification	5	0
Carrying Value after Specific Valuation Allowance, Post-Modification	$5	$0

Investments_Investment_in_Leve

Investments (Investment in Leverage Leases) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Investment in leveraged leases	'	'
Rental receivables, net	$1,491	$1,564
Estimated residual values	1,325	1,474
Subtotal	2,816	3,038
Unearned income	-870	-1,040
Investment in leveraged leases	$1,946	$1,998

Investments_Components_on_Inco

Investments (Components on Income from Investment in Leverage Leases) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net Income from Investment in leveraged leases	'	'	'
Net Investment income from investment in leveraged leases	$82	$57	$125
Less: Income tax expense on leveraged leases	29	20	44
Net investment income after income tax from investment in leveraged leases	$53	$37	$81

Investments_Net_Unrealized_Inv

Investments (Net Unrealized Investment Gains Losses) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Millions, unless otherwise specified
Components of net unrealized investment gains (losses) included in accumulated other comprehensive loss	'	'	'	'
Fixed maturity securities that were temporarily impaired	$16,672	$33,641	$21,096	'
Fixed maturity securities with noncredit OTTI losses in accumulated other comprehensive income (loss)	-218	-361	-724	'
Total fixed maturity securities	16,454	33,280	20,372	'
Equity securities	390	97	-167	'
Derivatives	375	1,274	1,514	'
Other	-73	-30	72	'
Subtotal	17,146	34,621	21,791	'
Insurance liability loss recognition	-898	-6,049	-3,996	'
DAC and VOBA related to noncredit OTTI losses recognized in accumulated other comprehensive income (loss)	6	19	47	'
DAC and VOBA	-1,190	-2,485	-1,800	'
Policyholder dividend obligation	-1,771	-3,828	-2,919	'
Subtotal	-3,853	-12,343	-8,668	'
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in accumulated other comprehensive income (loss)	73	119	236	'
Deferred income tax benefit (expense)	-4,956	-7,973	-4,694	'
Net unrealized investment gains (losses)	8,410	14,424	8,665	'
Net unrealized investment gains (losses) attributable to noncontrolling interests	4	-5	9	'
Net unrealized investment gains (losses) attributable to MetLife, Inc.	$8,414	$14,419	$8,674	$3,122

Investments_Changes_in_Fixed_M

Investments (Changes in Fixed Maturity Securities with Noncredit OTTI Losses) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Changes in fixed maturity securities with noncredit OTTI losses in accumulated other comprehensive income (loss)	'	'
Balance, beginning of period	($361)	($724)
Noncredit OTTI losses recognized	60	-29
Securities sold with a previous noncredit OTTI loss	149	177
Subsequent increases in estimated fair value	-66	215
Balance, end of period	($218)	($361)

Investments_Changes_in_Net_Unr

Investments (Changes in Net Unrealized Investment Gains Losses) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Changes In Net Unrealized Investment Gains Losses Included In Accumulated Other Comprehensive Loss [Abstract]	'	'	'
Balance, beginning of period	$14,419	$8,674	$3,122
Fixed maturity securities on which noncredit OTTI losses have been recognized	143	363	-123
Unrealized investment gains (losses) during the year	-17,618	12,467	14,823
Unrealized investment gains (losses) of subsidiaries at the date of disposal	0	0	-105
Unrealized investment gains (losses) relating to [Abstract]	'	'	'
Insurance liability gain (loss) recognition	5,151	-2,053	-3,406
Insurance liability gain (loss) recognition of subsidiaries at the date of disposal	0	0	82
DAC and VOBA related to noncredit OTTI losses recognized in accumulated other comprehensive income (loss)	-13	-28	9
DAC and VOBA	1,295	-685	-808
DAC and VOBA of subsidiaries at the date of disposal	0	0	11
Policyholder dividend obligation	2,057	-909	-2,043
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in accumulated other comprehensive income (loss)	-46	-117	39
Deferred income tax benefit (expense)	3,017	-3,279	-2,936
Deferred income tax benefit (expense) of subsidiaries at the date of disposal	0	0	4
Net unrealized investment gains (losses)	8,405	14,433	8,669
Net unrealized investment gains (losses) attributable to noncontrolling interests	9	-14	5
Balance, end of period	8,414	14,419	8,674
Changes in net unrealized investment gains (losses)	-6,014	5,759	5,547
Changes in net unrealized investment gains (losses) attributable to noncontrolling interests	9	-14	5
Changes in net unrealized investment gains (losses) attributable to MetLife, Inc.	($6,005)	$5,745	$5,552

Investments_Securities_Lending

Investments (Securities Lending) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Securities Financing Transaction [Line Items]	'	'
Total cash collateral liability	$28,319	$27,727
Security collateral on deposit from counterparties	0	104
Reinvestment portfolio - estimated fair value	28,481	28,112
Securities Financing Transaction, Cost [Member]	'	'
Securities Financing Transaction [Line Items]	'	'
Securities loaned	27,094	23,380
Securities Financing Transaction, Fair Value [Member]	'	'
Securities Financing Transaction [Line Items]	'	'
Securities loaned	$27,595	$27,077

Investments_Invested_Assets_on

Investments (Invested Assets on Deposit, Held In Trust and Pledged as Collateral) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Investments, Debt and Equity Securities [Abstract]	'	'
Invested assets on deposit	$2,153	$2,362
Invested assets held in trust	11,004	12,434
Invested assets pledged as collateral	23,770	23,251
Total invested assets on deposit, held in trust and pledged as collateral	$36,927	$38,047

Investments_PCI_Investments_by

Investments (PCI Investments by Invested Asset Class) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Mortgage loans, net [Member]	'	'
Purchased credit impaired investments, by invested asset class, held:	'	'
Outstanding principal and interest balance	$291	$440
Carrying value	138	199
Fixed maturity securities [Member]	'	'
Purchased credit impaired investments, by invested asset class, held:	'	'
Outstanding principal and interest balance	5,319	4,905
Carrying value	$4,109	$3,900

Investments_PCI_Investments_Ac

Investments (PCI Investments Acquired) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Mortgage loans, net [Member]	'	'
Purchased credit impaired investments as of their respective acquisition dates	'	'
Contractually required payments receivable (including interest)	$0	$0
Cash flows expected to be collected	0	0
Fair value of investments acquired	0	0
Fixed maturity securities [Member]	'	'
Purchased credit impaired investments as of their respective acquisition dates	'	'
Contractually required payments receivable (including interest)	1,872	2,083
Cash flows expected to be collected	1,446	1,524
Fair value of investments acquired	$978	$991

Investments_Activity_For_Accre

Investments (Activity For Accretable Yield on PCI Investments) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Mortgage loans, net [Member]	'	'
Accretable yield on purchased distressed assets acquired	'	'
Accretable yield, beginning of period	$184	$254
Accretion	-87	-71
Disposals	0	0
Reclassification to/ from nonaccretable difference	-23	1
Accretable yield, end of period	74	184
Fixed maturity securities [Member]	'	'
Accretable yield on purchased distressed assets acquired	'	'
Accretable yield, beginning of period	2,665	2,311
Accretion	-260	-203
Disposals	-152	-102
Reclassification to/ from nonaccretable difference	25	126
Accretable yield, end of period	2,746	2,665
Investments Purchased [Member] | Mortgage loans, net [Member]	'	'
Accretable yield on purchased distressed assets acquired	'	'
Additions	0	0
Investments Purchased [Member] | Fixed maturity securities [Member]	'	'
Accretable yield on purchased distressed assets acquired	'	'
Additions	$468	$533

Investments_Consolidated_Varia

Investments (Consolidated Variable Interest Entities) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Variable Interest Entity [Line Items]	'	'
Total Assets	$8,558	$6,692
Total Liabilities	3,684	2,567
Consolidated Securitization Entities [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	2,095	0
Total Liabilities	1,777	0
MRSC collateral financing arrangement [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	3,440	3,439
Total Liabilities	0	0
Operating joint venture [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	1,630	2,730
Total Liabilities	1,457	2,545
Other limited partnership interests [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	61	356
Total Liabilities	0	8
Real estate joint ventures [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	1,181	11
Total Liabilities	443	14
Other invested assets [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	82	85
Total Liabilities	7	0
Actively traded securities [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	69	71
Total Liabilities	$0	$0

Investments_Unconsolidated_Var

Investments (Unconsolidated Variable Interest Entities) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Variable Interest Entity [Line Items]	'	'
Total Assets	$78,522	$84,541
Total Liabilities	80,864	86,334
Real estate joint ventures [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	70	150
Total Liabilities	71	157
Other limited partnership interests [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	5,041	4,436
Total Liabilities	6,994	5,908
Trading securities [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	619	563
Total Liabilities	619	563
Mortgage loans, net [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	106	351
Total Liabilities	106	351
Other invested assets [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	1,509	1,117
Total Liabilities	1,897	1,431
Structured securities (RMBS, CMBS, and ABS) [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	67,176	72,605
Total Liabilities	67,176	72,605
U.S. corporate and foreign corporate securities [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	3,966	5,287
Total Liabilities	3,966	5,287
Non-redeemable preferred stock [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Total Assets	35	32
Total Liabilities	$35	$32

Investments_Net_Investment_Inc

Investments (Net Investment Income) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net Investment Income [Line Items]	'	'	'
Less: Investment expenses	$1,198	$1,090	$1,019
Subtotal	22,232	21,984	19,585
Securities Investment [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	21,123	21,248	20,716
Subtotal	19,925	20,158	19,697
Debt Securities [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	15,071	15,218	15,037
Equity Securities [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	127	133	141
Actively traded securities and FVO general account securities [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	65	88	31
Changes in estimated fair value included in net investment income	18	51	-3
Mortgage Loans on Real Estate [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	3,020	3,191	3,164
Policy Loans [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	620	626	641
Real Estate Investment [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	909	834	688
Partnership Interest [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	955	845	681
Cash and Cash Equivalents [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	181	163	167
International Joint Venture [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	10	19	-12
Other Investments [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	165	131	178
Consolidated Securitization Entities And Fair Value Option Contractholder-Directed Unit-Linked [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	2,307	1,826	-112
FVO contractholder-directed unit-linked investments [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	2,172	1,473	-453
Changes in estimated fair value included in net investment income	1,579	1,170	-647
Securitized Reverse Residential Mortgage Loan [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	0	177	0
Commercial Loan [Member] | Consolidated Securitization Entities [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	132	172	332
Available-for-sale Securities [Member] | Consolidated Securitization Entities [Member]	'	'	'
Net Investment Income [Line Items]	'	'	'
Subtotal	$3	$4	$9

Investments_Components_of_Net_

Investments (Components of Net Investment Gains Losses) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	($192)	($351)	($1,015)
Fixed maturity securities - net gains (losses) on sales and disposals	561	253	25
Equity securities - net gains (losses) on sales and disposals	31	38	37
Net investment gains (losses)	400	-60	-953
Other net investment gains (losses):	'	'	'
Trading and other securities FVO general account securities - changes in estimated fair value	15	17	-2
Mortgage Loans	22	57	175
Real estate and real estate joint ventures	-19	-36	134
Other limited partnership interests	-48	-36	4
Other investment portfolio gains (losses)	22	-151	-7
Subtotal - investment portfolio gains (losses)	392	-209	-649
FVO CSEs - changes in estimated fair value subsequent to consolidation:	'	'	'
Commercial mortgage loans	-52	7	-84
Securities	2	0	0
Long-term debt - related to commercial mortgage loans	85	25	97
Long-term debt - related to trading securities	-2	-7	-8
Non-investment portfolio gains (losses)	-264	-168	-223
Subtotal FVO CSEs and non-investment portfolio gains (losses)	-231	-143	-218
Total net investment gains (losses)	161	-352	-867
Fixed maturity securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	-166	-317	-955
Net investment gains (losses)	395	-64	-930
Utility Domestic Corporate Debt Securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	-48	-61	-10
Finance Domestic Corporate Debt Securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	-10	-32	-56
Consumer Domestic Corporate Debt Securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	-11	-19	-50
Communications Domestic Corporate Debt Securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	-2	-19	-41
Industrial Domestic Corporate Debt Securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	0	-5	-11
Transportation Domestic Corporate Debt Securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	-3	-17	0
Technology Domestic Corporate Debt Securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	0	-6	-1
Corporate fixed maturity securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	-74	-159	-169
RMBS [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	-80	-97	-214
CMBS [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	-12	-51	-32
ABS [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	0	-9	-54
State and political subdivision securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	0	-1	0
Foreign government debt securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	0	0	-486
Equity Securities [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	-26	-34	-60
Net investment gains (losses)	5	4	-23
Non-redeemable preferred stock [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	-20	0	-38
Common Stock [Member]	'	'	'
Marketable Securities, Gain (Loss) [Abstract]	'	'	'
Total OTTI losses recognized in earnings	($6)	($34)	($22)

Investments_Sales_or_Disposals

Investments (Sales or Disposals and Impairments of Fixed Maturity and Equity Securities) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Components of Sales or Disposals of Fixed Maturity and Equity Securities	'	'	'
Proceeds	$76,816	$60,867	$68,690
Gross investment gains	1,382	1,017	1,000
Gross investment losses	-790	-726	-938
Total OTTI losses recognized in earnings:	'	'	'
Total OTTI losses recognized in earnings	-192	-351	-1,015
Net investment gains (losses)	400	-60	-953
Credit-Related [Member]	'	'	'
Total OTTI losses recognized in earnings:	'	'	'
Total OTTI losses recognized in earnings	-147	-223	-645
Other [Member]	'	'	'
Total OTTI losses recognized in earnings:	'	'	'
Total OTTI losses recognized in earnings	-45	-128	-370
Fixed maturity securities [Member]	'	'	'
Components of Sales or Disposals of Fixed Maturity and Equity Securities	'	'	'
Proceeds	76,070	59,219	67,449
Gross investment gains	1,326	944	892
Gross investment losses	-765	-691	-867
Total OTTI losses recognized in earnings:	'	'	'
Total OTTI losses recognized in earnings	-166	-317	-955
Net investment gains (losses)	395	-64	-930
Fixed maturity securities [Member] | Credit-Related [Member]	'	'	'
Total OTTI losses recognized in earnings:	'	'	'
Total OTTI losses recognized in earnings	-147	-223	-645
Fixed maturity securities [Member] | Other [Member]	'	'	'
Total OTTI losses recognized in earnings:	'	'	'
Total OTTI losses recognized in earnings	-19	-94	-310
Equity Securities [Member]	'	'	'
Components of Sales or Disposals of Fixed Maturity and Equity Securities	'	'	'
Proceeds	746	1,648	1,241
Gross investment gains	56	73	108
Gross investment losses	-25	-35	-71
Total OTTI losses recognized in earnings:	'	'	'
Total OTTI losses recognized in earnings	-26	-34	-60
Net investment gains (losses)	5	4	-23
Equity Securities [Member] | Credit-Related [Member]	'	'	'
Total OTTI losses recognized in earnings:	'	'	'
Total OTTI losses recognized in earnings	0	0	0
Equity Securities [Member] | Other [Member]	'	'	'
Total OTTI losses recognized in earnings:	'	'	'
Total OTTI losses recognized in earnings	($26)	($34)	($60)

Investments_Credit_Loss_Rollfo

Investments (Credit Loss Rollforward) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]	'	'
Balance, beginning of period	$392	$471
Additions:	'	'
Initial impairments - credit loss OTTI recognized on securities not previously impaired	6	46
Additional impairments - credit loss OTTI recognized on securities previously impaired	69	70
Reductions:	'	'
Due to sales (maturities, pay downs or prepayments) during the period of securities previously credit loss OTTI impaired	-87	-176
Due to securities impaired to net present value of expected future cash flows	0	-17
Increases in cash flows- accretion of previous credit loss OTTI	-2	-2
Balance, end of period	$378	$392

Investments_Fixed_Maturity_and1

Investments (Fixed Maturity and Equity Securities Available-For-Sale - Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Millions, unless otherwise specified
Summary of Certain Fixed Maturity Securities	'	'	'
Gross Unrealized OTTI Loss	$218	$361	$724
Available-for-sale Securities, Debt Securities	350,187	374,266	'
Foreign corporate securities [Member]	'	'	'
Summary of Certain Fixed Maturity Securities	'	'	'
Gross Unrealized OTTI Loss	0	-1	'
Available-for-sale Securities, Debt Securities	63,152	67,184	'
Gross Unrealized Gain	3,939	5,654	'
Non-income producing fixed maturity securities [Member]	'	'	'
Summary of Certain Fixed Maturity Securities	'	'	'
Available-for-sale Securities, Debt Securities	74	85	'
Gross Unrealized Gain	$23	$11	'

Investments_Evaluation_of_Avai

Investments (Evaluation of Available-For-Sale Securities for OTTI and Evaluating Temporarily Impaired AFS Securities - Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Schedule of Available-for-sale Securities [Line Items]	'	'
Equity Securities Available For Sale With Gross Unrealized Loss Of Equal To Or Greater Than Stated Percentage	20.00%	'
Fixed maturity securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Change in Gross Unrealized Temporary Loss	$2,900	'
Gross Unrealized Temporary Loss	4,600	1,700
Gross Unrealized Temporary Loss	1,220	1,455
Equity Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Change in Gross Unrealized Temporary Loss	-42	'
Gross Unrealized Temporary Loss	117	159
Gross Unrealized Temporary Loss	48	141
Non-redeemable preferred stock [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Gross Unrealized Temporary Loss	47	140
20% or more [Member] | Six months or greater [Member] | Fixed maturity securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Gross Unrealized Temporary Loss	296	'
Number of Securities	95	'
20% or more [Member] | Six months or greater [Member] | Fixed maturity securities [Member] | Investment Grade [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Gross Unrealized Temporary Loss	165	'
Number of Securities	64	'
Percentage of gross unrealized loss	56.00%	'
20% or more [Member] | Six months or greater [Member] | Fixed maturity securities [Member] | Below Investment Grade [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Gross Unrealized Temporary Loss	131	'
Number of Securities	31	'
Percentage of gross unrealized loss	44.00%	'
20% or more [Member] | Twelve months or greater [Member] | Equity Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Number of Securities	11	'
Gross Unrealized Temporary Loss	$39	'
20% or more [Member] | Twelve months or greater [Member] | Non-redeemable preferred stock [Member] | Aaa/Aa/A [Member] | Financial Services Industry [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Percentage of gross unrealized loss	65.00%	'

Investments_Mortgage_Loans_Nar

Investments (Mortgage Loans - Narrative) (Details) (USD $)	12 Months Ended					12 Months Ended			12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2013
		Contracts	Agricultural [Member]	Agricultural [Member]	Agricultural [Member]	Residential [Member]	Residential [Member]	Residential [Member]	Commercial Loan [Member]	Residential Portfolio Segment [Member]	Maximum [Member]
										Contracts	Residential Portfolio Segment [Member]
Financing Receivable, Recorded Investment [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Financing Receivable, Significant Purchases	$2,200,000,000	$205,000,000	'	'	'	'	'	'	'	'	'
Estimated fair value of mortgage loans held-for-investment	'	'	'	12,700,000,000	13,300,000,000	'	2,800,000,000	1,000,000,000	'	'	'
Percentage of Mortgage Loans Classified as Performing	99.00%	99.00%	'	'	'	'	'	'	'	'	'
Impaired Financing Receivable, Average Recorded Investment	693,000,000	681,000,000	252,000,000	'	'	23,000,000	'	'	313,000,000	'	'
Impaired Financing Receivable, Interest Income, Cash Basis Method	'	'	5,000,000	'	'	0	'	'	6,000,000	'	'
Number of Mortgage Loans, Subsequent Default	'	0	'	'	'	'	'	'	'	1	'
Financing Receivable, Modifications, Subsequent Default, Recorded Investment	'	'	'	'	'	'	'	'	'	'	$1,000,000

Investments_Leverage_Leases_Na

Investments (Leverage Leases - Narrative) (Details) (USD $)	12 Months Ended
In Billions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Leveraged Leases [Abstract]	'	'
Deferred income tax liability related to leveraged leases	$1.60	$1.60
Loans and Leases Receivable, Other Information	'Rental receivables are generally due in periodic installments. The payment periods range from one to 15 years but in certain circumstances can be over 30 years.	'
Percentage of rental receivables performing	100.00%	100.00%

Investments_Cash_Equivalents_N

Investments (Cash Equivalents - Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Billions, unless otherwise specified
Investments, Debt and Equity Securities [Abstract]	'	'
Cash equivalents	$3.80	$6.10

Investments_Changes_in_Fixed_M1

Investments (Changes in Fixed Maturity Securities with Noncredit OTTI Losses - Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Investments, Debt and Equity Securities [Abstract]	'	'
Noncredit OTTI losses on fixed maturity securities, net of DAC, included in accumulated other comprehensive income (loss)	$52	($21)

Investments_Concentrations_of_

Investments (Concentrations of Credit Risk - Narrative) (Details) (USD $)	12 Months Ended
In Billions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
		Foreign government debt securities [Member]	Foreign government debt securities [Member]	Fixed maturity and equity securities [Member]	Fixed maturity and equity securities [Member]
		Japan [Member]	Japan [Member]	Japan [Member]	Japan [Member]
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]	'	'	'	'	'
Securities holdings exposure in single issuer greater than stated percentage of Company's equity	10.00%	'	'	'	'
Government and agency fixed maturity securities	'	$21.70	$22.40	$26.90	$28.70

Investments_Invested_Assets_on1

Investments (Invested Assets on Deposit, Held In Trust and Pledged as Collateral - Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Jan. 02, 2014
In Millions, unless otherwise specified			MetLife Insurance Company Of Connecticut [Member]
			Subsequent Event [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]	'	'	'
Invested assets on deposit	$2,153	$2,362	$6,300

Investments_Collectively_Signi

Investments (Collectively Significant Equity Method Investments - Narrative) (Details) (USD $)	12 Months Ended
In Billions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity Method Investment, Summarized Financial Information, Gross Profit (Loss)	'	'	'
Carrying Value of investments accounted for under the equity method	$12.10	'	'
Unfunded commitments for investments accounted for under the equity method	4	'	'
Total assets for investments accounted for under the equity method	303.4	285.2	'
Total liabilities for investments accounted for under the equity method	29.7	28.8	'
Net Income (loss) for investments accounted for under the equity method	$26.30	$17.90	$9.70
Aggregate Net income Exceeded Stated Percentage Of The Pre Tax Income (Loss) From Continuing Operations	10.00%	10.00%	'

Investments_Consolidated_Varia1

Investments (Consolidated Variable Interest Entities - Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Variable Interest Entity [Line Items]	'	'	'
Tax credits guaranteed by third parties that reduce maximum exposure to loss related to other invested assets	$257	$318	'
Financial or other support to investees designated as VIEs	0	0	0
Consolidated Securitization Entities [Member]	'	'	'
Variable Interest Entity [Line Items]	'	'	'
Variable interest, maximum exposure to loss in consolidated securitization entities	154	168	'
Long-term debt held by consolidated securitization entities, percentage range minimum	2.25%	2.25%	2.25%
Long-term debt held by consolidated securitization entities, percentage range maximum	5.57%	5.57%	5.57%
Interest expense on long-term debt held by consolidated securitization entities	122	163	324
Real estate joint ventures [Member]	'	'	'
Variable Interest Entity [Line Items]	'	'	'
Variable interest, maximum exposure to loss in consolidated securitization entities	178	'	'
Long-term debt held by consolidated securitization entities, percentage range minimum	1.39%	'	'
Long-term debt held by consolidated securitization entities, percentage range maximum	4.45%	'	'
Maximum [Member] | Real estate joint ventures [Member]	'	'	'
Variable Interest Entity [Line Items]	'	'	'
Interest expense on long-term debt held by consolidated securitization entities	$1	'	'

Investments_Net_Investment_Gai

Investments (Net Investment Gains Losses - Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'
Investment portfolio gains (losses)	'	$37	($153)
Non-investment portfolio gains (losses)	22	-151	-7
Goodwill Impairment Loss [Abstract]	'	'	'
Goodwill, Impairment Loss	0	1,868	0
Gains (losses) from foreign currency transactions	171	-112	37
Investments sold [Member]	'	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'
Investment portfolio gains (losses)	'	78	1
Impairments [Member]	'	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'
Investment portfolio gains (losses)	'	-41	-154
Non-investment portfolio gain (loss) related to disposal of certain closed blocks of business [Member]	'	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'
Non-investment portfolio gains (losses)	30	-33	-106
Goodwill Impairment Loss [Abstract]	'	'	'
Goodwill, Impairment Loss	'	'	$65

Derivatives_Primary_Risks_Deta

Derivatives (Primary Risks) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Mar. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified			Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Designated as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]	Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member]
					Fair Value Hedges [Member]	Fair Value Hedges [Member]	Fair Value Hedges [Member]	Fair Value Hedges [Member]	Fair Value Hedges [Member]	Fair Value Hedges [Member]	Fair Value Hedges [Member]	Fair Value Hedges [Member]	Cash Flow Hedges [Member]	Cash Flow Hedges [Member]	Cash Flow Hedges [Member]	Cash Flow Hedges [Member]	Cash Flow Hedges [Member]	Cash Flow Hedges [Member]	Cash Flow Hedges [Member]	Cash Flow Hedges [Member]	Foreign Operations Hedges [Member]	Foreign Operations Hedges [Member]	Foreign Operations Hedges [Member]	Foreign Operations Hedges [Member]	Foreign Operations Hedges [Member]	Foreign Operations Hedges [Member]			Interest rate swaps [Member]	Interest rate swaps [Member]	Interest rate floors [Member]	Interest rate floors [Member]	Interest rate caps [Member]	Interest rate caps [Member]	Interest rate futures [Member]	Interest rate futures [Member]	Interest rate options [Member]	Interest rate options [Member]	Synthetic GICs [Member]	Synthetic GICs [Member]	Foreign currency swaps [Member]	Foreign currency swaps [Member]	Foreign currency forwards [Member]	Foreign currency forwards [Member]	Currency futures [Member]	Currency futures [Member]	Currency options [Member]	Currency options [Member]	Credit default swaps - purchased [Member]	Credit default swaps - purchased [Member]	Credit default swaps - written [Member]	Credit default swaps - written [Member]	Equity futures [Member]	Equity futures [Member]	Equity Options [Member]	Equity Options [Member]	Variance swaps [Member]	Variance swaps [Member]	Total rate of return swaps [Member]	Total rate of return swaps [Member]
							Interest rate swaps [Member]	Interest rate swaps [Member]	Foreign currency swaps [Member]	Foreign currency swaps [Member]	Foreign currency forwards [Member]	Foreign currency forwards [Member]			Interest rate swaps [Member]	Interest rate swaps [Member]	Interest rate forwards [Member]	Interest rate forwards [Member]	Foreign currency swaps [Member]	Foreign currency swaps [Member]			Foreign currency forwards [Member]	Foreign currency forwards [Member]	Currency options [Member]	Currency options [Member]
Derivatives, Fair Value [Line Items]	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'
Notional Amount	$404,895	$334,351	$38,634	$28,866	$12,067	$8,584	$6,419	$5,397	$2,713	$3,187	$2,935	$0	$16,023	$13,355	$3,121	$3,642	$450	$675	$12,452	$9,038	$10,544	$6,927	$3,182	$2,552	$7,362	$4,375	$366,261	$305,485	$107,354	$83,250	$63,064	$56,246	$39,460	$49,465	$6,011	$11,684	$40,978	$16,328	$4,409	$4,162	$9,307	$8,208	$11,311	$9,202	$1,316	$1,408	$2,265	$129	$3,725	$3,674	$9,055	$8,879	$5,157	$7,008	$37,411	$22,920	$21,636	$19,830	$3,802	$3,092
Estimated Fair Value Assets	8,595	13,777	2,425	3,402	1,534	2,253	1,282	1,921	252	332	0	0	491	1,063	83	705	7	139	401	219	400	86	82	43	318	43	6,170	10,375	3,330	5,201	451	1,174	177	74	9	1	255	640	0	0	133	199	69	26	1	4	53	1	7	11	166	79	1	14	1,344	2,825	174	122	0	4
Estimated Fair Value Liabilities	$6,521	$5,536	$1,145	$594	$290	$175	$78	$90	$135	$85	$77	$0	$808	$355	$141	$0	$7	$0	$660	$355	$47	$64	$47	$61	$0	$3	$5,376	$4,942	$1,767	$2,043	$346	$837	$0	$0	$9	$38	$243	$60	$0	$0	$684	$736	$359	$288	$1	$0	$48	$0	$51	$34	$1	$5	$43	$132	$1,068	$356	$577	$310	$179	$103

Derivatives_Net_Derivative_Gai

Derivatives (Net Derivative Gains Losses) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Components of Net Derivatives Gains (Losses)	'	'	'
Derivatives and hedging gains (losses)	($8,343)	($3,158)	$6,108
Embedded derivatives	5,104	1,239	-1,284
Total net derivative gains (losses)	($3,239)	($1,919)	$4,824

Derivatives_Earned_Income_On_D

Derivatives (Earned Income On Derivatives) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Total earned income	$309	$667	$803
Derivatives Designated as Hedging Instruments [Member] | Net Investment Income [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Total earned income	135	111	98
Derivatives Designated as Hedging Instruments [Member] | Interest Credited to Policyholder Account Balance [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Total earned income	150	164	214
Derivatives Designated as Hedging Instruments [Member] | Other Expenses [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Total earned income	-6	-5	-4
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Investment Income [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Total earned income	-6	-6	-8
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Other Revenues [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Total earned income	0	47	75
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Total earned income	328	476	411
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Total earned income	($292)	($120)	$17

Derivatives_Gains_Losses_Recog

Derivatives (Gains Losses Recognized in Income Not Designated or Qualifying) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	($981)	($135)	$981
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-8,728	-3,660	5,636
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Derivative Gains (Losses) [Member] | Interest rate [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-3,458	-296	3,940
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Derivative Gains (Losses) [Member] | Foreign currency [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-1,716	-660	343
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Derivative Gains (Losses) [Member] | Credit derivatives - purchased [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-21	-298	250
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Derivative Gains (Losses) [Member] | Credit derivatives - written [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	130	150	-75
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Derivative Gains (Losses) [Member] | Equity market [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-3,663	-2,556	1,178
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-38	-23	-40
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Investment Gains (Losses) [Member] | Interest rate [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	0	0	-1
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Investment Gains (Losses) [Member] | Foreign currency [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	0	0	-9
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Investment Gains (Losses) [Member] | Credit derivatives - purchased [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-14	-14	6
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Investment Gains (Losses) [Member] | Credit derivatives - written [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	1	0	-1
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Net Investment Gains (Losses) [Member] | Equity market [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-25	-9	-35
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-754	-419	-87
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Policyholder Benefits and Claims [Member] | Interest rate [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-27	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Policyholder Benefits and Claims [Member] | Foreign currency [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Policyholder Benefits and Claims [Member] | Credit derivatives - purchased [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Policyholder Benefits and Claims [Member] | Credit derivatives - written [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Policyholder Benefits and Claims [Member] | Equity market [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-727	-419	-87
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Other Revenues [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	0	28	236
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Other Revenues [Member] | Interest rate [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	0	28	236
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Other Revenues [Member] | Foreign currency [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Other Revenues [Member] | Credit derivatives - purchased [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	'	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Other Revenues [Member] | Credit derivatives - written [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments [Member] | Other Revenues [Member] | Equity market [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Derivative, Gain (Loss) on Derivative, Net	$0	$0	$0

Derivatives_Fair_Value_Hedges_

Derivatives (Fair Value Hedges) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Net Derivatives Gains (Losses) Recognized for Derivatives	($981)	($135)	$981
Net Derivatives Gains (Losses) Recognized for Hedged Items	992	127	-1,005
Ineffectiveness Recognized in Net Derivatives Gains (Losses)	11	-8	-24
Interest rate swaps [Member] | Fixed maturity securities [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Net Derivatives Gains (Losses) Recognized for Derivatives	42	-4	-25
Net Derivatives Gains (Losses) Recognized for Hedged Items	-43	0	22
Ineffectiveness Recognized in Net Derivatives Gains (Losses)	-1	-4	-3
Interest rate swaps [Member] | Policyholder account balances [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Net Derivatives Gains (Losses) Recognized for Derivatives	-830	-82	1,054
Net Derivatives Gains (Losses) Recognized for Hedged Items	835	96	-1,030
Ineffectiveness Recognized in Net Derivatives Gains (Losses)	5	14	24
Foreign currency swaps [Member] | Foreign-denominated fixed maturity securities [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Net Derivatives Gains (Losses) Recognized for Derivatives	13	-1	1
Net Derivatives Gains (Losses) Recognized for Hedged Items	-12	1	3
Ineffectiveness Recognized in Net Derivatives Gains (Losses)	1	0	4
Foreign currency swaps [Member] | Foreign-denominated policyholder account balances [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Net Derivatives Gains (Losses) Recognized for Derivatives	-97	3	-24
Net Derivatives Gains (Losses) Recognized for Hedged Items	110	-20	-25
Ineffectiveness Recognized in Net Derivatives Gains (Losses)	13	-17	-49
Foreign currency forwards [Member] | Foreign-denominated fixed maturity securities [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Net Derivatives Gains (Losses) Recognized for Derivatives	-109	-51	-25
Net Derivatives Gains (Losses) Recognized for Hedged Items	102	50	25
Ineffectiveness Recognized in Net Derivatives Gains (Losses)	($7)	($1)	$0

Derivatives_Cash_Flow_Hedges_D

Derivatives (Cash Flow Hedges) (Details) (Cash Flow Hedges [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Derivatives in cash flow hedging relationships	'	'	'
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	($863)	($215)	$1,552
Interest rate swaps [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	-635	-34	1,023
Foreign currency swaps [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	-165	-164	175
Interest rate forwards [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	-59	-17	336
Credit forwards [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	-4	0	18
Net Derivative Gains (Losses) [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	27	25	-9
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	1	-4	5
Net Derivative Gains (Losses) [Member] | Interest rate swaps [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	20	1	-42
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	-3	2	1
Net Derivative Gains (Losses) [Member] | Foreign currency swaps [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	-3	23	0
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	3	-6	2
Net Derivative Gains (Losses) [Member] | Interest rate forwards [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	10	1	31
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	1	0	2
Net Derivative Gains (Losses) [Member] | Credit forwards [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	0	2
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0
Net Investment Gains (Losses) [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	9	2	-3
Net Investment Gains (Losses) [Member] | Interest rate swaps [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	8	4	1
Net Investment Gains (Losses) [Member] | Foreign currency swaps [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	-3	-5	-6
Net Investment Gains (Losses) [Member] | Interest rate forwards [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	3	2	1
Net Investment Gains (Losses) [Member] | Credit forwards [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	1	1	1
Other Expenses [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	-3	-9
Other Expenses [Member] | Interest rate swaps [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	-3	-10
Other Expenses [Member] | Foreign currency swaps [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	1	1	2
Other Expenses [Member] | Interest rate forwards [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	-1	-1	-1
Other Expenses [Member] | Credit forwards [Member]	'	'	'
Derivatives in cash flow hedging relationships	'	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	$0	$0	$0

Derivatives_Hedges_of_Net_Inve

Derivatives (Hedges of Net Investments in Foreign Operations) (Details) (Foreign Operations Hedges [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	$331	($14)	$68
Foreign currency forwards [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	69	-50	62
Currency options [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	262	36	0
Non-derivative hedging instruments [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Amount of Gains (Losses) Deferred in Accumulated Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	$0	$0	$6

Derivatives_Credit_Derivatives

Derivatives (Credit Derivatives) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	$165	$74
Maximum Amount of Future Payments under Credit Default Swaps	9,055	8,879
Weighted Average Years to Maturity	'3 years 4 months 24 days	'3 years 7 months 6 days
Aaa/Aa/A [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	36	52
Maximum Amount of Future Payments under Credit Default Swaps	3,284	3,490
Weighted Average Years to Maturity	'1 year 7 months 6 days	'2 years 2 months 12 days
Aaa/Aa/A [Member] | Single name credit default swaps (corporate) [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	10	10
Maximum Amount of Future Payments under Credit Default Swaps	545	777
Weighted Average Years to Maturity	'2 years 7 months 6 days	'2 years 8 months 12 days
Aaa/Aa/A [Member] | Credit default swaps referencing indices [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	26	42
Maximum Amount of Future Payments under Credit Default Swaps	2,739	2,713
Weighted Average Years to Maturity	'1 year 6 months 0 days	'2 years 1 month 6 days
Baa [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	97	19
Maximum Amount of Future Payments under Credit Default Swaps	5,391	5,064
Weighted Average Years to Maturity	'4 years 4 months 0 days	'4 years 6 months 0 days
Baa [Member] | Single name credit default swaps (corporate) [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	24	8
Maximum Amount of Future Payments under Credit Default Swaps	1,320	1,314
Weighted Average Years to Maturity	'3 years 1 month 0 days	'3 years 4 months 24 days
Baa [Member] | Credit default swaps referencing indices [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	73	11
Maximum Amount of Future Payments under Credit Default Swaps	4,071	3,750
Weighted Average Years to Maturity	'4 years 8 months 12 days	'4 years 10 months 24 days
Ba [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	0	0
Maximum Amount of Future Payments under Credit Default Swaps	5	25
Weighted Average Years to Maturity	'3 years 9 months 0 days	'2 years 8 months 12 days
Ba [Member] | Single name credit default swaps (corporate) [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	0	0
Maximum Amount of Future Payments under Credit Default Swaps	5	25
Weighted Average Years to Maturity	'3 years 9 months 0 days	'2 years 8 months 12 days
Ba [Member] | Credit default swaps referencing indices [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	0	0
Maximum Amount of Future Payments under Credit Default Swaps	0	0
Weighted Average Years to Maturity	'0 years	'0 years
B [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	32	3
Maximum Amount of Future Payments under Credit Default Swaps	375	300
Weighted Average Years to Maturity	'4 years 10 months 24 days	'4 years 10 months 24 days
B [Member] | Single name credit default swaps (corporate) [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	0	0
Maximum Amount of Future Payments under Credit Default Swaps	0	0
Weighted Average Years to Maturity	'0 years	'0 years
B [Member] | Credit default swaps referencing indices [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Credit Default Swaps	32	3
Maximum Amount of Future Payments under Credit Default Swaps	$375	$300
Weighted Average Years to Maturity	'4 years 10 months 24 days	'4 years 10 months 24 days

Derivatives_Estimated_Fair_Val

Derivatives (Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Offsetting Assets [Line Items]	'	'
Derivative Asset, Fair Value, Gross Asset	$8,595	$13,777
Derivative Liability, Fair Value, Gross Liability	6,521	5,536
Amounts offset in the consolidated balance sheet, Assets	0	0
Amounts offset in the consolidated balance sheet, Liabilities	0	0
Netting [Member]	'	'
Offsetting Assets [Line Items]	'	'
Derivative Asset, Fair Value, Gross Asset	8,850	14,067
Derivative Liability, Fair Value, Gross Liability	6,549	5,650
Estimated fair value of derivative assets presented in the consolidated balance sheets	8,850	14,067
Estimated fair value of derivative liabilities presented in the consolidated balance sheets	6,549	5,650
Net amount of derivative assets after application of master netting agreements and cash collateral	139	0
Net amount of derivative liabilities after application of master netting agreements and cash collateral	269	42
Netting [Member] | Over the Counter [Member]	'	'
Offsetting Assets [Line Items]	'	'
Derivative Asset, Fair Value, Gross Asset	8,537	14,048
Derivative Liability, Fair Value, Gross Liability	6,367	5,480
Gross estimated fair value of derivative assets	-4,631	-4,562
Gross estimated fair value of derivative liabilities	-4,631	-4,562
Cash collateral on derivative assets	-1,679	-5,960
Cash collateral on derivative liabilities	-3	-1
Securities collateral on derivative assets	-2,105	-3,526
Securities collateral on derivative liabilities	-1,464	-875
Netting [Member] | Exchange Traded [Member]	'	'
Offsetting Assets [Line Items]	'	'
Derivative Asset, Fair Value, Gross Asset	11	19
Derivative Liability, Fair Value, Gross Liability	53	170
Gross estimated fair value of derivative assets	-5	-19
Gross estimated fair value of derivative liabilities	-5	-19
Cash collateral on derivative assets	0	0
Cash collateral on derivative liabilities	-44	-151
Securities collateral on derivative assets	0	0
Securities collateral on derivative liabilities	-4	0
Netting [Member] | Cleared [Member]	'	'
Offsetting Assets [Line Items]	'	'
Derivative Asset, Fair Value, Gross Asset	302	0
Derivative Liability, Fair Value, Gross Liability	129	0
Gross estimated fair value of derivative assets	-122	0
Gross estimated fair value of derivative liabilities	-122	0
Cash collateral on derivative assets	-169	0
Cash collateral on derivative liabilities	-7	0
Securities collateral on derivative assets	0	0
Securities collateral on derivative liabilities	$0	$0

Derivatives_Credit_Risk_on_Fre

Derivatives (Credit Risk on Freestanding Derivatives) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Derivatives in Net Liability Position	$1,694	$850
Estimated Fair Value Of Incremental Collateral Provided Upon A One Notch Downgrade In The Company's Credit Rating	27	35
Estimated Fair Value Of Incremental Collateral Provided Upon A Downgrade In The Company's Credit Rating to a Level that Triggers Full Overnight Collateralization or Termination of the Derivative Position	34	73
Fixed Maturities [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Collateral Provided	1,530	875
Cash [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Collateral Provided	3	1
Derivatives Subject To Credit-Contingent Provisions [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Derivatives in Net Liability Position	1,674	771
Estimated Fair Value Of Incremental Collateral Provided Upon A One Notch Downgrade In The Company's Credit Rating	27	35
Estimated Fair Value Of Incremental Collateral Provided Upon A Downgrade In The Company's Credit Rating to a Level that Triggers Full Overnight Collateralization or Termination of the Derivative Position	34	73
Derivatives Subject To Credit-Contingent Provisions [Member] | Fixed Maturities [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Collateral Provided	1,530	775
Derivatives Subject To Credit-Contingent Provisions [Member] | Cash [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Collateral Provided	0	0
Derivatives Not Subject To Credit-Contingent Provisions [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Derivatives in Net Liability Position	20	79
Estimated Fair Value Of Incremental Collateral Provided Upon A One Notch Downgrade In The Company's Credit Rating	0	0
Estimated Fair Value Of Incremental Collateral Provided Upon A Downgrade In The Company's Credit Rating to a Level that Triggers Full Overnight Collateralization or Termination of the Derivative Position	0	0
Derivatives Not Subject To Credit-Contingent Provisions [Member] | Fixed Maturities [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Collateral Provided	0	100
Derivatives Not Subject To Credit-Contingent Provisions [Member] | Cash [Member]	'	'
Credit Derivatives [Line Items]	'	'
Estimated Fair Value of Collateral Provided	$3	$1

Derivatives_Embedded_Derivativ

Derivatives (Embedded Derivatives) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]	'	'
Embedded Derivative, Fair Value of Embedded Derivative Asset	$140	$418
Embedded Derivative, Fair Value of Embedded Derivative Liability	-969	3,684
Ceded Guaranteed Minimum Benefit [Member] | Premiums, reinsurance and other receivables [Member]	'	'
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]	'	'
Embedded Derivative, Fair Value of Embedded Derivative Asset	247	439
Direct Guaranteed Minimum Benefit [Member] | Policyholder account balances [Member]	'	'
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]	'	'
Embedded Derivative, Fair Value of Embedded Derivative Liability	-2,296	923
Funds withheld on assumed reinsurance [Member] | Other invested assets [Member]	'	'
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]	'	'
Embedded Derivative, Fair Value of Embedded Derivative Asset	38	66
Assumed Guaranteed Minimum Benefit [Member] | Policyholder account balances [Member]	'	'
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]	'	'
Embedded Derivative, Fair Value of Embedded Derivative Liability	1,262	2,582
Funds Withheld On Ceded Reinsurance [Member] | Other Liabilities [Member]	'	'
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]	'	'
Embedded Derivative, Fair Value of Embedded Derivative Liability	60	162
Other [Member] | Other invested assets [Member]	'	'
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]	'	'
Embedded Derivative, Fair Value of Embedded Derivative Asset	0	1
Other [Member] | Policyholder account balances [Member]	'	'
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]	'	'
Embedded Derivative, Fair Value of Embedded Derivative Liability	5	17
Options embedded in debt or equity securities [Member] | Investments [Member]	'	'
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]	'	'
Embedded Derivative, Fair Value of Embedded Derivative Asset	($145)	($88)

Derivatives_Changes_in_Estimat

Derivatives (Changes in Estimated Fair Value Related to Embedded Derivatives) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Net derivatives gains (losses)	$5,104	$1,239	($1,284)
Net Derivative Gain (Loss) [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Net derivatives gains (losses)	5,104	1,239	-1,284
Policyholder benefits and claims [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Net derivatives gains (losses)	($139)	$75	$86

Derivatives_Narrative_Details

Derivatives (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Derivatives, Fair Value [Line Items]	'	'	'
Estimated Fair Value Assets	$8,595	$13,777	'
Estimated Fair Value Liabilities	6,521	5,536	'
Maximum Amount of Future Payments under Credit Default Swaps	9,055	8,879	'
Estimated Fair Value of Credit Default Swaps	165	74	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Embedded derivatives	5,104	1,239	-1,284
Derivative Instrument Detail [Abstract]	'	'	'
Net amounts reclassified into net derivatives gains (losses) on discontinued cash flow hedges	-1	1	-13
Hedging exposure to variability in future cash flows for specific length of time	'7 years	'8 years	'
Accumulated Other Comprehensive Income Loss	375	1,300	'
Deferred net gains (losses) expected to be reclassified to earnings	-23	'	'
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	0	71
Immateriality of cash flow effectiveness	'no	'	'
Cumulative foreign currency translation gain (loss) recorded in accumulated other comprehensive income (loss) for net investment in foreign operations hedges	233	-98	'
Potential future recoveries available to offset maximum amount of future payments under credit default swaps	90	150	'
Excess securities collateral received on derivatives	104	0	'
Excess securities collateral provided on derivatives	236	290	'
Change in fair value of derivatives excluded from the assessment of hedge effectiveness	-2	-4	-3
Securities collateral received which the company is permitted to sell or repledge, amount that has been sold or repledged	0	'	'
Over the Counter [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Excess securities collateral received on derivatives	238	161	'
Excess securities collateral provided on derivatives	66	0	'
Exchange Traded [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Excess securities collateral received on derivatives	141	0	'
Excess securities collateral provided on derivatives	81	40	'
Nonperformance Risk [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Embedded derivatives	-952	-1,700	1,800
Hedge Funds [Member]	'	'	'
Derivatives, Fair Value [Line Items]	'	'	'
Maximum Amount of Future Payments under Credit Default Swaps	10	'	'
Estimated Fair Value of Credit Default Swaps	0	'	'
Accrued Liabilities [Member]	'	'	'
Derivatives, Fair Value [Line Items]	'	'	'
Estimated Fair Value Assets	255	290	'
Estimated Fair Value Liabilities	$28	$114	'

Fair_Value_Recurring_Fair_Valu

Fair Value (Recurring Fair Value Measurements) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	$350,187	$374,266
Available-for-sale Securities, Equity Securities	3,402	2,891
Actively Traded Securities	662	659
Fair Value Option And Trading Securities	17,423	16,348
Short-term Investments	13,955	16,906
Mortgage loans, at estimated fair value	57,703	56,592
Mortgage loans held-for-sale	3	414
Derivative assets	8,595	13,777
Net embedded derivatives within asset host contracts	140	418
Separate account assets	317,201	235,393
Liabilities [Abstract]	'	'
Derivative liabilities	6,521	5,536
Net embedded derivatives within liability host contracts	-969	3,684
Long-term debt at estimated fair value, relating to variable interest entities	18,653	19,062
Residential Mortgage Loans - FVO [Member]	'	'
Assets [Abstract]	'	'
Mortgage loans, at estimated fair value	338	0
Mortgage Loans Held-for-sale [Member]	'	'
Assets [Abstract]	'	'
Mortgage loans held-for-sale	0	49
Consolidated Securitization Entities [Member]	'	'
Assets [Abstract]	'	'
Mortgage loans, at estimated fair value	1,598	2,666
Liabilities [Abstract]	'	'
Long-term debt at estimated fair value, relating to variable interest entities	1,455	2,527
Recurring [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	350,187	374,266
Available-for-sale Securities, Equity Securities	3,402	2,891
Actively Traded Securities	662	659
Fair Value Option And Trading Securities	17,423	16,348
Short-term Investments	13,112	16,150
Total mortgage loans	1,936	2,715
Other investments	259	426
Derivative assets	8,595	13,777
Total other invested assets	8,854	14,203
Net embedded derivatives within asset host contracts	285	506
Separate account assets	317,201	235,393
Total assets	712,400	662,472
Liabilities [Abstract]	'	'
Derivative liabilities	6,521	5,536
Net embedded derivatives within liability host contracts	-969	3,684
Trading liabilities	262	163
Total liabilities	7,269	11,910
Recurring [Member] | Interest rate contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	5,594	9,855
Liabilities [Abstract]	'	'
Derivative liabilities	2,591	3,068
Recurring [Member] | Foreign currency exchange rate contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	1,309	867
Liabilities [Abstract]	'	'
Derivative liabilities	2,011	1,528
Recurring [Member] | Credit contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	173	90
Liabilities [Abstract]	'	'
Derivative liabilities	52	39
Recurring [Member] | Equity market contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	1,519	2,965
Liabilities [Abstract]	'	'
Derivative liabilities	1,867	901
Recurring [Member] | FVO general account securities [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	627	183
Recurring [Member] | FVO contractholder-directed unit-linked investments [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	16,111	15,465
Recurring [Member] | Residential Mortgage Loans - FVO [Member]	'	'
Assets [Abstract]	'	'
Mortgage loans, at estimated fair value	338	0
Recurring [Member] | Mortgage Loans Held-for-sale [Member]	'	'
Assets [Abstract]	'	'
Mortgage loans held-for-sale	0	49
Recurring [Member] | Consolidated Securitization Entities [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	23	41
Mortgage loans, at estimated fair value	1,598	2,666
Liabilities [Abstract]	'	'
Long-term debt at estimated fair value, relating to variable interest entities	1,455	2,527
Recurring [Member] | U.S. corporate securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	106,469	114,126
Recurring [Member] | Foreign corporate securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	63,152	67,184
Recurring [Member] | Foreign government debt securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	54,437	57,336
Recurring [Member] | U.S. Treasury and agency securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	45,123	47,967
Recurring [Member] | RMBS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	35,055	37,479
Recurring [Member] | CMBS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	16,550	19,129
Recurring [Member] | ABS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	15,571	15,997
Recurring [Member] | State and political subdivision securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	13,830	15,048
Recurring [Member] | Common Stock [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Equity Securities	2,353	2,162
Recurring [Member] | Non-redeemable preferred stock [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Equity Securities	1,049	729
Recurring [Member] | Level 1 [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	25,061	27,441
Available-for-sale Securities, Equity Securities	1,186	932
Actively Traded Securities	2	7
Fair Value Option And Trading Securities	11,222	9,110
Short-term Investments	5,915	9,426
Total mortgage loans	0	0
Other investments	188	303
Derivative assets	12	19
Total other invested assets	200	322
Net embedded derivatives within asset host contracts	0	0
Separate account assets	89,960	31,620
Total assets	133,544	78,851
Liabilities [Abstract]	'	'
Derivative liabilities	53	170
Net embedded derivatives within liability host contracts	0	0
Trading liabilities	260	163
Total liabilities	313	333
Recurring [Member] | Level 1 [Member] | Interest rate contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	10	1
Liabilities [Abstract]	'	'
Derivative liabilities	9	38
Recurring [Member] | Level 1 [Member] | Foreign currency exchange rate contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	1	4
Liabilities [Abstract]	'	'
Derivative liabilities	1	0
Recurring [Member] | Level 1 [Member] | Credit contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	0	0
Liabilities [Abstract]	'	'
Derivative liabilities	0	0
Recurring [Member] | Level 1 [Member] | Equity market contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	1	14
Liabilities [Abstract]	'	'
Derivative liabilities	43	132
Recurring [Member] | Level 1 [Member] | FVO general account securities [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	518	0
Recurring [Member] | Level 1 [Member] | FVO contractholder-directed unit-linked investments [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	10,702	9,103
Recurring [Member] | Level 1 [Member] | Residential Mortgage Loans - FVO [Member]	'	'
Assets [Abstract]	'	'
Mortgage loans, at estimated fair value	0	0
Recurring [Member] | Level 1 [Member] | Mortgage Loans Held-for-sale [Member]	'	'
Assets [Abstract]	'	'
Mortgage loans held-for-sale	0	0
Recurring [Member] | Level 1 [Member] | Consolidated Securitization Entities [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	0	0
Mortgage loans, at estimated fair value	0	0
Liabilities [Abstract]	'	'
Long-term debt at estimated fair value, relating to variable interest entities	0	0
Recurring [Member] | Level 1 [Member] | U.S. corporate securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	0	0
Recurring [Member] | Level 1 [Member] | Foreign corporate securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	0	0
Recurring [Member] | Level 1 [Member] | Foreign government debt securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	0	0
Recurring [Member] | Level 1 [Member] | U.S. Treasury and agency securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	25,061	27,441
Recurring [Member] | Level 1 [Member] | RMBS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	0	0
Recurring [Member] | Level 1 [Member] | CMBS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	0	0
Recurring [Member] | Level 1 [Member] | ABS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	0	0
Recurring [Member] | Level 1 [Member] | State and political subdivision securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	0	0
Recurring [Member] | Level 1 [Member] | Common Stock [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Equity Securities	1,186	932
Recurring [Member] | Level 1 [Member] | Non-redeemable preferred stock [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Equity Securities	0	0
Recurring [Member] | Level 2 [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	300,828	324,405
Available-for-sale Securities, Equity Securities	1,644	1,350
Actively Traded Securities	648	646
Fair Value Option And Trading Securities	5,557	6,263
Short-term Investments	6,943	6,295
Total mortgage loans	1,598	2,666
Other investments	71	123
Derivative assets	8,214	12,992
Total other invested assets	8,285	13,115
Net embedded derivatives within asset host contracts	0	1
Separate account assets	225,776	202,568
Total assets	550,631	556,663
Liabilities [Abstract]	'	'
Derivative liabilities	5,813	4,985
Net embedded derivatives within liability host contracts	4	17
Trading liabilities	2	0
Total liabilities	7,246	7,485
Recurring [Member] | Level 2 [Member] | Interest rate contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	5,557	9,648
Liabilities [Abstract]	'	'
Derivative liabilities	2,568	3,001
Recurring [Member] | Level 2 [Member] | Foreign currency exchange rate contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	1,280	819
Liabilities [Abstract]	'	'
Derivative liabilities	1,971	1,521
Recurring [Member] | Level 2 [Member] | Credit contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	144	47
Liabilities [Abstract]	'	'
Derivative liabilities	52	39
Recurring [Member] | Level 2 [Member] | Equity market contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	1,233	2,478
Liabilities [Abstract]	'	'
Derivative liabilities	1,222	424
Recurring [Member] | Level 2 [Member] | FVO general account securities [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	80	151
Recurring [Member] | Level 2 [Member] | FVO contractholder-directed unit-linked investments [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	4,806	5,425
Recurring [Member] | Level 2 [Member] | Residential Mortgage Loans - FVO [Member]	'	'
Assets [Abstract]	'	'
Mortgage loans, at estimated fair value	0	0
Recurring [Member] | Level 2 [Member] | Mortgage Loans Held-for-sale [Member]	'	'
Assets [Abstract]	'	'
Mortgage loans held-for-sale	0	0
Recurring [Member] | Level 2 [Member] | Consolidated Securitization Entities [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	23	41
Mortgage loans, at estimated fair value	1,598	2,666
Liabilities [Abstract]	'	'
Long-term debt at estimated fair value, relating to variable interest entities	1,427	2,483
Recurring [Member] | Level 2 [Member] | U.S. corporate securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	99,321	106,693
Recurring [Member] | Level 2 [Member] | Foreign corporate securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	56,448	60,976
Recurring [Member] | Level 2 [Member] | Foreign government debt securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	52,202	55,522
Recurring [Member] | Level 2 [Member] | U.S. Treasury and agency securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	20,000	20,455
Recurring [Member] | Level 2 [Member] | RMBS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	32,098	35,442
Recurring [Member] | Level 2 [Member] | CMBS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	15,578	17,982
Recurring [Member] | Level 2 [Member] | ABS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	11,361	12,341
Recurring [Member] | Level 2 [Member] | State and political subdivision securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	13,820	14,994
Recurring [Member] | Level 2 [Member] | Common Stock [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Equity Securities	990	1,040
Recurring [Member] | Level 2 [Member] | Non-redeemable preferred stock [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Equity Securities	654	310
Recurring [Member] | Level 3 [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	24,298	22,420
Available-for-sale Securities, Equity Securities	572	609
Actively Traded Securities	12	6
Fair Value Option And Trading Securities	644	975
Short-term Investments	254	429
Total mortgage loans	338	49
Other investments	0	0
Derivative assets	369	766
Total other invested assets	369	766
Net embedded derivatives within asset host contracts	285	505
Separate account assets	1,465	1,205
Total assets	28,225	26,958
Liabilities [Abstract]	'	'
Derivative liabilities	655	381
Net embedded derivatives within liability host contracts	-973	3,667
Trading liabilities	0	0
Total liabilities	-290	4,092
Recurring [Member] | Level 3 [Member] | Interest rate contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	27	206
Liabilities [Abstract]	'	'
Derivative liabilities	14	29
Recurring [Member] | Level 3 [Member] | Foreign currency exchange rate contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	28	44
Liabilities [Abstract]	'	'
Derivative liabilities	39	7
Recurring [Member] | Level 3 [Member] | Credit contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	29	43
Liabilities [Abstract]	'	'
Derivative liabilities	0	0
Recurring [Member] | Level 3 [Member] | Equity market contracts [Member]	'	'
Assets [Abstract]	'	'
Derivative assets	285	473
Liabilities [Abstract]	'	'
Derivative liabilities	602	345
Recurring [Member] | Level 3 [Member] | FVO general account securities [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	29	32
Recurring [Member] | Level 3 [Member] | FVO contractholder-directed unit-linked investments [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	603	937
Recurring [Member] | Level 3 [Member] | Residential Mortgage Loans - FVO [Member]	'	'
Assets [Abstract]	'	'
Mortgage loans, at estimated fair value	338	0
Recurring [Member] | Level 3 [Member] | Mortgage Loans Held-for-sale [Member]	'	'
Assets [Abstract]	'	'
Mortgage loans held-for-sale	0	49
Recurring [Member] | Level 3 [Member] | Consolidated Securitization Entities [Member]	'	'
Assets [Abstract]	'	'
Fair Value Option And Trading Securities	0	0
Mortgage loans, at estimated fair value	0	0
Liabilities [Abstract]	'	'
Long-term debt at estimated fair value, relating to variable interest entities	28	44
Recurring [Member] | Level 3 [Member] | U.S. corporate securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	7,148	7,433
Recurring [Member] | Level 3 [Member] | Foreign corporate securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	6,704	6,208
Recurring [Member] | Level 3 [Member] | Foreign government debt securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	2,235	1,814
Recurring [Member] | Level 3 [Member] | U.S. Treasury and agency securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	62	71
Recurring [Member] | Level 3 [Member] | RMBS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	2,957	2,037
Recurring [Member] | Level 3 [Member] | CMBS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	972	1,147
Recurring [Member] | Level 3 [Member] | ABS [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	4,210	3,656
Recurring [Member] | Level 3 [Member] | State and political subdivision securities [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Debt Securities	10	54
Recurring [Member] | Level 3 [Member] | Common Stock [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Equity Securities	177	190
Recurring [Member] | Level 3 [Member] | Non-redeemable preferred stock [Member]	'	'
Assets [Abstract]	'	'
Available-for-sale Securities, Equity Securities	$395	$419

Fair_Value_Quantitative_Inform

Fair Value (Quantitative Information) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Interest rate contracts [Member] | Minimum [Member] | Income Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Swap yield	2.48%	1.86%
Interest rate contracts [Member] | Maximum [Member] | Income Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Swap yield	4.50%	3.53%
Foreign currency exchange rate contracts [Member] | Minimum [Member] | Income Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Swap yield	0.97%	2.28%
Correlation	38.00%	43.00%
Foreign currency exchange rate contracts [Member] | Maximum [Member] | Income Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Swap yield	7.67%	7.95%
Correlation	47.00%	57.00%
Credit contracts [Member] | Minimum [Member] | Income Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Credit spreads	0.98%	1.00%
Credit contracts [Member] | Maximum [Member] | Income Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Credit spreads	1.01%	1.00%
Equity market contracts [Member] | Minimum [Member] | Income Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Correlation	60.00%	65.00%
Volatility	13.00%	13.00%
Equity market contracts [Member] | Maximum [Member] | Income Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Correlation	60.00%	65.00%
Volatility	28.00%	32.00%
Embedded derivatives direct and assumed guaranteed minimum benefits [Member] | Income Approach Valuation Technique [Member] | Durations 1-10 [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Lapse Rate, Low End	0.50%	0.50%
Lapse Rate, High End	100.00%	100.00%
Embedded derivatives direct and assumed guaranteed minimum benefits [Member] | Income Approach Valuation Technique [Member] | Durations 11-20 [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Lapse Rate, Low End	2.00%	2.00%
Lapse Rate, High End	100.00%	100.00%
Embedded derivatives direct and assumed guaranteed minimum benefits [Member] | Income Approach Valuation Technique [Member] | Durations 21-116 [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Lapse Rate, Low End	2.00%	2.00%
Lapse Rate, High End	100.00%	100.00%
Embedded derivatives direct and assumed guaranteed minimum benefits [Member] | Income Approach Valuation Technique [Member] | Ages 0-40 [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Mortality Rate, Low End	0.00%	0.00%
Mortality Rate, High End	0.14%	0.14%
Embedded derivatives direct and assumed guaranteed minimum benefits [Member] | Income Approach Valuation Technique [Member] | Ages 41-60 [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Mortality Rate, Low End	0.04%	0.05%
Mortality Rate, High End	0.88%	0.88%
Embedded derivatives direct and assumed guaranteed minimum benefits [Member] | Income Approach Valuation Technique [Member] | Ages 61-115 [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Mortality Rate, Low End	0.26%	0.26%
Mortality Rate, High End	100.00%	100.00%
Embedded derivatives direct and assumed guaranteed minimum benefits [Member] | Minimum [Member] | Income Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Utilization rates	20.00%	20.00%
Withdrawal rates	0.00%	0.07%
Long-term equity volatilities	9.14%	15.18%
Nonperformance risk spread	-1.08%	0.10%
Embedded derivatives direct and assumed guaranteed minimum benefits [Member] | Maximum [Member] | Income Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Utilization rates	50.00%	50.00%
Withdrawal rates	40.00%	20.00%
Long-term equity volatilities	40.00%	40.00%
Nonperformance risk spread	0.83%	1.72%
U.S. corporate and foreign corporate securities [Member] | Minimum [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Delta spread adjustments	-0.10%	-0.50%
Illiquidity premium	0.30%	0.30%
Offered quotes	33	0
Matrix Pricing - Offered quotes	4	0
Credit spreads	-14.89%	-14.16%
U.S. corporate and foreign corporate securities [Member] | Maximum [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Delta spread adjustments	2.40%	5.00%
Illiquidity premium	0.30%	0.30%
Offered quotes	145	555
Matrix Pricing - Offered quotes	145	348
Credit spreads	8.76%	8.76%
U.S. corporate and foreign corporate securities [Member] | Weighted Average [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Delta spread adjustments	0.46%	0.90%
Illiquidity premium	0.30%	0.30%
Offered quotes	95	92
Matrix Pricing - Offered quotes	100	115
Credit spreads	1.74%	2.72%
Foreign government debt securities [Member] | Minimum [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	84	82
Quoted prices	64	77
Credit spreads	0.04%	-0.58%
Foreign government debt securities [Member] | Maximum [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	156	200
Quoted prices	156	146
Credit spreads	0.72%	1.50%
Foreign government debt securities [Member] | Weighted Average [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	107	117
Quoted prices	100	99
Credit spreads	0.32%	0.72%
RMBS [Member] | Minimum [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	69	28
Quoted prices	10	13
Credit spreads	-1.36%	0.09%
RMBS [Member] | Maximum [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	101	100
Quoted prices	109	109
Credit spreads	36.09%	29.80%
RMBS [Member] | Weighted Average [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	93	75
Quoted prices	98	100
Credit spreads	2.88%	5.21%
CMBS [Member] | Minimum [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	90	'
Quoted prices	70	1
Credit spreads	2.15%	0.01%
CMBS [Member] | Maximum [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	101	'
Quoted prices	104	106
Credit spreads	20.25%	91.64%
CMBS [Member] | Weighted Average [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	95	'
Quoted prices	97	99
Credit spreads	4.09%	3.74%
ABS [Member] | Minimum [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	56	0
Quoted prices	0	40
Credit spreads	0.30%	0.00%
ABS [Member] | Maximum [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	106	111
Quoted prices	110	105
Credit spreads	18.78%	18.29%
ABS [Member] | Weighted Average [Member] | Market Approach Valuation Technique [Member]	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Offered quotes	98	97
Quoted prices	101	100
Credit spreads	1.45%	1.09%

Fair_Value_Unobservable_Input_

Fair Value (Unobservable Input Reconciliation) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Liability Related To Securitized Reverse Residential Mortgage Loans [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	'	($1,175)	$0
Other Comprehensive Income (Loss)	'	0	0
Purchases	'	0	0
Sales	'	1,149	0
Issuances	'	0	-1,175
Settlements	'	23	0
Transfers into Level 3	'	0	0
Transfers out of Level 3	'	2	0
Balance at December 31,	'	0	-1,175
Liability Related To Securitized Reverse Residential Mortgage Loans [Member] | Other Revenues [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	1	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Liability Related To Securitized Reverse Residential Mortgage Loans [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Liability Related To Securitized Reverse Residential Mortgage Loans [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Liability Related To Securitized Reverse Residential Mortgage Loans [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Liability Related To Securitized Reverse Residential Mortgage Loans [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Liability Related To Securitized Reverse Residential Mortgage Loans [Member] | Other Expenses [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
FVO general account securities [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	32	23	77
Other Comprehensive Income (Loss)	0	0	0
Purchases	0	0	0
Sales	-30	-9	-33
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	15	0	0
Transfers out of Level 3	0	0	-14
Balance at December 31,	29	32	23
FVO general account securities [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
FVO general account securities [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
FVO general account securities [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	6	18	-7
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	5	14	-8
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	5	14	-8
FVO general account securities [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	6	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
FVO general account securities [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
FVO general account securities [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
FVO contractholder-directed unit-linked investments [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	937	1,386	735
Other Comprehensive Income (Loss)	0	0	0
Purchases	340	604	1,246
Sales	-608	-1,040	-478
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	235	0	121
Transfers out of Level 3	-293	-38	-243
Balance at December 31,	603	937	1,386
FVO contractholder-directed unit-linked investments [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
FVO contractholder-directed unit-linked investments [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
FVO contractholder-directed unit-linked investments [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	-8	25	5
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-1	25	-4
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-1	25	-4
FVO contractholder-directed unit-linked investments [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
FVO contractholder-directed unit-linked investments [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
FVO contractholder-directed unit-linked investments [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Residential Mortgage Loans - FVO [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	0	0	0
Other Comprehensive Income (Loss)	0	0	0
Purchases	339	0	0
Sales	-2	0	0
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	0	0	0
Transfers out of Level 3	0	0	0
Balance at December 31,	338	0	0
Residential Mortgage Loans - FVO [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Residential Mortgage Loans - FVO [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Residential Mortgage Loans - FVO [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	1	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	1	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	1	0	0
Residential Mortgage Loans - FVO [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Residential Mortgage Loans - FVO [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Residential Mortgage Loans - FVO [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Mortgage Loans Held-for-sale [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	49	1,414	24
Other Comprehensive Income (Loss)	0	0	0
Purchases	0	1	3
Sales	-45	-1,348	0
Issuances	0	7	1,361
Settlements	-4	-43	-87
Transfers into Level 3	0	56	109
Transfers out of Level 3	0	-3	-1
Balance at December 31,	0	49	1,414
Mortgage Loans Held-for-sale [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	-35	5
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	-29	5
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	-29	5
Mortgage Loans Held-for-sale [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Mortgage Loans Held-for-sale [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Mortgage Loans Held-for-sale [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Mortgage Loans Held-for-sale [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Mortgage Loans Held-for-sale [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Long-term Debt [Member] | Consolidated Securitization Entities [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	-44	-116	-184
Other Comprehensive Income (Loss)	0	0	0
Purchases	0	0	0
Sales	0	0	0
Issuances	0	0	0
Settlements	18	79	76
Transfers into Level 3	0	0	0
Transfers out of Level 3	0	0	0
Balance at December 31,	-28	-44	-116
Long-term Debt [Member] | Consolidated Securitization Entities [Member] | Other Revenues [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Long-term Debt [Member] | Consolidated Securitization Entities [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Long-term Debt [Member] | Consolidated Securitization Entities [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Long-term Debt [Member] | Consolidated Securitization Entities [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	-2	-7	-8
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	-7	-8
Long-term Debt [Member] | Consolidated Securitization Entities [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Long-term Debt [Member] | Consolidated Securitization Entities [Member] | Other Expenses [Member]	'	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Interest rate contracts [Member]	'	'	'
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Balance at January 1,	177	300	-86
Other Comprehensive Income (Loss)	-102	0	329
Purchases	0	0	-1
Sales	0	0	0
Issuances	0	0	0
Settlements	-31	-71	-44
Transfers into Level 3	0	0	-1
Transfers out of Level 3	-15	0	0
Balance at December 31,	13	177	300
Interest rate contracts [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	68
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	-67	62
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	68
Interest rate contracts [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Interest rate contracts [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Interest rate contracts [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Interest rate contracts [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-8	0	24
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	-16	15	41
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-8	0	24
Interest rate contracts [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign currency exchange rate contracts [Member]	'	'	'
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Balance at January 1,	37	44	73
Other Comprehensive Income (Loss)	-1	0	0
Purchases	0	0	0
Sales	0	0	0
Issuances	0	0	0
Settlements	2	-17	-1
Transfers into Level 3	0	0	0
Transfers out of Level 3	0	0	0
Balance at December 31,	-11	37	44
Foreign currency exchange rate contracts [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign currency exchange rate contracts [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign currency exchange rate contracts [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign currency exchange rate contracts [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign currency exchange rate contracts [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-46	-12	-24
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	-49	10	-28
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-46	-12	-24
Foreign currency exchange rate contracts [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Credit contracts [Member]	'	'	'
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Balance at January 1,	43	1	44
Other Comprehensive Income (Loss)	0	0	14
Purchases	0	0	1
Sales	0	0	0
Issuances	-1	-3	-3
Settlements	-1	-3	-12
Transfers into Level 3	0	0	0
Transfers out of Level 3	0	0	0
Balance at December 31,	29	43	1
Credit contracts [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Credit contracts [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Credit contracts [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Credit contracts [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Credit contracts [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-10	47	-42
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	-12	48	-43
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-10	47	-42
Credit contracts [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Equity market contracts [Member]	'	'	'
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Balance at January 1,	128	889	142
Other Comprehensive Income (Loss)	0	-3	1
Purchases	14	19	228
Sales	0	0	0
Issuances	0	-44	-4
Settlements	1	-156	-8
Transfers into Level 3	0	0	0
Transfers out of Level 3	0	0	-75
Balance at December 31,	-317	128	889
Equity market contracts [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Equity market contracts [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	19	29	7
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	19	29	7
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	19	29	7
Equity market contracts [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	-3
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Equity market contracts [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Equity market contracts [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-463	-593	601
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	-479	-606	601
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-463	-593	601
Equity market contracts [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Net Embedded Derivatives [Member]	'	'	'
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Balance at January 1,	-3,162	-4,203	-2,438
Other Comprehensive Income (Loss)	300	259	-119
Purchases	0	0	0
Sales	0	0	0
Issuances	0	0	0
Settlements	-782	-598	-455
Transfers into Level 3	0	0	0
Transfers out of Level 3	0	0	0
Balance at December 31,	1,258	-3,162	-4,203
Net Embedded Derivatives [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Net Embedded Derivatives [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-135	78	94
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	-139	75	86
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-135	78	94
Net Embedded Derivatives [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Net Embedded Derivatives [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Net Embedded Derivatives [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	5,022	1,275	-1,303
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	5,041	1,305	-1,277
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	5,022	1,275	-1,303
Net Embedded Derivatives [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
U.S. corporate securities [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	7,433	6,784	7,149
Other Comprehensive Income (Loss)	-94	328	327
Purchases	1,555	1,718	912
Sales	-1,178	-1,207	-887
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	1,092	661	169
Transfers out of Level 3	-1,639	-869	-914
Balance at December 31,	7,148	7,433	6,784
U.S. corporate securities [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
U.S. corporate securities [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
U.S. corporate securities [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	10	14	11
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	8	12	10
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	8	12	10
U.S. corporate securities [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	-31	4	17
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-39	-4	-27
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-39	-4	-27
U.S. corporate securities [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
U.S. corporate securities [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign corporate securities [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	6,208	4,370	5,726
Other Comprehensive Income (Loss)	-75	294	-66
Purchases	1,972	2,654	1,740
Sales	-999	-855	-2,094
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	310	186	211
Transfers out of Level 3	-688	-383	-1,165
Balance at December 31,	6,704	6,208	4,370
Foreign corporate securities [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign corporate securities [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign corporate securities [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	9	20	27
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	8	19	19
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	8	19	19
Foreign corporate securities [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	-33	-78	-9
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-3	-30	-31
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-3	-30	-31
Foreign corporate securities [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign corporate securities [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign government debt securities [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	1,814	2,322	3,134
Other Comprehensive Income (Loss)	-84	45	0
Purchases	734	431	529
Sales	-128	-673	-179
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	81	28	123
Transfers out of Level 3	-199	-350	-1,303
Balance at December 31,	2,235	1,814	2,322
Foreign government debt securities [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign government debt securities [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign government debt securities [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	9	14	18
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	9	16	18
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	9	16	18
Foreign government debt securities [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	8	-3	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	-3
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	-3
Foreign government debt securities [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Foreign government debt securities [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
U.S. Treasury and agency securities [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	71	31	79
Other Comprehensive Income (Loss)	-3	0	3
Purchases	0	48	6
Sales	-6	-8	-1
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	0	0	0
Transfers out of Level 3	0	0	-56
Balance at December 31,	62	71	31
U.S. Treasury and agency securities [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
U.S. Treasury and agency securities [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
U.S. Treasury and agency securities [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
U.S. Treasury and agency securities [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
U.S. Treasury and agency securities [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
U.S. Treasury and agency securities [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
RMBS [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	2,037	1,602	2,541
Other Comprehensive Income (Loss)	155	275	-5
Purchases	1,155	952	393
Sales	-399	-704	-213
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	56	161	20
Transfers out of Level 3	-75	-269	-1,103
Balance at December 31,	2,957	2,037	1,602
RMBS [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
RMBS [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
RMBS [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	31	27	10
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	36	27	11
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	36	27	11
RMBS [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	-3	-7	-41
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-3	-4	-41
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-3	-4	-41
RMBS [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
RMBS [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
CMBS [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	1,147	753	1,011
Other Comprehensive Income (Loss)	-45	-4	71
Purchases	546	682	283
Sales	-450	-397	-178
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	114	177	52
Transfers out of Level 3	-331	-30	-495
Balance at December 31,	972	1,147	753
CMBS [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
CMBS [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
CMBS [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	5	8	25
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	3	2	24
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	3	2	24
CMBS [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	-14	-42	-16
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-12	-1	-14
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-12	-1	-14
CMBS [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
CMBS [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
ABS [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	3,656	1,850	3,026
Other Comprehensive Income (Loss)	-70	-2	81
Purchases	1,870	2,007	1,033
Sales	-814	-177	-659
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	33	6	14
Transfers out of Level 3	-478	-48	-1,651
Balance at December 31,	4,210	3,656	1,850
ABS [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
ABS [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
ABS [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	8	18	24
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	1	18	20
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	1	18	20
ABS [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	5	2	-18
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	-10
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	-10
ABS [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
ABS [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
State and political subdivision securities [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	54	53	46
Other Comprehensive Income (Loss)	-1	3	-8
Purchases	0	5	11
Sales	-7	-7	-4
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	0	0	10
Transfers out of Level 3	-36	0	-2
Balance at December 31,	10	54	53
State and political subdivision securities [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
State and political subdivision securities [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
State and political subdivision securities [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
State and political subdivision securities [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
State and political subdivision securities [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
State and political subdivision securities [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Common Stock [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	190	281	268
Other Comprehensive Income (Loss)	0	13	5
Purchases	9	99	106
Sales	-45	-140	-46
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	1	3	0
Transfers out of Level 3	-4	-65	-66
Balance at December 31,	177	190	281
Common Stock [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Common Stock [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Common Stock [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Common Stock [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	26	-1	14
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-3	-11	-6
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-3	-11	-6
Common Stock [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Common Stock [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Non-redeemable preferred stock [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	419	438	905
Other Comprehensive Income (Loss)	100	40	5
Purchases	21	5	3
Sales	-113	-66	-416
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	0	0	12
Transfers out of Level 3	0	0	0
Balance at December 31,	395	419	438
Non-redeemable preferred stock [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Non-redeemable preferred stock [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Non-redeemable preferred stock [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Non-redeemable preferred stock [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	-32	2	-71
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-20	0	-19
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	-20	0	-19
Non-redeemable preferred stock [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Non-redeemable preferred stock [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Actively traded securities [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	6	0	10
Other Comprehensive Income (Loss)	0	0	0
Purchases	9	6	0
Sales	0	0	-8
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	0	0	0
Transfers out of Level 3	-3	0	-2
Balance at December 31,	12	6	0
Actively traded securities [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Actively traded securities [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Actively traded securities [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Actively traded securities [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Actively traded securities [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Actively traded securities [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Short-term Investments [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	429	590	858
Other Comprehensive Income (Loss)	17	-26	2
Purchases	256	425	600
Sales	-427	-559	-870
Issuances	0	0	0
Settlements	0	0	0
Transfers into Level 3	0	5	0
Transfers out of Level 3	-1	-8	-1
Balance at December 31,	254	429	590
Short-term Investments [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Short-term Investments [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Short-term Investments [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	3	2	3
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	2	1	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	2	1	0
Short-term Investments [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	-23	0	-2
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	-1
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	-1
Short-term Investments [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Short-term Investments [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Separate account assets [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	1,205	1,325	1,983
Other Comprehensive Income (Loss)	0	0	0
Purchases	294	244	284
Sales	-319	-443	-743
Issuances	72	2	0
Settlements	0	-1	0
Transfers into Level 3	240	24	19
Transfers out of Level 3	-62	-45	-257
Balance at December 31,	1,465	1,205	1,325
Separate account assets [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Separate account assets [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Separate account assets [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Separate account assets [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	35	99	39
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Separate account assets [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Separate account assets [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	0	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	0	0	0
Mortgage Servicing Rights [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	'	666	950
Other Comprehensive Income (Loss)	'	0	0
Purchases	'	0	0
Sales	'	-485	0
Issuances	'	43	173
Settlements	'	-141	-143
Transfers into Level 3	'	0	0
Transfers out of Level 3	'	0	0
Balance at December 31,	'	0	666
Mortgage Servicing Rights [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	-83	-314
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	-282
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	-282
Mortgage Servicing Rights [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Mortgage Servicing Rights [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Mortgage Servicing Rights [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Mortgage Servicing Rights [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Mortgage Servicing Rights [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	0	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	0	0
Other Debt Obligations [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Balance at January 1,	'	'	4
Other Comprehensive Income (Loss)	'	'	0
Purchases	'	'	0
Sales	'	'	-4
Issuances	'	'	0
Settlements	'	'	0
Transfers into Level 3	'	'	0
Transfers out of Level 3	'	'	0
Balance at December 31,	'	'	0
Other Debt Obligations [Member] | Other Revenues [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	'	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	0
Other Debt Obligations [Member] | Policyholder Benefits and Claims [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	'	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	0
Other Debt Obligations [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	'	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	0
Other Debt Obligations [Member] | Net Investment Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	'	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	0
Other Debt Obligations [Member] | Net Derivative Gains (Losses) [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	'	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	0
Other Debt Obligations [Member] | Other Expenses [Member]	'	'	'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]	'	'	'
Net Income (Loss)	'	'	0
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'	'	'
Changes in Unrealized Gains (Losses) Included in Net Income (Loss)	'	'	$0

Fair_Value_Fair_Value_Option_f

Fair Value (Fair Value Option for Certain Assets and Liabilities) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Fair Value, Option, Quantitative Disclosures [Line Items]	'	'
Carrying value at estimated fair value	$57,703	$56,592
Carrying value at estimated fair value	18,653	19,062
Consolidated Securitization Entities [Member]	'	'
Fair Value, Option, Quantitative Disclosures [Line Items]	'	'
Unpaid principal balance	1,528	2,539
Difference between estimated fair value and unpaid principal balance	70	127
Carrying value at estimated fair value	1,598	2,666
Loans in non-accrual status	0	0
Loans more than 90 days past due	0	0
Loans in non-accrual status or more than 90 days past due, or both - difference between aggregate estimated fair value and unpaid principal balance	0	0
Contractual principal balance	1,445	2,430
Difference between estimated fair value and contractual principal balance	10	97
Carrying value at estimated fair value	1,455	2,527
Residential Mortgage Loans - FVO [Member]	'	'
Fair Value, Option, Quantitative Disclosures [Line Items]	'	'
Unpaid principal balance	508	0
Difference between estimated fair value and unpaid principal balance	-170	0
Carrying value at estimated fair value	338	0
Loans in non-accrual status	0	0
Loans more than 90 days past due	81	0
Loans in non-accrual status or more than 90 days past due, or both - difference between aggregate estimated fair value and unpaid principal balance	($82)	$0

Fair_Value_Fair_Value_Option_G

Fair Value (Fair Value Option Gains Losses for Mortgage Loans Held-for-Sale) (Details) (Residential Mortgage Loans - FVO [Member], Net Investment Income [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Residential Mortgage Loans - FVO [Member] | Net Investment Income [Member]	'	'	'
Fair Value, Option, Quantitative Disclosures [Line Items]	'	'	'
Instrument-specific credit risk based on changes in credit spreads for non-agency loans and adjustments in individual loan quality	($1)	$0	$0
Other changes in estimated fair value	1	0	0
Total gains (losses) recognized	$0	$0	$0

Fair_Value_Nonrecurring_Fair_V

Fair Value (Nonrecurring Fair Value Measurements) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Level 3 [Member] | Goodwill [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Carrying Value After Measurement	$0	$0	$0
Level 3 [Member] | Customer Relationships [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Carrying Value After Measurement	0	32	0
Level 3 [Member] | Held-for-investment [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Carrying Value After Measurement	211	428	151
Level 3 [Member] | Held-for-sale [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Carrying Value After Measurement	3	319	58
Level 3 [Member] | Other limited partnership interests [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Carrying Value After Measurement	77	54	13
Level 3 [Member] | Real Estate Joint Ventures [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Carrying Value After Measurement	3	10	0
Nonrecurring [Member] | Goodwill [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Gains (Losses)	0	-1,868	-65
Nonrecurring [Member] | Customer Relationships [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Gains (Losses)	0	-77	0
Nonrecurring [Member] | Held-for-investment [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Gains (Losses)	20	-11	-15
Nonrecurring [Member] | Held-for-sale [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Gains (Losses)	0	-31	-3
Nonrecurring [Member] | Other limited partnership interests [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Gains (Losses)	-46	-33	-5
Nonrecurring [Member] | Real Estate Joint Ventures [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Gains (Losses)	($2)	($6)	$0

Fair_Value_Financial_Instrumen

Fair Value (Financial Instruments Carried at Other Than Fair Value) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Assets	'	'
Policy loans	$11,764	$11,884
Liabilities	'	'
Collateral financing arrangements	4,196	4,196
Junior subordinated debt securities	3,193	3,192
Separate account liabilities	317,201	235,393
Estimated Fair Value [Member]	'	'
Assets	'	'
Held-for-investment	57,921	57,381
Held-for-sale	3	365
Mortgage loans, net	57,924	57,746
Policy loans	13,206	14,257
Real estate joint ventures	169	171
Other Limited Partnership Interests	1,109	1,277
Other invested assets	844	815
Premiums, reinsurance and other receivables	3,110	3,705
Other assets	352	292
Liabilities	'	'
Policyholder account balances	144,631	158,040
Bank deposits	0	6,416
Long-term Debt	18,564	18,978
Collateral financing arrangements	3,984	3,839
Junior subordinated debt securities	3,789	3,984
Other Liabilities	2,240	1,916
Separate account liabilities	117,562	58,726
Estimated Fair Value [Member] | Level 1 [Member]	'	'
Assets	'	'
Held-for-investment	0	0
Held-for-sale	0	0
Mortgage loans, net	0	0
Policy loans	0	0
Real estate joint ventures	0	0
Other Limited Partnership Interests	0	0
Other invested assets	322	305
Premiums, reinsurance and other receivables	0	0
Other assets	0	0
Liabilities	'	'
Policyholder account balances	0	0
Bank deposits	0	0
Long-term Debt	0	0
Collateral financing arrangements	0	0
Junior subordinated debt securities	0	0
Other Liabilities	0	0
Separate account liabilities	0	0
Estimated Fair Value [Member] | Level 2 [Member]	'	'
Assets	'	'
Held-for-investment	0	0
Held-for-sale	0	0
Mortgage loans, net	0	0
Policy loans	1,694	1,690
Real estate joint ventures	0	0
Other Limited Partnership Interests	0	0
Other invested assets	163	144
Premiums, reinsurance and other receivables	728	745
Other assets	210	214
Liabilities	'	'
Policyholder account balances	0	0
Bank deposits	0	2,018
Long-term Debt	18,564	18,978
Collateral financing arrangements	0	0
Junior subordinated debt securities	3,789	3,984
Other Liabilities	948	673
Separate account liabilities	117,562	58,726
Estimated Fair Value [Member] | Level 3 [Member]	'	'
Assets	'	'
Held-for-investment	57,921	57,381
Held-for-sale	3	365
Mortgage loans, net	57,924	57,746
Policy loans	11,512	12,567
Real estate joint ventures	169	171
Other Limited Partnership Interests	1,109	1,277
Other invested assets	359	366
Premiums, reinsurance and other receivables	2,382	2,960
Other assets	142	78
Liabilities	'	'
Policyholder account balances	144,631	158,040
Bank deposits	0	4,398
Long-term Debt	0	0
Collateral financing arrangements	3,984	3,839
Junior subordinated debt securities	0	0
Other Liabilities	1,292	1,243
Separate account liabilities	0	0
Carrying Value [Member]	'	'
Assets	'	'
Held-for-investment	55,767	53,926
Held-for-sale	3	365
Mortgage loans, net	55,770	54,291
Policy loans	11,764	11,884
Real estate joint ventures	102	113
Other Limited Partnership Interests	950	1,154
Other invested assets	844	815
Premiums, reinsurance and other receivables	3,116	3,287
Other assets	324	260
Liabilities	'	'
Policyholder account balances	139,735	149,928
Bank deposits	0	6,416
Long-term Debt	17,170	16,502
Collateral financing arrangements	4,196	4,196
Junior subordinated debt securities	3,193	3,192
Other Liabilities	2,239	1,913
Separate account liabilities	$117,562	$58,726

Fair_Value_Recurring_Fair_Valu1

Fair Value (Recurring Fair Value Measurements) (Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available-for-sale Securities, Equity Securities	$3,402	$2,891
Net Embedded Derivatives [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available-for-sale Securities, Equity Securities	($145)	($88)

Fair_Value_Transfers_Between_L

Fair Value (Transfers Between Levels) (Narrative) (Details) (USD $)	Dec. 31, 2013
In Millions, unless otherwise specified
Fair Value Disclosures [Abstract]	'
Fair Value Assets And Liabilities Transferred Between Levels 1 And Levels 2	$101

Fair_Value_Fair_Value_Option_N

Fair Value (Fair Value Option) (Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
In Millions, unless otherwise specified			Mortgage Loans Held-for-sale [Member]	Mortgage Loans Held-for-sale [Member]	Mortgage Loans Held-for-sale [Member]	Mortgage Loans Held-for-sale [Member]	Mortgage Loans Held-for-sale [Member]
					Other Revenues [Member]	Other Revenues [Member]	Other Revenues [Member]
							Maximum [Member]
Fair Value, Option, Quantitative Disclosures [Line Items]	'	'	'	'	'	'	'
Mortgage loans held-for-sale	$3	$414	$0	$49	'	'	'
Instrument-specific credit risk	'	'	'	'	-1	-3	-1
Other changes in estimated fair value	'	'	'	'	$68	$511	$1

Fair_Value_Nonrecurring_Fair_V1

Fair Value (Nonrecurring Fair Value Measurments) (Narrative) (Details)	12 Months Ended
	Dec. 31, 2013
Private Equity And Debt Funds [Member] | Minimum [Member]	'
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]	'
Liquidation period	'2 years
Private Equity And Debt Funds [Member] | Maximum [Member]	'
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]	'
Liquidation period	'10 years
Real Estate Funds [Member] | Minimum [Member]	'
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]	'
Liquidation period	'1 year
Real Estate Funds [Member] | Maximum [Member]	'
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]	'
Liquidation period	'10 years

Goodwill_Goodwill_Details

Goodwill (Goodwill) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Goodwill Rollforward and by Segment	'	'	'
Goodwill	$11,886	$12,000	$11,781
Accumulated impairment	-1,933	'	0
Goodwill total	9,953	11,935	11,781
Acquisitions	1,141	1	39
Dispositions	-8	'	'
Impairments	0	-1,868	0
Goodwill allocation	'	'	0
Effect of foreign currency translation and other	-544	-115	180
Goodwill	12,410	11,886	12,000
Accumulated impairment	-1,868	-1,933	'
Goodwill total	10,542	9,953	11,935
American Life Insurance Company [Member]	'	'	'
Goodwill Rollforward and by Segment	'	'	'
Goodwill	0	0	6,809
Accumulated impairment	0	0	0
Goodwill total	0	0	6,809
Acquisitions	0	0	0
Dispositions	0	'	'
Reduction of goodwill	0	'	'
Reduction of accumulated impairment	0	'	'
Impairments	'	0	0
Goodwill allocation	'	'	-6,809
Effect of foreign currency translation and other	0	0	0
Goodwill	0	0	0
Accumulated impairment	0	0	0
Goodwill total	0	0	0
MetLife Bank [Member]	'	'	'
Goodwill Rollforward and by Segment	'	'	'
Reduction of goodwill	-65	'	'
Reduction of accumulated impairment	65	'	'
Impairments	'	'	-65
Accumulated impairment	'	'	-65
Retail [Member]	'	'	'
Goodwill Rollforward and by Segment	'	'	'
Goodwill	3,125	3,125	3,125
Accumulated impairment	-1,692	0	0
Goodwill total	1,433	3,125	3,125
Acquisitions	0	0	0
Dispositions	0	'	'
Reduction of goodwill	0	'	'
Reduction of accumulated impairment	0	'	'
Impairments	'	-1,692	0
Goodwill allocation	'	'	0
Effect of foreign currency translation and other	0	0	0
Goodwill	3,125	3,125	3,125
Accumulated impairment	-1,692	-1,692	0
Goodwill total	1,433	1,433	3,125
Group, Voluntary & Worksite Benefits [Member]	'	'	'
Goodwill Rollforward and by Segment	'	'	'
Goodwill	138	138	138
Accumulated impairment	0	0	0
Goodwill total	138	138	138
Acquisitions	0	0	0
Dispositions	0	'	'
Reduction of goodwill	0	'	'
Reduction of accumulated impairment	0	'	'
Impairments	'	0	0
Goodwill allocation	'	'	0
Effect of foreign currency translation and other	0	0	0
Goodwill	138	138	138
Accumulated impairment	0	0	0
Goodwill total	138	138	138
Corporate Benefit Funding [Member]	'	'	'
Goodwill Rollforward and by Segment	'	'	'
Goodwill	900	900	900
Accumulated impairment	0	0	0
Goodwill total	900	900	900
Acquisitions	0	0	0
Dispositions	0	'	'
Reduction of goodwill	0	'	'
Reduction of accumulated impairment	0	'	'
Impairments	'	0	0
Goodwill allocation	'	'	0
Effect of foreign currency translation and other	0	0	0
Goodwill	900	900	900
Accumulated impairment	0	0	0
Goodwill total	900	900	900
Corporate & Other [Member]	'	'	'
Goodwill Rollforward and by Segment	'	'	'
Goodwill	470	470	470
Accumulated impairment	-241	-65	0
Goodwill total	229	405	470
Acquisitions	0	0	0
Dispositions	0	'	'
Reduction of goodwill	-65	'	'
Reduction of accumulated impairment	65	'	'
Impairments	'	-176	-65
Goodwill allocation	'	'	0
Effect of foreign currency translation and other	0	0	0
Goodwill	405	470	470
Accumulated impairment	-176	-241	-65
Goodwill total	229	229	405
Latin America [Member]	'	'	'
Goodwill Rollforward and by Segment	'	'	'
Goodwill	527	501	229
Accumulated impairment	0	0	0
Goodwill total	527	501	229
Acquisitions	1,140	0	0
Dispositions	0	'	'
Reduction of goodwill	0	'	'
Reduction of accumulated impairment	0	'	'
Impairments	'	0	0
Goodwill allocation	'	'	312
Effect of foreign currency translation and other	-79	26	-40
Goodwill	1,588	527	501
Accumulated impairment	0	0	0
Goodwill total	1,588	527	501
Asia [Member]	'	'	'
Goodwill Rollforward and by Segment	'	'	'
Goodwill	5,387	5,533	72
Accumulated impairment	0	0	0
Goodwill total	5,387	5,533	72
Acquisitions	0	0	39
Dispositions	0	'	'
Reduction of goodwill	0	'	'
Reduction of accumulated impairment	0	'	'
Impairments	'	0	0
Goodwill allocation	'	'	5,163
Effect of foreign currency translation and other	-489	-146	259
Goodwill	4,898	5,387	5,533
Accumulated impairment	0	0	0
Goodwill total	4,898	5,387	5,533
Europe, the Middle East and Africa [Member]	'	'	'
Goodwill Rollforward and by Segment	'	'	'
Goodwill	1,339	1,333	38
Accumulated impairment	0	0	0
Goodwill total	1,339	1,333	38
Acquisitions	1	1	0
Dispositions	-8	'	'
Reduction of goodwill	0	'	'
Reduction of accumulated impairment	0	'	'
Impairments	'	0	0
Goodwill allocation	'	'	1,334
Effect of foreign currency translation and other	24	5	-39
Goodwill	1,356	1,339	1,333
Accumulated impairment	0	0	0
Goodwill total	$1,356	$1,339	$1,333

Goodwill_Narrative_Details

Goodwill (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Goodwill [Line Items]	'	'	'	'
Acquisitions	$1,141,000,000	$1,000,000	$39,000,000	'
Goodwill	10,542,000,000	9,953,000,000	11,935,000,000	11,781,000,000
Impairments	0	-1,868,000,000	0	'
Parent Company [Member]	'	'	'	'
Goodwill [Line Items]	'	'	'	'
Impairments	0	-1,384,000,000	0	'
Japan [Member]	'	'	'	'
Goodwill [Line Items]	'	'	'	'
Goodwill	4,700,000,000	5,200,000,000	5,400,000,000	'
Retail [Member]	'	'	'	'
Goodwill [Line Items]	'	'	'	'
Acquisitions	0	0	0	'
Goodwill	1,433,000,000	1,433,000,000	3,125,000,000	3,125,000,000
Impairments	'	-1,692,000,000	0	'
Goodwill impairment testing attributed to reportable segments	'	34,000,000	'	'
Reduction of accumulated impairment	0	'	'	'
Group, Voluntary & Worksite Benefits [Member]	'	'	'	'
Goodwill [Line Items]	'	'	'	'
Acquisitions	0	0	0	'
Goodwill	138,000,000	138,000,000	138,000,000	138,000,000
Impairments	'	0	0	'
Goodwill impairment testing attributed to reportable segments	'	9,000,000	'	'
Reduction of accumulated impairment	0	'	'	'
Corporate Benefit Funding [Member]	'	'	'	'
Goodwill [Line Items]	'	'	'	'
Acquisitions	0	0	0	'
Goodwill	900,000,000	900,000,000	900,000,000	900,000,000
Impairments	'	0	0	'
Goodwill impairment testing attributed to reportable segments	'	186,000,000	'	'
Reduction of accumulated impairment	0	'	'	'
Asia Segment [Member]	'	'	'	'
Goodwill [Line Items]	'	'	'	'
Acquisitions	0	0	39,000,000	'
Goodwill	4,898,000,000	5,387,000,000	5,533,000,000	72,000,000
Impairments	'	0	0	'
Reduction of accumulated impairment	0	'	'	'
Corporate and Other [Member]	'	'	'	'
Goodwill [Line Items]	'	'	'	'
Acquisitions	0	0	0	'
Goodwill	229,000,000	229,000,000	405,000,000	470,000,000
Impairments	'	-176,000,000	-65,000,000	'
Reduction of accumulated impairment	65,000,000	'	'	'
Retail Segment, Annuities Reporting Unit [Member]	'	'	'	'
Goodwill [Line Items]	'	'	'	'
Goodwill impairment, net of income tax	'	-1,600,000,000	'	'
MetLife Bank [Member]	'	'	'	'
Goodwill [Line Items]	'	'	'	'
Reduction of accumulated impairment	$65,000,000	'	'	'

Longterm_and_Shortterm_Debt_Lo

Long-term and Short-term Debt (Long-term and Short-term Outstanding) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'
Capital lease obligations	$28	$33
Long-term debt	17,198	16,535
Short-term debt	175	100
Total	17,373	16,635
Senior Notes [Member]	'	'
Debt Instrument [Line Items]	'	'
Interest Rate Range Minimum	1.52%	'
Interest Rate Range Maximum	7.72%	'
Weighted Average Interest Rate	4.96%	'
Debt Instrument, Maturity Date Range, Start	6-Feb-14	'
Debt Instrument, Maturity Date Range, End	15-Jun-45	'
Long-term Debt	15,938	15,669
Surplus Notes [Member]	'	'
Debt Instrument [Line Items]	'	'
Interest Rate Range Minimum	7.63%	'
Interest Rate Range Maximum	7.88%	'
Weighted Average Interest Rate	7.84%	'
Debt Instrument, Maturity Date Range, Start	1-Nov-15	'
Debt Instrument, Maturity Date Range, End	1-Nov-25	'
Long-term Debt	701	700
Other Notes [Member]	'	'
Debt Instrument [Line Items]	'	'
Interest Rate Range Minimum	1.39%	'
Interest Rate Range Maximum	8.00%	'
Weighted Average Interest Rate	4.04%	'
Debt Instrument, Maturity Date Range, Start	1-Feb-14	'
Debt Instrument, Maturity Date Range, End	30-Nov-30	'
Long-term Debt	$531	$133

Longterm_and_Shortterm_Debt_Sh

Long-term and Short-term Debt (Short-term with Maturities of Year or Less) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Debt Disclosure [Abstract]	'	'
Commercial Paper	$175	$100
Short-term Debt, average daily balance	103	119
Short-term Debt Average Days Outstanding	'55 days	'40 days
Short-term Debt [Line Items]	'	'
Short-term debt	$175	$100

Longterm_and_Shortterm_Debt_Cr

Long-term and Short-term Debt (Credit Facilities) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'
Collateral financing arrangements	$4,196	$4,196
General Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Line of Credit Facility, Maximum Borrowing Capacity	4,000	'
Letter of Credit Issuances	192	'
Collateral financing arrangements	0	'
Unused Commitments	3,808	'
General Credit Facility One [Member]	'	'
Debt Instrument [Line Items]	'	'
Borrowers	'MetLife, Inc. and MetLife Funding, Inc.	'
Expiration	30-Sep-17	'
Line of Credit Facility, Maximum Borrowing Capacity	1,000	'
Letter of Credit Issuances	59	'
Collateral financing arrangements	0	'
Unused Commitments	941	'
Fees associated with credit facilities	'	4
General Credit Facility Two [Member]	'	'
Debt Instrument [Line Items]	'	'
Borrowers	'MetLife, Inc. and MetLife Funding, Inc.	'
Expiration	31-Aug-16	'
Line of Credit Facility, Maximum Borrowing Capacity	3,000	'
Letter of Credit Issuances	133	'
Collateral financing arrangements	0	'
Unused Commitments	$2,867	'

Longterm_and_Shortterm_Debt_Co

Long-term and Short-term Debt (Commited Facilities) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
In Millions, unless otherwise specified			Committed Credit Facility Total [Member]	Committed Credit Facility One [Member]	Committed Credit Facility Two [Member]	Committed Credit Facility Three [Member]	Committed Credit Facility Four [Member]	Committed Credit Facility Five [Member]	Committed Credit Facility Six [Member]	Committed Credit Facility Seven [Member]
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'	'
Borrowers	'	'	'	'MetLife, Inc.	'Exeter Reassurance Company, Ltd., MetLife, Inc.B & Missouri Reinsurance, Inc.	'MetLife Reinsurance Company of VermontB & MetLife, Inc.	'Exeter Reassurance Company, Ltd.	'MetLife Reinsurance Company of South CarolinaB & MetLife, Inc.	'MetLife Reinsurance Company of VermontB & MetLife, Inc.	'MetLife Reinsurance Company of VermontB & MetLife, Inc.
Expiration	'	'	'	31-Aug-14	30-Jun-16	31-Dec-20	31-Dec-27	30-Jun-37	31-Dec-37	30-Sep-38
Line of Credit Facility, Maximum Borrowing Capacity	'	'	$12,446	$300	$500	$350	$650	$3,500	$2,896	$4,250
Letter of Credit Issuances	'	'	6,739	300	490	350	600	0	1,937	3,062
Collateral financing arrangements	4,196	4,196	2,797	0	0	0	0	2,797	0	0
Unused Commitments	'	'	$2,910	$0	$10	$0	$50	$703	$959	$1,188

Longterm_and_Shortterm_Debt_Na

Long-term and Short-term Debt (Narrative) (Details) (USD $)

3 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2013

Sep. 11, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2010

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Certain Businesses of MetLife Bank [Member]

General Credit Facility [Member]

General Credit Facility [Member]

General Credit Facility [Member]

Committed Credit Facility [Member]

Committed Credit Facility [Member]

Committed Credit Facility [Member]

General Credit Facility One [Member]

General Credit Facility One [Member]

Senior Notes [Member]

Senior Notes [Member]

Consolidated Securitization Entities [Member]

Consolidated Securitization Entities [Member]

Debt Remarketing Series D [Member]

Debt Remarketing Series D [Member]

Debt Remarketing Series D [Member]

Senior Debt $750M Maturing August 2042 [Member]

Senior Debt $750M Maturing August 2042 [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Debt Series E [Member]

Senior Debt Series C Tranche 1 [Member]

Senior Debt Series C Tranche 2 [Member]

Senior Debt Series E Tranche 1 [Member]

Senior Debt Series E Tranche 2 [Member]

Debt Disclosure [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long Term Debt Aggregate Maturities, Year One

$1,400,000,000

$1,400,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long Term Debt Aggregate Maturities, Year Two

1,200,000,000

1,200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long Term Debt Aggregate Maturities, Year Three

1,300,000,000

1,300,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long Term Debt Aggregate Maturities, Year Four

502,000,000

502,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long Term Debt Aggregate Maturities, Year Five

1,500,000,000

1,500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Maturities, Repayments of Principal after Year Five

11,300,000,000

11,300,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Short-term Debt, Weighted Average Interest Rate

0.12%

0.12%

0.17%

0.33%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total interest expense

'

854,000,000

871,000,000

975,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Effective date of acquisition

'

'

'

'

1-Nov-10

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1-Nov-10

1-Nov-10

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000,000,000

750,000,000

3,000,000,000

3,000,000,000

'

'

'

'

'

Debt Instrument, Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000,000,000

3,000,000,000

'

'

'

'

'

Long-term debt, at estimated fair value, relating to variable interest entities

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15,938,000,000

15,669,000,000

1,500,000,000

2,500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.37%

4.37%

4.88%

4.13%

'

'

2.46%

1.76%

3.05%

'

'

Debt Instrument, Average Interest Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.96%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Maturity Date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15-Sep-23

15-Sep-23

'

30-Nov-43

13-Aug-42

'

'

15-Jun-45

15-Dec-17

15-Dec-22

15-Jun-18

15-Jun-45

Debt Issuance Costs Incurred and Capitalized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000,000

7,000,000

'

'

'

'

'

'

'

Line of Credit Facility [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

'

'

'

'

4,000,000,000

'

'

12,400,000,000

'

'

1,000,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Collateral financing arrangements

4,196,000,000

4,196,000,000

4,196,000,000

'

'

'

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unused Commitments

'

'

'

'

'

'

'

'

'

'

'

'

941,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Expiration Date

'

'

'

'

'

'

'

'

'

'

'

'

30-Sep-17

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fees associated with credit facilities

'

'

'

'

'

'

24,000,000

30,000,000

35,000,000

103,000,000

96,000,000

93,000,000

'

4,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Liabilities of business transferred to subsidiary under funding agreements that are included in policyholder account balances

'

0

3,806,000,000

0

'

3,800,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Increase (Decrease), Other, Net

1,900,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Federal Home Loan Bank, Liability for Debt Advances

0

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Federal Home Loan Bank Advances

'

0

0

1,300,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Federal Home Loan Bank Repayments, Long Term Debt

'

'

$374,000,000

$750,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Collateral_Financing_Arrangeme1

Collateral Financing Arrangements (Collateral Financing Arrangements) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2007
Collateral Financing Arrangements (Textuals) [Abstract]	'	'	'	'
Drawings upon the Collateral Financing Arrangement	$4,196,000,000	$4,196,000,000	'	'
Secured Debt [Member]	'	'	'	'
Collateral Financing Arrangements (Textuals) [Abstract]	'	'	'	'
Increase (Decrease) in Other Receivables	'	-59,000,000	-84,000,000	'
Partial repurchase	'	451,000,000	650,000,000	'
Parent Company [Member]	'	'	'	'
Collateral Financing Arrangements (Textuals) [Abstract]	'	'	'	'
Drawings upon the Collateral Financing Arrangement	2,797,000,000	2,797,000,000	'	'
Interest expense	1,122,000,000	985,000,000	1,007,000,000	'
MRC [Member] | Secured Debt [Member]	'	'	'	'
Collateral Financing Arrangements (Textuals) [Abstract]	'	'	'	'
Debt Instrument, Principal Outstanding	1,400,000,000	1,400,000,000	'	'
Debt Instrument, Term in Years	'	'	'	'35 years
MRC [Member] | Secured Debt [Member]	'	'	'	'
Collateral Financing Arrangements (Textuals) [Abstract]	'	'	'	'
Partial repurchase	'	451,000,000	650,000,000	'
Debt Instrument, Face Amount	'	'	'	2,500,000,000
Debt Instrument, Interest Rate Terms	'	'	'	'3-month LIBOR plus 0.55%
Debt Instrument, Basis Spread on Variable Rate	'	'	'	0.55%
Cash Collateral Returned, Net	0	0	100,000,000	'
Other Receivables	182,000,000	182,000,000	'	'
Invested assets pledged as collateral	23,000,000	120,000,000	'	'
Estimated fair value of assets held in trust	1,700,000,000	1,600,000,000	'	'
Interest expense	20,000,000	26,000,000	35,000,000	'
MRC [Member] | Parent Company [Member] | Secured Debt [Member]	'	'	'	'
Collateral Financing Arrangements (Textuals) [Abstract]	'	'	'	'
Debt Instrument, Interest Rate Terms	'	'	'	'3-month LIBOR plus 1.12%
Debt Instrument, Basis Spread on Variable Rate	'	'	'	1.12%
MRSC [Member]	'	'	'	'
Collateral Financing Arrangements (Textuals) [Abstract]	'	'	'	'
Debt Instrument, Term in Years	'	'	'	'30 years
MRSC [Member] | Secured Debt [Member]	'	'	'	'
Collateral Financing Arrangements (Textuals) [Abstract]	'	'	'	'
Statutory Reserve Support	'	'	'	3,500,000,000
Drawings upon the Collateral Financing Arrangement	2,800,000,000	2,800,000,000	'	'
Cash Collateral Paid	0	0	0	'
Cash Collateral Paid, Cumulative Net	680,000,000	'	'	'
Invested assets pledged as collateral	0	78,000,000	'	'
Estimated fair value of assets held in trust	3,400,000,000	3,400,000,000	'	'
Interest expense	$28,000,000	$33,000,000	$29,000,000	'
MRSC [Member] | Parent Company [Member] | Secured Debt [Member]	'	'	'	'
Collateral Financing Arrangements (Textuals) [Abstract]	'	'	'	'
Debt Instrument, Interest Rate Terms	'	'	'	'3-month LIBOR plus 0.70
Debt Instrument, Basis Spread on Variable Rate	'	'	'	0.70%

Junior_Subordinated_Debt_Secur2

Junior Subordinated Debt Securities (Junior Subordinated Debt Securities) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'
Junior Subordinated Notes	$3,193	$3,192
MetLife Inc $500M Maturing 2069 [Member]	'	'
Debt Instrument [Line Items]	'	'
Debt Instrument, Issuance Date	8-Jul-09	'
Debt Instrument, Face Amount	500	'
Debt Instrument, Interest Rate, Stated Percentage	10.75%	'
Debt Conversion, Converted Instrument, Expiration or Due Date, Month and Year	'2039-08	'
Debt Instrument, Description of Variable Rate Basis	'LIBORB + 7.548%	'
Debt Instrument, Basis Spread on Variable Rate	7.55%	'
Debt Instrument, Maturity Date	1-Aug-69	'
Debt Instrument, Principal Outstanding	500	500
MetLife Capital Trust X $750M Maturing 2068 [Member]	'	'
Debt Instrument [Line Items]	'	'
Debt Instrument, Issuance Date	8-Apr-08	'
Debt Instrument, Face Amount	750	'
Debt Instrument, Interest Rate, Stated Percentage	9.25%	'
Debt Conversion, Converted Instrument, Expiration or Due Date, Month and Year	'2038-04	'
Debt Instrument, Description of Variable Rate Basis	'LIBORB + 5.540%	'
Debt Instrument, Basis Spread on Variable Rate	5.54%	'
Debt Instrument, Maturity Date	8-Apr-68	'
Debt Instrument, Principal Outstanding	750	750
MetLife Capital Trust IV $700M Maturing 2067 [Member]	'	'
Debt Instrument [Line Items]	'	'
Debt Instrument, Issuance Date	15-Dec-07	'
Debt Instrument, Face Amount	700	'
Debt Instrument, Interest Rate, Stated Percentage	7.88%	'
Debt Conversion, Converted Instrument, Expiration or Due Date, Month and Year	'2037-12	'
Debt Instrument, Description of Variable Rate Basis	'LIBORB + 3.960%	'
Debt Instrument, Basis Spread on Variable Rate	3.96%	'
Debt Instrument, Maturity Date	15-Dec-67	'
Debt Instrument, Principal Outstanding	695	694
MetLife Inc $1,250M Maturing 2066 [Member]	'	'
Debt Instrument [Line Items]	'	'
Debt Instrument, Issuance Date	19-Dec-06	'
Debt Instrument, Face Amount	1,250	'
Debt Instrument, Interest Rate, Stated Percentage	6.40%	'
Debt Conversion, Converted Instrument, Expiration or Due Date, Month and Year	'2036-12	'
Debt Instrument, Description of Variable Rate Basis	'LIBORB + 2.205%	'
Debt Instrument, Basis Spread on Variable Rate	2.21%	'
Debt Instrument, Maturity Date	15-Dec-66	'
Debt Instrument, Principal Outstanding	$1,248	$1,248

Junior_Subordinated_Debt_Secur3

Junior Subordinated Debt Securities (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Debt Instrument [Line Items]	'	'	'
Interest Expense, Junior Subordinated Debentures	$258	$258	$258
Senior Note MLINC $1B maturing in June 2035 [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt Instrument, Interest Rate, Stated Percentage	5.70%	'	'
Debt Instrument, Maturity Date	30-Jun-35	'	'
Junior Subordinated Debt Instrument One [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt Instrument, Interest Rate, Stated Percentage	10.75%	'	'
Debt Instrument, Maturity Date	1-Aug-69	'	'
Junior Subordinated Debt Instrument Four [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt Instrument, Interest Rate, Stated Percentage	6.40%	'	'
Debt Instrument, Maturity Date	15-Dec-66	'	'
Junior Subordinated Debt Instrument Three [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt Instrument, Interest Rate, Stated Percentage	7.88%	'	'
Debt Instrument, Maturity Date	15-Dec-67	'	'
Junior Subordinated Debt Instrument Two [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt Instrument, Interest Rate, Stated Percentage	9.25%	'	'
Debt Instrument, Maturity Date	8-Apr-68	'	'

Common_Equity_Units_Common_Equ

Common Equity Units (Common Equity Units) (Details) (USD $)

12 Months Ended

1 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Sep. 30, 2013

Oct. 31, 2012

Dec. 31, 2013

Sep. 11, 2013

Oct. 10, 2012

Sep. 30, 2013

Dec. 31, 2013

Sep. 11, 2013

Oct. 31, 2012

Oct. 04, 2012

Oct. 31, 2012

Oct. 04, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2010

Dec. 31, 2012

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2013

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Senior Notes [Member]

Estimated Fair Value [Member]

Series C Purchase Contract [Member]

Series E Purchase Contract [Member]

Series D Purchase Contract [Member]

Alico Transaction [Member]

Minimum [Member]

Maximum [Member]

Debt Remarketing Series D [Member]

Debt Remarketing Series D [Member]

Debt Remarketing Series D [Member]

Debt Remarketing Series C Tranche 1 [Member]

Debt Remarketing Series C Tranche 1 [Member]

Debt Remarketing Series C Tranche 2 [Member]

Debt Remarketing Series C Tranche 2 [Member]

Debt Remarketing Series C [Member]

Debt Remarketing Series C [Member]

Temporary Equity Disclosure [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Effective date of acquisition

'

'

'

1-Nov-10

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity Units, Shares Transferred

'

'

'

40,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity Units Stated Interest Percentage

'

'

'

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity Units, Aggregate Purchase Price per Unit

'

'

'

$75

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Par, Common Equity Units

$0.01

$0.01

'

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity Units, Purchase Price Per Contract Settlement

'

'

'

$25

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity Units, Beneficial Interest Stated Percentage

'

'

2.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Share Price, Trading Day Periods

'

'

'

'20 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity Units, Stock Reference Price

$35.15

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity Units, Stock Threshold Appreciation Price

$43.93

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Purchase Contracts Settlement

1,000,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Purchase Contracts, Value at Issuance

'

'

'

247,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Purchase Contracts, Payments Made

48,000,000

84,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Average Stated

'

'

'

1.98%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Purchase Contracts, Average Stated Interest Rate

'

'

'

3.02%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of stock purchase contracts related to common equity units

'

'

'

-69,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Value of securities issued for business acquisition

'

'

'

3,000,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,200,000,000

'

'

'

'

'

'

Debt Security, Principle Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000,000,000

'

'

Purchase Contract Settlement Date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10-Oct-12

8-Oct-14

11-Sep-13

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

'

4.37%

4.37%

'

1.76%

'

3.05%

'

'

'

'

'

'

'

'

'

Debt Instrument, Maturity Date

'

'

'

'

'

'

'

'

'

15-Sep-23

15-Sep-23

'

15-Dec-17

'

15-Dec-22

'

'

'

'

'

'

'

'

'

'

Proceeds from remarketing

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

Proceeds from issuance of common stock

$1,000,000,000

$1,000,000,000

$2,950,000,000

'

$1,000,000,000

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock, shares issued

1,125,224,024

1,094,880,623

'

'

'

'

22,679,955

22,679,955

28,231,956

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Purchase Contracts, Maximum Shares of Common Stock issued from Settlement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

22,800,000

28,500,000

Equity_Preferred_Stock_Details

Equity (Preferred Stock) (Details) (USD $)

3 Months Ended

12 Months Ended

In Millions, except Per Share data, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2011

Sep. 30, 2011

Jun. 30, 2011

Mar. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Preferred Stock [Member]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Declaration Date

15-Nov-13

15-Aug-13

15-May-13

5-Mar-13

15-Nov-12

15-Aug-12

15-May-12

5-Mar-12

15-Nov-11

15-Aug-11

16-May-11

7-Mar-11

'

'

'

Record Date

30-Nov-13

31-Aug-13

31-May-13

28-Feb-13

30-Nov-12

31-Aug-12

31-May-12

29-Feb-12

30-Nov-11

31-Aug-11

31-May-11

28-Feb-11

'

'

'

Series A Preferred Stock [Member]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, dividend rate

$0.25

$0.26

$0.26

$0.25

$0.25

$0.26

$0.26

$0.25

$0.25

$0.26

$0.26

$0.25

'

'

'

Preferred stock, dividends

$7

$6

$7

$6

$7

$6

$7

$6

$7

$6

$7

$6

$26

$26

$26

Series B Preferred Stock [Member]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, dividend rate

$0.41

$0.41

$0.41

$0.41

$0.41

$0.41

$0.41

$0.41

$0.41

$0.41

$0.41

$0.41

'

'

'

Preferred stock, dividends

$24

$24

$24

$24

$24

$24

$24

$24

$24

$24

$24

$24

$96

$96

$96

Equity_Common_Stock_Details

Equity (Common Stock) (Details) (USD $)	3 Months Ended				12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Dividends Payable [Line Items]	'	'	'	'	'	'	'
Dividend Per Share	'	'	'	'	$1.01	$0.74	$0.74
Dividend Aggregate	'	'	'	'	$1,119	$811	$787
Common Stock [Member]	'	'	'	'	'	'	'
Dividends Payable [Line Items]	'	'	'	'	'	'	'
Declaration Date	22-Oct-13	25-Jun-13	23-Apr-13	4-Jan-13	'	23-Oct-12	25-Oct-11
Record Date	8-Nov-13	9-Aug-13	9-May-13	6-Feb-13	'	9-Nov-12	9-Nov-11
Dividend Per Share	$0.28	$0.28	$0.28	$0.19	'	$0.74	$0.74
Dividend Aggregate	$311	$303	$302	$203	$1,119	$811	$787

Equity_Compensation_Expense_Re

Equity (Compensation Expense Related to Stock-Based Compensation - Related to Phantom Stock-Based Awards) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Compensation Expense	$175	$168	$144
Income tax benefits	61	59	50
Stock Options [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Compensation Expense	39	61	58
Performance Shares [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Compensation Expense	91	80	68
Restricted Stock Units [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Compensation Expense	$45	$27	$18

Equity_Unrecognized_Compensati

Equity (Unrecognized Compensation Expense Related to Stock-Based Compensation) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Stock Options [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expense	$25
Weighted Average Period	'1 year 3 months 9 days
Performance Shares [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expense	61
Weighted Average Period	'1 year 8 months 16 days
Restricted Stock Units [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expense	$42
Weighted Average Period	'1 year 10 months 18 days

Equity_Summary_of_Activity_Rel

Equity (Summary of Activity Related to Stock Options) (Details) (Stock Options [Member], USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Options [Member]	'	'	'
Shares Under Option	'	'	'
Shares Under Option Outstanding at January 1,	35,153,071	'	'
Granted Shares Under Option	1,310,019	'	'
Exercised Shares Under Option	-6,357,522	'	'
Expired Shares Under Option	-183,662	'	'
Forfeited Shares Under Option	-170,530	'	'
Shares Under Option Outstanding at December 31,	29,751,376	35,153,071	'
Shares Under Option Aggregate number of stock options expected to vest at December 31,	29,536,674	'	'
Shares Under Option Exercisable at December 31,	22,786,277	'	'
Weighted Average Exercise Price	'	'	'
Weighted Average Exercise Price Outstanding at January 1,	$40.89	'	'
Granted Weighted Average Exercise Price	$35.96	$37.91	$45.16
Exercised Weighted Average Exercise Price	$31.80	'	'
Expired Weighted Average Exercise Price	$50.46	'	'
Forfeited Weighted Average Exercise Price	$39.86	'	'
Weighted Average Exercise Price Outstanding at December 31,	$42.56	$40.89	'
Weighted Average Exercise Price Aggregate number of stock options expected to vest at December 31,	$42.60	'	'
Weighted Average Exercise Price Exercisable at December 31,	$43.56	'	'
Weighted Average Remaining Contractual Term	'	'	'
Weighted Average Remaining Contractual Term Outstanding at January 1,	'5 years 2 months 7 days	'5 years 6 months	'
Weighted Average Remaining Contractual Term Aggregate number of stock options expected to vest at December 31,	'5 years 1 month 29 days	'	'
Weighted Average Remaining Contractual Term Exercisable at December 31,	'4 years 3 months 25 days	'	'
Aggregate Intrinsic Value	'	'	'
Aggregate Intrinsic Value Outstanding at January 1,	$51	'	'
Aggregate Intrinsic Value Outstanding at December 31,	379	51	'
Aggregate Intrinsic Value Aggregate number of stock options expected to vest at December 31,	376	'	'
Aggregate Intrinsic Value Exercisable at December 31,	$277	'	'

Equity_Weighted_Average_Assump

Equity (Weighted Average Assumptions Used to Determine Fair Value of Stock Options) (Details) (Stock Options [Member], USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Options [Member]	'	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'	'
Dividend yield	2.13%	1.95%	1.65%
Risk-free rate of return, Minimum	0.16%	0.21%	0.29%
Risk-free rate of return, Maximum	3.89%	4.17%	5.51%
Expected volatility	32.98%	35.59%	32.64%
Exercise multiple	1.51	1.58	1.69
Post-vesting termination rate	3.16%	3.14%	3.36%
Contractual term (years)	'10 years	'10 years	'10 years
Expected life (years)	'7 years	'7 years	'7 years
Weighted average exercise price of stock options granted	$35.96	$37.91	$45.16
Weighted average fair value of stock options granted	$9.88	$11.33	$14.27

Equity_Summary_of_Stock_Option

Equity (Summary of Stock Option Exercise Activity) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]	'	'	'
Total intrinsic value of stock options exercised	$79	$29	$41
Cash received from exercise of stock options	202	109	88
Tax benefit realized from stock options exercised	$28	$10	$14

Equity_Performance_Share_and_R

Equity (Performance Share and Restricted Stock Unit) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Performance Shares [Member]	'
Summary of performance share activity	'
Shares Outstanding at January 1,	4,822,028
Granted Shares	1,749,212
Forfeited Shares	-151,075
Paid	-1,346,025
Shares Outstanding at December 31,	5,074,140
Expected to vest at December 31,	5,067,337
Summary of Weighted Average Grant Date Fair Value	'
Weighted Average Grant Date Fair Value Outstanding January 1,	$36.93
Granted Weighted Average Grant Date Fair Value	$50.86
Forfeited Weighted Average Grant Date Fair Value	$40.87
Payable Weighted Average Grant Date Fair Value	$32.24
Weighted Average Grant Date Fair Value Outstanding December 31,	$42.86
Weighted Average Grant Date Fair Value Share expected to vest at December 31,	$38.60
Restricted Stock Units [Member]	'
Summary of performance share activity	'
Shares Outstanding at January 1,	2,080,148
Granted Shares	2,182,213
Forfeited Shares	-395,365
Paid	-538,480
Shares Outstanding at December 31,	3,328,516
Expected to vest at December 31,	2,995,664
Summary of Weighted Average Grant Date Fair Value	'
Weighted Average Grant Date Fair Value Outstanding January 1,	$36.55
Granted Weighted Average Grant Date Fair Value	$32.34
Forfeited Weighted Average Grant Date Fair Value	$33.97
Payable Weighted Average Grant Date Fair Value	$33.17
Weighted Average Grant Date Fair Value Outstanding December 31,	$33.35
Weighted Average Grant Date Fair Value Share expected to vest at December 31,	$33.34

Equity_Liability_Award_Activit

Equity (Liability Award Activity) (Details)	12 Months Ended
	Dec. 31, 2013
Stock Options [Member]	'
Summary of performance share activity	'
Exercised Shares Under Option	-6,357,522
Vesting period	'3 years
Stock Options [Member] | Phantom Share Units [Member]	'
Summary of performance share activity	'
Shares Outstanding at January 1,	1,370,317
Granted Shares	48,301
Exercised Shares Under Option	-127,386
Forfeited Shares	-69,606
Paid	0
Shares Outstanding at December 31,	1,221,626
Expected to vest at December 31,	1,137,832
Stock Options [Member] | Phantom Share Units [Member] | Minimum [Member]	'
Summary of performance share activity	'
Vesting period	'1 year
Stock Options [Member] | Phantom Share Units [Member] | Maximum [Member]	'
Summary of performance share activity	'
Vesting period	'3 years
Performance Shares [Member]	'
Summary of performance share activity	'
Shares Outstanding at January 1,	4,822,028
Granted Shares	1,749,212
Forfeited Shares	-151,075
Paid	-1,346,025
Shares Outstanding at December 31,	5,074,140
Expected to vest at December 31,	5,067,337
Vesting period	'3 years
Performance Shares [Member] | Phantom Share Units [Member]	'
Summary of performance share activity	'
Shares Outstanding at January 1,	305,164
Granted Shares	297,834
Exercised Shares Under Option	0
Forfeited Shares	-15,761
Paid	-55,349
Shares Outstanding at December 31,	531,888
Expected to vest at December 31,	478,699
Restricted Stock Units [Member]	'
Summary of performance share activity	'
Shares Outstanding at January 1,	2,080,148
Granted Shares	2,182,213
Forfeited Shares	-395,365
Paid	-538,480
Shares Outstanding at December 31,	3,328,516
Expected to vest at December 31,	2,995,664
Vesting period	'3 years
Restricted Stock Units [Member] | Phantom Share Units [Member]	'
Summary of performance share activity	'
Shares Outstanding at January 1,	740,436
Granted Shares	445,740
Exercised Shares Under Option	0
Forfeited Shares	-127,329
Paid	-79,325
Shares Outstanding at December 31,	979,522
Expected to vest at December 31,	881,570
Vesting period	'3 years

Equity_Statutory_Net_Income_Lo

Equity (Statutory Net Income (Loss)) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Metropolitan Life Insurance Company [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Statutory net income (loss)	$369	$1,320	$1,970
Statutory capital and surplus	12,428	14,295	'
American Life Insurance Company [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Statutory net income (loss)	631	317	334
Statutory capital and surplus	2,711	3,044	'
MetLife Insurance Company Of Connecticut [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Statutory net income (loss)	790	848	46
Statutory capital and surplus	4,795	5,331	'
Metropolitan Property and Casualty Insurance Company [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Statutory net income (loss)	282	235	41
Statutory capital and surplus	2,225	1,987	'
Metropolitan Tower Life Insurance Company [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Statutory net income (loss)	52	61	63
Statutory capital and surplus	$735	$781	'

Equity_Dividend_Restrictions_D

Equity (Dividend Restrictions) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Metropolitan Life Insurance Company [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Permitted w/o Approval	$1,116,000,000	$1,428,000,000	$1,350,000,000
Paid	1,428,000,000	1,023,000,000	'
American Life Insurance Company [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Permitted w/o Approval	0	523,000,000	168,000,000
Paid	0	1,300,000,000	'
Total amount of dividend pre-approved by regulatory agency	1,500,000,000	'	'
MetLife Insurance Company Of Connecticut [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Permitted w/o Approval	1,061,000,000	1,330,000,000	504,000,000
Paid	1,000,000,000	'	'
Total dividends paid	'	706,000,000	'
In-kind dividend	'	202,000,000	'
Metropolitan Property and Casualty Insurance Company [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Permitted w/o Approval	218,000,000	74,000,000	0
Paid	100,000,000	100,000,000	'
Metropolitan Tower Life Insurance Company [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Permitted w/o Approval	73,000,000	77,000,000	82,000,000
Paid	'	82,000,000	'
Total dividends paid	109,000,000	'	'
In-kind dividend	32,000,000	'	'
MetLife Investors Insurance Company [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Permitted w/o Approval	99,000,000	129,000,000	18,000,000
Paid	129,000,000	18,000,000	'
Delaware American Life Insurance Company [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Permitted w/o Approval	16,000,000	7,000,000	12,000,000
Paid	$0	$0	'

Equity_Components_of_Accumulat

Equity (Components of Accumulated Other Comprehensive Income (Loss)) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Balance beginning of period	$11,397	$6,083	$1,145
OCI before reclassifications	-9,283	7,929	8,381
Income tax expense (benefit)	2,551	-2,766	-3,011
OCI before reclassifications, net of income tax	4,665	11,246	6,515
Amounts reclassified from AOCI	661	236	-654
Income tax expense (benefit)	-222	-85	222
Amounts reclassified from AOCI, net of income tax	439	151	-432
Balance end of period	5,104	11,397	6,083
Unrealized Investment Gains (Losses), Net of Related Offsets [Member]	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Balance beginning of period	13,588	7,689	3,161
OCI before reclassifications	-8,487	9,321	7,637
Income tax expense (benefit)	2,807	-3,457	-2,604
OCI before reclassifications, net of income tax	7,908	13,553	8,194
Amounts reclassified from AOCI	411	58	-766
Income tax expense (benefit)	-136	-23	261
Amounts reclassified from AOCI, net of income tax	275	35	-505
Balance end of period	8,183	13,588	7,689
Unrealized Gains (Losses) on Derivatives [Member]	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Balance beginning of period	831	985	-39
OCI before reclassifications	-937	-262	1,595
Income tax expense (benefit)	312	92	-557
OCI before reclassifications, net of income tax	206	815	999
Amounts reclassified from AOCI	36	24	-21
Income tax expense (benefit)	-11	-8	7
Amounts reclassified from AOCI, net of income tax	25	16	-14
Balance end of period	231	831	985
Foreign Currency Translation Adjustments [Member]	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Balance beginning of period	-533	-648	-528
OCI before reclassifications	-937	-134	42
Income tax expense (benefit)	-189	249	-162
OCI before reclassifications, net of income tax	-1,659	-533	-648
Amounts reclassified from AOCI	0	0	0
Income tax expense (benefit)	0	0	0
Amounts reclassified from AOCI, net of income tax	0	0	0
Balance end of period	-1,659	-533	-648
Defined Benefit Plans Adjustment [Member]	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'
Balance beginning of period	-2,489	-1,943	-1,449
OCI before reclassifications	1,078	-996	-893
Income tax expense (benefit)	-379	350	312
OCI before reclassifications, net of income tax	-1,790	-2,589	-2,030
Amounts reclassified from AOCI	214	154	133
Income tax expense (benefit)	-75	-54	-46
Amounts reclassified from AOCI, net of income tax	139	100	87
Balance end of period	($1,651)	($2,489)	($1,943)

Equity_Reclassifications_Out_o

Equity (Reclassifications Out of Accumulated Other Comprehensive Income (Loss)) (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Other net investment gains (losses)	'	'	'	'	'	'	'	'	$327	($35)	$88
Net derivative gains (losses)	'	'	'	'	'	'	'	'	-3,239	-1,919	4,824
Net investment income	'	'	'	'	'	'	'	'	22,232	21,984	19,585
Other Expenses	'	'	'	'	'	'	'	'	-16,602	-17,755	-18,537
Other-than-temporary impairments on fixed maturity securities	'	'	'	'	'	'	'	'	-106	-346	-924
Income (loss) from continuing operations before provision for income tax	'	'	'	'	'	'	'	'	4,052	1,442	9,184
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	-661	-128	-2,793
Net income (loss)	916	975	510	992	136	-957	2,303	-120	3,393	1,362	6,415
Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'	'	'	'	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net income (loss)	'	'	'	'	'	'	'	'	439	151	-432
Reclassification out of Accumulated Other Comprehensive Income [Member] | Unrealized Investment Gains (Losses), Net of Related Offsets [Member]	'	'	'	'	'	'	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Other net investment gains (losses)	'	'	'	'	'	'	'	'	404	-34	-952
Net investment income	'	'	'	'	'	'	'	'	93	73	73
Income (loss) from continuing operations before provision for income tax	'	'	'	'	'	'	'	'	411	58	-766
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	-136	-23	261
Net income (loss)	'	'	'	'	'	'	'	'	275	35	-505
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Other-than-Temporary Impairment [Member]	'	'	'	'	'	'	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net derivative gains (losses)	'	'	'	'	'	'	'	'	-26	-10	144
Other-than-temporary impairments on fixed maturity securities	'	'	'	'	'	'	'	'	-60	29	-31
Reclassification out of Accumulated Other Comprehensive Income [Member] | Unrealized Gains (Losses) on Derivatives [Member]	'	'	'	'	'	'	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Income (loss) from continuing operations before provision for income tax	'	'	'	'	'	'	'	'	36	24	-21
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	-11	-8	7
Net income (loss)	'	'	'	'	'	'	'	'	25	16	-14
Reclassification out of Accumulated Other Comprehensive Income [Member] | Unrealized Gains (Losses) on Derivatives [Member] | Interest rate forwards [Member]	'	'	'	'	'	'	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net derivative gains (losses)	'	'	'	'	'	'	'	'	10	1	31
Net investment income	'	'	'	'	'	'	'	'	3	2	1
Other Expenses	'	'	'	'	'	'	'	'	-1	-1	-1
Reclassification out of Accumulated Other Comprehensive Income [Member] | Unrealized Gains (Losses) on Derivatives [Member] | Foreign currency swaps [Member]	'	'	'	'	'	'	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net derivative gains (losses)	'	'	'	'	'	'	'	'	-3	23	0
Net investment income	'	'	'	'	'	'	'	'	-3	-5	-6
Other Expenses	'	'	'	'	'	'	'	'	1	1	2
Reclassification out of Accumulated Other Comprehensive Income [Member] | Unrealized Gains (Losses) on Derivatives [Member] | Credit forwards [Member]	'	'	'	'	'	'	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net derivative gains (losses)	'	'	'	'	'	'	'	'	0	0	2
Net investment income	'	'	'	'	'	'	'	'	1	1	1
Reclassification out of Accumulated Other Comprehensive Income [Member] | Unrealized Gains (Losses) on Derivatives [Member] | Interest rate swaps [Member]	'	'	'	'	'	'	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net derivative gains (losses)	'	'	'	'	'	'	'	'	20	1	-42
Net investment income	'	'	'	'	'	'	'	'	8	4	1
Other Expenses	'	'	'	'	'	'	'	'	0	-3	-10
Reclassification out of Accumulated Other Comprehensive Income [Member] | Defined Benefit Plans Adjustment [Member]	'	'	'	'	'	'	'	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Amortization of net actuarial gains (losses)	'	'	'	'	'	'	'	'	283	252	237
Amortization of prior service (costs) credit	'	'	'	'	'	'	'	'	-69	-98	-104
Income (loss) from continuing operations before provision for income tax	'	'	'	'	'	'	'	'	214	154	133
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	-75	-54	-46
Net income (loss)	'	'	'	'	'	'	'	'	$139	$100	$87

Equity_Preferred_Stock_Narrati

Equity (Preferred Stock - Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013
			Convertible Preferred Stock [Member]	Convertible Preferred Stock [Member]	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]	'	'	'	'	'	'
Preferred stock, shares issued	84,000,000	84,000,000	6,857,000	6,857,000	'	'
Preferred stock, shares outstanding	84,000,000	84,000,000	'	'	24,000,000	60,000,000
Preferred stock dividends fixed rate	'	'	'	'	'	6.50%
Preferred Stock, Dividend Payment Rate, Variable	'	'	'	'	'(i)B 1.00% above three-month LIBOR on the related LIBOR determination date; or (ii)B 4.00%.	'
Preferred stock, par value	$0.01	$0.01	'	$0.01	$0.01	$0.01
Preferred stock, aggregate liquidation preference	$2,100	$2,100	'	$0.01	$25	$25
Preferred stock, shares authorized	200,000,000	200,000,000	'	'	'	'
Preferred stock redemption price per share	$25	'	'	'	'	'

Equity_Convertible_Preferred_S

Equity (Convertible Preferred Stock - Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]	'	'	'
Preferred stock, shares issued	84,000,000	84,000,000	'
Preferred stock, par value	$0.01	$0.01	'
Preferred stock, aggregate liquidation preference	$2,100	$2,100	'
Fair Value of Stock Issued	'	'	$2,805,000,000
Redemption premium on convertible preferred stock	0	0	146,000,000
Convertible Preferred Stock [Member]	'	'	'
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]	'	'	'
Preferred stock, shares issued	6,857,000	6,857,000	'
Preferred stock, par value	'	$0.01	'
Preferred stock, aggregate liquidation preference	'	$0.01	'
Redemption premium on convertible preferred stock	'	'	146,000,000
Convertible Preferred Stock Redemption Date	'	'	8-Mar-11
Redemption of Convertible Preferred Stock	'	'	$3,000,000,000

Equity_Common_Stock_Narrative_

Equity (Common Stock - Narrative) (Details) (USD $)

12 Months Ended

1 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Sep. 30, 2013

Oct. 31, 2012

Dec. 31, 2013

Sep. 11, 2013

Oct. 10, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Common Class A [Member]

Common Class A [Member]

Common Class A [Member]

Common Class A [Member]

Common Class A [Member]

Repurchase Convertible Preferred Stock [Member]

October 2012 Common Stock Issuance [Member]

Treasury Shares Issued For Stock Options [Member]

Treasury Shares Issued For Stock Options [Member]

Treasury Shares Issued For Stock Options [Member]

Common Shares Issued For Stock Options [Member]

Common Shares Issued For Stock Options [Member]

Common Shares Issued For Stock Options [Member]

September 2013 Common Stock Issuance [Member]

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Issued

1,125,224,024

1,094,880,623

'

'

'

22,679,955

22,679,955

28,231,956

'

'

'

'

'

'

'

'

'

Common stock, shares issued

'

'

'

'

'

'

'

'

68,570,000

28,231,956

'

'

'

7,663,446

5,497,752

3,549,211

'

Price per share of common stock issued

'

'

'

'

'

'

'

'

$43.25

'

'

'

'

'

'

'

'

Fair Value of Stock Issued

'

'

$2,805,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from issuance of common stock

1,000,000,000

1,000,000,000

2,950,000,000

1,000,000,000

0

'

'

'

3,000,000,000

1,000,000,000

'

'

'

'

'

'

1,000,000,000

Issuance costs

'

'

'

'

'

'

'

'

16,000,000

'

'

'

'

'

'

'

'

Issued Treasury Stock

'

'

'

'

'

'

'

'

'

'

0

0

0

'

'

'

'

Cost of shares issued

305,000,000

229,000,000

215,000,000

'

'

'

'

'

'

'

'

'

'

250,000,000

171,000,000

115,000,000

'

Equity, Class of Treasury Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repurchase amount outstanding

$1,300,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repurchase Shares

0

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Equity_StockBased_Compensation

Equity (Stock-Based Compensation Plans - Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
2005 Stock and Incentive Compensation Plan [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Aggregate number of shares authorized for issuance	68,000,000	'
Shares available for grant	20,098,440	'
Stock Options [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Vesting period	'3 years	'
Award Expiration Date	'10 years	'
Closing share price	$53.92	$32.94
Stock Options [Member] | Phantom Share Units [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Awards granted	48,301	'
Stock Options [Member] | Phantom Share Units [Member] | Minimum [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Vesting period	'1 year	'
Stock Options [Member] | Phantom Share Units [Member] | Maximum [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Vesting period	'3 years	'
2005 Non-Management Director Stock Compensation Plan [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Aggregate number of shares authorized for issuance	2,000,000	'
Shares available for grant	1,695,352	'
Performance Shares [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Vesting period	'3 years	'
Awards granted	1,749,212	'
Performance Shares to which performance factor will be applied	1,545,020	'
Performance Factor	'	0.92
Performance Shares [Member] | Minimum [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Performance Factor	'	0
Future Performance Factor	0	'
Performance Shares [Member] | Maximum [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Performance Factor	'	2
Future Performance Factor	1.75	'
Performance Shares [Member] | Phantom Share Units [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Awards granted	297,834	'
Restricted Stock Units [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Vesting period	'3 years	'
Awards granted	2,182,213	'
Restricted Stock Units [Member] | Phantom Share Units [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Vesting period	'3 years	'
Awards granted	445,740	'
Other Restricted Stock Units [Member]	'	'
Equity - Stock-based Compensation Plans [Line Items]	'	'
Vesting period	'5 years	'

Equity_Statutory_Equity_Income

Equity (Statutory Equity & Income and Dividend Restrictions - Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
American Life Insurance Company [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Statutory capital and surplus	$2,711,000,000	$3,044,000,000	'
Prescribed accounting practice difference in statutory captial and surplus	20,000,000	413,000,000	'
Statutory net income (loss)	631,000,000	317,000,000	334,000,000
MetLife Reinsurance Company of Vermont [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Prescribed accounting practice difference in statutory captial and surplus	5,500,000,000	5,100,000,000	'
MetLife's Domestic Captive Life Reinsurance Subsidiaries [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Statutory capital and surplus	4,300,000,000	4,200,000,000	'
Statutory net income (loss)	-612,000,000	-154,000,000	-130,000,000
Principal U.S. Insurance Subsidiaries, Excluding American Life [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Combined RBC ratio of the principal U.S. insurance subsidiaries, excluding American Life	'in excess of 400%	'in excess of 400%	'
Certain Foreign Insurance Subsidiaries [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Statutory capital and surplus	4,500,000,000	'	'
Statutory net income (loss)	423,000,000	'	'
Other Foreign Operations, Excluding Japan [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Statutory capital and surplus required	2,400,000,000	'	'
Statutory capital and surplus	$8,400,000,000	'	'
Japan [Member]	'	'	'
Statutory Accounting Practices [Line Items]	'	'	'
Adjusted capital	'in excess of four times the 200% solvency margin ratio	'in excess of four times the 200% solvency margin ratio	'

Other_Expenses_Other_Expenses_

Other Expenses (Other Expenses) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Other Income and Expenses [Abstract]	'	'	'
Compensation	$5,108	$5,562	$5,287
Pension, postretirement and postemployment benefit costs	488	428	463
Commissions	5,428	5,909	6,378
Volume-related costs	842	599	335
Interest credited to bank deposits	2	78	95
Capitalization of DAC	-4,786	-5,289	-5,558
Amortization of DAC and VOBA	3,550	4,199	4,898
Amortization of negative VOBA	-579	-622	-697
Interest expense on debt and debt issuance costs	1,282	1,356	1,629
Premium taxes, licenses and fees	658	677	633
Professional services	1,454	1,664	1,597
Rent and related expenses, net of sublease income	376	422	426
Other	2,779	2,772	3,051
Total other expenses	$16,602	$17,755	$18,537

Other_Expenses_Restructuring_C

Other Expenses (Restructuring Charges) (Details) (Other Expenses [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Restructuring Charges	'	'
Balance, beginning of period	$23	$0
Restructuring charges	115	159
Cash payments	-92	-136
Balance, end of period	46	23
Total restructuring charges incurred since inception of initiative	274	159
Severance [Member]	'	'
Restructuring Charges	'	'
Balance, beginning of period	23	0
Restructuring charges	99	141
Cash payments	-82	-118
Balance, end of period	40	23
Total restructuring charges incurred since inception of initiative	240	141
Lease and Asset Impairment [Member]	'	'
Restructuring Charges	'	'
Balance, beginning of period	0	0
Restructuring charges	16	18
Cash payments	-10	-18
Balance, end of period	6	0
Total restructuring charges incurred since inception of initiative	$34	$18

Other_Expenses_Other_Expenses_1

Other Expenses Other Expenses (ALICO Restructuring Charges - Narrative) (Details) (American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
American Life Insurance Company (''American Life'') and Delaware American Life Insurance (''DelAm'') [Member]	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'
Business acquisition integration related expenses	$138	$305	$362

Employee_Benefit_Plans_Obligat

Employee Benefit Plans (Obligations and Funded Status) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Pension Benefits U.S. Plans [Member]	'	'	'
Change in benefit obligations:	'	'	'
Benefit obligations at January 1,	$9,480	$8,327	'
Service costs	236	224	187
Interest costs	389	406	404
Plan participants' contributions	0	0	'
Net actuarial (gains) losses	-1,050	999	'
Acquisition, divestitures and curtailments	0	0	'
Change in benefits	0	0	'
Benefits paid	-464	-476	'
Effect of foreign currency translation and other	0	0	'
Benefit obligations at December 31,	8,591	9,480	8,327
Change in plan assets:	'	'	'
Fair value of plan assets at January 1,	7,879	7,108	'
Actual return on plan assets	-22	740	'
Acquisition, divestitures and settlements	0	0	'
Employer contributions	383	507	'
Benefits paid	-464	-476	'
Effect of foreign currency translation	0	0	'
Fair value of plan assets at December 31,	7,776	7,879	7,108
Over (under) funded status at end of year	-815	-1,601	'
Amounts recognized in the consolidated balance sheets consist of:	'	'	'
Other assets	223	0	'
Other liabilities	-1,038	-1,601	'
Net amount recognized	-815	-1,601	'
Accumulated other comprehensive (income) loss:	'	'	'
Net actuarial (gains) losses	2,274	3,047	'
Prior service costs (credit)	18	24	'
Accumulated other comprehensive (income) loss, before income tax	2,292	3,071	'
Accumulated benefit obligation	8,104	8,866	'
Pension Benefits Non-U.S. Plans [Member]	'	'	'
Change in benefit obligations:	'	'	'
Benefit obligations at January 1,	823	773	'
Service costs	67	75	64
Interest costs	14	17	16
Plan participants' contributions	0	0	'
Net actuarial (gains) losses	34	32	'
Acquisition, divestitures and curtailments	-19	-12	'
Change in benefits	0	-1	'
Benefits paid	-41	-41	'
Effect of foreign currency translation and other	-134	-20	'
Benefit obligations at December 31,	744	823	773
Change in plan assets:	'	'	'
Fair value of plan assets at January 1,	224	185	'
Actual return on plan assets	34	20	'
Acquisition, divestitures and settlements	-19	-11	'
Employer contributions	83	74	'
Benefits paid	-41	-41	'
Effect of foreign currency translation	-33	-3	'
Fair value of plan assets at December 31,	248	224	185
Over (under) funded status at end of year	-496	-599	'
Amounts recognized in the consolidated balance sheets consist of:	'	'	'
Other assets	7	6	'
Other liabilities	-503	-605	'
Net amount recognized	-496	-599	'
Accumulated other comprehensive (income) loss:	'	'	'
Net actuarial (gains) losses	28	27	'
Prior service costs (credit)	2	2	'
Accumulated other comprehensive (income) loss, before income tax	30	29	'
Accumulated benefit obligation	636	724	'
Other Postretirement Benefits U.S. Plans [Member]	'	'	'
Change in benefit obligations:	'	'	'
Benefit obligations at January 1,	2,375	2,093	'
Service costs	20	21	16
Interest costs	92	103	106
Plan participants' contributions	30	29	'
Net actuarial (gains) losses	-551	261	'
Acquisition, divestitures and curtailments	0	0	'
Change in benefits	0	0	'
Benefits paid	-132	-132	'
Effect of foreign currency translation and other	0	0	'
Benefit obligations at December 31,	1,834	2,375	2,093
Change in plan assets:	'	'	'
Fair value of plan assets at January 1,	1,320	1,240	'
Actual return on plan assets	58	105	'
Acquisition, divestitures and settlements	0	0	'
Employer contributions	76	78	'
Benefits paid	-132	-132	'
Effect of foreign currency translation	0	0	'
Fair value of plan assets at December 31,	1,352	1,320	1,240
Over (under) funded status at end of year	-482	-1,055	'
Amounts recognized in the consolidated balance sheets consist of:	'	'	'
Other assets	0	0	'
Other liabilities	-482	-1,055	'
Net amount recognized	-482	-1,055	'
Accumulated other comprehensive (income) loss:	'	'	'
Net actuarial (gains) losses	211	799	'
Prior service costs (credit)	1	-74	'
Accumulated other comprehensive (income) loss, before income tax	212	725	'
Other Postretirement Benefits Non-U.S. Plans [Member]	'	'	'
Change in benefit obligations:	'	'	'
Benefit obligations at January 1,	43	39	'
Service costs	2	1	1
Interest costs	2	2	2
Plan participants' contributions	0	0	'
Net actuarial (gains) losses	-1	4	'
Acquisition, divestitures and curtailments	-3	-3	'
Change in benefits	0	0	'
Benefits paid	-2	-2	'
Effect of foreign currency translation and other	0	2	'
Benefit obligations at December 31,	41	43	39
Change in plan assets:	'	'	'
Fair value of plan assets at January 1,	15	13	'
Actual return on plan assets	-1	2	'
Acquisition, divestitures and settlements	-3	-3	'
Employer contributions	5	4	'
Benefits paid	-2	-2	'
Effect of foreign currency translation	0	1	'
Fair value of plan assets at December 31,	14	15	13
Over (under) funded status at end of year	-27	-28	'
Amounts recognized in the consolidated balance sheets consist of:	'	'	'
Other assets	0	0	'
Other liabilities	-27	-28	'
Net amount recognized	-27	-28	'
Accumulated other comprehensive (income) loss:	'	'	'
Net actuarial (gains) losses	2	3	'
Prior service costs (credit)	1	1	'
Accumulated other comprehensive (income) loss, before income tax	$3	$4	'

Employee_Benefit_Plans_Accumul

Employee Benefit Plans (Accumulated Benefit Obligations in Excess of Fair Value) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Pension Benefits U.S. Plans [Member]	'	'
Accumulated benefit obligation [Abstract]	'	'
Projected benefit obligations	$1,037	$1,323
Accumulated benefit obligations	927	1,166
Fair value of plan assets	0	157
Pension Benefits Non-U.S. Plans [Member]	'	'
Accumulated benefit obligation [Abstract]	'	'
Projected benefit obligations	644	690
Accumulated benefit obligations	579	651
Fair value of plan assets	$167	$144

Employee_Benefit_Plans_Project

Employee Benefit Plans (Projected Benefit Obligation in Excess of Plan Assets) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Pension Benefits U.S. Plans [Member]	'	'
Defined Benefit Plan Pension Plans With Projected Benefit Obligations In Excess Of Plan Assets [Abstract]	'	'
Projected benefit obligations	$1,170	$9,480
Fair value of plan assets	133	7,879
Pension Benefits Non-U.S. Plans [Member]	'	'
Defined Benefit Plan Pension Plans With Projected Benefit Obligations In Excess Of Plan Assets [Abstract]	'	'
Projected benefit obligations	701	763
Fair value of plan assets	199	188
Other Postretirement Benefits U.S. Plans [Member]	'	'
Defined Benefit Plan Pension Plans With Projected Benefit Obligations In Excess Of Plan Assets [Abstract]	'	'
Projected benefit obligations	1,834	2,375
Fair value of plan assets	1,352	1,320
Other Postretirement Benefits Non-U.S. Plans [Member]	'	'
Defined Benefit Plan Pension Plans With Projected Benefit Obligations In Excess Of Plan Assets [Abstract]	'	'
Projected benefit obligations	41	43
Fair value of plan assets	$14	$15

Employee_Benefit_Plans_Net_Per

Employee Benefit Plans (Net Periodic Benefit Costs and Other Changes Recognized in OCI) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net Periodic Benefit Cost Amortized From Accumulated Other Comprehensive Income (Loss) [Abstract]	'	'	'
Total recognized in other comprehensive income (loss)	($1,292)	$842	$760
Pension Benefits U.S. Plans [Member]	'	'	'
Net periodic benefit costs [Abstract]	'	'	'
Service costs	236	224	187
Interest costs	389	406	404
Settlement and curtailment costs	0	0	0
Expected return on plan assets	-483	-484	-448
Amortization of net actuarial (gains) losses	228	195	194
Amortization of prior service costs (credit)	6	6	4
Total net periodic benefit costs (credit)	376	347	341
Net Periodic Benefit Cost Amortized From Accumulated Other Comprehensive Income (Loss) [Abstract]	'	'	'
Net actuarial (gains) losses	-545	744	575
Prior service costs (credit)	0	0	17
Amortization of net actuarial gains (losses)	-228	-195	-194
Amortization of prior service (costs) credit	-6	-6	-4
Total recognized in other comprehensive income (loss)	-779	543	394
Total recognized in net periodic benefit costs and other comprehensive income (loss)	-403	890	735
Pension Benefits Non-U.S. Plans [Member]	'	'	'
Net periodic benefit costs [Abstract]	'	'	'
Service costs	67	75	64
Interest costs	14	17	16
Settlement and curtailment costs	-2	0	0
Expected return on plan assets	-6	-6	-6
Amortization of net actuarial (gains) losses	0	0	0
Amortization of prior service costs (credit)	0	0	0
Total net periodic benefit costs (credit)	73	86	74
Net Periodic Benefit Cost Amortized From Accumulated Other Comprehensive Income (Loss) [Abstract]	'	'	'
Net actuarial (gains) losses	1	18	34
Prior service costs (credit)	0	-1	0
Amortization of net actuarial gains (losses)	0	0	0
Amortization of prior service (costs) credit	0	0	0
Total recognized in other comprehensive income (loss)	1	17	34
Total recognized in net periodic benefit costs and other comprehensive income (loss)	74	103	108
Other Postretirement Benefits U.S. Plans [Member]	'	'	'
Net periodic benefit costs [Abstract]	'	'	'
Service costs	20	21	16
Interest costs	92	103	106
Settlement and curtailment costs	0	0	0
Expected return on plan assets	-75	-77	-76
Amortization of net actuarial (gains) losses	55	57	43
Amortization of prior service costs (credit)	-75	-104	-108
Total net periodic benefit costs (credit)	17	0	-19
Net Periodic Benefit Cost Amortized From Accumulated Other Comprehensive Income (Loss) [Abstract]	'	'	'
Net actuarial (gains) losses	-533	234	262
Prior service costs (credit)	0	0	0
Amortization of net actuarial gains (losses)	-55	-57	-43
Amortization of prior service (costs) credit	75	104	108
Total recognized in other comprehensive income (loss)	-513	281	327
Total recognized in net periodic benefit costs and other comprehensive income (loss)	-496	281	308
Other Postretirement Benefits Non-U.S. Plans [Member]	'	'	'
Net periodic benefit costs [Abstract]	'	'	'
Service costs	2	1	1
Interest costs	2	2	2
Settlement and curtailment costs	1	1	1
Expected return on plan assets	-1	-1	-1
Amortization of net actuarial (gains) losses	0	0	0
Amortization of prior service costs (credit)	0	0	0
Total net periodic benefit costs (credit)	4	3	3
Net Periodic Benefit Cost Amortized From Accumulated Other Comprehensive Income (Loss) [Abstract]	'	'	'
Net actuarial (gains) losses	1	2	5
Prior service costs (credit)	0	-1	0
Amortization of net actuarial gains (losses)	-2	0	0
Amortization of prior service (costs) credit	0	0	0
Total recognized in other comprehensive income (loss)	-1	1	5
Total recognized in net periodic benefit costs and other comprehensive income (loss)	$3	$4	$8

Employee_Benefit_Plans_Assumpt

Employee Benefit Plans (Assumptions in Determining Benefit Obligations) (Details)	Dec. 31, 2013	Dec. 31, 2012
Pension Benefits U.S. Plans [Member]	'	'
Assumptions used in determining benefit obligations [Abstract]	'	'
Weighted average discount rate	5.15%	4.20%
Pension Benefits U.S. Plans [Member] | Minimum [Member]	'	'
Assumptions used in determining benefit obligations [Abstract]	'	'
Rate of compensation increase	3.50%	3.50%
Pension Benefits U.S. Plans [Member] | Maximum [Member]	'	'
Assumptions used in determining benefit obligations [Abstract]	'	'
Rate of compensation increase	7.50%	7.50%
Pension Benefits Non-U.S. Plans [Member]	'	'
Assumptions used in determining benefit obligations [Abstract]	'	'
Weighted average discount rate	1.94%	1.98%
Pension Benefits Non-U.S. Plans [Member] | Minimum [Member]	'	'
Assumptions used in determining benefit obligations [Abstract]	'	'
Rate of compensation increase	2.00%	2.01%
Pension Benefits Non-U.S. Plans [Member] | Maximum [Member]	'	'
Assumptions used in determining benefit obligations [Abstract]	'	'
Rate of compensation increase	5.50%	5.50%
Other Postretirement Benefits U.S. Plans [Member]	'	'
Assumptions used in determining benefit obligations [Abstract]	'	'
Weighted average discount rate	5.15%	4.20%
Other Postretirement Benefits Non-U.S. Plans [Member]	'	'
Assumptions used in determining benefit obligations [Abstract]	'	'
Weighted average discount rate	6.47%	4.94%

Employee_Benefit_Plans_Assumpt1

Employee Benefit Plans (Assumptions in Determining Net Periodic Benefit Costs) (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Pension Benefits U.S. Plans [Member]	'	'	'
Assumptions used in determining net periodic benefit costs [Abstract]	'	'	'
Weighted average discount rate	4.20%	4.95%	5.80%
Weighted average expected rate of return on plan assets	6.25%	7.00%	7.25%
Pension Benefits U.S. Plans [Member] | Minimum [Member]	'	'	'
Assumptions used in determining net periodic benefit costs [Abstract]	'	'	'
Rate of compensation increase	3.50%	3.50%	3.50%
Pension Benefits U.S. Plans [Member] | Maximum [Member]	'	'	'
Assumptions used in determining net periodic benefit costs [Abstract]	'	'	'
Rate of compensation increase	7.50%	7.50%	7.50%
Pension Benefits Non-U.S. Plans [Member]	'	'	'
Assumptions used in determining net periodic benefit costs [Abstract]	'	'	'
Weighted average discount rate	1.98%	2.35%	2.40%
Weighted average expected rate of return on plan assets	2.07%	3.35%	3.19%
Pension Benefits Non-U.S. Plans [Member] | Minimum [Member]	'	'	'
Assumptions used in determining net periodic benefit costs [Abstract]	'	'	'
Rate of compensation increase	1.50%	2.00%	3.00%
Pension Benefits Non-U.S. Plans [Member] | Maximum [Member]	'	'	'
Assumptions used in determining net periodic benefit costs [Abstract]	'	'	'
Rate of compensation increase	5.50%	4.00%	5.50%
Other Postretirement Benefits U.S. Plans [Member]	'	'	'
Assumptions used in determining net periodic benefit costs [Abstract]	'	'	'
Weighted average discount rate	4.20%	4.95%	5.80%
Weighted average expected rate of return on plan assets	5.76%	6.26%	7.25%
Other Postretirement Benefits Non-U.S. Plans [Member]	'	'	'
Assumptions used in determining net periodic benefit costs [Abstract]	'	'	'
Weighted average discount rate	5.01%	5.78%	6.34%
Weighted average expected rate of return on plan assets	7.25%	6.54%	7.01%

Employee_Benefit_Plans_Assumed

Employee Benefit Plans (Assumed Healthcare Cost Trend Rates) (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Assumed healthcare cost trend rates	'	'
Healthcare cost trend rate	6.40%	7.80%
Year that rate reaches ultimate trend rate	'2094	'2094
Ultimate healthcare cost trend rate for Pre-Medicare	4.40%	4.40%
Ultimate healthcare cost trend rate for Post-Medicare	4.60%	4.60%

Employee_Benefit_Plans_One_Per

Employee Benefit Plans (One Percent Change in Assumed Healthcare Cost Trend Rates) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Other Postretirement Benefits U.S. Plans [Member]	'
One-percentage point change in assumed healthcare cost trend rates [Abstract]	'
Effect on total of service and interest costs components, one percent increase	$16
Effect on total of service and interest costs components, one percent decrease	-13
Effect of accumulated postretirement benefit obligations, one percent increase	235
Effect of accumulated postretirement benefit obligations, one percent decrease	-193
Other Postretirement Benefits Non-U.S. Plans [Member]	'
One-percentage point change in assumed healthcare cost trend rates [Abstract]	'
Effect on total of service and interest costs components, one percent increase	0
Effect on total of service and interest costs components, one percent decrease	0
Effect of accumulated postretirement benefit obligations, one percent increase	1
Effect of accumulated postretirement benefit obligations, one percent decrease	($1)

Employee_Benefit_Plans_Actual_

Employee Benefit Plans (Actual & Target Allocation of Fair Value by Asset Class) (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Pension Benefits U.S. Plans [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Actual	100.00%	100.00%
Pension Benefits U.S. Plans [Member] | Fixed maturity securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	75.00%	'
Actual	64.00%	69.00%
Pension Benefits U.S. Plans [Member] | Equity Securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	12.00%	'
Actual	23.00%	21.00%
Pension Benefits U.S. Plans [Member] | Alternative Securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	13.00%	'
Actual	13.00%	10.00%
Pension Benefits Non-U.S. Plans [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Actual	100.00%	100.00%
Pension Benefits Non-U.S. Plans [Member] | Fixed maturity securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	76.00%	'
Actual	50.00%	54.00%
Pension Benefits Non-U.S. Plans [Member] | Equity Securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	17.00%	'
Actual	33.00%	24.00%
Pension Benefits Non-U.S. Plans [Member] | Alternative Securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	7.00%	'
Actual	17.00%	22.00%
Other Postretirement Benefits U.S. Plans [Member] | Postretirement Medical [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Actual	100.00%	100.00%
Other Postretirement Benefits U.S. Plans [Member] | Postretirement Medical [Member] | Fixed maturity securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	70.00%	'
Actual	52.00%	63.00%
Other Postretirement Benefits U.S. Plans [Member] | Postretirement Medical [Member] | Equity Securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	30.00%	'
Actual	47.00%	37.00%
Other Postretirement Benefits U.S. Plans [Member] | Postretirement Medical [Member] | Alternative Securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	0.00%	'
Actual	1.00%	0.00%
Other Postretirement Benefits U.S. Plans [Member] | Postretirement Life [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Actual	100.00%	100.00%
Other Postretirement Benefits U.S. Plans [Member] | Postretirement Life [Member] | Fixed maturity securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	0.00%	'
Actual	0.00%	0.00%
Other Postretirement Benefits U.S. Plans [Member] | Postretirement Life [Member] | Equity Securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	0.00%	'
Actual	0.00%	0.00%
Other Postretirement Benefits U.S. Plans [Member] | Postretirement Life [Member] | Alternative Securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	100.00%	'
Actual	100.00%	100.00%
Other Postretirement Benefits Non-U.S. Plans [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Actual	100.00%	100.00%
Other Postretirement Benefits Non-U.S. Plans [Member] | Fixed maturity securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	100.00%	'
Actual	100.00%	100.00%
Other Postretirement Benefits Non-U.S. Plans [Member] | Equity Securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	0.00%	'
Actual	0.00%	0.00%
Other Postretirement Benefits Non-U.S. Plans [Member] | Alternative Securities [Member]	'	'
Actual weighted average asset allocation by major asset class for the Invested Plans [Abstract]	'	'
Target	0.00%	'
Actual	0.00%	0.00%

Employee_Benefit_Plans_Estimat

Employee Benefit Plans (Estimated Fair Value on a Recurring Basis) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Millions, unless otherwise specified
Pension Benefits U.S. Plans [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	$7,776	$7,879	$7,108	'
Pension Benefits U.S. Plans [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	4,971	5,452	'	'
Pension Benefits U.S. Plans [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	2,132	2,279	'	'
Pension Benefits U.S. Plans [Member] | U.S. government bonds [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	292	336	'	'
Pension Benefits U.S. Plans [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	729	769	'	'
Pension Benefits U.S. Plans [Member] | Federal agencies securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	1,090	1,313	'	'
Pension Benefits U.S. Plans [Member] | Municipals securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	219	258	'	'
Pension Benefits U.S. Plans [Member] | Other securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	509	497	'	'
Pension Benefits U.S. Plans [Member] | Equity Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	1,763	1,629	'	'
Pension Benefits U.S. Plans [Member] | Common stock - domestic [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	1,303	1,267	'	'
Pension Benefits U.S. Plans [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	460	362	'	'
Pension Benefits U.S. Plans [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	600	564	'	'
Pension Benefits U.S. Plans [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	362	214	'	'
Pension Benefits U.S. Plans [Member] | Money Market Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	13	12	'	'
Pension Benefits U.S. Plans [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	67	8	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	2,588	2,610	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	924	1,154	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | U.S. government bonds [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	1	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Federal agencies securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	924	1,153	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Municipals securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Other securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Equity Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	1,593	1,454	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Common stock - domestic [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	1,133	1,092	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	460	362	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	53	0	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Money Market Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	1	2	'	'
Pension Benefits U.S. Plans [Member] | Level 1 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	17	0	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	4,316	4,650	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	3,958	4,264	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	2,073	2,260	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | U.S. government bonds [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	292	335	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	718	761	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Federal agencies securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	166	160	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Municipals securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	219	258	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Other securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	490	490	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Equity Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	22	38	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Common stock - domestic [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	22	38	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	117	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	309	214	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Money Market Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	12	10	'	'
Pension Benefits U.S. Plans [Member] | Level 2 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	15	7	'	'
Pension Benefits U.S. Plans [Member] | Level 3 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	872	619	'	'
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	89	34	'	'
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	59	19	32	49
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | U.S. government bonds [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	11	8	5	4
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Federal agencies securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Municipals securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Other securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	19	7	2	2
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Equity Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	148	137	'	'
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Common stock - domestic [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	148	137	206	240
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	600	447	531	471
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Money Market Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits U.S. Plans [Member] | Level 3 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	35	1	4	0
Pension Benefits Non-U.S. Plans [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	248	224	185	'
Pension Benefits Non-U.S. Plans [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	123	'	'	'
Pension Benefits Non-U.S. Plans [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	27	'	'	'
Pension Benefits Non-U.S. Plans [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	96	120	'	'
Pension Benefits Non-U.S. Plans [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	83	54	'	'
Pension Benefits Non-U.S. Plans [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	32	24	'	'
Pension Benefits Non-U.S. Plans [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	6	6	'	'
Pension Benefits Non-U.S. Plans [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	2	13	'	'
Pension Benefits Non-U.S. Plans [Member] | Real Estate [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	2	7	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 1 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	32	24	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	'	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	'	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	32	24	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Real Estate [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 2 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	212	180	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	123	'	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	27	'	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	96	120	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	83	54	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	6	6	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Real Estate [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 3 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	4	20	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	'	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	'	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Pension Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	2	13	13	11
Pension Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Real Estate [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	2	7	8	8
Other Postretirement Benefits U.S. Plans [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	1,352	1,320	1,240	'
Other Postretirement Benefits U.S. Plans [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	476	553	'	'
Other Postretirement Benefits U.S. Plans [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	171	169	'	'
Other Postretirement Benefits U.S. Plans [Member] | U.S. government bonds [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	33	26	'	'
Other Postretirement Benefits U.S. Plans [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	63	51	'	'
Other Postretirement Benefits U.S. Plans [Member] | Federal agencies securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	140	178	'	'
Other Postretirement Benefits U.S. Plans [Member] | Municipals securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	15	71	'	'
Other Postretirement Benefits U.S. Plans [Member] | Other securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	54	58	'	'
Other Postretirement Benefits U.S. Plans [Member] | Equity Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	430	333	'	'
Other Postretirement Benefits U.S. Plans [Member] | Common stock - domestic [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	328	250	'	'
Other Postretirement Benefits U.S. Plans [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	102	83	'	'
Other Postretirement Benefits U.S. Plans [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	439	432	'	'
Other Postretirement Benefits U.S. Plans [Member] | Money Market Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	4	1	'	'
Other Postretirement Benefits U.S. Plans [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	3	1	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	569	508	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	135	175	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | U.S. government bonds [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Federal agencies securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	135	175	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Municipals securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Other securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Equity Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	430	332	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Common stock - domestic [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	328	249	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	102	83	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Money Market Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	4	1	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 1 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	782	804	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	340	370	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	170	165	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | U.S. government bonds [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	33	26	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	63	51	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Federal agencies securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	5	3	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Municipals securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	15	70	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Other securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	54	55	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Equity Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	1	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Common stock - domestic [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	1	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	439	432	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Money Market Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 2 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	3	1	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	1	8	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	1	8	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	1	4	4	4
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | U.S. government bonds [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Federal agencies securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Municipals securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	1	1	1
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Other securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	3	5	6
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Equity Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Common stock - domestic [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Money Market Securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits U.S. Plans [Member] | Level 3 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	1	0
Other Postretirement Benefits Non-U.S. Plans [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	14	15	13	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	14	'	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	'	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	14	15	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Real Estate [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 1 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	'	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	'	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 1 [Member] | Real Estate [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 2 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	14	15	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	14	'	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	'	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	14	15	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 2 [Member] | Real Estate [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 3 [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	'	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Corporate fixed maturity securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	'	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Foreign government debt securities [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Common Stock - foreign [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Other investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Short-term Investments [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Derivative Assets [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	0	0	'	'
Other Postretirement Benefits Non-U.S. Plans [Member] | Level 3 [Member] | Real Estate [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Fair value of plan assets	$0	$0	'	'

Employee_Benefit_Plans_Signifi

Employee Benefit Plans (Significant Unobservable Inputs) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Pension Benefits U.S. Plans [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	$7,879	$7,108	'
Purchases, Sales, Issuances and Settlements, Net	0	0	'
Fair value of plan assets at December 31,	7,776	7,879	'
Pension Benefits U.S. Plans [Member] | Corporate fixed maturity securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	2,132	2,279	'
Pension Benefits U.S. Plans [Member] | Municipals securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	219	258	'
Pension Benefits U.S. Plans [Member] | Foreign government debt securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	729	769	'
Pension Benefits U.S. Plans [Member] | Other securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	509	497	'
Pension Benefits U.S. Plans [Member] | Common stock - domestic [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	1,303	1,267	'
Pension Benefits U.S. Plans [Member] | Other investments [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	600	564	'
Pension Benefits U.S. Plans [Member] | Derivative Assets [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	67	8	'
Other Postretirement Benefits U.S. Plans [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	1,320	1,240	'
Purchases, Sales, Issuances and Settlements, Net	0	0	'
Fair value of plan assets at December 31,	1,352	1,320	'
Other Postretirement Benefits U.S. Plans [Member] | Corporate fixed maturity securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	171	169	'
Other Postretirement Benefits U.S. Plans [Member] | Municipals securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	15	71	'
Other Postretirement Benefits U.S. Plans [Member] | Foreign government debt securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	63	51	'
Other Postretirement Benefits U.S. Plans [Member] | Other securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	54	58	'
Other Postretirement Benefits U.S. Plans [Member] | Common stock - domestic [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	328	250	'
Other Postretirement Benefits U.S. Plans [Member] | Other investments [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	0	0	'
Other Postretirement Benefits U.S. Plans [Member] | Derivative Assets [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	3	1	'
Pension Benefits Non-U.S. Plans [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	224	185	'
Purchases, Sales, Issuances and Settlements, Net	-19	-11	'
Fair value of plan assets at December 31,	248	224	'
Pension Benefits Non-U.S. Plans [Member] | Corporate fixed maturity securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	27	'	'
Pension Benefits Non-U.S. Plans [Member] | Foreign government debt securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	96	120	'
Pension Benefits Non-U.S. Plans [Member] | Other investments [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	32	24	'
Pension Benefits Non-U.S. Plans [Member] | Derivative Assets [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	2	13	'
Pension Benefits Non-U.S. Plans [Member] | Real Estate [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	2	7	'
Level 3 [Member] | Pension Benefits U.S. Plans [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	872	619	'
Level 3 [Member] | Pension Benefits U.S. Plans [Member] | Corporate fixed maturity securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	19	32	49
Realized gains (losses)	0	0	0
Unrealized gains (losses)	-2	-1	-4
Purchases, Sales, Issuances and Settlements, Net	19	-12	-13
Transfers Into and/or Out of Level 3	23	0	0
Fair value of plan assets at December 31,	59	19	32
Level 3 [Member] | Pension Benefits U.S. Plans [Member] | Municipals securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	0	0	'
Level 3 [Member] | Pension Benefits U.S. Plans [Member] | Foreign government debt securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	8	5	4
Realized gains (losses)	0	0	0
Unrealized gains (losses)	1	8	-1
Purchases, Sales, Issuances and Settlements, Net	-3	-5	2
Transfers Into and/or Out of Level 3	5	0	0
Fair value of plan assets at December 31,	11	8	5
Level 3 [Member] | Pension Benefits U.S. Plans [Member] | Other securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	7	2	2
Realized gains (losses)	0	0	-1
Unrealized gains (losses)	0	0	1
Purchases, Sales, Issuances and Settlements, Net	11	5	-1
Transfers Into and/or Out of Level 3	1	0	1
Fair value of plan assets at December 31,	19	7	2
Level 3 [Member] | Pension Benefits U.S. Plans [Member] | Common stock - domestic [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	137	206	240
Realized gains (losses)	-1	-27	-59
Unrealized gains (losses)	9	10	118
Purchases, Sales, Issuances and Settlements, Net	3	-52	-93
Transfers Into and/or Out of Level 3	0	0	0
Fair value of plan assets at December 31,	148	137	206
Level 3 [Member] | Pension Benefits U.S. Plans [Member] | Other investments [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	447	531	471
Realized gains (losses)	0	55	85
Unrealized gains (losses)	59	-36	45
Purchases, Sales, Issuances and Settlements, Net	-62	-103	-70
Transfers Into and/or Out of Level 3	156	0	0
Fair value of plan assets at December 31,	600	447	531
Level 3 [Member] | Pension Benefits U.S. Plans [Member] | Derivative Assets [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	1	4	0
Realized gains (losses)	-3	6	2
Unrealized gains (losses)	-18	-7	4
Purchases, Sales, Issuances and Settlements, Net	55	-2	-2
Transfers Into and/or Out of Level 3	0	0	0
Fair value of plan assets at December 31,	35	1	4
Level 3 [Member] | Other Postretirement Benefits U.S. Plans [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	1	8	'
Level 3 [Member] | Other Postretirement Benefits U.S. Plans [Member] | Corporate fixed maturity securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	4	4	4
Realized gains (losses)	0	0	0
Unrealized gains (losses)	0	0	0
Purchases, Sales, Issuances and Settlements, Net	-3	0	0
Transfers Into and/or Out of Level 3	0	0	0
Fair value of plan assets at December 31,	1	4	4
Level 3 [Member] | Other Postretirement Benefits U.S. Plans [Member] | Municipals securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	1	1	1
Realized gains (losses)	0	0	0
Unrealized gains (losses)	0	0	0
Purchases, Sales, Issuances and Settlements, Net	-1	0	0
Transfers Into and/or Out of Level 3	0	0	0
Fair value of plan assets at December 31,	0	1	1
Level 3 [Member] | Other Postretirement Benefits U.S. Plans [Member] | Foreign government debt securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	0	0	'
Level 3 [Member] | Other Postretirement Benefits U.S. Plans [Member] | Other securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	3	5	6
Realized gains (losses)	-3	-2	-1
Unrealized gains (losses)	4	2	1
Purchases, Sales, Issuances and Settlements, Net	-4	-2	-1
Transfers Into and/or Out of Level 3	0	0	0
Fair value of plan assets at December 31,	0	3	5
Level 3 [Member] | Other Postretirement Benefits U.S. Plans [Member] | Common stock - domestic [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	0	0	'
Level 3 [Member] | Other Postretirement Benefits U.S. Plans [Member] | Other investments [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	0	0	'
Level 3 [Member] | Other Postretirement Benefits U.S. Plans [Member] | Derivative Assets [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	'	1	0
Realized gains (losses)	'	2	0
Unrealized gains (losses)	'	-2	1
Purchases, Sales, Issuances and Settlements, Net	'	-1	0
Transfers Into and/or Out of Level 3	'	0	0
Fair value of plan assets at December 31,	0	0	1
Level 3 [Member] | Pension Benefits Non-U.S. Plans [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	4	20	'
Level 3 [Member] | Pension Benefits Non-U.S. Plans [Member] | Corporate fixed maturity securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	0	'	'
Level 3 [Member] | Pension Benefits Non-U.S. Plans [Member] | Foreign government debt securities [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	0	0	'
Level 3 [Member] | Pension Benefits Non-U.S. Plans [Member] | Other investments [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at December 31,	0	0	'
Level 3 [Member] | Pension Benefits Non-U.S. Plans [Member] | Derivative Assets [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	13	13	11
Realized gains (losses)	-2	-1	0
Unrealized gains (losses)	3	1	2
Purchases, Sales, Issuances and Settlements, Net	-12	0	0
Fair value of plan assets at December 31,	2	13	13
Level 3 [Member] | Pension Benefits Non-U.S. Plans [Member] | Real Estate [Member]	'	'	'
Rollforward fair value measurement using significant unobservable inputs (level 3) [Roll Forward]	'	'	'
Fair value of plan assets at January 1,	7	8	8
Realized gains (losses)	-1	-1	0
Unrealized gains (losses)	1	0	0
Purchases, Sales, Issuances and Settlements, Net	-5	0	0
Fair value of plan assets at December 31,	$2	$7	$8

Employee_Benefit_Plans_Expecte

Employee Benefit Plans (Expected Gross Benefit Payments) (Details) (USD $)	Dec. 31, 2013
In Millions, unless otherwise specified
Pension Benefits U.S. Plans [Member]	'
Defined benefit plan estimated future benefit payments [Abstract]	'
2014	$461
2015	474
2016	487
2017	515
2018	524
2019-2023	2,928
Pension Benefits Non-U.S. Plans [Member]	'
Defined benefit plan estimated future benefit payments [Abstract]	'
2014	35
2015	38
2016	42
2017	42
2018	45
2019-2023	263
Other Postretirement Benefits U.S. Plans [Member]	'
Defined benefit plan estimated future benefit payments [Abstract]	'
2014	84
2015	86
2016	86
2017	89
2018	93
2019-2023	522
Other Postretirement Benefits Non-U.S. Plans [Member]	'
Defined benefit plan estimated future benefit payments [Abstract]	'
2014	4
2015	4
2016	4
2017	4
2018	4
2019-2023	$16

Employee_Benefit_Plans_Narrati

Employee Benefit Plans (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Aggregate change in other comprehensive income (loss) before income tax	$1,292	($842)	($760)
Percentage of benefits calculated with the traditional formula	90.00%	'	'
Amortization of net actuarial gains or losses threshold percentage	10.00%	'	'
Aggregate change in other comprehensive income (loss) net of income tax	838	'	'
Total revenue from annuity and life insurance contracts recognized	49	54	47
Total investment income (loss) from annuity and life insurance contracts	20	867	885
Defined Contribution Plan, Cost Recognized	93	96	95
Pension Benefits U.S. Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Aggregate change in other comprehensive income (loss) before income tax	779	-543	-394
Aggregate projected benefit obligations	8,591	9,480	8,327
Estimated net actuarial losses amortized into net periodic benefit cost over the next year	151	'	'
Estimated prior service cost amortized into net periodic benefit cost over the next year	5	'	'
Weighted average expected return on plan assets	6.24%	'	'
Pension Benefits U.S. Plans [Member] | Qualified Plan Pension Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Expected future discretionary contributions	230	'	'
Pension Benefits U.S. Plans [Member] | Non-Qualified Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Aggregate projected benefit obligations	1,000	1,100	'
Expected future discretionary contributions	70	'	'
Pension Benefits Non-U.S. Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Aggregate change in other comprehensive income (loss) before income tax	-1	-17	-34
Aggregate projected benefit obligations	744	823	773
Weighted average expected return on plan assets	3.01%	'	'
Other Postretirement Benefits U.S. Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Aggregate change in other comprehensive income (loss) before income tax	513	-281	-327
Aggregate projected benefit obligations	1,834	2,375	2,093
Expected future discretionary contributions	50	'	'
Estimated net actuarial losses amortized into net periodic benefit cost over the next year	6	'	'
Estimated prior service cost amortized into net periodic benefit cost over the next year	-1	'	'
Weighted average expected return on plan assets	5.64%	'	'
Other Postretirement Benefits Non-U.S. Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Aggregate change in other comprehensive income (loss) before income tax	1	-1	-5
Aggregate projected benefit obligations	$41	$43	$39
Weighted average expected return on plan assets	7.25%	'	'

Income_Tax_Provision_for_Incom

Income Tax (Provision for Income Tax from Continuing Operations) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Current:	'	'	'
Federal	$85	($29)	($200)
State and local	2	6	-1
Foreign	422	846	614
Subtotal	509	823	413
Deferred:	'	'	'
Federal	-250	-244	2,241
State and local	-11	-1	-3
Foreign	413	-450	142
Subtotal	152	-695	2,380
Current and Deferred:	'	'	'
Provision for income tax expense (benefit)	$661	$128	$2,793

Income_Tax_Income_Loss_from_Co

Income Tax (Income Loss from Continuing Operations Before Income Tax Expense from Domestic and Foreign Operations) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income from continuing operations:	'	'	'
Domestic	$1,186	($1,496)	$6,869
Foreign	2,866	2,938	2,315
Income (loss) from continuing operations before provision for income tax	$4,052	$1,442	$9,184

Income_Tax_Reconciliation_of_I

Income Tax (Reconciliation of Income Tax Provision between US Statutory Rate and As Reported for Continuing Operations) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income tax expense benefit continuing operations income tax reconciliation	'	'	'
Tax provision at U.S. statutory rate	$1,418	$505	$3,215
Tax effect of:	'	'	'
Dividend received deduction	-166	-162	-160
Tax-exempt income	-96	-94	-86
Prior year tax	75	23	-4
Low income housing tax credits	-194	-150	-102
Other Tax credits	-54	-28	-36
Foreign tax rate differential	-340	-45	-41
Goodwill impairment	0	408	0
Deferred tax effects of branch conversions	4	-324	0
Change in valuation allowance	30	15	16
Other, net	-16	-20	-9
Provision for income tax expense (benefit)	$661	$128	$2,793

Income_Tax_Net_Deferred_Income

Income Tax (Net Deferred Income Tax Assets and Liabilities) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Deferred income tax assets:	'	'
Policyholder liabilities and receivables	$1,014	$6,233
Investments, including derivatives	86	0
Net operating loss carryforwards	1,808	1,408
Employee benefits	737	1,234
Capital loss carryforwards	32	160
Tax credit carryforwards	1,653	545
Litigation-related and government mandated	232	197
Other	471	484
Total gross deferred income tax assets	6,033	10,261
Less: Valuation allowance	357	368
Total net deferred income tax assets	5,676	9,893
Deferred income tax liabilities:	'	'
Investments, including derivatives	0	3,149
Intangibles	2,081	2,668
Net unrealized investment gains	4,883	7,854
DAC	5,133	4,775
Other	222	140
Total deferred income tax liabilities	12,319	18,586
Deferred tax assets and liabilities [Abstract]	'	'
Net deferred income tax asset (liability)	($6,643)	($8,693)

Income_Tax_Net_Operating_and_C

Income Tax (Net Operating and Capital Loss Carryforwards for Tax Purposes) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
In Millions, unless otherwise specified			Foreign Tax Authority [Member]	Foreign Tax Authority [Member]	Domestic Country [Member]	Domestic Country [Member]	State Country [Member]	State Country [Member]
				Capital Loss Carryforwards [Member]		Capital Loss Carryforwards [Member]		Capital Loss Carryforwards [Member]
Operating Loss Carryforwards [Line Items]	'	'	'	'	'	'	'	'
Net operating loss carryforwards	'	'	$1,576	'	$4,153	'	$153	'
Expiration period for net operating loss carryforwards	'	'	1-Jan-14	'	1-Jan-18	'	1-Jan-14	'
Capital Loss Carryforwards [Line Items]	'	'	'	'	'	'	'	'
Capital loss carryforwards	$1,653	$545	$991	$40	'	$52	'	$0
Expiration period for capital loss carryforwards	'	'	1-Jan-15	1-Jan-14	'	1-Jan-18	'	'

Income_Tax_Deferred_Tax_Asset_

Income Tax (Deferred Tax Asset Valuation Allowance Associated With Branch Restructuring) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Valuation Allowance [Line Items]	'	'	'
Balance, beginning of period	$368	'	'
Income tax expense (benefit)	152	-695	2,380
Deferred income tax expense (benefit) related to unrealized investment gains (losses)	3,017	-3,279	-2,936
Balance, end of period	357	368	'
American Life Branch Restructuring [Member]	'	'	'
Valuation Allowance [Line Items]	'	'	'
Balance, beginning of period	25	23	'
Income tax expense (benefit)	4	12	'
Deferred income tax expense (benefit) related to unrealized investment gains (losses)	2	-10	'
Offsetting Reduction In Gross Deferred Tax Asset Related To The Branch Transfer Of Assets To Foreign Subsidies	-31	0	'
Balance, end of period	$0	$25	'

Income_Tax_Reconciliation_of_U

Income Tax (Reconciliation of Unrecognized Tax Benefits) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Reconciliation of Unrecognized Tax Benefits	'	'	'
Balance at beginning of period	$708	$679	$810
Additions for tax positions of prior years	117	105	30
Reductions for tax positions of prior years	-37	-82	-161
Additions for tax positions of current year	39	32	13
Reductions for tax positions of current year	-1	-9	-8
Settlements with tax authorities	-52	-15	-5
Lapses of statutes of limitations	0	-2	0
Balance at end of the period	774	708	679
Unrecognized tax benefits that, if recognized would impact the effective rate	$661	$566	$527

Income_Tax_Interest_Accrued_Re

Income Tax (Interest Accrued Related to Unrecognized Tax Benefits) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Interest recognized in the consolidated statements of operations	$20	$2	$31
Interest included in other liabilities in the consolidated balance sheets	$257	$237	'

Income_Tax_Narrative_Details

Income Tax (Narrative) (Details)

12 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

USD ($)

USD ($)

USD ($)

Indemnification Agreement [Member]

Foreign Tax Authority [Member]

JAPAN

American Life [Member]

American Life [Member]

Maximum [Member]

General business credit member

Certain Foreign Capital Loss Carryforwards [Member]

Certain State and Foreign Net Operating Loss Carryforwards [Member]

Foreign Branch Restructuring [Member]

Certain Foreign Other Assets [Member]

USD ($)

USD ($)

USD ($)

JAPAN

JAPAN

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

JPY (¥)

Year that tax credit carryforwards will begin to expire

'

'

'

'

1-Jan-15

'

'

'

'

1-Jan-25

'

'

'

'

Valuation allowance recorded against U.S. deferred tax assets related to American Life's foreign branches

$357,000,000

$368,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Valuation allowance, change during year

'

'

'

'

'

'

'

'

'

'

6,000,000

-36,000,000

-4,000,000

45,000,000

Tax credit carryforwards

1,653,000,000

545,000,000

'

'

991,000,000

'

'

'

'

662,000,000

'

'

'

'

Portion of tax credit carryforwards that will have expired before 2020

12,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Amounts excluded from the provision for deferred taxes on cumulative earnings of certain non-U.S. affiliates and associated companies

3,300,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Federal statutory tax rate

35.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

Income tax benefit related to the separate account dividends received deduction

164,000,000

152,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Penalties recognized in the consolidated statements of operations

3,000,000

0

0

'

'

'

'

'

'

'

'

'

'

'

True-up of the prior year tax return included in current year benefit related to the separate account dividends received deduction

-6,000,000

'

'

'

'

'

'

'

-1,000,000

'

'

'

'

'

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repatriation assumptions for foreign earnings of certain european countries

-65,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Foreign tax rate differential

-340,000,000

-45,000,000

-41,000,000

'

'

-69,000,000

'

'

'

'

'

'

'

'

American Life income tax exam refund

'

'

'

'

'

'

176,000,000

16,000,000,000

'

'

'

'

'

'

Net charge related to indemnification provisions of Stock Purchase Agreement

16,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Other expenses

16,602,000,000

17,755,000,000

18,537,000,000

154,000,000

'

'

'

'

'

'

'

'

'

'

Other net investment gains (losses)

327,000,000

-35,000,000

88,000,000

19,000,000

'

'

'

'

'

'

'

'

'

'

Provision for income tax expense (benefit)

$661,000,000

$128,000,000

$2,793,000,000

($119,000,000)

'

'

'

'

'

'

'

'

'

'

Earnings_Per_Common_Share_Earn

Earnings Per Common Share (Earnings Per Common Share) (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Weighted Average Shares:	'	'	'	'	'	'	'	'	'	'	'
Weighted average common stock outstanding for basic earnings per common share	'	'	'	'	'	'	'	'	1,105,579,693	1,070,755,561	1,059,580,442
Incremental common shares from assumed:	'	'	'	'	'	'	'	'	'	'	'
Stock purchase contracts underlying common equity units	'	'	'	'	'	'	'	'	1,164,018	0	1,641,444
Exercise or issuance of stock-based awards	'	'	'	'	'	'	'	'	9,458,999	6,084,078	6,872,474
Weighted average common stock outstanding for diluted earnings per common share	'	'	'	'	'	'	'	'	1,116,202,710	1,076,839,639	1,068,094,360
Income (Loss) from Continuing Operations:	'	'	'	'	'	'	'	'	'	'	'
Income (loss) from continuing operations, net of income tax	$915	$973	$508	$995	$105	($957)	$2,300	($134)	$3,391	$1,314	$6,391
Less: Income (loss) from continuing operations, net of income tax, attributable to noncontrolling interests	'	'	'	'	'	'	'	'	25	38	-8
Less: Preferred stock dividends	31	30	31	30	31	30	31	30	122	122	122
Preferred stock redemption premium	'	'	'	'	'	'	'	'	0	0	146
Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.'s common shareholders	'	'	'	'	'	'	'	'	3,244	1,154	6,131
Basic	$0.78	$0.85	$0.43	$0.87	$0.06	($0.92)	$2.13	($0.17)	$2.94	$1.08	$5.79
Diluted	$0.77	$0.84	$0.43	$0.87	$0.06	($0.92)	$2.12	($0.17)	$2.91	$1.08	$5.74
Income (Loss) from Discontinued Operations:	'	'	'	'	'	'	'	'	'	'	'
Income (loss) from discontinued operations, net of income tax	1	2	2	-3	31	0	3	14	2	48	24
Less: Income (loss) from discontinued operations, net of income tax, attributable to noncontrolling interests	'	'	'	'	'	'	'	'	0	0	0
Income (loss) from discontinued operations, net of income tax, available to MetLife, Inc.'s common shareholders	'	'	'	'	'	'	'	'	2	48	24
Basic	$0	$0	$0	$0	$0.03	$0	$0	$0.01	$0	$0.04	$0.02
Diluted	$0	$0	$0	$0	$0.03	$0	$0	$0.01	$0	$0.04	$0.02
Net Income (Loss):	'	'	'	'	'	'	'	'	'	'	'
Net income (loss)	916	975	510	992	136	-957	2,303	-120	3,393	1,362	6,415
Less: Net income (loss) attributable to noncontrolling interests	8	3	8	6	9	-3	8	24	25	38	-8
Less: Preferred stock dividends	31	30	31	30	31	30	31	30	122	122	122
Preferred stock redemption premium	'	'	'	'	'	'	'	'	0	0	146
Net income (loss) available to MetLife, Inc.'s common shareholders	$877	$942	$471	$956	$96	($984)	$2,264	($174)	$3,246	$1,202	$6,155
Basic	$0.78	$0.85	$0.43	$0.87	$0.09	($0.92)	$2.13	($0.16)	$2.94	$1.12	$5.81
Diluted	$0.77	$0.84	$0.43	$0.87	$0.09	($0.92)	$2.12	($0.16)	$2.91	$1.12	$5.76

Contingencies_Commitments_and_2

Contingencies, Commitments and Guarantees (Asbestos Claims) (Details) (Asbestos Related Claims [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	Claims	Claims	Claims
Asbestos Related Claims [Member]	'	'	'
Loss Contingencies [Line Items]	'	'	'
Asbestos personal injury claims at year end	67,983	65,812	66,747
Number of new claims during the year	5,898	5,303	4,972
Settlement payments during the year	$37	$36.40	$34.20
Asbestos-related claims liability, beginning balance	417	'	'
Asbestos-related claims liability, ending balance	$572	$417	'

Contingencies_Commitments_and_3

Contingencies, Commitments and Guarantees (Insolvency Assessments) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Loss Contingencies [Line Items]	'	'	'
Receivable for reimbursement of paid assessments	$21,634	'	$21,859
Other Assets:	'	'	'
Premium tax offset for future undiscounted assessments	60	114	'
Premium tax offsets currently available for paid assessments	69	14	'
Other Liabilities:	'	'	'
Insolvency assessments	93	205	'
Insurance-related Assessments [Member]	'	'	'
Loss Contingencies [Line Items]	'	'	'
Receivable for reimbursement of paid assessments	'	'	5
Total assets held for insolvency assessments	$134	$134	$134

Contingencies_Commitments_and_4

Contingencies, Commitments and Guarantees (Leases) (Details) (USD $)	Dec. 31, 2013
In Millions, unless otherwise specified
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]	'
Gross rental payments 2014	$320
Gross rental payments 2015	259
Gross rental payments 2016	212
Gross rental payments 2017	161
Gross rental payments 2018	141
Gross rental payments, thereafter	794
Gross rental payments, total	1,887
Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals	$139

Contingencies_Commitments_and_5

Contingencies, Commitments and Guarantees (Contingencies - Narrative) (Details) (USD $)

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Mar. 31, 2012

Dec. 31, 2013

Mar. 31, 2013

Dec. 31, 2013

Minimum [Member]

Maximum [Member]

Superfund Site Settlement Agreements [Member]

Merrill Haviland, et Al v. Metropolitan Life Insurance Company [Member]

Total Asset Recovery Services, LLC Florida v. MetLife, Inc et Al [Member]

C-Mart, Inc. V. Metropolitan Life Insurance Company, Et Al [Member]

Insurance-related Assessments [Member]

Insurance-related Assessments [Member]

Insurance-related Assessments [Member]

Unclaimed Property [Member]

Derivative Actions And Demands [Member]

Met Life Bank Mortgage Regulatory and Law Enforcement Authorities' Inquiries [Member]

Met Life Bank Mortgage Regulatory and Law Enforcement Authorities' Inquiries [Member]

Claims

Plaintiffs

Contracts

Plaintiffs

Plaintiffs

Loss Contingencies

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of regulatory matters and other claims

'

'

2

'

'

'

'

'

'

'

'

'

'

Damages Sought

'

'

'less than $1 million and an additional amount

'

'

'$500 for each violation

'

'

'

'

'

'

'

Damages Sought

'

'

'

'

$767,000,000

'

'

'

'

'

'

'

'

Assumed average face amount of life insurance policies in lawsuit

'

'

'

'

120,000

'

'

'

'

'

'

'

'

Number of life insurance contracts named in legal action

'

'

'

'

9,022

'

'

'

'

'

'

'

'

Number of plaintiffs

'

'

'

45

'

36,000

'

'

'

'

5

'

'

Loss Contingency, Range of Possible Loss, Maximum

'

'

'

'

'

'

'

'

'

'

'

'

3,200,000

Maximum estimate of aggregate costs to resolve matter

'

'

1,000,000

'

'

'

'

'

'

'

'

'

'

Multistate Examination Payment and Expected Benefit Payments to Policyholders

'

'

'

'

'

'

'

'

'

52,000,000

'

'

'

Maximum estimate of costs for environmental testing

'

'

100,000

'

'

'

'

'

'

'

'

'

'

Loss Contingency, Estimate of Possible Loss

'

'

'

'

'

'

-31,000,000

38,000,000

40,000,000

'

'

'

'

Litigation Settlement, Amount

'

'

'

'

'

'

'

'

'

'

'

46,000,000

'

Loss Contingency, Range of Possible Loss, Portion Not Accrued

$0

$520,000,000

'

'

'

'

'

'

'

'

'

'

'

Contingencies_Commitments_and_6

Contingencies, Commitments and Guarantees (Commitments and Guarantees - Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Contingencies, Commitments and Guarantees (Textuals) [Abstract]	'	'
Number of years over which commitments will be invested in partnerships	'5 years	'
Commitments To Fund Partnership Investments	$4,400,000,000	$3,400,000,000
Minimum indemnities and guarantees contractual limitation	'less than $1 million	'
Maximum indemnities and guarantees contractual limitation	800,000,000	'
Liabilities for indemnities, guarantees and commitments	5,000,000	5,000,000
Cumulative maximum indemnities and guarantees contractual limitiation	1,400,000,000	'
Commitments to Fund Bank Credit Facilities, Bridge Loans and Private Corporate Bond Investments [Member]	'	'
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]	'	'
Fair Value Disclosure, Off-balance Sheet Risks, Face Amount, Liability	925,000,000	1,200,000,000
Mortgage Loan Commitments [Member]	'	'
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]	'	'
Fair Value Disclosure, Off-balance Sheet Risks, Amount, Liability	$3,400,000,000	$3,000,000,000

Quarterly_Results_of_Operation2

Quarterly Results of Operations (Unaudited) (Quarterly Results of Operations) (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Quarterly Results of Operations (Unaudited)	'	'	'	'	'	'	'	'	'	'	'
Total revenues	$18,458	$16,337	$15,721	$17,683	$17,333	$16,503	$18,398	$15,916	$68,199	$68,150	$70,241
Total expenses	17,190	15,361	15,160	16,436	17,810	17,513	15,060	16,325	64,147	66,708	61,057
Income (loss) from continuing operations, net of income tax	915	973	508	995	105	-957	2,300	-134	3,391	1,314	6,391
Income (loss) from discontinued operations, net of income tax	1	2	2	-3	31	0	3	14	2	48	24
Net income (loss)	916	975	510	992	136	-957	2,303	-120	3,393	1,362	6,415
Less: Net income (loss) attributable to noncontrolling interests	8	3	8	6	9	-3	8	24	25	38	-8
Net income (loss) attributable to MetLife, Inc.	908	972	502	986	127	-954	2,295	-144	3,368	1,324	6,423
Less: Preferred stock dividends	31	30	31	30	31	30	31	30	122	122	122
Net income (loss) available to MetLife, Inc.'s common shareholders	$877	$942	$471	$956	$96	($984)	$2,264	($174)	$3,246	$1,202	$6,155
Basic earnings per common share:	'	'	'	'	'	'	'	'	'	'	'
Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.'s common shareholders	$0.78	$0.85	$0.43	$0.87	$0.06	($0.92)	$2.13	($0.17)	$2.94	$1.08	$5.79
Income (loss) from discontinued operations, net of income tax, attributable to MetLife, Inc.	$0	$0	$0	$0	$0.03	$0	$0	$0.01	$0	$0.04	$0.02
Net income (loss) attributable to MetLife, Inc.	$0.81	$0.88	$0.46	$0.90	$0.12	($0.90)	$2.16	($0.14)	'	'	'
Net income (loss) available to MetLife, Inc.'s common shareholders	$0.78	$0.85	$0.43	$0.87	$0.09	($0.92)	$2.13	($0.16)	$2.94	$1.12	$5.81
Diluted earnings per common share:	'	'	'	'	'	'	'	'	'	'	'
Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.'s common shareholders	$0.77	$0.84	$0.43	$0.87	$0.06	($0.92)	$2.12	($0.17)	$2.91	$1.08	$5.74
Income (loss) from discontinued operations, net of income tax, attributable to MetLife, Inc.	$0	$0	$0	$0	$0.03	$0	$0	$0.01	$0	$0.04	$0.02
Net income (loss) attributable to MetLife, Inc.	$0.80	$0.87	$0.45	$0.89	$0.12	($0.90)	$2.14	($0.14)	'	'	'
Net income (loss) available to MetLife, Inc.'s common shareholders	$0.77	$0.84	$0.43	$0.87	$0.09	($0.92)	$2.12	($0.16)	$2.91	$1.12	$5.76

Subsequent_Events_Dividends_Na

Subsequent Events (Dividends - Narrative) (Details) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

In Millions, except Per Share data, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2011

Sep. 30, 2011

Jun. 30, 2011

Mar. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2011

Sep. 30, 2011

Jun. 30, 2011

Mar. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Dividends Declared [Member]

Dividends Declared [Member]

Dividends Declared [Member]

Series A Preferred Stock [Member]

Series B Preferred Stock [Member]

Common Stock [Member]

Subsequent Event [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, dividend rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.25

$0.41

'

Preferred stock, dividends

$7

$6

$7

$6

$7

$6

$7

$6

$7

$6

$7

$6

$26

$26

$26

$24

$24

$24

$24

$24

$24

$24

$24

$24

$24

$24

$24

$96

$96

$96

'

$6

$24

'

Approved annual dividend, amount per share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.28

Estimated aggregate dividend payment

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$310

'

'

'

Subsequent_Events_Subsequent_E

Subsequent Events Subsequent Events (Disposition - Narrative) (Details) (Subsequent Event [Member], MetLife Assurance Limited [Member], USD $)	Feb. 14, 2014
In Millions, unless otherwise specified
Minimum [Member]	'
Subsequent Event [Line Items]	'
Gain (loss) on disposal	$350
Maximum [Member]	'
Subsequent Event [Line Items]	'
Gain (loss) on disposal	$390

Consolidated_Summary_of_Invest1

Consolidated Summary of Investments - Other Than Investments in Related Parties (Details) (USD $)	Dec. 31, 2013
In Millions, unless otherwise specified
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	$470,781
Estimated Fair Value	488,779
Fixed Maturities [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	333,599
Estimated Fair Value	350,187
Amount at Which Shown on Balance Sheet	350,187
Foreign government debt securities [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	50,717
Estimated Fair Value	54,437
Amount at Which Shown on Balance Sheet	54,437
U.S. Treasury and agency securities [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	43,928
Estimated Fair Value	45,123
Amount at Which Shown on Balance Sheet	45,123
Public utilities [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	27,512
Estimated Fair Value	29,897
Amount at Which Shown on Balance Sheet	29,897
State and political subdivision securities [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	13,233
Estimated Fair Value	13,830
Amount at Which Shown on Balance Sheet	13,830
All other corporate bonds [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	130,469
Estimated Fair Value	137,682
Amount at Which Shown on Balance Sheet	137,682
Total bonds [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	265,859
Estimated Fair Value	280,969
Amount at Which Shown on Balance Sheet	280,969
Mortgage-backed and asset-backed securities [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	65,740
Estimated Fair Value	67,176
Amount at Which Shown on Balance Sheet	67,176
Redeemable preferred stock [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	2,000
Estimated Fair Value	2,042
Amount at Which Shown on Balance Sheet	2,042
Fair value option and trading securities [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	16,403
Estimated Fair Value	17,423
Amount at Which Shown on Balance Sheet	17,423
Equity Securities, Investment Summary [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	3,012
Estimated Fair Value	3,402
Amount at Which Shown on Balance Sheet	3,402
Industrial, miscellaneous and all others [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	1,760
Estimated Fair Value	2,143
Amount at Which Shown on Balance Sheet	2,143
Banks, trust and insurance companies [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	167
Estimated Fair Value	210
Amount at Which Shown on Balance Sheet	210
Non-redeemable preferred stock [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	1,085
Estimated Fair Value	1,049
Amount at Which Shown on Balance Sheet	1,049
Mortgage loans, net [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	57,706
Estimated Fair Value	57,706
Held-for-investment [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	57,703
Estimated Fair Value	57,703
Held-for-sale [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	3
Estimated Fair Value	3
Policy loans [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	11,764
Estimated Fair Value	11,764
Real estate and real estate joint ventures [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	10,267
Estimated Fair Value	10,267
Real estate acquired in satisfaction of debt [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	445
Estimated Fair Value	445
Other limited partnership interests [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	7,401
Estimated Fair Value	7,401
Short-term investments [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	13,955
Estimated Fair Value	13,955
Other invested assets [Member]	'
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]	'
Cost or Amortized Cost	16,229
Estimated Fair Value	$16,229

Condensed_Financial_Informatio1

Condensed Financial Information (Parent Company) (Condensed Balance Sheet) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Millions, except Share data, unless otherwise specified
Investments:	'	'	'	'
Available-for-sale Securities, Debt Securities	$350,187	$374,266	'	'
Available-for-sale Securities, Equity Securities	3,402	2,891	'	'
Short-term Investments	13,955	16,906	'	'
Other Investments	16,229	21,145	'	'
Total investments	488,779	517,052	'	'
Cash and Cash Equivalents, at Carrying Value	7,585	15,738	10,461	12,957
Accrued Investment Income Receivable	4,255	4,374	'	'
Other Assets	8,369	7,876	'	'
Total assets	885,296	836,781	'	'
Liabilities	'	'	'	'
Payables for collateral under securities loaned and other transactions	30,411	33,687	'	'
Collateral financing arrangements	4,196	4,196	'	'
Junior subordinated debt securities	3,193	3,192	'	'
Other Liabilities	23,168	22,492	'	'
Total liabilities	822,313	771,823	'	'
Stockholders' Equity	'	'	'	'
Preferred stock, par value $0.01 per share; 200,000,000 shares authorized: 84,000,000 shares issued and outstanding; $2,100 aggregate liquidation preference	1	1	'	'
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,125,224,024 and 1,094,880,623 shares issued at December 31, 2013 and 2012, respectively; 1,122,030,137 and 1,091,686,736 shares outstanding at December 31, 2013 and 2012, respectively	11	11	'	'
Additional paid-in capital	29,277	28,011	'	'
Retained earnings	27,332	25,205	'	'
Treasury stock, at cost; 3,193,887 shares at December 31, 2013 and 2012	-172	-172	'	'
Accumulated other comprehensive income (loss)	5,104	11,397	6,083	1,145
Total stockholders' equity	61,553	64,453	'	'
Total liabilities and stockholders' equity	885,296	836,781	'	'
Balance Sheet Related Disclosures [Abstract]	'	'	'	'
Amortized cost of fixed maturity securities available-for-sale	333,599	340,870	'	'
Cost of equity securities available-for-sale	3,012	2,838	'	'
Preferred stock, par value	$0.01	$0.01	'	'
Preferred stock, shares authorized	200,000,000	200,000,000	'	'
Preferred stock, shares issued	84,000,000	84,000,000	'	'
Preferred stock, shares outstanding	84,000,000	84,000,000	'	'
Preferred stock, aggregate liquidation preference	$2,100	$2,100	'	'
Common stock, par value	$0.01	$0.01	'	$0.01
Common stock, shares authorized	3,000,000,000	3,000,000,000	'	'
Common stock, shares issued	1,125,224,024	1,094,880,623	'	'
Common stock, shares outstanding	1,122,030,137	1,091,686,736	'	'
Treasury stock, shares	3,193,887	3,193,887	'	'
Parent Company [Member]	'	'	'	'
Investments:	'	'	'	'
Available-for-sale Securities, Debt Securities	4,531	4,967	'	'
Available-for-sale Securities, Equity Securities	0	13	'	'
Short-term Investments	560	295	'	'
Other Investments	557	155	'	'
Total investments	5,648	5,430	'	'
Cash and Cash Equivalents, at Carrying Value	648	188	309	624
Accrued Investment Income Receivable	40	37	'	'
Investment in subsidiaries	76,871	81,769	'	'
Loans to subsidiaries	2,333	750	'	'
Receivables from subsidiaries	0	7	'	'
Other Assets	1,677	1,369	'	'
Total assets	87,217	89,550	'	'
Liabilities	'	'	'	'
Payables for collateral under securities loaned and other transactions	85	0	'	'
Long-term debt - unaffiliated	15,938	15,669	'	'
Long-term debt - affiliated	3,600	3,250	'	'
Collateral financing arrangements	2,797	2,797	'	'
Junior subordinated debt securities	1,748	1,748	'	'
Payables to subsidiaries	13	0	'	'
Other Liabilities	1,483	1,633	'	'
Total liabilities	25,664	25,097	'	'
Stockholders' Equity	'	'	'	'
Preferred stock, par value $0.01 per share; 200,000,000 shares authorized: 84,000,000 shares issued and outstanding; $2,100 aggregate liquidation preference	1	1	'	'
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,125,224,024 and 1,094,880,623 shares issued at December 31, 2013 and 2012, respectively; 1,122,030,137 and 1,091,686,736 shares outstanding at December 31, 2013 and 2012, respectively	11	11	'	'
Additional paid-in capital	29,277	28,011	'	'
Retained earnings	27,332	25,205	'	'
Treasury stock, at cost; 3,193,887 shares at December 31, 2013 and 2012	-172	-172	'	'
Accumulated other comprehensive income (loss)	5,104	11,397	'	'
Total stockholders' equity	61,553	64,453	'	'
Total liabilities and stockholders' equity	87,217	89,550	'	'
Balance Sheet Related Disclosures [Abstract]	'	'	'	'
Amortized cost of fixed maturity securities available-for-sale	4,497	4,867	'	'
Cost of equity securities available-for-sale	$0	$15	'	'
Preferred stock, par value	$0.01	$0.01	'	'
Preferred stock, shares authorized	200,000,000	200,000,000	'	'
Preferred stock, shares issued	84,000,000	84,000,000	'	'
Preferred stock, shares outstanding	84,000,000	84,000,000	'	'
Preferred stock, aggregate liquidation preference	$2,100	$2,100	'	'
Common stock, par value	$0.01	$0.01	'	'
Common stock, shares authorized	3,000,000,000	3,000,000,000	'	'
Common stock, shares issued	1,125,224,024	1,094,880,623	'	'
Common stock, shares outstanding	1,122,030,137	1,091,686,736	'	'
Treasury stock, shares	3,193,887	3,193,887	'	'

Condensed_Financial_Informatio2

Condensed Financial Information (Parent Company) (Condensed Statements of Operations) (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Condensed Income Statements, Captions [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net investment income	'	'	'	'	'	'	'	'	$22,232	$21,984	$19,585
Other revenues	'	'	'	'	'	'	'	'	1,920	1,906	2,532
Net investment gains (losses)	'	'	'	'	'	'	'	'	161	-352	-867
Net derivative gains (losses)	'	'	'	'	'	'	'	'	-3,239	-1,919	4,824
Total revenues	18,458	16,337	15,721	17,683	17,333	16,503	18,398	15,916	68,199	68,150	70,241
Expenses	'	'	'	'	'	'	'	'	'	'	'
Goodwill impairment	'	'	'	'	'	'	'	'	0	1,868	0
Other expenses	'	'	'	'	'	'	'	'	16,602	17,755	18,537
Total expenses	17,190	15,361	15,160	16,436	17,810	17,513	15,060	16,325	64,147	66,708	61,057
Income (loss) before provision for income tax	'	'	'	'	'	'	'	'	4,052	1,442	9,184
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	661	128	2,793
Net income (loss)	908	972	502	986	127	-954	2,295	-144	3,368	1,324	6,423
Less: Preferred stock dividends	31	30	31	30	31	30	31	30	122	122	122
Preferred stock redemption premium	'	'	'	'	'	'	'	'	0	0	146
Net income (loss) available to common shareholders	877	942	471	956	96	-984	2,264	-174	3,246	1,202	6,155
Comprehensive income (loss)	'	'	'	'	'	'	'	'	-2,925	6,638	11,361
Parent Company [Member]	'	'	'	'	'	'	'	'	'	'	'
Condensed Income Statements, Captions [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Equity in earnings of subsidiaries	'	'	'	'	'	'	'	'	4,163	3,444	6,979
Net investment income	'	'	'	'	'	'	'	'	304	94	121
Other revenues	'	'	'	'	'	'	'	'	155	159	155
Net investment gains (losses)	'	'	'	'	'	'	'	'	-80	29	-146
Net derivative gains (losses)	'	'	'	'	'	'	'	'	-99	-259	82
Total revenues	'	'	'	'	'	'	'	'	4,443	3,467	7,191
Expenses	'	'	'	'	'	'	'	'	'	'	'
Interest expense	'	'	'	'	'	'	'	'	1,122	985	1,007
Goodwill impairment	'	'	'	'	'	'	'	'	0	1,384	0
Other expenses	'	'	'	'	'	'	'	'	373	167	149
Total expenses	'	'	'	'	'	'	'	'	1,495	2,536	1,156
Income (loss) before provision for income tax	'	'	'	'	'	'	'	'	2,948	931	6,035
Provision for income tax expense (benefit)	'	'	'	'	'	'	'	'	-420	-393	-388
Net income (loss)	'	'	'	'	'	'	'	'	3,368	1,324	6,423
Less: Preferred stock dividends	'	'	'	'	'	'	'	'	122	122	122
Preferred stock redemption premium	'	'	'	'	'	'	'	'	0	0	146
Net income (loss) available to common shareholders	'	'	'	'	'	'	'	'	3,246	1,202	6,155
Comprehensive income (loss)	'	'	'	'	'	'	'	'	($2,925)	$6,638	$11,361

Condensed_Financial_Informatio3

Condensed Financial Information (Parent Company) (Condensed Statements of Cash Flows) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities	'	'	'
Net income (loss)	$3,368	$1,324	$6,423
Goodwill impairment	0	1,868	0
Net cash provided by (used in) operating activities	16,131	17,160	10,273
Cash flows from investing activities	'	'	'
Sales of fixed maturity securities	117,523	103,823	104,302
Purchases of fixed maturity securities	-117,826	-115,793	-116,939
Sales of equity securities	725	1,140	2,006
Cash received in connection with freestanding derivatives	1,567	1,933	2,815
Cash paid in connection with freestanding derivatives	-6,710	-3,258	-3,478
Net change in short-term investments	2,955	593	-7,949
Other, net	-86	-158	-169
Net cash provided by (used in) investing activities	-15,165	-11,929	-22,218
Cash flows from financing activities	'	'	'
Net change in payables for collateral under securities loaned and other transactions	-3,276	-29	6,444
Long-term debt issued	1,372	750	1,346
Long-term debt repaid	-1,746	-1,702	-2,042
Cash received (paid) in connection with collateral financing arrangements	0	-44	37
Common stock issued, net of issuance costs	1,000	1,000	2,950
Redemption of convertible preferred stock	0	0	-2,805
Preferred stock redemption premium	0	0	-146
Dividends on preferred stock	-122	-122	-122
Dividends on common stock	-1,119	-811	-787
Other, net	-192	609	212
Net cash provided by (used in) financing activities	-8,907	35	9,382
Change in cash and cash equivalents	-8,153	5,277	-2,585
Cash and cash equivalents, from continuing operations, beginning of year	15,738	10,461	12,957
Cash and cash equivalents, from continuing operations, end of year	7,585	15,738	10,461
Supplemental disclosures of cash flow information:	'	'	'
Net cash paid (received) for Interest	1,270	1,335	1,565
Parent Company [Member]	'	'	'
Cash flows from operating activities	'	'	'
Net income (loss)	3,368	1,324	6,423
Earnings of subsidiaries	-4,163	-3,444	-6,979
Dividends from subsidiaries	2,734	3,177	2,578
Goodwill impairment	0	1,384	0
Other, net	-74	177	697
Net cash provided by (used in) operating activities	1,865	2,618	2,719
Cash flows from investing activities	'	'	'
Sales of fixed maturity securities	5,108	5,645	3,265
Purchases of fixed maturity securities	-4,795	-6,200	-4,787
Sales of equity securities	13	2	1
Cash received in connection with freestanding derivatives	424	197	257
Cash paid in connection with freestanding derivatives	-465	-203	-276
Sales of businesses	17	0	180
Expense paid on behalf of subsidiaries	-85	-80	-75
Repayments of loans to subsidiaries	645	175	1,275
Issuances of loans to subsidiaries	-1,942	-175	0
Redemption of preferred stock of subsidiary	300	0	0
Investment in preferred stock of subsidiary	0	0	-250
Returns of capital from subsidiaries	267	9	591
Capital contributions to subsidiaries	-748	-1,223	-1,439
Net change in short-term investments	-265	372	-620
Other, net	-49	-48	-10
Net cash provided by (used in) investing activities	-1,575	-1,529	-1,888
Cash flows from financing activities	'	'	'
Net change in payables for collateral under securities loaned and other transactions	85	-1,180	520
Long-term debt issued	994	750	0
Long-term debt repaid	-750	-797	-750
Cash received (paid) in connection with collateral financing arrangements	0	-44	37
Common stock issued, net of issuance costs	1,000	1,000	2,950
Redemption of convertible preferred stock	0	0	-2,805
Preferred stock redemption premium	0	0	-146
Dividends on preferred stock	-122	-122	-122
Dividends on common stock	-1,119	-811	-787
Other, net	82	-6	-43
Net cash provided by (used in) financing activities	170	-1,210	-1,146
Change in cash and cash equivalents	460	-121	-315
Cash and cash equivalents, from continuing operations, beginning of year	188	309	624
Cash and cash equivalents, from continuing operations, end of year	648	188	309
Supplemental disclosures of cash flow information:	'	'	'
Net cash paid (received) for Interest	1,100	937	997
Net cash paid (received) for Income tax	69	24	-659
Non-cash transactions:	'	'	'
Dividends from subsidiaries	32	203	170
Returns of capital from subsidiaries	0	356	47
Capital contributions to subsidiaries	121	559	316
Assumption of long-term debt from subsidiary	0	2,000	0
Investment in preferred stock of subsidiary	0	2,000	0
Issuance of long-term debt to subsidiary	350	750	0
Issuance of loan to subsidiary	350	750	0
Allocation of interest expense to subsidiary	28	33	29
Allocation of interest income to subsidiary	$68	$76	$68

Condensed_Financial_Informatio4

Condensed Financial Information (Parent Company) (Long-term Debt Outstanding) (Details) (Parent Company [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Long-term Debt [Abstract]	'	'
Senior notes	$15,938	$15,669
Notes Payable, Related Parties	3,600	3,250
Long-term Debt	19,538	18,919
Senior Notes, Unaffiliated [Member]	'	'
Long-term Debt [Abstract]	'	'
Interest Rate Range Minimum	1.52%	'
Interest Rate Range Maximum	7.72%	'
Weighted Average Interest Rate	4.96%	'
Debt Instrument, Maturity Date Range, Start	6-Aug-14	'
Debt Instrument, Maturity Date Range, End	15-Jun-45	'
Senior notes	15,938	15,669
Senior Notes, Affiliated [Member]	'	'
Long-term Debt [Abstract]	'	'
Interest Rate Range Minimum	3.57%	'
Interest Rate Range Maximum	7.44%	'
Weighted Average Interest Rate	5.43%	'
Debt Instrument, Maturity Date Range, Start	30-Jun-14	'
Debt Instrument, Maturity Date Range, End	30-Sep-33	'
Notes Payable, Related Parties	3,100	2,750
Other Affiliated Debt [Member]	'	'
Long-term Debt [Abstract]	'	'
Interest Rate Range Minimum	0.95%	'
Interest Rate Range Maximum	1.01%	'
Weighted Average Interest Rate	0.98%	'
Debt Instrument, Maturity Date Range, Start	30-Dec-15	'
Debt Instrument, Maturity Date Range, End	31-Mar-16	'
Notes Payable, Related Parties	$500	$500

Condensed_Financial_Informatio5

Condensed Financial Information (Parent Company) (Interest Expense) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Interest Expense [Abstract]	'	'	'
Total interest expense	$854	$871	$975
Parent Company [Member]	'	'	'
Interest Expense [Abstract]	'	'	'
Total interest expense	1,122	985	1,007
Parent Company [Member] | Long-term Debt [Member]	'	'	'
Interest Expense [Abstract]	'	'	'
Total interest expense	790	779	806
Parent Company [Member] | Long-term Debt [Member] | Affiliated Entity [Member]	'	'	'
Interest Expense [Abstract]	'	'	'
Total interest expense	163	28	16
Parent Company [Member] | Secured Debt [Member]	'	'	'
Interest Expense [Abstract]	'	'	'
Total interest expense	35	42	43
Parent Company [Member] | Junior Subordinated Debt [Member]	'	'	'
Interest Expense [Abstract]	'	'	'
Total interest expense	134	134	134
Parent Company [Member] | Stock Purchase Contracts [Member]	'	'	'
Interest Expense [Abstract]	'	'	'
Total interest expense	$0	$2	$8

Condensed_Financial_Informatio6

Condensed Financial Information (Parent Company) (Loans to Subsidiaries - Narrative) (Details) (USD $)

12 Months Ended

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Senior Note Issued To Metlife Reinsurance Company Of Delaware [Member]

Senior Note Issued To Metlife Reinsurance Company Of Delaware [Member]

Interest Income [Member]

Interest Income [Member]

Interest Income [Member]

Metropolitan Life Insurance Company Capital Note [Member]

Metropolitan Life Insurance Company Surplus Note [Member]

MetLife Reinsurance Company of Delaware Surplus Note [Member]

MetLife Reinsurance Company of Delaware Surplus Note [Member]

MetLife Ireland Treasury Limited loan from MetLife, Inc.

Senior Notes Affiliated [Member]

Senior Notes Affiliated [Member]

Parent Company [Member]

Parent Company [Member]

Notes to Condensed Financial Information of Parent Company (Textuals) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Effective date of acquisition

1-Nov-10

'

'

'

'

'

'

'

'

'

'

'

'

'

Loans to Subsidiaries, Repayment Amount

'

$645,000,000

$175,000,000

$1,275,000,000

'

'

'

$500,000,000

$775,000,000

'

'

$245,000,000

'

'

Loans to subsidiaries and affiliates

'

2,333,000,000

750,000,000

'

'

'

'

'

'

350,000,000

750,000,000

1,500,000,000

'

'

Loans to subsidiaries, maturity date

'

'

'

'

'

'

'

'

'

1-Dec-33

30-Sep-32

1-Jul-23

'

'

Loans to subsidiaries, debt instrument, interest rate, effective percentage

'

'

'

'

'

'

'

'

'

6.00%

5.13%

8.50%

'

'

Senior notes

'

15,938,000,000

15,669,000,000

'

'

'

'

'

'

'

'

'

350,000,000

750,000,000

Loans to Subsidiaries, Interest Income

'

'

'

'

103,000,000

1,000,000

40,000,000

'

'

'

'

'

'

'

Long Term Debt Aggregate Maturities, Year One

'

1,900,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Long Term Debt Aggregate Maturities, Year Two

'

1,300,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Long Term Debt Aggregate Maturities, Year Three

'

1,700,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Long Term Debt Aggregate Maturities, Year Four

'

500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Long Term Debt Aggregate Maturities, Year Five

'

1,500,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Long Term Debt Aggregate Maturities, After Year Five

'

$12,600,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Condensed_Financial_Informatio7

Condensed Financial Information (Parent Company) (Investment in Subsidiaries - Narrative) (Details) (USD $)	12 Months Ended				12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012
	Series B Non-Cumulative Perpetual Preferred Shares [Member]	Parent Company [Member]	Parent Company [Member]	Parent Company [Member]	Parent Company [Member]	Parent Company [Member]
				Investments in Majority-owned Subsidiaries [Member]	Investments in Majority-owned Subsidiaries [Member]	Investments in Majority-owned Subsidiaries [Member]
					Series A Non-Cumulative Perpetual Preferred Shares [Member]	Series B Non-Cumulative Perpetual Preferred Shares [Member]
Condensed Financial Statements, Captions [Line Items]	'	'	'	'	'	'
Investment in subsidiaries	'	$76,871	$81,769	$2,000	'	'
Investments in subsidiaries, shares	'	'	'	'	75,000	125,000
Investments in subsidiaries, annual rate	6.50%	'	'	'	7.69%	7.75%

Condensed_Financial_Informatio8

Condensed Financial Information (Parent Company) (Long-term Debt - Narrative) (Details) (Parent Company [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Condensed Financial Statements, Captions [Line Items]	'	'
Senior notes	$15,938	$15,669
Investment in subsidiaries	76,871	81,769
Advances to Affiliate	2,333	750
Metlife Reinsurance Company of Delaware Surplus Note [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Advances to Affiliate	350	750
Investments in Majority-owned Subsidiaries [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Investment in subsidiaries	'	2,000
Investments in Majority-owned Subsidiaries [Member] | $750 Million Preferred Stock of Exeter [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Investment in subsidiaries	'	750
Investments in Majority-owned Subsidiaries [Member] | $1.25 Billion Preferred Stock of Exeter [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Investment in subsidiaries	'	1,250
Senior Notes, Affiliated [Member] | $750 Million Senior Note Issued to Metropolitan Life Insurance Company [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Senior notes	'	750
Senior Notes, Affiliated [Member] | $750 Million Senior Note Issued to Metropolitan Life Insurance Company [Member] | $250 Million Senior Note Metropolitan Life Insurance Company [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Maturities of Senior Debt	'	250
Senior Notes, Affiliated [Member] | $750 Million Senior Note Issued to Metropolitan Life Insurance Company [Member] | $500 Million Senior Note Metropolitan Life Insurance Company [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Senior notes	'	500
Debt Instrument, Maturity Date	'	30-Jun-14
Debt Instrument, Interest Rate, Effective Percentage	'	6.44%
Senior Notes, Affiliated [Member] | $250 Million Senior Note Issued to Metropolitan Life Insurance Company [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Senior notes	'	250
Debt Instrument, Maturity Date	'	1-Oct-19
Debt Instrument, Interest Rate, Effective Percentage	'	3.57%
Senior Notes, Affiliated [Member] | $1.25 Billion Senior Note Issued to Affiliates [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Senior notes	'	1,250
Senior Notes, Affiliated [Member] | $1.25 Billion Senior Note Issued to Affiliates [Member] | $250 Million Senior Note Affiliated [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Senior notes	'	250
Debt Instrument, Maturity Date	'	30-Sep-16
Debt Instrument, Interest Rate, Effective Percentage	'	7.44%
Senior Notes, Affiliated [Member] | $1.25 Billion Senior Note Issued to Affiliates [Member] | $500 Million Senior Note Affiliated [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Senior notes	'	500
Debt Instrument, Maturity Date	'	15-Jul-21
Debt Instrument, Interest Rate, Effective Percentage	'	5.64%
Senior Notes, Affiliated [Member] | $1.25 Billion Senior Note Issued to Affiliates [Member] | $500 Million Senior Note Affiliated [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Senior notes	'	500
Debt Instrument, Maturity Date	'	16-Dec-21
Debt Instrument, Interest Rate, Effective Percentage	'	5.86%
Senior Notes, Affiliated [Member] | $750 Million Senior Note issued to MetLife Reinsurance Company of Delaware [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Senior notes	$350	$750
Debt Instrument, Maturity Date	31-Dec-33	30-Sep-32
Debt Instrument, Interest Rate, Effective Percentage	5.10%	4.21%

Condensed_Financial_Informatio9

Condensed Financial Information (Parent Company) (Support Agreements - Narrative) (Details) (USD $)

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Oct. 29, 2013

Feb. 11, 2013

Jan. 09, 2013

Mitsui Sumitomo MetLife Insurance Co Ltd (MSI MetLife) [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Metlife Bank Liquidity Agreement [Member]

Metlife Bank Liquidity Agreement [Member]

Metlife Bank Liquidity Agreement [Member]

Support Agreement Exeter Obligations [Member]

Support Agreement MetLife Reinsurance Company of Vermont [Member]

Support Agreement MetLife Reinsurance Company of Charleston [Member]

Support Agreement MetLife Reinsurance Company of South Carolina [Member]

Support Agreement MetLife Investors Insurance Company and First MetLife Investors Insurance Company [Member]

Support Agreement MetLife Reinsurance Company of Delaware [Member]

Support Agreement - Guarantees of Subsidiary Derivative Obligations [Member]

Support Agreement - Guarantees of Subsidiary Derivative Obligations [Member]

Support Agreement MetLIfe Bank [Member]

Support Agreement MetLIfe Bank [Member]

Support Agreement - Exeter, MICC and MLI-USA [Member]

Parent Company [Member]

Parent Company [Member]

Parent Company [Member]

Condensed Financial Statements, Captions [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Guarantor Obligations, Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'500

'

'

'

Line of Credit Facility, Amount Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0

'

'

Line of Credit Facility, Interest Rate Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'0.0247

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000,000

500,000,000

Guaranteed adjusted capital levels

'

'

'

'

'

'equal to or greater than 200% of authorized control level risk-based capital

'equal to or greater than 200% of the company action level risk-based capital

'equal to or greater than 100% of authorized control level risk-based capital

'equal to or greater than 150% of the company action level risk-based capital

'equal to or greater than 200% of the company action level risk-based capital

'

'

'

'

'

'

'

'

Capital contributions to subsidiaries

'

748,000,000

1,223,000,000

1,439,000,000

'

'

'

'

'

'

'

'

21,000,000

34,000,000

'

'

'

'

Interest in Mitsui Sumitomo MetLife Insurance Co., LTD. (MSI MetLife)

50.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount guaranteed under support agreement

'

'

'

'

1,000,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Minimum capital and surplus

'

'

'

'

'

'

'

250,000

10,000,000

'

'

'

'

'

'

'

'

'

Derivative Assets, Fair Value, Net

'

'

'

'

'

'

'

'

'

'

568,000,000

3,200,000,000

'

'

'

'

'

'

Estimated fair value of collateral provided to counterparties by the subsidiaries

'

'

'

'

'

'

'

'

'

'

651,000,000

12,000,000

'

'

'

'

'

'

Unsecured derivative liability positions guaranteed by MetLife, Inc.

'

'

'

'

'

'

'

'

'

'

734,000,000

22,000,000

'

'

'

'

'

'

Derivative Liability, Fair Value, Amount Offset Against Collateral

'

'

'

'

'

'

'

'

'

'

$83,000,000

$10,000,000

'

'

'

'

'

'

Consolidated_Supplementary_Ins1

Consolidated Supplementary Insurance Information (Balance Sheet Items) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Millions, unless otherwise specified
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
DAC & VOBA	$26,706	$24,761	$24,619
Future Policy Benefits, Other Policy-related Balances and Policyholder Dividend Obligation	204,927	211,642	202,793
Policyholder account balances	212,885	225,821	217,700
Policyholder Dividends Payable	675	728	774
Unearned Premiums	4,403	3,931	3,374
Unearned Revenue	2,865	2,678	2,316
Retail [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
DAC & VOBA	12,882	11,500	11,681
Future Policy Benefits, Other Policy-related Balances and Policyholder Dividend Obligation	73,953	74,887	72,238
Policyholder account balances	62,733	67,023	69,553
Policyholder Dividends Payable	601	610	659
Unearned Premiums	918	873	791
Unearned Revenue	860	911	995
Group, Voluntary and Worksite Benefits [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
DAC & VOBA	382	382	377
Future Policy Benefits, Other Policy-related Balances and Policyholder Dividend Obligation	20,946	21,078	19,626
Policyholder account balances	8,575	8,918	9,273
Policyholder Dividends Payable	0	0	0
Unearned Premiums	886	852	822
Unearned Revenue	0	0	0
Corporate Benefit Funding [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
DAC & VOBA	99	96	89
Future Policy Benefits, Other Policy-related Balances and Policyholder Dividend Obligation	50,548	53,542	49,858
Policyholder account balances	62,043	63,523	56,367
Policyholder Dividends Payable	0	0	0
Unearned Premiums	0	0	0
Unearned Revenue	32	39	49
Corporate & Other [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
DAC & VOBA	26	0	2
Future Policy Benefits, Other Policy-related Balances and Policyholder Dividend Obligation	6,928	6,697	6,699
Policyholder account balances	1,201	2,476	2,374
Policyholder Dividends Payable	0	0	0
Unearned Premiums	9	9	10
Unearned Revenue	0	0	0
Latin America [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
DAC & VOBA	2,201	1,231	1,050
Future Policy Benefits, Other Policy-related Balances and Policyholder Dividend Obligation	8,985	8,856	7,731
Policyholder account balances	7,177	7,199	6,159
Policyholder Dividends Payable	0	0	4
Unearned Premiums	499	428	284
Unearned Revenue	678	627	514
Asia [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
DAC & VOBA	9,077	9,554	9,554
Future Policy Benefits, Other Policy-related Balances and Policyholder Dividend Obligation	35,863	39,061	38,528
Policyholder account balances	57,203	64,003	59,739
Policyholder Dividends Payable	65	65	53
Unearned Premiums	1,895	1,554	1,267
Unearned Revenue	1,035	831	655
Europe, the Middle East and Africa [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
DAC & VOBA	2,039	1,998	1,866
Future Policy Benefits, Other Policy-related Balances and Policyholder Dividend Obligation	7,704	7,521	8,113
Policyholder account balances	13,953	12,679	14,235
Policyholder Dividends Payable	9	53	58
Unearned Premiums	196	215	200
Unearned Revenue	$260	$270	$103

Consolidated_Supplementary_Ins2

Consolidated Supplementary Insurance Information (Income Statement Items) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
Premium Revenue and Policy Charges	$47,125	$46,531	$44,167
Net investment income	22,232	21,984	19,585
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	46,286	45,716	41,074
Amortization of DAC and VOBA Charged to Other Expenses	3,550	4,199	4,898
Other Operating Expenses	14,311	14,925	15,085
Retail [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
Premium Revenue and Policy Charges	11,783	11,411	11,077
Net investment income	7,427	7,275	7,156
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	11,460	11,247	10,447
Amortization of DAC and VOBA Charged to Other Expenses	850	1,603	2,365
Other Operating Expenses	5,006	4,941	4,902
Group, Voluntary and Worksite Benefits [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
Premium Revenue and Policy Charges	15,938	15,456	14,579
Net investment income	1,684	1,628	1,631
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	14,381	13,858	13,193
Amortization of DAC and VOBA Charged to Other Expenses	140	133	186
Other Operating Expenses	2,241	2,215	2,022
Corporate Benefit Funding [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
Premium Revenue and Policy Charges	3,106	3,462	3,080
Net investment income	5,805	5,765	5,639
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	6,604	7,105	6,664
Amortization of DAC and VOBA Charged to Other Expenses	23	22	17
Other Operating Expenses	505	457	497
Latin America [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
Premium Revenue and Policy Charges	3,820	3,438	3,371
Net investment income	1,326	1,354	1,105
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	2,793	3,014	2,899
Amortization of DAC and VOBA Charged to Other Expenses	310	228	211
Other Operating Expenses	1,182	1,047	1,056
Corporate & Other [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
Premium Revenue and Policy Charges	255	211	209
Net investment income	491	1,193	1,565
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	105	158	126
Amortization of DAC and VOBA Charged to Other Expenses	1	2	1
Other Operating Expenses	2,517	3,272	3,627
Asia [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
Premium Revenue and Policy Charges	9,525	9,835	9,059
Net investment income	4,335	3,421	1,954
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	9,200	8,246	6,360
Amortization of DAC and VOBA Charged to Other Expenses	1,527	1,567	1,505
Other Operating Expenses	1,825	1,933	1,862
Europe, the Middle East and Africa [Member]	'	'	'
Supplementary Insurance Information, by Segment [Line Items]	'	'	'
Premium Revenue and Policy Charges	2,698	2,718	2,792
Net investment income	1,164	1,348	535
Policyholder Benefits and Claims and Interest Credited to Policyholder Account Balances	1,743	2,088	1,385
Amortization of DAC and VOBA Charged to Other Expenses	699	644	613
Other Operating Expenses	$1,035	$1,060	$1,119

Consolidated_Reinsurance_Conso

Consolidated Reinsurance (Consolidated Reinsurance) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]	'	'	'
Direct Premiums, Life Insurance in Force	$4,517,797	$4,432,178	$4,263,421
Ceded Premiums, Life Insurance in Force	763,754	761,993	754,781
Assumed Premiums, Life Insurance in Force	607,591	594,062	604,555
Premiums, Net, Life Insurance in Force	4,361,634	4,264,247	4,113,195
Life Insurance in Force Premiums, Percentage Assumed to Net	13.90%	13.90%	14.70%
Consolidated Reinsurance	'	'	'
Gross Amount	38,476	38,719	37,185
Ceded	2,274	2,232	2,308
Assumed	1,472	1,488	1,484
Net premiums	37,674	37,975	36,361
% Amount Assumed to Net	3.90%	3.90%	4.10%
Life Insurance [Member]	'	'	'
Consolidated Reinsurance	'	'	'
Gross Amount	22,206	22,006	21,930
Ceded	1,862	1,550	1,670
Assumed	1,269	1,268	1,198
Net premiums	21,613	21,724	21,458
% Amount Assumed to Net	5.90%	5.80%	5.60%
Accident and Health Insurance [Member]	'	'	'
Consolidated Reinsurance	'	'	'
Gross Amount	12,957	13,567	12,186
Ceded	333	605	568
Assumed	196	211	275
Net premiums	12,820	13,173	11,893
% Amount Assumed to Net	1.50%	1.60%	2.30%
Property and Casualty Insurance [Member]	'	'	'
Consolidated Reinsurance	'	'	'
Gross Amount	3,313	3,146	3,069
Ceded	79	77	70
Assumed	7	9	11
Net premiums	$3,241	$3,078	$3,010
% Amount Assumed to Net	0.20%	0.30%	0.40%